Part II

[Federal Register: August 22, 2006 (Volume 71, Number 162)]

[Proposed Rules]

[Page 48981-49252]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr22au06-20]

[[Page 48981]]

Part II

Department of Health and Human Services

Centers for Medicare & Medicaid Services

42 CFR Parts 405, 410, et al.

Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2007 and Other Changes to Payment Under Part B; Proposed Rule

[[Page 48982]]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

42 CFR Parts 405, 410, 411, 414, 415, and 424

[CMS-1321-P]

RIN 0938-AO24

Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2007 and Other Changes to Payment Under Part B

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Proposed rule.

SUMMARY: This proposed rule would address certain provisions of the Deficit Reduction Act of 2005, as well as make other proposed changes to Medicare Part B payment policy.

We are proposing these changes to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. This proposed rule also discusses geographic practice cost indices (GPCI) changes; requests for additions to the list of telehealth services; payment for covered outpatient drugs and biologicals; payment for renal dialysis services; policies related to private contracts and opt-out; policies related to bone mass measurement services, independent diagnostic testing facilities, the physician self-referral prohibition; laboratory billing for the technical component (TC) of physician pathology services; the clinical laboratory fee schedule; certification of advanced practice nurses; health information technology, and the health care information transparency initiative.

DATES: Comment Date: Comments will be considered if we receive them at one of the addresses provided below, no later than 5 p.m. on October 10, 2006.

ADDRESSES: In commenting, please refer to file code CMS-1321-P. Because of staff and resource limitations, we cannot accept comments by facsimile (fax) transmission.

You may submit comments in one of three ways (no duplicates, please):

1. Electronically. You may submit electronic comments on specific issues in this regulation to http://www.cms.hhs.gov/eRulemaking. Click

on the link ``Submit electronic comments on CMS regulations with an open comment period.'' (Attachments should be in Microsoft Word, WordPerfect, or Excel; however, we prefer Microsoft Word.)

2. By mail. You may mail written comments (one original and two copies) to the following address only: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-1321- P, P.O. Box 8015, Baltimore, MD 21244-8015.

Please allow sufficient time for mailed comments to be received before the close of the comment period.

3. By express or overnight mail. You may send written comments (one original and two copies) to the following address only: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-1321-P, Mail Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.

4. By hand or courier. If you prefer, you may deliver (by hand or courier) your written comments (one original and two copies) before the close of the comment period to one of the following addresses. If you intend to deliver your comments to the Baltimore address, please call telephone number (410) 786-7197 in advance to schedule your arrival with one of our staff members.

Room 445-G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; or 7500 Security Boulevard, Baltimore, MD 21244-1850.

(Because access to the interior of the HHH Building is not readily available to persons without Federal Government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available for persons wishing to retain a proof of filing by stamping in and retaining an extra copy of the comments being filed.)

Comments mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and received after the comment period.

Submission of comments on paperwork requirements. You may submit comments on this document's paperwork requirements by mailing your comments to the addresses provided at the end of the ``Collection of Information Requirements'' section in this document.

For information on viewing public comments, see the beginning of the SUPPLEMENTARY INFORMATION section.

FOR FURTHER INFORMATION CONTACT: Pam West, (410) 786-2302 (for issues related to practice expense).

Stephanie Monroe, (410) 786-6864 (for issues related to the geographic practice cost index).

Craig Dobyski, (410) 786-4584 (for issues related to list of telehealth services).

Roberta Epps, (410) 786-4503 (for issues related to diagnostic imaging services).

Bill Larson, (410) 786-4639 (for issues related to coverage of bone mass measurement and addition of ultrasound screening for abdominal aortic aneurysm to the ``Welcome to Medicare'' benefit).

Dorothy Shannon, (410) 786-3396 (for issues related to the outpatient therapy cap).

Catherine Jansto, (410) 786-7762 (for issues related to payment for covered outpatient drugs and biologicals).

Henry Richter, (410) 786-4562 (for issues related to payments for end-stage renal disease facilities).

Fred Grabau, (410) 786-0206 (for issues related to private contracts and opt-out provision).

Lisa Ohrin, (410) 786-4565 (for issues related to physician self- referral prohibitions).

David Walczak (410) 786-4475 (for issues related to reassignment provisions).

August Nemec (410) 786-0612 (for issues related to independent diagnostic testing facilities).

Anita Greenberg, (410) 786-4601 (for issues related to the clinical laboratory fee schedule).

James Menas (410) 786-4507 (for issues related to payment for physician pathology services).

Diane Milstead, (410) 786-3355 or Gaysha Brooks (410) 786-9649 (for all other issues).

SUPPLEMENTARY INFORMATION:

Submitting Comments: We welcome comments from the public on all issues set forth in this rule to assist us in fully considering issues and developing policies. You can assist us by referencing the file code CMS-1321-P and the specific ``issue identifier'' that precedes the section on which you choose to comment.

Inspection of Public Comments: All comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. We post all comments received before the close of the comment period on the following Web site as soon as possible after they have been received: http://www.cms.hhs.gov/eRulemaking. Click on the link ``Electronic Comments on

CMS Regulations'' on that Web site to view public comments.

Comments received timely will also be available for public inspection as

[[Page 48983]]

they are received, generally beginning approximately 3 weeks after publication of a document, at the headquarters of the Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 4 p.m. To schedule an appointment to view public comments, phone 1-800- 743-3951.

Information on the physician fee schedule can be found on the CMS homepage. You can access this data by using the following directions:

1. Go to the following Web site: http://www.cms.hhs.gov/PhysicianFeeSched/ .

2. Select ``PFS Federal Regulation Notices.''

To assist readers in referencing sections contained in this preamble, we are providing the following table of contents. Some of the issues discussed in this preamble affect the payment policies, but do not require changes to the regulations in the Code of Federal Regulations. Information on the regulation's impact appears throughout the preamble and is not exclusively in section VI.

Table of Contents

I. Background

A. Development of the Relative Value System

1. Work RVUs

2. Practice Expense Relative Value Units (PE RVUs)

3. Resource-Based Malpractice RVUs

4. Refinements to the RVUs

5. Adjustments to RVUs Are Budget Neutral

B. Components of the Fee Schedule Payment Amounts

C. Most Recent Changes to the Fee Schedule II. Provisions of the Proposed Rule

A. Resource-Based PE RVUs and Practice Expense Proposals for Calendar Year 2007

B. Geographic Practice Cost Indices

C. Medicare Telehealth Services

D. Miscellaneous Coding Issues

1. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures

2. Assignment of RVUS to CPT Codes for Proton Beam Treatment Delivery Services

E. Deficit Reduction Act (DRA) Related Proposals

1. Section 5102 of the DRA--Proposed Adjustments for Payments to Imaging Services

2. Section 5107 of the DRA--Revisions to Payments for Therapy Services

3. Section 5112 of the DRA--Proposed Addition of Ultrasound Screening for Abdominal Aortic Aneurysm (AAA)

4. Section 5113 of the DRA--Proposed Non-Application of the Part B Deductible for Colorectal Cancer Screening Tests

5. Section 5114--Proposed Addition of Diabetes Outpatient Self- Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program

F. Proposed Payment for Covered Outpatient Drugs and Biologicals (ASP Issues)

G. Proposed Provisions Related to Payment for Renal Dialysis Services Furnished by End Stage Renal Disease (ESRD) Facilities

H. Private Contracts and Opt-Out Provision--Practitioner Definition

I. Proposed Changes to Reassignment and Physician Self-Referral Rules Relating to Diagnostic Tests

J. Supplier Access to Claims Billed on Reassignment

K. Coverage of Bone Mass Measurement Tests

L. Independent Diagnostic Testing Facility (IDTF) Issues

1. Proposed IDTF Changes in the Physician Fee Schedule Proposed Rule

2. Proposed Performance Standards for IDTFs

3. Supervision

4. Place of Service

M. Independent Laboratory Billing for the Technical Component (TC) of Physician Pathology Services to Hospital Patients

N. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests

O. Proposal To Establish Criteria for National Certifying Bodies That Certify Advanced Practice Nurses

P. Chiropractic Services Demonstration

Q. Promoting Effective Use of Health Information Technology

R. Health Care Information Transparency Initiative III. Collection of Information Requirements IV. Response to Comments V. Regulatory Impact Analysis Regulation Text Addendum A--Explanation and Use of Addendum B Addendum B--2007 Relative Value Units and Related Information Used in Determining Medicare Payments for 2007 Addendum C--Codes for Which We Received Practice Expense Review Committee (PERC) Recommendations on Practice Expense Direct Cost Inputs Addendum D--2007 Geographic Practice Cost Indices (GPCIs) by Medicare Carrier and Locality Addendum E--2007 Geographic Adjustment Factors (GAF) Addendum F--Proposed CPT/HCPCS Imaging Codes Defined by Section 5102(b) of the DRA

In addition, because of the many organizations and terms to which we refer by acronym in this proposed final rule, we are listing these acronyms and their corresponding terms in alphabetical order below:

AADA American Academy of Dermatology Association AAH American Association of Homecare AAP Average acquisition price ACC American College of Cardiology ACG American College of Gastroenterology ACHPN Advanced Certified Hospice and Palliative Nurse ACOG American College of Obstetrics and Gynecology ACR American College of Radiology ADA American Dietetic Association AFROC Association of Freestanding Radiation Oncology Centers AGA American Gastroenterological Association AHRQ Agency for Healthcare Research and Quality AMA American Medical Association AMP Average manufacturer price ASA American Society of Anesthesiologists ASGE American Society of Gastrointestinal Endoscopy ASP Average sales price ASTRO American Society for Therapeutic Radiation Oncology ATA American Telemedicine Association AUA American Urological Association AWP Average wholesale price BBA Balanced Budget Act of 1997 BBRA Balanced Budget Refinement Act of 1999 BES (Bureau of the Census) Business Expenditure Survey BIPA Medicare, Medicaid, and SCHIP Benefits Improvement Protection Act of 2000 BLS Bureau of Labor Statistics BMD Bone mineral density BMI Body mass index BMM Bone mass measurement BNF Budget neutrality factor BP Best price BSA Body surface area CAH Critical access hospital CAP College of American Pathologists CBSA Core-Based Statistical Area CCI Correct Coding Initiative CF Conversion factor CFR Code of Federal Regulations CMA California Medical Association CMS Centers for Medicare & Medicaid Services CNS Clinical nurse specialist CPEP Clinical Practice Expert Panel CPI Consumer Price Index CPO Care Plan Oversight CPT (Physicians') Current Procedural Terminology (4th Edition, 2002, copyrighted by the American Medical Association) CRNA Certified Registered Nurse Anesthetist CT Computed tomography CTA Computed tomographic angiography CY Calendar year DHS Designated health services DME Durable medical equipment DMERC Durable Medical Equipment Regional Carrier DRA Deficit Reduction Act DSMT Diabetes outpatient self-management training services DXA Dual energy x-ray absorptiometry E&M Evaluation and management EPO Erythopoeitin ESRD End stage renal disease FAX Facsimile FI Fiscal intermediary FR Federal Register GAF Geographic adjustment factor GAO General Accounting Office GDP Gross domestic product GPO Group purchasing organization

[[Page 48984]]

GPCI Geographic practice cost index HCPAC Health Care Professional Advisory Committee HCPCS Healthcare Common Procedure Coding System HCRIS Healthcare Cost Report Information System HSA Health Savings Account HHA Home health agency HHS (Department of) Health and Human Services HIT Health information technology HOCM High osmolar contrast media HPSA Health Professional Shortage Area HRSA Health Resources Services Administration (HHS) HUD (Department of) Housing and Urban Development IDTF Independent diagnostic testing facility IPF Inpatient psychiatric facility IPPS Inpatient prospective payment system IRF Inpatient rehabilitation facility ISO Insurance Services Office IVIG Intravenous immune globulin JCAAI Joint Council of Allergy, Asthma, and Immunology JUA Joint underwriting association LCD Local coverage determination LTCH Long-term care hospital LOCM Low osmolar contrast media LOINC[supreg] Logical Observation Identifiers Names and Codes MA Medicare Advantage MCAC Medicare Coverage Advisory Committee MCG Medical College of Georgia MedPAC Medicare Payment Advisory Commission MEI Medicare Economic Index MMA Medicare Prescription Drug, Improvement, and Modernization Act of 2003 MNT Medical nutrition therapy MRA Magnetic resonance angiography MRI Magnetic resonance imaging MSA Metropolitan statistical area NCD National coverage determination NCQDIS National Coalition of Quality Diagnostic Imaging Services NDC National drug code NECMA New England County Metropolitan Area NECTA New England City and Town Area NP Nurse practitioner NPP Nonphysician practitioners NPWP Nonphysician Work Pool OBRA Omnibus Budget Reconciliation Act OIG Office of Inspector General OMB Office of Management and Budget OPD Outpatient Department OPPS Outpatient prospective payment system OSCAR Online Survey and Certification and Reporting PA Physician assistant PBM Pharmacy benefit managers PC Professional component PE Practice Expense PEAC Practice Expense Advisory Committee PERC Practice Expense Review Committee PET Positron emission tomography PFS Physician Fee Schedule PLI Professional liability insurance PPI Producer price index PPO Preferred provider organization PPS Prospective payment system PRA Paperwork Reduction Act PT Physical therapy QCT Quantitative computerized tomography RFA Regulatory Flexibility Act RIA Regulatory impact analysis RN Registered nurse RUC (AMA's Specialty Society) Relative (Value) Update Committee RVU Relative value unit SXA Single energy x-ray absorptiometry SPA Single photon absorptiometry SGR Sustainable growth rate SMS (AMA's) Socioeconomic Monitoring System SNF Skilled Nursing Facility SNM Society for Nuclear Medicine TA Technology Assessment TC Technical Component UAF Update adjustment factor UPIN Unique Physician Identification Number WAC Wholesale acquisition cost WAMP Widely available market price

I. Background

[If you choose to comment on issues in this section, please include the caption ``BACKGROUND'' at the beginning of your comments.]

Since January 1, 1992, Medicare has paid for physicians' services under section 1848 of the Social Security Act (the Act), ``Payment for Physicians' Services.'' The Act requires that payments under the physician fee schedule (PFS) be based on national uniform relative value units (RVUs) based on the resources used in furnishing a service. Section 1848(c) of the Act requires that national RVUs be established for physician work, practice expense (PE), and malpractice expense. Before the establishment of the resource-based relative value system, Medicare payment for physicians' services was based on reasonable charges.

A. Development of the Relative Value System

1. Work RVUs

The concepts and methodology underlying the PFS were enacted as part of the Omnibus Budget Reconciliation Act (OBRA) of 1989, Pub. L. 101-239, and OBRA 1990, (Pub. L. 101-508). The final rule, published November 25, 1991 (56 FR 59502), set forth the fee schedule for payment for physicians' services beginning January 1, 1992. Initially, only the physician work RVUs were resource-based, and the PE and malpractice RVUs were based on average allowable charges.

The physician work RVUs established for the implementation of the fee schedule in January 1992 were developed with extensive input from the physician community. A research team at the Harvard School of Public Health developed the original physician work RVUs for most codes in a cooperative agreement with the Department of Health and Human Services (HHS). In constructing the code-specific vignettes for the original physician work RVUs, Harvard worked with panels of experts, both inside and outside the Federal government, and obtained input from numerous physician specialty groups.

Section 1848(b)(2)(A) of the Act specifies that the RVUs for radiology services are based on relative value scale we adopted under section 1834(b)(1)(A) of the Act, (the American College of Radiology (ACR) relative value scale), which we integrated into the overall PFS. Section 1848(b)(2)(B) of the Act specifies that the RVUs for anesthesia services are based on RVUs from a uniform relative value guide. We established a separate conversion factor (CF) for anesthesia services, and we continue to utilize time units as a factor in determining payment for these services. As a result, there is a separate payment methodology for anesthesia services.

We establish physician work RVUs for new and revised codes based on recommendations received from the American Medical Association's (AMA) Specialty Society Relative Value Update Committee (RUC). 2. Practice Expense Relative Value Units (PE RVUs)

Section 121 of the Social Security Act Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, amended section 1848(c)(2)(C)(ii) of the Act and required us to develop resource-based PE RVUs for each physician's service beginning in 1998. We were to consider general categories of expenses (such as office rent and wages of personnel, but excluding malpractice expenses) comprising practice expenses.

Section 4505(a) of the Balanced Budget Act of 1997 (BBA) (Pub. L. 105-33), amended section 1848(c)(2)(C)(ii) of the Act to delay implementation of the resource-based PE RVU system until January 1, 1999. In addition, section 4505(b) of the BBA provided for a 4-year transition period from charge-based PE RVUs to resource-based RVUs.

We established the resource-based PE RVUs for each physician's service in a final rule, published November 2, 1998 (63 FR 58814), effective for services furnished in 1999. Based on the requirement to transition to a resource-based system for PE over a 4-year period, resource-based PE RVUs did not become fully effective until 2002.

[[Page 48985]]

This resource-based system was based on two significant sources of actual PE data: The Clinical Practice Expert Panel (CPEP) data and the AMA's Socioeconomic Monitoring System (SMS) data. The CPEP data were collected from panels of physicians, practice administrators, and nonphysicians (for example, registered nurses) nominated by physician specialty societies and other groups. The CPEP panels identified the direct inputs required for each physician's service in both the office setting and out-of-office setting. The AMA's SMS data provided aggregate specialty-specific information on hours worked and practice expenses.

Separate PE RVUs are established for procedures that can be performed in both a nonfacility setting, such as a physician's office, and a facility setting, such as a hospital outpatient department. The difference between the facility and nonfacility RVUs reflects the fact that a facility receives separate payment from Medicare for its costs of providing the service, apart from payment under the PFS. The nonfacility RVUs reflect all of the direct and indirect practice expenses of providing a particular service.

Section 212 of the Balanced Budget Refinement Act of 1999 (BBRA) (Pub. L. 106-113) directed the Secretary of Health and Human Services (the Secretary) to establish a process under which we accept and use, to the maximum extent practicable and consistent with sound data practices, data collected or developed by entities and organizations to supplement the data we normally collect in determining the PE component. On May 3, 2000, we published the interim final rule (65 FR 25664) that set forth the criteria for the submission of these supplemental PE survey data. The criteria were modified in response to comments received, and published in the Federal Register (65 FR 65376) as part of a November 1, 2000 final rule. The PFS final rules published in 2001 and 2003, respectively, (66 FR 55246 and 68 FR 63196) extended the period during which we would accept these supplemental data. 3. Resource-Based Malpractice RVUs

Section 4505(f) of the BBA amended section 1848(c) of the Act to require us to implement resource-based malpractice RVUs for services furnished on or after 2000. The resource-based malpractice RVUs were implemented in the PFS final rule published November 2, 1999 (64 FR 59380). The malpractice RVUs were based on malpractice insurance premium data collected from commercial and physician-owned insurers from all the States, the District of Columbia, and Puerto Rico. 4. Refinements to the RVUs

Section 1848(c)(2)(B)(i) of the Act requires that we review all RVUs no less often than every 5 years. The first 5-year review of the physician work RVUs went into effect in 1997, published on November 22, 1996 (61 FR 59489). The second 5-year review went into effect in 2002, published on November 1, 2001 (66 FR 55246). The next scheduled 5-year review is scheduled to go into effect in 2007.

In 1999, the AMA's RUC established the Practice Expense Advisory Committee (PEAC) for the purpose of refining the direct PE inputs. Through March of 2004, the PEAC provided recommendations to CMS for over 7,600 codes (all but a few hundred of the codes currently listed in the AMA's Current Procedural Terminology (CPT) codes).

In the November 15, 2004, PFS final rule (69 FR 66236), we implemented the first 5-year review of the malpractice RVUs (69 FR 66263). 5. Adjustments to RVUS Are Budget Neutral

Section 1848(c)(2)(B)(ii)(II) of the Act provides that adjustments in RVUs for a year may not cause total PFS payments to differ by more than $20 million from what they would have been if the adjustments were not made. In accordance with section 1848(c)(2)(B)(ii)(II) of the Act, if adjustments to RVUs cause expenditures to change by more than $20 million, we make adjustments to ensure that expenditures do not increase or decrease by more than $20 million.

B. Components of the Fee Schedule Payment Amounts

To calculate the payment for every physician service, the components of the fee schedule (physician work, PE, and malpractice RVUs) are adjusted by a geographic practice cost index (GPCI). The GPCIs reflect the relative costs of physician work, PEs, and malpractice insurance in an area compared to the national average costs for each component.

Payments are converted to dollar amounts through the application of a CF, which is calculated by the Office of the Actuary and is updated annually for inflation.

The general formula for calculating the Medicare fee schedule amount for a given service and fee schedule area can be expressed as:

Payment = [(RVU work x GPCI work) + (RVU PE x GPCI PE) + (RVU malpractice x GPCI malpractice)] x CF.

(Note: As discussed in the June 29, 2006 proposed notice for the Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule and Proposed Changes to the Practice Expense Methodology (71 FR 37170), we have proposed to establish a separate budget neutrality adjustor that would be applied in the calculation of the work RVUs. Application of this budget neutrality adjustor would enable us to meet the budget neutrality provisions of section 1848(c)(2)(B)(ii) of the Act.)

C. Most Recent Changes to the Fee Schedule

The final rule with comment period that appeared in the Federal Register on November 21, 2005 (70 FR 70116) addressed Medicare Part B payment policy, including the physician fee schedule, that is applicable for calendar year (CY) 2006; and finalized certain provisions of the interim final rule to implement the Competitive Acquisition Program (CAP) for Part B Drugs.

It also revised Medicare Part B payment and related policies regarding: Physician work, practice expense and malpractice RVUs; Medicare telehealth services; multiple diagnostic imaging procedures; covered outpatient drugs and biologicals; supplemental payments to Federally Qualified Health Centers (FQHCs); renal dialysis services; coverage for glaucoma screening services; National Coverage Determination (NCD) timeframes; and physician referrals for nuclear medicine services and supplies to health care entities with which physicians have financial relationships.

In addition, the rule finalized the interim RVUs for CY 2005 and issued interim RVUs for new and revised procedure codes for CY 2006. The rule also updated the codes subject to the physician self-referral prohibition and discussed payment policies relating to teaching anesthesia services, therapy caps, private contracts and opt-out, and chiropractic and oncology demonstrations.

In accordance with section 1848(d)(1)(E)(i) of the Act, we also announced that the PFS update for CY 2006 would be -4.4 percent; the initial estimate for the sustainable growth rate for CY 2006 would be 1.7; and the CF for CY 2006 would be $36.1770. However, subsequent to publication of the CY 2005 PFS final rule with comment period, section 5104 of the Deficit Reduction Act (DRA) of 2005 (Pub. L. 109-171, February 8, 2006), was enacted which amended section 1848(d)

[[Page 48986]]

of the statute to provide for a 0 percent update effective January 1, 2006.

We also note that the Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule and Proposed Changes to the Practice Expense Methodology proposed notice appeared in the Federal Register on June 29, 2006 (71 FR 37170). In that notice, we proposed revisions to work RVUs affecting payment for physicians' services. The revisions reflect changes in medical practice, coding changes, and new data on relative value components that affect the relative amount of physician work required to perform each service, as required by the statute. We also proposed revisions to our methodology for calculating PE RVUs, including changes based on supplemental survey data for PE. This revised methodology would be used to establish payment for services beginning January 1, 2007.

As indicated in the June 29, 2006 proposed notice, we will respond to the comments received on that notice as part of the final Medicare PFS rule for CY 2007 scheduled for publication this fall. If adopted, the RVU revisions would be fully implemented for services furnished to Medicare beneficiaries on or after January 1, 2007. The PE revisions would be phased-in over a four-year period; although, as we gain experience with the new methodology, we will reexamine this policy beginning next year and propose necessary revisions through future rulemaking.

II. Provisions of the Proposed Rule

[If you choose to comment on issues in this section, please include the caption ``PROVISIONS'' at the beginning of your comments.]

A. Resource-Based Practice Expense (PE) RVU Proposals for CY 2007

Major changes to the PE methodology for 2007, as well as a detailed discussion of the current PE methodology, are discussed in the June 29, 2006 proposed notice (71 FR 37170 through 37430).

This proposed rule contains proposals for direct PE including clinical labor, medical supplies and medical equipment. 1. RUC Recommendations for Direct PE Inputs and Other PE Input Issues

The following discussions are proposals concerning direct PE inputs. (a) RUC Recommendations

The AMA's Relative Value Update Committee (RUC) established a new committee, the Practice Expense Review Committee (PERC), to assist the RUC in recommending direct PE inputs (clinical staff, supplies, and equipment) for new and existing CPT codes.

The PERC reviewed the PE inputs for over 2000 existing codes, some of which were unresolved PE issues from the CY 2006 PFS final rule with comment period, at their meetings held in September 2005, February 2006 and April 2006. (A list of these reviewed codes can be found in Addendum C of this proposed rule.)

We have reviewed the PERC-submitted recommendations and propose to adopt all of them. We have worked with the AMA staff to make corrections for any typographical errors and to ensure that previously PEAC-accepted standards are incorporated in the recommendations.

The complete PERC recommendations and the revised PE database can be found on our Web site. (See the SUPPLEMENTARY INFORMATION section of this proposed rule for directions on accessing our Web site.) (b) Standard Supplies and Equipment for 90-Day Global Codes

We are proposing to revise the CPEP supply and equipment inputs for those 90-day global procedures for which the RUC has only refined the clinical labor inputs. We are proposing to apply the standard supply and equipment inputs for the facility setting for 90-day global services to these remaining unrefined 90-day global procedure codes. As recommended by the RUC, for supplies, we propose to include one minimum supply visit package for each post-operative visit assigned to each code and a post-surgical incision care kit (suture, staples, or both) where appropriate, along with additional items recommended by the RUC for certain procedures. For equipment, we are proposing to include an exam table and light. However, there are several issues on which we need input before we finalize the recommended standards. For example, for many of the 90-day codes in question, the current supply input data contain supplies in far larger quantities than are contained in either the visit package or incision care kit. For other codes, the current data includes items that are not contained in the package or kit. In other cases, the recommendations from the RUC contain additional items in quantities that appear excessive. We plan to work with all the concerned specialties to ensure that the finalized inputs do represent the typical supplies needed to perform each procedure.

Because the application of the 90-day global standard supplies and equipment would result in the deletion of some original CPEP inputs, we are requesting that all the medical specialties examine the direct PE inputs on our Web site and let us know whether there are additional items from the original CPEP data that are a necessary part of the post-operative care and if the PE inputs listed are correct. (See the SUPPLEMENTARY INFORMATION section of this proposed rule for directions on accessing our Web site.) 2. Payment for Splint and Cast Supplies

In the PFS final rules published November 1999 (64 FR 59380) and November 2000 (65 FR 65376), we removed splint and cast supplies from the PE database for the CPT codes for fracture management and cast/ strapping application procedures. Because splint and cast supplies could be separately billed using Healthcare Common Procedure Coding System (HCPCS) codes (Q4001-Q4051) that were established for payment of these supplies under section 1861(s)(5) of the Act, we did not want to make duplicate payment under the PFS for these items.

In the CY 2006 PFS proposed rule (70 FR 70116), we proposed to reinstate payment for all splints and cast supplies through the PE component of the PFS because we believed we may have unintentionally prohibited remuneration for these supplies when they are not used for reduction of a fracture or dislocation (covered under section 1861(s)(5) of the Act), but rather are provided (and covered) as ``incident to'' a physician service under section 1861(s)(2)(A) of the Act. This proposal was not finalized; however, in our final rule we asked the medical specialties and the PERC to determine the typical supplies for splints and casts necessary for each of the fracture management codes and the cast/strapping application codes because we wanted to make certain that the supply inputs were correct before we proceeded with rulemaking for the CY 2007 PFS. At its February 2006 meeting, the PERC reviewed and approved the supply inputs submitted by the AAOS for each CPT code for fracture management and cast/strapping application and these were forwarded to us as PERC recommendations. During this interim period we also reassessed the options for payment of materials for splints and casts.

We believe that the majority of the splint and cast supplies that are currently paid through the Q-codes are furnished in relationship to cast/strapping procedures for the management of fractures and dislocations. However, we did not intend for the medically necessary

[[Page 48987]]

splint and cast supplies used for other reasons (for example, serial casting, wound care, or protection) not to be paid. Because it may be difficult for the contractors to identify the purpose for the cast/ strapping application procedure on a claim form, we believe that contractors may have been paying for the splint and cast supply Q-codes when the service is performed for other purposes than treatment of fractures and dislocations.

Since these splint and cast supplies can be covered under both sections 1861(s)(5) and 1861(s)(2)(A) of the Act, we are proposing to include payment for both statutory benefits using the separate HCPCS Q- codes. This would allow for payment for these medically necessary supplies whether based on sections 1861(s)(5) or 1861(s)(2)(A) of the Act, while ensuring that no duplicate payments are made. Physicians would continue to bill the HCPCS Q-codes, in addition to the cast/ strapping application procedure codes, to be paid for these materials.

The following supplies would continue to be paid separately using the HCPCS Q-codes and would not be included in the PE database upon adoption of this proposal:

Fiberglass roll.

Cast padding.

Cast shoe.

Stockingnet/stockinette.

Plaster bandage.

Denver splint.

Dome paste bandage.

Cast sole.

Elastoplast roll.

Fiberglass splint.

Ace wrap.

Kerlix.

Webril.

Malleable arch bars and elastics.

The splint and cast supplies would not be included in the PEs for the following CPT codes:

24500 through 24685

25500 through 25695

26600 through 26785

27500 through 27566

27750 through 27848

28400 through 28675

29000 through 29750.

We are requesting input, specifically from medical specialties and contractors on this proposal. 3. Medical Nutrition Therapy Services

In 2000, the Health Care Professional Advisory Committee (HCPAC) recommended that we assign work RVUs to three new medical nutrition therapy (MNT) CPT codes--97802 Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes at 0.45 RVUs, 97803 Medical nutrition therapy; re- assessment and intervention, individual, face-to-face with the patient, each 15 minutes at 0.37 RVUs, and 97804 Medical nutrition therapy; group (two or more individuals), each 30 minutes at 0.25 RVUs. However, during rulemaking for the CY 2001 PFS final rule, we indicated that MNT was not covered because there was yet no statutory benefit category that would allow medical nutritionists to bill these services. We also did not accept the HCPAC recommendations for work RVUs for these MNT services because the codes were designed for use only by nonphysicians. The following year, section 105(c) of the Medicare, Medicaid, and SCHIP Benefits Improvement Protection Act of 2000 (BIPA) provided for the coverage of MNT services when furnished by registered dietitians or nutritional professionals at 85 percent of the amount that a physician would be paid for the same services. As a result, we established values for these MNT services for the 2002 PFS. In keeping with our earlier decision, we did not assign the HCPAC-recommended work values. However, the associated work value for each code was utilized in the conversion of work to clinical labor time for MNTs as part of the PE component. At that time we received several comments, including one from the American Dietetic Association (ADA), urging us to adopt the work values recommended by the HCPAC.

More recently, the ADA has requested us to reconsider our decision not to accept the HCPAC recommended work RVUs. The ADA contends that the payment rate established by section 105(c) of BIPA, 85 percent of the PFS amount that would be paid for the same service if furnished by a physician, is based on the premise that work values are inherent to these MNT services. The ADA believes that without work RVUs, the payment for these services does not reflect 85 percent of what a physician would be paid for performing the same service. Because these MNT codes were created specifically for MNT professionals, the ADA compared the work associated with their services to physician E/M services of CPT 99203 and 99213, which have respective work RVUs of 1.34 and 0.67.

After reviewing the issues and relevant arguments raised by the ADA, we are persuaded that it would be appropriate to include work RVUs for the MNT services. Consequently, we are proposing to establish work RVUs for each code at the level previously recommended by the HCPAC, as follows:

CPT 97802 = 0.45 RVUs.

CPT 97803 = 0.37 RVUs.

CPT 97804 = 0.25.

Because we propose to add the work RVUs to these services, the MNT clinical labor time in the direct input database would be removed with the adoption of this proposal. Additionally, two HCPCS codes, G0270 MNT subs tx for change dx and G0271 Group MNT 2 or more 30 mins were created to track MNT services following the second referral in the same year. These HCPCS codes correspond to CPT codes 97803 and 97804, respectively. Therefore, we would also propose to add the same work RVUs to these HCPCS codes and to delete the clinical labor inputs from the PE database upon adoption of this policy. We encourage specialty societies and other professional groups to comment on this proposal. 4. Surgical Pathology Codes

We heard from the College of American Pathologists (CAP) regarding the equipment times assigned to CPT codes 88304 and 88305 in the basic surgical pathology family of codes. While all six codes in this family have been refined by the PEAC, this refinement occurred at 4 separate PEAC meetings. CPT codes 88304 and 88305 were refined at the first PEAC meeting in April 1999 before time standards were established for the equipment at subsequent PEAC meetings when the other four CPT codes 88300, 88302, 88307, and 88309 were reviewed. Using our proposed bottom-up PE methodology to value these codes, the lack of the equipment time standards for CPT codes 88304 and 88305 create a rank- order anomaly in this family. Consequently, CAP, after reviewing and applying current standards for the equipment times, submitted suggested revised equipment times to us. We are proposing to accept these times and the proposed times will be reflected in the PE database on our Web site (See the SUPPLEMENTARY INFORMATION section of this proposed notice for directions on accessing our Web site.) 5. Other PE Issues

In the CY 2006 PFS final rule with comment period (70 FR 70116), we explained that we were not implementing the PERC or other proposed PE changes for CY 2006 due to issues with the PE methodology. In this proposed rule, we are proposing that the PERC and other PE changes originally proposed for CY 2006 would be implemented and effective with the CY 2007 PFS. The following

[[Page 48988]]

subsections, (a) through (j), summarize the PE proposals from the CY 2006 PFS final rule with comment period that we are including in this proposed rule. Additionally, we are including several other items which concern inputs for PE that are discussed below in subsections (k) through (n). (a) PE Recommendations on CPEP Inputs for CY 2006

We are proposing to use a clinical labor time of 167 minutes for the service period for CPT code 36522, Extracorporeal Photopheresis; maintain the nonfacility setting PE RVUs for CPT code 78350, single photon bone densitometry; and remove the PE inputs for the nonfacility setting for CPT codes 76975, GI endoscopic ultrasound, and 15852, Dressing change not for burn. (70 FR 70136 through 70137) (b) Supply Items for CPT Code 95015 (Which Is Used for Intradermal Allergy Tests With Drugs, Biologicals, or Venoms)

We are proposing to implement the allergy and immunology specialty's recommendation to change the test substance in CPT code 95015 to venom, at $10.70 (from single antigen, at $5.18) and the quantity to 0.3 ml (from 0.1 ml). (See 70 FR 70138.) (c) Flow Cytometry Services

Based on information from the society representing independent laboratories, we are proposing to implement the following direct PE inputs:

Clinical Labor--We are proposing to change the staff type in the service (intra) period in both CPT codes 88184 and 88185 to cytotechnologist, at $0.45 per minute (currently lab technician, at $0.33 per minute).

Supplies--We are proposing to change the antibody cost for both CPT codes 88184 and 88185 to $8.50 (from $3.544).

Equipment--We are proposing to add the following equipment to CPT code 88184:

+ Computer.

+ Printer.

+ Slide strainer.

+ Biohazard hood.

+ Wash assistant.

+ FAC loader.

+ We are proposing to add a computer and printer to the equipment for CPT code 88185 (70 FR 70138). (d) Low Osmolar Contrast Media (LOCM) and High Osmolar Contrast Media (HOCM)

Because separate payment is available for both types of contrast media, we are proposing to delete LOCM and HOCM from the PE database with the CY 2007 PFS rule. (See 70 FR 70138). (e) Imaging Rooms

We are proposing to implement the updates for the contents and prices of 5 ``rooms'' used in imaging procedures including--

Basic radiology room;

Radiographic-fluoroscopic room;

Mammography room;

Computed tomography (CT) room; and

Magnetic resonance imaging (MRI) room (See 70 FR 70139). (f) Equipment Pricing for Select Services and Procedures

We are proposing to accept the following equipment pricing information provided by various specialty societies for select services and procedures as discussed in the CY 2006 PFS final rule with comment period. (See 70 FR 70139):

Equipment pricing for certain radiology services received from the ACR as presented in Table 15 of the CY 2006 PFS proposed rule.

Equipment pricing on the ultrasound color doppler transducers and vaginal probe received from the American College of Obstetrics and Gynecology (ACOG).

For CPT 36522, extracorporeal photopheresis, equipment pricing information specific to this procedure.

Pricing of EMG botox machine used in CPT code 92265 as presented by the American Academy of Ophthalmology. (g) Supply Item for In Situ Hybridization Codes (CPT Codes 88365, 88367, and 88368)

We are proposing to implement the Society for Clinical Pathologists' request to change the probe quantity for CPT code 88367 In situ hybridization, auto to 1.5, equal to that of the other two codes in the family. (h) Supply Item for Percutaneous Vertebroplasty Procedures (CPT codes 22520 and 22525)

Based on documentation provided by the Society for Interventional Radiology, we are proposing to implement a new price of $696.00 for the vertebroplasty kit, to replace a temporary price of $660.50 that was a placeholder price from the CY 2006 PFS final rule with comment period. (See 70 FR 70139.) (i) Clinical Labor for G-Codes Related to Home Health and Hospice Physician Supervision, Certification and Recertification

We are proposing to apply the refinements made to the PE inputs to CPT codes 99375 and 99378 for home health and hospice supervision to 4 G-codes that are related to home health and hospice physician supervision, certification and recertification, G0179, GO180, GO181, and GO182. These G-codes are incorrectly valued for clinical labor. These G-codes are cross-walked from CPT codes 99375 and 99378, which underwent PEAC refinement in January 2003 for the CY 2004 PFS. However, at that time we inadvertently did not apply the new refinements to these specific G-codes. (See 70 FR 70139 through 70140.) (j) Programmers for Implantable Neurostimulators and Intrathecal Drug Infusion Pumps

Although we had initially proposed, in the CY 2006 PFS proposed rule, to remove two programmers from the PE database (EQ208 for medication pump from two codes (CPT 62367 and 62368) and EQ209 for the neurostimulator from 8 codes (CPT 95970-97979)), based on comments received as discussed in the CY 2006 PFS final rule with comment period (see 70 FR 70140), we determined that we will retain these programmers in the database. In addition, we added ``with printer'' to the description of EQ208 based on comments received. We are proposing to implement these decisions for CY 2007. (k) Cardiac Monitoring Services

We are requesting more specific PE information related to remote cardiac monitoring services because these services do not fit the direct PE model used for typical physician services. These services are overwhelmingly performed by specialized independent diagnostic testing facilities (IDTFs) that are paid under the PFS, but due to the characteristics of cardiac monitoring services, frequently maintain more extensive operating hours than the typical physician office. Specifically, we are looking for data to indicate the typical number and type of transmissions or other encounters per day between the beneficiary and the IDTF for each of the remote monitoring services. We would also like to know the number and type of clinical staff, as well as the corresponding time, that are necessary to ensure appropriate services are available for each patient. Additionally, we are interested in identifying any other direct PE inputs for typical supplies and equipment relating to these services, and any data that would reflect indirect PEs, such as overhead and non-clinical payroll expenses. We believe that the following codes represent atypical PE scenarios

[[Page 48989]]

and would like to receive PE information regarding these services:

Cardiac event monitoring (CPT codes 93271, 93012 and 93270).

Pacemaker monitoring (CPT codes 93733 and 93736).

Holter monitoring (CPT codes 93232, 93226, 93231 and 93225).

INR monitoring (HCPCS codes G0248 and G0249). (l) Clarification With Respect to Non-Facility PE RVUs

In the CY 2006 PFS final rule with comment (70 FR 70335) we provided a clarification in Addendum A concerning use of ``NA'' in the PE RVU columns for Addendum B. Commenters requested that further clarification be made concerning the payment amount for procedures performed in the non-facility setting if there is an ``NA'' in the non- facility PE RVU column. Our policy is that if the Medicare carrier pays for the service in the non-facility setting, the service will be paid at the facility PE RVU rate. In this proposed rule, we are proposing revisions to Addendum A to include this clarification. (m) Supply for CPT Code 50384, Removal (via Snare/Capture) of Internally Dwelling Ureteral Stent Via Percutaneous Approach, Including Radiological Supervision and Interpretation

Upon review of the RUC-recommended direct PE inputs for CPT 50384, a new procedure for CPT 2006, we identified the inappropriate inclusion of a ureteral stent that we are proposing to delete for CY 2007. We believe that the addition of the ureteral stent, valued by the specialty at $162, to CPT code 50384, which is the procedure for the removal of a stent, was an inadvertent error by the specialty during the April 2005 RUC meeting. (n) Supply and Equipment Items Needing Specialty Input

We have identified certain supply and equipment items for which we were unable to verify the pricing information (see Table 1: Supply Items Needing Specialty Input for Pricing and Table 2: Equipment Items Needing Specialty Input for Pricing). During the CY 2006 rulemaking process, we listed both supply and equipment items for which pricing documentation was needed from the medical specialty societies and, for many of these items, we received sufficient documentation in the form of catalog listings, vendor Web sites, invoices, and manufacturer quotes. We have accepted the documented prices for many of these items and these prices are reflected in the PE RVUs in Addendum B of this proposed rule. The items listed below in Tables 1 and 2 represent the outstanding items from CY 2006 and new items added from the current RUC recommendations. We are requesting that commenters provide pricing information on items in these tables along with acceptable documentation, as noted in the footnote to each table, to support recommended prices. For supplies or equipment that have previously appeared on this list, and for which we received no or inadequate documentation, we are proposing to delete these items unless we receive adequate information to support current pricing by the conclusion of the comment period for this proposed rule. BILLING CODE 4120-01-P

[[Page 48990]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.000

[[Page 48991]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.001

[[Page 48992]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.002

BILLING CODE 4120-01-C

[[Page 48993]]

B. Geographic Practice Cost Indices (GPCI)

[If you choose to comment on issues in this section, please include the caption ``GPCI'' at the beginning of your comments.]

Section 1848(e)(1)(A) of the Act requires us to develop separate GPCIs to measure resource cost differences among localities compared to the national average for each of the three fee schedule components. While requiring that the PE and malpractice GPCIs reflect the full relative cost differences, section 1848(e)(1)(A)(iii) of the Act requires that the physician work GPCIs reflect only one-quarter of the relative cost differences compared to the national average.

Section 1848(e)(1)(C) of the Act requires us, in consultation with appropriate physician representatives, to review the GPCIs at least every 3 years and allows us to make adjustments based on our review. This section of the Act also requires us to phase-in the adjustment over 2 years, implementing only one-half of any adjustment in the first year if more than 1 year has elapsed since the last GPCI revision. The GPCIs were first implemented in 1992. The first review and revision was implemented in 1995 and the last GPCI revision was implemented in 2005. The next update is scheduled to be implemented in January 2008.

We do not anticipate proposing significant changes to the GPCIs in response to changes in the source data. There have been no new Census data to affect the work GPCI, the PE GPCI will reflect any changes in the Department of Housing and Urban Development (HUD) rental data, and the malpractice GPCI (based on malpractice RVUs) will reflect the national claims-based premium data for 2004 and 2005. Details of the methodology, data sources, and adjustments to the GPCIs will be made available for public comment in the CY 2008 PFS proposed rule.

In addition, section 412 of the MMA amended section 1848(e)(1) of the Act to establish a floor of 1.0 for the work GPCI for any locality where the GPCI would otherwise fall below 1.0 for purposes of payment for services furnished on or after January 1, 2004 and before January 1, 2007. Beginning on January 1, 2007, the 1.00 floor will be removed and the work GPCI will revert to the fully implemented value. The values for the work GPCI and subsequent changes to the Geographic Adjustment Factor (GAF) published in this proposed rule reflect the removal of the 1.0 floor. For many payment localities this change had no impact on the GAF; however, the GAFs for a number of payment localities were reduced due to this change. The impact of this change on the GAFs for those payment localities is shown below in Table 3.

The proposed GPCIs for 2007 are shown in Addendum D and the proposed GAFs for 2007 are shown in Addendum E. The GPCIs shown in Addendum D are fully implemented and reflect 2007 budget neutrality scaling coefficients provided by the Office of the Actuary.

Table 3.--Payment Localities With Negative Percent Change in GAF 1 Between 2006 and 2007 Due to Removal of the 1.000 Work Floor

Percent Locality name

2006 GAF 2007 GAF change

Fort Worth, TX......................... 0.998 0.996 -0.17 Rest of Michigan....................... 0.986 0.984 -0.20 Rest of New York....................... 0.952 0.950 -0.21 Rest of Maryland....................... 0.982 0.978 -0.36 Metropolitan St. Louis, MO............. 0.978 0.974 -0.41 Rest of Pennsylvania................... 0.950 0.946 -0.44 Ohio................................... 0.970 0.966 -0.44 Austin, TX............................. 1.020 1.015 -0.47 New Hampshire.......................... 1.010 1.005 -0.50 Minnesota.............................. 0.980 0.975 -0.53 Galveston, TX.......................... 0.991 0.986 -0.54 Metropolitan Kansas City, MO........... 0.987 0.981 -0.56 Fort Lauderdale, FL.................... 1.022 1.016 -0.59 Arizona................................ 0.999 0.993 -0.65 Wisconsin.............................. 0.956 0.950 -0.65 Colorado............................... 0.998 0.991 -0.67 East St. Louis, IL..................... 1.003 0.996 -0.68 New Orleans, LA........................ 0.984 0.977 -0.73 Rest of Washington..................... 0.984 0.976 -0.77 Indiana................................ 0.937 0.930 -0.79 Beaumont, TX........................... 0.951 0.942 -0.96 Alabama................................ 0.923 0.914 -0.99 Virginia............................... 0.958 0.948 -1.06 Southern Maine......................... 0.992 0.981 -1.09 Rest of Georgia........................ 0.943 0.932 -1.14 Tennessee.............................. 0.933 0.921 -1.27 Utah................................... 0.960 0.948 -1.30 South Carolina......................... 0.930 0.917 -1.41 Rest of Illinois....................... 0.952 0.938 -1.43 Rest of Florida........................ 0.982 0.968 -1.45 West Virginia.......................... 0.942 0.928 -1.47 North Carolina......................... 0.951 0.936 -1.55 New Mexico............................. 0.947 0.932 -1.57 Kansas*................................ 0.934 0.919 -1.60 Rest of Louisiana...................... 0.936 0.919 -1.78 Kentucky............................... 0.932 0.915 -1.80 Kansas*................................ 0.936 0.919 -1.81 Rest of Oregon......................... 0.946 0.929 -1.81

[[Page 48994]]

Vermont................................ 0.968 0.950 -1.82 Virgin Islands......................... 1.007 0.989 -1.83 Rest of Texas.......................... 0.947 0.929 -1.87 Idaho.................................. 0.922 0.904 -1.91 Iowa................................... 0.927 0.909 -1.97 Rest of Maine.......................... 0.936 0.916 -2.14 Oklahoma............................... 0.913 0.893 -2.14 Mississippi............................ 0.919 0.898 -2.31 Arkansas............................... 0.905 0.884 -2.34 Puerto Rico............................ 0.905 0.883 -2.44 Nebraska............................... 0.925 0.902 -2.44 Wyoming................................ 0.934 0.910 -2.55 Montana................................ 0.928 0.902 -2.83 Rest of Missouri *..................... 0.910 0.883 -2.97 North Dakota........................... 0.924 0.895 -3.16 South Dakota........................... 0.922 0.891 -3.35

\1\ Calculation for the GAF: (.52466*work gpci) + (.03865*mp gpci) + (.52466*pe gpci).

In the CY 2005 PFS proposed rule, published August 15, 2004, we discussed the issue of changes to the GPCI payment localities (69 FR 47504). In that proposed rule, we noted that we look for the support of a State medical society as the impetus for changes to existing payment localities. Because the GPCIs for each locality are calculated using the average of the county-specific data from all of the counties in the locality, removing high cost counties from a locality will result in lower GPCIs for the remaining counties. Therefore, because of this redistributive impact, we have refrained, in the past, from making changes to payment localities unless the State medical association provides evidence that any proposed change has statewide support.

We would be interested in receiving suggestions on alternative ways that we could administratively reconfigure payment localities that could be developed and proposed in future rulemaking. In addition, MEDPAC and the GAO have both expressed interest in studying the physician payment localities. CMS intends to work with both groups to study our current methodology and develop alternative options.

C. Medicare Telehealth Services

[If you choose to comment on issues in this section, please include the caption ``TELEHEALTH'' at the beginning of your comments.] 1. Requests for Adding Services to the List of Medicare Telehealth Services

Section 1834(m)(4)(F) of the Act defines telehealth services as professional consultations, office visits, and office psychiatry services (identified as of July 1, 2000 by CPT codes 99241 through 99275, 99201 through 99215, 90804 through 90809, and 90862) and any additional service specified by the Secretary. In addition, the statute requires us to establish a process for adding services to or deleting services from the list of telehealth services on an annual basis.

In the December 31, 2002 Federal Register (67 FR 79988), we established a process for adding services to or deleting services from the list of Medicare telehealth services. This process provides the public an ongoing opportunity to submit requests for adding services. We assign any request to make additions to the list of Medicare telehealth services to one of the following categories:

Category #1: Services that are similar to office and other outpatient visits, consultation, and office psychiatry services. In reviewing these requests, we look for similarities between the proposed and existing telehealth services for the roles of, and interactions among, the beneficiary, the physician (or other practitioner) at the distant site and, if necessary, the telepresenter. We also look for similarities in the telecommunications system used to deliver the proposed service, for example, the use of interactive audio and video equipment.

Category #2: Services that are not similar to the current list of telehealth services. Our review of these requests includes an assessment of whether the use of a telecommunications system to deliver the service produces similar diagnostic findings or therapeutic interventions as compared with the face[pi]to[pi]face ``hands on'' delivery of the same service. Requestors should submit evidence showing that the use of a telecommunications system does not affect the diagnosis or treatment plan as compared to a face[pi]to[pi]face delivery of the requested service.

Since establishing the process, we have added the following to the list of Medicare telehealth services: psychiatric diagnostic interview examination; ESRD services with two to three visits per month and four or more visits per month (although we require at least one visit a month by a physician, CNS, NP, or PA to examine the vascular access site); and individual medical nutritional therapy.

Requests to add services to the list of Medicare telehealth services must be submitted and received no later than December 31 of each CY to be considered for the next proposed rule. For example, requests submitted before the end of CY 2005 are considered for the CY 2007 proposed rule. For more information on submitting a request for an addition to the list of Medicare telehealth services, visit our Web site at http://www.cms.hhs.gov/telehealth.

2. Submitted Requests for Addition to the List of Telehealth Services

We received the following requests for additional approved services in CY 2005: (1) Nursing facility care; (2) speech language pathology; (3) audiology; and (4) physical therapy services. The following is a discussion of the requests submitted in CY 2005. Nursing Facility Care

The American Telemedicine Association (ATA) and an individual practitioner submitted a request to add the following services: Initial nursing facility care (as represented by HCPCS

[[Page 48995]]

codes 99304 through 99306); subsequent nursing facility care (HCPCS codes 99307 through 99310); nursing facility discharge services (HCPCS codes 99315 and 99316); and other nursing facility services as described by HCPCS code 99318. The requestors explained that the primary purpose of using telehealth in the Skilled Nursing Facility (SNF) setting is to provide urgent consultation when the patient has a sudden change in his or her condition, and to provide increased availability to primary and specialty care on days when the physician is not present in the SNF or when traveling is a hardship. The requestors believe that the current list of Medicare telehealth services is not appropriate because the list does not include codes that are specifically intended for nursing facility residents. CMS Review Nursing Facility Care

Section 1834(m)(C)(ii) of the Act defines a telehealth originating site as a physician's or practitioner's office; or a hospital, critical access hospital (CAH), rural health clinic, or FQHC. SNFs are not defined in the statute as originating sites.

However, section 418 of the MMA required the Health Resources Services Administration (HRSA), a component of HHS, in consultation with CMS, to conduct an evaluation of demonstration projects under which SNFs, as defined in section 1819(a) of the Act, are treated as originating sites for Medicare telehealth services. The MMA also required the Secretary to submit a report to the Congress that includes recommendations on ``mechanisms to ensure that permitting a SNF to serve as an originating site for the use of telehealth services or any other service delivered via a telecommunications system does not serve as a substitute for in-person visits furnished by a physician, or for in-person visits furnished by a physician assistant (PA), nurse practitioner (NP), or clinical nurse specialist (CNS), as is otherwise required by the Secretary'' and provides the authority to include SNFs as a Medicare telehealth originating site, if the Secretary concludes in the report that it is advisable to do so and that mechanisms could be established to ensure that the use of a telecommunications system does not serve as a substitute for the required in-person physician or practitioner SNF visits. This report is currently under review in DHHS.

Given that SNFs are not defined in the statute as a telehealth originating site and the report to the Congress, as discussed above, is currently being reviewed within DHHS, we cannot consider approving nursing facility care for telehealth at this time. We will review and consider the recommendations of the report to the Congress once it is issued. If it is determined that SNFs should be added as an originating site, this change will be considered in future rulemaking. Speech Language Pathology, Audiology and Physical Therapy

The ATA and an individual practitioner submitted a request to add various speech therapy, audiology and physical therapy services to the list of Medicare telehealth services. The requestors also asked us to add physical therapists, speech language pathologists and audiologists to the list of approved telehealth practitioners. CMS Review

Physical therapists, speech language pathologists and audiologists are not permitted under current law to provide and receive payment for Medicare telehealth services at the distant site. The statute permits only a physician, as defined by section 1861(r) of the Act or a practitioner as described in section 1842(b)(18)(C) of the Act (CNS, NP, PA, nurse midwife, clinical psychologist, clinical social worker, registered dietitian or other nutrition professional), to furnish Medicare telehealth services. Since speech language pathologists, audiologists and physical therapists are not permitted under current law to provide and receive payment for Medicare telehealth services at the distant site, we cannot fully consider the request to add speech therapy, audiology services and physical therapy to the list of Medicare telehealth services. We are exploring this issue as part of a report to the Congress (required by section 223(d) of BIPA) on additional sites and settings, geographic areas, and types of non- physician practitioners that could be reimbursed for the provision of telehealth services.

D. Miscellaneous Coding Issues

[If you choose to comment on issues in this section, please include the caption ``Miscellaneous Coding Issues'' at the beginning of your comments.]

The following sections address specific coding issues related to payment for services under the PFS. 1. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures

CPT Code 77783, Remote afterloading high intensity brachytherapy; 9-12 source positions or catheters, resides in a family of codes with varying numbers of source positions. All of the codes in the family, CPT codes 77781-77784 are currently designated as 90-day global services. CPT codes 77781-77784 are used to treat many clinical conditions, but primarily patients with prostate cancer, breast cancer and sarcoma. Patients with any of these conditions usually receive several treatments (2-10) over a two to ten day period of time. Due to the increasing variability in treatment regimens, it is difficult to assign RVUs for a ``typical'' patient based on a global period of 90 days.

Therefore, we are proposing that this family of codes (CPT codes 77781, 77782, 77783 and 77784) be assigned a global period of ``XXX'', which will permit separate payment each time the services are provided and allow payment to be based on the actual service(s) provided. We will request that the RUC revalue the work RVUs and the PE inputs for these services if a change in the global period is finalized. However we are proposing, on an interim basis, to revise the work RVUs and PE inputs to reflect the removal of the postoperative visit, CPT code 99212, that is currently assigned to these services. The proposed interim work RVUs for these services would be as follows:

77781 = 1.21

77782 = 2.04

77783 = 3.27

77784 = 5.15

We are also proposing to delete the registered nurse (RN) time in the post-service period as well as the patient gowns for the post- service visit. We would also note that, to the extent that these services are performed as staged procedures, providers may make use of applicable modifiers. 2. Assignment of RVUs to CPT Codes for Proton Beam Treatment Delivery Services

We have received a request to assign PE inputs for the non-facility setting to Proton Beam treatment delivery services represented by CPT codes 77520 through 77525.

These services are currently carrier-priced; therefore, payment in the facility or non-facility setting is established by each carrier. To the extent that physicians and suppliers wish to have national RVUs assigned for these services, there is an established process utilizing the AMA-RUC to recommend work RVUs, as well as the direct PE inputs used to compute the PE RVUs, to CMS. We would strongly encourage the physicians and suppliers to use this established process, and would also be

[[Page 48996]]

interested in receiving comments on this issue.

E. Deficit Reduction Act (DRA) Related Proposals

[If you choose to comment on issues in this section, please include the caption ``DRA PROPOSALS'' at the beginning of your comments.]

The DRA of 2005 (Pub. L. 109-171), was enacted February 8, 2006 and included provisions that affect the Medicare program. The following section addresses the specific DRA provisions that are being addressed in this proposed rule. 1. Section 5102--Proposed Adjustments for Payments to Imaging Services

Section 5102 of the DRA includes two provisions that affect payment of imaging services under the Medicare physician fee schedule. The first provision addresses payment for certain multiple imaging procedures for CY 2007 and application of budget neutrality while the second provision addresses limiting the payment amount under PFS to the outpatient department (OPD) payment amount for the technical component (TC) of certain imaging services. (a) Payment for Multiple Imaging Procedures for 2007

In general, Medicare prices diagnostic imaging procedures in the following three ways:

The professional component (PC) represents the physician's interpretation (PC-only services are billed with the 26 modifier).

The TC represents PE and includes clinical staff, supplies, and equipment (TC-only services are billed with the TC modifier).

The global service represents both PC and TC.

As discussed in the CY 2006 PFS final rule with comment period (70 FR 70261), in the CY 2006 PFS proposed rule (70 FR 45764 through 46064), we had proposed to reduce payment for the TC of selected diagnostic imaging procedures belonging to one of eleven imaging families when the procedures are performed on contiguous body areas by 50 percent for CY 2006. However, in the final rule with comment period, we stated that we would phase-in the 50 percent reduction over two years, beginning with a 25 percent reduction in 2006. We also sought additional data and comments on the appropriateness of 50 percent as the final level of reduction. The reduction applies to the TC and the technical portion of the global service, but does not apply to the PC of the service. Currently, we make full payment for the highest priced procedure and reduce payment for each additional procedure by 25 percent, when more than one procedure from the same imaging family is performed during the same session on the same day.

As described in the CY 2006 PFS final rule with comment period, at the time, the statute required us to make changes such as this in a budget neutral manner, meaning that the estimated savings generated by the application of the multiple imaging procedure payment reduction were used to increase payment for other physician fee schedule services. We increased the CY 2006 PE RVUs by 0.3 percent to offset the estimated savings generated by the multiple imaging payment reduction policy.

Subsequent to the publication of the CY 2006 PFS final rule with comment period, section 5102(a) of the DRA (Multiple Procedure Payment Reduction for Imaging Exempted From Budget Neutrality), required that ``effective for fee schedules established beginning with 2007, reduced expenditures attributable to the multiple procedure payment reduction for imaging under the final rule published by the Secretary in the Federal Register on November 21, 2005 (42 CFR 405, et al.) insofar as it relates to the physician fee schedules for 2006 and 2007'' are exempted from the budget neutrality provision. As a result, we are proposing to remove the 0.3 percent increase to the CY 2006 PE RVUs from the CY 2007 PE RVUs in accordance with the statute.

In addition, in response to our request for data on the appropriateness of the 50 percent reduction in the CY 2006 PFS final rule with comment period (70 FR 70261), the ACR provided information for 25 code combinations supporting a reduction of between 21 and 44 percent. Given the expected interaction between the multiple procedure imaging policy and the further imaging payment reductions mandated by section 5102(b) of the DRA described below, along with the new information we have received from the ACR on the multiple imaging procedure policy as it applies to common combinations of imaging services, we believe it would be prudent to maintain the multiple imaging payment reduction at its current 25 percent level while we continue to examine the appropriate payment levels. Therefore, we are proposing to continue the multiple imaging payment reduction for 2007 at the 25 percent level. We would proceed through future rulemaking in the event we determine that revisions to the policy are warranted. (b) Reduction in TC for Imaging Services Under the PFS to OPD Payment Amount

Section 5102(b)(1) of the DRA amended section 1848 of the Act and requires that, with respect to imaging services, if--

``(i) The technical component (including the technical component portion of a global fee) of the service established for a year under the fee schedule * * *, without application of the geographic adjustment factor * * *, exceeds,

(ii) The Medicare OPD fee schedule amount established under the prospective payment system for hospital outpatient department services * * * for such service for such year, determined without regard to geographic adjustment * * *, the Secretary shall substitute the amount described in clause (ii), adjusted by the geographic adjustment factor

[under the PFS] * * *, for the fee schedule amount for such technical component for such year.''

As required by the statute, for imaging services (described below) furnished on or after January 1, 2007, we will cap the PFS payment amount for the year (prior to geographic adjustment) by the CY 2007 outpatient prospective payment system (OPPS) payment amount (prior to geographic adjustment). We will then apply the PFS geographic adjustment to the capped payment amount.

Section 5102(b)(2) of the DRA exempts the estimated savings from this provision from the PFS budget neutrality requirement. Section 5102(b)(1) of the DRA defines imaging services as ``* * * imaging and computer-assisted imaging services, including X-ray, ultrasound (including echocardiography), nuclear medicine (including positron emission tomography), magnetic resonance imaging, computed tomography, and fluoroscopy, but excluding diagnostic and screening mammography.''

In order to apply section 5102(b) of the DRA, we needed to determine the CPT and alpha-numeric HCPCS codes that fall within the scope of ``imaging services'' defined by the DRA provision. In general, we believe that imaging services provide visual information regarding areas of the body that are not normally visible, thereby assisting in the diagnosis or treatment of illness or injury. We began by considering the CPT 7XXXX series codes for radiology services and then adding in other CPT codes and alpha-numeric HCPCS codes that describe imaging services. We then excluded nuclear medicine services that were either non-imaging diagnostic or treatment services. We also excluded all

[[Page 48997]]

codes for unlisted procedures, since we would not know in advance of any specific clinical scenario whether or not the unlisted procedure was an imaging service. We excluded all mammography services, consistent with the statute. We excluded radiation oncology services that were not imaging or computer-assisted imaging services. We also excluded all HCPCS codes for imaging services that are not separately paid under the OPPS since there would be no corresponding OPPS payment to serve as a TC cap. We excluded any service where the CPT code describes a procedure for which fluoroscopy, ultrasound, or another imaging modality is either included in the code whether or not it is used or is employed peripherally in the performance of the main procedure, for example, 31622 for bronchoscopy with or without fluoroscopic guidance and 43242 for upper gastrointestinal endoscopy with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s). In these cases, we are unable to clearly distinguish imaging from non-imaging services because, for example, a specific procedure may or may not utilize an imaging modality, or the use of an imaging technology cannot be segregated from the performance of the main procedure. Note that we included carrier priced services since these services are within the statutory definition of imaging services and are also within the statutory definition of PFS services (that is, carrier-priced TCs of PET scans).

Our proposed list of codes that identify imaging services defined by the DRA OPPS cap provision can be found in Addendum F to this proposed rule. Note that this is the list of imaging services for which we propose to make the comparison between the PFS TC payment amount and the OPPS payment amount used to establish OPD payment. Payment for an individual service on this list would only be capped if the PFS TC payment amount exceeds the OPPS payment amount.

To the extent changes are made to codes for services already on the list, we propose to update the list through program instructions to our contractors. To the extent that the same imaging service is coded differently under the PFS and the OPPS, we propose to crosswalk the code under the PFS to the appropriate code under the OPPS that could be reported for the same service provided in the hospital outpatient setting. Our proposed list of crosswalks is below:

MFS code

Descriptor

OPPS code

Desc

74185........ Mri angio, abdom w or C8900....... MRA w/cont, abd. w/o dye. 76093........ Magnetic image,

C8905....... MRI w/o fol w/cont, breast.

brst, un. 76094........ Magnetic image, both C8908....... MRI w/o fol w/cont, breasts.

breast. 71555........ Mri angio chest w or C8909....... MRA w/cont, chest. w/o dye. 73725........ Mr ang lwr ext w or w/ C8912....... MRA w/cont, lwr ext. o dye. 72198........ Mr angio pelvis w/o & C8918....... MRA w/cont, pelvis. w/dye.

(c) Interaction of the Multiple Imaging Payment Reduction and the OPPS Cap

For CY 2007 imaging services potentially subject to both the multiple imaging reduction and the OPPS cap, we propose to first apply the multiple imaging payment reduction and then apply the OPPS cap to the reduced amount as illustrated in the following example.

25% Pre-OPPS Multiple OPPS cap Final MPFS HCPCS

cap MPFS imaging

rate payment rate reduction

7XXX1....................................................... $341.89 $256.42 $316.55 $256.42 7XXX2....................................................... 552.86 414.65 391.83 391.83

We considered first applying the OPPS cap and then applying the multiple procedure reduction. However, as indicated in the CY 2006 OPPS final rule, we received public comments suggesting that the OPPS payment rates may implicitly include at least some multiple imaging discount. While we continue to examine this issue, we believe the most appropriate policy is to apply the multiple imaging payment reduction prior to the application of the OPPS cap. 2. Section 5107--Revisions to Payments for Therapy Services

Section 1833(g) of the Act applies an annual per beneficiary combined cap beginning January 1, 1999, on outpatient physical therapy and speech-language pathology services and a similar separate cap on outpatient occupational therapy services. These caps apply to expenses incurred for the respective therapy services under Medicare Part B, with the exception of outpatient hospital services. The caps were in effect from January 1, through December 31, 1999, from September 1, 2003 through December 7, 2003, and beginning January 1, 2006. In 2000 through 2002, and from December 8, 2003 through December 31, 2005, the Congress placed moratoria on implementation of the caps. Section 1833(g)(2) of the Act provides that, for 1999 through 2001, the caps were $1500, and for years after 2001, the caps are equal to the preceding year's cap increased by the percentage increase in the Medicare Economic Index (MEI) (except that if an increase for a year is not a multiple of $10, it is rounded to the nearest multiple of $10).

We implemented the separate statutory limits of $1740 for outpatient physical therapy and speech-language pathology services and $1740 for occupational therapy on January 1, 2006. The DRA of 2005 was enacted on February 8, 2006. Section 5107(a) of the DRA required the Secretary to develop an exceptions process for the therapy caps effective January 1, 2006. The exceptions process applies only to expenses incurred in 2006. Details of the exceptions process were published in a manual change on February 13, 2006 (CR4364). The change request

[[Page 48998]]

consists of three transmittals with current numbers of--

Transmittal 855, CR 4364, Pub. L. 100-04;

Transmittal 47, CR 4365, Pub. L. 100-02; and

Transmittal 140, CR 4364, Pub. L. 100-08.

The transmittals are available on our Web site at http://www.cms.hhs.gov/Transmittals/ .

In accordance with the statute, the therapy caps will remain in effect, but without the exceptions process, with respect to expenses incurred beginning on January 1, 2007. The dollar amount of the therapy caps in 2007 will be the 2006 rate ($1740) increased by the percentage increase in the MEI. As noted above, under current law, the exceptions process will not apply to therapy services incurred after December 31, 2006, but the therapy caps will remain inapplicable to therapy services provided in the outpatient hospital setting as provided in section 1833(g) of the Act.

Section 5107(b) of the DRA requires the Secretary to implement, by July 1, 2006, edits for clinically illogical combinations of procedure codes and other edits in order to limit inappropriate payment for therapy services. In January 2006, we implemented Correct Coding Initiative (CCI) edits for the therapy providers that bill to the fiscal intermediaries, thus, addressing the section 5107 of the DRA requirement with respect to edits for clinically illogical combinations of procedure codes. Adoption of these code edits ensures that these providers of outpatient Part B therapy services, including SNFs, comprehensive outpatient rehabilitation facilities, certain outpatient physical therapy and speech-language therapy providers (rehabilitation agencies) and home health agencies (HHAs) (where beneficiary is not under a Part A plan of care) meet the same CCI edit requirements as those that have been in place for physicians, private practice therapists, and OPPS hospitals. We are considering the implementation of other edits in the future to further address concerns about inappropriate payment for therapy services. 3. Section 5112-Proposed Addition of Ultrasound Screening for Abdominal Aortic Aneurysm (AAA)

Section 5112 of the DRA of 2005 amended section 1861 of the Act to provide for coverage under Part B of ultrasound screening for AAAs, effective for services furnished on or after January 1, 2007, subject to certain eligibility and other limitations. This screening test will be available even if the qualifying patient does not present signs or symptoms of disease or illness.

To conform the regulations to the statutory requirements of section 5112 of the DRA, we are proposing to include an exception in Sec. 411.15(a)(1) to permit coverage for ultrasound screening for AAAs that meet the conditions for coverage that we are proposing to specify under new Sec. 410.19(b) (Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms). We are also adding a new Sec. 411.15(k)(12).

As provided in the DRA, this new coverage allows payment for a one- time only screening examination. We are proposing to add new Sec. 410.19(b) to provide for the coverage of the screening examinations for AAAs as specified in section 5112 of the DRA. We are also proposing to add new Sec. 410.19(c) (Limitation on coverage of ultrasound screening for abdominal aortic aneurysms.) to provide the limitation on coverage for an individual who is not an eligible beneficiary as defined in proposed new Sec. 410.19(a).

We are proposing definitions set forth in new Sec. 410.19(a) of this proposed rule that would be included to implement the statutory provisions and to help the reader in understanding the provisions of this regulation. The proposed definitions include the following terms:

Eligible beneficiary.

Ultrasound screening for abdominal aortic aneurysms.

Specifically, section 5112(a)(1) of the DRA amended section 1861 of the Act to provide that coverage of ultrasound screening for AAAs will be available for an individual--(i) who receives a referral for such an ultrasound screening as a result of an initial preventive physical examination (as defined in section 1861(ww)(1) of the Act); (ii) who has not been previously furnished such an ultrasound screening under this title; and (iii) who has a family history of AAA or manifests risk factors included in a beneficiary category recommended for screening by the United States Preventive Services Task Force regarding AAAs.

Section 5112(a)(2) of the DRA also adds a definition of the term ``ultrasound screening for an Abdominal Aortic Aneurysm'' to mean, ``(1) a procedure using sound waves (or other procedures using alternative technologies, of commensurate accuracy and cost, that the Secretary may specify) provided for the early detection of abdominal aortic aneurysm; and (2) includes a physician's interpretation of the results of the procedure.''

In developing the proposed rule based on this provision, we reviewed the 2005 United States Preventive Services Task Force (USPSTF) recommendations and related material on ultrasound screening for AAAs. This includes--

A recommendation for a one-time ultrasound screening for men aged 65 to 75 who have smoked at least 100 cigarettes in their lifetime;

No recommendation for or against ultrasound screening for AAAs for men who have not smoked at least 100 cigarettes in their lifetime; and

A recommendation against routine screening for AAAs in women.

Based on the statutory language and the USPSTF recommendations outlined above, we are proposing to define the term ``eligible beneficiary'' for coverage of ultrasound screening examinations for AAA to mean an individual who--

Has received a referral for an ultrasound screening as a result of an initial preventive physical examination (as defined in section 1861(ww)(1) of the Act);

Has not been previously furnished such a covered ultrasound screening examination under the Medicare program; and

Is included in at least one of the following risk categories:

+ Has a family history of an AAA; or

+ Is a man age 65 to 75 years who smoked at least 100 cigarettes in his lifetime; or

+ Is an individual who manifests other risk factors that are described in a benefit category recommended by the USPSTF regarding an AAA that has been determined by the Secretary through the NCD process.

To facilitate our consideration of possible expansions of coverage in the future for identifying (1) other risk factors in a benefit category recommended for screening for the early detection of AAAs by the USPSTF, and (2) alternative screening technologies to ultrasound screening for AAAs of commensurate accuracy and cost, we are proposing to add language to our regulations that would allow us to make determinations through the NCD process. The NCD process would allow the Secretary to expand coverage more quickly following an assessment of those subjects than is possible under the standard rulemaking process. We intend to use the NCD process, which includes an opportunity for public comments, for evaluating the medical and scientific issues relating to the coverage of alternative screening technologies and the identification of other risk factors for AAAs recommended by the USPSTF that may be brought to our attention in the future. Use of an NCD to establish

[[Page 48999]]

a change in the scope of benefits is authorized by section 1871(a)(2) of the Act. An aggrieved party can challenge an NCD under the procedures established by section 1869(f) of the Act. These proposed coverage provisions would be set forth in proposed new Sec. 410.19 (a)(1)(i) and Sec. 410.19(a)(2)(iii)(C).

Section 5112(b) of DRA also amended section 1861(ww)(2) of the Act (the initial preventive physical examination benefit) by adding the new ultrasound screening benefit to the list of preventive services for which physicians and other qualified nonphysician practitioners must provide ``education, counseling and referral'' to new beneficiaries who take advantage of the initial preventive physical examination benefit within the first 6 months after the effective date of their first Part B coverage period. Therefore, we are also proposing to amend Sec. 410.16(a)(7) of the regulations so that it reflects the additional responsibilities that physicians and qualified nonphysician practitioners will have under the initial preventive physical examination benefit with respect to the new ultrasound screening benefit.

Beginning January 1, 2007, we are proposing to pay for ultrasound screening for AAAs through the use of a new HCPCS code GXXX1, Ultrasound, B-scan and/or real time with image documentation; for abdominal aortic aneurysm (AAA) screening. We are proposing that payment for this service be made at the same level as CPT code 76775 Ultrasound, retroperitoneal (e.g., renal, aorta, nodes), B-scan and/or real time with image documentation; limited. CPT code 76775 is used to bill for the service when it is provided as a diagnostic test, and we believe the service associated with the proposed HCPCS code reflects equivalent resources and work intensity to those contained in CPT code 76775.

In addition, since the DRA provides that the Medicare Part B deductible will not apply with respect to ultrasound screening for abdominal aortic aneurysm (as defined in section 1861(bbb) of the Act), we are proposing to revise Sec. 410.160 to include an exception from the Medicare Part B deductible for the ultrasound screening for abdominal aortic aneurysm as described in proposed Sec. 410.19. (Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms.) 4. Section 5113--Proposed Non-Application of the Part B Deductible for Colorectal Cancer Screening Tests

Current Medicare policy requires that, with limited exceptions, incurred expenses for covered part B services are subject to, and count toward meeting the Part B annual deductible. Section 5113 of the DRA amended section 1833(b) of the Act to provide for an exception to the application of the Part B deductible with respect to colorectal cancer screening tests. Beginning January 1, 2007, colorectal cancer screening services, as described in section 1861(pp)(1) of the Act, are no longer subject to the Part B deductible. The conditions for and limitations on coverage for colorectal cancer screening tests under Medicare part B are described in Sec. 410.37.

To conform our regulations to this statutory change, we are proposing to revise Sec. 410.160 to include an exception from the Part B annual deductible for the colorectal cancer screening services described in Sec. 410.37. 5. Section 5114--Proposed Addition of Diabetes Outpatient Self- Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program

Section 5114 of the DRA amended section 1861(aa)(3) of the Act to add DSMT and MNT services to the list of Medicare covered and reimbursed services under the Medicare FQHC benefit, effective for services provided on or after January 1, 2006. Although this statutory change has already been implemented in administrative instructions, we are proposing to conform the regulations to the new statutory requirement.

FQHCs certified as DSMT and MNT providers have been allowed to bundle the cost of those services into their FQHC payment rates. But before the enactment of the DRA, the provision of these services would not generate a separate FQHC visit payment. Effective for services furnished on or after January 1, 2006, FQHCs that are certified providers of DSMT and MNT services can receive per visit payments for covered services furnished by registered dietitians or nutrition professionals. In other words, if all relevant program requirements are met, these services are included under the Medicare FQHC benefit as billable visits.

In order to conform the regulations, we are proposing to amend Sec. 405.2446(b) to expand the scope of FQHC services to include certified providers of DSMT and MNT services by adding a new paragraph (10). We are also proposing to revise Sec. 405.2463 by--

Revising paragraph (a) to expand the definition of an FQHC visit to include certified providers of DSMT and MNT services under new sub-paragraph (a)(1)(ii)(B). We would also revise the definition of an RHC visit in new subparagraph (a)(1)(i) to include a face-to-face encounter between a patient and a clinical psychologist or clinical social worker to conform to statutory language at section 1861(aa)(1)(B) of the Act. We are also proposing to redesignate and revise paragraphs (b) and (c) as new paragraphs (a)(2) and (a)(3), respectively.

We are proposing to incorporate paragraph (a)(2) into (a)(1), and to redesignate and revise current paragraph (a)(3) as new paragraph (b). We would also clarify that it is generally permissible for both FQHCs and Rural Health Clinics to furnish, when necessary, most types of medical and other health visits on the same day to the same patient. We are also proposing to amend this paragraph to permit a separate additional FQHC visit for DSMT and MNT services (which may occur on the same date of service when the beneficiary receives care from their FQHC physician or non-physician practitioner) when reasonable and necessary, consistent with the Congressional mandate under section 5114 of the DRA to provide coverage and adequate access to these services in the FQHC setting.

We are proposing to redesignate and revise current paragraph (a)(4) as new paragraph (c).

F. Proposed Payment for Covered Outpatient Drugs and Biologicals (ASP Issues)

[If you choose to comment on issues in this section, please include the caption ``ASP Issues'' at the beginning of your comments.]

Medicare Part B covers a limited number of prescription drugs and biologicals. For the purposes of this proposed rule, the term ``drugs'' will hereafter refer to both drugs and biologicals. Medicare Part B covered drugs not paid on a cost or prospective payment basis generally fall into the following three categories:

Drugs furnished incident to a physician's service.

DME drugs.

Drugs specifically covered by statute (certain immunosuppressive drugs, for example).

Beginning in CY 2005, the vast majority of Medicare Part B drugs not paid on a cost or prospective payment basis are paid under the ASP

[[Page 49000]]

methodology. The ASP methodology is based on data submitted to us quarterly by manufacturers. In addition to the payment for the drug, Medicare currently pays a furnishing fee for blood clotting factors, a dispensing fee for inhalation drugs, and a supplying fee to pharmacies for certain Part B drugs.

In January 2006, the drug coverage available to Medicare beneficiaries expanded with the implementation of Medicare Part D. The Medicare Part D program does not change Medicare Part B drug coverage.

This section of the preamble discusses proposed changes and issues related to the determination of the payment amounts for covered Part B drugs and furnishing blood clotting factor. This section also discusses proposed changes to how manufacturers calculate and report ASP data to us. 1. ASP Issues

Section 303(c) of the MMA amended Title XVIII of the Act by adding new section 1847A. This new section revised the payment methodology for the vast majority of drugs and biologicals not paid on a cost or prospective payment basis furnished on or after January 1, 2005. The ASP reporting requirements are set forth in section 1927(b) of the Act. Manufacturers must submit ASP data for each 11-digit National Drug Code (NDC) to us quarterly. The manufacturers' submissions are due to us not later than 30 days after the last day of each calendar quarter. The methodology for developing Medicare drug payment allowances based on the manufacturers' submitted ASP data is specified in the regulations in part 414, subpart K. We update the Part B drug payment amounts quarterly based on the data we receive.

In this section of the preamble, we discuss our intent to issue a final rule to implement the provisions in the MMA related to the calculation and submission of manufacturers' ASP data, and seek further comments on specific issues related to price concessions and certain fees.

On April 6, 2004, we published the Manufacturer's Submission of Average Sales Price Data for Medicare Part B Drugs and Biologicals (ASP) interim final rule with comment period (IFC) (69 FR 17935) to implement the ASP calculation and reporting requirements. Manufacturers were required to submit their initial quarterly ASP data to us shortly thereafter, beginning April 30, 2004. We received comments from drug manufacturers, pharmacies, physicians, national associations of the pharmaceutical industry, national associations of physicians, and consultants. These comments addressed a variety of aspects of calculating and reporting ASPs. On September 16, 2004, we published the Manufacturer's Submission of Average Sales Price Data for Medicare Part B Drugs and Biologicals (ASP) final rule (69 FR 55763) addressing only the comments pertaining to the methodology for estimating lagged price concessions. We have also addressed ASP calculation and reporting requirements in other proposed and final rules and information collection notices, including rulemaking to implement the Competitive Acquisition Program for Part B Drugs and Biologicals (CAP). (See 70 FR 39069, 70 FR 45842, 70 FR 70215, and 70 FR 70477.) In addition, we posted official agency guidance, including responses to frequently asked questions, on our Web site to implement the ASP provisions in accordance with section 1847A(c)(5)(C) of the Act.

We intend to publish a final rule addressing comments on the April 6, 2004 IFC in the near future. We may publish the final rule as part of this rulemaking, or we may publish a separate final rule, in either case after the close of the comment period for this proposed rule. Because the comments received during the comment period in response to the April 6, 2004 IFC were made during the initial months of manufacturers' experience with calculating and reporting ASPs and prior to publication of payment amounts based on the ASP methodology, we believe there is good reason to provide the public with the opportunity for additional comments based on what is now more than a year and a half of experience with the ASP reporting requirements. Therefore, we seek comments on the ASP reporting provisions in the April 6, 2004 IFC. In particular, we seek comments on the issues discussed in the sections below.

We note that we received many comments in response to the April 6, 2004 interim final rule on the use and potential impacts of the ASP payment methodology. As noted above, we are reopening the comment period on the issue of ASP reporting. Thus, comments about the use or appropriateness of the ASP payment methodology are outside the scope of this rulemaking and the ASP reporting rule (CMS-1380-IFC). Therefore, comments about the appropriateness and use of 106 percent of ASP as the basis for the Medicare Part B drug payment rates will be outside the scope of the comments considered for the final ASP reporting rule we are preparing to publish. a. Fees Not Considered Price Concessions

Section 1847A(c)(5)(A) of the Act states that the ASP is to be calculated by the manufacturer on a quarterly basis. As a part of that calculation, manufacturers are to take into account price concessions such as--

Volume discounts;

Prompt pay discounts;

Cash discounts;

Free goods that are contingent on any purchase requirement;

Chargebacks; and

Rebates (other than rebates under the Medicaid drug rebate programs).

If the data on these price concessions are lagged, then the manufacturer is required to estimate costs attributable to these price concessions using the required ratio methodology as specified in 42 CFR part 414, subpart J, Sec. 414.804(a)(3).

Among the comments from drug manufacturers and national associations representing wholesalers and distributors, we received requests for clarification and detailed guidance on the treatment of administrative fees, service fees and fees paid to pharmacy benefit managers (PBMs) in the ASP calculation. We posted guidance on our Web site (http://questions.cms.hhs.gov/cgi-bin/ cmshhs.cfg/php/enduser/

std--adp.php?p --faqid=3323&p-- created=1095344721& p--sid=Ghuscgci&p-- accessibility=0& p--lva=&p-- sp=cF9zcmNoPTEmcF9zb3J 0X2J5PSZwX2dyaWRzb3J0 PSZwX3Jvd19jbnQ9M zEmcF9wcm9kcz04LD U2LDYwNCZwX2N hdHM9JnBfc HY9My42MDQ mcF9jdj0mcF9zZWFyY 2hfdHlwZT1hb nN3ZXJzLnNl YXJjaF9ubCZw X3BhZ2U9MQ**& p--li=& p--topview=1) to clarify that in the absence of specific guidance in the Social Security Act or Federal regulations, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and intent of the Social Security Act, Federal regulations, and its customary business practices. These assumptions should be submitted along with the ASP data. In December 2004, we posted further guidance on our website addressing service fees and administrative fees paid to buyers (http://questions.cms.hhs.gov/ cgi-bin/cmshhs.cfg/php/enduser/

std--adp.php?p-- faqid=3318&p-- created=1095343992& p--sid=a2qUcgci &p--accessibility=0&p --lva=&p --sp=cF9zcmNoPTEmc F9zb3J0X2J5PSZ wX2dyaWRzb3J0PSZ wX3Jvd19jbnQ9Mz EmcF9wcm9kcz04LDU2LDY wNCZwX2NhdHM9

[[Page 49001]]

JnBfcHY9 My42MDQmcF9jdj0 mcF9zZWFyY2hfdH lwZT1hbnN3ZXJzLnNlYXJ jaF9ubCZwX3BhZ2U9MQ **&p--li=&p --topview=1 and http://questions.cms.hhs.gov/ cgi-bin/cmshhs.cfg/php/ enduser/std--adp.

php?p--faqid=4136&p --created=1109786814 &p--sid=bxw-cgci &p-- accessibility=0 &p--lva=& p--sp=cF9zcmNoPTE mcF9zb3J0X2J5PSZwX2 dyaWRzb3J0PSZwX3Jvd19jbn Q9MzEmcF9wcm9kcz04LDU2LDY wNCZwX2NhdHM9JnBfcHY9 My42MDQmcF9jdj0mcF9zZWFyY2hfd HlwZT1hbnN3ZXJzLnNlYXJjaF9 ubCZwX3BhZ2U9MQ**&p --li=&p--topview=1).

On July 6, 2005, we restated our guidance on service fees in the preamble of the Competitive Acquisition of Outpatient Drugs and Biologicals Under Part B (CAP) interim final rule with comment (70 FR 39069). Subsequently, we have received requests for clarification on how fees paid to entities such as group purchasing organizations (GPOs) or PBMs must be treated for purposes of the ASP calculation.

We propose to further clarify in the final ASP reporting rule that, beginning with the ASP reporting for sales during the first calendar quarter of 2007, bona fide service fees that are paid by a manufacturer to an entity, whether or not the entity takes title to the drug, are not considered price concessions under Sec. 414.804(a)(2) insofar as, and to the extent that, they satisfy the definition of a bona fide service fee that we are proposing at Sec. 414.802. In Sec. 414.802, we propose to define bona fide service fees as fees paid by a manufacturer to an entity that represent fair market value for a bona fide, itemized service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for) in the absence of the service arrangement, and that are not passed on, in whole or in part, to a client or customer of an entity, whether or not the entity takes title to the drug. Our current guidance, which provides that bona fide service fees means expenses that would have generally been paid for by the manufacturer at the same rate had these services been performed by other entities, would continue unless we provide an alternative approach as discussed below. Further, we propose to clarify in the final ASP reporting rule that fees, including service fees, administrative fees and other fees, paid to GPOs or PBMs are not considered price concessions under Sec. 414.804(a)(2) insofar as, and to the extent that, they satisfy the definition of a bona fide service fee that we have proposed at Sec. 414.802.

In comments on the April 6, 2004 IFC, groups representing wholesalers, distributors and specialty pharmacies provided some insight into the types of activities that are performed in the distribution of drugs. These commenters suggested that costs for handling, storage, inventory reporting, shipping, receiving, patient education, disease management and data should be borne by manufacturers and be excluded from the ASP calculation as bona fide services. However, these commenters did not provide detailed information about whether and how one would determine the extent to which these activities are bona fide services actually performed on behalf of the manufacturer or otherwise.

Because the scope of appropriate services may vary across categories of drugs, we are considering providing guidance on the types of services that may qualify as bona fide services for purposes of the ASP calculation. We are also considering providing further guidance on or revising the approach or methodology manufacturers must use to determine the fair market value of bona fide services performed on their behalf and whether the service fee paid was passed on in whole or in part. In either case, we may implement our policy through rulemaking or through program instruction or other guidance (consistent with our authority under section 1847A(c)(5)(C) of the Act).

We seek comments on the specific types of services entities perform on behalf of manufacturers that a manufacturer would otherwise perform (or contract for) and the necessity of those services in the efficient distribution of drugs. We also seek comments on activities that should not be considered bona fide services performed on behalf of manufacturers. To better understand which services may be considered bona fide services performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for), we seek to understand the bona fide services that may be appropriate for all or specific types of products, as well as the specific services that may be applicable to unique products or circumstances. We also seek to understand the costs and relative costs of services performed on behalf of manufacturers.

To exclude a bona fide service fee from the ASP calculation, a manufacturer must determine whether the fee paid to an entity represents fair market value for a bona fide service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for), and that the fee is not passed on, in whole or in part, to a client or customer of the entity. Our current guidance provides that bona fide service fees means expenses that would have generally been paid for by the manufacturer at the same rate had these services been performed by other entities. We seek comments on appropriate additional guidance or alternative methods for determining fair market value for purposes of identifying bona fide service fees that are excluded from the calculation of ASP, as well as comments on whether, and the extent to which, fees tied to performance of a service, fixed fee, revenue generated by product sales, or other basis may represent fair market prices for purposes of identifying bona fide service fees that are excluded from the calculation of ASP. In addition, we seek comments on the appropriate methods for determining whether a fee is passed on in whole or in part. We also seek comments on how Medicare's guidance on the treatment of service fees for ASP calculation purposes may differ with the treatment of service fees for financial accounting or other purposes, and any implications that this may have for manufacturers. b. Estimation Methodology for Lagged Exempted Sales

Section 1847A(c)(2) of the Act requires manufacturers to exclude from the calculation of ASP those sales that are exempt from the Medicaid best price (BP) calculation (for example, Federal sales, sales to State pharmacy assistance programs, sales to a prescription drug plan for use under Medicare Part D). In the comments on the April 6, 2004 IFC, commenters requested more guidance on the method manufacturers should use to exclude exempted sales that are known on a lagged basis. Manufacturers identify exempted sales based on direct sales and through chargeback and rebate data that may not be sufficiently available at the time the ASP is calculated. In the absence of specific guidance on how to account for lagged exempted sales (that is, exempted sales identified through chargeback or rebate processes), manufacturers have relied upon assumptions in accordance with their customary business practices to develop their approach for excluding these sales from the ASP calculation. In our work with manufacturers that submit ASP data, we understand that some manufacturers have used a ratio methodology for estimating exempted sales known on a lagged basis which is similar to the ratio methodology manufacturers must use to estimate

[[Page 49002]]

price concessions known on a lagged basis.

To establish a uniform approach, in Sec. 414.804(a)(4), we propose to require, in the final ASP reporting rule, that all manufacturers use a 12-month (or less, if applicable) rolling average ratio methodology to estimate exempted sales known on a lagged basis (through chargebacks or rebates) in order to more accurately exclude these sales from the ASP calculation. Specifically, for exempted sales known on a lagged basis, the manufacturer sums the lagged exempted sales for the most recent 12-month period available (or the number of months the NDC has been sold for NDCs with less than 12 months of sales, except for redesignated NDCs as described in section d below). The manufacturer then calculates a percentage using this summed amount as the numerator and the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the same period (12 months or less, if applicable) as the denominator. The result is a rolling average percentage estimate for lagged exempted sales that is applied to the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the quarter being reported. The product that results from multiplying the rolling average percentage estimate of lagged exempted sales and sales (the number of units after non-lagged exempted sales have been subtracted from total sales) determines the number of lagged exempted sales (in units) to be excluded from the denominator of the ASP calculation. Manufacturers must make a corresponding adjustment to the numerator of the ASP calculation to ensure that the total in dollars for the reporting quarter does not include revenue related to lagged exempted sales excluded from the denominator using the proposed estimation methodology. Further, manufacturers must remove the dollar value of lagged exempted sales from their estimates of lagged price concessions by subtracting the dollar value of estimated lagged exempted sales from the denominator as specified in Sec. 414.804(a)(3)(i).

Our proposed methodology for excluding lagged exempted sales is similar to the methodology manufacturers are required to use to estimate price concessions known on a lagged basis, and was recommended by manufacturers. We believe requiring similar methods to estimate both lagged exempted sales and lagged price concessions is reasonable and reduces potential errors in the manufacturers' ASP calculations, while ensuring that exempted sales are appropriately removed from the ASP calculation. In addition, using an estimation methodology to remove lagged exempted sales reduces the likelihood of quarter to quarter variations in the ASP.

We seek comments on the proposed methodology for excluding exempted sales known on a lagged basis from the ASP calculation and estimate of lagged price concessions. We also solicit suggestions on appropriate alternative methodologies that may be less complex. c. Nominal Sales

Section 1847A(c)(2)(B) of the Act requires manufacturers to exclude from the ASP calculation sales that are merely nominal in amount, as applied for purposes of section 1927(c)(1)(C)(ii)(III) of the Act, except as the Secretary may otherwise provide. Effective January 1, 2007, the DRA (Pub. L. 109-171) modifies section 1927(c)(1)(C)(ii)(III) of the Act. Limitations on nominal sales have been added in new section 1927(c)(1)(D) of the Act. The DRA also modified the average manufacturer price (AMP) calculation and frequency of AMP reporting. Therefore, we are proposing to clarify the method manufacturers must follow, beginning in 2007, to identify nominal sales for ASP reporting purposes and to exclude nominal sales from the calculation of the ASP. We also are seeking comments on whether we should establish an alternative definition of nominal sales for ASP purposes.

In the preamble to the ASP reporting interim final rule, we stated sales to an entity that are nominal in amount are defined in the Medicaid drug rebate agreement (see sample agreement at http://www.cms.hhs.gov/MedicaidDrugRebateProgram/downloads/rebateagreement.pdf ). That is, for ASP purposes, a nominal sale is a

sale at a price less than 10 percent of the AMP in the same quarter for which the AMP is computed. Effective January 1, 2007, the DRA revises the AMP calculation (to omit customary prompt pay discounts extended to wholesalers), added a monthly AMP reporting requirement, and established limitations on nominal sales (only sales to certain entities may qualify as nominal sales). Section 1927(c)(1)(D) of the Act limits the nominal sales exclusion to nominal sales made to the following entities:

340B covered entities as described in section 340B(a)(4) of the Public Health Services Act (PHS Act).

Intermediate care facilities for the mentally retarded (ICFs/MR).

State-owned or operated nursing facilities.

Any other facility or entity that the Secretary determines is a safety net provider to which sales of such drugs at a nominal price would be appropriate based on the factors described in section 1927(c)(1)(D)(ii) of the Act.

Because section 1847A(c)(2)(B) of the Act requires manufacturers to exclude from the ASP calculation sales that are merely nominal in amount, as applied for purposes of section 1927(c)(1)(C)(ii)(III) of the Act, except as the Secretary may otherwise provide, the DRA changes will have implications for ASP reporting beginning January 1, 2007 (unless we provide an alternative policy for determining nominal sales as permitted under section 1847A(c)(2)(B) of the Act). One implication is that the limitations set forth in section 1927(c)(1)(D) of the Act will continue the exclusion of nominal sales to certain entities while requiring that sales to entities not identified under section 1927(c)(1)(D) of the Act are included in the ASP calculation, even if such sales are at very low prices. Another implication is the AMP calculation will exclude customary prompt pay discounts extended to wholesalers, yet prompt pay discounts will continue to be a type of price concession that manufacturers must include in their ASP calculations. The change in treatment of customary prompt pay discounts extended to wholesalers in the AMP calculation may result in a higher number of sales that are at less than 10 percent of the AMP than in past ASP reporting periods (notwithstanding the new limitation on what is considered a nominal sale under section 1927(c)(1)(D) of the Act). Still another implication is that the frequency of AMP reporting will include monthly reporting; thus, for ASP purposes, there is further need to clarify how nominal sales are to be identified in 2007. Separate Medicaid rulemaking will address the DRA provisions related to AMP reporting.

We believe the DRA modifications to section 1927 of the Act noted above will have minimal effect on reported ASPs. We would expect that the exclusion of customary prompt pay discounts extended to wholesalers from AMP would lead to a modest increase in AMP, and as a result a modest increase in the number of sales that would qualify as nominal under the current ASP reporting regulations. At the same time, we anticipate that the limitation on nominal sales in section 1927(c)(1)(D) of the Act will result in a modest reduction in the number of sales that qualify as nominal sales for

[[Page 49003]]

purposes of ASP reporting because we believe that the entities outlined in section 1927(c)(1)(D) of the Act generally represent the types of entities to which manufacturers may offer sales at a nominal amount. Consequently, we would expect these two countervailing changes would have a minimal overall impact on nominal sales that would be excluded from the ASP calculation. For 2007 and beyond, we propose to revise Sec. 414.804(a)(4) to clarify that manufacturers must continue to use the Medicaid threshold (less than 10 percent of AMP) to determine nominal sales that are excluded (subject to the limitations in section 1927(c)(1)(D) of the Act) from the ASP calculation. Further, we propose that, in identifying nominal sales, manufacturers must use the AMP for the calendar quarter that is the same calendar quarter for the ASP reporting period. For these reasons, we are proposing to continue the current methodology for identifying and excluding nominal sales (that is, sales that are exempt from the Medicaid best price calculation under section 1927(c)(1)(C)(ii)(III) of the Act) from the manufacturer's calculation of the ASP. We believe this approach helps maintain continuity in the ASP calculation and minimizes manufacturers' reporting burden, as Medicare continues to follow the Medicaid approach for identifying nominal sales and manufacturers can use a single method for identifying nominal sales for both ASP and AMP purposes.

We seek comments on our proposal to continue use of the AMP as the basis for identifying nominal sales excluded from the ASP calculation and on whether an alternative threshold for identifying nominal sales for ASP calculation purposes is necessary or desirable to ensure the accuracy of the ASP payment methodology. Specifically, we seek comments on whether sales at less than 10 percent of the ASP (instead of the AMP) should be used to identify nominal sales for ASP purposes (with the new requirement in section 1927(c)(1)(D) of the Act allowing only sales to certain entities to be considered nominal sales still being applicable). We also seek comments on our belief that the new limitations on nominal sales and change to the AMP calculation will have minimal impact on reported ASPs.

Subsequent to the April 6, 2004 IFC, we received requests for clarification on a technical aspect related to the identification of nominal sales. Specifically, some manufacturers have asked whether nominal sales are identified by performing a series of calculations once or whether the manufacturer repeats the series of calculations until no remaining ASP eligible sales are below the nominal threshold. Consistent with current Medicaid reporting, for 2005 and 2006, manufacturers must identify nominal sales by performing the following steps once:

The manufacturer calculates the AMP for the reporting quarter to identify the dollar amount that represents 10 percent of the AMP for that reporting period.

The manufacturer then identifies sales below this amount and excludes these sales from the ASP calculation.

Beginning in 2007, the limitations in section 1927(c)(1)(D) of the Act must also be met to exclude the sale. d. Other Price Concession Issues

In our ongoing work with manufacturers that submit ASP data, some manufacturers have posed questions or raised concerns about how the estimate of lagged price concessions is done prior to having 12 months of data for a NDC and, when a product is redesignated with a new NDC, whether price concessions from the prior NDC must be included in calculating the ASP for the new NDC. Manufacturers and other stakeholders have also asked us about how Medicare's ASP guidance concerning price concessions is to be applied when drugs are sold under bundling arrangements.

In response, we are proposing clarifications and seeking comment on these issues. (1) Price Concessions for NDCs With Less Than 12 Months of Sales

To address situations when a NDC with price concessions known on a lagged basis has not been sold for a full 12 months, we propose to revise Sec. 414.804(a)(3) to specify that the period used to estimate lagged price concessions is the total number of months the NDC has been sold. We propose to require that manufacturers use less than 12 months of data in the estimation methodology for lagged price concessions for NDCs with less than 12 months of sales (except when the manufacturer has redesignated the product's NDC, as discussed below). Manufacturers may include the current ASP reporting quarter in the most recent 12 month period (or less for NDCs with less than 12 months of sales) so long as the manufacturer follows this approach in calculating the ASP for all of its reported NDCs. Using less than 12 months in the estimation methodology for lagged price concessions is consistent with our proposal for estimating lagged excluded sales described in section b. above. (2) Redesignated NDCs

From time to time, a manufacturer may change the NDC assigned to a specific product and package size while continuing or offering price concessions that span across sales of the product under its prior and redesignated NDCs. For example, an NDC may be changed to reflect a change in the labeler code while lagged price concessions in place under the prior NDC remain in effect and carry over to the redesignated NDC. Another example would be a manufacturer that modifies its package design or other non-drug feature of the NDC and assigns a new NDC to reflect the revised packaging.

We propose to clarify in the final ASP reporting rule that, when an NDC is changed (except when a product is repackaged or relabeled by a different manufacturer or relabeler or is privately labeled) and lagged price concessions offered for the prior NDC remain in effect, the manufacturer must use 12 months (or the total number of months of sales of the prior and redesignated NDCs if the total number of months of sales is less than 12 months) of sales and price concession data from the prior and redesignated NDCs to estimate lagged price concessions applicable to the redesignated NDC. In establishing this methodology, we are relying on our authority under section 1847A(c)(5)(A) of the Act.

We seek comments on our proposed refinements to the estimation of lagged price concessions for NDCs with less than 12 months of sales and when a manufacturer redesignates the NDC assigned to a product. We also solicit suggestions for potentially clarifying these policies further. (3) Bundled Price Concessions

We have heard a few concerns about how Medicare's ASP guidance concerning price concessions is to be applied when drugs are sold under bundling arrangements (for example, when a purchaser's price for one or more drugs is contingent upon the purchase of other drugs or items). We would like to better understand how bundling affects sales of Part B drugs and the ASP calculation, and any concerns stakeholders may have on this issue. Therefore, we are soliciting comments on a number of these issues. We note that we expect manufacturers of drugs reimbursed by Medicare Part B to comply with all applicable laws, regulations, and legal decisions including, but not limited to the Stark law, other relevant anti-kickback laws,

[[Page 49004]]

antitrust laws, and laws governing fair trade practices. Our discussion of this issue in this proposed rule should not be construed as an endorsement or authorization of any pricing practices that contravene any laws, legal decisions, or regulations.

Thus far, we have not provided specific guidance in the ASP context on the issue of apportioning price concessions across drugs that are sold under bundling arrangements. In the absence of specific guidance, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and the intent of the Social Security Act, Federal regulations, and its customary business practices. Manufacturers must include assumptions in their ASP submissions. We are now considering providing guidance, through rulemaking or through program instruction or other guidance (consistent with our authority under section 1847A(c)(5)(C) of the Act) on the methodology manufacturers must use for apportioning price concessions across Part B drugs sold under bundling arrangements for purposes of the calculation of ASP. As we consider this issue, our goal is to ensure that the ASP is an accurate reflection of market prices for Part B drugs and that the treatment of bundled price concessions in the ASP calculation does not create inappropriate financial incentives.

We are soliciting comments on a number of issues, including how frequently Part B drugs are sold under bundling arrangements, the different structures of bundling arrangements that may exist (for example, the number of products included in a bundling arrangement; whether the price concessions are contingent on the purchase of only one product, the purchase of multiple products, or the inclusion of one or more products on a formulary; and the timing of the price concessions), and the extent to which sales of Part B drugs are bundled with sales of non-Part B drugs or non-drug products. We also seek comment on what effect bundling arrangements may have on the ASP calculation, on beneficiary access to high quality, appropriate care (including access to drugs that may not have clinical alternatives), and on costs to the Medicare program and beneficiaries. In addition, we seek comments on whether additional guidance on apportioning bundled price concessions for purposes of the calculation of ASP is needed and potential methodologies that Medicare could consider requiring. Furthermore, we seek comment on how variation in the structure of bundling arrangements may affect the impact of potential apportionment methodologies on the ASP calculation. 2. Clotting Factor Furnishing Fee

Section 303(e)(1) of the MMA added section 1842(o)(5) of the Act which requires the Secretary, beginning in CY 2005, to pay a furnishing fee, in an amount the Secretary determines to be appropriate, to hemophilia treatment centers and homecare companies for the items and services associated with the furnishing of blood clotting factor. Section 1842(o)(5)(C) of the Act specifies that the furnishing fee for clotting factor for years after CY 2006 and subsequent years will be equal to the fee for the previous year increased by the percentage increase in the consumer price index (CPI) for medical care for the 12 month period ending with June of the previous year. In the CY 2006 PFS final rule, we announced that, based on the percentage increase in the CPI of 4.2 percent for the 12-month period ending June 2005, the furnishing fee is $0.146 per unit clotting factor for CY 2006.

The CPI data for the 12-month period ending in June 2006 is not yet available. In the FY 2007 PFS final rule, we will include the actual figure for the percent change in the CPI for medical care for the 12- month period ending June 2006, and the updated furnishing fee for CY 2007 calculated based on that figure. 3. Widely Available Market Prices (WAMP) and AMP Threshold

Section 1847A(d)(1) of the Act states that ``the Inspector General of HHS shall conduct studies, which may include surveys to determine the widely available market prices (WAMP) of drugs and biologicals to which this section applies, as the Inspector General, in consultation with the Secretary, determines to be appropriate.'' Section 1847A(d)(2) of the Act states that, ``Based upon such studies and other data for drugs and biologicals, the Inspector General shall compare the ASP under this section for drugs and biologicals with--

The widely available market price (WAMP) for these drugs and biologicals (if any); and

The average manufacturer price (AMP) (as determined under section 1927(k)(1) of the Act for such drugs and biologicals.''

Section 1847A(d)(3)(A) of the Act states that, ``The Secretary may disregard the ASP for a drug or biological that exceeds the WAMP or the AMP for such drug or biological by the applicable threshold percentage (as defined in subparagraph (B)).'' The applicable threshold is specified as 5 percent for CY 2005. For CY 2006 and subsequent years, section 1847A(d)(3)(B) of the Act establishes that the applicable threshold is ``the percentage applied under this subparagraph subject to such adjustment as the Secretary may specify for the WAMP or the AMP, or both.'' In CY 2006, we specified an applicable threshold percentage of 5 percent for both the WAMP and AMP. We based this decision on the limited data available to support a change in the current threshold percentage.

For CY 2007, we propose to specify an applicable threshold percentage of 5 percent for the WAMP and the AMP. At present, the OIG is continuing its comparison of both the WAMP and the AMP. Since, at this time we do not have data that suggest another level is more appropriate, we believe that continuing the 5 percent applicable threshold percentage for both the WAMP and AMP is appropriate.

There are a number of operational issues associated with Medicare's authority to substitute a lower payment amount for a drug if the OIG finds and informs the Secretary, at such times as the Secretary may specify, that the ASP exceeds the WAMP or AMP by more than the established threshold (currently 5 percent). We would welcome public comment on operational issues such as the timing and frequency of the ASP, AMP, and WAMP comparisons and effective date and duration of the rate substitution. 4. Payment for Drugs Furnished During CY 2006 and Subsequent Years in Connection With the Furnishing of Renal Dialysis Services if Separately Billed by Renal Dialysis Facilities

In the November 21, 2005 PFS final rule (70 FR 70116), we stated that payment for a drug furnished during CY 2006 in connection with renal dialysis services and separately billed by freestanding renal dialysis facilities and hospital-based facilities would be based on section 1847A of the Act. We intended this to mean CY 2006 and subsequent years. Therefore, in this proposed rule, we are not proposing a policy change, but rather, we are clarifying that this policy will apply to CY 2006 and subsequent years until otherwise specified.

G. Proposed Provisions Related To Payment for Renal Dialysis Services Furnished by End-Stage Renal Disease (ESRD) Facilities

[If you choose to comment on issues in this section, please include the

[[Page 49005]]

caption ``ESRD PROVISIONS'' at the beginning of your comments.]

Since August 1, 1983, payment for dialysis services furnished by ESRD facilities has been based on a composite rate payment system that provides a fixed, prospectively determined amount per dialysis treatment, adjusted for geographic differences in area wage levels. In accordance with section 1881(b)(7) of the Act, separate composite rates have been established for hospital-based and independent ESRD facilities. The composite rate is designed to cover a package of goods and services needed to furnish dialysis treatments that include certain routinely provided drugs, laboratory tests, supplies, and equipment. Unless specifically included in the composite rate, other injectable drugs and laboratory tests medically necessary for the care of the dialysis patient are separately billable. The base composite rates per treatment, effective on August 1, 1983, were $123 for independent ESRD facilities and $127 for hospital-based ESRD facilities. The Congress has enacted a number of adjustments to the composite rate since that time. The current 2006 base composite rates are $130.40 for independent ESRD facilities and $134.53 for hospital-based ESRD facilities.

Section 623 of the MMA amended section 1881 of the Act to require changes to the composite rate payment methodology, as well as to the pricing methodology for separately billable drugs and biologicals furnished by ESRD facilities.

Section 1881(b)(12) of the Act, as added by MMA, required the establishment of a basic case-mix adjusted prospective payment system (PPS) that would include the services comprising the composite rate and an add-on to the composite rate component for the difference between current payments for separately billed drugs and the revised drug pricing specified in the statute. In addition, section 1881(b)(12) of the Act required that the composite rate be adjusted for a limited number of patient characteristics (case-mix) and section 1881(b)(12)(D) of the Act gave the Secretary discretion to revise the wage indices and the urban and rural definitions used to develop them. Finally, section 1881(b)(12)(E) of the Act imposed a budget neutrality requirement, so that aggregate payments under the basic case-mix adjusted composite payment system for 2005 would equal the aggregate payments that would have been made for the same period if section 1881(b)(12) of the Act did not apply.

Before January 1, 2005, payment to both independent and hospital- based facilities for the anti-anemia drug, Erythropoietin (EPO) was established pursuant to section 1881(b)(11) of the Act at $10.00 per 1,000 units. For independent ESRD facilities, payment for all other separately billable drugs and biologicals was based on the lower of actual charges or 95 percent of the average wholesale price (AWP). Hospital-based ESRD facilities were paid based on the reasonable cost methodology for separately billed drugs and biologicals (other than EPO) furnished to dialysis patients. Changes to the payment methodology for separately billed ESRD drugs and biologicals that were established by the MMA and were effective January 1, 2005 are described in sections G.1. and G.2. below. These changes affected payments in both CYs 2005 and 2006. 1. CY 2005 Revisions

On November 15, 2004, we published the CY 2005 PFS final rule with comment period (69 FR 66319 through 66334), that revised payments to ESRD facilities based on changes enacted by the MMA. The November 15, 2004 final rule with comment period implemented section 1881(b) of the Act, as amended by section 623 of the MMA. Changes effective January 1, 2005, included implementation of a case-mix adjusted payment system that incorporates services that comprise the composite rate; an update of 1.6 percent to the composite rate component of the payment system; and a drug add-on of 8.7 percent to the composite rate for the difference between current payments for separately billable drugs and payments based on the revised drug pricing for 2005 which used acquisition costs. The final rule also implemented case-mix adjustments to the composite rate for a limited number of patient characteristics (age, low body mass index (BMI), and body surface area (BSA)), effective April 1, 2005.

In addition, to implement section 1881(b)(13) of the Act, we revised payments for drugs billed separately by independent ESRD facilities, paying for the top 10 ESRD drugs based on acquisition costs (as determined by the OIG) and for other separately billed drugs at the average sales price +6 percent (hereafter referred to as ASP+6 percent). Hospital-based ESRD facilities continued to receive cost- based payments for all separately billable drugs and biologicals except for EPO which was paid based on average acquisition costs. 2. CY 2006 Revisions

In the November 21, 2005 Federal Register (70 FR 70161), we published the CY 2006 PFS final rule with comment period (70 FR 70161) implementing additional revisions to payments to ESRD facilities under section 623 of the MMA. For CY 2006, we further revised the drug payment methodology applicable to drugs furnished by ESRD facilities. All separately billed drugs and biologicals furnished by both hospital- based and independent ESRD facilities are now paid based on ASP+6 percent.

We recalculated the 2005 drug add-on adjustment to reflect the difference in payments between the pre-MMA AWP pricing and the revised pricing based on ASP+6 percent. The recalculation did not affect the actual add-on adjustment applied to payments in 2005, but provided an estimate of what the adjustment would have been had the 2006 payment methodology been in effect in 2005. The drug add-on adjustment was then updated to reflect the expected growth in expenditures for separately billable drugs in CY 2006.

As of January 1, 2006, we also implemented a revised geographic adjustment authorized by section 1881(b)(12) of the Act. As part of that change, we--

Revised the labor market areas to incorporate the new CBSA designations established by the Office of Management and Budget (OMB);

Eliminated the wage index ceiling and reduced the floor to .8500; and

Revised the labor portion of the composite rate to which the geographic adjustment is applied.

We also provided a 4-year transition from the previous wage- adjusted composite rates to the current wage-adjusted rates. For CY 2006, only 25 percent of the payment is based on the revised geographic adjustments, and the remaining 75 percent of payment is based on the old Metropolitan Statistical Area-based (MSA-based) payments.

In addition, section 5106 of the DRA (Pub. L. 109-171), provided for a 1.6 percent update to the composite rate component of the basic case-mix adjusted payment system, effective January 1, 2006. As a result, the current base composite rate is $130.40 for independent ESRD facilities and $134.53 for hospital-based facilities. The drug add-on adjustment (including the growth update) for 2006 is 14.5 percent. 3. Provisions of the Proposed Rule

For CY 2007, we are proposing the following provisions which are described in more detail below:

[[Page 49006]]

A method to annually calculate the growth update to the drug add-on adjustment required by section 1881(b)(12) of the Act, as well as an estimated growth update adjustment to the add-on amount of 0.6 percent for CY 2007.

An update to the wage index adjustments to reflect the latest hospital wage data, including a budget neutrality adjustment of 1.053069 to the wage index for CY 2007. 4. Proposed Growth Update to the Drug Add-On Adjustment to the Composite Rates

Section 623(d) of the MMA added section 1881(b)(12)(B)(ii) of the Act which required the establishment of an add-on to the composite rate to account for changes in the drug payment methodology stemming from enactment of the MMA. Section 1881(b)(12)(C) of the Act provides that the drug add-on must reflect the difference in aggregate payments between the revised drug payment methodology for separately billable ESRD drugs (acquisition costs in CY 2005; ASP+6 percent in CY 2006) and the AWP payment methodology in effect in CY 2004.

In addition, section 1881(b)(12)(F) of the Act requires that, beginning in CY 2006, we establish an annual update to the drug add-on to reflect estimated growth in expenditures for separately billable drugs and biologicals furnished by ESRD facilities. This growth update applies only to the drug add-on portion of the case-mix adjusted payment system.

The CY 2006 drug add-on adjustment to the composite rate is 14.5 percent. The drug add-on adjustment for CY 2006 incorporates an inflation adjustment of 1.4 percent. This computation is explained in detail in the CY 2006 PFS final rule with comment period (70 FR 70162). We note that the drug add-on adjustment of 14.7 percent that was published in November 21, 2005 PFS final rule with comment period did not account for the 1.6 percent update to the composite rate portion of the basic case-mix adjustment payment system that was subsequently enacted by the DRA, effective January 1, 2006. Since we compute the drug add-on adjustment as a percentage of the weighted average base composite rate, the drug add-on percentage was decreased to account for the higher composite payment rate resulting in a 14.5 percent add-on adjustment for CY 2006. This adjustment was necessary to ensure that the total drug add-on dollars remained constant. a. Estimating Growth in Expenditures for Drugs and Biologicals for CY 2007

In developing the growth update to the drug add-on for CY 2006 we conducted a trend analysis of prior years' ESRD drug expenditure data (2001 through 2004). All 4 years of data used for the trend analysis reflected expenditures associated with payment for separately billed drugs and biologicals under the AWP methodology. We could, therefore, develop growth estimates for CY 2006 using comparable historical expenditure data. To extend the trend analysis for CY 2007, we would need to include drug expenditure data from CY 2005. However, in CY 2005, section 1881(b)(13)(A)(ii) of the Act required that we use a different drug payment methodology, based on average acquisition costs, rather than the AWP methodology used in prior years. Therefore, ESRD drug expenditure data for CY 2005 are not comparable to expenditure data for CY 2001 through CY 2004 for trend analysis purposes. This data issue will extend to subsequent years' data as well, as we are now paying for separately billable drugs using ASP+6 percent. Because we do not have comparable data on which to base continuing trend analysis, we believe it is necessary to re-evaluate our methodology for updating the drug add-on adjustment.

In order to address the issue of data comparability described above, we considered using available drug proxy measures to predict growth in ESRD drug expenditures for CY 2007. We note that section 1881(b)(12)(F) of the Act specifies that the drug update must reflect ``the estimated growth in expenditures for drugs and biologicals that are separately billable * * *.'' By referring to ``expenditures'', we believe the statute contemplates that the update would account for both increases in drug prices as well as increases in utilization of those drugs.

One available proxy measure that reflects both price and utilization is the national health expenditure projection for prescription drugs that is developed by CMS. However, because of uncertainties regarding the impact of the Medicare Part D prescription drug program on expenditures, we are concerned that the current estimates for CY 2007 will likely change, as actual Part D expenditure data become available. Therefore, we do not believe this measure would be an appropriate proxy measure for this purpose.

Another widely recognized proxy measure is the producer price index (PPI) for prescription drugs. The PPI is a good measure of drug pricing growth, but does not capture the growth in per patient drug utilization that must also be part of an accurate estimate of growth in ESRD drug expenditures. However, if the PPI is used in conjunction with an estimate of per patient growth in drug utilization, we believe this measure would provide a simple and accurate approach to updating the drug add-on that could be readily used in subsequent years. Moreover, using the PPI would significantly reduce any data bias that is inherent in using historical drug expenditure data that do not reflect current drug payment methodologies. As discussed in detail below, we are proposing to estimate growth in per patient utilization of drugs by using historical data from 2004 and 2005.

Another approach to estimating the growth in ESRD drug expenditures is to continue using historical trend analysis by making adjustments to the available data to permit year to year comparisons. This would be accomplished by making an adjustment to the CY 2005 data based on average acquisition price (AAP) using the weighted average difference between AWP prices and AAP prices. We would use trend analysis to project the growth in drug expenditures for CY 2007.

While we believe this approach is reasonably accurate for developing the CY 2007 growth estimates, since only one year of data would require adjustment, we are concerned about applying this methodology to future updates. Future year updates would require multiple year to year adjustments in prices. Moreover, historical AWP data does not provide an accurate measure of price changes for EPO under the revised drug payment methodology, since EPO pricing was held constant during that historical period.

In addition, our estimate of the weighted average difference between AAP prices and AWP prices (and ASP versus AWP prices in CY 2006) was based on a projection of price levels. It is likely that the weighted average difference would change based on actual pricing data for each of those years. To be consistent with the statute, we expect to update the established adjustment to reflect estimated growth in drug expenditures, but we do not anticipate re-computing the drug add- on adjustment annually. Adjusting our assumptions to estimate projected growth without changing the underlying assumptions in the add-on adjustment would create inconsistencies between the two elements. Therefore, we are proposing to discontinue use of older historical drug spending data to

[[Page 49007]]

estimate the growth update to the drug add-on adjustment. We will reconsider our methodology when we have sufficient historical data reflecting the revised drug payment methodology using ASP pricing.

For the reasons discussed above, we are proposing to develop an estimate of the growth in expenditures for ESRD drugs and biologicals using the PPI for prescription drugs as a measure of price increases in conjunction with two years of historical data from 2004 and 2005 as a basis for estimating utilization growth at the per patient level. We believe that this approach will best reflect the estimated growth in expenditures for ESRD drugs and biologicals. b. Estimating Growth in Per Patient Drug Utilization

To isolate and project the growth in per patient utilization of ESRD drugs for CY 2007, we need to remove the enrollment and price growth components from historical drug expenditure data and consider the residual utilization growth. We propose to use total drug expenditure data from CYs 2004 and 2005 to estimate per patient utilization growth for CY 2007.

We first needed to estimate total drug expenditures. For this proposed rule, we used the final CY 2004 ESRD claims data and the latest available CY 2005 ESRD facility claims, updated through December 31, 2005, that is, claims with dates of service from January 1 through December 31, 2005, that were received, processed, paid, and passed to the National Claims History File as of December 31, 2005. For the final rule, we will use more updated CY 2005 claims with dates of service for the same time period. This updated CY 2005 data file will include claims that are received, processed, paid, and passed to the National Claims History File as of June 30, 2006.

While the December 2005 update of CY 2005 claims used in this proposed rule is the most recently available claims data, we recognize that it is not a fully complete year as claims with dates of service towards the end of the year have not all been processed. To more accurately estimate the update to the drug add-on, we need aggregate drug expenditures. Based on an analysis of the 2004 claims data, we inflated the CY 2005 drug expenditures to estimate the June 30, 2006 update of the 2005 claims file. We used the relationship between the December 2004 and the June 2005 versions of 2004 claims to estimate the more complete 2005 claims that will be available in June 2006. We applied that ratio to the 2005 claims data from the December 2005 claims file. We did this for drug expenditures in aggregate, for each of top ten separately billable drugs, and within each for independent and hospital-based ESRD facilities. All components were then combined to estimate aggregate CY 2005 ESRD drug expenditures. The net adjustment to the CY 2005 claims data was an increase of 13 percent to the 2005 expenditure data. This adjustment allows us to more accurately compare the 2004 and 2005 data, to estimate utilization growth.

The next step is to remove the enrollment and price growth components from that total. As discussed earlier in this section, in developing the per patient utilization growth for this proposed rule, we limited our analysis to the latest 2 years of available ESRD drug data, that is, 2004 and 2005. We believe that per patient utilization growth between these years would be a better proxy for future growth, as it best represents current utilization trends. Furthermore, because of the implementation of the new EPO utilization monitoring policy that took effect on April 1, 2006 (Medicare Claims Processing Manual, Chapter 8, section 60-4ff, p. 51-53), we believe that per patient utilization of ESRD drugs will remain relatively stable or decline slightly in future years. We note that EPO accounts for nearly 70 percent of ESRD drug expenditures.

To calculate the per patient utilization growth, we removed the enrollment component by using the growth in enrollment data between 2004 and 2005. This was approximately 3 percent. To remove the price effect we used a two-step process. First we calculated a weighted average between EPO and non-EPO price growth factors to account for the growth in pre-MMA pricing between 2004 and 2005. Since EPO was priced at $10 per thousand units prior to the enactment of the MMA, there is no growth for EPO. For the non-EPO drugs, we used the PPI as a proxy for the growth between the 2 years to maintain consistency with the established methodology for calculating the drug add-on adjustment which used the PPI to estimate the price growth in separately billable drugs (November 15, 2004, CY 2005 PFS final rule with comment period, 69 FR 66321). Next, we incorporated the estimated negative 13 percent weighted price difference between 2005 AWP and 2005 AAP pricing as was published in the CY 2005 PFS final rule with comment period (69 FR 66319 through 66334). This two-step process to account for the price effect from 2004 to 2005 led to an overall 12 percent reduction in price between 2004 and 2005.

After removing the enrollment and price effects from the expenditure data, we believe the residual growth would reflect the per patient utilization growth. To do this, we divided the product of the enrollment growth of 3 percent (1.03) and the price reduction of 12 percent (1.00 - .12 = .88) into the total drug expenditure decrease between 2004 and 2005 of 9 percent (1.00-.09 = .91). The result is a utilization factor equal to 1.00 (.91/(1.03 * .88) = 1.00).

As we observed no growth in per patient utilization of drugs between 2004 and 2005, we are, therefore, projecting no growth in per patient utilization for CY 2007.

1. Applying the Proposed Growth Update to the Drug Add-on Adjustment

In CY 2006, we estimated the growth update by trending drug expenditures forward based on four years of AWP payment data (CY 2001 through CY 2004). We then applied the estimated growth update percentage to the total amount of drug add-on dollars established for CY 2005 to come up with a dollar amount for the CY 2006 growth update. In addition, we projected the growth in dialysis treatments for CY 2006 based on the projected growth in ESRD enrollment. We divided the projected total dialysis treatments for CY 2006 into the projected dollar amount of the CY 2006 growth to develop the per treatment growth update amount. This growth update amount, combined with the CY 2005 per treatment drug add-on amount, resulted in an average drug add-on amount per treatment of $18.88 (or a 14.5 percent adjustment to the composite rate) for CY 2006.

Beginning in CY 2007, we are proposing to annually update the per treatment drug add-on amount of $18.88 established in CY 2006 and convert the update to an adjustment factor as stipulated in section 1881(b)(12)(F) of the Act. As explained above, we believe this approach is more accurate than recalculating the per treatment add-on adjustment each year using an estimate of growth in treatments. We note that we had received comments that our projections of treatment growth used to calculate the CY 2006 adjustment may have been overstated, however, we believe that the use of enrollment data was and remains the best measure available to predict treatment growth. By proposing to apply the update to the CY 2006 per treatment add-on amount, this estimation component is eliminated for CY 2007 and future years.

[[Page 49008]]

2. Proposed Update to the Drug Add-On Adjustment

As discussed above, we estimate no growth in per patient utilization of ESRD drugs for CY 2007. Using the projected CY 2007 PPI for prescription drugs of 4.9 percent, we are projecting that the combined growth in per patient utilization and pricing for CY 2007 would result in an update equal to the PPI or 4.9 percent (1.0*1.049 = 1.049). This update factor would be applied to the CY 2006 average per treatment drug add-on amount of $18.88 (reflecting a 14.5 percent adjustment in CY 2006), resulting in a proposed weighted average increase to the composite rate of $.93 for CY 2007 or a 0.6 percent increase in the CY 2006 drug add-on percentage. Thus, the total proposed drug add-on adjustment to the composite rate for CY 2007, including the growth update, would be 15.2 percent (1.145*1.006 = 1.152).

In addition, we are proposing to continue to use this method to estimate the growth update to the drug add-on component of the case-mix adjusted payment system until we have at least three years worth of ASP-based historical drug expenditure data that could be used to conduct a trend analysis to estimate the growth in drug expenditures. Given the time lag in the availability of ASP drug expenditure data, we expect that the earliest we could consider using trend analysis to update the drug add-on adjustment would be 2010. We propose to reevaluate our methodology for estimating the growth update at that time. c. OIG Report on New Drug Codes

Section 623(c)(1) of the MMA mandated that the OIG conduct two studies to determine the difference between the Medicare payment amount for separately billable ESRD drugs and the facilities'' acquisition costs for these drugs, as well as estimating the growth rate of expenditures for these drugs. The initial study, ``Medicare Reimbursement for Existing End Stage Renal Disease Drugs'' (OEI-03-04- 00120) was completed in May 2004, and reported on existing ESRD drugs. This report was used to set the CY 2005 reimbursement rates for ESRD drugs billed by independent dialysis facilities (69 FR 66322). The second study (``Medicare Reimbursement for New ESRD Drugs'' (OEI-03-06- 00200)) focused on new drugs. New drugs for the purpose of this study were defined as an ESRD drug that did not have a BILLING CODE prior to January 1, 2004.

One drug, darbepoetin alfa (Aranesp) accounted for the majority of all payments for new drugs. Therefore, this was the only new ESRD drug studied. The OIG report found that use of this drug was limited to a small number of facilities (only 157 facilities reported using this drug with concentrated use in approximately 55 of these facilities). Because of the recent changes we made to the drug payment methodology and the lack of comparable historical data, the OIG report made no estimate of an expenditure growth rate for this drug.

Darbepoetin alfa (Aranesp) is currently paid as a separately billable drug at ASP+6 percent. Because of the recent (CY 2006) implementation of the ASP+6 percent drug reimbursement methodology, the small number of facilities using this drug for ESRD patients, and the lack of historical data for trending purposes, we have no data to indicate that any difference in payment methods for Aranesp (between 2004 and 2006) would affect our calculation of the drug add-on or of the growth update. Moreover, since Aranesp was approved in 2001 for use in ESRD patients, we believe that expenditures for Aranesp were reflected in the historical data used to establish the 2005 drug add-on under a generic drug code. Therefore, we are proposing to make no additional changes to the drug add-on adjustment for CY 2007. 5. Proposed Update to the Geographic Adjustments to the Composite Rates

Section 1881(b)(12)(D) of the Act, as amended by section 623(d) of the MMA, gave the Secretary the authority to revise the wage indexes previously applied to the ESRD composite rates. The wage indexes are calculated for each urban and rural area. The purpose of the wage index is to adjust the composite rates for differing wage levels covering the areas in which ESRD facilities are located. a. Updates to CBSA Definitions

In the CY 2006 PFS final rule with comment period (70 FR 70167), we announced our adoption of the OMB's CBSA-based geographic area designations to develop revised urban/rural definitions and corresponding wage index values for purposes of calculating ESRD composite rates. OMB's CBSA-based geographic area designations were described in Bulletin 03-04 originally issued June 6, 2003. On February 22, 2005 and December 5, 2005, OMB released Bulletins 05-02 and 06-01, respectively. Those bulletins contained updates to the metropolitan and micropolitan statistical area designations initially announced in Bulletin 03-04. OMB's revisions had no effect on the classification of counties which comprise the urban and rural areas used to develop the ESRD wage index values. However, Bulletins 05-02 and 06-01 changed the titles of several of the MSAs and Metropolitan Divisions used in connection with the ESRD urban wage index. Table 5 below, which contains the proposed wage index values for the ESRD urban areas, includes all of the changes announced by OMB in the February 22, 2005 and December 5, 2005 bulletins. b. Updated Wage Index Values

In the CY 2006 PFS final rule with comment period, we stated that we intended to update the wage index values annually (70 FR 70167). Current ESRD wage index values for CY 2006 were developed from FY 2002 wage and employment data obtained from the Medicare hospital cost reports. The values are calculated without regard to geographic reclassifications authorized under sections 1886(d)(8) and (d)(10) of the Act and utilize pre-floor hospital data that is unadjusted for occupational mix.

The methodology for calculating the CY 2006 wage index values was described in the CY 2006 PFS final rule with comment period (70 FR 70168). We propose to use the same methodology for CY 2007, with the exception that FY 2003 hospital data will be used to develop the CY 2007 ESRD wage index values. For a detailed description of the development of the proposed CY 2007 ESRD wage index values based on FY 2003 hospital data, see the FY 2007 IPPS proposed rule entitled, ``Proposed Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2007 Rates,'' (April 25, 2006, 71 FR 24080). Section III F. (Computation of the Proposed FY 2007 Unadjusted Wage Index) of the preamble to that proposed rule describes the cost report schedules, line items, data elements, adjustments, and wage index computations. The wage index data affecting ESRD composite rates for each urban and rural locale may also be accessed on the CMS website at: http://www.cms.hhs.gov/AcuteInpatientPPS/WIFN/list.asp.

The wage data are located in the section entitled, ``FY 2007 Proposed Rule Occupational Mix Adjusted and Unadjusted Average Hourly Wage and Pre-reclassified Wage Index by CBSA''. (1) Wage Index Values for Areas With No Hospital Data

In CY 2006, while adopting the CBSA designations, we identified a small number of ESRD facilities in both urban and rural geographic areas where there

[[Page 49009]]

is no hospital wage data on which to base the calculations of the CY 2006 ESRD wage index values. Our CY 2005 policy and CY 2006 proposal for each area are discussed separately below.

The first situation was rural Massachusetts. Because there were no reasonable proxies for rural data within Massachusetts, we used the prior year's acute care hospital wage index value for rural Massachusetts. For CY 2007, we propose to continue to use this value and request public input on an alternative methodology.

Since there may be additional rural areas in the future similarly impacted by a lack of hospital wage data on which to derive a hospital wage index, we are considering alternative methodologies for imputing a rural wage index for areas in States where no hospital wage data are available. We believe that an evaluation of alternative methodologies for imputing a rural wage index in these areas should adhere to four basic policy criteria. First, an alternative methodology should retain our current longstanding policy to use pre-floor, pre-reclassified hospital wage data to compute wage index values for post acute care facilities, including ESRD facilities. Second, any methodology to impute a rural wage index should use rural wage data to derive the rural wage index value. Third, any methodology to impute a rural wage index should be easy to evaluate. Fourth, any methodology to impute a rural wage index would be able to update wage data from year-to-year.

We arrived at one alternative that meets all of the above policy criteria. Under this alternative, we would impute a rural wage index value by using a simple average CBSA-based rural wage index value at the Census Division level. Census Divisions are defined by the U.S. Census Bureau and may be found at (http://www.census.gov/geo/www/us_regdiv.pdf ). As stated above, for CY 2007, hospital wage data are not

available to compute a rural wage index for ESRD facilities in rural Massachusetts, and this alternative methodology could be applied in this case. Massachusetts is located in Census Division I (New England). The States in this Census Division, and their respective rural wage index values (using hospital cost report wage data for FY 2003) include--

Connecticut (1.1753);

Maine (0.8410);

New Hampshire (1.0800);

Vermont (0.9944)

Rhode Island (all five counties classified as urban); and

Massachusetts.

Under this alternative methodology, the States in Census Division I for which rural wage index values are available, as shown above, would be used; this would result in a simple average rural wage index value of 1.0227 (1.0770 after applying budget neutrality factor (BNF)). Although this methodology would result in a rural Massachusetts wage index that is currently greater than the value under the current proposed policy (1.0216, 1.0758 after applying BNF), we believe this methodology may be able to accurately reflect future increases or decreases of wage data for the States within the applicable Census Division.

Rural Puerto Rico is similar to rural Massachusetts in that there are ESRD facilities where there are no acute care hospitals and, therefore, no hospital data. However, the situation for facilities in rural Puerto Rico is different in that the floor would be applied to rural Puerto Rico ESRD facilities. All areas in Puerto Rico that have an index are eligible for the floor because they have wage-index values that are below .8000. For CY 2007, we propose to apply the floor to rural Puerto Rico.

The third situation involves an urban area in Hinesville, GA (CBSA 25980). For CY 2006, we used a wage index value based on wage index values in all of the other urban areas within the same State to serve as a reasonable proxy for the urban areas without hospital wage index data. Specifically, we used the average wage index value for all urban areas within the State of Georgia as the urban wage index for purposes of calculating the value for Hinesville for CY 2006. For CY 2007, we are proposing to continue using this method for Hinesville, GA (CBSA 25980).

We solicit comments on maintaining our current policy for establishing wage index values for rural and urban areas without hospitals, the alternative approach outlined above in developing wage index values for rural areas without hospitals for CY 2007 and subsequent years, and other methods that meet the policy criteria for imputing wage index values. We will also continue to evaluate existing hospital wage data and, possibly, wage data from other sources, such as the Bureau of Labor Statistics, to determine if other methodologies of imputing a wage index value where hospital wage data are not available may be feasible. (2) Second Year of the Transition

In the CY 2006 PFS final rule with comment period, we indicated that we would apply a 4-year transition period to mitigate the impact on composite rates resulting from our adoption of CBSA-based geographic designations (70 FR 70169). Beginning January 1, 2006, during each year of the transition, an ESRD facility's wage-adjusted composite rate (that is, without regard to any case-mix adjustments) will be a blend of its old MSA-based wage-adjusted payment rate and its new CBSA-based wage adjusted payment rate for the transition year involved. For each transition year, the share of the blended wage-adjusted base payment rate that is derived from the MSA-based and CBSA-based wage index values is shown in Table 4 below. In CY 2006, the first year of the transition, we implemented a 75/25 blend. CY 2007 is the second year of the 4-year transition period. Consistent with the transition blends announced in the November 21, 2005 PFS final rule with comment period (70 FR 70170), we are proposing a 50/50 blend between an ESRD facility's MSA-based composite rate, and its CY 2007 CBSA-based rate reflecting its revised wage index values.

In CY 2006, we also eliminated the wage index cap of 1.30, and stated that we would implement a gradual reduction in the wage index floor of .90. Prior to January 1, 2006, the wage indexes were restricted to values no less than .90 and no greater than 1.30, meaning that payments to facilities in areas where labor costs fell below 90 percent of the national average, or exceeded 130 percent of that average, were not adjusted beyond the 90 percent or 130 percent level. Although we stated that the ESRD wage index values should not be constrained by the application of floors and ceilings, we also expressed concern that the immediate elimination of the floor could adversely affect ESRD beneficiary access to care. Therefore, we reduced the floor to .85 in CY 2006.

For CY 2007, we are proposing to reduce the wage index floor to .80. As we stated in the CY 2006 PFS final rule with comment period, we intend to reassess the continuing need for a wage index floor in CY 2008 and CY 2009 (CY 2006 PFS final rule with comment period, November 21, 2005, 70 FR 70169 through 70170). The proposed wage index floors, caps, and blended shares of the composite rates applicable to all ESRD facilities during CYs 2007 through 2009 are shown in Table 4 below. They are identical to the values shown in Table 20 of the CY 2006 PFS final rule with comment period (70 FR 70170) for the applicable years.

[[Page 49010]]

Table 4.--Wage Index Transition Blend

Old MSA

New CBSA CY payment

Floor

Ceiling

(percent) (percent)

2007.............................. .80 *................ None.................

50

50 2008.............................. Reassess............. None.................

25

75 2009.............................. Reassess............. None.................

0

100

* Each wage index floor is multiplied by a budget neutrality adjustment factor. For CY 2007 the budget neutrality adjustment is 1.053069 resulting in an actual wage index floor of 0.8425.

An example of how the wage-adjusted composite rates would be blended during CY 2007 and the two subsequent transition years follows.

Example: An ESRD facility has a wage-adjusted composite rate (without regard to any case-mix adjustments) of $135.00 per treatment in CY 2006. Using CBSA-based geographic area designations, the facility's CY 2007 wage-adjusted composite rate, reflecting its wage index value as shown in Table 5 below, would be $145.00. During the remaining 3 years of the four-year transition period to the new CBSA-based wage index values, this facility's blended rate through 2009 would be calculated as follows:

CY 2007 .50 x $135.00 + .50 x $145.00 = $140.00 CY 2008 .25 x $135.00 + .75 x $145.00 = $142.50 CY 2009 0 x $135.00 + 1.0 x $145.00 = $145.00

We note that this hypothetical example assumes that the calculated wage-adjusted composite rate of $145.00 for CY 2007 does not change in CYs 2008 and 2009. In actuality, the wage-adjusted composite rate would change because of annual revisions to the wage index. However, the example serves only to demonstrate the effect on the composite rate of the CBSA-based wage index values which will be phased-in during the remaining 3 years of the transition period. c. Budget Neutrality Adjustment

Section 1881(b)(12)(E)(i) of the Act, as added by section 623(d) of the MMA, requires that any revisions to the ESRD composite rate payment system as a result of the MMA provision (including the geographic adjustment) be made in a budget neutral manner. This means that aggregate payments to ESRD facilities in CY 2007 should be the same as aggregate payments that would have been made if we had not made any changes to the geographic adjusters. We note that this budget neutrality adjustment only addresses the impact of changes in the geographic adjustments. A separate budget neutrality adjustment was developed for the case-mix adjustments, currently in effect. Since we are not proposing any changes to the case-mix measures for CY 2007, the current case-mix budget neutrality will remain in effect for CY 2007. For CY 2007, we again propose to apply a BNF directly to the ESRD wage index values, as we did in CY 2006. As we explained in the CY 2006 PFS final rule with comment period (70 FR 70170 through 70171), we believe this is the simplest approach because it allows us to maintain our base composite rates during the transition from the current wage adjustments to the revised wage adjustments described earlier in this section. Because the ESRD wage index is only applied to the labor-related portion of the composite rate, we computed the BNF adjustment based on that proportion (53.711 percent).

In order to compute the proposed CY 2007 wage index BNF, we used the wage index values in Tables 5 and 6 below, 2005 outpatient claims (paid and processed as of December 31, 2005), and geographic location information for each facility which may be found through Dialysis Facility Compare. Dialysis Facility Compare can be found by going to the following Web site: http://www.cms.hhs.gov/DialysisFacilityCompare/ .

Using treatment counts from the 2005 claims and facility-specific CY 2006 composite rates, we computed the estimated total dollar amount each ESRD provider would have received in CY 2006 (the first year of the 4-year transition). The total of these payments became the target amount of expenditures for all ESRD facilities for CY 2007. Next, we computed the estimated dollar amount that would have been paid to the same ESRD facilities using the proposed ESRD wage index for CY 2007 (the second year of the 4-year transition). The total of these payments became the second year new amount of wage-adjusted composite rate expenditures for all ESRD facilities.

After comparing these two dollar amounts (target amount divided by second year new amount), we calculated an adjustment factor that, when multiplied by the applicable CY 2007 ESRD wage index shown in Tables 5 and 6 below, will result in payments to each facility that will remain within the target amount of composite rate expenditures when totaled for all ESRD facilities. The proposed budget neutrality adjustment factor for the CY 2007 wage index is 1.053069.

To ensure budget neutrality we also must apply the BNF to the wage index floor of 0.8000 which results in a proposed adjusted wage index floor of 0.8425 for CY 2007. d. ESRD Wage Index Tables

The following two tables show the proposed CY 2007 ESRD wage index, including the BNF adjustment, for urban areas (Table 5) and rural areas (Table 6). BILLING CODE 4120-01-P

[[Page 49011]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.003

[[Page 49012]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.004

[[Page 49013]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.005

[[Page 49014]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.006

[[Page 49015]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.007

[[Page 49016]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.008

[[Page 49017]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.009

[[Page 49018]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.010

[[Page 49019]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.011

[[Page 49020]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.012

[[Page 49021]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.013

[[Page 49022]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.014

[[Page 49023]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.015

[[Page 49024]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.016

[[Page 49025]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.017

[[Page 49026]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.018

[[Page 49027]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.019

[[Page 49028]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.020

[[Page 49029]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.021

[[Page 49030]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.022

[[Continued on page 49031]]

From the Federal Register Online via GPO Access [wais.access.gpo.gov] ]

[[pp. 49031-49080]] Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2007 and Other Changes to Payment Under Part B

[[Continued from page 49030]]

[[Page 49031]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.023

[[Page 49032]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.024

[[Page 49033]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.025

[[Page 49034]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.026

[[Page 49035]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.027

[[Page 49036]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.028

[[Page 49037]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.029

[[Page 49038]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.030

[[Page 49039]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.031

[[Page 49040]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.032

[[Page 49041]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.033

[[Page 49042]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.034

[[Page 49043]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.035

[[Page 49044]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.036

[[Page 49045]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.037

[[Page 49046]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.038

[[Page 49047]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.039

[[Page 49048]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.040

[[Page 49049]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.041

[[Page 49050]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.042

[[Page 49051]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.043

[[Page 49052]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.044

BILLING CODE 4120-01-C

[[Page 49053]]

Table 6.--Proposed CY 2007 ESRD Wage Index for Rural Areas Based on CBSA Labor Market Areas

CBSA code

Nonurban area

Wage index

1.............................. Alabama................

0.8425 2.............................. Alaska.................

1.1247 3.............................. Arizona................

0.9398 4.............................. Arkansas...............

0.8425 5.............................. California.............

1.1902 6.............................. Colorado...............

0.9838 7.............................. Connecticut............

1.2377 8.............................. Delaware...............

1.0239 10............................. Florida................

0.9051 11............................. Georgia................

0.8425 12............................. Hawaii.................

1.1022 13............................. Idaho..................

0.8566 14............................. Illinois...............

0.8769 15............................. Indiana................

0.8927 16............................. Iowa...................

0.9159 17............................. Kansas.................

0.8425 18............................. Kentucky...............

0.8425 19............................. Louisiana..............

0.8425 20............................. Maine..................

0.8856 21............................. Maryland...............

0.9417 22............................. Massachusetts..........

1.0758 23............................. Michigan...............

0.9532 24............................. Minnesota..............

0.9653 25............................. Mississippi............

0.8425 26............................. Missouri...............

0.8425 27............................. Montana................

0.9062 28............................. Nebraska...............

0.9154 29............................. Nevada.................

0.9435 30............................. New Hampshire..........

1.1373 31............................. \1\ New Jersey......... .............. 32............................. New Mexico.............

0.8790 33............................. New York...............

0.8688 34............................. North Carolina.........

0.9055 35............................. North Dakota...........

0.8425 36............................. Ohio...................

0.9134 37............................. Oklahoma...............

0.8425 38............................. Oregon.................

1.0288 39............................. Pennsylvania...........

0.8774 41............................. \1\ Rhode Island....... .............. 42............................. South Carolina.........

0.8425 43............................. South Dakota...........

0.9038 44............................. Tennessee..............

0.8425 45............................. Texas..................

0.8425 46............................. Utah...................

0.8587 47............................. Vermont................

1.0472 48............................. Virgin Islands.........

0.8425 49............................. Virginia...............

0.8425 50............................. Washington.............

1.0827 51............................. West Virginia..........

0.8425 52............................. Wisconsin..............

0.9970 53............................. Wyoming................

0.9805

\1\ All counties in the States of New Jersey and Rhode Island are urban.

H. Private Contracts and Opt-Out Provision--Practitioner Definition

[If you choose to comment on issues in this section, please include the caption ``PRIVATE CONTRACTS AND OPT-OUT'' at the beginning of your comments.]

Section 4507 of the BBA of 1997 amended section 1802 of the Act to permit certain physicians and practitioners to opt-out of Medicare if certain conditions were met, and to provide through private contracts services that would otherwise be covered by Medicare. Before enactment of BIPA (Pub.L. 106-554), section 1802(b)(5)(C) of the Act, which refers to the definition of ``practitioner'' at section 1842(b)(18)(C) of the Act, did not include registered dietitians or nutrition professionals among the practitioners who may choose to opt-out of Medicare. Section 105(d) of BIPA amended the definition of practitioner located at section 1842(b)(18)(c) of the Act to include registered dietitians or nutrition professionals. Because section 1802(b)(5)(C) of the Act references section 1842(b)(18)(c) of the Act in order to define the term practitioner for purposes of opting out of Medicare, current law permits registered dietitians or nutrition professionals to opt-out of Medicare. Because the definition of practitioner located in the current regulations at Sec. 405.400 does not include registered dietitians or nutrition professionals, we are proposing to amend that section so that it is consistent with section 1802(b)(5)(C) of the Act.

[[Page 49054]]

I. Proposed Changes to Reassignment and Physician Self-Referral Rules Relating to Diagnostic Tests

[If you choose to comment on issues in this section, please include the caption ``REASSIGNMENT AND PHYSICIAN SELF-REFERRAL'' at the beginning of your comments.]

Historically, Medicare rules have prohibited the markup of the TC of certain diagnostic tests that are performed by outside suppliers and billed to Medicare by a different individual or entity. In addition, Medicare rules restrict who may bill Medicare for the PC (hereafter, also referred to as the ``interpretation'') of diagnostic tests. Recent changes to our rules on reassignment of the right to receive Medicare payment may have led to some confusion as to whether the anti-markup and purchased interpretation requirements apply to certain situations where a reassignment has occurred pursuant to a contractual arrangement.

Likewise, we are concerned about the existence of certain arrangements that are not within the intended purpose of our physician self-referral rules, which allow physician group practices to bill for services furnished by a contractor physician in a ``centralized building.'' We are concerned that allowing physician group practices or other suppliers to purchase or otherwise contract for the provision of diagnostic tests and then to realize a profit when billing Medicare may lead to patient and program abuse in the form of overutilization of services and result in higher costs to the Medicare program.

Therefore, we are proposing to amend our reassignment regulations to clarify how the purchased test and purchased test interpretation rules apply in the case of a reassignment made under the contractual arrangement exception set forth at Sec. 424.80(d)(2). Specifically, in our reassignment regulations, we propose to incorporate provisions similar to those that currently appear in Sec. 414.50 of our regulations on purchased tests, and we are considering incorporating provisions on purchased test interpretations that currently appear in our manual instructions. In addition, we are proposing to change the definition of ``centralized building'' at Sec. 411.351 of the physician self-referral regulations to place certain restrictions on what types of space ownership or leasing arrangements will qualify for purposes of the physician self-referral in-office ancillary services exception and physician services exception.

Our proposals regarding the reassignment regulations are based on existing requirements for purchased tests and purchased test interpretations. Section 1842(n) of the Act contains certain limitations on billing for the TC of diagnostic tests described in section 1861(s)(3) of the Act (other than clinical diagnostic laboratory tests paid under section 1833(a)(2)(D) of the Act, which are subject to the special rules set forth in section 1833(h)(5)(A) of the Act). Section 1842(n)(1)(A) of the Act provides that if the test was not performed by the billing physician and also was not performed or supervised by a physician with whom the billing physician shares a practice, Medicare payment is the lower of the costs (net of any discount) charged by the performing supplier to the billing physician, or the performing supplier's reasonable charge (or other applicable limit). This is commonly known as the anti-markup provision. Section 1842(n)(2) of the Act further provides that a physician may not bill a beneficiary any amount other than the amount specified in section 1842(n)(1)(A) of the Act and any applicable deductible and coinsurance. Under section 1842(n)(3) of the Act, if a physician knowingly, willfully, and repeatedly bills a Medicare beneficiary for more than the amount allowed under section 1842(n)(2) of the Act, he or she is subject to civil monetary penalties and assessments, and exclusion from Medicare and Medicaid for up to 5 years. Our regulations implementing section 1842(n) of the Act appear at Sec. 414.50 and Sec. 402.1(c)(15).

In addition, our Claims Processing Manual (Pub. 100-4) outlines certain conditions regarding who can submit a claim for purchased diagnostic test intepretations. As set forth in Chapter 1, Section 30.2.9.1 of the Claims Processing Manual, the following requirements must be satisfied in order to submit a claim for a purchased diagnostic test interpretation:

The test must be ordered by a physician or medical group that is independent of the person or entity performing the TC of the test, and also must be independent of the physician or medical group performing the interpretations.

The physician or medical group performing the interpretations does not see the patient.

The purchaser (or employee, partner, or owner of the purchaser) performs the TC of the test, and the interpreting physician must be enrolled in the Medicare program.

Section 1842(b)(6) of the Act generally prohibits Medicare payment to anyone other than the Medicare beneficiary or the physician or other person who performed the service for the beneficiary. However, section 1842(b)(6) of the Act, also provides exceptions, known as the reassignment exceptions, to this general rule. These exceptions allow us to make payment to an individual or an entity other than the beneficiary or the physician or other person who performed the service for the beneficiary. For example, the reassignment exceptions allow us to make payment to an employer of a physician, such as a group practice or a hospital, to which the physician employee has reassigned his or her right to payment.

Prior to the MMA, a physician or other individual supplier could reassign his or her right to bill and receive payment under a contractual arrangement, rather than an employee-employer relationship, only if the services being paid for were performed on the premises of the contracting hospital, critical access hospital, clinic, or other facility. Section 952 of the MMA, however, amended section 1842(b)(6)(A)(ii) of the Act to extend the reassignment exception to contractual arrangements regardless of whether the services are performed on the premises of the billing entity. Section 952 of the MMA permits us to recognize this type of reassignment to the extent that the contractual arrangement between the physician or other individual supplier and the billing entity (excluding a billing agent, which cannot receive reassigned benefits) meets program integrity and other safeguards as the Secretary may determine to be appropriate. A motivating factor behind the passage of section 952 of the MMA appears to have been the desire by the Congress to permit us to allow hospital emergency department staffing companies that employ physicians on a contract basis to bill Medicare (if the staffing companies enroll in Medicare).

Our proposed implementation of section 952 of the MMA appeared in the Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2005 proposed rule, 69 FR 47488, 47524 through 47525 (August 5, 2004). We proposed program safeguards, whereby the parties to the contractual arrangement would have joint and several liability for any Medicare overpayments, and the physician or other individual supplier would have unrestricted access to billings submitted on his or her behalf by the entity receiving reassigned payments. In that proposed rule, we stated our awareness that the changes to the reassignment rules authorized by section 952 of the MMA may create new fraud and abuse vulnerabilities, which may not become apparent until the program has

[[Page 49055]]

experience with new contractual arrangements. We solicited comments on these potential program vulnerabilities and on possible additional safeguards to protect against such vulnerabilities.

Comments submitted in response to the CY 2005 PFS proposed rule expressed concern over the recent growth of ``pod'' or ``condo'' laboratories (hereinafter ``pod labs''). In a typical pod lab arrangement involving pathology services, an entity leases space in a medical building and then subdivides the space into separate areas or cubicles, which are equipped with microscopes and a minimal amount of other laboratory equipment. The entity subleases each space to a physician group practice, even though the space may be located many miles away from any medical office of the group practice and is often located in a different state. The entity hires a histologist who performs the TC of the pathology service, by preparing a microscopic slide of each specimen for review by a pathologist. The entity also makes arrangements with a pathologist, who performs the PC of the pathology service and who also supervises the pod lab.

In one type of arrangement, the pathologist and histologist perform their services for the different group practices by moving from cubicle to cubicle. Each group practice pays the pathologist a fee for every slide reviewed and pays the entity a management fee, which covers the rental of the pod lab and the histologist's salary. The group practice then bills Medicare for the entire pathology service, typically at a markup from what the group practice paid the pathologist for the professional service and the entity for its services. In another common arrangement, the histologist performs the TC of the pathology service for the entity and the entity bills Medicare for that service, while the group practice bills for the interpretation that was performed by its independent contractor pathologist, who has reassigned to the group practice his or her right to receive Medicare payment.

The commenters stated that pod lab arrangements are subject to fraud, waste and abuse, including, but not limited to the following:

Generation of medically unnecessary biopsies.

Kickbacks.

Fee-splitting.

Referrals that would otherwise be prohibited under the physician self-referral statute.

The commenters provided several suggestions. One commenter suggested that we prohibit a physician from reassigning benefits to another physician if the physicians do not practice in substantially the same medical specialty. Some commenters also stated that our regulations need to state more clearly that all requirements of the purchased diagnostic test rules and purchased test interpretation rules need to be met.

In the CY 2005 PFS final rule, we responded that we shared the commenters concerns, although we declined to incorporate the suggested revisions at that time. We said that we would be paying close attention to this issue, and that we might initiate future rulemaking to address arrangements that are fraudulent or abusive. (See 69 FR 66316, November 15, 2004.) In that final rule, we amended our reassignment regulation at Sec. 424.80(a) to state that nothing in Sec. 424.80 alters an individual's or entity's obligations under other Medicare statutes or rules, including, but not limited to, the physician self-referral law (section 1877 of the Act), the anti-kickback statute (section 1128B(b)(1) of the Act), the regulations regarding purchased diagnostic tests, and the regulations regarding services and supplies provided incident to a physician's service.

At about the same time as we published our proposed rule for implementing section 952 of the MMA, we published an IFC concerning exceptions to the physician self-referral law in section 1877 of the Act (69 FR 16054). Section 1877 of the Act prohibits a physician from making referrals for DHS, as defined in section 1877(h)(6) of the Act, payable by Medicare to an entity with which he or she (or an immediate family member) has a financial relationship (ownership or compensation), and it prohibits the entity from billing Medicare, another payor, or the beneficiary for those referred services, unless an exception applies. The statute establishes a number of specific exceptions to these prohibitions and grants the Secretary the authority to create regulatory exceptions for financial relationships that pose no risk of fraud or abuse.

One significant exception is at Sec. 411.355(a) for the provision of ``physician services'' as defined in Sec. 410.20(a). Under this exception, professional physician services that are DHS must be furnished personally by another physician who is a member of the referring physician's group practice, or by a physician in the same group practice as the referring physician, or by someone under the supervision of one of these physicians. A ``member'' of a group practice is a physician owner, a physician employee, a locum tenens physician, or an on-call physician while the physician is providing on- call services for members of the group practice. ``Physician in the group practice'' means a member of the group practice, as well as an independent contractor physician during the time the independent contractor is furnishing patient care services for the group practice to the group practice's patients in the group practice's facilities. (See Sec. 411.351.)

Another significant exception, at Sec. 411.355(b), is for the provision of in-office ancillary services. This exception allows group practice physicians to refer patients for DHS to other members of their group or to nonphysician staff, provided that certain supervision, location, and billing requirements are satisfied. Specifically, the DHS must be furnished personally by the referring physician, a member of the group practice, or an individual who is supervised by the referring physician or by a physician in the group practice. In addition, the DHS must be furnished in--(1) the ``same building'' where group physicians perform a certain amount of physician services (as set forth in Sec. 411.355(b)(2)), including physician services unrelated to the provision of DHS; or (2) in a ``centralized building.'' We define ``centralized building,'' in pertinent part, as all or part of building that is owned or leased on a full-time basis 24 hours per day, 7 days per week. In the ``Phase II'' physician self-referral IFC, we reaffirmed our earlier position, set forth in the ``Phase I'' final rule with comment period that, a group practice may have more than one centralized building (69 FR at 16075).

In response to the Phase II IFC, several commenters strongly criticized the centralized building prong of the in-office ancillary services exception. They requested that the rule be changed to require full-time use of the facility and the addition of a commercially reasonable test. According to the commenters, the Phase II IFC encourages numerous abusive arrangements that are designed solely to permit medical groups to bill in circumvention of the prohibition in section 1877 of the Act. Commenters objected to medical groups establishing satellite DHS facilities, sometimes in different States, specifically to capture ancillary income. Several commenters identified pod labs that rent space to urology groups as among the types of abusive arrangements that are proliferating. Several other commenters requested clarification that the in-office ancillary services exception did not

[[Page 49056]]

override our policies on reassignment and purchased diagnostic tests. According to the comments, some of the arrangements do not satisfy the rules regarding purchased diagnostic tests. On the other hand, a professional association complained that the requirement that the centralized building be occupied exclusively by the medical group is too restrictive.

As noted above, we stated, in response to the comments on the proposed rule implementing section 952 of the MMA, that we might address suspect arrangements in a future rulemaking. After additional consideration, including consideration of the comments we received in response to the Phase II IFC, we are now proposing to amend our regulations on reassignment and physician self-referral in this proposed rule.

We are proposing to amend Sec. 424.80 of our regulations to clarify that any reassignment pursuant to the contractual arrangement exception is subject to program integrity safeguards that relate to the right to payment for diagnostic tests. First, we would amend Sec. 424.80 of our regulations to provide that if the TC of a diagnostic test (other than clinical diagnostic laboratory tests paid under section 1833(a)(2)(D) of the Act, which are subject to the special rules set forth in section 1833(h)(5)(A) of the Act) is billed by a physician or medical group (the ``billing entity'') under a reassignment involving a contractual arrangement with a physician or other supplier who performs the service, the amount billed to Medicare by the billing entity, less the applicable deductibles and coinsurance, may not exceed the lowest of the following amounts:

The physician or other supplier's net charge to the billing physician or medical group.

The billing physician's or medical group's actual charge.

The fee schedule amount for the service that would be allowed if the physician or other supplier billed directly.

Second, we would also require that, in order to bill for the TC, the billing entity would be required to perform the interpretation. Third, we are considering further amendments to Sec. 424.80(d) that would impose certain conditions on when a physician or medical group can bill for a reassigned PC of a diagnostic test. We are considering the following conditions:

The test must be ordered by a physician that is financially independent of the person or entity performing the test and also of the physician or medical group performing the interpretation.

The physician or medical group performing the interpretation does not see the patient.

The physician or medical group billing for the interpretation must have performed the TC of the test.

We believe that we are comfortably within our authority to place the proposed restrictions on reassignments made before a contractual arrangement, in order to guard against patient and program abuse, and we also believe that we would be within our authority to adopt the conditions on billing for a reassigned PC before a contractual arrangement that we continue to consider.

We note that there is no right to effect a reassignment under section 1842(b)(6) of the Act (rather, this section allows, but does not require us to make payment to someone other than the beneficiary or the physician or other person who performed the service), and that section 952 of the MMA permits us to recognize reassignments under the contractual arrangement exception only to the extent that the arrangement meets program integrity and other safeguards as the Secretary may determine to be appropriate. Moreover, we believe that our current rules on purchased diagnostic tests generally should be applicable to both situations in which the billing entity is purchasing the test without a formal reassignment as well as situations in which the physician performing the test has reassigned his or her right to Medicare payment to the billing physician or medical group.

Although we welcome comments on all aspects of our proposals, we are particularly interested in soliciting comments on the amendments we have proposed, as well as those we are still considering involving reassigned interpretations, to Sec. 424.80(d). In particular, we are soliciting comments as to whether diagnostic tests in the DHS category of radiology and certain other imaging services should be excepted from any those provisions; whether the proposal in whole or in part should apply only to pathology services; whether any of these provisions should apply to services performed on the premises of the billing entity and if so, how to define the premises appropriately. We are also soliciting suggested regulatory text for the proposal under consideration involving purchased test interpretations, as well as any other comments regarding the appropriate scope of the provisions under consideration.

In addition, we are soliciting comments on whether an anti-markup provision should apply to the reassignment of the PC of diagnostic tests performed under a contractual arrangement, and if so, how to determine the correct amount that should be billed to the Medicare program.

In addition to our proposed changes to the reassignment rules, we are proposing to change the definition of ``centralized building'' in Sec. 411.351 for purposes of our physician self-referral regulations. We are persuaded by the commenters who responded to the Phase II IFC that our present definition may encourage the unnecessary ordering of ancillary services. Section 1877(b)(1) of the Act, in conjunction with section 1877(h)(4)(vi) of the Act, states that the Secretary may define by regulation what constitutes a ``group practice'' for purposes of the physician services exception. Similarly, section 1877(b)(2) of the Act authorizes the Secretary to determine additional terms and conditions relating to the supervision and location requirements of the in-office ancillary services exception as may be necessary to prevent a risk of program or patient abuse. Accordingly, we propose to modify the definition of ``centralized building'' to include a minimum square footage requirement of 350 square feet. Our modified definition would be relevant to both the physician services exception and the in-office ancillary services exception. That is because, under Sec. 411.351, a ``physician in the group practice'' includes an independent contractor physician during the time he or she is providing services to the group's patients in the group's facilities. Thus, to the extent that an independent contractor physician would qualify as a ``physician in the group'' on the basis of furnishing services to a group's patients in a centralized building, the space owned or leased by the group would need to comply with the proposed modification to the definition of ``centralized building'' in order for the group to rely on the physician services exception or the in-office ancillary services exception when billing Medicare for services furnished by the independent contractor physician.

Although we believe that the arrangements we seek to address through our proposed change to the definition of ``centralized building'' primarily involves independent contractor physicians, the proposed definition would also apply to services performed by physicians who are employees of a group practice.

The proposed minimum square footage requirement would not apply to

[[Page 49057]]

space owned or rented in a building in which no more than three group practices own or lease space in the ``same building,'' as defined in Sec. 411.351 (that is, in a building with the same street address) and share the same ``physician in the group practice'' (as defined in Sec. 411.351). The purpose of the square foot minimum and the exception is to prevent abusive arrangements such as pod labs, while not disqualifying legitimate, stand-alone physician offices that are unusually small. The following examples are intended to illustrate how the proposed exception might apply:

+ Example 1--A space of 200 square feet located in a building in which only two other group practices lease space could qualify as a centralized building, irrespective of whether all three group practices contract with the same individual as a ``physician in the group practice.''

+ Example 2--A space of 200 square feet is located in a building in which seven other group practices lease space. Dr. Jones has a contractual relationship with three group practices as a ``physician in the group practice.'' Dr. Smith also has a contractual relationship with three group practices. No physician has a contractual relationship as a ``physician in the group practice'' with four or more group practices that are located in that building. The space could qualify as a ``centralized building.''

We would also require the space to contain, on a permanent basis, the necessary equipment to perform substantially all of the DHS that are performed in this space, in order to meet the definition of a ``centralized building.'' That is, we wish to prevent the situation in which an entity would routinely move equipment as needed from one group's space to another group's space (for example, from cubicle to cubicle). We believe these situations are abusive and contrary to the purpose of concept of the ``centralized building'' concept, but we recognize that there may be an occasional need to bring specialized equipment into the space on a temporary basis.

We believe that the proposed clarification to our reassignment rules, in tandem with our proposed changes to the definition of ``centralized building'' for purposes of our physician self-referral rules would prevent abusive arrangements while preserving legitimate small physician offices. In particular, we anticipate that restrictions on marking up the TC of diagnostic tests as well as the limits we are considering for who can bill for the PC of diagnostic tests, combined with square footage limits and requirements of having necessary equipment on site would make it not financially feasible for pod labs to exist.

With respect to our proposed change to the definition of ``centralized building,'' we seek comments on whether there should be a minimum square foot requirement, and if so, whether the minimum should be 350 square feet or an amount more or less than that. In addition, we seek comments regarding whether there should be an exception to any minimum square foot requirement, and if so, the circumstances under which an exception should apply.

With respect to our proposal that the ``centralized building'' permanently contain the necessary equipment to perform substantially all of the DHS that is furnished in the ``centralized building,'' we seek comments on whether this test should be imposed, and whether at least 90 percent or some other minimum percentage or measurement is appropriate. We are also considering whether to require that, for space to qualify as a ``centralized building,'' the group practice must employ, in that space, a nonphysician employee or independent contractor who will perform services exclusively for the group for at least 35 hours per week. We seek comments on whether we should have this requirement or similar requirement, or whether this requirement would be unduly burdensome on a small group practice, and whether this requirement would be likely to reduce the number of existing pod labs and to discourage the development of new pod labs. Finally, we seek comments on whether a group practice should be allowed to maintain a ``centralized building'' in a State different from the State(s) in which it has an office that meets the criteria of Sec. 411.355(b)(2)(i), and if so, whether space that is located in a different State must be within a certain number of miles from an office of the group practice that meets the criteria of Sec. 411.355(b)(2)(i), in order to qualify as a ``centralized building.''

J. Supplier Access to Claims Billed on Reassignment

Section 1833(e) of the Act provides that, ``no payment shall be made to any provider of services or other person under this part unless there has been furnished such information as may be necessary in order to determine the amounts due such provider or other person under this part for the period with respect to which the amounts are being paid or for any prior period.'' Section 1842(b)(6) of the Act generally provides that payment may not be made to anyone other than the beneficiary or the physician or other person who provided the service. There are certain exceptions to this prohibition whereby payment may be made to others. These are commonly referred to as the reassignment exceptions and are found at section 1842(b)(6)(A) of the Act.

Taking these two statutory provisions together, we are permitted, but not required, to make payment to someone other than the beneficiary, or the physician or other person who furnished the service, but only if we have determined that Medicare has received all necessary information to determine the amounts due the provider. Where Medicare makes payment to an entity rather than to the physician or other person who furnished the service, there is a heightened concern that payment may not be correct. By allowing physicians and other individual suppliers who reassign benefits to an entity such as a group practice to have access to the billing information concerning the services they allegedly furnish, we believe we will reduce the risk of inappropriate billing.

Moreover, as noted in section I.2. of this proposed rule, section 952 of the MMA amended section 1842(b)(6)(A)(ii) of the Act to allow a physician or other person who was in a contractual arrangement rather than in an employee-employer relationship to reassign his or her right to bill and receive payment, irrespective of whether the services were performed on the premises of the entity. Section 952 of the MMA permits reassignment to the extent that the contractual arrangement between the physician or other individual supplier and the billing entity meets program integrity and other safeguards that the Secretary may determine to be appropriate.

In the FY 2005 Physician Fee Schedule proposed rule, published August 5, 2005 (69 FR 47488, 47524 through 47525), we stated our awareness that changes in the reassignment rules based on section 952 of the MMA may create new fraud and abuse vulnerabilities, which may not become apparent until the program has experience with new contractual arrangements. We proposed program safeguards, whereby the parties to the contractual arrangement would have joint and several liability for any Medicare overpayments, and the physician or other individual supplier would have unrestricted access to billings submitted on their behalf by the entity receiving reassigned payments. In response to the August 5, 2005 proposed

[[Page 49058]]

rule, we received a comment that questioned the need for the two program integrity safeguards (joint and several liability and unrestricted access to billing records) as a requirement for a reassignment of claims involving a contractual arrangement. The commenter believed that it was premature for CMS to implement these program safeguards, that CMS already imposes joint and several liability through Medicare participation agreements and the signing of the enrollment form for billing reassigned claims (the CMS-855-R form), and questioned why the program safeguards applied only to independent contractors and not to employees. (69 FR 66316 through 66317 (November 15, 2004).)

In response to the commenter, we stated that those program integrity safeguards were necessary to monitor the billings of entities with which we have had billing problems (for example, billing for services never furnished and upcoding resulting in Medicare overpayments) in the past, and that the reason the safeguards applied to independent contractors and not to employees, was that the billing problems identified thus far involved certain entities (which, for the most part, contracted with, rather than employed, emergency room (ER) physicians). We also stated that we would study whether the same program integrity safeguards applicable to independent contractors should also apply to employees.

Prior to January 1, 2005, the effective date of the program integrity safeguards for the contractual arrangement reassignment exception, we received public inquiries asking why employees do not have unrestricted access to billing records. Since the January 1, 2005 effective date of the program integrity safeguards, we have received an inquiry from an ER physician employee of a medium-sized ER physician staffing company, who was denied access to billing records for services that he claims to have furnished, and who had his employment terminated. We also note that the MMA Conference Report, in its discussion of section 952 of the MMA, states that the Conference Committee supports appropriate program integrity efforts for any entities billing the Medicare program, including entities with independent contractors as well as employees. Having reconsidered the issue, we find no valid reason why an employee should not have access to records on billings for services furnished by that employee. Therefore, we are proposing to change the title of Sec. 424.80(d) and amend Sec. 424.80(d)(2) of our regulations to state that the supplier who reassigns his or her right to bill and receive Medicare payment to an entity has unrestricted access to claims information submitted by that entity for services supposedly furnished by the individual supplier, irrespective of whether the supplier is an employee or independent contractor of the entity. If adopted, our proposal would also mean that if an entity receiving the reassigned benefits were to refuse to provide the billing information to the employee supplier requesting the information, the entity's right to receive reassigned benefits may be revoked under 42 CFR 424.82(c)(3) (which is currently the case with respect to an entity's refusal to provide billing information to an independent contractor supplier).

K. Coverage of Bone Mass Measurement (BMM) Tests

[If you choose to comment on issues in this section, please include the caption ``BONE MASS MEASUREMENT TESTS'' at the beginning of your comments.]

In an IFC entitled ``Medicare Coverage of and Payment for Bone Mass Measurements'' published in the Federal Register on June 24, 1998 (63 FR 34320), we implemented section 4106 of the BBA by establishing a new regulatory section, 42 CFR 410.31 (Bone Mass Measurement: Conditions for Coverage and Frequency Standards). Section 4106 of the BBA statutorily defined BMM and individuals that are qualified to receive a BMM. The June 24, 1998 IFC, under the ``reasonable and necessary'' provisions of 1862(a)(1)(A) of the Act, also established conditions for coverage of the tests that must be ordered by physicians or nonphysician practitioners. Lastly, as directed by section 4106 of the BBA, we established frequency standards governing the time period when qualified individuals would be eligible to receive covered BMMs. 1. Provisions of the June 24, 1998 IFC

As stated earlier in this section, the June 24, 1998 IFC implemented section 4106 of the BBA by establishing conditions for coverage and frequency standards for BMMs to ensure that they are paid for uniformly throughout the Medicare program and that they are reasonable and necessary for Medicare beneficiaries who are eligible to receive these measurements. This section summarizes the provisions discussed in the June 24, 1998 IFC. a. Coverage Conditions and Frequency Standards

We established conditions for coverage and frequency standards for medically necessary BMMs for five categories of Medicare beneficiaries in Sec. 410.31.

In Sec. 410.31(a), we defined ``bone mass measurement'' based on the statutory definition in section 4106 of the BBA. In accordance with the ``reasonable and necessary'' provisions of section 1862(a)(1)(A) of the Act, we established the conditions for coverage of BMMs in Sec. 410.31(b) of the regulations. Consistent with Sec. 410.32 (Diagnostic x-ray tests, diagnostic laboratory tests, and diagnostic tests: Conditions), we provided that coverage be available for the BMM only if it is ordered by the physician or a qualified nonphysician practitioner (as defined in Sec. 410.32(a)) treating the beneficiary following an evaluation of the beneficiary's need for the test, including a determination as to the medically appropriate procedure to be used for the beneficiary. We believed that BMMs were not demonstrably reasonable and necessary unless (among other things) they are ordered by the physician treating the beneficiary following a careful evaluation of the beneficiary's medical need, and they are employed to manage the beneficiary's care.

To ensure that the BMM is performed as accurately and consistently in accordance with appropriate quality assurance guidelines as possible, we required that it be performed under the appropriate supervision of a physician as defined in Sec. 410.32(b)(3). To ensure that the BMM is medically appropriate for the five categories specified in the law, we provided that it be reasonable and necessary for diagnosing, treating, or monitoring the condition of the beneficiary who meets the coverage requirements specified in Sec. 410.31(d).

Furthermore, in Sec. 410.31(c), we set forth limitations on the frequency for covering a BMM. Generally, we cover a BMM for a beneficiary if at least 23 months have passed since the month the last BMM was performed. However, we allow for coverage of follow-up BMMs performed more frequently than once every 23 months when medically necessary. We listed the following examples of situations where more frequent BMMs procedures may be medically necessary to include:

Monitoring beneficiaries on long-term glucocorticoid (steroid) therapy of more than 3 months.

Allowing for a confirmatory baseline bone mass measurement (either central or peripheral) to permit

[[Page 49059]]

monitoring of beneficiaries in the future if the initial test was performed with a technique that is different from the proposed monitoring method. b. Beneficiaries Who May Be Covered

In Sec. 410.31(d), we amended our regulations to conform to the statutory requirement that the following categories of beneficiaries may receive Medicare coverage for a medically necessary BMM:

A woman who has been determined by the physician or a qualified nonphysician practitioner treating her to be estrogen- deficient and at clinical risk for osteoporosis, based on her medical history and other findings.

An individual with vertebral abnormalities as demonstrated by an x-ray to be indicative of osteoporosis, osteopenia, or vertebral fracture.

An individual receiving (or expecting to receive) glucocorticoid (steroid) therapy equivalent to 7.5 mg of prednisone, or greater, per day, for more than 3 months.

An individual with primary hyperparathyroidism.

An individual being monitored to assess the response to or efficacy of an FDA-approved osteoporosis drug therapy. c. Waiver of Liability

Section 410.31(e) provides that Medicare payment would be denied for a BMM in accordance with section 1862(a)(1)(A) of the Act if the regulatory standards are not satisfied. Existing regulations concerning limitation on liability are set forth in Sec. Sec. 411.400 through 411.406 and are applicable to denial of BMMs under Sec. 410.31. d. Payments for BMMs

Medicare payments for covered BMMs are paid for under the PFS (42 CFR part 414) as required by statute. In the June 24, 1998 IFC, we revised the definition of ``physician services'' in Sec. 414.2 to include bone mass measurements. When BMM procedures are furnished to hospital inpatients and outpatients, the TCs of these procedures are payable under existing payment methods for hospital services. These methods include payments under the prospective payment system, on a reasonable cost basis, or under a special provision for determining payment rates for hospital outpatient radiology services.

In the June 24, 1998 IFC, we revised Sec. 414.50(a), regarding physician billing for purchased diagnostic tests, to clarify that the section does not apply to payment for BMMs. e. Conforming Changes

In the June 24, 1998 IFC, to allow for appropriate placement in the CFR of the BMM coverage requirements, we redesignated Sec. 410.31 (Prescription drugs used in immunosuppressive therapy) as Sec. 410.30. 2. Additional Scientific Evidence

In 2004, the Surgeon General issued a report, Bone Health and Osteoporosis (U.S. Department of Health and Human Services, Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004). This report provides scientific evidence related to the prevention, assessment, diagnosis, and treatment of bone disease. The report states that identification of those at risk of bone disease and fracture is important so that appropriate interventions can be implemented. However, as the report states, ``Assessing the risk of bone disease and fracture remains a challenge. Not all of the risk factors have been identified, and the relative importance of those that are known remains unclear.''

As bone strength is not measured directly, bone mineral density (BMD) remains the single best predictor of fracture risk, with the most widely accepted method for measuring BMD being the dual energy x-ray absorptiometry (DXA) for a bone density study at the axial skeleton (for example, hips and spine). As there are many sources of variability in the measurement of BMD, a quality control system related to both the methodology and reporting of test results is important to ensure the validity of DXA analysis.

In addition to DXA of the axial skeleton, bone mass can also be measured using other techniques. These other techniques include DXA bone density study for the appendicular skeleton (for example, radius, wrist, heel); quantitative computerized tomography (QCT), bone mineral density study for the axial skeleton or appendicular skeleton; radiographic absorptiometry (photodensitometry, radiogrammetry); single-photon absorptiometry (SPA); single energy x-ray absorptiometry (SXA) for the appendicular skeleton; and ultrasound bone mineral density study for the appendicular skeleton. With regard to these techniques (except for SPA which was not discussed), the 2004 Surgeon General report states, ``While these methods do assess bone density and may provide an indication of fracture risk, it is important to note that the WHO [World Health Organization] recommendations and other guidelines for using BMD and interpreting BMD results for diagnosis are based on DXA measurements of the hip or spine.'' The report further states, ``Incorporating these techniques for bone assessment into future clinical trials and observational studies will help in better understanding their appropriate use as a means of predicting the risk of bone disease and fracture.'' 3. Proposed Changes to the June 24, 1998 IFC

We received 18 public comments on the June 24, 1998 IFC. The majority of the comments had specific recommendations for changes to the IFC. In addition to responding to comments that we may receive on our proposed revisions to Sec. 410.31, it is our intent to address all these previous comments in the CY 2007 PFS final rule.

Based on the comments received on the IFC, the Surgeon General's report, and other evidence, we are proposing changes to Sec. 410.31. We encourage comments on these proposals. a. Proposed ``BMM'' Definition (Sec. 410.31(a))

We are proposing to revise the definition of ``bone mass measurement'' at Sec. 410.31(a)(2) to remove coverage for the use of SPA, which uses isotope sources to measure BMD. Many medical experts indicate that SPA has largely been replaced by the newer techniques of DXA, which are believed to be superior in accuracy and precision. Medicare claims data in recent years continue to show a steady decline in the use of the SPA procedure by the beneficiary population. Further, there is a lack of evidence to support continued use of SPA, an older procedure where the metrics have not been correlated with fracture rate.

We are proposing to revise the definition of a ``bone mass measurement'' to read, ``Is performed with either a bone densitometer (other than a single-photon or dual-photon absorptiometry) or with a bone sonometer system that has been cleared for marketing for this use by the FDA under 21 CFR part 807, or approved for marketing by the FDA for this use under 21 CFR part 814.''

We are specifically requesting comments on this proposal regarding the evidence of benefit for SPA, particularly in comparison with other alternatives. b. Conditions for Coverage (Sec. 410.31(b))

We are proposing to revise the conditions for coverage for BMMs in

[[Page 49060]]

Sec. 410.31(b) by requiring that for a medically necessary BMM to be covered for an individual being monitored to assess the response to or efficacy of an FDA-approved osteoporosis drug therapy (Sec. 410.31(d)(5)) the individual would be required to meet the present conditions for coverage under Sec. 410.31(b), and the monitoring would have to be performed by the use of an dual energy x-ray absorptiometry system (axial system).

We recognize that in the June 24, 1998 IFC, we allowed the physician or qualified nonphysician practitioner treating the beneficiary more flexibility in ordering those diagnostic measurements, but we are proposing to limit that flexibility with respect to the type of BMM that is used for monitoring individuals receiving osteoporosis drug therapy and other purposes (as discussed later in this section) because of new evidence and other information received since publication of the June 24, 1998 IFC that supports the need for requiring the use of the DXA measurement (axial skeleton) in those circumstances. In addition to the 2004 Surgeon General's Report that recognized the superiority of the DXA (axial skeleton) for measuring bone mass over time, the International Society for Clinical Densitometry currently recommends that if an individual has a low bone mass using a peripheral measurement (appendicular skeleton) he or she should have a DXA (axial skeleton) performed for monitoring or confirmatory diagnostic purposes.

Therefore, we are also proposing to revise Sec. 410.31(b) by adding a requirement that in the case of any individual who qualifies for a bone mass measurement as provided for in Sec. 410.31(d) and who receives a confirmatory baseline BMM to permit monitoring in the future, Medicare may cover a medically necessary BMM for that individual, if the present conditions for coverage under Sec. 410.31(b) are met, and the BMM is performed by a dual energy x-ray absorptiometry system (axial skeleton) (if the initial measurement was not performed by this system).

As indicated previously, the most widely accepted method for measuring bone mineral density (BMD) is the use of DXA (Surgeons General's Report 2004) at axial skeletal sites. DXA (axial skeleton) measures BMD at the hip and spine (sites likely to fracture in patients who have osteoporosis). DXA is precise, safe, and low in radiation exposure, and permits more accurate and reliable monitoring of individuals over time. DXA of the femoral neck is the best validated test to predict hip fracture and is comparable to forearm measurements for predicting fractures at other sites (Evidence Report/Technology Assessment No 28, Agency for Healthcare Research and Quality (AHRQ), January 2001). c. Bone Mass Measurement: Standards on Frequency of Coverage (Sec. 410.31(c))

To conform the examples of a BMM exception to the standards on frequency of coverage in Sec. 410.31(c)(2) to the regulation change we are proposing in Sec. 410.31(b)(3), we are proposing to revise the confirmatory baseline test example in Sec. 410.31(c)(2)(ii) to read, ``Allowing for a confirmatory baseline measurement to permit monitoring of beneficiaries in the future if the requirements of paragraph (b)(3) of this section are met.'' d. Bone Mass Measurement: Beneficiaries Who May Be Covered (Sec. 410.31(d))

The Congress has recognized that individuals receiving long-term glucocorticoid steroid therapy are qualified individuals for purposes of section 1861(rr)(1) of the Act. Therapy to prevent bone loss in most patients beginning long-term therapy has been recommended at a prednisone equivalent of >= 5 mg/day for at least 3 months (McIlwain, 2003). Based on our review of the current evidence, we are proposing to reduce the dosage equivalent in Sec. 410.31(d)(3) from an average of 7.5 mg/day of prednisone for at least 3 months to an average of 5.0 mg/ day of prednisone for the same period. e. Use of the NCD Process (Sec. 410.31(f))

To facilitate future consideration of coverage of additional BMM systems for purposes of proposed paragraphs Sec. 410.31(b)(2) and (b)(3), which would limit coverage of BMMs for monitoring individuals receiving osteoporosis drug therapy and for performing confirmatory baseline measurements, we are proposing to allow CMS, through the NCD process, to identify additional BMM systems for those purposes. By using the NCD process, we could conduct a timely assessment of FDA- approved BMMs. Use of an NCD to add coverage of effective BMM systems for these purposes is authorized by the reasonable and necessary provision of sections 1862(a)(1)(A) and 1871(a)(2) of the Act.

In summary, in view of the 18 comments and our review of the post- 1998 medical literature, we have decided to propose several revisions to Sec. 410.31 relative to the definition of the term ``Bone Mass Measurement'' (Sec. 410.31(a)(2)), the conditions for coverage (Sec. 410.31(b)), the examples of exceptions to the standards on frequency of coverage (Sec. 410.31(c)(2)), the category of individuals receiving (or expecting to receive) glucocorticoid (steroid) therapy (Sec. 410.31(d)(3)), and the addition of a new subparagraph (Sec. 410.31(f)) on use of the NCD process.

L. Independent Diagnostic Testing Facility (IDTF) Issues

[If you choose to comment on issues in this section, please include the caption ``IDTF ISSUES'' at the beginning of your comments.] 1. Proposed IDTF Changes in the Physician Fee Schedule Proposed Rule

During the course of a national review in 2003-2004, the Office of Inspector General (OIG) found a potential $71 million in improper payments made to IDTFs (Review of Claims Billed by Independent Diagnostic Testing Facilities for Services Provided to Medicare Beneficiaries During Calendar Year 2001 (A-03-03-00002)). The OIG found that erroneous payments were made as the result of poor or missing documentation or the lack of medical necessity. Moreover, in recent years, CMS and its contractors have determined that a number of IDTFs in California and other States are perpetrating schemes to defraud the Medicare program.

Since 2000, the number of IDTFs in California has increased by 40 percent, which is a far greater percentage increase than the Medicare population in that State. The number of IDTFs billing Medicare in California alone increased more than 400 percent from 2000 to 2005. The increased use of IDTF services has not lowered the use of diagnostic testing within other settings. The increased rates of utilization within IDTFs is likely to be unrealistic due to an increase in the need of diagnostic testing within California's Medicare population. Also, these IDTFs are growing at a rate faster than CMS can survey these facilities. The actual growth of IDTFs is not a problem, however, the results of the OIG audit make it clear that we need to closely monitor IDTFs and establish standards to ensure quality care for Medicare beneficiaries. To address the erroneous payments identified by the OIG above, we are proposing to establish IDTF supplier standards similar to those we adopted for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Suppliers on October 11, 2000 (see 42 CFR 424.57).

We are proposing that each IDTF be required to be in compliance with the

[[Page 49061]]

proposed fourteen suppler standards discussed in section L.2. below in order to obtain or retain enrollment in the Medicare program. Accordingly, at proposed Sec. 410.33(h), we are proposing that if an IDTF fails to meet one or more of the proposed standards at the time of enrollment or at the time of re-enrollment, then its enrollment application would be denied. Also, if at any time we determine that an enrolled IDTF no longer meets the proposed supplier standards, its billing privileges would be revoked.

We believe that these supplier standards are needed to ensure that minimum quality standards are met to protect beneficiaries as well as the Medicare Trust Fund. These standards are merely good business practices which will help to ensure that suppliers are providing a quality care to Medicare beneficiaries. Examples of the kind of standards are a primary business phone number and address. Another example is a posting of standards for review by patients and the public.

We are proposing to adopt, for IDTFs, a number of standards we adopted for DMEPOS suppliers, including supplier standard number 6 which requires a supplier to maintain a comprehensive liability insurance policy of $300,000 or 20 percent of its average annual Medicare billings, whichever amount is greater, that covers both the place of business and all customers and employees of the IDTF.

Furthermore, we are proposing in the new performance standard number 7 that an IDTF agrees not to directly solicit patients. This provision does not preclude the IDTF from public advertisement or marketing its services to physicians and other suppliers, however it does prohibit recruitment of beneficiaries through direct solicitation.

Additionally, the IDTF would be required to grant CMS, or its designated fee-for-service contractors, including our agents, to have access to the IDTF physical location, all equipment, and beneficiary medical records during normal business hours. For portable equipment, an IDTF would be required to maintain a catalog of portable equipment and be able to produce the cataloged equipment within two business days. If the IDTF denies this access, the IDTF's Medicare enrollment would be immediately revoked.

To ensure that equipment used by an IDTF is maintained and operates properly, we are seeking public comment regarding IDTF supplier standard number 11, which would require that an IDTF must have its testing equipment calibrated per equipment instructions or in compliance with applicable industry standards. Specifically, we are seeking public comment regarding the organizations or entities that may currently establish testing specifications for diagnostics equipment. Further, if these organizations or entities do not exist, we invite public comment regarding establishment of a supplier standard that relies on the manufacturer's maintenance and calibration standards.

While we understand that these proposed additional standards could lead certain IDTFs to withdraw from the Medicare program rather than comply with the new standards, we believe that legitimate businesses would not oppose these changes. Moreover, we emphasize that services provided by an IDTF are also readily available to beneficiaries through other avenues such as physicians' offices, outpatient laboratories, outpatient radiology facilities, and outpatient clinics. We believe that the implementation of these proposed standards would improve the quality of services provided to Medicare beneficiaries by IDTFs without any associated access concerns. 2. Proposed Performance Standards for IDTFs

The IDTF would be required to meet the following standards as of January 1, 2007 and any newly or reenrolling IDTF would be required to certify in its enrollment application that it meets and would continue to meet the standards. At Sec. 410.33, we are proposing to revise the regulation to specify that the IDTF would be required to--

Operate its business in compliance with all applicable Federal, State, and local licensure and regulatory requirements with regard to the health and safety of patients;

Provide complete and accurate information on its enrollment application as stated in the ``Requirements for Providers and Suppliers to Establish and Maintain Enrollment final rule'' (April 21, 2006 (42 FR 20754)). Any change in enrollment information would be required to be reported to the designated fee-for-service contractor on the Medicare enrollment application within 30 calendar days;

Maintain a physical facility on an appropriate site. For the purposes of this proposed standard, a post office box or commercial mailbox would not be considered a physical facility. The physical facility would be required to contain space for equipment appropriate to the services designated on the enrollment application, facilities for hand washing, adequate patient privacy accommodations, and the storage of both business records and current medical records;

Have all applicable testing equipment available at the physical site, excluding portable equipment. A catalog of portable equipment, including equipment serial numbers, would be maintained at the physical site. In addition, portable equipment would be made available for inspection within two business days of our inspection request. The IDTF would be required to maintain a current inventory of the equipment (including serial/registration numbers), provide this information to the designated fee-for-service contractor and notify the contractor of any changes in equipment;

Maintain a primary business phone under the name of the business. The business phone would be located at the designated site of the business. The telephone number or toll free numbers would be available in a local directory and through directory assistance;

Have a comprehensive liability insurance policy of at least $300,000 or 20 percent of its average annual Medicare billings, whichever amount is greater, that covers both the place of business and all customers and employees of the IDTF. The insurance policy would be carried by a non-relative owned company. The policy would be required to list the serial numbers of any and all equipment used by the IDTF;

Agree not to directly solicit patients, which includes, but is not limited to, a prohibition on telephone, computer, or in- person contracts. The IDTF would accept only those patients referred for diagnostic testing by an attending physician, who is furnishing a consultation or treating a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. Nonphysician practictioners may order tests as set forth in Sec. 410.32(a)(3);

Answer beneficiaries' questions and respond to their complaints. Documentation of those contacts would be maintained at the physical site;

Openly post these standards for review by patients and the public;

Disclose to the government, any person having ownership, financial or control interest, or any other legal interest in the supplier at the time of enrollment or within 30 days of a change;

Have its testing equipment calibrated per equipment instructions and in compliance with applicable national standards;

[[Page 49062]]

Have technical staff on duty with the appropriate credentials to perform tests. The IDTF would be required to produce the applicable Federal or State licenses and/or certifications of the individuals performing these services;

Have proper medical record storage and be able to retrieve medical records upon request from CMS or its designated fee-for-service contractor within 2 business days; and

Permit CMS, including its agents or its designated fee- for-service contractors, to conduct unannounced, on-site inspections to confirm the IDTF's compliance with these proposed standards. The IDTF would be required to provide access, during regular business hours, to CMS and beneficiaries, as well as maintain a visible sign posting the normal business hours of the IDTF. 3. Supervision

To ensure quality care is provided to Medicare beneficiaries, we are proposing to revise Sec. 410.33(b)(1) to read that physicians will be limited to providing supervision to ``no more than three (3) IDTF sites.'' 4. Place of Service

In addition to proposing the establishment of specific supplier standards for IDTFs, at proposed Sec. 410.33(i), we are proposing to define the ``point of the actual delivery of service'' as the correct ``Place of Service'' for the claim form in the case of diagnostic testing performed outside the IDTF's physical location. For example, when an IDTF performs a diagnostic test at a beneficiary's residence, we believe that it is reasonable to establish the beneficiary's residence as the ``Place of Service.'' Previously, there has been no set procedure, so therefore, we believe that the information is gathered at the collection point from the beneficiary, and this is the point service. While most diagnostic tests are performed in an office setting, we are seeking public comment regarding the types of services that can be safely and appropriately used in a residential setting.

M. Independent Laboratory Billing for the TC of Physician Pathology Services to Hospital Patients

[If you choose to comment on issues in this section, please include the caption ``INDEPENDENT LAB BILLING'' at the beginning of your comments.]

The TC of physician pathology services refers to the preparation of the slide involving tissue or cells that a pathologist will interpret. (In contrast, the pathologist's interpretation of the slide is the PC service. If this service is furnished by the hospital pathologist for a hospital patient, it is separately billable. If the independent laboratory's pathologist furnishes the PC service, it is usually billed with the TC service as a combined service.)

In the ``Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2000'' final rule published in the Federal Register on November 2, 1999 (64 FR 59380 and 59408 through 59409), we stated that we would implement a policy to pay only the hospital for the TC of physician pathology services furnished to hospital patients. Before that proposal, any independent laboratory could bill the carrier under the PFS for the TC of physician pathology services for hospital patients. As pointed out in the November 2, 1999 final rule, this policy has contributed to the Medicare program paying twice for the TC service, first through the inpatient prospective payment rate to the hospital where the patient is an inpatient and again to the independent laboratory that bills the carrier, instead of the hospital, for the TC service.

Therefore, in that final rule at Sec. 415.130, we provided that, for services furnished on or after January 11, 2001, the carriers would no longer pay claims to the independent laboratory under the physician fee schedule for the TC of physician pathology services for hospital patients.

Ordinarily, the provisions in the final PFS are implemented in the following year. However, in this case, the change to Sec. 415.130 was delayed one year (until January 1, 2001), at the request of the industry, to allow independent laboratories and hospitals sufficient time to negotiate arrangements. Moreover, our full implementation of Sec. 415.130 was further delayed through CY 2006.

We continue to believe, however, that hospital prospective payment amounts already compensate hospitals for the TC of physician pathology tests and that additional payment under the PFS is inappropriate. Therefore, we are proposing to amend Sec. 415.130 to provide that, for services furnished after December 31, 2006, an independent laboratory may not bill the carrier for physician pathology services furnished to a hospital inpatient or outpatient. Under proposed Sec. 415.130(d), we would pay under the PFS for the TC of a physician pathology service furnished by an independent laboratory for services provided to an inpatient or outpatient of a ``covered hospital'' on or before December 31, 2006. A ``covered hospital'' is defined in Sec. 415.130(a)(1).

N. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests

[If you choose to comment on issues in this section, please include the caption ``CLINICAL DIAGNOSTIC LAB TESTS'' at the beginning of your comments.]

Section 1833(h) of the Act requires the Secretary to establish fee schedules for clinical laboratory tests under Medicare Part B. In this section of the preamble, we are proposing to implement section 942(b) of the MMA which specifies annual procedures for consulting the public on how to establish payment for new clinical laboratory test codes to be included in the annual update of the clinical laboratory fee schedule. 1. BIPA (Pub. L. 106-554)

Section 531(b) of BIPA mandated that we establish, no later than 1 year after the date of enactment, procedures that permit public consultation for payment determinations for new clinical diagnostic laboratory tests under Medicare Part B in a manner consistent with the procedures established for implementing ICD-9-CM coding modifications. In the November 23, 2001 Federal Register (66 FR 58743), we specified the procedures to implement section 531(b) of BIPA.

These procedures were most recently used to determine the payments for new 2006 clinical laboratory fee schedule codes. First, we convened a public meeting to solicit expert input on the nature of the new tests before rate determinations were made. We have held these meetings each year since 2002 to receive this expert input on the next year's codes. Our most recent meeting was announced in the Federal Register on May 27, 2005 (70 FR 30734) and occurred on July 18, 2005. In that meeting, we requested that presenters address the new test codes, each test's purpose, method, cost, and a recommendation for one of two methods (crosswalking or gapfilling) for determining payment for the new clinical laboratory codes. Crosswalking and gapfilling are discussed below in section N.2.d.

Following the public meeting, we posted, on our Website, a summary of the new codes and the payment recommendations that were presented during the public meeting. The summary also displayed our tentative payment determinations and indicated a comment period for interested parties to submit written comments. After reviewing the comments received, we issued Medicare Transmittal 750, 2006 Annual Update for Clinical Laboratory

[[Page 49063 ]]

Fee Schedule, which provided all instructions and final rate determinations for the 2006 clinical laboratory fee schedule including the new codes and fees, on November 18, 2005. 2. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) (Pub. L. 108-173)

Further legislation affecting public consultation for new clinical laboratory tests was enacted at section 942(b) of the MMA (Pub. L. 108- 173), which added section 1833(h)(8) to the Act. Section 1833(h)(8)(A) of the Act requires the Secretary to establish by regulation procedures for determining the basis for and amount of payment for a clinical diagnostic laboratory test that is assigned a new or substantially revised Healthcare Common Procedure Coding System (HCPCS) code on or after January 1, 2005. We refer to these tests as ``new tests.''

Section 1833(h)(8)(B) of the Act provides that determinations of payment amounts for new tests shall be made only after the Secretary--

Makes available to the public (through an Internet Web site and other appropriate mechanisms) a list that includes codes for which establishment of a payment amount is being considered for the next calendar year;

On the same day the list of codes is made available, publishes a Federal Register notice of a meeting to receive public comments and recommendations (and data on which recommendations are based) on the appropriate basis for establishing payment amounts for the list of codes made available to the public;

Not less than 30 days after publication of the notice in the Federal Register, convenes a meeting that includes representatives of CMS officials involved in determining payment amounts, to receive public comments and recommendations (and data on which the recommendations are based); and

Taking into account the comments and recommendations (and accompanying data) received at the public meeting, develops and makes available to the public (through an Internet Web site and other appropriate mechanisms)--

+ A list of proposed determinations with respect to the appropriate basis for establishing a payment amount for each code, together with an explanation of the reasons for each determination, the data on which the determinations are based, and a request for public written comments on the proposed determination; and

+ A list of final determinations of the payment amounts for tests, together with the rationale for each determination, the data on which the determinations are based, and responses to comments and suggestions from the public.

We believe that our current process for providing for public consultation on the establishment of payment amounts for new clinical laboratory tests is consistent with the requirements of section 1833(h)(8)(B) of the Act. We currently make available to the public through a posting on the CMS Web site a list of new laboratory test codes for the next calendar year. We publish a Federal Register notice of a meeting to receive public comments and recommendations and convene the meeting with appropriate CMS officials in attendance. We take into account the input received at the public meeting and we make available to the public on the CMS Web site a list of the proposed determinations and seek comment. We then make available to the public our final determinations in the instructions that we provide to our claims processing contractors to implement the Medicare Part B clinical laboratory fee schedule each year.

The most significant change required by section 1886(h)(8)(A) of the Act with respect to our procedures for public consultation is that we codify this process in regulations. Therefore, in this proposed rule, we are proposing to codify our current process for public consultation for new clinical diagnostic laboratory tests paid under the Medicare Part B clinical laboratory fee schedule at proposed new Subpart F--Payment for New Clinical Diagnostic Laboratory Tests (Sec. 414.402 through Sec. 414.406).

a. Proposed Basis and Scope (Sec. 414.400)

This proposed new subpart would implement provisions of section 1833(h)(8) of the Act--procedures for determining the basis for, and amount of, payment for a new clinical diagnostic laboratory test with respect to which a new or substantially revised Healthcare Common Procedure Coding System code is assigned on or after January 1, 2005.

b. Proposed Definition (Sec. 414.402)

As specified in section 942(b) of the MMA, we propose to define the term ``Substantially Revised Healthcare Common Procedure Coding System Code'' to mean a code for which there has been a substantive change to the definition of the test or procedure to which the code applies (such as a new analyte or a new methodology for measuring an existing analyte specific test).

c. Proposed Procedures for Public Consultation for Payment for a New Clinical Diagnostic Laboratory Test (Sec. 414.406)

For a clinical laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, we would establish a local fee schedule amount only after the following:

We make available to the public (through an Internet Web site and other appropriate mechanisms) a list that includes codes for which establishment of a payment amount is being considered for the next calendar year.

We publish a Federal Register notice of a meeting to receive public comments and recommendations (and data on which recommendations are based) on the appropriate basis, as specified in proposed new Sec. 414.408, for establishing payment amounts for the list of codes made available to the public.

Not less than 30 days after publication of the notice in the Federal Register, we convene a meeting, that includes representatives of CMS officials involved in determining payment amounts, to receive public comments and recommendations (and data on which the recommendations are based).

Taking into account the comments and recommendations (and accompanying data) received at the public meeting, we develop and make available to the public (through an Internet Web site and other appropriate mechanisms)--

+ A list of proposed determinations with respect to the appropriate basis for establishing a payment amount for each code, together with an explanation of the reasons for each determination, the data on which the determinations are based, and a request for public written comments on the proposed determination within a specified time period; and

+ A list of final determinations of the payment amounts for tests, together with the rationale for each determination, the data on which the determinations are based, and responses to comments and suggestions from the public.

d. Proposed Payment for a New Clinical Diagnostic Laboratory Test-- Crosswalking and Gapfilling (Sec. 414.408)

We are proposing to add a new Sec. 414.408 to indicate when, in establishing the payment amount for a new clinical laboratory test, one of two payment methods can be utilized. The

[[Page 49064]]

first payment method, called ``crosswalking,'' is used if a new test is determined to be comparable to an existing test, multiple existing test codes, or a portion of an existing test code. We propose that a new test code would be assigned the related existing local fee schedule amounts and national limitation amount.

In new Sec. 414.408, we propose to use the second method, called ``gapfilling,'' when no comparable, existing test is available. Currently when using this method, manual instructions are provided to each Medicare carrier to determine a payment amount for its geographic area(s) for use in the first year, and the carrier-specific amounts are used to establish a national limitation amount for following years. Consistent with our current process, the sources of information carriers examine in determining gapfill amounts, if available, include--

Charges for the test and routine discounts to charges;

Resources required to perform the test;

Payment amounts determined by other payers; and

Charges, payment amounts, and resources required for other tests that may be comparable or otherwise relevant.

Currently, our manual instructions allow carriers to consider other sources of information as appropriate, including clinical studies and information provided by clinicians practicing in the area, manufacturers, or other interested parties. Carriers are also instructed to establish carrier specific amounts on or before March 31 of the year and to revise their carrier specific amount, if necessary, on or before September 1 of the year. In this manner, a carrier may revise its carrier specific amount based on additional information, but there is also a specific time frame to perform this revision so that we have adequate time to receive and use the carrier specific amounts for the calculation of the next year's clinical laboratory fee schedule.

Currently for new gapfilled laboratory tests, the payment amount beginning in the second year is based on the lower of the carrier specific amount determined in the first year or the national limitation amount. In accordance with section 1833(h) of the Act, the national limitation amount is set at the median of the carrier-specific amounts.

In light of new MMA provisions, however, we are proposing, in new Sec. 414.408, to prospectively eliminate payment of new gapfilled tests at a carrier specific amount after the first year. Section 1833(h)(8)(A) of the Act gives the Secretary authority to establish procedures for determining the payment amount for laboratory tests for which new or substantially revised HCPCS codes were established on or after January 1, 2005. Under this authority, we propose, in new Sec. 414.408(b), to pay for a new gapfilled laboratory test under our existing methodology for the first year (the carrier would establish a gapfill amount.) Beginning in the second year, the test would be paid at the national limitation amount. This would result in consistent payment in geographic areas for a new test using the median of the carrier gapfill amounts. 3. Other Laboratory Issues

This section discusses other laboratory issues related to quality and glucose monitoring in SNFs. a. Quality

In addition to providing payments, Medicare's clinical laboratory fee schedule for both new and existing tests should foster the provision of quality care and the prevention of avoidable health care costs. We are exploring the development of measures related to the quality and efficiency of care, including those involving clinical laboratory fee schedule services. Physicians' decisions are central to the health care their patients receive and are informed by appropriate clinical laboratory testing. We want to work with physicians, providers and the clinical laboratory community to identify ways to promote utilization decisions that clearly increase the quality of care while avoiding unnecessary costs for beneficiaries and the Medicare program.

As part of its strategies to improve quality of care, CMS could require those who perform laboratory tests to submit laboratory values using common vocabulary standards, such as those found in the Logical Observation Identifiers Names and Codes (LOINC[supreg]) database.

The LOINC[supreg] database currently contains about 41,000 observational terms, of which nearly 31,000 are observational terms related to laboratory testing. The laboratory subset of the LOINC[supreg] database provides universal names and codes for identifying the results of clinical laboratory tests and it facilitates the exchange and pooling of clinical laboratory results for clinical care, outcomes management and research. Note that LOINC[supreg] describes the test result, but does not provide it. It is, therefore, only one possible component of a comprehensive system of collecting clinical laboratory fee test results. Each LOINC[supreg] record corresponds to a single test result or panel. The following are some examples of LOINC records:

LOINC code LOINC name (component: property: timing: specimen: scale) 2951-2 SODIUM:SCNC:PT:SER/PLAS:QN 2955-2 SODIUM:SCNC:PT:UR:QN 2956-1 SODIUM:SRAT:24H:UR:QN 2164-2 CREATININE RENAL CLEARANCE:VRAT:24H:UR:QN 1514-9 GLUCOSE[caret]2H POST 100 G GLUCOSE PO:MCNC:PT:SER/PLAS:QN 3665-7 GENTAMICIN[caret]TROUGH:MCNC:PT:SER/PLAS:QN 17863-2 CALCIUM.IONIZED: MCNC:PT:SER/PLAS:QN 2863-9 ALBUMIN:MCNC:PT:SNV: QN:ELECTROPHORESIS

The parts of the LOINC[supreg] name refer to different aspects of the test result. The component is the analyte (for example, sodium). The property is the characteristic of the analyte that is measured, evaluated or observed (for example SCNC = substance concentration). Timing indicates whether the measurement is an observation at a moment of time, or an observation integrated over an extended duration of time (for example, PT = point in time). The specimen is the type of sample (for example, SER/PLAS = serum or plasma). The scale is the type of scale (for example QN = quantitative). For further detail, please see the LOINC[supreg] Web site at http://www.loinc.org.

On September 23, 2005 (70 FR 55900-56025), we published the proposed rule ``HIPAA Administrative Simplification: Standards for Electronic Health Care Claims Attachments.'' This rule proposed standards for electronically requesting and supplying particular types of additional health care information in the form of an electronic attachment to support submitted health care claims data. The proposed rule specified a standard attachment form for reporting laboratory results (among other standards) and proposed adoption of LOINC[supreg] as the standard code set for reporting such results.

While the laboratory claims attachment standard and use of LOINC[supreg] could provide a means for reporting test result data, we recognize that there are significant operational and other challenges that would need to be addressed before Medicare could begin to collect laboratory values in a comprehensive fashion using common vocabulary standards and that these challenges need to be met in partnership with the clinical laboratory community. We look forward to working

[[Page 49065]]

collaboratively with the clinical laboratory community on these issues. b. Blood Glucose Monitoring in SNFs

In response to inquiries regarding our policy on blood glucose monitoring in SNFs, we are taking this opportunity to restate our long- standing policy on coverage of blood glucose monitoring services and to propose to codify physician certification requirements for blood glucose monitoring in SNFs.

Generally, section 1862(a)(1)(A) of the Act requires that a service be reasonable and necessary for diagnosis and treatment in order to be eligible for coverage by Medicare. Our regulations at Sec. 410.32(a) already require that, for any diagnostic test, including a clinical diagnostic laboratory test, to be considered reasonable and necessary, it must be both ordered by the physician and the ordering physician must use the result in the management of the beneficiary's specific medical problem. Tests not ordered by the physician who is treating the beneficiary are not reasonable and necessary.

In the context of blood glucose monitoring, we most recently stated this policy in Transmittal AB-00-108, ``Glucose Monitoring'', which is available on our Web site at http://www.cms.hhs.gov/transmittals/downloads/ab00108.pdf. This interpretation of Sec. 410.32 is also the

basis for our policy in Chapter 7 of the Medicare Claims Processing Manual (``Skilled Nursing Facility Part B Billing'' available on our Web site at http://www.cms.hhs.gov/manuals/downloads/clm104c07.pdf.)

In addition, section 1835(a)(2)(B) of the Act provides that, in the case of certain ``medical and other health services'' (including clinical diagnostic laboratory services), payment may be made for Part B services that are furnished by a provider of services only if a physician certifies--and recertifies where those services are furnished over a period of time, with such frequency, and accompanied by such supporting material, as may be provided by regulation--that those services were medically necessary. The regulations currently implementing this provision at Sec. 424.24 do not specifically address the issue of blood glucose monitoring in SNFs. Therefore, we are proposing to amend Sec. 424.24 to provide that, for each blood glucose test furnished to a resident of a SNF, the physician must certify that the test is medically necessary. We are also proposing to amend Sec. 424.24 to clarify that a physician's standing order is not sufficient to order routine blood glucose monitoring. c. Other Lab Issues--Proposed Clinical Diagnostic Laboratory Date of Service (DOS) for Stored Specimens

We are proposing to add a new Sec. 414.410 to address concerns that have been raised regarding the date of service of a clinical diagnostic laboratory test that use a stored (or ``archived'') specimen. In the final rule of coverage and administrative policies for clinical diagnostic laboratory services that we published on November 23, 2001 (66 FR 58792), we adopted a policy under which the date of service for clinical diagnostic laboratory services generally is the date the specimen is collected. For laboratory tests that use an archived specimen, however, the date of service is the date the specimen was obtained from the storage. In 2002, we issued Program Memorandum AB-02-134 which permitted contractors discretion in making determinations regarding the length of time a specimen must be stored to be considered archived. In response to comments requesting that we issue a national standard to clarify when a stored specimen can be considered ``archived,'' in the Procedures for Maintaining Code Lists in the Negotiated National Coverage Determinations for Clinical Diagnostic Laboratory Services final notice, published in the Federal Register on February 25, 2005 (70 FR 9355), we defined an ``archived'' specimen as a specimen that is stored for more than 30 calendar days before testing. The date of service for these archived specimens is the date the specimen was obtained from storage. Specimens stored 30 days or less have a date of service of the date the specimen was collected. The February 25, 2005 final notice also clarified that the date of service for tests when the collection spanned more than two calendar days is the date the collection ended. Instructions that implemented these policies were added to Chapter 16, section 40.8 of the Medicare Claims Processing Manual (Pub. 100-04) with the issuance of Transmittal 800 (CR 4156), on December 30, 2005.

Recently, we have received correspondence that expressed concern that our policies have created some unintended consequences, especially in situations in which a specimen is taken in a hospital setting, but then later used for a test after the patient has left the hospital. Under the current manual instructions, if the specimen used for a test ordered subsequent to the beneficiary's discharge is obtained less than 31 calendar days following the date the specimen was collected, the date of service of the test is the date of collection. The date of service of a test may affect payment because, if the date of service falls during an inpatient stay or on a day on which the beneficiary had an outpatient procedure, payment for the laboratory test usually is bundled with the hospital service. To address these concerns, we are proposing to change our current policy so that the date of service would be the date the specimen is obtained from storage, even if the specimen is obtained less than 31 days from the date it was collected, without violating the unbundling rules as long as the following conditions are met:

The test is ordered by the patient's physician at least 14 days following the date of the patient's discharge from the hospital.

The test could not reasonably have been ordered while the patient was hospitalized.

The procedure performed while the beneficiary is a patient of the hospital is for purposes other than collection of the specimen needed for the test.

The test is reasonable and medically necessary.

These conditions are consistent with the guidance in Chapter 16, sec 40.3 of the Claims Processing Manual, which states that ``When the hospital obtains laboratory tests for outpatients under arrangements with clinical laboratories or other hospital laboratories, only the hospital can bill for the arranged services.''

In addition, Chapter 3 of the Program Integrity Manual contains instructions for additional documentation if further development of laboratory claims for pre-or postpay are required. Although we believe these changes will help to maintain beneficiary access to care, we are concerned about the potential for these policy changes creating inappropriate incentives in the development of technology and the implications for the unbundling of services. We solicit comment on the proposed changes and these concerns.

O. Proposal to Establish Criteria for National Certifying Bodies That Certify Advanced Practice Nurses

[If you choose to comment on issues in this section, please include the caption ``Criteria for National Certifying Bodies-Advanced Practice Nurses'' at the beginning of your comments.]

Federal regulatory qualifications for nurse practitioners (NPs) at 42 CFR 410.75 require that an individual be certified as an NP by a recognized national certifying body that has established standards for NPs. Similarly, Federal regulatory qualifications for clinical nurse specialists (CNSs) at 42

[[Page 49066]]

CFR 410.76 require that an individual be certified as a CNS by a national certifying body that has established standards for CNSs and that is approved by the Secretary.

Currently, there is not a list of recognized or approved national certifying bodies for NPs and CNSs in regulations. However, Chapter 15, section 200 of the Benefit Policy Manual, Pub. 100-02 contains a list of national certifying bodies that are recognized by Medicare as being appropriate for certification of NPs. Although the manual provision regarding CNS services at Chapter 15, section 210 of the Benefit Policy Manual lists only the American Nurses Credentialing Center as an approved national certifying body for CNSs, we indicated that the list of recognized certifying bodies in the manual provision for NP services would also apply for CNSs in the ``Revisions to Payment Policies Under the CY 2003 Physician Fee Schedule and Inclusion of Registered Nurses in the Personnel Provision of the Critical Access Hospital Emergency Services Requirement for Frontier Areas and Remote Locations; Payment Policies final rule (December 31, 2002, 67 FR 79987). The national certifying bodies that are listed under the manual instruction at section 200, and that currently apply for both NPs and CNSs (collectively, advanced practice nurses) are as follows:

American Academy of Nurse Practitioners;

American Nurses Credentialing Center;

National Certification Corporation for Obstetric, Gynecologic and Neonatal Nursing Specialties;

National Certification Board of Pediatric Nurse Practitioners and Nurses;

Oncology Nurses Certification Corporation;

Critical Care Certification Corporation.

In the December 31, 2002 final rule, in response to a public comment, we stated, ``it is not the agency's intention to be overly restrictive in our program requirements and consequently prevent qualified CNSs who specialize in areas of medicine other than those certified by the American Nurses Credentialing Center (ANCC) from participating under the CNS benefit and from rendering care to patients in need of specialized services. Furthermore, the intent of the revision to the certification requirement for CNSs is to recognize all appropriate national certifying bodies for CNSs as the program does for NPs.'' Accordingly, in an effort to recognize all appropriate national certifying bodies for CNSs and NPs, we added, at that time, the Oncology Nurses Certification Corporation (ONCC) and the Critical Care Certification Corporation (CCCC) to the list of recognized national certifying bodies for advanced practice nurses.

The National Board on Certification of Hospice and Palliative Care Nurses (NBCHPN) has requested that we now follow the same course of action as we did for the ONCC and the CCCC by adding its name to the list of recognized national certifying bodies. That is, NBCHPN believes that it is an appropriate national certifying body based on its certification experience, principles, services, and the certification exam that it administers to advanced practice nurses who specialize in palliative care for hospice patients.

The NBCHPN stated in information it sent to the agency that its organization is a well-established certification body with more than 12-years history of certification and that it has been certifying advanced practice hospice and palliative nurses since 2003 in partnership with the ANCC. Starting in 2005, the NBCHPN became sole proprietor of the Advanced Certified Hospice and Palliative Nurse (ACHPN) examination. Master's level nurse practitioners and clinical nurse specialists sit for this ACHPN examination that is based on a role delineation study for the advanced practice level of hospice and palliative nursing. Additionally, the NBCHPN stated that it has met the requirements of the American Board of Nursing Specialties and is an active member of the Board of Specialties, as is the ANCC. The Executive Director of the NBCHPN stated that she believes that the absence of the NBCHPN from the current list of recognized national certifying bodies presents a barrier for advanced practice nurses in the hospice palliative care specialty because they are denied enrollment on the basis that they do not meet the certification qualification requirement. The Web site for the NBCHPN can be found at http://www.nbchpn.com.

We are soliciting public comments on whether it would be appropriate to include the NBCHPN under the list of recognized and approved national certifying bodies for NPs and CNSs under manual instructions for both NPs and CNSs. We are also soliciting public comments on criteria or standards that we could use to determine whether an organization is an appropriate national certifying body for advanced practice nurses. CMS realizes that the agency may receive other requests in the future from organizations that wish to be to be added to the list of recognized or approved national certifying bodies. In anticipation of those requests, the agency is interested in developing certification standards that would facilitate the process for making these decisions.

P. Chiropractic Services Demonstration

[If you choose to comment on issues in this section, please include the caption ``Chiropractic Services Demonstration'' at the beginning of your comments.]

In the FY 2006 PFS final rule (November 21, 2005), we included a discussion of the 2-year demonstration authorized by section 651 of the MMA to evaluate the feasibility and advisability of covering chiropractic services under Medicare. These services extend beyond the current coverage for manipulation to care for neuromusculoskeletal conditions typical among eligible beneficiaries, and cover diagnostic and other services that a chiropractor is legally authorized to perform by the State or jurisdiction in which the treatment is provided. The demonstration is being conducted in four sites, two rural and two urban. The demonstration must be budget neutral as the statute requires the Secretary to ensure that the aggregate payment made under the Medicare program does not exceed the amount which would be paid in the absence of the demonstration.

Ensuring budget neutrality requires that the Secretary develop a strategy for recouping funds should the demonstration result in costs higher than those that would occur in the absence of the demonstration. As we stated in the FY 2006 PFS, we would make adjustments in the national chiropractor fee schedule to recover the costs of the demonstration in excess of the amount estimated to yield budget neutrality. We will assess budget neutrality by determining the change in costs based on a pre/post comparison of costs and the rate of change for specific diagnoses that are treated by chiropractors and physicians in the demonstration sites and control sites. We will not limit our analysis to reviewing only chiropractor claims, because the costs of the expanded chiropractor services may have an impact on other Medicare costs.

Any needed reduction would be made in the 2010 and 2011 physician fee schedules as it will take approximately 2 years to complete the claims analysis. If we determine that the adjustment for budget neutrality is greater than 2 percent of spending for the chiropractor fee schedule codes (comprised of the 3

[[Page 49067]]

currently covered CPT codes 98940, 98941, and 98942), we would implement the adjustment over a 2-year period. However, if the adjustment is less than 2 percent of spending under the chiropractor fee schedule codes, we would implement the adjustment over a 1-year period. We will include the detailed analysis of budget neutrality and the proposed offset during the 2009 rulemaking process. PT services performed by chiropractors under the demonstration are subject to the PT therapy cap. These services are included under the cap because chiropractors are subject to the same rules as medical doctors for therapy services under the demonstration.

Q. Promoting Effective Use of Health Information Technology (HIT)

(If you choose to comment on issues in this section, please include the caption ``Promoting Effective Use of HIT'' at the beginning of your comment.)

We recognize the potential for health information technology (HIT) to facilitate improvements in the quality and efficiency of health care services. One recent RAND study found that broad adoption of electronic health records could save more than $81 billion annually and, at the same time, improve quality of care.\1\ The largest potential savings that the study identified was in the hospital setting because of shorter hospital stays promoted by better coordinated care; less nursing time spent on administrative tasks; better use of medications in hospitals; and better utilization of drugs, laboratory services, and radiology services in hospital outpatient settings. The study also identified potential quality gains through enhanced patient safety, decision support tools for evidence-based medicine, and reminder mechanisms for screening and preventive care. Despite these large potential benefits, the study found that only about 20 to 25 percent of hospitals have adopted HIT systems.

\1\ RAND News Release: Rand Study Says Computerizing Medical Records Could Save $81 Billion Annually and Improve the Quality of Medical Care, September 14, 2005, available at http://rand.org/news/press.05/09.14.html .

It is important to note the caveats to the RAND study. The projected savings are across the health care sector, and any Federal savings would be a reduced percentage. In addition, there are significant assumptions made in the RAND study. National savings are projected in some cases based on one or two small studies. Also, the study assumes patient compliance, in the form of participation in disease management programs and following medical advice. For these reasons, extreme caution should be used in interpreting these results.

In summary, there are mixed signals about the potential of HIT to reduce costs. Some studies have indicated that HIT adoption does not necessarily lead to lower costs and improved quality. In addition, some industry experts have stated that factors such as an aging population, medical advances, and increasing provider expenses would make any projected savings impossible.

In his 2004 State of the Union Address, the President announced a plan to ensure that most Americans have electronic health records within 10 years.\2\ One part of this plan involves developing voluntary standards and promoting the adoption of interoperable HIT systems that use these standards. The 2007 Budget states that ``The Administration supports the adoption of health information technology (IT) as a normal cost of doing business to ensure patients receive high quality care.''

\2\ Transforming Health Care: The President's Health Information Technology Plan, available at: http://www.whitehouse.gov/infocus/technology/economic_policy200404/chap3.html .

Over the past several years, we have undertaken several activities to promote the adoption and effective use of HIT in coordination with other Federal agencies and with the Office of the National Coordinator for Health Information Technology. One of those activities is promotion of data standards for clinical information, as well as for claims and administrative data.

As noted above, the Administration supports the adoption of HIT as a normal cost of doing business. The adoption and use of HIT may contribute to improved processes and outcomes of care, including shortened illnesses and the avoidance of adverse drug reactions.

R. Health Care Information Transparency Initiative

(If you choose to comment on issues in this section, please include the caption ``Health Care Information Transparency Initiative'' at the beginning of your comment.)

The United States (U.S.) faces a dilemma in health care. Although the rate of increase in health care spending slowed last year, costs are still growing at an unsustainable rate. The U.S. spends $1.9 trillion on health care, or 16 percent of the gross domestic product (GDP). By 2015, projections are that health care will consume 20 percent of GDP. As indicated in the 2006 Annual Report of the Boards of Trustees, the Medicare program alone consumes 3.2 percent of the GDP and by 2040, it will consume 8.0 percent of the GDP.

Part of the reason health care costs are rising so quickly is that most consumers of health care--the patients--are frequently not aware of the actual cost of their care. Health insurance shields them from the full cost of services, and they have only limited information about the quality and costs of their care. Consequently, consumers do not have the incentive or means to carefully shop for providers offering the best value. Thus, providers of care are not subject to the competitive pressures that exist in other markets for offering quality services at the best possible price. Reducing the rate of increase in health care prices and avoiding health services of little value could help to stem the growth in health care spending, and potentially reduce the number of individuals who are unable to afford health insurance. Part of the President's health care agenda is to expand Health Savings Accounts (HSAs), which would provide consumers with greater financial incentives to compare providers in terms of price and quality, and choose those that offer the best value.

In order to exercise those choices, consumers must have accessible and useful information on the price and quality of health care items and services. Typically, health care providers do not publicly quote or publish their prices. Moreover, list prices, or charges, generally differ from the actual prices negotiated and paid by different health plans. Thus, even if consumers were financially motivated to shop for the best price, it would be very difficult at the current time for them to access usable information.

For these reasons, DHHS is launching a major health care information transparency initiative in 2006. This effort builds on steps taken by CMS to make quality and price information available. For example, Medicare has provided unprecedented information about drug prices in the Medicare drug benefit, and is now adding to these efforts in other areas. Medicare payment information for common elective procedures and other common admissions for all hospitals by county has been posted on our Web site at: http://www.cms.hhs.gov/HealthCareConInit/01 Overview.asp#TopOfP.

We will post geographically-based Medicare payment information for common elective procedures for ambulatory surgery centers this summer and for common hospital outpatient and physician services this fall.

[[Page 49068]]

In addition, a number of tools providing usable healthcare information are already available to Medicare beneficiaries. Supported by the public-private quality alliances, consumers can access ``Compare'' Web sites through http://www.medicare.gov where they can evaluate

important aspects of their health care options for care at a hospital, nursing home, home health agency, and dialysis facility, as well as compare their costs and coverage when choosing a prescription drug plan.

We are developing a project with the goals of providing more comprehensive information on quality and costs, including more complete measures of health outcomes, satisfaction, and volume of services that matter to consumers, and more comprehensive measures of costs for entire episodes of care, not just payments for particular services and admissions. We intend for the project to combine public and private health care data to measure cost and quality of care information at the physician and hospital levels. Quality, cost, pricing, and patient information will be reported to consumers and purchasers of health care in a meaningful and transparent way.

III. Collection of Information Requirements

Under the Paperwork Reduction Act of 1995, we are required to provide 60-day notice in the Federal Register and solicit public comment before a collection of information requirement is submitted to the Office of Management and Budget (OMB) for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires that we solicit comment on the following issues:

The need for the information collection and its usefulness in carrying out the proper functions of our agency.

The accuracy of our estimate of the information collection burden.

The quality, utility, and clarity of the information to be collected.

Recommendations to minimize the information collection burden on the affected public, including automated collection techniques.

We are soliciting public comment on each of these issues for the following sections of this document that contain information collection requirements:

Section 410.33 Independent Diagnostic Testing Facility

Section 410.33(e)(1) imposes a recordkeeping requirement on multi- state entities. Specifically, an independent diagnostic testing facility (IDTF) that operates across State boundaries must maintain documentation that its supervising physicians and technicians are licensed and certified in each of the States in which it operates. The burden associated with this requirement is the time and effort it takes the IDTF to collect and maintain the aforementioned information.

While subject to the PRA, we believe this information collection requirement is exempt as defined in 5 CFR 1320.3(b)(2), because the time, effort, and financial resources necessary to comply with the requirement would be incurred by persons in the normal course of their activities (for example, in compiling and maintaining business records) and is considered to be usual and customary.

Section 410.33(g) discusses the application certification standards that an IDTF must meet. An IDTF must complete an enrollment application and certify the information contained in the application. The certification is part of an application that is subject to the PRA. The burden associated with this requirement is the time and effort necessary to complete the application. This requirement is currently approved in OMB No. 0938-0685, with a current expiration date of April 30, 2009.

If you comment on these information collection and recordkeeping requirements, please mail copies directly to the following:

Centers for Medicare & Medicaid Services, Office of Strategic Operations and Regulatory Affairs, Regulations Development Group, Attn: William N. Parham, III, [CMS-1321-P], Room C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850; and Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503, Attn: Carolyn Lovett, CMS Desk Officer, [CMS-1321-P], carolyn_lovett@omb.eop.gov. Fax (202) 395-6974.

IV. Response to Comments

Because of the large number of public comments we normally receive on Federal Register documents, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the DATES section of this preamble, and, when we proceed with a subsequent document, we will respond to the comments in the preamble to that document.

V. Regulatory Impact Analysis

[If you choose to comment on issues in this section, please include the caption ``IMPACT'' at the beginning of your comments.]

We have examined the impact of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 19, 1980 Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), and Executive Order 13132.

Executive Order 12866 (as amended by Executive Order 13258, which merely reassigns responsibilities of duties) directs agencies to assess all costs and benefits of available regulatory alternatives and, when regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis must be prepared for proposed rules with economically significant effects (that is, a proposed rule that would have an annual effect on the economy of $100 million or more in any one year, or would adversely affect in a material way the economy, a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or State, local, or tribal governments or communities). As indicated in more detail below, we estimate that the PFS provisions included in this proposed rule will redistribute more than $100 million in one year. We are considering this proposed rule to be economically significant because its provisions are estimated to result in an increase, decrease or aggregate redistribution of Medicare spending that will exceed $100 million. Therefore, this proposed rule is a major rule and we have prepared a regulatory impact analysis.

The RFA requires that we analyze regulatory options for small businesses and other entities. We prepare a regulatory flexibility analysis unless we certify that a rule would not have a significant economic impact on a substantial number of small entities. The analysis must include a justification concerning the reason action is being taken, the kinds and number of small entities the rule affects, and an explanation of any meaningful options that achieve the objectives with less significant adverse economic impact on the small entities.

Section 1102(b) of the Act requires us to prepare a regulatory impact analysis for any proposed rule that may have a significant impact on the operations of

[[Page 49069]]

a substantial number of small rural hospitals. This analysis must conform to the provisions of section 603 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside a Metropolitan Statistical Area and has fewer than 100 beds. We have determined that this proposed rule would have minimal impact on small hospitals located in rural areas. Of the 222 hospital-based ESRD facilities located in rural areas, only 40 are affiliated with hospitals with fewer than 100 beds.

For purposes of the RFA, physicians, nonphysician practitioners, and suppliers are considered small businesses if they generate revenues of $6 million or less. Approximately 95 percent of physicians are considered to be small entities. There are about 980,000 physicians, other practitioners and medical suppliers that receive Medicare payment under the PFS.

For purposes of the RFA, approximately 80 percent of clinical diagnostic laboratories are considered small businesses according to the Small Business Administration's size standards.

In addition, most ESRD facilities are considered small entities, either based on nonprofit status or by having revenues of $29 million or less in any year. We consider a substantial number of entities to be affected if the proposed rule is estimated to impact more than 5 percent of the total number of small entities. Based on our analysis of the 927 nonprofit ESRD facilities considered small entities in accordance with the above definitions, we estimate that the combined impact of the proposed changes to payment for renal dialysis services included in this proposed rule would have a 0.9 percent increase in overall payments relative to current overall payments.

IDTFs are suppliers under the Medicare program. For purposes of the RFA, suppliers with annual sales of $6 million or less are considered to be small entities. (Individuals and States are not included in the definition of a small entity.) We believe that our proposed standards for IDTFs will help bar fraudulent suppliers from participating in the Medicare program and provide an added level of protection to Medicare beneficiaries. Therefore, we expect to have an impact on an unknown number of persons and entities who will effectively be prevented from practicing their aberrant billing activities. The vast majority of suppliers would not be significantly affected by this proposed rule. The reduction in program overpayments and the added level of protection to beneficiaries that we expect to achieve as a result of this proposed rule justifies the relatively small burden this proposed rule would impose on all small entities.

The analysis and discussion provided in this section, as well as elsewhere in this proposed rule, complies with the RFA requirements.

Section 202 of the Unfunded Mandates Reform Act of 1995 also requires that agencies assess anticipated costs and benefits before issuing any rule that may result in expenditures in any year by State, local, or tribal governments, in the aggregate, or by the private sector, of $120 million. Medicare beneficiaries are considered to be part of the private sector for this purpose.

We have examined this proposed rule in accordance with Executive Order 13132 and have determined that this regulation would not have any significant impact on the rights, roles, or responsibilities of State, local, or tribal governments. A discussion concerning the impact of this rule on beneficiaries is found later in this section.

We have prepared the following analysis, which, together with the information provided in the rest of this preamble, meets all assessment requirements. The analysis explains the rationale for and purposes of this proposed rule; details the costs and benefits of the rule; analyzes alternatives; and presents the measures we propose to use to minimize the burden on small entities. As indicated elsewhere in this proposed rule, we propose to change our methodology for calculating resource-based PE RVUs and make a variety of other changes to our regulations, payments, or payment policies to ensure that our payment systems reflect changes in medical practice and the relative value of services. We provide information for each of the policy changes in the relevant sections of this proposed rule. We are unaware of any relevant Federal rules that duplicate, overlap or conflict with this proposed rule. The relevant sections of this proposed rule contain a description of significant alternatives if applicable.

A. Resource Based PE RVU Proposals for CY 2007 and Section 5102 of the DRA-Proposed Adjustments for Payments for Imaging Services

As required by section 5102(a) of the DRA and described earlier in section II.E.1. of this proposed rule, we are removing, from the PE RVUs under the PFS the 0.3 percent increase made to the PE RVUs in the CY 2006 PFS final rule with comment period to ensure the budget neutrality of the impact of the multiple imaging policy adopted for CY 2006. Section 5102(a) of the DRA exempts the CY 2006 and 2007 impact of the multiple imaging policy from budget neutrality. Because we are proposing to maintain the current 25 percent payment reduction for multiple imaging procedures in CY 2007, there is no additional impact resulting from our proposals for CY 2007. Section 5102 of the DRA also exempts the estimated savings from the application of the OPPS-based payment limitation on PFS imaging services from the PFS budget neutrality requirement. We estimate that the combined impact of the budget neutrality exemptions in section 5102 of the DRA would reduce PFS expenditures by approximately 1.3 percent in CY 2007.

Table 7 below shows the specialty-level impact of section 5102 of the DRA and our most recent estimate (-5.1 percent) of the CY 2007 Medicare PFS update. For reference purposes, we have also included the specialty-level impacts using the methodology from the separate June 29, 2006 proposed notice (71 FR 37170), which solicited comments on proposed changes to the PE methodology as well as changes to work RVUs for certain services based on the agency's completion of a five-year review of work RVUs. The CY 2007 impact of the PE input changes described in section II.A. of this proposed rule that were not included in the June 29, 2006 proposed notice are minimal at the specialty level. Additionally, the impacts in this proposed rule reflect the use of updated physician time data from the AMA-RUC.

Our estimates of changes in Medicare revenues for PFS services compare payment rates for CY 2006 with proposed payment rates for CY 2007 using CY 2005 Medicare utilization for all years. We are using CY 2005 Medicare claims processed and paid through March 30, 2005, that we estimate are 98 percent complete. To the extent that there are year-to- year changes in the volume and mix of services provided by physicians, the actual impact on total Medicare revenues will be different than those shown here. The payment impacts reflect averages for each specialty based on Medicare utilization. The payment impact for an individual physician would be different from the average, based on the mix of services the physician provides. The average change in total revenues would be less than the impact displayed here because physicians furnish services to both Medicare and non-Medicare patients

[[Page 49070]]

and specialties may receive substantial Medicare revenues for services that are not paid under the PFS. For instance, independent laboratories receive approximately 80 percent of their Medicare revenues from clinical laboratory services that are not paid under the PFS.

Table 7 shows only the payment impact on PFS services. The following is an explanation of the information represented in Table 7:

Specialty--The physician specialty or type of practitioner/supplier.

Allowed Charges--Allowed charges are the Medicare Fee Schedule amounts for covered services and include copayments and deductibles (which are the financial responsibility of the beneficiary.) These amounts have been summed across all services provided by physicians, practitioners, or suppliers with a specialty to arrive at the total allowed charges for the specialty.

Impact of Work and PE RVU Changes using the June 29, 2006 proposed notice methodology--For references purposes, the combined CY 2007 percentage increase or decrease in allowed charges attributed to changes in the work and PE RVUs described in and republished from the June 29, 2006 proposed notice methodology.

Impact of section 5102 of the DRA--The CY 2007 percentage decrease in allowed charges attributed to section 5102 of the DRA.

Combined impact of the June 29, 2006 proposed notice methodology and section 5102 of the DRA.

CY 2007 Update--The percentage decrease in allowed charges attributed to the most recent estimate of the CY 2007 PFS conversion factor update (-5.1 percent).

Combined impact with CY 2007 update--The CY 2007 percentage decrease in allowed charges attributed to the June 29, 2006 proposed notice methodology, section 5102 of the DRA, and the CY 2007 update.

[GRAPHIC] [TIFF OMITTED] TP22AU06.045

[[Page 49071]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.046

Table 8 below shows the impact on total payments for selected high- volume procedures of all of the changes previously discussed. We selected these procedures because they are the most commonly provided by a broad

[[Page 49072]]

spectrum of physician specialties. There are separate columns that show the change in the facility rates and the nonfacility rates. For an explanation of facility and nonfacility PE refer to Addendum A of this proposed rule. If we change any of the proposed provisions following the consideration of public comments, these figures may change.

[GRAPHIC] [TIFF OMITTED] TP22AU06.047

[[Page 49073]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.048

B. Geographic Practice Cost Indices (GPCI)--Payment Localities

As discussed in section II.B. of the preamble to this proposed rule, we are proposing new GPCIs for 2007. In the November 15, 2004 PFS final rule, we published 2005 and 2006 GPCI and GAF values reflecting the 2 year phase-in of updated GPCI data. In 2007, the proposed GPCI and GAF values will reflect new budget neutrality scalers (developed by the Office of the Actuary) and the removal of the 1.000 MMA floor from the physician work GPCI. The negative impact of these changes on a number of payment localities is shown in 4 of section II.B. in this proposed rule.

C. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures

As discussed in section II.D.1. of this proposed rule, we are proposing changes to the global period for these

[[Page 49074]]

services. We do not anticipate this proposed change will have a significant impact on Medicare expenditures.

D. DRA 5112--Proposed Addition of the Ultrasound Screening for Abdominal Aortic Aneurysm to Welcome to Medicare Benefit

As discussed earlier in section II.E.3. of this preamble, section 5112 of the DRA authorizes coverage of an ultrasound screening for abdominal aortic aneurysms effective January 1, 2007, subject to certain eligibility and other limitations. We estimate that this new benefit would result in an increase in Medicare expenditures to physicians and other practitioners and suppliers of ultrasound services and related follow-up tests and treatment that may be required as a result of the coverage of these screening examinations. However, this is not expected to have a significant cost impact on the Medicare program.

E. DRA 5113--Proposed Colorectal Screening Exemption From Part B Deductible

As discussed earlier in section II.E.4. of this preamble, beginning January 1, 2007, colorectal cancer screening services as described in section 1861(pp)(1) of the Act are no longer subject to the Part B deductible. While waiver of this deductible will be beneficial to Medicare beneficiaries, we do not anticipate that this change will have a significant cost impact on the Medicare program.

F. Section 5114--Proposed Addition of Diabetes Outpatient Self- Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program

As discussed earlier in section E.4. of this preamble, section 5114 of the DRA amended section 1861(aa)(3) the Act to add DSMT and MNT to the list of Medicare covered and reimbursed services under the Medicare FQHC benefit, effective for services provided on or after January 1, 2006. Although this statutory change has already been implemented in administrative instructions, we are proposing to conform the regulations to meet the new statutory requirement. FQHCs certified as DSMT and MNT providers have been allowed to bundle the cost of those services into their FQHC payment rates. But before the enactment of the DRA, the provision of these services would not generate a separate FQHC visit payment. Effective for services furnished on or after January 1, 2006, FQHCs that are certified providers of DSMT and MNT services can receive per visit payments for covered services furnished by registered dietitians or nutrition professionals. In light of the fact there are a limited number of qualified centers for DSMT and MNT services, the increase in Medicare expenditures should be negligible.

G. Proposed Payment for Covered Outpatient Drugs and Biologicals (ASP Issues)

The proposed changes discussed in section II.F. of this proposed rule, with respect to payment for covered outpatient drugs and biologicals, are estimated to have no impact on Medicare expenditures. However, we believe the changes will assist in clarifying existing policy with respect to ASP payment.

H. Proposed Provisions Related to Payment for Renal Dialysis Services Furnished by End State Renal Disease (ESRD) Facilities

The ESRD related provisions in this proposed rule are discussed in section II.G. of this preamble. In order to understand the impact of the proposed changes affecting payments to different categories of ESRD facilities, it is necessary to compare estimated payments under the current year (current 2006 payments) to estimated payments under the proposed revisions to the composite rate payment system as discussed in II.G. of this proposed rule (proposed 2007 payments). To estimate the impact among various classes of ESRD facilities, it is imperative that the estimates of current payments and proposed payments contain similar inputs. Therefore, we simulated payments only for those ESRD facilities that we are able to calculate both current 2006 payments and proposed 2007 payments.

Due to data limitations, we are unable to estimate current and proposed payments for 226 facilities that bill for ESRD dialysis treatments. ESRD providers were grouped into the categories based on characteristics provided in the Online Survey and Certification and Reporting (OSCAR) file and the most recent cost report data from the Healthcare Cost Report Information System (HCRIS). We also used the December 2005 update of CY 2005 National Claims History file as a basis for Medicare dialysis treatments and separately billable drugs and biologicals. While the December 2005 update of the 2005 claims file is not complete, we wanted to use the most recent data available, and plan to use an updated version of the 2005 claims file for the final rule. BILLING CODE 4120-01-P

[[Page 49075]]

[GRAPHIC] [TIFF OMITTED] TP22AU06.049

Table 9 above shows the impact of this year's proposed changes to CY 2007 payments to hospital-based and independent ESRD facilities. The first column of Table 9 identifies the type of ESRD provider, the second column

[[Page 49076]]

indicates the number of ESRD facilities for each type, and the third column indicates the number of dialysis treatments.

The fourth column shows the effect of CY 2007 proposed changes to the ESRD wage index as it affects the composite rate payments to ESRD facilities. The fourth column compares aggregate ESRD wage adjusted composite rate payments in the second year of the transition (CY 2007) to aggregate ESRD wage adjusted composite rate payments in first year of the transition (CY 2006). In the second year of the transition (CY 2007), ESRD facilities receive 50 percent of the CBSA wage adjusted composite rate and 50 percent of the MSA adjusted composite rate. In the first year of the transition, ESRD facilities receive 25 percent of the CBSA wage adjusted composite rate and 75 percent of the MSA adjusted composite rate. The overall effect to all ESRD providers in aggregate is zero because the proposed CY 2007 ESRD wage index has been multiplied by a budget neutrality factor to comply with the statutory requirement that any wage index revisions be done in a manner that results in the same aggregate amount of expenditures as would have been made without any changes in the wage index. The decreases shown among census regions is primarily due to reducing the wage index floor, as there were areas in these areas with wage index values below the proposed floor.

The fifth column shows the overall effect of the proposed changes in composite rate payments to ESRD providers. The overall effect is measured as the difference between CY 2007 proposed payment with all changes as proposed in this rule and CY 2006 current payment. This amount is computed by multiplying the wage adjusted composite rate with the drug add-on for each provider times dialysis treatments from 2005 claims. The CY 2007 proposed payment is transition year two wage adjusted composite rate for each provider (with the proposed 15.2 percent drug add-on) times dialysis treatments from 2005 claims. The CY 2006 current payment is transition year one wage adjusted composite rate for each provider (with the current 14.5 percent drug add on) times dialysis treatments from 2005 claims.

The overall impact to ESRD providers in aggregate is 0.6 percent. This increase corresponds to the proposed 0.6 percent increase to the drug add-on. The variation seen in column 5 is due to variation in change in the wage index (column 4). All provider types receive the same 0.6 percent increase to the drug add on.

I. Private Contracts and Opt-Out Provision

The changes discussed in this proposed rule, with respect to private contracts and the opt-out provision, are currently estimated to have no significant impact on Medicare expenditures.

J. Proposals Related to Physician Self Referral Prohibitions

As discussed in section II.I of this proposed rule, we would clarify in regulations at Sec. 424.80(d) under the contractual arrangement reassignment exception that, if a physician or other individual supplier reassigns his or her right to bill for the TC of a diagnostic test, the entity to which the reassignment is made may not be paid more than the physician or other individual supplier would have been paid for the TC. In addition, in order to bill for the TC of the diagnostic test, the entity to which the reassignment is made must perform the PC. We also propose that, in order to bill for the PC of a diagnostic test following a reassignment, the billing entity must meet current requirements in our manual instructions.

In addition, as discussed in section II.I., we also propose to revise Sec. Sec. 424.80(b) and (d) to provide that a physician or other individual supplier who reassigns his or her right to benefits has a right to review the bills for his or her services, irrespective of whether the individual is an employee or an independent contractor of the entity to which the reassignment is made.

We also propose the following changes to the physician self- referral provisions:

A ``centralized building'' for purposes of the physician services exception and the in-office ancillary services exception at Sec. Sec. 411.355(a) and (b), respectively, would have to measure at least 350 square feet and include permanent placement of the equipment used in the provision of substantially all of the designated health services. We believe that these changes would have little effect on Medicare expenditures.

K. Supplier Access to Claims Billed on Reassignment

The reassignment provisions discussed in section II.J.2. of this preamble are currently estimated to have no significant impact on Medicare expenditures.

L. Proposed Coverage of Bone Mass Measurement

As discussed in section II.K. of this preamble, we have decided to propose several revisions to Sec. 410.31 relative to the definition of the term ``Bone Mass Measurement'' (Sec. 410.31(a)(2)), the conditions for coverage (Sec. 410.31(b)), the examples of exceptions to the standards on frequency of coverage (Sec. 410.31(c)(2)), and the category of individuals receiving glucocorticoid (steroid) therapy (Sec. 410.31(d)(3)). We are also proposing the addition of a new paragraph (f) that would allow CMS, through the NCD process, to identify additional BMM systems for monitoring individuals receiving osteoporosis drug therapy and for performing confirmatory baseline measurements. We do not expect that this addition would have a significant cost impact on the Medicare program in the next several years.

Based on the projected impact of the first three changes that would place greater reliance on the use of the more expensive DXA (axial skeleton) devices, we estimate that this revised benefit would result in an increase in Medicare payments for providers who use the DXA (axial skeleton) devices and a somewhat smaller decrease in payments to providers who use QCT (axial skeleton) and peripheral devices. However, we do not expect that these changes would have a significant cost impact on the Medicare program due to the fact that at present a very small percentage of our total Medicare payments for bone mass measurements are being made to providers who use QCT or peripheral devices. In addition, we estimate that lowering the eligibility standard for coverage of individuals on steroid therapy from 7.5 mg/day to 5.0 mg/day of prednisone (the fourth change) would result in an increase in Medicare payment for testing of additional patients, but this modest lowering of the steroid standard is not expected to have a significant cost impact on the program.

M. Proposed IDTF Changes

The costs associated with these proposed changes would be as follows: 1. Liability Insurance Requirement (Sec. 424.57(c)(10))

We estimate that only 10 percent of IDTFs do not already have liability insurance that meets this requirement. Based on Medicare data as of June 2005, 10 percent of the total number of IDTFs is approximately 559 suppliers. Using the previously highest estimate received ($1,800 annually), results in an approximate additional liability insurance cost of $1 million annually (559 times $1,800) to the IDTF industry due to this proposed rule.

[[Page 49077]]

2. Primary Business Telephone Listed Under the Name of the Business Locally or Toll-free for Beneficiaries Proposed Requirement (Sec. 424.57(c)(9))

We estimate that only 1 percent of IDTFs do not already meet this requirement. Based on Medicare data as of June 2005, we determined that 1 percent of IDTFs is approximately 56 suppliers. Therefore, 56 times the approximate $600 annual cost of telephone service results in an additional cost of $33,600 annually. Total Cost = $1 Million + $33,600 = approximately $1.04 million annually.

N. Independent Lab Billing for TC Component of Physician Pathology Services for Hospital Patients

The most current information on the number of affected hospitals and the impact on laboratories and hospitals comes from a report issued by the General Accounting Office (GAO) in September 2003.

The GAO estimated that approximately 95 percent of the total of all Medicare hospitals on the prospective payment system, as well as CAHs sent the TC of physician pathology services to independent laboratories and the independent laboratories billed the carrier under the PFS.

The GAO estimated that the median number of services sent by each hospital to outside independent laboratories was small, approximately 81 services. The GAO was unable to identify the number of laboratories billing for the TC service because a single laboratory may submit claims under multiple provider numbers. In general, the impact on the individual hospital is small; however, we do not know the impact on the individual independent laboratory

If the independent laboratories had not received payments from the carriers for these TC services for hospital patients, the GAO estimates that Medicare spending would have been $42 million less in 2001 and beneficiary cost sharing obligations for inpatient and outpatient services would have been reduced by $2 million.

Based on what they learned from the hospital industry, the GAO thought that Medicare beneficiaries' access to pathology services would not likely be affected if independent laboratories could not longer bill the carrier for these services. Hospital representatives indicated that they would likely continue to use independent laboratories to provide TC pathology services.

In is unclear if the hospitals contracting with independent laboratories would pay the laboratories at the same rates that the laboratories received by billing the Medicare carriers under the physician fee schedule.

O. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests

This codification of our process for public consultation for new clinical diagnostic laboratory tests paid under the Medicare Part B clinical laboratory fee schedule, if adopted, would not increase or decrease payment amounts for existing clinical diagnostic laboratory tests because it would not alter our current methodology for calculating payment amounts for existing clinical diagnostic laboratory tests. For new tests, this proposal would primarily codify an existing process for the determination of payment amounts. Because any new laboratory tests to be gapfilled are unknown to us at the current time, we do not have any data to estimate the impact of our proposal to pay for new gapfilled lab tests at the median of the local carrier amounts for all carriers rather than the lower of that amount and the local carrier amount.

P. Alternatives Considered

This proposed rule contains a range of policies, including some proposals related to specific MMA provisions. The preamble provides descriptions of the statutory provisions that are addressed, identifies those policies when discretion has been exercised, presents rationale for our decisions and, where relevant, alternatives that were considered.

Q. Impact on Beneficiaries

There are a number of changes made in this proposed rule that would have an effect on beneficiaries. In general, we believe these proposed changes, particularly the DRA provisions that provide for an exception to the application of the Part B deductible with respect to colorectal cancer screening tests and coverage of an ultrasound screening for the early detection of AAAs, as part of the Initial Preventive Physical Examination benefit (referred to as the Welcome to Medicare benefit) would improve beneficiary access to services that are currently covered or expand the Medicare benefit package to include new services. As explained in more detail below, the regulatory provisions may affect beneficiary liability in some cases. Any changes in aggregate beneficiary liability from a particular provision would be a function of the coinsurance (20 percent if applicable for the particular provision after the beneficiary has met the deductible) and the effect of the aggregate cost (savings) of the provision on the calculation of the Medicare Part B premium rate (generally 25 percent of the provision's cost or savings).

To illustrate this point, as shown in Table 8, the 2006 national payment amount in the nonfacility setting for CPT code 99203 (Office/ outpatient visit, new), is $97.02 which means that currently a beneficiary is responsible for 20 percent of this amount, or $19.40. Based on the June 29, 2006 proposed notice (71 FR 37170) and this proposed rule, the 2007 national payment amount in the nonfacility setting for CPT code 99203, as shown in Table 8, is $91.71 which means that, in 2007, the beneficiary coinsurance for this service would be $18.34.

Very few of the changes we are proposing impact overall payments and, therefore, would affect Medicare beneficiaries' coinsurance liability. Proposals discussed above that do affect overall spending, such as DRA 5102 imaging provisions, would similarly impact beneficiaries' coinsurance.

R. Accounting Statement

As required by OMB Circular A-4 (available at http://www.whitehouse.gov/omb/circulars/a004/a-4.pdf ), in Table 10 below, we

have prepared an accounting statement showing the classification of the expenditures associated with the provisions of this proposed rule. This table includes the impact of the proposed changes in this rule on providers and suppliers.

Expenditures are classified as transfers to Medicare providers/or suppliers (that is, ESRD facilities and physicians, other practitioners, clinical laboratories and medical suppliers that receive payment under the physician fee schedule or Medicare Part B). Based on the proposals contained in this proposed rule, there would be an estimated decrease in expenditures from CY 2006 to 2007. This is a result of the CY 2007 increased payment to ESRD facilities the reduction to the payments for imaging services under the PFS required by section 5102 of the DRA and the -5.1 percent Medicare PFS conversion factor update required by the statutory update formula.

Table 10.--Accounting Statement: Classification of Estimated Expenditures, From CY 2006 to the CY 2007 (in Millions)

Category

Transfers

Annualized Monetized Transfers............ Estimated decrease in expenditures of $3,600

[[Page 49078]]

From Whom To Whom?

Federal Government To ESRD Medicare Providers; physicians, other practitioners and suppliers who receive payment under the Medicare Physician Fee Schedule; and Medicare Suppliers billing for Part B drugs.

In accordance with the provisions of Executive Order 12866, this final rule was reviewed by the Office of Management and Budget.

List of Subjects

42 CFR Part 405

Administrative practice and procedure, Health facilities, Health professions, Kidney diseases, Medical devices, Medicare, Reporting and recordkeeping requirements, Rural areas, X-rays.

42 CFR Part 410

Health facilities, Health professions, Kidney diseases, Laboratories, Medicare, Reporting and recordkeeping requirements, Rural areas, X-rays.

42 CFR Part 411

Kidney diseases, Medicare, Physician Referral, Reporting and recordkeeping requirements.

42 CFR Part 414

Administrative practice and procedure, Health facilities, Health professions, Kidney diseases, Medicare, Reporting and recordkeeping.

42 CFR Part 415

Health facilities, Health professions, Medicare, Reporting and recordkeeping requirements.

42 CFR Part 424

Emergency medical services, Health facilities, Health professions, Medicare, Reporting and recordkeeping requirements.

For the reasons set forth in the preamble, the Centers for Medicare & Medicaid Services proposes to amend 42 CFR chapter IV as set forth below:

PART 405--FEDERAL HEALTH INSURANCE FOR THE AGED AND DISABLED

1. The authority citation for part 405 continues to read as follows:

Authority: Secs. 1102, 1861, 1862(a), 1871, 1874, 1881, and 1886(k) of the Social Security Act (42 U.S.C. 1302, 1395x, 1395y(a), 1395hh, 1395kk, 1395rr, and 1395ww(k)), and sec. 353 of the Public Health Service Act (42 U.S.C. 263a).

Subpart D--Private Contracts

2. Section 405.400 is amended by revising the definition of ``Practitioner'' to read as follows:

Sec. 405.400 Definitions.

* * * * *

Practitioner means a physician assistant, nurse practitioner, clinical nurse specialist, certified registered nurse anesthetist, certified nurse midwife, clinical psychologist, clinical social worker, registered dietitian or nutrition professional, who is currently legally authorized to practice in that capacity by each State in which he or she furnishes services to patients or clients. * * * * *

Subpart X--Rural Health Clinic and Federally Qualified Health Center Services Payment for Rural Health Clinic and Federally Qualified Health Center Services

3. Section 405.2446 is amended by adding paragraph (b)(10) to read as follows:

Sec. 405.2446 Scope of services.

* * * * *

(b) * * *

(10) Medical nutrition therapy services as specified in part 410, subpart G of this chapter, and diabetes outpatient self-management training services as specified in part 410, subpart H of this chapter. * * * * *

4. Section 405.2463 is revised to read as follows:

Sec. 405.2463 What constitutes a visit.

(a) Visit--(1) General. (i) For RHCs, a visit is a face-to-face encounter between a clinic or center patient and a physician, physician assistant, nurse practitioner, nurse midwife, visiting nurse, clinical psychologist, or clinical social worker.

(ii) For FQHCs, a visit means--

(A) A face-to-face encounter, as described in paragraph (a)(1)(i) of this section; or

(B) A face-to-face encounter between a patient and a qualified provider of medical nutrition therapy services as defined in part 410, subpart G of this chapter; or a qualified provider of outpatient diabetes self-management training services as defined in part 410, subpart H of this chapter.

(2) Medical visit. For purposes of this section, a medical visit is a face-to-face encounter between a clinic or center patient and a physician, physician assistant, nurse practitioner, nurse midwife, or a visiting nurse; and for FQHCs only, a medical visit also includes a separately billable medical nutrition therapy visit or a diabetes outpatient self-management training visit.

(3) Other health visit. For purposes of this section, a other health visit is a face-to-face encounter between a clinic or center patient and a clinical psychologist, clinical social worker, or other health professional for mental health services.

(b) Encounters. Encounters with more than one health professional and multiple encounters with the same health professional that take place on the same day and at a single location constitute a single visit, except when one of the following conditions exist:

(1) After the first encounter, the patient suffers illness or injury requiring additional diagnosis or treatment.

(2) The patient has a medical visit and other health visit(s), as defined in paragraph (a) of this section.

(c) Payment. Medicare pays for more than one visit per day when the conditions in paragraph (b) of this section are met or a separate visit under paragraph (a)(1)(ii)(B) of this section is made.

PART 410--SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITS

5. The authority citation for part 410 continues to read as follows:

Authority: Secs. 1102, 1834, and 1871 of the Social Security Act (42 U.S.C. 1302, 1395m, and 1395hh).

Subpart B--Medical and Other Health Services

6. Section 410.16 is amended in paragraph (a) by revising paragraph (7) of the definition of ``Initial preventive physical examination'' to read as follows:

Sec. 410.16 Initial preventive physical examination: Conditions for and limitations on coverage.

(a) * * * * * * * *

[[Page 49079]]

Initial preventive physical examination * * * * * * * *

(7) Education, counseling, and referral, including a written plan such as a checklist provided to the beneficiary for obtaining the appropriate screening and other preventive services that are covered as separate Medicare Part B benefits as described in section 1861(s)(10), section 1861(jj), section 1861(nn), section 1861(oo), section 1861(pp), section 1861(qq)(1), section 1861(rr), section 1861(uu), section 1861(vv), section 1861(xx)(1), section 1861(yy), and section 1861(bbb) of the Act. * * * * *

7. A new Sec. 410.19 is added to read as follows:

Sec. 410.19 Ultrasound screening for abdominal aortic aneurysms: Condition for and limitation on coverage.

(a) Definitions: As used in this section, the following definitions apply:

Eligible beneficiary means an individual who--

(1) Has received a referral for an ultrasound screening for an abdominal aortic aneurysm as a result of an initial preventive physical examination (as defined in section 1861(ww)(1) of the Act);

(2) Has not been previously furnished an ultrasound screening for an abdominal aortic aneurysm under the Medicare program; and

(3) Is included in at least one of the following risk categories:

(i) Has a family history of an abdominal aortic aneurysm.

(ii) Is a man age 65 to 75 who has smoked at least 100 cigarettes in his lifetime.

(iii) Is an individual who manifests other risk factors in a beneficiary category recommended for screening by the United States Preventive Services Task Force regarding abdominal aortic aneurysms, as specified by the Secretary through a national coverage determination process.

Ultrasound screening for abdominal aortic aneurysms means the following services furnished to an asymptomatic individual for the early detection of an abdominal aortic aneurysm:

(1) A procedure using soundwaves (or other procedures using alternative technologies of commensurate accuracy and cost, as specified by the Secretary through a national coverage determination process) provided for the early detection of abdominal aortic aneurysms.

(2) Includes a physician's interpretation of the results of the procedure.

(b) Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms. Medicare Part B pays for one ultrasound screening for an abdominal aortic aneurysm provided to eligible beneficiaries, as described in this section, after a referral from a physician or a qualified nonphysician practitioner as defined in Sec. 410.16(a).

(c) Limitation on coverage of ultrasound screening for abdominal aortic aneurysms. Payment may not be made for an ultrasound screening for an abdominal aortic aneurysm that is performed for an individual who is not an eligible beneficiary, as described in the definition of ``Eligible beneficiary'' in this section.

8. Section 410.31 is revised to read as follows:

Sec. 410.31 Bone mass measurement: Conditions for coverage and frequency standards.

(a) Definition. As used in this section unless specified otherwise, the following definition applies:

Bone mass measurement means a radiologic, radioisotopic, or other procedure that meets the following conditions:

(1) Is performed for the purpose of identifying bone mass, detecting bone loss, or determining bone quality.

(2) Is performed with either a bone densitometer (other than single-photon or dual-photon absorptiometry) or with a bone sonometer system that has been cleared for marketing for this use by the FDA under 21 CFR part 807, or approved for marketing by the FDA for this use under 21 CFR part 814.

(3) Includes a physician's interpretation of the results of the procedure.

(b) Conditions for coverage. (1) Medicare covers a medically necessary bone mass measurement if the following conditions are met:

(i) Following an evaluation of the beneficiary's need for the measurement, including a determination as to the medically appropriate procedure to be used for the beneficiary, it is ordered by the physician or a qualified nonphysician practitioner (as these terms are defined in Sec. 410.32(a)) treating the beneficiary.

(ii) It is performed under the appropriate level of supervision of a physician (as set forth in Sec. 410.32(b)).

(iii) It is reasonable and necessary for diagnosing and treating the condition of a beneficiary who meets the conditions described in paragraph (d) of this section.

(2) Medicare covers a medically necessary bone mass measurement for an individual defined under paragraph (d)(5) of this section if the conditions under paragraph (b)(1) of this section are met and the monitoring is performed by the use of a dual energy x-ray absorptiometry system (axial skeleton).

(3) Medicare covers a medically necessary confirmatory baseline bone mass measurement for an individual defined under paragraph (d) of this section, if the conditions under paragraph (b)(1) of this section are met and the confirmatory baseline bone mass measurement is performed by a dual energy x-ray absorptiometry system (axial skeleton) and the initial measurement was not performed by a dual energy x-ray absorptiometry system (axial skeleton).

(c) Standards on frequency of coverage --(1) General rule. Except as allowed under paragraph (c)(2) of this section, Medicare may cover a bone mass measurement for a beneficiary if at least 23 months have passed since the month the last bone mass measurement was performed.

(2) Exception. If medically necessary, Medicare may cover a bone mass measurement for a beneficiary more frequently than allowed under paragraph (c)(1) of this section. Examples of situations where more frequent bone mass measurement procedures may be medically necessary include, but are not limited to the following medical circumstances.

(i) Monitoring beneficiaries on long-term glucocorticoid (steroid) therapy of more than 3 months.

(ii) Allowing for a confirmatory baseline measurement to permit monitoring of beneficiaries in the future if the requirements of paragraph (b)(3) of this section are met.

(d) Beneficiaries who may be covered. The following categories of beneficiaries may receive Medicare coverage for a medically necessary bone mass measurement:

(1) A woman who has been determined by the physician (or a qualified nonphysician practitioner) treating her to be estrogen- deficient and at clinical risk for osteoporosis, based on her medical history and other findings.

(2) An individual with vertebral abnormalities as demonstrated by an x-ray to be indicative of osteoporosis, osteopenia, or vertebral fracture.

(3) An individual receiving (or expecting to receive) glucocorticoid (steroid) therapy equivalent to an average of 5.0 mg of prednisone, or greater, per day for more than 3 months.

(4) An individual with primary hyperparathyroidism.

(5) An individual being monitored to assess the response to or efficacy of an

[[Page 49080]]

FDA-approved osteoporosis drug therapy.

(e) Denial as not reasonable and necessary. If CMS determines that a bone mass measurement does not meet the conditions for coverage in paragraphs (b) or (d) of this section, or the standards on frequency of coverage in paragraph (c) of this section, it is excluded from Medicare coverage as not ``reasonable'' and ``necessary'' under section 1862(a)(1)(A) of the Act and Sec. 411.15(k) of this chapter.

(f) Use of the National Coverage Determination Process. For the purposes of paragraphs (b)(2) and (b)(3) of this section, CMS may determine through the National Coverage Determination process that additional bone mass measurement systems are reasonable and necessary under section 1862(a)(1) of the Act for monitoring and confirming baseline bone mass measurements. * * * * *

9. Section 410.33 is amended by--

A. Revising paragraph (b)(1).

B. Revising paragraph (e).

C. Adding paragraphs (g), (h), and (i).

The revision and additions read as follows:

Sec. 410.33 Independent diagnostic testing facility.

* * * * * *

(b) Supervising physician. (1) Each supervising physician must be limited to providing supervision to no more than three (3) IDTF sites. The IDTF supervising physician is responsible for the overall operation and administration of the IDTFs, including the employment of personnel who are competent to perform test procedures, record and report test results promptly, accurately and proficiently, and for assuring compliance with the applicable regulations. * * * * *

(e) Multi-State entities. (1) An IDTF that operates across State boundaries must--

(i) Maintain documentation that its supervising physicians and technicians are licensed and certified in each of the States in which it operates; and

(ii) Operate in compliance with all applicable Federal, State, and local licensure and regulatory requirements with regard to the health and safety of patients.

(2) The point of the actual delivery of services is the Place of Service on the claim form. When an IDTF performs a diagnostic test at the beneficiary's residence, the beneficiary's residence is the Place of Service. * * * * *

(g) Application certification standards. The IDTF must certify in its enrollment application that it meets the following standards:

(1) Operate its business in compliance with all applicable Federal and State licensure and regulatory requirements.

(2) Provide complete and accurate information on their enrollment application. Any change in enrollment information must be reported to the designated fee-for-service contractor on the Medicare enrollment application within 30 calendar days of the change.

(3) Maintain a physical facility on an appropriate site. For the purposes of this standard, a post office box or commercial mail box is not considered a physical facility. The physical facility must contain space for equipment appropriate to the services designated on the enrollment application, facilities for hand washing, adequate patient privacy accommodations, and the storage of both business records and current medical records.

(4) Have all applicable testing equipment available at the physical site excluding portable equipment. A catalog of portable equipment, including equipment serial numbers, must be maintained at the physical site. In addition, portable equipment must be available for inspection within two business days of a CMS inspection request. The IDTF must maintain a current inventory of the equipment, including serial and registration numbers, provide this information to the designated fee- for-service contractor upon request, and notify the contractor of any changes in equipment within 90 days.

(5) Maintain a primary business phone under the name of the designated business. The business phone must be located at the designated site of the business. The telephone number or toll free numbers must be available in a local directory and through directory assistance.

(6) Have a comprehensive liability insurance policy of at least $300,000 or 20 percent of its average annual Medicare billings, whichever amount is greater, that covers both the place of business and all customers and employees of the IDTF. The policy must be carried by a non-relative owned company and list the serial numbers of any and all equipment used by the IDTF.

(7) Agree not to directly solicit patients through any means including, but not limited to, a prohibition on telephone, computer, or in-person contacts. The IDTF must accept only those patients referred for diagnostic testing by an attending physician, who is furnishing a consultation or treating a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. Nonphysician practictioners may order tests as set forth in Sec. 410.32(a)(3).

(8) Answer beneficiaries' questions and respond to their complaints. Documentation of those contacts must be maintained at the physical site.

(9) Openly post these standards for review by patients and the public.

(10) Disclose to the government any person having ownership, financial, or control interest or any other legal interest in the supplier.

(11) Have its testing equipment calibrated per equipment instructions and in compliance with applicable national standards.

(12) Have technical staff on duty with the appropriate credentials to perform tests. The IDTF must be able to produce the applicable Federal or State licenses or certifications of the individuals performing these services.

(13) Have proper medical record storage and be able to retrieve medical records upon request from CMS or its fee-for-service contractor within 2 business days.

(14) Permit CMS, including its agents, or its designated fee-for- service contractors, to conduct unannounced, on-site inspections to confirm the IDTF's compliance with these standards. The IDTF must be accessible during regular business hours to CMS and beneficiaries and must maintain a visible sign posting the normal business hours of the IDTF.

(h) Failure to meet standards. If an IDTF fails to meet one or more of the standards in paragraph (g) of this section at the time of enrollment, its enrollment will be denied. CMS will revoke a supplier's billing privileges if and IDTF is found not to meet the standards in paragraph (g) or (b)(1) of this section.

(i) Definition. For purposes of this section, the following definition applies:

Point of actual delivery of service. The point of the actual delivery of service means the Place of Service on the claim form. When an IDTF performs a diagnostic test at the beneficiary's residence, the beneficiary's residence is the Place of Service.

Subpart I--Payment of SMI Benefits

10. Section 410.160 is amended by adding paragraphs (b)(7) and (b)(8) to read as follows:

Sec. 410.160 Part B annual deductible.

* * * * *

[[Continued on page 49081]]

From the Federal Register Online via GPO Access [wais.access.gpo.gov] ]

[[pp. 49081-49130]] Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2007 and Other Changes to Payment Under Part B

[[Continued from page 49080]]

[[Page 49081]]

(b) * * *

(7) Beginning January 1, 2007, colorectal cancer screening tests as described in Sec. 410.37.

(8) Beginning January 1, 2007, ultrasound screening for abdominal aortic aneurysms described in Sec. 410.19. * * * * *

PART 411--EXCLUSIONS FROM MEDICARE AND LIMITATIONS ON MEDICARE PAYMENT

11. The authority citation for part 411 is amended to read as follows:

Authority: Secs. 1102, 1860D-1 through 1860D-42, 1871, and 1877 of the Social Security Act (42 U.S.C. 1302, 1395w-101 through 1395w- 152, 1395hh, and 1395nn).

Subpart A--General Exclusions and Exclusion of Particular Services

12. Section 411.15 is amended by--

A. Revising paragraph (a)(1).

B. Adding a new paragraph (k)(12).

C. Revising paragraph (o).

The revisions and addition read as follows:

Sec. 411.15 Particular services excluded from coverage.

* * * * *

(a) * * *

(1) Examinations performed for a purpose other than treatment or diagnosis of a specific illness, symptoms, complaint, or injury, except for screening mammography, colorectal cancer screening tests, screening pelvic exams, prostate cancer screening tests, glaucoma screening exams, initial preventive physical examinations, or ultrasound screening for abdominal aortic aneurysms that meet the criteria specified in paragraphs (k)(6) through (k)(12) of this section. * * * * *

(k) * * *

(12) In the case of ultrasound screening for abdominal aortic aneurysms, with the goal of early detection of abdominal aortic aneurysms, subject to the conditions and limitation specified in Sec. 410.19 of this chapter. * * * * *

(o) Experimental or investigational devices, except for certain devices--

(1) Categorized by the FDA as a Category A or B device defined in Sec. 405.201(b) of this chapter; and

(2) Furnished in accordance with the CMS clinical research policy.

Subpart J--Financial Relationships Between Physicians and Entities Furnishing Designated Health Services

13. Section 411.351 is amended by--

A. Revising the definition ``Centralized building''.

B. Revising the definition ``Physician in the group practice''.

The revisions read as follows:

Sec. 411.351 Definitions.

* * * * *

Centralized building means all or part of a building, including, for purposes of this subpart only, a mobile vehicle, van, or trailer that is owned or leased on a full-time basis (that is, 24 hours per day, 7 days per week, for a term of not less than 6 months) by a group practice and that is used exclusively by the group practice. Space in a building or a mobile vehicle, van, or trailer that is shared by more than one group practice, by a group practice and one or more solo practitioners, or by a group practice and another provider or supplier (for example, a diagnostic imaging facility) is not a centralized building for purposes of this subpart. This definition does not preclude a group practice from providing services to other providers or suppliers (for example, purchased diagnostic tests) in the group practice's centralized building. A group practice may have more than one centralized building. A centralized building does not include space that is owned or leased by a group practice if that space is less than 350 square feet. This limitation does not apply to space owned or rented in a building where no more than three group practices own or lease space in the ``same building'' (as defined in this section) and share the same ``physician in the group practice'' (as defined in this section). A centralized building does not include space owned or leased by a group practice if equipment needed to perform substantially all (at least 90 percent) of the designated health services furnished in that space in any given calendar year is not permanently located in that space. That is, equipment needed to perform more than 10 percent of the designated health services furnished in that space in a calendar year cannot be temporarily moved into that space from another space in the ``same building'' or from outside the ``same building'' (as defined in this section). * * * * *

Physician in the group practice means a member of the group practice, as well as an independent contractor physician during the time the independent contractor is furnishing patient care services (as defined in this section) for the group practice under a contractual arrangement with the group practice to provide services to the group practice's patients in the group practice's facilities. The contract must contain the same restrictions on compensation that apply to members of the group practice under Sec. 411.352(g) (or the contract must fit in the personal services exception in Sec. 411.357(d)), and the independent contractor's arrangement with the group practice and must comply with the reassignment rules at Sec. 424.80(d)(3) of this chapter or section 30.2.9.1 of the CMS Internet-only manual, publication 100-04, Claims Processing Manual, chapter 1 on general billing requirements (as amended or replaced from time to time). Referrals from an independent contractor who is a physician in the group practice are subject to the prohibition on referrals in Sec. 411.353(a), and the group practice is subject to the limitation on billing for those referrals in Sec. 411.353(b). * * * * *

PART 414--PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES

14. The authority citation for part 414 continues to read as follows:

Authority: Secs. 1102, 1871, and 1881(b)(1) of the Social Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(1).

15. A new subpart F is added as follows:

Subpart F--Payment for New Clinical Diagnostic Laboratory Tests

Sec. 414.400 Basis and scope. 414.402 Definitions. 414.404 [Reserved] 414.406 Procedures for public consultation for payment for a new clinical diagnostic laboratory test. 414.408 Payment for a new clinical diagnostic laboratory test. 414.410 Clinical Diagnostic Laboratory Date of Service for Specimens

Subpart F--Payment for New Clinical Diagnostic Laboratory Tests

Sec. 414.400 Basis and scope.

This subpart implements provisions of 1833(h)(8) of the Act procedures for determining the basis for, and amount of, payment for a new clinical diagnostic laboratory test with respect to which a new or substantially revised Healthcare Common Procedure Coding System code is assigned on or after January 1, 2005.

Sec. 414.402 Definitions.

For purposes of this subpart--

Substantially Revised Healthcare Common Procedure Coding System Code means a code for which there has been a substantive change to the definition of the test or procedure to which the code applies (such as a new

[[Page 49082]]

analyte or a new methodology for measuring an existing analyte specific test).

Sec. 414.404 [Reserved]

Sec. 414.406 Procedures for public consultation for payment for a new clinical diagnostic laboratory test.

For a new clinical diagnostic laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, CMS determines the payment after the performance of the following:

(a) CMS makes available to the public (through an Internet Web site and other appropriate mechanisms) a list that includes codes for which establishment of a payment amount is being considered for the next calendar year.

(b) CMS publishes a Federal Register notice of a meeting to receive public comments and recommendations (and data on which recommendations are based) on the appropriate basis, as specified in Sec. 414.408, for establishing payment amounts for the list of codes made available to the public.

(c) Not fewer than 30 days after publication of the notice in the Federal Register, CMS convenes a meeting that includes representatives of CMS officials involved in determining payment amounts, to receive public comments and recommendations (and data on which the recommendations are based).

(d) Taking into account the comments and recommendations (and accompanying data) received at the public meeting, CMS develops and makes available to the public (through an Internet Web site and other appropriate mechanisms)--

(1) A list of proposed determinations with respect to the appropriate basis for establishing a payment amount for each code, with an explanation of the reasons for each determination, the data on which the determinations are based, and a request for public written comments within a specified time period on the proposed determination; and

(2) A list of final determinations of the payment amounts for tests, with the rationale for each determination, the data on which the determinations are based, and responses to comments and suggestions from the public.

Sec. 414.408 Payment for a new clinical diagnostic laboratory test.

For a new clinical diagnostic laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, CMS determines the payment amount based on either of the following:

(a) Crosswalking. Crosswalking is used if it is determined that a new test is comparable to an existing test, multiple existing test codes, or a portion of an existing test code.

(1) CMS assigns to the new test code, the local fee schedule amounts and national limitation amount of the existing test.

(2) Payment for the new test code is made at the lesser of the local fee schedule amount or the national limitation amount.

(b) Gapfilling. Gapfilling is used when no comparable existing test is available.

(1) Carrier-specific amounts are established for the new test code for the first year using the following sources of information to determine gapfill amounts, if available:

(i) Charges for the test and routine discounts to charges;

(ii) Resources required to perform the test;

(iii) Payment amounts determined by other payers; and

(iv) Charges, payment amounts, and resources required for other tests that may be comparable or otherwise relevant.

(2) In the second year, the test code is paid at the national limitation amount, which is the median of the carrier-specific amounts.

Sec. 414.410 Clinical Diagnostic Laboratory Date of Service for Specimens.

The date of service for a laboratory test is as follows:

(a) Except as provided under paragraph (b) of this section, the date of service of the test shall be the date the specimen was collected.

(b)(1) If a specimen is collected over a period that spans two calendar days, then the date of service shall be the date the collection ended.

(2) If a specimen was stored for more than 30 calendar days before testing (otherwise known as ``an archived specimen''), the date of service of the test shall be the date the specimen was obtained from storage.

(3) If a specimen was stored for less than or equal to 30 calendar days from the date it was collected, the date of service of the test must be the date the specimen was obtained from storage if--

(i) The test is ordered by the patient's physician at least 14 days following the date of the patient's discharge from the hospital.

(ii) The test could not reasonably have been ordered while the patient was hospitalized.

(iii) The procedure performed while the beneficiary is a patient of the hospital is for purposes other than collection of the specimen needed for the test.

(iv) The test is reasonable and medically necessary.

Subpart J--Submission of Manufacturer's Average Sales Price Data

16. Section 414.802 is amended by adding the definition of ``Bona fide service fees'' in alphabetical order to read as follows:

Sec. 414.802 Definitions.

* * * * *

Bona fide service fees means fees paid by a manufacturer to an entity, that represent fair market value for a bona fide, itemized service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for) in the absence of the service arrangement, and that are not passed on in whole or in part to a client or customer of an entity, whether or not the entity takes title to the drug. * * * * *

17. Section 414.804 is amended by revising paragraphs (a)(1), (a)(2), (a)(3), and (a)(4).

The revisions read as follows:

Sec. 414.804 Basis of Payment.

(a) * * *

(1) The manufacturer's average sales price for a quarter for a drug represented by a particular 11-digit National Drug Code must be calculated as the manufacturer's sales to all purchasers in the United States for that particular 11-digit National Drug Code (after excluding sales as specified in paragraph (a)(4) of this section and then deducting price concessions as specified in paragraphs (a)(2) and (a)(3) of this section) divided by the total number of units sold by the manufacturer in that quarter (after excluding units associated with sales as specified in paragraph (a)(4) of this section).

(2) Price concessions. (i) In calculating the manufacturer's average sales price, a manufacturer must deduct price concessions. Price concessions include the following types of transactions and items:

(A) Volume discounts.

(B) Prompt pay discounts.

(C) Cash discounts.

(D) Free goods that are contingent on any purchase requirement.

(E) Chargebacks and rebates (other than rebates under the Medicaid program).

(ii) For the purposes of paragraph (a)(2)(i), bona fide services fees are not considered price concessions.

(3) To the extent that data on price concessions, as described in paragraph (a)(2) of this section, are available on a

[[Page 49083]]

lagged basis, the manufacturer must estimate this amount in accordance with the methodology described in this paragraph.

(i)(A) For each National Drug Code with at least 12 months of sales (including products for which the manufacturer has redesignated the National Drug Code for the specific product and package size and has 12 months of sales across the prior and current National Drug Codes), after adjusting for exempted sales, the manufacturer calculates a percentage equal to the sum of the price concessions for the most recent 12-month period available associated with sales subject to the average sales price reporting requirement divided by the total in dollars for the sales subject to the average sales price reporting requirement for the same 12-month period.

(B) For each National Drug Code with less than 12 months of sales, the calculation described in paragraph (i)(A) of this section is performed for the time period equaling the total number of months of sales.

(ii) The manufacturer multiplies the applicable percentage described in paragraph (a)(3)(i)(A) or (a)(3)(i)(B) of this section by the total in dollars for the sales subject to the average sales price reporting requirement (after adjusting for exempted sales) for the quarter being submitted. (The manufacturer must carry a sufficient number of decimal places in the calculation of the price concessions percentage in order to round accurately the net total sales amount for the quarter to the nearest whole dollar.) The result of this multiplication is then subtracted from the total in dollars for the sales subject to the average sales price reporting requirement (after adjusting for exempted sales) for the quarter being submitted.

(iii) The manufacturer uses the result of the calculation described in paragraph (a)(3)(ii) of this section as the numerator and the number of units sold in the quarter (after adjusting for exempted sales) as the denominator to calculate the manufacturer's average sales price for the National Drug Code for the quarter being submitted.

(iv) Example. After adjusting for exempted sales, the total lagged price concessions (discounts, rebates, etc.) over the most recent 12- month period available associated with sales for National Drug Code 12345-6789-01 subject to the ASP reporting requirement equal $200,000, and the total in dollars for the sales subject to the average sales price reporting requirement for the same period equals $600,000. The lagged price concessions percentage for this period equals 200,000/ 600,000 = .33333. The total in dollars for the sales subject to the average sales price reporting requirement for the quarter being reported, after accounting for non-lagged price concessions, equals $50,000 for 10,000 units sold. The manufacturer's average sales price calculation for this National Drug Code for this quarter is: $50,000 - (0.33333 x 50,000) = $33,334 (net total sales amount); $33,334/10,000 = $3.33 (average sales price).

(4) Exempted sales. (i) In calculating the manufacturer's average sales price, a manufacturer must exclude sales that are exempt from the Medicaid best price calculation under sections 1927(c)(1)(C)(i) and 1927(c)(1)(C)(ii)(III) of the Act as limited by section 1927(c)(1)(D) of the Act.

(ii) In determining nominal sales exempted under section 1927(c)(1)(C)(ii)(III) of the Act, the manufacturer calculates the average manufacturer price as defined in section 1927(k) of the Act and then identifies sales that are eligible to be considered a nominal sale under section 1927(c)(1)(D) of the Act and are at less than 10 percent of the average manufacturer price. To identify nominal sales, the manufacturer must use the average manufacturer price for the calendar quarter that is the same calendar quarter as the average sales price reporting period.

(iii) For exempted sales under section 1927(c)(1)(C)(i) of the Act known on a lagged basis because of chargebacks or rebates, manufacturers must estimate such lagged exempted sales using the ratio methodology specified in this paragraph to exclude lagged exempted sales before accounting for price concessions as specified in paragraphs (a)(2) and (a)(3) of this section.

(A) For each National Drug Code with at least 12 months of sales (including products for which the manufacturer has redesignated the Nation Drug Code and has 12 months of sales across the prior and current National Drug Codes), the manufacturer calculates a percentage using the sum of lagged exempted sales (in units) for the most recent 12 month period available as the numerator and the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the same 12 month period as the denominator. The result is a rolling average percentage estimate of lagged exempted sales that is applied to the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the quarter being submitted. The product that results from the multiplication of the rolling average percentage estimate of lagged exempted sales and the sales for the quarter determines the estimated lagged exempted sales in units to subtract from the denominator of the average sales price calculation. Manufacturers must make a corresponding adjustment to the numerator of the average sales price calculation to ensure that the total in dollars for the reporting quarter does not include revenue related to lagged exempted sales removed from the denominator using the estimation methodology.

(B) For National Drug Codes with less than 12 months of sales, the calculation described in paragraph (4)(iii)(A) of this section is calculated based on the sales and exempted sales (lagged and non- lagged) for the period equaling the total number of months of sales.

(C) Manufacturers must exclude lagged exempted sales (as calculated using the ratio methodology in paragraph (a)(4)(iii)(A) of this section) from their estimates of lagged price concessions described in paragraph (a)(3) of this section. * * * * *

Subpart K--Payment for Drugs and Biologicals Under Part B

18. Section 414.904 is amended by revising paragraphs (d)(2)(iii) and (d)(3) to read as follows:

Sec. 414.904 Average sales price as the basis for payment.

* * * * *

(d) * * *

(2) * * *

(iii) Effective for drugs and biologicals furnished in CY 2006 and subsequent calendar years, the payment for such drugs and biologicals furnished in connection with renal dialysis services and separately billed by freestanding and hospital-based renal dialysis facilities not paid on a cost basis is 106 percent of the average sales price.

(3) Widely available market price and average manufacturer price. If the Inspector General finds that the average sales price exceeds the widely available market price or the average manufacturer price by 5 percent or more in CY 2007, the payment limit in the quarter following the transmittal of this information to the Secretary is the lesser of the widely available market price or 103 percent of the average manufacturer price. * * * * *

[[Page 49084]]

PART 415--SERVICES FURNISHED BY PHYSICIANS IN PROVIDERS, SUPERVISING PHYSICIANS IN TEACHING SETTINGS, AND RESIDENTS IN CERTAIN SETTINGS

19. The authority citation for part 415 continues to read as follows:

Authority: Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).

Subpart C--Part B Carrier Payments for Physician Services to Beneficiaries in Providers

20. Section 415.130 is amended by revising paragraph (d) to read as follows:

Sec. 415.130 Conditions for payment: Physician pathology services.

* * * * *

(d) Physician pathology services furnished by an independent laboratory. The technical component of physician pathology services furnished by an independent laboratory to a hospital inpatient or outpatient on or before December 31, 2006 may be paid to the laboratory by the carrier under the physician fee schedule if the Medicare beneficiary is a patient of a covered hospital as defined in paragraph (a)(1) of this section. For services furnished after December 31, 2006, an independent laboratory may not bill the carrier for physician pathology services furnished to a hospital inpatient or outpatient. * * * * *

PART 424--CONDITIONS FOR MEDICARE PAYMENT

21. The authority citation for part 424 continues to read as follows:

Authority: Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).

Subpart B--Certification and Plan of Treatment Requirements

22. Section 424.24 is amended by--

A. Redesignating paragraph (f) as paragraph (g).

B. Adding a new paragraph (f).

The addition reads as follows:

Sec. 424.24 Requirements for medical and other health services furnished by providers under Medicare Part B.

* * * * *

(f) Blood glucose monitoring in skilled nursing facilities. For each blood glucose test furnished to a resident of a skilled nursing facility, the physician must certify that the test is medically necessary. A physician's standing order is not sufficient to order a series of blood glucose tests. * * * * *

Subpart F--Limitations on Assignment and Reassignment of Claims

23. Section 424.80 is amended by--

A. Revising the heading of paragraph (d).

B. Revising paragraph (d)(2)

C. Adding a new paragraph (d)(3).

The revisions and addition read as follows:

Sec. 424.80 Prohibition of reassignment of claims by suppliers.

* * * * *

(d) Reassignment to an entity under an employer-employee relationship or under a contractual arrangement: Conditions and limitations. (1) * * *

(2) Access to records. The supplier who furnishes the service has unrestricted access to claims submitted by an entity for services provided by that supplier. This paragraph applies irrespective of whether the supplier is an employee or whether the service is provided under a contractual arrangement. If an entity refuses to provide, upon request, the billing information to the supplier performing the service, the entity's right to receive reassigned benefits may be revoked under Sec. 424.82(c)(3).

(3) Contractual arrangements for provision of diagnostic test services. If a physician or medical group bills for the technical component of a diagnostic test covered under section 1861(s)(3) of the Act and paid for under part 414 of this chapter (other than clinical diagnostic laboratory tests paid under section 1833(a)(2)(D) of the Act, which are subject to the special rules set forth in section 1833(h)(5)(A) of the Act), following a reassignment involving a contractual arrangement with the physician or other supplier who performed the technical component, each of the following conditions must be met:

(i) The payment to the billing physician, or medical group, less the applicable deductibles and coinsurance, may not exceed the lowest of the following amounts:

(A) The physician or other supplier's net charge to the billing physician or medical group.

(B) The billing physician's or medical group's actual charge.

(C) The fee schedule amount for the service that would be allowed if the physician or other supplier billed directly.

(ii) The physician or medical group billing for the test must identify the physician or other supplier that performed the test and indicate the supplier's net charge for the test. If the physician or medical group billing for the test fails to provide this information, CMS will not make any payment to the physician or medical group billing for the test and the billing physician or medical group can not bill the beneficiary.

(iii) In order to bill for the technical component of the service, the physician or medical group must directly perform the professional component of the service.

(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare--Supplementary Medical Insurance Program)

Dated: June 29, 2006. Mark B. McClellan, Administrator, Centers for Medicare & Medicaid Services.

Approved: August 3, 2006. Michael O. Leavitt, Secretary.

Note: These addenda will not appear in the Code of Federal Regulations.

Addendum A: Explanation and Use of Addenda B

The addenda on the following pages provide various data pertaining to the Medicare fee schedule for physicians' services furnished in 2007. Addendum B contains the RVUs for work, non-facility PE, facility PE, and malpractice expense, and other information for all services included in the PFS.

In previous years, we have listed many services in Addendum B that are not paid under the PFS. To avoid publishing as many pages of codes for these services, we are not including clinical laboratory codes or the alphanumeric codes (Healthcare Common Procedure Coding System (HCPCS) codes not included in CPT) not paid under the PFS in Addendum B.

Addendum B--2007 Relative Value Units and Related Information Used in Determining Medicare Payments for 2007

This addendum contains the following information for each CPT code and alphanumeric HCPCS code, except for: alphanumeric codes beginning with B (enteral and parenteral therapy), E (durable medical equipment), K (temporary stcodes for nonphysicians' services or items), or L (orthotics); and codes for anesthesiology. Please also note the following:

An ``NA'' in the ``Non-facility PE RVUs'' column of Addendum B means that CMS has not developed a PE RVU

[[Page 49085]]

in the non-facility setting for the service because it is typically performed in the hospital (for example, an open heart surgery is generally performed in the hospital setting and not a physician's office). If there is an ``NA'' in the non-facility PE RVU column, and the contractor determines that this service can be performed in the non-facility setting, the service will be paid at the facility PE RVU rate.

Services that have an ``NA'' in the ``Facility PE RVUs'' column of Addendum B are typically not paid using the PFS when provided in a facility setting. These services (which include ``incident to'' services and the technical portion of diagnostic tests) are generally paid under either the outpatient hospital prospective payment system or bundled into the hospital inpatient prospective payment system payment.

1. CPT/HCPCS code. This is the CPT or alphanumeric HCPCS number for the service. Alphanumeric HCPCS codes are included at the end of this addendum.

2. Modifier. A modifier is shown if there is a technical component (modifier TC) and a professional component (PC) (modifier -26) for the service. If there is a PC and a TC for the service, Addendum B contains three entries for the code. A code for: the global values (both professional and technical); modifier -26 (PC); and, modifier TC. The global service is not designated by a modifier, and physicians must bill using the code without a modifier if the physician furnishes both the PC and the TC of the service.

Modifier-53 is shown for a discontinued procedure, for example, a colonoscopy that is not completed. There will be RVUs for a code with this modifier.

3. Status indicator. This indicator shows whether the CPT/HCPCS code is in the PFS and whether it is separately payable if the service is covered.

A = Active code. These codes are separately payable under the PFS if covered. There will be RVUs for codes with this status. The presence of an ``A'' indicator does not mean that Medicare has made a national coverage determination regarding the service. Carriers remain responsible for coverage decisions in the absence of a national Medicare policy.

B = Bundled code. Payments for covered services are always bundled into payment for other services not specified. If RVUs are shown, they are not used for Medicare payment. If these services are covered, payment for them is subsumed by the payment for the services to which they are incident (an example is a telephone call from a hospital nurse regarding care of a patient).

C = Carriers price the code. Carriers will establish RVUs and payment amounts for these services, generally on an individual case basis following review of documentation, such as an operative report.

D* = Deleted/discontinued code.

E = Excluded from the PFS by regulation. These codes are for items and services that CMS chose to exclude from the fee schedule payment by regulation. No RVUs are shown, and no payment may be made under the PFS for these codes. Payment for them, when covered, continues under reasonable charge procedures.

F = Deleted/discontinued codes. (Code not subject to a 90-day grace period.) These codes are deleted effective with the beginning of the year and are never subject to a grace period. This indicator is no longer effective beginning with the 2005 fee schedule as of January 1, 2005.

G = Code not valid for Medicare purposes. Medicare uses another code for reporting of, and payment for, these services. (Codes subject to a 90-day grace period.) This indicator is no longer effective with the 2005 PFS as of January 1, 2005.

H* = Deleted modifier. For 2000 and later years, either the TC or PC component shown for the code has been deleted and the deleted component is shown in the database with the H status indicator.

I = Not valid for Medicare purposes. Medicare uses another code for the reporting of, and the payment for these services. (Codes not subject to a 90-day grace period.)

L = Local codes. Carriers will apply this status to all local codes in effect on January 1, 1998 or subsequently approved by central office for use. Carriers will complete the RVUs and payment amounts for these codes.

M = Measurement codes, used for reporting purposes only. There are no RVUs and no payment amounts for these codes. Medicare uses them to aid with performance measurement. No separate payment is made. These codes should be billed with a zero (($0.00) charge and are denied) on the MPFSDB.

N = Non-covered service. These codes are noncovered services. Medicare payment may not be made for these codes. If RVUs are shown, they are not used for Medicare payment.

R = Restricted coverage. Special coverage instructions apply. If the service is covered and no RVUs are shown, it is carrier-priced.

T = There are RVUs for these services, but they are only paid if there are no other services payable under the PFS billed on the same date by the same provider. If any other services payable under the PFS are billed on the same date by the same provider, these services are bundled into the service(s) for which payment is made.

X = Statutory exclusion. These codes represent an item or service that is not within the statutory definition of ``physicians' services'' for PFS payment purposes. No RVUs are shown for these codes, and no payment may be made under the PFS. (Examples are ambulance services and clinical diagnostic laboratory services.)

4. Description of code. This is an abbreviated version of the narrative description of the code.

5. Physician work RVUs. These are the RVUs for the physician work for this service in 2007. As stated in the June 29, 2006 proposed notice, the RVUs for codes with a 10- or 90-day global period reflect the application of the RUC-recommended values for the E/M services that are included as part of the global period for the service.

Note: The separate budget neutrality adjustor is not reflected in these physician work RVUs.

6. Fully implemented non-facility practice expense RVUs. These are the fully implemented resource-based PE RVUs for non-facility settings.

7. Transitional Non-facility practice expense RVUs. These are the 2007 resource-based PE RVUs for non-facility settings.

8. Fully implemented facility practice expense RVUs. These are the fully implemented resource-based PE RVUs for facility settings.

9. Transitional facility practice expense RVUs. These are the 2007 resource-based PE RVUs for facility settings.

10. Malpractice expense RVUs. These are the RVUs for the malpractice expense for the service for 2006.

11. Non-facility total. This is the sum of the work, fully implemented non-facility PE, and malpractice expense RVUs.

12. Transitional non-facility total. This is the sum of the work, 2007 transitional non-facility PE, and malpractice expense RVUs.

13. Facility total. This is the sum of the work, fully implemented facility PE, and malpractice expense RVUs.

14. Transitional facility total. This is the sum of the work, 2007 transitional facility PE, and malpractice expense RVUs.

15. Global period. This indicator shows the number of days in the global period for the code (0, 10, or 90 days).

[[Page 49086]]

An explanation of the alpha codes follows:

MMM = Code describes a service furnished in uncomplicated maternity cases including antepartum care, delivery, and postpartum care. The usual global surgical concept does not apply. See the 1999 Physicians' Current Procedural Terminology for specific definitions.

XXX = The global concept does not apply.

YYY = The global period is to be set by the carrier (for example, unlisted surgery codes).

ZZZ = Code related to another service that is always included in the global period of the other service. (Note: Physician work and PE are associated with intra service time and in some instances in the post service time.

*Codes with these indicators had a 90-day grace period before January 1, 2005.

[[Page 49087]]

Addendum B.--Relative Value Units (RVUs) and Related Information Used In Determining Medicare Payments For 2007

Fully

Fully Implemented Year 2007 Fully Year 2007 Mal- Implemented Year 2007 Fully Year 2007

CPT\1\/

Mod Status Description Physician Non- Transitional Implemented Transitional Practice Non- Transitional Implemented Transitional Global HCPCS\2\

Work RVUs Facility PE Non-Facility Facility PE Facility PE RVUs Facility Non-Facility Facility Facility RVUs

PE RVUs

RVUs

RVUs

Total

Total

Total

Total

0003T......... ........ C

Cervicography.. 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 0008T......... ........ C

Upper gi

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX endoscopy w/ suture. 0016T......... ........ C

Thermotx

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX choroid vasc lesion. 0017T......... ........ C

Photocoagulat

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX macular drusen. 0018T......... ........ C

Transcranial

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX magnetic stimul. 0019T......... ........ C

Extracorp shock 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX wv tx,ms nos. 0021T......... ........ C

Fetal oximetry, 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX trnsvag/cerv. 0024T......... ........ C

Transcath

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX cardiac reduction. 0026T......... ........ C

Measure remnant 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX lipoproteins. 0027T......... ........ C

Endoscopic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX epidural lysis. 0028T......... ........ C

Dexa body

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX composition study. 0029T......... ........ C

Magnetic tx for 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX incontinence. 0030T......... ........ C

Antiprothrombin 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX antibody. 0031T......... ........ C

Speculoscopy... 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 0032T......... ........ C

Speculoscopy w/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX direct sample. 0041T......... ........ C

Detect ur

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX infect agnt w/ cpas. 0042T......... ........ C

Ct perfusion w/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX contrast, cbf. 0043T......... ........ C

Co expired gas

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX analysis. 0044T......... ........ C

Whole body

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX photography. 0045T......... ........ C

Whole body

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX photography. 0046T......... ........ C

Cath lavage,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX mammary duct(s. 0047T......... ........ C

Cath lavage,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX mammary duct(s). 0048T......... ........ C

Implant

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ventricular device. 0049T......... ........ C

External

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX circulation assist. 0050T......... ........ C

Removal

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX circulation assist. 0051T......... ........ C

Implant total

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart system. 0052T......... ........ C

Replace

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX component heart syst. 0053T......... ........ C

Replace

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX component heart syst. 0054T......... ........ C

Bone surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX using computer. 0055T......... ........ C

Bone surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX using computer. 0056T......... ........ C

Bone surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX using computer. 0058T......... ........ C

Cryopreservatio 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX n, ovary tiss. 0059T......... ........ C

Cryopreservatio 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX n, oocyte. 0060T......... ........ C

Electrical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX impedance scan. 0061T......... ........ C

Destruction of

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX tumor, breast. 0062T......... ........ C

Rep intradisc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX annulus;1 lev. 0063T......... ........ C

Rep intradisc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX annulus;>1lev. 0064T......... ........ C

Spectroscop

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX eval expired gas. 0065T......... ........ C

Ocular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX photoscreen bilat. 0067T......... ........ C

Ct

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX colonography;d x. 0067T......... 26...... C

Ct

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX colonography;d x. 0067T......... TC...... C

Ct

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX colonography;d x. 0068T......... ........ C

Interp/rept

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart sound. 0069T......... ........ C

Analysis only

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart sound. 0070T......... ........ C

Interp only

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart sound. 0071T......... ........ C

U/s leiomyomata 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ablate 200. 0073T......... ........ A

Delivery, comp

0.00 13.02

16.77

NA

NA

0.13 13.15

16.90

NA

NA

XXX imrt. 0075T......... ........ C

Perq stent/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX chest vert art. 0075T......... 26...... C

Perq stent/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX chest vert art. 0075T......... TC...... C

Perq stent/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX chest vert art. 0076T......... ........ C

S&i stent/chest 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX vert art. 0076T......... 26...... C

S&i stent/chest 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX vert art. 0076T......... TC...... C

S&i stent/chest 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX vert art. 0077T......... ........ C

Cereb therm

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX perfusion probe. 0078T......... ........ C

Endovasc aort

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX repr w/device.

[[Page 49088]]

0079T......... ........ C

Endovasc visc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX extnsn repr. 0080T......... ........ C

Endovasc aort

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX repr rad s&i. 0081T......... ........ C

Endovasc visc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX extnsn s&i. 0082T......... ........ C

Stereotactic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX rad delivery. 0083T......... ........ C

Stereotactic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX rad tx mngmt. 0084T......... ........ C

Temp prostate

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX urethral stent. 0085T......... ........ C

Breath test

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart reject. 0086T......... ........ C

L ventricle

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX fill pressure. 0087T......... ........ C

Sperm eval

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX hyaluronan. 0088T......... ........ C

Rf tongue base

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX vol reduxn. 0089T......... ........ C

Actigraphy

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX testing, 3-day. 0090T......... ........ C

Cervical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX artific disc. 0091T......... ........ C

Lumbar artific

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX disc. 0092T......... ........ C

Artific disc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX addl. 0093T......... ........ C

Cervical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX artific diskectomy. 0094T......... ........ C

Lumbar artific

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX diskectomy. 0095T......... ........ C

Artific

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX diskectomy addl. 0096T......... ........ C

Rev cervical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX artific disc. 0097T......... ........ C

Rev lumbar

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX artific disc. 0098T......... ........ C

Rev artific

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX disc addl. 0099T......... ........ C

Implant corneal 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ring. 0100T......... ........ C

Prosth retina

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX receive&gen. 0101T......... ........ C

Extracorp

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX shockwv tx,hi enrg. 0102T......... ........ C

Extracorp

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX shockwv tx,anesth. 0103T......... ........ C

Holotranscobala 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX min. 0104T......... ........ C

At rest cardio

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX gas rebreathe. 0105T......... ........ C

Exerc cardio

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX gas rebreathe. 0106T......... ........ C

Touch quant

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX sensory test. 0107T......... ........ C

Vibrate quant

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX sensory test. 0108T......... ........ C

Cool quant

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX sensory test. 0109T......... ........ C

Heat quant

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX sensory test. 0110T......... ........ C

Nos quant

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX sensory test. 0111T......... ........ C

Rbc membranes

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX fatty acids. 0115T......... ........ C

Med tx mngmt 15 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX min. 0116T......... ........ C

Med tx mngmt

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX subsqt. 0117T......... ........ C

Med tx mngmt

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX addl 15 min. 0120T......... ........ C

Fibroadenoma

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX cryoablate, ea. 0123T......... ........ C

Scleral

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX fistulization. 0124T......... ........ C

Conjunctival

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX drug placement. 0126T......... ........ C

Chd risk imt

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX study. 0130T......... ........ C

Chron care drug 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX investigatn. 0133T......... ........ C

Esophageal

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX implant injexn. 0135T......... ........ C

Perq cryoablate 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX renal tumor. 0137T......... ........ C

Prostate

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX saturation sampling. 0140T......... ........ C

Exhaled breath

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX condensate ph. 0144T......... ........ C

CT heart wo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dye; qual calc. 0144T......... 26...... C

CT heart wo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dye; qual calc. 0144T......... TC...... C

CT heart wo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dye; qual calc. 0145T......... ........ C

CT heart w/wo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dye funct. 0145T......... 26...... C

CT heart w/wo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dye funct. 0145T......... TC...... C

CT heart w/wo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dye funct. 0146T......... ........ C

CCTA w/wo dye.. 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 0146T......... 26...... C

CCTA w/wo dye.. 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 0146T......... TC...... C

CCTA w/wo dye.. 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 0147T......... ........ C

CCTA w/wo, quan 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX calcium. 0147T......... 26...... C

CCTA w/wo, quan 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX calcium.

[[Page 49089]]

0147T......... TC...... C

CCTA w/wo, quan 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX calcium. 0148T......... ........ C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX strxr. 0148T......... 26...... C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX strxr. 0148T......... TC...... C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX strxr. 0149T......... ........ C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX strxr quan calc. 0149T......... 26...... C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX strxr quan calc. 0149T......... TC...... C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX strxr quan calc. 0150T......... ........ C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX disease strxr. 0150T......... 26...... C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX disease strxr. 0150T......... TC...... C

CCTA w/wo,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX disease strxr. 0151T......... ........ C

CT heart funct

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX add-on. 0151T......... 26...... C

CT heart funct

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX add-on. 0151T......... TC...... C

CT heart funct

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX add-on. 0152T......... ........ C

Computer chest

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX add-on. 0153T......... ........ C

Implant aneur

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX sensor add-on. 0154T......... ........ C

Implant aneur

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX sensor study. 0155T......... ........ C

Lap ins gastr

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX eltrd for mo. 0156T......... ........ C

Lap redo gastr

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX eltrd for mo. 0157T......... ........ C

Opn ins gastr

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX eltrd for mo. 0158T......... ........ C

Opn redo gastr

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX eltrd for mo. 0159T......... ........ C

Computer breast 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ MRI add-on. 0159T......... 26...... C

Computer breast 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ MRI add-on. 0159T......... TC...... C

Computer breast 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ MRI add-on. 0160T......... ........ C

Transcran mag

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX stim planning. 0161T......... ........ C

Transcran mag

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX stim delivery. 10021......... ........ A

Fna w/o image.. 1.27

2.13

2.15

0.36

0.50

0.10

3.50

3.52

1.73

1.87

XXX 10022......... ........ A

Fna w/image.... 1.27

2.13

2.44

0.38

0.41

0.08

3.48

3.79

1.73

1.76

XXX 10040......... ........ A

Acne surgery... 1.18

1.26

1.07

0.93

0.83

0.05

2.49

2.30

2.16

2.06

010 10060......... ........ A

Drainage of

1.17

1.50

1.28

1.08

0.97

0.12

2.79

2.57

2.37

2.26

010 skin abscess. 10061......... ........ A

Drainage of

2.40

2.07

1.88

1.51

1.50

0.26

4.73

4.54

4.17

4.16

010 skin abscess. 10080......... ........ A

Drainage of

1.17

2.65

2.99

1.09

1.11

0.11

3.93

4.27

2.37

2.39

010 pilonidal cyst. 10081......... ........ A

Drainage of

2.45

3.49

3.93

1.44

1.49

0.24

6.18

6.62

4.13

4.18

010 pilonidal cyst. 10120......... ........ A

Remove foreign

1.22

2.10

2.15

0.94

0.96

0.12

3.44

3.49

2.28

2.30

010 body. 10121......... ........ A

Remove foreign

2.69

3.52

3.51

1.65

1.75

0.33

6.54

6.53

4.67

4.77

010 body. 10140......... ........ A

Drainage of

1.53

2.27

1.90

1.29

1.29

0.19

3.99

3.62

3.01

3.01

010 hematoma/fluid. 10160......... ........ A

Puncture

1.20

1.85

1.66

1.07

1.08

0.14

3.19

3.00

2.41

2.42

010 drainage of lesion. 10180......... ........ A

Complex

2.25

3.30

3.06

1.83

1.94

0.35

5.90

5.66

4.43

4.54

010 drainage, wound. 11000......... ........ A

Debride

0.60

0.73

0.62

0.16

0.21

0.07

1.40

1.29

0.83

0.88

000 infected skin. 11001......... ........ A

Debride

0.30

0.23

0.23

0.08

0.10

0.04

0.57

0.57

0.42

0.44

ZZZ infected skin add-on. 11004......... ........ A

Debride

10.31

NA

NA

3.04

3.69

0.67

NA

NA

14.02

14.67

000 genitalia & perineum. 11005......... ........ A

Debride abdom

13.75

NA

NA

4.06

5.19

0.96

NA

NA

18.77

19.90

000 wall. 11006......... ........ A

Debride genit/ 12.61

NA

NA

3.61

4.54

1.28

NA

NA

17.50

18.43

000 per/abdom wall. 11008......... ........ A

Remove mesh

5.00

NA

NA

1.36

1.86

0.61

NA

NA

6.97

7.47

ZZZ from abd wall. 11010......... ........ A

Debride skin,

4.19

6.77

6.85

2.33

2.55

0.66 11.62

11.70

7.18

7.40

010 fx. 11011......... ........ A

Debride skin/

4.94

7.09

7.89

2.04

2.27

0.74 12.77

13.57

7.72

7.95

000 muscle, fx. 11012......... ........ A

Debride skin/

6.87

9.03

11.33

3.12

3.66

1.16 17.06

19.36

11.15

11.69

000 muscle/bone, fx. 11040......... ........ A

Debride skin,

0.48

0.68

0.56

0.16

0.20

0.06

1.22

1.10

0.70

0.74

000 partial. 11041......... ........ A

Debride skin,

0.60

0.73

0.68

0.19

0.30

0.10

1.43

1.38

0.89

1.00

000 full. 11042......... ........ A

Debride skin/

0.80

0.96

0.97

0.25

0.39

0.13

1.89

1.90

1.18

1.32

000 tissue. 11043......... ........ A

Debride tissue/ 3.00

3.64

3.45

2.71

2.62

0.32

6.96

6.77

6.03

5.94

010 muscle. 11044......... ........ A

Debride tissue/ 4.05

4.96

4.58

3.67

3.73

0.43

9.44

9.06

8.15

8.21

010 muscle/bone. 11055......... ........ R

Trim skin

0.43

0.82

0.63

0.11

0.16

0.05

1.30

1.11

0.59

0.64

000 lesion. 11056......... ........ R

Trim skin

0.61

0.89

0.70

0.16

0.21

0.07

1.57

1.38

0.84

0.89

000 lesions, 2 to 4. 11057......... ........ R

Trim skin

0.79

1.00

0.81

0.21

0.28

0.10

1.89

1.70

1.10

1.17

000 lesions, over 4. 11100......... ........ A

Biopsy, skin

0.81

1.83

1.40

0.37

0.37

0.03

2.67

2.24

1.21

1.21

000 lesion. 11101......... ........ A

Biopsy, skin

0.41

0.40

0.35

0.19

0.19

0.02

0.83

0.78

0.62

0.62

ZZZ add-on. 11200......... ........ A

Removal of skin 0.77

1.20

1.08

0.88

0.79

0.04

2.01

1.89

1.69

1.60

010 tags. 11201......... ........ A

Remove skin

0.29

0.16

0.16

0.11

0.12

0.02

0.47

0.47

0.42

0.43

ZZZ tags add-on. 11300......... ........ A

Shave skin

0.51

1.17

1.04

0.20

0.21

0.03

1.71

1.58

0.74

0.75

000 lesion. 11301......... ........ A

Shave skin

0.85

1.47

1.20

0.37

0.38

0.04

2.36

2.09

1.26

1.27

000 lesion. 11302......... ........ A

Shave skin

1.05

1.73

1.41

0.47

0.46

0.05

2.83

2.51

1.57

1.56

000 lesion. 11303......... ........ A

Shave skin

1.24

1.97

1.68

0.53

0.52

0.07

3.28

2.99

1.84

1.83

000 lesion. 11305......... ........ A

Shave skin

0.67

1.06

0.90

0.20

0.25

0.07

1.80

1.64

0.94

0.99

000 lesion. 11306......... ........ A

Shave skin

0.99

1.39

1.17

0.37

0.41

0.07

2.45

2.23

1.43

1.47

000 lesion. 11307......... ........ A

Shave skin

1.14

1.66

1.38

0.46

0.48

0.07

2.87

2.59

1.67

1.69

000 lesion. 11308......... ........ A

Shave skin

1.41

1.71

1.52

0.50

0.57

0.13

3.25

3.06

2.04

2.11

000 lesion.

[[Page 49090]]

11310......... ........ A

Shave skin

0.73

1.35

1.17

0.30

0.32

0.04

2.12

1.94

1.07

1.09

000 lesion. 11311......... ........ A

Shave skin

1.05

1.60

1.32

0.46

0.48

0.05

2.70

2.42

1.56

1.58

000 lesion. 11312......... ........ A

Shave skin

1.20

1.87

1.53

0.54

0.55

0.06

3.13

2.79

1.80

1.81

000 lesion. 11313......... ........ A

Shave skin

1.62

2.13

1.88

0.71

0.72

0.10

3.85

3.60

2.43

2.44

000 lesion. 11400......... ........ A

Exc tr-ext

0.85

1.86

1.96

0.92

0.89

0.06

2.77

2.87

1.83

1.80

010 b9+marg 0.5 4.0 cm. 11420......... ........ A

Exc h-f-nk-sp

0.98

1.82

1.78

0.92

0.93

0.09

2.89

2.85

1.99

2.00

010 b9+marg 0.5 4 cm. 11440......... ........ A

Exc face-mm

1.00

1.99

2.15

1.30

1.31

0.08

3.07

3.23

2.38

2.39

010 b9+marg 0.5 4 cm. 11450......... ........ A

Removal, sweat

3.11

5.19

5.07

2.44

2.13

0.34

8.64

8.52

5.89

5.58

090 gland lesion. 11451......... ........ A

Removal, sweat

4.32

6.17

6.49

2.79

2.60

0.53 11.02

11.34

7.64

7.45

090 gland lesion. 11462......... ........ A

Removal, sweat

2.89

5.33

5.17

2.47

2.13

0.32

8.54

8.38

5.68

5.34

090 gland lesion. 11463......... ........ A

Removal, sweat

4.32

6.64

6.78

2.98

2.76

0.54 11.50

11.64

7.84

7.62

090 gland lesion. 11470......... ........ A

Removal, sweat

3.63

5.61

5.20

2.70

2.37

0.40

9.64

9.23

6.73

6.40

090 gland lesion. 11471......... ........ A

Removal, sweat

4.78

6.48

6.65

2.99

2.82

0.58 11.84

12.01

8.35

8.18

090 gland lesion. 11600......... ........ A

Exc tr-ext

1.56

2.71

2.65

1.12

1.01

0.10

4.37

4.31

2.78

2.67

010 mlg+marg 0.5 4 cm. 11620......... ........ A

Exc h-f-nk-sp

1.57

2.81

2.65

1.17

1.01

0.09

4.47

4.31

2.83

2.67

010 mlg+marg 0.5 4 cm. 11640......... ........ A

Exc face-mm

1.60

3.00

2.74

1.26

1.15

0.11

4.71

4.45

2.97

2.86

010 malig+marg 0.5 4 cm. 11719......... ........ R

Trim nail(s)... 0.17

0.38

0.28

0.04

0.06

0.02

0.57

0.47

0.23

0.25

000 11720......... ........ A

Debride nail, 1- 0.32

0.47

0.37

0.08

0.11

0.04

0.83

0.73

0.44

0.47

000 5. 11721......... ........ A

Debride nail, 6 0.54

0.55

0.47

0.14

0.19

0.07

1.16

1.08

0.75

0.80

000 or more. 11730......... ........ A

Removal of nail 1.10

1.35

1.11

0.29

0.40

0.14

2.59

2.35

1.53

1.64

000 plate. 11732......... ........ A

Remove nail

0.57

0.55

0.47

0.15

0.20

0.07

1.19

1.11

0.79

0.84

ZZZ plate, add-on. 11740......... ........ A

Drain blood

0.37

0.80

0.61

0.44

0.37

0.04

1.21

1.02

0.85

0.78

000 from under nail. 11750......... ........ A

Removal of nail 2.36

2.98

2.37

1.89

1.79

0.22

5.56

4.95

4.47

4.37

010 bed. 11752......... ........ A

Remove nail bed/ 3.42

4.12

3.27

2.82

2.95

0.35

7.89

7.04

6.59

6.72

010 finger tip. 11755......... ........ A

Biopsy, nail

1.31

2.02

1.68

0.76

0.77

0.14

3.47

3.13

2.21

2.22

000 unit. 11760......... ........ A

Repair of nail

1.58

3.45

2.83

1.44

1.70

0.21

5.24

4.62

3.23

3.49

010 bed.

[[Page 49091]]

11762......... ........ A

Reconstruction

2.89

3.72

3.09

1.69

2.18

0.36

6.97

6.34

4.94

5.43

010 of nail bed. 11765......... ........ A

Excision of

0.69

2.69

2.01

1.01

0.82

0.08

3.46

2.78

1.78

1.59

010 nail fold, toe. 11770......... ........ A

Removal of

2.61

3.49

3.48

1.53

1.51

0.33

6.43

6.42

4.47

4.45

010 pilonidal lesion. 11771......... ........ A

Removal of

5.91

6.72

5.91

3.74

3.42

0.74 13.37

12.56

10.39

10.07

090 pilonidal lesion. 11772......... ........ A

Removal of

7.15

8.06

7.64

5.56

5.19

0.89 16.10

15.68

13.60

13.23

090 pilonidal lesion. 11900......... ........ A

Injection into

0.52

0.89

0.71

0.24

0.22

0.02

1.43

1.25

0.78

0.76

000 skin lesions. 11901......... ........ A

Added skin

0.80

0.98

0.74

0.38

0.36

0.03

1.81

1.57

1.21

1.19

000 lesions injection. 11920......... ........ R

Correct skin

1.61

2.40

3.38

1.12

1.10

0.24

4.25

5.23

2.97

2.95

000 color defects. 11921......... ........ R

Correct skin

1.93

2.67

3.64

1.26

1.27

0.29

4.89

5.86

3.48

3.49

000 color defects. 11922......... ........ R

Correct skin

0.49

0.93

1.09

0.22

0.24

0.07

1.49

1.65

0.78

0.80

ZZZ color defects. 11950......... ........ R

Therapy for

0.84

0.86

1.07

0.35

0.38

0.06

1.76

1.97

1.25

1.28

000 contour defects. 11951......... ........ R

Therapy for

1.19

1.18

1.41

0.53

0.52

0.11

2.48

2.71

1.83

1.82

000 contour defects. 11952......... ........ R

Therapy for

1.69

1.71

1.82

0.81

0.71

0.16

3.56

3.67

2.66

2.56

000 contour defects. 11954......... ........ R

Therapy for

1.85

1.76

2.27

0.76

0.87

0.25

3.86

4.37

2.86

2.97

000 contour defects. 11960......... ........ A

Insert tissue

10.85

NA

NA

10.58

10.44

1.31

NA

NA

22.74

22.60

090 expander(s). 11970......... ........ A

Replace tissue

7.80

NA

NA

6.20

6.15

1.05

NA

NA

15.05

15.00

090 expander. 11971......... ........ A

Remove tissue

3.13

7.42

8.69

4.01

3.85

0.32 10.87

12.14

7.46

7.30

090 expander(s). 11975......... ........ N

Insert

1.48

1.55

1.45

0.34

0.51

0.17

3.20

3.10

1.99

2.16

XXX contraceptive cap. 11976......... ........ R

Removal of

1.78

1.71

1.72

0.47

0.63

0.21

3.70

3.71

2.46

2.62

000 contraceptive cap. 11977......... ........ N

Removal/

3.30

2.00

2.20

0.77

1.14

0.37

5.67

5.87

4.44

4.81

XXX reinsert contra cap. 11980......... ........ A

Implant hormone 1.48

1.17

1.10

0.55

0.54

0.13

2.78

2.71

2.16

2.15

000 pellet(s). 11981......... ........ A

Insert drug

1.48

1.92

1.76

0.59

0.66

0.12

3.52

3.36

2.19

2.26

XXX implant device. 11982......... ........ A

Remove drug

1.78

2.05

1.97

0.71

0.80

0.17

4.00

3.92

2.66

2.75

XXX implant device. 11983......... ........ A

Remove/insert

3.30

2.67

2.38

1.34

1.44

0.23

6.20

5.91

4.87

4.97

XXX drug implant. 12001......... ........ A

Repair

1.70

1.73

1.92

0.72

0.76

0.15

3.58

3.77

2.57

2.61

010 superficial wound(s). 12002......... ........ A

Repair

1.86

1.79

1.98

0.83

0.88

0.17

3.82

4.01

2.86

2.91

010 superficial wound(s). 12004......... ........ A

Repair

2.24

2.07

2.26

0.92

0.99

0.21

4.52

4.71

3.37

3.44

010 superficial wound(s). 12005......... ........ A

Repair

2.86

2.52

2.75

1.06

1.17

0.27

5.65

5.88

4.19

4.30

010 superficial wound(s). 12006......... ........ A

Repair

3.66

3.03

3.30

1.30

1.46

0.35

7.04

7.31

5.31

5.47

010 superficial wound(s). 12007......... ........ A

Repair

4.11

3.40

3.72

1.49

1.73

0.45

7.96

8.28

6.05

6.29

010 superficial wound(s). 12011......... ........ A

Repair

1.76

1.89

2.07

0.75

0.77

0.16

3.81

3.99

2.67

2.69

010 superficial wound(s). 12013......... ........ A

Repair

1.99

2.05

2.22

0.88

0.92

0.18

4.22

4.39

3.05

3.09

010 superficial wound(s). 12014......... ........ A

Repair

2.46

2.28

2.50

0.97

1.04

0.23

4.97

5.19

3.66

3.73

010 superficial wound(s). 12015......... ........ A

Repair

3.19

2.76

3.04

1.11

1.22

0.29

6.24

6.52

4.59

4.70

010 superficial wound(s). 12016......... ........ A

Repair

3.92

3.16

3.45

1.29

1.46

0.37

7.45

7.74

5.58

5.75

010 superficial wound(s). 12017......... ........ A

Repair

4.70

NA

NA

1.48

1.79

0.47

NA

NA

6.65

6.96

010 superficial wound(s). 12018......... ........ A

Repair

5.52

NA

NA

1.96

2.18

0.64

NA

NA

8.12

8.34

010 superficial wound(s). 12020......... ........ A

Closure of

2.62

3.75

3.80

1.77

1.88

0.30

6.67

6.72

4.69

4.80

010 split wound. 12021......... ........ A

Closure of

1.84

1.86

1.83

1.33

1.39

0.24

3.94

3.91

3.41

3.47

010 split wound. 12031......... ........ A

Layer closure

2.15

3.82

2.67

1.73

1.15

0.17

6.14

4.99

4.05

3.47

010 of wound(s). 12032......... ........ A

Layer closure

2.47

5.08

4.15

2.21

1.90

0.16

7.71

6.78

4.84

4.53

010 of wound(s). 12034......... ........ A

Layer closure

2.92

4.50

3.52

1.93

1.57

0.25

7.67

6.69

5.10

4.74

010 of wound(s). 12035......... ........ A

Layer closure

3.42

5.25

5.21

2.08

2.13

0.39

9.06

9.02

5.89

5.94

010 of wound(s). 12036......... ........ A

Layer closure

4.04

5.38

5.51

2.22

2.46

0.55

9.97

10.10

6.81

7.05

010 of wound(s). 12037......... ........ A

Layer closure

4.66

5.94

6.05

2.59

2.87

0.66 11.26

11.37

7.91

8.19

010 of wound(s). 12041......... ........ A

Layer closure

2.37

3.77

2.85

1.72

1.28

0.19

6.33

5.41

4.28

3.84

010 of wound(s). 12042......... ........ A

Layer closure

2.74

4.36

3.54

2.04

1.61

0.17

7.27

6.45

4.95

4.52

010 of wound(s). 12044......... ........ A

Layer closure

3.14

5.27

3.73

1.89

1.67

0.27

8.68

7.14

5.30

5.08

010 of wound(s). 12045......... ........ A

Layer closure

3.63

5.07

5.21

2.06

2.23

0.41

9.11

9.25

6.10

6.27

010 of wound(s). 12046......... ........ A

Layer closure

4.24

5.64

6.29

2.27

2.63

0.54 10.42

11.07

7.05

7.41

010 of wound(s). 12047......... ........ A

Layer closure

4.64

6.16

6.30

2.51

2.94

0.58 11.38

11.52

7.73

8.16

010 of wound(s). 12051......... ........ A

Layer closure

2.47

4.01

3.46

1.86

1.55

0.20

6.68

6.13

4.53

4.22

010 of wound(s). 12052......... ........ A

Layer closure

2.77

4.69

3.59

2.44

1.68

0.17

7.63

6.53

5.38

4.62

010 of wound(s). 12053......... ........ A

Layer closure

3.12

5.23

3.74

2.05

1.66

0.23

8.58

7.09

5.40

5.01

010 of wound(s). 12054......... ........ A

Layer closure

3.45

5.30

4.00

2.01

1.73

0.30

9.05

7.75

5.76

5.48

010 of wound(s). 12055......... ........ A

Layer closure

4.42

6.00

4.86

2.10

2.12

0.45 10.87

9.73

6.97

6.99

010 of wound(s). 12056......... ........ A

Layer closure

5.23

6.21

6.62

2.38

2.88

0.59 12.03

12.44

8.20

8.70

010 of wound(s). 12057......... ........ A

Layer closure

5.95

7.45

6.46

2.79

3.51

0.56 13.96

12.97

9.30

10.02

010 of wound(s). 13100......... ........ A

Repair of wound 3.12

4.32

4.12

2.39

2.32

0.26

7.70

7.50

5.77

5.70

010 or lesion. 13101......... ........ A

Repair of wound 3.91

5.79

4.94

2.88

2.73

0.26

9.96

9.11

7.05

6.90

010 or lesion. 13102......... ........ A

Repair wound/

1.24

1.34

1.21

0.52

0.56

0.13

2.71

2.58

1.89

1.93

ZZZ lesion add-on. 13120......... ........ A

Repair of wound 3.30

4.46

4.22

2.50

2.38

0.26

8.02

7.78

6.06

5.94

010 or lesion. 13121......... ........ A

Repair of wound 4.32

6.47

5.26

3.46

2.96

0.25 11.04

9.83

8.03

7.53

010 or lesion. 13122......... ........ A

Repair wound/

1.44

1.37

1.48

0.58

0.62

0.15

2.96

3.07

2.17

2.21

ZZZ lesion add-on. 13131......... ........ A

Repair of wound 3.78

4.86

4.49

2.78

2.71

0.26

8.90

8.53

6.82

6.75

010 or lesion. 13132......... ........ A

Repair of wound 6.44

7.64

6.34

4.77

4.31

0.32 14.40

13.10

11.53

11.07

010 or lesion.

[[Page 49092]]

13133......... ........ A

Repair wound/

2.19

1.82

1.70

0.94

1.01

0.18

4.19

4.07

3.31

3.38

ZZZ lesion add-on. 13150......... ........ A

Repair of wound 3.80

4.59

4.80

2.64

2.73

0.34

8.73

8.94

6.78

6.87

010 or lesion. 13151......... ........ A

Repair of wound 4.44

5.35

4.94

3.11

3.13

0.31 10.10

9.69

7.86

7.88

010 or lesion. 13152......... ........ A

Repair of wound 6.32

7.31

6.35

3.77

3.97

0.40 14.03

13.07

10.49

10.69

010 or lesion. 13153......... ........ A

Repair wound/

2.38

1.98

1.94

0.98

1.10

0.24

4.60

4.56

3.60

3.72

ZZZ lesion add-on. 13160......... ........ A

Late closure of 11.76

NA

NA

7.07

7.14

1.54

NA

NA

20.37

20.44

090 wound. 14000......... ........ A

Skin tissue

6.76

8.78

8.08

5.92

5.58

0.59 16.13

15.43

13.27

12.93

090 rearrangement. 14001......... ........ A

Skin tissue

9.52 10.90

9.78

7.40

7.15

0.82 21.24

20.12

17.74

17.49

090 rearrangement. 14020......... ........ A

Skin tissue

7.58

9.79

8.91

6.70

6.57

0.64 18.01

17.13

14.92

14.79

090 rearrangement. 14021......... ........ A

Skin tissue

11.10 12.13

10.52

8.40

8.31

0.81 24.04

22.43

20.31

20.22

090 rearrangement. 14040......... ........ A

Skin tissue

8.36

9.92

9.08

6.77

7.09

0.62 18.90

18.06

15.75

16.07

090 rearrangement. 14041......... ........ A

Skin tissue

12.59 13.17

11.24

9.03

8.76

0.73 26.49

24.56

22.35

22.08

090 rearrangement. 14060......... ........ A

Skin tissue

8.99

9.40

8.94

6.94

7.31

0.68 19.07

18.61

16.61

16.98

090 rearrangement. 14061......... ........ A

Skin tissue

13.58 14.41

12.30

9.84

9.59

0.76 28.75

26.64

24.18

23.93

090 rearrangement. 14300......... ........ A

Skin tissue

13.17 13.26

11.66

9.24

9.19

1.16 27.59

25.99

23.57

23.52

090 rearrangement. 14350......... ........ A

Skin tissue

10.73

NA

NA

6.92

7.09

1.34

NA

NA

18.99

19.16

090 rearrangement. 15000......... ........ A

Wound prep, 1st 3.99

4.24

3.90

1.73

2.07

0.54

8.77

8.43

6.26

6.60

000 100 sq cm. 15001......... ........ A

Wound prep,

1.00

0.56

1.15

0.35

0.40

0.14

1.70

2.29

1.49

1.54

ZZZ addl 100 sq cm. 15040......... ........ A

Harvest

2.00

3.86

4.39

1.03

1.11

0.24

6.10

6.63

3.27

3.35

000 cultured skin graft. 15050......... ........ A

Skin pinch

5.29

7.65

7.10

5.02

5.09

0.57 13.51

12.96

10.88

10.95

090 graft. 15100......... ........ A

Skin splt grft, 9.66

9.84

11.90

6.73

7.55

1.28 20.78

22.84

17.67

18.49

090 trnk/arm/leg. 15101......... ........ A

Skin splt grft

1.72

2.51

3.43

0.87

1.10

0.24

4.47

5.39

2.83

3.06

ZZZ t/a/l, add-on. 15110......... ........ A

Epidrm autogrft 10.82

8.92

10.23

6.50

6.88

1.31 21.05

22.36

18.63

19.01

090 trnk/arm/leg. 15111......... ........ A

Epidrm autogrft 1.85

0.89

1.19

0.64

0.75

0.26

3.00

3.30

2.75

2.86

ZZZ t/a/l add-on. 15115......... ........ A

Epidrm a-grft

11.13

9.16

9.21

6.68

7.18

1.15 21.44

21.49

18.96

19.46

090 face/nck/hf/g. 15116......... ........ A

Epidrm a-grft f/ 2.50

1.22

1.49

0.89

1.06

0.33

4.05

4.32

3.72

3.89

ZZZ n/hf/g addl. 15120......... ........ A

Skn splt a-grft 10.88 11.18

10.84

7.32

7.67

1.16 23.22

22.88

19.36

19.71

090 fac/nck/hf/g. 15121......... ........ A

Skn splt a-grft 2.67

3.47

4.24

1.33

1.71

0.36

6.50

7.27

4.36

4.74

ZZZ f/n/hf/g add. 15130......... ........ A

Derm autograft, 7.33

8.03

9.40

5.64

6.17

0.97 16.33

17.70

13.94

14.47

090 trnk/arm/leg. 15131......... ........ A

Derm autograft

1.50

0.70

0.98

0.52

0.61

0.21

2.41

2.69

2.23

2.32

ZZZ t/a/l add-on. 15135......... ........ A

Derm autograft 10.83

9.41

9.76

6.98

7.84

1.23 21.47

21.82

19.04

19.90

090 face/nck/hf/g. 15136......... ........ A

Derm autograft, 1.50

0.68

0.84

0.53

0.64

0.20

2.38

2.54

2.23

2.34

ZZZ f/n/hf/g add. 15150......... ........ A

Cult epiderm

9.24

7.22

8.15

5.92

6.31

1.14 17.60

18.53

16.30

16.69

090 grft t/arm/leg. 15151......... ........ A

Cult epiderm

2.00

0.90

1.21

0.70

0.81

0.28

3.18

3.49

2.98

3.09

ZZZ grft t/a/l addl. 15152......... ........ A

Cult epiderm

2.50

1.08

1.44

0.87

1.01

0.35

3.93

4.29

3.72

3.86

ZZZ graft t/a/l +%. 15155......... ........ A

Cult epiderm

9.99

7.60

7.77

6.25

6.78

1.05 18.64

18.81

17.29

17.82

090 graft, f/n/hf/ g. 15156......... ........ A

Cult epidrm

2.75

1.18

1.47

0.98

1.18

0.36

4.29

4.58

4.09

4.29

ZZZ grft f/n/hfg add. 15157......... ........ A

Cult epiderm

3.00

1.37

1.67

1.07

1.28

0.39

4.76

5.06

4.46

4.67

ZZZ grft f/n/hfg +%. 15170......... ........ A

Acell graft

5.99

3.65

3.79

2.36

2.36

0.55 10.19

10.33

8.90

8.90

090 trunk/arms/ legs. 15171......... ........ A

Acell graft t/

1.55

0.65

0.67

0.51

0.59

0.19

2.39

2.41

2.25

2.33

ZZZ arm/leg add-on. 15175......... ........ A

Acellular

7.99

5.24

5.38

3.75

3.94

0.82 14.05

14.19

12.56

12.75

090 graft, f/n/hf/ g. 15176......... ........ A

Acell graft, f/ 2.45

1.07

1.10

0.81

0.95

0.29

3.81

3.84

3.55

3.69

ZZZ n/hf/g add-on. 15200......... ........ A

Skin full

8.90

9.85

9.51

6.29

6.22

0.98 19.73

19.39

16.17

16.10

090 graft, trunk. 15201......... ........ A

Skin full graft 1.32

2.11

2.45

0.56

0.61

0.19

3.62

3.96

2.07

2.12

ZZZ trunk add-on. 15220......... ........ A

Skin full graft 7.86 10.21

9.44

6.51

6.64

0.84 18.91

18.14

15.21

15.34

090 sclp/arm/leg. 15221......... ........ A

Skin full graft 1.19

2.01

2.24

0.50

0.55

0.16

3.36

3.59

1.85

1.90

ZZZ add-on. 15240......... ........ A

Skin full grft 10.03 11.73

10.58

8.64

8.12

0.92 22.68

21.53

19.59

19.07

090 face/genit/hf. 15241......... ........ A

Skin full graft 1.86

2.51

2.46

0.79

0.88

0.23

4.60

4.55

2.88

2.97

ZZZ add-on. 15260......... ........ A

Skin full graft 11.29 12.63

10.82

9.02

8.69

0.69 24.61

22.80

21.00

20.67

090 een & lips. 15261......... ........ A

Skin full graft 2.23

2.91

2.75

1.12

1.33

0.21

5.35

5.19

3.56

3.77

ZZZ add-on. 15300......... ........ A

Apply

4.65

3.36

3.24

2.10

2.20

0.49

8.50

8.38

7.24

7.34

090 skinallogrft, t/arm/lg. 15301......... ........ A

Apply

1.00

0.47

0.47

0.34

0.39

0.14

1.61

1.61

1.48

1.53

ZZZ sknallogrft t/ a/l addl. 15320......... ........ A

Apply skin

5.36

3.75

3.65

2.32

2.48

0.58

9.69

9.59

8.26

8.42

090 allogrft f/n/ hf/g. 15321......... ........ A

Aply

1.50

0.68

0.69

0.50

0.57

0.21

2.39

2.40

2.21

2.28

ZZZ sknallogrft f/ n/hfg add. 15330......... ........ A

Aply acell

3.99

3.14

3.18

1.90

2.14

0.49

7.62

7.66

6.38

6.62

090 alogrft t/arm/ leg. 15331......... ........ A

Aply acell grft 1.00

0.46

0.46

0.34

0.39

0.14

1.60

1.60

1.48

1.53

ZZZ t/a/l add-on.

[[Page 49093]]

15335......... ........ A

Apply acell

4.50

3.40

3.45

2.06

2.35

0.55

8.45

8.50

7.11

7.40

090 graft, f/n/hf/ g. 15336......... ........ A

Aply acell grft 1.43

0.72

0.70

0.48

0.55

0.20

2.35

2.33

2.11

2.18

ZZZ f/n/hf/g add. 15340......... ........ A

Apply cult skin 3.72

3.79

3.95

2.72

2.74

0.41

7.92

8.08

6.85

6.87

010 substitute. 15341......... ........ A

Apply cult skin 0.50

0.72

0.64

0.17

0.19

0.06

1.28

1.20

0.73

0.75

ZZZ sub add-on. 15360......... ........ A

Apply cult derm 3.87

4.31

4.43

3.11

3.09

0.43

8.61

8.73

7.41

7.39

090 sub, t/a/l. 15361......... ........ A

Aply cult derm

1.15

0.57

0.58

0.38

0.44

0.14

1.86

1.87

1.67

1.73

ZZZ sub t/a/l add. 15365......... ........ A

Apply cult derm 4.15

4.35

4.50

3.19

3.19

0.46

8.96

9.11

7.80

7.80

090 sub f/n/hf/g. 15366......... ........ A

Apply cult derm 1.45

0.69

0.70

0.48

0.56

0.17

2.31

2.32

2.10

2.18

ZZZ f/hf/g add. 15400......... ........ A

Apply skin

4.32

4.91

4.24

3.69

3.93

0.47

9.70

9.03

8.48

8.72

090 xenograft, t/a/ l. 15401......... ........ A

Apply skn

1.00

1.02

1.67

0.35

0.42

0.14

2.16

2.81

1.49

1.56

ZZZ xenogrft t/a/l add. 15420......... ........ A

Apply skin

4.83

5.04

4.85

3.86

3.81

0.52 10.39

10.20

9.21

9.16

090 xgraft, f/n/hf/ g. 15421......... ........ A

Apply skn xgrft 1.50

1.20

1.29

0.52

0.60

0.21

2.91

3.00

2.23

2.31

ZZZ f/n/hf/g add. 15430......... ........ A

Apply acellular 5.75

7.01

6.93

6.44

6.57

0.66 13.42

13.34

12.85

12.98

090 xenograft. 15431......... ........ C

Apply acellular 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ xgraft add. 15570......... ........ A

Form skin

9.94 10.36

11.07

6.46

6.69

1.34 21.64

22.35

17.74

17.97

090 pedicle flap. 15572......... ........ A

Form skin

9.88

9.74

9.55

6.62

6.49

1.20 20.82

20.63

17.70

17.57

090 pedicle flap. 15574......... ........ A

Form skin

10.48 10.36

10.60

6.89

7.57

1.20 22.04

22.28

18.57

19.25

090 pedicle flap. 15576......... ........ A

Form skin

9.18

9.50

9.69

6.39

6.76

0.87 19.55

19.74

16.44

16.81

090 pedicle flap. 15600......... ........ A

Skin graft..... 1.91

5.28

7.02

2.71

2.97

0.27

7.46

9.20

4.89

5.15

090 15610......... ........ A

Skin graft..... 2.42

5.55

4.91

3.03

3.32

0.35

8.32

7.68

5.80

6.09

090 15620......... ........ A

Skin graft..... 3.57

6.33

7.42

3.80

3.86

0.35 10.25

11.34

7.72

7.78

090 15630......... ........ A

Skin graft..... 3.90

6.89

7.00

4.18

4.16

0.34 11.13

11.24

8.42

8.40

090 15650......... ........ A

Transfer skin

4.59

7.02

7.11

4.20

4.21

0.42 12.03

12.12

9.21

9.22

090 pedicle flap. 15732......... ........ A

Muscle-skin

19.62 14.71

17.21

11.13

11.94

1.99 36.32

38.82

32.74

33.55

090 graft, head/ neck. 15734......... ........ A

Muscle-skin

19.52 15.75

17.52

11.89

12.25

2.61 37.88

39.65

34.02

34.38

090 graft, trunk. 15736......... ........ A

Muscle-skin

16.86 13.77

17.12

9.95

10.90

2.45 33.08

36.43

29.26

30.21

090 graft, arm. 15738......... ........ A

Muscle-skin

18.86 14.03

16.99

10.41

11.39

2.65 35.54

38.50

31.92

32.90

090 graft, leg. 15740......... ........ A

Island pedicle 11.48 13.10

10.87

9.05

8.46

0.63 25.21

22.98

21.16

20.57

090 flap graft. 15750......... ........ A

Neurovascular

12.64

NA

NA

8.80

8.98

1.42

NA

NA

22.86

23.04

090 pedicle graft. 15756......... ........ A

Free myo/skin

36.64

NA

NA

18.38

20.02

4.61

NA

NA

59.63

61.27

090 flap microvasc. 15757......... ........ A

Free skin flap, 36.85

NA

NA

16.63

20.35

3.89

NA

NA

57.37

61.09

090 microvasc. 15758......... ........ A

Free fascial

36.60

NA

NA

16.47

20.30

4.23

NA

NA

57.30

61.13

090 flap, microvasc. 15760......... ........ A

Composite skin

9.61 10.14

10.05

6.84

7.16

0.85 20.60

20.51

17.30

17.62

090 graft. 15770......... ........ A

Derma-fat-

8.64

NA

NA

6.56

6.65

1.05

NA

NA

16.25

16.34

090 fascia graft. 15775......... ........ R

Hair transplant 3.95

3.50

4.05

1.70

1.40

0.52

7.97

8.52

6.17

5.87

000 punch grafts. 15776......... ........ R

Hair transplant 5.53

3.98

5.01

1.61

2.50

0.72 10.23

11.26

7.86

8.75

000 punch grafts. 15780......... ........ A

Abrasion

8.41 11.65

11.55

6.74

7.87

0.67 20.73

20.63

15.82

16.95

090 treatment of skin. 15781......... ........ A

Abrasion

4.84

8.43

7.29

5.47

5.39

0.34 13.61

12.47

10.65

10.57

090 treatment of skin. 15782......... ........ A

Abrasion

4.31

9.44

9.75

5.43

6.27

0.34 14.09

14.40

10.08

10.92

090 treatment of skin. 15783......... ........ A

Abrasion

4.28

7.83

7.11

4.89

4.36

0.28 12.39

11.67

9.45

8.92

090 treatment of skin. 15786......... ........ A

Abrasion,

2.03

3.76

3.45

1.22

1.30

0.11

5.90

5.59

3.36

3.44

010 lesion, single. 15787......... ........ A

Abrasion,

0.33

0.83

1.03

0.10

0.15

0.04

1.20

1.40

0.47

0.52

ZZZ lesions, add- on. 15788......... ........ R

Chemical peel,

2.09

8.43

7.14

3.66

3.23

0.11 10.63

9.34

5.86

5.43

090 face, epiderm. 15789......... ........ R

Chemical peel,

4.91

9.00

8.32

5.56

4.99

0.20 14.11

13.43

10.67

10.10

090 face, dermal. 15792......... ........ R

Chemical peel,

1.86

6.85

7.03

3.46

4.20

0.13

8.84

9.02

5.45

6.19

090 nonfacial. 15793......... ........ A

Chemical peel,

3.73

5.54

6.10

3.27

4.10

0.19

9.46

10.02

7.19

8.02

090 nonfacial. 15819......... ........ A

Plastic

10.37

NA

NA

6.67

7.05

0.97

NA

NA

18.01

18.39

090 surgery, neck. 15820......... ........ A

Revision of

6.02

6.47

6.85

5.25

5.48

0.40 12.89

13.27

11.67

11.90

090 lower eyelid. 15821......... ........ A

Revision of

6.59

6.73

7.20

5.41

5.64

0.45 13.77

14.24

12.45

12.68

090 lower eyelid. 15822......... ........ A

Revision of

4.44

5.34

5.71

4.18

4.41

0.37 10.15

10.52

8.99

9.22

090 upper eyelid. 15823......... ........ A

Revision of

8.04

7.59

7.79

6.29

6.40

0.50 16.13

16.33

14.83

14.94

090 upper eyelid. 15831......... ........ A

Excise

13.57

NA

NA

8.73

8.30

1.75

NA

NA

24.05

23.62

090 excessive skin tissue. 15832......... ........ A

Excise

12.57

NA

NA

8.30

8.33

1.66

NA

NA

22.53

22.56

090 excessive skin tissue. 15833......... ........ A

Excise

11.62

NA

NA

7.09

7.93

1.49

NA

NA

20.20

21.04

090 excessive skin tissue. 15834......... ........ A

Excise

11.89

NA

NA

7.73

7.70

1.61

NA

NA

21.23

21.20

090 excessive skin tissue. 15835......... ........ A

Excise

12.71

NA

NA

7.81

7.61

1.60

NA

NA

22.12

21.92

090 excessive skin tissue. 15836......... ........ A

Excise

10.33

NA

NA

7.02

6.84

1.34

NA

NA

18.69

18.51

090 excessive skin tissue. 15837......... ........ A

Excise

9.30

8.79

8.61

5.78

6.97

1.18 19.27

19.09

16.26

17.45

090 excessive skin tissue. 15838......... ........ A

Excise

8.00

NA

NA

4.88

5.77

0.58

NA

NA

13.46

14.35

090 excessive skin tissue. 15839......... ........ A

Excise

10.25

9.40

8.97

6.19

6.34

1.22 20.87

20.44

17.66

17.81

090 excessive skin tissue. 15840......... ........ A

Graft for face 14.67

NA

NA

8.55

9.62

1.32

NA

NA

24.54

25.61

090 nerve palsy. 15841......... ........ A

Graft for face 25.57

NA

NA

13.05

14.51

2.54

NA

NA

41.16

42.62

090 nerve palsy. 15842......... ........ A

Flap for face

40.55

NA

NA

21.01

22.44

4.93

NA

NA

66.49

67.92

090 nerve palsy. 15845......... ........ A

Skin and muscle 13.93

NA

NA

8.77

9.17

0.81

NA

NA

23.51

23.91

090 repair, face. 15850......... ........ B

Removal of

0.78

1.21

1.47

0.18

0.27

0.05

2.04

2.30

1.01

1.10

XXX sutures. 15851......... ........ A

Removal of

0.86

1.33

1.59

0.24

0.29

0.06

2.25

2.51

1.16

1.21

000 sutures.

[[Page 49094]]

15852......... ........ A

Dressing change 0.86

1.62

1.79

0.25

0.31

0.09

2.57

2.74

1.20

1.26

000 not for burn. 15860......... ........ A

Test for blood

1.95

NA

NA

0.70

0.76

0.27

NA

NA

2.92

2.98

000 flow in graft. 15920......... ........ A

Removal of tail 8.06

NA

NA

5.83

5.62

1.04

NA

NA

14.93

14.72

090 bone ulcer. 15922......... ........ A

Removal of tail 10.13

NA

NA

7.01

7.16

1.42

NA

NA

18.56

18.71

090 bone ulcer. 15931......... ........ A

Remove sacrum

9.89

NA

NA

5.55

5.65

1.25

NA

NA

16.69

16.79

090 pressure sore. 15933......... ........ A

Remove sacrum

11.49

NA

NA

7.34

7.72

1.52

NA

NA

20.35

20.73

090 pressure sore. 15934......... ........ A

Remove sacrum

13.45

NA

NA

7.61

7.93

1.78

NA

NA

22.84

23.16

090 pressure sore. 15935......... ........ A

Remove sacrum

15.45

NA

NA

10.14

10.28

2.09

NA

NA

27.68

27.82

090 pressure sore. 15936......... ........ A

Remove sacrum

12.96

NA

NA

7.49

8.04

1.76

NA

NA

22.21

22.76

090 pressure sore. 15937......... ........ A

Remove sacrum

14.91

NA

NA

8.96

9.61

2.06

NA

NA

25.93

26.58

090 pressure sore. 15940......... ........ A

Remove hip

10.05

NA

NA

5.84

6.09

1.31

NA

NA

17.20

17.45

090 pressure sore. 15941......... ........ A

Remove hip

12.13

NA

NA

8.51

9.22

1.66

NA

NA

22.30

23.01

090 pressure sore. 15944......... ........ A

Remove hip

12.16

NA

NA

8.24

8.51

1.65

NA

NA

22.05

22.32

090 pressure sore. 15945......... ........ A

Remove hip

13.45

NA

NA

9.15

9.52

1.84

NA

NA

24.44

24.81

090 pressure sore. 15946......... ........ A

Remove hip

23.72

NA

NA

13.95

14.27

3.16

NA

NA

40.83

41.15

090 pressure sore. 15950......... ........ A

Remove thigh

7.83

NA

NA

5.40

5.41

1.04

NA

NA

14.27

14.28

090 pressure sore. 15951......... ........ A

Remove thigh

11.30

NA

NA

8.00

7.90

1.49

NA

NA

20.79

20.69

090 pressure sore. 15952......... ........ A

Remove thigh

12.03

NA

NA

7.77

7.76

1.60

NA

NA

21.40

21.39

090 pressure sore. 15953......... ........ A

Remove thigh

13.27

NA

NA

9.10

9.02

1.79

NA

NA

24.16

24.08

090 pressure sore. 15956......... ........ A

Remove thigh

16.46

NA

NA

9.66

10.49

2.21

NA

NA

28.33

29.16

090 pressure sore. 15958......... ........ A

Remove thigh

16.42

NA

NA

10.28

10.85

2.25

NA

NA

28.95

29.52

090 pressure sore. 15999......... ........ C

Removal of

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY pressure sore. 16000......... ........ A

Initial

0.89

0.73

0.83

0.24

0.26

0.08

1.70

1.80

1.21

1.23

000 treatment of burn(s). 16020......... ........ A

Dress/debrid p- 0.80

1.11

1.25

0.56

0.58

0.08

1.99

2.13

1.44

1.46

000 thick burn, s. 16025......... ........ A

Dress/debrid p- 1.85

1.61

1.72

0.88

0.94

0.19

3.65

3.76

2.92

2.98

000 thick burn, m. 16030......... ........ A

Dress/debrid p- 2.08

1.98

2.12

0.96

1.08

0.24

4.30

4.44

3.28

3.40

000 thick burn, l. 16035......... ........ A

Incision of

3.74

NA

NA

1.27

1.50

0.46

NA

NA

5.47

5.70

090 burn scab, initi. 16036......... ........ A

Escharotomy;

1.50

NA

NA

0.49

0.57

0.20

NA

NA

2.19

2.27

ZZZ addIl incision. 17000......... ........ A

Destroy benign/ 0.60

1.36

1.07

0.71

0.58

0.03

1.99

1.70

1.34

1.21

010 premlg lesion. 17003......... ........ A

Destroy

0.07

0.10

0.11

0.03

0.06

0.01

0.18

0.19

0.11

0.14

ZZZ lesions, 2-14. 17004......... ........ A

Destroy

1.58

2.23

2.28

1.20

1.49

0.11

3.92

3.97

2.89

3.18

010 lesions, 15 or more. 17106......... ........ A

Destruction of

4.58

4.56

4.59

3.18

3.29

0.35

9.49

9.52

8.11

8.22

090 skin lesions. 17107......... ........ A

Destruction of

9.15

7.08

7.17

5.01

5.34

0.63 16.86

16.95

14.79

15.12

090 skin lesions. 17108......... ........ A

Destruction of 13.18

9.19

9.24

6.64

7.41

0.54 22.91

22.96

20.36

21.13

090 skin lesions. 17110......... ........ A

Destruct

0.65

1.74

1.65

0.85

0.74

0.05

2.44

2.35

1.55

1.44

010 lesion, 1-14. 17111......... ........ A

Destruct

0.92

2.23

1.81

1.09

0.88

0.05

3.20

2.78

2.06

1.85

010 lesion, 15 or more. 17250......... ........ A

Chemical

0.50

1.32

1.25

0.38

0.35

0.06

1.88

1.81

0.94

0.91

000 cautery, tissue. 17260......... ........ A

Destruction of

0.91

1.37

1.30

0.68

0.67

0.04

2.32

2.25

1.63

1.62

010 skin lesions. 17261......... ........ A

Destruction of

1.17

2.42

1.81

1.02

0.88

0.05

3.64

3.03

2.24

2.10

010 skin lesions. 17262......... ........ A

Destruction of

1.58

2.74

2.10

1.22

1.07

0.06

4.38

3.74

2.86

2.71

010 skin lesions. 17263......... ........ A

Destruction of

1.79

2.97

2.28

1.31

1.15

0.07

4.83

4.14

3.17

3.01

010 skin lesions. 17264......... ........ A

Destruction of

1.94

3.17

2.46

1.38

1.19

0.08

5.19

4.48

3.40

3.21

010 skin lesions. 17266......... ........ A

Destruction of

2.34

3.42

2.73

1.54

1.30

0.09

5.85

5.16

3.97

3.73

010 skin lesions. 17270......... ........ A

Destruction of

1.32

2.36

1.87

1.05

0.92

0.05

3.73

3.24

2.42

2.29

010 skin lesions. 17271......... ........ A

Destruction of

1.49

2.58

1.97

1.17

1.03

0.06

4.13

3.52

2.72

2.58

010 skin lesions. 17272......... ........ A

Destruction of

1.77

2.88

2.21

1.31

1.16

0.07

4.72

4.05

3.15

3.00

010 skin lesions. 17273......... ........ A

Destruction of

2.05

3.12

2.43

1.43

1.27

0.08

5.25

4.56

3.56

3.40

010 skin lesions. 17274......... ........ A

Destruction of

2.59

3.50

2.80

1.68

1.50

0.10

6.19

5.49

4.37

4.19

010 skin lesions. 17276......... ........ A

Destruction of

3.20

3.78

3.15

1.91

1.74

0.16

7.14

6.51

5.27

5.10

010 skin lesions. 17280......... ........ A

Destruction of

1.17

2.29

1.78

0.99

0.86

0.05

3.51

3.00

2.21

2.08

010 skin lesions. 17281......... ........ A

Destruction of

1.72

2.65

2.09

1.28

1.14

0.07

4.44

3.88

3.07

2.93

010 skin lesions. 17282......... ........ A

Destruction of

2.04

3.04

2.37

1.43

1.29

0.08

5.16

4.49

3.55

3.41

010 skin lesions. 17283......... ........ A

Destruction of

2.64

3.45

2.77

1.70

1.54

0.11

6.20

5.52

4.45

4.29

010 skin lesions. 17284......... ........ A

Destruction of

3.21

3.86

3.16

1.95

1.80

0.13

7.20

6.50

5.29

5.14

010 skin lesions. 17286......... ........ A

Destruction of

4.43

4.28

3.82

2.38

2.43

0.23

8.94

8.48

7.04

7.09

010 skin lesions. 17304......... ........ A

1 stage mohs,

7.59 11.63

9.09

3.58

3.57

0.30 19.52

16.98

11.47

11.46

000 up to 5 spec.

[[Page 49095]]

17305......... ........ A

2 stage mohs,

2.85

6.74

4.60

1.34

1.34

0.11

9.70

7.56

4.30

4.30

000 up to 5 spec. 17306......... ........ A

3 stage mohs,

2.85

6.99

4.68

1.33

1.35

0.11

9.95

7.64

4.29

4.31

000 up to 5 spec. 17307......... ........ A

Mohs addl stage 2.85

6.74

4.36

1.34

1.36

0.11

9.70

7.32

4.30

4.32

000 up to 5 spec. 17310......... ........ A

Mohs any stage

0.95

1.94

1.70

0.45

0.46

0.03

2.92

2.68

1.43

1.44

ZZZ > 5 spec each. 17340......... ........ A

Cryotherapy of

0.76

0.33

0.36

0.36

0.36

0.05

1.14

1.17

1.17

1.17

010 skin. 17360......... ........ A

Skin peel

1.43

1.38

1.43

0.95

0.89

0.06

2.87

2.92

2.44

2.38

010 therapy. 17999......... ........ C

Skin tissue

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 19000......... ........ A

Drainage of

0.84

1.90

1.96

0.24

0.29

0.08

2.82

2.88

1.16

1.21

000 breast lesion. 19001......... ........ A

Drain breast

0.42

0.24

0.25

0.12

0.14

0.04

0.70

0.71

0.58

0.60

ZZZ lesion add-on. 19020......... ........ A

Incision of

3.68

6.67

6.42

3.05

2.77

0.45 10.80

10.55

7.18

6.90

090 breast lesion. 19030......... ........ A

Injection for

1.53

2.62

2.80

0.48

0.50

0.09

4.24

4.42

2.10

2.12

000 breast x-ray. 19100......... ........ A

Bx breast

1.27

2.09

2.08

0.33

0.40

0.16

3.52

3.51

1.76

1.83

000 percut w/o image. 19101......... ........ A

Biopsy of

3.18

4.35

4.46

1.77

1.88

0.39

7.92

8.03

5.34

5.45

010 breast, open. 19102......... ........ A

Bx breast

2.00

3.41

3.73

0.61

0.65

0.14

5.55

5.87

2.75

2.79

000 percut w/image. 19103......... ........ A

Bx breast

3.69 10.05

11.13

1.09

1.20

0.30 14.04

15.12

5.08

5.19

000 percut w/ device. 19110......... ........ A

Nipple

4.29

6.45

5.96

3.28

2.97

0.57 11.31

10.82

8.14

7.83

090 exploration. 19112......... ........ A

Excise breast

3.66

6.31

6.12

3.17

2.80

0.48 10.45

10.26

7.31

6.94

090 duct fistula. 19120......... ........ A

Removal of

5.80

5.12

4.69

3.39

3.14

0.73 11.65

11.22

9.92

9.67

090 breast lesion. 19125......... ........ A

Excision,

6.55

5.60

4.99

3.68

3.38

0.80 12.95

12.34

11.03

10.73

090 breast lesion. 19126......... ........ A

Excision, addl

2.93

NA

NA

0.76

0.94

0.38

NA

NA

4.07

4.25

ZZZ breast lesion. 19140......... ........ A

Removal of

5.13

8.06

7.37

3.85

3.51

0.69 13.88

13.19

9.67

9.33

090 breast tissue. 19160......... ........ A

Partial

5.98

NA

NA

3.64

3.48

0.79

NA

NA

10.41

10.25

090 mastectomy. 19162......... ........ A

P-mastectomy w/ 13.81

NA

NA

6.16

6.29

1.79

NA

NA

21.76

21.89

090 ln removal. 19180......... ........ A

Removal of

15.61

NA

NA

7.07

5.53

1.18

NA

NA

23.86

22.32

090 breast. 19182......... ........ A

Removal of

7.72

NA

NA

5.01

4.82

1.04

NA

NA

13.77

13.58

090 breast. 19200......... ........ A

Removal of

17.14

NA

NA

8.22

8.03

1.92

NA

NA

27.28

27.09

090 breast. 19220......... ........ A

Removal of

17.74

NA

NA

8.69

8.35

2.07

NA

NA

28.50

28.16

090 breast. 19240......... ........ A

Removal of

17.84

NA

NA

8.85

8.36

2.12

NA

NA

28.81

28.32

090 breast. 19260......... ........ A

Removal of

17.53

NA

NA

10.33

10.95

2.13

NA

NA

29.99

30.61

090 chest wall lesion. 19271......... ........ A

Revision of

21.73

NA

NA

16.03

17.47

2.62

NA

NA

40.38

41.82

090 chest wall. 19272......... ........ A

Extensive chest 24.68

NA

NA

17.13

18.48

2.99

NA

NA

44.80

46.15

090 wall surgery. 19290......... ........ A

Place needle

1.27

2.85

2.85

0.39

0.41

0.07

4.19

4.19

1.73

1.75

000 wire, breast. 19291......... ........ A

Place needle

0.63

1.12

1.19

0.20

0.21

0.04

1.79

1.86

0.87

0.88

ZZZ wire, breast. 19295......... ........ A

Place breast

0.00

2.30

2.59

0.00

2.02

0.01

2.31

2.60

0.01

2.03

ZZZ clip, percut. 19296......... ........ A

Place po breast 3.63 85.32

115.4

1.21

1.45

0.36 89.31

119.4

5.20

5.44

000 cath for rad. 19297......... ........ A

Place breast

1.72

NA

NA

0.47

0.60

0.17

NA

NA

2.36

2.49

ZZZ cath for rad. 19298......... ........ A

Place breast

6.00 22.79

37.32

1.92

2.29

0.43 29.22

43.75

8.35

8.72

000 rad tube/caths. 19316......... ........ A

Suspension of

10.92

NA

NA

7.10

7.41

1.64

NA

NA

19.66

19.97

090 breast. 19318......... ........ A

Reduction of

15.85

NA

NA

9.99

10.88

2.92

NA

NA

28.76

29.65

090 large breast. 19324......... ........ A

Enlarge breast. 6.59

NA

NA

4.67

4.84

0.84

NA

NA

12.10

12.27

090 19325......... ........ A

Enlarge breast

8.44

NA

NA

6.46

6.51

1.33

NA

NA

16.23

16.28

090 with implant. 19328......... ........ A

Removal of

6.30

NA

NA

5.03

5.02

0.91

NA

NA

12.24

12.23

090 breast implant. 19330......... ........ A

Removal of

8.33

NA

NA

6.21

6.08

1.26

NA

NA

15.80

15.67

090 implant material. 19340......... ........ A

Immediate

6.32

NA

NA

2.86

3.05

1.06

NA

NA

10.24

10.43

ZZZ breast prosthesis. 19342......... ........ A

Delayed breast 12.31

NA

NA

9.01

8.94

1.83

NA

NA

23.15

23.08

090 prosthesis. 19350......... ........ A

Breast

8.91

9.93

12.86

6.61

7.03

1.41 20.25

23.18

16.93

17.35

090 reconstruction. 19355......... ........ A

Correct

8.31

7.78

9.63

4.93

4.76

0.92 17.01

18.86

14.16

13.99

090 inverted nipple(s). 19357......... ........ A

Breast

20.33

NA

NA

15.50

15.58

2.93

NA

NA

38.76

38.84

090 reconstruction. 19361......... ........ A

Breast

20.63

NA

NA

12.36

12.41

2.92

NA

NA

35.91

35.96

090 reconstruction. 19364......... ........ A

Breast

42.30

NA

NA

22.88

23.38

6.22

NA

NA

71.40

71.90

090 reconstruction. 19366......... ........ A

Breast

21.62

NA

NA

10.10

11.21

3.24

NA

NA

34.96

36.07

090 reconstruction. 19367......... ........ A

Breast

26.51

NA

NA

15.33

16.35

4.03

NA

NA

45.87

46.89

090 reconstruction. 19368......... ........ A

Breast

33.51

NA

NA

18.23

18.75

5.52

NA

NA

57.26

57.78

090 reconstruction. 19369......... ........ A

Breast

30.92

NA

NA

15.98

17.80

4.50

NA

NA

51.40

53.22

090 reconstruction. 19370......... ........ A

Surgery of

8.92

NA

NA

6.86

6.89

1.29

NA

NA

17.07

17.10

090 breast capsule. 19371......... ........ A

Removal of

10.34

NA

NA

7.74

7.80

1.62

NA

NA

19.70

19.76

090 breast capsule. 19380......... ........ A

Revise breast

10.13

NA

NA

7.67

7.69

1.44

NA

NA

19.24

19.26

090 reconstruction. 19396......... ........ A

Design custom

2.17

4.52

1.94

1.24

1.05

0.30

6.99

4.41

3.71

3.52

000 breast implant. 19499......... ........ C

Breast surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 20000......... ........ A

Incision of

2.12

2.79

2.72

1.53

1.68

0.25

5.16

5.09

3.90

4.05

010 abscess. 20005......... ........ A

Incision of

3.53

3.72

3.55

2.04

2.20

0.46

7.71

7.54

6.03

6.19

010 deep abscess. 20100......... ........ A

Explore wound, 10.31

NA

NA

3.63

4.25

1.21

NA

NA

15.15

15.77

010 neck. 20101......... ........ A

Explore wound,

3.22

6.46

6.06

1.52

1.60

0.44 10.12

9.72

5.18

5.26

010 chest. 20102......... ........ A

Explore wound,

3.93

6.99

7.34

1.85

1.89

0.49 11.41

11.76

6.27

6.31

010 abdomen. 20103......... ........ A

Explore wound,

5.29

7.72

8.37

2.73

3.23

0.75 13.76

14.41

8.77

9.27

010 extremity. 20150......... ........ A

Excise

14.54

NA

NA

7.73

7.21

2.03

NA

NA

24.30

23.78

090 epiphyseal bar.

[[Page 49096]]

20200......... ........ A

Muscle biopsy.. 1.46

3.17

3.07

0.70

0.74

0.23

4.86

4.76

2.39

2.43

000 20205......... ........ A

Deep muscle

2.35

3.86

3.88

1.11

1.17

0.33

6.54

6.56

3.79

3.85

000 biopsy. 20206......... ........ A

Needle biopsy,

0.99

5.25

6.19

0.54

0.61

0.07

6.31

7.25

1.60

1.67

000 muscle. 20220......... ........ A

Bone biopsy,

1.27

2.71

4.10

0.65

0.76

0.08

4.06

5.45

2.00

2.11

000 trocar/needle. 20225......... ........ A

Bone biopsy,

1.87 13.16

21.63

1.03

1.11

0.22 15.25

23.72

3.12

3.20

000 trocar/needle. 20240......... ........ A

Bone biopsy,

3.23

NA

NA

2.07

2.43

0.44

NA

NA

5.74

6.10

010 excisional. 20245......... ........ A

Bone biopsy,

8.71

NA

NA

5.79

6.38

1.31

NA

NA

15.81

16.40

010 excisional. 20250......... ........ A

Open bone

5.14

NA

NA

3.74

3.56

1.02

NA

NA

9.90

9.72

010 biopsy. 20251......... ........ A

Open bone

5.67

NA

NA

3.91

4.10

1.15

NA

NA

10.73

10.92

010 biopsy. 20500......... ........ A

Injection of

1.23

1.30

2.02

0.85

1.36

0.12

2.65

3.37

2.20

2.71

010 sinus tract. 20501......... ........ A

Inject sinus

0.76

2.35

2.77

0.24

0.25

0.04

3.15

3.57

1.04

1.05

000 tract for x- ray. 20520......... ........ A

Removal of

1.85

2.59

2.83

1.44

1.68

0.21

4.65

4.89

3.50

3.74

010 foreign body. 20525......... ........ A

Removal of

3.49

7.09

8.63

2.20

2.52

0.51 11.09

12.63

6.20

6.52

010 foreign body. 20526......... ........ A

Ther injection, 0.94

0.82

0.93

0.41

0.49

0.13

1.89

2.00

1.48

1.56

000 carp tunnel. 20550......... ........ A

Inj tendon

0.75

0.63

0.69

0.28

0.24

0.09

1.47

1.53

1.12

1.08

000 sheath/ ligament. 20551......... ........ A

Inj tendon

0.75

0.64

0.67

0.29

0.32

0.08

1.47

1.50

1.12

1.15

000 origin/ insertion. 20552......... ........ A

Inj trigger

0.66

0.58

0.69

0.25

0.21

0.05

1.29

1.40

0.96

0.92

000 point, 1/2 muscl. 20553......... ........ A

Inject trigger

0.75

0.65

0.78

0.27

0.23

0.04

1.44

1.57

1.06

1.02

000 points, =/> 3. 20600......... ........ A

Drain/inject,

0.66

0.67

0.66

0.31

0.34

0.08

1.41

1.40

1.05

1.08

000 joint/bursa. 20605......... ........ A

Drain/inject,

0.68

0.74

0.76

0.33

0.35

0.08

1.50

1.52

1.09

1.11

000 joint/bursa. 20610......... ........ A

Drain/inject,

0.79

1.07

0.98

0.40

0.42

0.11

1.97

1.88

1.30

1.32

000 joint/bursa. 20612......... ........ A

Aspirate/inj

0.70

0.70

0.71

0.32

0.35

0.10

1.50

1.51

1.12

1.15

000 ganglion cyst. 20615......... ........ A

Treatment of

2.28

2.72

3.31

1.41

1.73

0.20

5.20

5.79

3.89

4.21

010 bone cyst. 20650......... ........ A

Insert and

2.23

2.51

2.40

1.48

1.53

0.31

5.05

4.94

4.02

4.07

010 remove bone pin. 20660......... ........ A

Apply, rem

2.51

3.39

3.14

1.50

1.58

0.59

6.49

6.24

4.60

4.68

000 fixation device. 20661......... ........ A

Application of

5.06

NA

NA

6.00

5.18

1.14

NA

NA

12.20

11.38

090 head brace. 20662......... ........ A

Application of

6.18

NA

NA

4.85

5.35

0.56

NA

NA

11.59

12.09

090 pelvis brace. 20663......... ........ A

Application of

5.54

NA

NA

5.14

4.91

0.94

NA

NA

11.62

11.39

090 thigh brace. 20664......... ........ A

Halo brace

9.78

NA

NA

8.13

7.31

1.74

NA

NA

19.65

18.83

090 application. 20665......... ........ A

Removal of

1.31

1.38

1.96

0.97

1.26

0.19

2.88

3.46

2.47

2.76

010 fixation device. 20670......... ........ A

Removal of

1.74

6.70

10.33

1.68

2.00

0.28

8.72

12.35

3.70

4.02

010 support implant. 20680......... ........ A

Removal of

5.86

8.20

8.64

4.10

3.82

0.56 14.62

15.06

10.52

10.24

090 support implant. 20690......... ........ A

Apply bone

3.63

NA

NA

2.27

2.45

0.59

NA

NA

6.49

6.67

090 fixation device. 20692......... ........ A

Apply bone

6.40

NA

NA

3.29

3.65

1.05

NA

NA

10.74

11.10

090 fixation device. 20693......... ........ A

Adjust bone

5.91

NA

NA

4.54

5.22

0.98

NA

NA

11.43

12.11

090 fixation device. 20694......... ........ A

Remove bone

4.15

5.37

6.70

3.56

3.92

0.71 10.23

11.56

8.42

8.78

090 fixation device. 20802......... ........ A

Replantation,

42.16

NA

NA

24.05

21.73

3.81

NA

NA

70.02

67.70

090 arm, complete. 20805......... ........ A

Replant

51.00

NA

NA

25.95

32.22

4.84

NA

NA

81.79

88.06

090 forearm, complete. 20808......... ........ A

Replantation

62.63

NA

NA

38.79

41.36

6.86

NA

NA 108.28

110.85

090 hand, complete. 20816......... ........ A

Replantation

31.64

NA

NA

24.53

34.48

4.52

NA

NA

60.69

70.64

090 digit, complete. 20822......... ........ A

Replantation

26.30

NA

NA

22.24

31.50

4.18

NA

NA

52.72

61.98

090 digit, complete. 20824......... ........ A

Replantation

31.64

NA

NA

25.77

33.85

4.61

NA

NA

62.02

70.10

090 thumb, complete. 20827......... ........ A

Replantation

27.12

NA

NA

23.90

33.33

3.66

NA

NA

54.68

64.11

090 thumb, complete. 20838......... ........ A

Replantation

42.42

NA

NA

13.65

20.12

1.12

NA

NA

57.19

63.66

090 foot, complete. 20900......... ........ A

Removal of bone 5.69

9.33

8.66

4.95

5.49

0.94 15.96

15.29

11.58

12.12

090 for graft. 20902......... ........ A

Removal of bone 7.90

NA

NA

5.84

6.62

1.30

NA

NA

15.04

15.82

090 for graft. 20910......... ........ A

Remove

5.33

NA

NA

4.62

5.04

0.71

NA

NA

10.66

11.08

090 cartilage for graft. 20912......... ........ A

Remove

6.34

NA

NA

4.67

5.51

0.69

NA

NA

11.70

12.54

090 cartilage for graft. 20920......... ........ A

Removal of

5.36

NA

NA

4.36

4.26

0.66

NA

NA

10.38

10.28

090 fascia for graft. 20922......... ........ A

Removal of

6.78

7.52

7.54

4.96

4.89

0.70 15.00

15.02

12.44

12.37

090 fascia for graft. 20924......... ........ A

Removal of

6.53

NA

NA

5.00

5.66

1.04

NA

NA

12.57

13.23

090 tendon for graft. 20926......... ........ A

Removal of

5.64

NA

NA

4.41

4.67

0.87

NA

NA

10.92

11.18

090 tissue for graft. 20931......... ........ A

Spinal bone

1.81

NA

NA

0.69

0.87

0.43

NA

NA

2.93

3.11

ZZZ allograft. 20937......... ........ A

Spinal bone

2.79

NA

NA

1.09

1.36

0.54

NA

NA

4.42

4.69

ZZZ autograft. 20938......... ........ A

Spinal bone

3.02

NA

NA

1.16

1.46

0.64

NA

NA

4.82

5.12

ZZZ autograft. 20950......... ........ A

Fluid pressure, 1.26

4.19

6.18

0.88

0.96

0.20

5.65

7.64

2.34

2.42

000 muscle.

[[Page 49097]]

20955......... ........ A

Fibula bone

39.90

NA

NA

18.08

22.72

4.89

NA

NA

62.87

67.51

090 graft, microvasc. 20956......... ........ A

Iliac bone

40.79

NA

NA

20.77

23.75

7.01

NA

NA

68.57

71.55

090 graft, microvasc. 20957......... ........ A

Mt bone graft, 42.17

NA

NA

19.43

19.06

7.05

NA

NA

68.65

68.28

090 microvasc. 20962......... ........ A

Other bone

39.21

NA

NA

21.28

25.21

6.55

NA

NA

67.04

70.97

090 graft, microvasc. 20969......... ........ A

Bone/skin

44.99

NA

NA

20.27

25.04

4.79

NA

NA

70.05

74.82

090 graft, microvasc. 20970......... ........ A

Bone/skin

44.14

NA

NA

20.21

24.09

6.60

NA

NA

70.95

74.83

090 graft, iliac crest. 20972......... ........ A

Bone/skin

44.07

NA

NA

17.61

19.84

5.30

NA

NA

66.98

69.21

090 graft, metatarsal. 20973......... ........ A

Bone/skin

46.83

NA

NA

15.05

22.63

5.54

NA

NA

67.42

75.00

090 graft, great toe. 20974......... ........ A

Electrical bone 0.62

0.99

0.77

0.49

0.53

0.11

1.72

1.50

1.22

1.26

000 stimulation. 20975......... ........ A

Electrical bone 2.60

NA

NA

1.48

1.65

0.51

NA

NA

4.59

4.76

000 stimulation. 20979......... ........ A

Us bone

0.62

0.58

0.75

0.19

0.30

0.09

1.29

1.46

0.90

1.01

000 stimulation. 20982......... ........ A

Ablate, bone

7.27 83.20

103.0

2.62

2.88

0.69 91.16

110.9

10.58

10.84

000 tumor(s) perq. 20999......... ........ C

Musculoskeletal 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery. 21010......... ........ A

Incision of jaw 10.82

NA

NA

5.85

6.78

1.11

NA

NA

17.78

18.71

090 joint. 21015......... ........ A

Resection of

5.53

NA

NA

4.30

4.83

0.70

NA

NA

10.53

11.06

090 facial tumor. 21025......... ........ A

Excision of

10.99 12.48

12.30

8.68

9.18

1.32 24.79

24.61

20.99

21.49

090 bone, lower jaw. 21026......... ........ A

Excision of

5.46

8.70

8.07

5.84

6.20

0.60 14.76

14.13

11.90

12.26

090 facial bone(s). 21029......... ........ A

Contour of face 8.20

9.26

9.34

6.27

6.83

0.94 18.40

18.48

15.41

15.97

090 bone lesion. 21030......... ........ A

Excise max/

4.74

7.18

6.54

4.67

4.94

0.54 12.46

11.82

9.95

10.22

090 zygoma b9 tumor. 21031......... ........ A

Remove

3.24

5.99

5.38

3.51

3.59

0.48

9.71

9.10

7.23

7.31

090 exostosis, mandible. 21032......... ........ A

Remove

3.24

6.07

5.52

3.37

3.48

0.47

9.78

9.23

7.08

7.19

090 exostosis, maxilla. 21034......... ........ A

Excise max/

17.09 13.17

15.23

9.51

11.87

1.71 31.97

34.03

28.31

30.67

090 zygoma mlg tumor. 21040......... ........ A

Excise mandible 4.74

7.25

6.61

4.67

4.71

0.54 12.53

11.89

9.95

9.99

090 lesion. 21044......... ........ A

Removal of jaw 12.53

NA

NA

7.48

8.90

1.12

NA

NA

21.13

22.55

090 bone lesion. 21045......... ........ A

Extensive jaw

18.03

NA

NA

10.01

11.77

1.52

NA

NA

29.56

31.32

090 surgery. 21046......... ........ A

Remove mandible 13.85

NA

NA

11.62

11.83

1.85

NA

NA

27.32

27.53

090 cyst complex. 21047......... ........ A

Excise lwr jaw 19.71

NA

NA

9.74

12.52

2.12

NA

NA

31.57

34.35

090 cyst w/repair. 21048......... ........ A

Remove maxilla 14.35

NA

NA

11.37

11.94

1.76

NA

NA

27.48

28.05

090 cyst complex. 21049......... ........ A

Excis uppr jaw 18.96

NA

NA

9.09

12.04

1.59

NA

NA

29.64

32.59

090 cyst w/repair. 21050......... ........ A

Removal of jaw 11.44

NA

NA

8.18

9.13

1.47

NA

NA

21.09

22.04

090 joint. 21060......... ........ A

Remove jaw

10.83

NA

NA

7.52

8.34

1.38

NA

NA

19.73

20.55

090 joint cartilage. 21070......... ........ A

Remove coronoid 8.44

NA

NA

6.15

6.86

1.27

NA

NA

15.86

16.57

090 process. 21076......... ........ A

Prepare face/

13.40

7.85

11.23

4.80

8.70

1.99 23.24

26.62

20.19

24.09

010 oral prosthesis. 21077......... ........ A

Prepare face/

33.70 18.26

28.06

12.31

22.58

4.55 56.51

66.31

50.56

60.83

090 oral prosthesis. 21079......... ........ A

Prepare face/

22.31 13.35

19.46

8.28

14.93

3.15 38.81

44.92

33.74

40.39

090 oral prosthesis. 21080......... ........ A

Prepare face/

25.06 15.43

22.23

9.22

16.83

3.74 44.23

51.03

38.02

45.63

090 oral prosthesis. 21081......... ........ A

Prepare face/

22.85 14.17

20.27

8.48

15.24

3.20 40.22

46.32

34.53

41.29

090 oral prosthesis. 21082......... ........ A

Prepare face/

20.84 14.12

18.04

8.42

13.90

3.11 38.07

41.99

32.37

37.85

090 oral prosthesis. 21083......... ........ A

Prepare face/

19.27 14.06

17.61

7.91

12.80

2.88 36.21

39.76

30.06

34.95

090 oral prosthesis. 21084......... ........ A

Prepare face/

22.48 15.56

20.71

8.82

15.48

2.18 40.22

45.37

33.48

40.14

090 oral prosthesis. 21085......... ........ A

Prepare face/

8.99

6.54

7.85

3.57

5.98

1.27 16.80

18.11

13.83

16.24

010 oral prosthesis. 21086......... ........ A

Prepare face/

24.88 12.62

20.96

8.63

16.73

3.71 41.21

49.55

37.22

45.32

090 oral prosthesis. 21087......... ........ A

Prepare face/

24.88 12.85

20.67

8.82

16.60

3.44 41.17

48.99

37.14

44.92

090 oral prosthesis. 21088......... ........ C

Prepare face/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 oral prosthesis. 21089......... ........ C

Prepare face/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 oral prosthesis. 21100......... ........ A

Maxillofacial

4.46 13.75

12.09

5.05

4.82

0.34 18.55

16.89

9.85

9.62

090 fixation. 21110......... ........ A

Interdental

5.70 13.26

10.49

9.89

8.74

0.72 19.68

16.91

16.31

15.16

090 fixation. 21116......... ........ A

Injection, jaw

0.81

2.44

3.86

0.22

0.30

0.06

3.31

4.73

1.09

1.17

000 joint x-ray. 21120......... ........ A

Reconstruction

4.92 10.02

10.44

6.88

7.34

0.60 15.54

15.96

12.40

12.86

090 of chin. 21121......... ........ A

Reconstruction

7.63 10.59

9.95

7.50

7.74

0.90 19.12

18.48

16.03

16.27

090 of chin. 21122......... ........ A

Reconstruction

8.51

NA

NA

7.64

8.38

1.07

NA

NA

17.22

17.96

090 of chin. 21123......... ........ A

Reconstruction 11.14

NA

NA

10.06

10.62

1.40

NA

NA

22.60

23.16

090 of chin. 21125......... ........ A

Augmentation,

10.60 68.89

58.64

7.04

8.00

0.79 80.28

70.03

18.43

19.39

090 lower jaw bone. 21127......... ........ A

Augmentation,

12.16 86.74

53.79

7.70

9.01

1.52 100.4

67.47

21.38

22.69

090 lower jaw bone. 21137......... ........ A

Reduction of

10.06

NA

NA

6.30

7.37

1.32

NA

NA

17.68

18.75

090 forehead. 21138......... ........ A

Reduction of

12.67

NA

NA

8.50

9.27

1.74

NA

NA

22.91

23.68

090 forehead. 21139......... ........ A

Reduction of

14.84

NA

NA

8.49

10.42

1.18

NA

NA

24.51

26.44

090 forehead. 21141......... ........ A

Reconstruct

19.13

NA

NA

11.47

13.11

2.35

NA

NA

32.95

34.59

090 midface, lefort. 21142......... ........ A

Reconstruct

19.84

NA

NA

10.53

12.25

2.38

NA

NA

32.75

34.47

090 midface, lefort. 21143......... ........ A

Reconstruct

20.61

NA

NA

8.90

12.96

1.66

NA

NA

31.17

35.23

090 midface, lefort. 21145......... ........ A

Reconstruct

23.52

NA

NA

12.75

13.61

2.84

NA

NA

39.11

39.97

090 midface, lefort. 21146......... ........ A

Reconstruct

24.42

NA

NA

9.45

13.86

3.09

NA

NA

36.96

41.37

090 midface, lefort. 21147......... ........ A

Reconstruct

26.01

NA

NA

13.58

14.68

1.84

NA

NA

41.43

42.53

090 midface, lefort. 21150......... ........ A

Reconstruct

25.70

NA

NA

13.25

15.88

2.55

NA

NA

41.50

44.13

090 midface, lefort. 21151......... ........ A

Reconstruct

28.76

NA

NA

11.72

20.14

2.30

NA

NA

42.78

51.20

090 midface, lefort. 21154......... ........ A

Reconstruct

30.95

NA

NA

21.25

22.65

2.48

NA

NA

54.68

56.08

090 midface, lefort.

[[Page 49098]]

21155......... ........ A

Reconstruct

34.88

NA

NA

13.43

21.28

6.64

NA

NA

54.95

62.80

090 midface, lefort. 21159......... ........ A

Reconstruct

42.80

NA

NA

15.27

25.63

8.18

NA

NA

66.25

76.61

090 midface, lefort. 21160......... ........ A

Reconstruct

46.85

NA

NA

23.11

26.38

4.13

NA

NA

74.09

77.36

090 midface, lefort. 21172......... ........ A

Reconstruct

28.01

NA

NA

13.59

13.71

3.55

NA

NA

45.15

45.27

090 orbit/forehead. 21175......... ........ A

Reconstruct

33.37

NA

NA

12.92

16.57

4.83

NA

NA

51.12

54.77

090 orbit/forehead. 21179......... ........ A

Reconstruct

22.47

NA

NA

10.96

13.34

2.80

NA

NA

36.23

38.61

090 entire forehead. 21180......... ........ A

Reconstruct

25.40

NA

NA

13.01

14.79

3.48

NA

NA

41.89

43.67

090 entire forehead. 21181......... ........ A

Contour cranial 10.14

NA

NA

7.05

7.36

1.32

NA

NA

18.51

18.82

090 bone lesion. 21182......... ........ A

Reconstruct

32.39

NA

NA

14.29

17.91

2.80

NA

NA

49.48

53.10

090 cranial bone. 21183......... ........ A

Reconstruct

35.51

NA

NA

15.48

19.49

4.47

NA

NA

55.46

59.47

090 cranial bone. 21184......... ........ A

Reconstruct

38.43

NA

NA

21.02

21.71

5.70

NA

NA

65.15

65.84

090 cranial bone. 21188......... ........ A

Reconstruction 22.91

NA

NA

14.82

17.86

1.69

NA

NA

39.42

42.46

090 of midface. 21193......... ........ A

Reconst lwr jaw 18.55

NA

NA

10.06

12.00

2.23

NA

NA

30.84

32.78

090 w/o graft. 21194......... ........ A

Reconst lwr jaw 21.43

NA

NA

11.45

13.18

2.02

NA

NA

34.90

36.63

090 w/graft. 21195......... ........ A

Reconst lwr jaw 18.77

NA

NA

13.26

14.43

1.64

NA

NA

33.67

34.84

090 w/o fixation. 21196......... ........ A

Reconst lwr jaw 20.44

NA

NA

13.20

15.07

2.07

NA

NA

35.71

37.58

090 w/fixation. 21198......... ........ A

Reconstr lwr

15.39

NA

NA

11.05

12.29

1.44

NA

NA

27.88

29.12

090 jaw segment. 21199......... ........ A

Reconstr lwr

16.56

NA

NA

6.79

8.53

1.39

NA

NA

24.74

26.48

090 jaw w/advance. 21206......... ........ A

Reconstruct

15.27

NA

NA

11.15

12.26

1.33

NA

NA

27.75

28.86

090 upper jaw bone. 21208......... ........ A

Augmentation of 11.03 32.43

24.86

7.71

9.11

1.09 44.55

36.98

19.83

21.23

090 facial bones. 21209......... ........ A

Reduction of

7.46 12.33

11.18

7.42

7.91

0.90 20.69

19.54

15.78

16.27

090 facial bones. 21210......... ........ A

Face bone graft 11.28 43.84

29.61

7.70

8.94

1.30 56.42

42.19

20.28

21.52

090 21215......... ........ A

Lower jaw bone 11.82 86.57

53.05

7.99

9.02

1.53 99.92

66.40

21.34

22.37

090 graft. 21230......... ........ A

Rib cartilage

11.00

NA

NA

6.94

7.77

1.29

NA

NA

19.23

20.06

090 graft. 21235......... ........ A

Ear cartilage

7.21

9.70

9.81

5.89

6.28

0.61 17.52

17.63

13.71

14.10

090 graft. 21240......... ........ A

Reconstruction 15.65

NA

NA

11.31

11.87

2.24

NA

NA

29.20

29.76

090 of jaw joint. 21242......... ........ A

Reconstruction 14.20

NA

NA

10.64

11.29

1.78

NA

NA

26.62

27.27

090 of jaw joint. 21243......... ........ A

Reconstruction 23.83

NA

NA

15.77

17.02

3.25

NA

NA

42.85

44.10

090 of jaw joint. 21244......... ........ A

Reconstruction 13.23

NA

NA

10.93

11.80

1.25

NA

NA

25.41

26.28

090 of lower jaw. 21245......... ........ A

Reconstruction 12.78 13.37

14.14

7.99

9.39

1.19 27.34

28.11

21.96

23.36

090 of jaw. 21246......... ........ A

Reconstruction 12.70

NA

NA

6.67

8.45

1.35

NA

NA

20.72

22.50

090 of jaw. 21247......... ........ A

Reconstruct

23.91

NA

NA

13.59

16.41

2.83

NA

NA

40.33

43.15

090 lower jaw bone. 21248......... ........ A

Reconstruction 12.46 12.60

12.25

7.51

8.93

1.55 26.61

26.26

21.52

22.94

090 of jaw. 21249......... ........ A

Reconstruction 18.49 16.13

16.57

9.94

12.00

2.48 37.10

37.54

30.91

32.97

090 of jaw. 21255......... ........ A

Reconstruct

18.00

NA

NA

13.33

15.43

2.38

NA

NA

33.71

35.81

090 lower jaw bone. 21256......... ........ A

Reconstruction 17.32

NA

NA

9.98

11.36

1.50

NA

NA

28.80

30.18

090 of orbit. 21260......... ........ A

Revise eye

17.66

NA

NA

9.51

11.95

0.97

NA

NA

28.14

30.58

090 sockets. 21261......... ........ A

Revise eye

33.66

NA

NA

14.88

21.89

3.42

NA

NA

51.96

58.97

090 sockets. 21263......... ........ A

Revise eye

30.60

NA

NA

14.17

17.85

2.62

NA

NA

47.39

51.07

090 sockets. 21267......... ........ A

Revise eye

20.35

NA

NA

16.14

18.86

1.70

NA

NA

38.19

40.91

090 sockets. 21268......... ........ A

Revise eye

26.66

NA

NA

15.74

19.09

3.65

NA

NA

46.05

49.40

090 sockets. 21270......... ........ A

Augmentation,

10.46 11.17

11.53

5.89

6.91

0.72 22.35

22.71

17.07

18.09

090 cheek bone. 21275......... ........ A

Revision,

11.59

NA

NA

7.41

7.97

1.29

NA

NA

20.29

20.85

090 orbitofacial bones. 21280......... ........ A

Revision of

6.84

NA

NA

5.84

5.90

0.42

NA

NA

13.10

13.16

090 eyelid. 21282......... ........ A

Revision of

4.05

NA

NA

4.26

4.43

0.26

NA

NA

8.57

8.74

090 eyelid. 21295......... ........ A

Revision of jaw 1.78

NA

NA

2.61

2.55

0.16

NA

NA

4.55

4.49

090 muscle/bone. 21296......... ........ A

Revision of jaw 4.61

NA

NA

5.46

5.05

0.34

NA

NA

10.41

10.00

090 muscle/bone. 21299......... ........ C

Cranio/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY maxillofacial surgery. 21300......... ........ A

Treatment of

0.72

0.28

1.84

0.28

0.27

0.13

1.13

2.69

1.13

1.12

000 skull fracture. 21310......... ........ A

Treatment of

0.58

1.97

2.20

0.11

0.14

0.05

2.60

2.83

0.74

0.77

000 nose fracture. 21315......... ........ A

Treatment of

1.76

4.46

4.29

1.65

1.82

0.14

6.36

6.19

3.55

3.72

010 nose fracture. 21320......... ........ A

Treatment of

1.85

4.05

3.95

1.25

1.53

0.18

6.08

5.98

3.28

3.56

010 nose fracture. 21325......... ........ A

Treatment of

4.01

NA

NA

6.72

8.15

0.31

NA

NA

11.04

12.47

090 nose fracture. 21330......... ........ A

Treatment of

5.62

NA

NA

7.44

9.14

0.56

NA

NA

13.62

15.32

090 nose fracture. 21335......... ........ A

Treatment of

8.85

NA

NA

7.74

9.15

0.74

NA

NA

17.33

18.74

090 nose fracture. 21336......... ........ A

Treat nasal

6.46

NA

NA

8.16

9.25

0.55

NA

NA

15.17

16.26

090 septal fracture.

[[Page 49099]]

21337......... ........ A

Treat nasal

3.20

5.87

6.06

3.36

3.52

0.28

9.35

9.54

6.84

7.00

090 septal fracture. 21338......... ........ A

Treat

6.70

NA

NA

9.66

12.93

0.82

NA

NA

17.18

20.45

090 nasoethmoid fracture. 21339......... ........ A

Treat

8.33

NA

NA

10.63

13.08

0.96

NA

NA

19.92

22.37

090 nasoethmoid fracture. 21340......... ........ A

Treatment of

11.25

NA

NA

7.36

8.14

1.15

NA

NA

19.76

20.54

090 nose fracture. 21343......... ........ A

Treatment of

14.01

NA

NA

12.51

14.73

1.47

NA

NA

27.99

30.21

090 sinus fracture. 21344......... ........ A

Treatment of

21.26

NA

NA

13.04

15.64

2.43

NA

NA

36.73

39.33

090 sinus fracture. 21345......... ........ A

Treat nose/jaw

8.77

9.69

9.80

5.98

6.87

0.92 19.38

19.49

15.67

16.56

090 fracture. 21346......... ........ A

Treat nose/jaw 11.21

NA

NA

10.76

11.84

1.21

NA

NA

23.18

24.26

090 fracture. 21347......... ........ A

Treat nose/jaw 13.29

NA

NA

11.56

15.03

1.47

NA

NA

26.32

29.79

090 fracture. 21348......... ........ A

Treat nose/jaw 17.28

NA

NA

6.42

9.94

2.48

NA

NA

26.18

29.70

090 fracture. 21355......... ........ A

Treat cheek

4.26

5.61

6.08

3.00

3.36

0.34 10.21

10.68

7.60

7.96

010 bone fracture. 21356......... ........ A

Treat cheek

4.64

6.78

7.04

3.92

4.39

0.46 11.88

12.14

9.02

9.49

010 bone fracture. 21360......... ........ A

Treat cheek

6.95

NA

NA

5.25

5.76

0.74

NA

NA

12.94

13.45

090 bone fracture. 21365......... ........ A

Treat cheek

16.42

NA

NA

8.90

10.35

1.69

NA

NA

27.01

28.46

090 bone fracture. 21366......... ........ A

Treat cheek

18.36

NA

NA

10.35

11.09

2.49

NA

NA

31.20

31.94

090 bone fracture. 21385......... ........ A

Treat eye

9.40

NA

NA

6.90

7.94

0.97

NA

NA

17.27

18.31

090 socket fracture. 21386......... ........ A

Treat eye

9.40

NA

NA

5.69

6.73

0.97

NA

NA

16.06

17.10

090 socket fracture. 21387......... ........ A

Treat eye

9.94

NA

NA

7.25

8.53

1.08

NA

NA

18.27

19.55

090 socket fracture. 21390......... ........ A

Treat eye

11.01

NA

NA

7.05

7.61

0.90

NA

NA

18.96

19.52

090 socket fracture. 21395......... ........ A

Treat eye

14.58

NA

NA

7.78

8.71

1.44

NA

NA

23.80

24.73

090 socket fracture. 21400......... ........ A

Treat eye

1.40

2.74

2.64

1.98

1.90

0.15

4.29

4.19

3.53

3.45

090 socket fracture. 21401......... ........ A

Treat eye

3.51

7.21

7.80

3.10

3.39

0.38 11.10

11.69

6.99

7.28

090 socket fracture. 21406......... ........ A

Treat eye

7.25

NA

NA

5.08

5.83

0.73

NA

NA

13.06

13.81

090 socket fracture. 21407......... ........ A

Treat eye

8.85

NA

NA

5.89

6.62

0.94

NA

NA

15.68

16.41

090 socket fracture. 21408......... ........ A

Treat eye

12.61

NA

NA

7.91

8.64

1.44

NA

NA

21.96

22.69

090 socket fracture. 21421......... ........ A

Treat mouth

5.70 12.09

10.02

8.96

8.47

0.73 18.52

16.45

15.39

14.90

090 roof fracture. 21422......... ........ A

Treat mouth

8.56

NA

NA

6.79

7.76

0.99

NA

NA

16.34

17.31

090 roof fracture. 21423......... ........ A

Treat mouth

10.63

NA

NA

7.28

8.81

1.27

NA

NA

19.18

20.71

090 roof fracture. 21431......... ........ A

Treat

7.66

NA

NA

9.34

9.48

0.70

NA

NA

17.70

17.84

090 craniofacial fracture. 21432......... ........ A

Treat

8.72

NA

NA

7.18

7.84

0.81

NA

NA

16.71

17.37

090 craniofacial fracture. 21433......... ........ A

Treat

26.05

NA

NA

12.51

15.43

2.78

NA

NA

41.34

44.26

090 craniofacial fracture. 21435......... ........ A

Treat

19.92

NA

NA

10.77

12.22

1.98

NA

NA

32.67

34.12

090 craniofacial fracture. 21436......... ........ A

Treat

29.89

NA

NA

14.38

17.26

3.09

NA

NA

47.36

50.24

090 craniofacial fracture. 21440......... ........ A

Treat dental

3.20 10.31

7.90

7.63

6.53

0.38 13.89

11.48

11.21

10.11

090 ridge fracture. 21445......... ........ A

Treat dental

5.94 12.48

10.43

8.61

8.43

0.78 19.20

17.15

15.33

15.15

090 ridge fracture. 21450......... ........ A

Treat lower jaw 3.47 10.41

8.14

7.64

7.06

0.33 14.21

11.94

11.44

10.86

090 fracture. 21451......... ........ A

Treat lower jaw 5.36 12.93

10.25

9.63

8.71

0.63 18.92

16.24

15.62

14.70

090 fracture. 21452......... ........ A

Treat lower jaw 2.23 11.77

12.71

5.89

4.93

0.27 14.27

15.21

8.39

7.43

090 fracture. 21453......... ........ A

Treat lower jaw 6.28 14.74

11.74

11.59

10.95

0.74 21.76

18.76

18.61

17.97

090 fracture. 21454......... ........ A

Treat lower jaw 7.07

NA

NA

5.64

6.11

0.82

NA

NA

13.53

14.00

090 fracture. 21461......... ........ A

Treat lower jaw 8.95 41.23

28.65

12.59

12.64

0.98 51.16

38.58

22.52

22.57

090 fracture. 21462......... ........ A

Treat lower jaw 10.65 42.46

31.32

13.17

12.83

1.27 54.38

43.24

25.09

24.75

090 fracture. 21465......... ........ A

Treat lower jaw 12.76

NA

NA

8.26

9.42

1.50

NA

NA

22.52

23.68

090 fracture. 21470......... ........ A

Treat lower jaw 17.12

NA

NA

10.05

11.53

1.96

NA

NA

29.13

30.61

090 fracture. 21480......... ........ A

Reset

0.61

1.51

1.71

0.18

0.19

0.06

2.18

2.38

0.85

0.86

000 dislocated jaw. 21485......... ........ A

Reset

4.48 12.20

9.22

9.18

8.04

0.51 17.19

14.21

14.17

13.03

090 dislocated jaw. 21490......... ........ A

Repair

12.59

NA

NA

7.86

9.23

1.96

NA

NA

22.41

23.78

090 dislocated jaw. 21495......... ........ A

Treat hyoid

6.43

NA

NA

9.57

8.71

0.46

NA

NA

16.46

15.60

090 bone fracture. 21497......... ........ A

Interdental

4.35 11.96

9.33

9.14

8.02

0.50 16.81

14.18

13.99

12.87

090 wiring. 21499......... ........ C

Head surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 21501......... ........ A

Drain neck/

3.80

6.42

6.42

3.43

3.72

0.43 10.65

10.65

7.66

7.95

090 chest lesion. 21502......... ........ A

Drain chest

7.35

NA

NA

4.77

5.42

0.97

NA

NA

13.09

13.74

090 lesion. 21510......... ........ A

Drainage of

5.97

NA

NA

4.71

5.42

0.80

NA

NA

11.48

12.19

090 bone lesion. 21550......... ........ A

Biopsy of neck/ 2.06

4.28

3.76

1.73

1.72

0.16

6.50

5.98

3.95

3.94

010 chest. 21555......... ........ A

Remove lesion,

4.34

5.76

5.57

3.41

3.25

0.56 10.66

10.47

8.31

8.15

090 neck/chest. 21556......... ........ A

Remove lesion,

5.56

NA

NA

4.01

4.08

0.65

NA

NA

10.22

10.29

090 neck/chest. 21557......... ........ A

Remove tumor,

8.87

NA

NA

4.42

5.12

1.08

NA

NA

14.37

15.07

090 neck/chest. 21600......... ........ A

Partial removal 7.06

NA

NA

5.79

5.75

0.99

NA

NA

13.84

13.80

090 of rib. 21610......... ........ A

Partial removal 15.70

NA

NA

8.13

8.68

3.07

NA

NA

26.90

27.45

090 of rib. 21615......... ........ A

Removal of rib. 10.22

NA

NA

5.46

6.38

1.45

NA

NA

17.13

18.05

090 21616......... ........ A

Removal of rib 12.44

NA

NA

7.15

7.80

1.86

NA

NA

21.45

22.10

090 and nerves. 21620......... ........ A

Partial removal 7.08

NA

NA

4.88

5.70

0.98

NA

NA

12.94

13.76

090 of sternum. 21627......... ........ A

Sternal

7.10

NA

NA

5.62

6.13

1.02

NA

NA

13.74

14.25

090 debridement. 21630......... ........ A

Extensive

18.90

NA

NA

10.55

11.52

2.58

NA

NA

32.03

33.00

090 sternum surgery. 21632......... ........ A

Extensive

19.40

NA

NA

9.62

10.74

2.65

NA

NA

31.67

32.79

090 sternum surgery. 21685......... ........ A

Hyoid myotomy & 14.77

NA

NA

7.81

9.43

1.06

NA

NA

23.64

25.26

090 suspension.

[[Page 49100]]

21700......... ........ A

Revision of

6.18

NA

NA

3.93

4.31

0.32

NA

NA

10.43

10.81

090 neck muscle. 21705......... ........ A

Revision of

9.77

NA

NA

4.71

5.36

1.43

NA

NA

15.91

16.56

090 neck muscle/ rib. 21720......... ........ A

Revision of

5.67

NA

NA

4.32

2.93

0.91

NA

NA

10.90

9.51

090 neck muscle. 21725......... ........ A

Revision of

7.04

NA

NA

4.60

5.23

1.21

NA

NA

12.85

13.48

090 neck muscle. 21740......... ........ A

Reconstruction 17.43

NA

NA

8.77

8.58

2.36

NA

NA

28.56

28.37

090 of sternum. 21742......... ........ C

Repair stern/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 nuss w/o scope. 21743......... ........ C

Repair sternum/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 nuss w/scope. 21750......... ........ A

Repair of

11.33

NA

NA

5.45

5.95

1.63

NA

NA

18.41

18.91

090 sternum separation. 21800......... ........ A

Treatment of

0.96

1.35

1.34

1.42

1.36

0.09

2.40

2.39

2.47

2.41

090 rib fracture. 21805......... ........ A

Treatment of

2.75

NA

NA

3.56

3.29

0.38

NA

NA

6.69

6.42

090 rib fracture. 21810......... ........ A

Treatment of

6.85

NA

NA

5.27

5.05

0.94

NA

NA

13.06

12.84

090 rib fracture(s). 21820......... ........ A

Treat sternum

1.28

1.80

1.82

1.87

1.79

0.16

3.24

3.26

3.31

3.23

090 fracture. 21825......... ........ A

Treat sternum

7.58

NA

NA

5.46

6.16

1.11

NA

NA

14.15

14.85

090 fracture. 21899......... ........ C

Neck/chest

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure. 21920......... ........ A

Biopsy soft

2.06

4.32

3.54

1.82

1.56

0.14

6.52

5.74

4.02

3.76

010 tissue of back. 21925......... ........ A

Biopsy soft

4.48

5.50

5.25

3.45

3.29

0.60 10.58

10.33

8.53

8.37

090 tissue of back. 21930......... ........ A

Remove lesion,

4.99

6.05

5.80

3.77

3.49

0.66 11.70

11.45

9.42

9.14

090 back or flank. 21935......... ........ A

Remove tumor,

18.29

NA

NA

8.56

9.36

2.47

NA

NA

29.32

30.12

090 back. 22010......... ........ A

I&d, p-spine, c/ 12.49

NA

NA

8.06

8.68

1.73

NA

NA

22.28

22.90

090 t/cerv-thor. 22015......... ........ A

I&d, p-spine, l/ 12.38

NA

NA

8.02

8.62

1.71

NA

NA

22.11

22.71

090 s/ls. 22100......... ........ A

Remove part of 10.72

NA

NA

8.01

7.65

2.13

NA

NA

20.86

20.50

090 neck vertebra. 22101......... ........ A

Remove part,

10.80

NA

NA

7.94

7.80

1.90

NA

NA

20.64

20.50

090 thorax vertebra. 22102......... ........ A

Remove part,

10.80

NA

NA

7.24

7.89

1.87

NA

NA

19.91

20.56

090 lumbar vertebra. 22103......... ........ A

Remove extra

2.34

NA

NA

0.89

1.13

0.44

NA

NA

3.67

3.91

ZZZ spine segment. 22110......... ........ A

Remove part of 13.72

NA

NA

9.09

9.14

2.76

NA

NA

25.57

25.62

090 neck vertebra. 22112......... ........ A

Remove part,

13.79

NA

NA

8.97

9.20

2.52

NA

NA

25.28

25.51

090 thorax vertebra. 22114......... ........ A

Remove part,

13.79

NA

NA

9.08

9.21

2.63

NA

NA

25.50

25.63

090 lumbar vertebra. 22116......... ........ A

Remove extra

2.32

NA

NA

0.87

1.10

0.50

NA

NA

3.69

3.92

ZZZ spine segment. 22210......... ........ A

Revision of

25.03

NA

NA

14.74

15.24

5.44

NA

NA

45.21

45.71

090 neck spine. 22212......... ........ A

Revision of

20.64

NA

NA

12.49

13.08

3.90

NA

NA

37.03

37.62

090 thorax spine. 22214......... ........ A

Revision of

20.67

NA

NA

12.59

13.51

3.91

NA

NA

37.17

38.09

090 lumbar spine. 22216......... ........ A

Revise, extra

6.03

NA

NA

2.37

2.94

1.29

NA

NA

9.69

10.26

ZZZ spine segment. 22220......... ........ A

Revision of

22.59

NA

NA

13.42

13.57

5.06

NA

NA

41.07

41.22

090 neck spine. 22222......... ........ A

Revision of

22.74

NA

NA

12.19

11.40

4.12

NA

NA

39.05

38.26

090 thorax spine. 22224......... ........ A

Revision of

22.74

NA

NA

13.17

13.96

4.18

NA

NA

40.09

40.88

090 lumbar spine. 22226......... ........ A

Revise, extra

6.03

NA

NA

2.15

2.86

1.29

NA

NA

9.47

10.18

ZZZ spine segment. 22305......... ........ A

Treat spine

2.05

2.16

2.27

1.81

1.89

0.39

4.60

4.71

4.25

4.33

090 process fracture. 22310......... ........ A

Treat spine

3.61

2.99

2.85

2.50

2.39

0.50

7.10

6.96

6.61

6.50

090 fracture. 22315......... ........ A

Treat spine

9.83

9.81

9.71

7.39

7.35

1.85 21.49

21.39

19.07

19.03

090 fracture. 22318......... ........ A

Treat odontoid 22.46

NA

NA

13.25

13.35

5.28

NA

NA

40.99

41.09

090 fx w/o graft. 22319......... ........ A

Treat odontoid 25.07

NA

NA

14.00

14.53

6.03

NA

NA

45.10

45.63

090 fx w/graft. 22325......... ........ A

Treat spine

19.52

NA

NA

12.03

12.06

3.87

NA

NA

35.42

35.45

090 fracture. 22326......... ........ A

Treat neck

20.56

NA

NA

12.13

12.56

4.42

NA

NA

37.11

37.54

090 spine fracture. 22327......... ........ A

Treat thorax

20.42

NA

NA

12.07

12.29

3.98

NA

NA

36.47

36.69

090 spine fracture. 22328......... ........ A

Treat each add

4.60

NA

NA

1.80

2.15

0.94

NA

NA

7.34

7.69

ZZZ spine fx. 22505......... ........ A

Manipulation of 1.87

NA

NA

1.06

0.97

0.36

NA

NA

3.29

3.20

010 spine. 22520......... ........ A

Percut

9.15 44.71

57.42

4.39

4.92

1.71 55.57

68.28

15.25

15.78

010 vertebroplasty thor. 22521......... ........ A

Percut

8.58 45.98

53.47

4.20

4.76

1.60 56.16

63.65

14.38

14.94

010 vertebroplasty lumb. 22522......... ........ A

Percut

4.30

NA

NA

1.41

1.61

0.82

NA

NA

6.53

6.73

ZZZ vertebroplasty addIl. 22523......... ........ A

Percut

9.19

NA

NA

4.75

5.61

1.71

NA

NA

15.65

16.51

010 kyphoplasty, thor. 22524......... ........ A

Percut

8.79

NA

NA

4.60

5.42

1.60

NA

NA

14.99

15.81

010 kyphoplasty, lumbar. 22525......... ........ A

Percut

4.47

NA

NA

1.68

2.12

0.82

NA

NA

6.97

7.41

ZZZ kyphoplasty, add-on. 22532......... ........ A

Lat thorax

25.73

NA

NA

13.79

14.56

4.34

NA

NA

43.86

44.63

090 spine fusion. 22533......... ........ A

Lat lumbar

24.53

NA

NA

13.43

13.55

3.15

NA

NA

41.11

41.23

090 spine fusion. 22534......... ........ A

Lat thor/lumb,

5.99

NA

NA

2.31

2.85

1.25

NA

NA

9.55

10.09

ZZZ addIl seg. 22548......... ........ A

Neck spine

26.78

NA

NA

15.08

15.62

5.59

NA

NA

47.45

47.99

090 fusion.

[[Page 49101]]

22554......... ........ A

Neck spine

17.48

NA

NA

10.74

11.94

4.45

NA

NA

32.67

33.87

090 fusion. 22556......... ........ A

Thorax spine

24.42

NA

NA

13.07

14.32

4.34

NA

NA

41.83

43.08

090 fusion. 22558......... ........ A

Lumbar spine

23.25

NA

NA

11.53

12.85

3.15

NA

NA

37.93

39.25

090 fusion. 22585......... ........ A

Additional

5.52

NA

NA

2.09

2.62

1.25

NA

NA

8.86

9.39

ZZZ spinal fusion. 22590......... ........ A

Spine & skull

21.48

NA

NA

13.10

13.27

4.78

NA

NA

39.36

39.53

090 spinal fusion. 22595......... ........ A

Neck spinal

20.36

NA

NA

12.61

12.78

4.40

NA

NA

37.37

37.54

090 fusion. 22600......... ........ A

Neck spine

17.12

NA

NA

11.28

11.21

3.72

NA

NA

32.12

32.05

090 fusion. 22610......... ........ A

Thorax spine

17.00

NA

NA

10.88

11.28

3.52

NA

NA

31.40

31.80

090 fusion. 22612......... ........ A

Lumbar spine

22.50

NA

NA

12.92

13.88

4.46

NA

NA

39.88

40.84

090 fusion. 22614......... ........ A

Spine fusion,

6.43

NA

NA

2.49

3.14

1.38

NA

NA

10.30

10.95

ZZZ extra segment. 22630......... ........ A

Lumbar spine

21.81

NA

NA

12.64

13.36

4.72

NA

NA

39.17

39.89

090 fusion. 22632......... ........ A

Spine fusion,

5.22

NA

NA

2.01

2.50

1.16

NA

NA

8.39

8.88

ZZZ extra segment. 22800......... ........ A

Fusion of spine 19.22

NA

NA

11.15

12.37

3.75

NA

NA

34.12

35.34

090 22802......... ........ A

Fusion of spine 31.83

NA

NA

16.17

18.74

6.15

NA

NA

54.15

56.72

090 22804......... ........ A

Fusion of spine 37.22

NA

NA

18.20

21.57

6.98

NA

NA

62.40

65.77

090 22808......... ........ A

Fusion of spine 27.23

NA

NA

13.85

15.69

4.92

NA

NA

46.00

47.84

090 22810......... ........ A

Fusion of spine 31.22

NA

NA

14.93

17.50

5.13

NA

NA

51.28

53.85

090 22812......... ........ A

Fusion of spine 33.90

NA

NA

16.75

19.23

5.28

NA

NA

55.93

58.41

090 22818......... ........ A

Kyphectomy, 1-2 34.12

NA

NA

16.65

18.32

6.45

NA

NA

57.22

58.89

090 segments. 22819......... ........ A

Kyphectomy, 3

39.10

NA

NA

19.45

19.90

7.65

NA

NA

66.20

66.65

090 or more. 22830......... ........ A

Exploration of 11.07

NA

NA

7.11

7.75

2.29

NA

NA

20.47

21.11

090 spinal fusion. 22840......... ........ A

Insert spine

12.52

NA

NA

4.84

6.08

2.78

NA

NA

20.14

21.38

ZZZ fixation device. 22842......... ........ A

Insert spine

12.56

NA

NA

4.86

6.09

2.74

NA

NA

20.16

21.39

ZZZ fixation device. 22843......... ........ A

Insert spine

13.44

NA

NA

5.26

6.27

2.85

NA

NA

21.55

22.56

ZZZ fixation device. 22844......... ........ A

Insert spine

16.42

NA

NA

6.47

8.18

3.18

NA

NA

26.07

27.78

ZZZ fixation device. 22845......... ........ A

Insert spine

11.94

NA

NA

4.55

5.69

2.85

NA

NA

19.34

20.48

ZZZ fixation device. 22846......... ........ A

Insert spine

12.40

NA

NA

4.72

5.93

2.95

NA

NA

20.07

21.28

ZZZ fixation device. 22847......... ........ A

Insert spine

13.78

NA

NA

5.34

6.60

2.99

NA

NA

22.11

23.37

ZZZ fixation device. 22848......... ........ A

Insert pelv

5.99

NA

NA

2.37

2.98

1.15

NA

NA

9.51

10.12

ZZZ fixation device. 22849......... ........ A

Reinsert spinal 19.02

NA

NA

10.28

11.37

3.89

NA

NA

33.19

34.28

090 fixation. 22850......... ........ A

Remove spine

9.69

NA

NA

6.51

6.87

2.04

NA

NA

18.24

18.60

090 fixation device. 22851......... ........ A

Apply spine

6.70

NA

NA

2.58

3.17

1.49

NA

NA

10.77

11.36

ZZZ prosth device. 22852......... ........ A

Remove spine

9.24

NA

NA

6.23

6.65

1.89

NA

NA

17.36

17.78

090 fixation device. 22855......... ........ A

Remove spine

15.71

NA

NA

9.28

9.57

3.51

NA

NA

28.50

28.79

090 fixation device. 22899......... ........ C

Spine surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 22900......... ........ A

Remove

6.09

NA

NA

3.56

3.31

0.76

NA

NA

10.41

10.16

090 abdominal wall lesion. 22999......... ........ C

Abdomen surgery 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 23000......... ........ A

Removal of

4.35

7.83

8.36

3.68

4.24

0.68 12.86

13.39

8.71

9.27

090 calcium deposits. 23020......... ........ A

Release

9.16

NA

NA

6.51

7.30

1.54

NA

NA

17.21

18.00

090 shoulder joint. 23030......... ........ A

Drain shoulder

3.42

6.32

7.12

2.41

2.78

0.57 10.31

11.11

6.40

6.77

010 lesion. 23031......... ........ A

Drain shoulder

2.74

6.53

7.53

2.23

2.60

0.46

9.73

10.73

5.43

5.80

010 bursa. 23035......... ........ A

Drain shoulder

8.96

NA

NA

7.02

7.96

1.47

NA

NA

17.45

18.39

090 bone lesion. 23040......... ........ A

Exploratory

9.55

NA

NA

6.80

7.60

1.60

NA

NA

17.95

18.75

090 shoulder surgery. 23044......... ........ A

Exploratory

7.41

NA

NA

5.59

6.22

1.24

NA

NA

14.24

14.87

090 shoulder surgery. 23065......... ........ A

Biopsy shoulder 2.27

2.91

2.59

1.70

1.64

0.20

5.38

5.06

4.17

4.11

010 tissues. 23066......... ........ A

Biopsy shoulder 4.15

7.72

7.68

3.60

3.89

0.63 12.50

12.46

8.38

8.67

090 tissues. 23075......... ........ A

Removal of

2.39

3.74

3.68

1.74

1.77

0.34

6.47

6.41

4.47

4.50

010 shoulder lesion. 23076......... ........ A

Removal of

7.68

NA

NA

5.33

5.50

1.13

NA

NA

14.14

14.31

090 shoulder lesion. 23077......... ........ A

Remove tumor of 17.98

NA

NA

9.81

10.11

2.33

NA

NA

30.12

30.42

090 shoulder. 23100......... ........ A

Biopsy of

6.02

NA

NA

5.15

5.53

1.04

NA

NA

12.21

12.59

090 shoulder joint. 23101......... ........ A

Shoulder joint

5.57

NA

NA

4.58

5.14

0.96

NA

NA

11.11

11.67

090 surgery. 23105......... ........ A

Remove shoulder 8.28

NA

NA

6.12

6.87

1.42

NA

NA

15.82

16.57

090 joint lining. 23106......... ........ A

Incision of

5.95

NA

NA

4.62

5.43

0.99

NA

NA

11.56

12.37

090 collarbone joint. 23107......... ........ A

Explore treat

8.67

NA

NA

6.27

7.11

1.49

NA

NA

16.43

17.27

090 shoulder joint. 23120......... ........ A

Partial

7.16

NA

NA

5.50

6.22

1.23

NA

NA

13.89

14.61

090 removal, collar bone. 23125......... ........ A

Removal of

9.44

NA

NA

6.38

7.27

1.62

NA

NA

17.44

18.33

090 collar bone. 23130......... ........ A

Remove shoulder 7.54

NA

NA

6.10

6.87

1.30

NA

NA

14.94

15.71

090 bone, part. 23140......... ........ A

Removal of bone 6.94

NA

NA

4.82

5.12

1.08

NA

NA

12.84

13.14

090 lesion. 23145......... ........ A

Removal of bone 9.20

NA

NA

5.83

7.04

1.49

NA

NA

16.52

17.73

090 lesion. 23146......... ........ A

Removal of bone 7.88

NA

NA

5.99

6.83

1.35

NA

NA

15.22

16.06

090 lesion. 23150......... ........ A

Removal of

8.71

NA

NA

6.06

6.71

1.32

NA

NA

16.09

16.74

090 humerus lesion. 23155......... ........ A

Removal of

10.63

NA

NA

7.36

8.09

1.80

NA

NA

19.79

20.52

090 humerus lesion. 23156......... ........ A

Removal of

8.91

NA

NA

6.42

7.14

1.50

NA

NA

16.83

17.55

090 humerus lesion. 23170......... ........ A

Remove collar

7.03

NA

NA

5.08

5.79

1.12

NA

NA

13.23

13.94

090 bone lesion. 23172......... ........ A

Remove shoulder 7.13

NA

NA

4.98

5.96

1.01

NA

NA

13.12

14.10

090 blade lesion. 23174......... ........ A

Remove humerus

9.80

NA

NA

7.30

8.10

1.65

NA

NA

18.75

19.55

090 lesion.

[[Page 49102]]

23180......... ........ A

Remove collar

8.76

NA

NA

7.08

8.51

1.47

NA

NA

17.31

18.74

090 bone lesion. 23182......... ........ A

Remove shoulder 8.38

NA

NA

6.91

8.14

1.37

NA

NA

16.66

17.89

090 blade lesion. 23184......... ........ A

Remove humerus

9.67

NA

NA

7.55

8.87

1.63

NA

NA

18.85

20.17

090 lesion. 23190......... ........ A

Partial removal 7.29

NA

NA

5.43

5.99

1.17

NA

NA

13.89

14.45

090 of scapula. 23195......... ........ A

Removal of head 10.16

NA

NA

6.80

7.50

1.70

NA

NA

18.66

19.36

090 of humerus. 23200......... ........ A

Removal of

12.60

NA

NA

7.51

8.42

1.93

NA

NA

22.04

22.95

090 collar bone. 23210......... ........ A

Removal of

13.07

NA

NA

8.24

8.80

2.02

NA

NA

23.33

23.89

090 shoulder blade. 23220......... ........ A

Partial removal 15.26

NA

NA

9.09

10.39

2.48

NA

NA

26.83

28.13

090 of humerus. 23221......... ........ A

Partial removal 18.31

NA

NA

6.67

10.46

3.05

NA

NA

28.03

31.82

090 of humerus. 23222......... ........ A

Partial removal 25.36

NA

NA

13.58

15.23

3.94

NA

NA

42.88

44.53

090 of humerus. 23330......... ........ A

Remove shoulder 1.85

3.37

3.60

1.53

1.79

0.24

5.46

5.69

3.62

3.88

010 foreign body. 23331......... ........ A

Remove shoulder 7.43

NA

NA

5.89

6.57

1.27

NA

NA

14.59

15.27

090 foreign body. 23332......... ........ A

Remove shoulder 12.14

NA

NA

8.03

9.00

2.02

NA

NA

22.19

23.16

090 foreign body. 23350......... ........ A

Injection for

1.00

2.72

3.28

0.32

0.33

0.06

3.78

4.34

1.38

1.39

000 shoulder x-ray. 23395......... ........ A

Muscle

18.19

NA

NA

11.26

12.46

2.93

NA

NA

32.38

33.58

090 transfer,shoul der/arm. 23397......... ........ A

Muscle

16.53

NA

NA

9.70

10.95

2.73

NA

NA

28.96

30.21

090 transfers. 23400......... ........ A

Fixation of

13.64

NA

NA

8.57

9.70

2.29

NA

NA

24.50

25.63

090 shoulder blade. 23405......... ........ A

Incision of

8.36

NA

NA

5.97

6.68

1.45

NA

NA

15.78

16.49

090 tendon & muscle. 23406......... ........ A

Incise

10.83

NA

NA

6.95

7.99

1.87

NA

NA

19.65

20.69

090 tendon(s) & muscle(s). 23410......... ........ A

Repair rotator 12.55

NA

NA

7.84

9.01

2.16

NA

NA

22.55

23.72

090 cuff, acute. 23412......... ........ A

Repair rotator 13.47

NA

NA

8.23

9.48

2.31

NA

NA

24.01

25.26

090 cuff, chronic. 23415......... ........ A

Release of

10.02

NA

NA

6.62

7.65

1.73

NA

NA

18.37

19.40

090 shoulder ligament. 23420......... ........ A

Repair of

14.65

NA

NA

9.78

10.58

2.31

NA

NA

26.74

27.54

090 shoulder. 23430......... ........ A

Repair biceps

9.97

NA

NA

6.81

7.78

1.73

NA

NA

18.51

19.48

090 tendon. 23440......... ........ A

Remove/

10.46

NA

NA

6.82

7.90

1.82

NA

NA

19.10

20.18

090 transplant tendon. 23450......... ........ A

Repair shoulder 13.50

NA

NA

8.21

9.43

2.32

NA

NA

24.03

25.25

090 capsule. 23455......... ........ A

Repair shoulder 14.47

NA

NA

8.60

9.98

2.49

NA

NA

25.56

26.94

090 capsule. 23460......... ........ A

Repair shoulder 15.59

NA

NA

9.36

10.87

2.66

NA

NA

27.61

29.12

090 capsule. 23462......... ........ A

Repair shoulder 15.52

NA

NA

9.11

10.34

2.59

NA

NA

27.22

28.45

090 capsule. 23465......... ........ A

Repair shoulder 16.07

NA

NA

9.61

10.79

2.76

NA

NA

28.44

29.62

090 capsule. 23466......... ........ A

Repair shoulder 15.45

NA

NA

10.11

11.06

2.46

NA

NA

28.02

28.97

090 capsule. 23470......... ........ A

Reconstruct

17.66

NA

NA

10.20

11.74

2.98

NA

NA

30.84

32.38

090 shoulder joint. 23472......... ........ A

Reconstruct

22.39

NA

NA

12.25

13.87

3.66

NA

NA

38.30

39.92

090 shoulder joint. 23480......... ........ A

Revision of

11.34

NA

NA

7.37

8.42

1.94

NA

NA

20.65

21.70

090 collar bone. 23485......... ........ A

Revision of

13.71

NA

NA

8.33

9.50

2.33

NA

NA

24.37

25.54

090 collar bone. 23490......... ........ A

Reinforce

11.96

NA

NA

6.69

8.19

1.47

NA

NA

20.12

21.62

090 clavicle. 23491......... ........ A

Reinforce

14.31

NA

NA

8.89

10.26

2.46

NA

NA

25.66

27.03

090 shoulder bones. 23500......... ........ A

Treat clavicle

2.08

2.64

2.81

2.71

2.57

0.30

5.02

5.19

5.09

4.95

090 fracture. 23505......... ........ A

Treat clavicle

3.68

4.03

4.32

3.63

3.79

0.61

8.32

8.61

7.92

8.08

090 fracture. 23515......... ........ A

Treat clavicle

7.40

NA

NA

5.59

6.31

1.28

NA

NA

14.27

14.99

090 fracture. 23520......... ........ A

Treat clavicle

2.16

2.65

2.80

2.72

2.74

0.34

5.15

5.30

5.22

5.24

090 dislocation. 23525......... ........ A

Treat clavicle

3.59

4.51

4.53

3.92

3.94

0.46

8.56

8.58

7.97

7.99

090 dislocation. 23530......... ........ A

Treat clavicle

7.30

NA

NA

5.28

5.77

1.20

NA

NA

13.78

14.27

090 dislocation. 23532......... ........ A

Treat clavicle

8.00

NA

NA

6.08

6.75

1.38

NA

NA

15.46

16.13

090 dislocation. 23540......... ........ A

Treat clavicle

2.23

2.62

2.80

2.70

2.45

0.29

5.14

5.32

5.22

4.97

090 dislocation. 23545......... ........ A

Treat clavicle

3.25

3.75

4.08

3.27

3.34

0.35

7.35

7.68

6.87

6.94

090 dislocation. 23550......... ........ A

Treat clavicle

7.41

NA

NA

5.54

6.16

1.25

NA

NA

14.20

14.82

090 dislocation. 23552......... ........ A

Treat clavicle

8.62

NA

NA

6.28

7.06

1.46

NA

NA

16.36

17.14

090 dislocation. 23570......... ........ A

Treat shoulder

2.23

2.80

2.96

2.94

2.90

0.36

5.39

5.55

5.53

5.49

090 blade fx. 23575......... ........ A

Treat shoulder

4.05

4.36

4.75

3.86

4.20

0.59

9.00

9.39

8.50

8.84

090 blade fx. 23585......... ........ A

Treat scapula

9.07

NA

NA

6.52

7.36

1.54

NA

NA

17.13

17.97

090 fracture. 23600......... ........ A

Treat humerus

2.93

4.08

4.43

3.66

3.58

0.48

7.49

7.84

7.07

6.99

090 fracture. 23605......... ........ A

Treat humerus

4.86

5.42

5.97

4.63

4.99

0.84 11.12

11.67

10.33

10.69

090 fracture. 23615......... ........ A

Treat humerus

10.83

NA

NA

8.33

8.71

1.62

NA

NA

20.78

21.16

090 fracture. 23616......... ........ A

Treat humerus

21.60

NA

NA

11.56

13.50

3.69

NA

NA

36.85

38.79

090 fracture. 23620......... ........ A

Treat humerus

2.40

3.42

3.56

3.16

3.03

0.40

6.22

6.36

5.96

5.83

090 fracture.

[[Page 49103]]

23625......... ........ A

Treat humerus

3.92

4.44

4.82

3.91

4.19

0.67

9.03

9.41

8.50

8.78

090 fracture. 23630......... ........ A

Treat humerus

7.40

NA

NA

5.69

6.40

1.27

NA

NA

14.36

15.07

090 fracture. 23650......... ........ A

Treat shoulder

3.38

3.27

3.65

2.80

2.77

0.30

6.95

7.33

6.48

6.45

090 dislocation. 23655......... ........ A

Treat shoulder

4.56

NA

NA

4.17

4.17

0.69

NA

NA

9.42

9.42

090 dislocation. 23660......... ........ A

Treat shoulder

7.48

NA

NA

5.63

6.19

1.29

NA

NA

14.40

14.96

090 dislocation. 23665......... ........ A

Treat

4.46

4.85

5.21

4.26

4.61

0.71 10.02

10.38

9.43

9.78

090 dislocation/ fracture. 23670......... ........ A

Treat

7.95

NA

NA

5.89

6.60

1.36

NA

NA

15.20

15.91

090 dislocation/ fracture. 23675......... ........ A

Treat

6.04

6.16

6.66

5.16

5.66

1.01 13.21

13.71

12.21

12.71

090 dislocation/ fracture. 23680......... ........ A

Treat

10.22

NA

NA

7.02

7.84

1.75

NA

NA

18.99

19.81

090 dislocation/ fracture. 23700......... ........ A

Fixation of

2.52

NA

NA

1.92

2.11

0.44

NA

NA

4.88

5.07

010 shoulder. 23800......... ........ A

Fusion of

14.50

NA

NA

7.55

9.70

2.35

NA

NA

24.40

26.55

090 shoulder joint. 23802......... ........ A

Fusion of

18.07

NA

NA

10.99

10.38

2.70

NA

NA

31.76

31.15

090 shoulder joint. 23900......... ........ A

Amputation of

20.47

NA

NA

10.72

11.46

3.18

NA

NA

34.37

35.11

090 arm & girdle. 23920......... ........ A

Amputation at

15.95

NA

NA

9.56

9.83

2.46

NA

NA

27.97

28.24

090 shoulder joint. 23921......... ........ A

Amputation

5.54

NA

NA

4.88

5.03

0.78

NA

NA

11.20

11.35

090 follow-up surgery. 23929......... ........ C

Shoulder

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure. 23930......... ........ A

Drainage of arm 2.94

5.00

5.99

1.99

2.23

0.43

8.37

9.36

5.36

5.60

010 lesion. 23931......... ........ A

Drainage of arm 1.79

4.34

5.52

1.75

2.07

0.28

6.41

7.59

3.82

4.14

010 bursa. 23935......... ........ A

Drain arm/elbow 6.20

NA

NA

5.14

5.72

1.05

NA

NA

12.39

12.97

090 bone lesion. 24000......... ........ A

Exploratory

5.93

NA

NA

4.78

5.25

0.97

NA

NA

11.68

12.15

090 elbow surgery. 24006......... ........ A

Release elbow

9.54

NA

NA

6.67

7.48

1.50

NA

NA

17.71

18.52

090 joint. 24065......... ........ A

Biopsy arm/

2.08

4.08

3.43

1.87

1.77

0.17

6.33

5.68

4.12

4.02

010 elbow soft tissue. 24066......... ........ A

Biopsy arm/

5.20

8.33

8.78

3.94

4.08

0.80 14.33

14.78

9.94

10.08

090 elbow soft tissue. 24075......... ........ A

Remove arm/

3.91

7.22

7.32

3.27

3.37

0.56 11.69

11.79

7.74

7.84

090 elbow lesion. 24076......... ........ A

Remove arm/

6.29

NA

NA

4.59

4.79

0.95

NA

NA

11.83

12.03

090 elbow lesion. 24077......... ........ A

Remove tumor of 11.86

NA

NA

6.96

7.55

1.72

NA

NA

20.54

21.13

090 arm/elbow. 24100......... ........ A

Biopsy elbow

4.92

NA

NA

4.28

4.46

0.85

NA

NA

10.05

10.23

090 joint lining. 24101......... ........ A

Explore/treat

6.12

NA

NA

5.08

5.72

1.03

NA

NA

12.23

12.87

090 elbow joint. 24102......... ........ A

Remove elbow

8.08

NA

NA

5.82

6.60

1.33

NA

NA

15.23

16.01

090 joint lining. 24105......... ........ A

Removal of

3.60

NA

NA

4.04

4.30

0.61

NA

NA

8.25

8.51

090 elbow bursa. 24110......... ........ A

Remove humerus

7.38

NA

NA

5.66

6.41

1.28

NA

NA

14.32

15.07

090 lesion. 24115......... ........ A

Remove/graft

9.92

NA

NA

6.83

7.12

1.67

NA

NA

18.42

18.71

090 bone lesion. 24116......... ........ A

Remove/graft

12.03

NA

NA

7.67

8.72

2.05

NA

NA

21.75

22.80

090 bone lesion. 24120......... ........ A

Remove elbow

6.64

NA

NA

5.22

5.75

1.10

NA

NA

12.96

13.49

090 lesion. 24125......... ........ A

Remove/graft

7.94

NA

NA

6.03

6.13

1.06

NA

NA

15.03

15.13

090 bone lesion. 24126......... ........ A

Remove/graft

8.42

NA

NA

6.22

6.82

1.16

NA

NA

15.80

16.40

090 bone lesion. 24130......... ........ A

Removal of head 6.24

NA

NA

5.13

5.80

1.04

NA

NA

12.41

13.08

090 of radius. 24134......... ........ A

Removal of arm 10.02

NA

NA

7.49

8.51

1.64

NA

NA

19.15

20.17

090 bone lesion. 24136......... ........ A

Remove radius

8.22

NA

NA

5.67

6.83

1.38

NA

NA

15.27

16.43

090 bone lesion. 24138......... ........ A

Remove elbow

8.22

NA

NA

6.71

7.51

1.34

NA

NA

16.27

17.07

090 bone lesion. 24140......... ........ A

Partial removal 9.35

NA

NA

7.20

8.63

1.51

NA

NA

18.06

19.49

090 of arm bone. 24145......... ........ A

Partial removal 7.63

NA

NA

6.30

7.62

1.25

NA

NA

15.18

16.50

090 of radius. 24147......... ........ A

Partial removal 7.59

NA

NA

6.90

8.18

1.30

NA

NA

15.79

17.07

090 of elbow. 24149......... ........ A

Radical

15.80

NA

NA

10.86

11.43

2.34

NA

NA

29.00

29.57

090 resection of elbow. 24150......... ........ A

Extensive

13.61

NA

NA

8.54

9.63

2.32

NA

NA

24.47

25.56

090 humerus surgery. 24151......... ........ A

Extensive

15.98

NA

NA

9.77

11.08

2.59

NA

NA

28.34

29.65

090 humerus surgery. 24152......... ........ A

Extensive

10.16

NA

NA

6.29

7.37

1.48

NA

NA

17.93

19.01

090 radius surgery. 24153......... ........ A

Extensive

11.64

NA

NA

4.92

5.41

0.74

NA

NA

17.30

17.79

090 radius surgery. 24155......... ........ A

Removal of

11.89

NA

NA

7.61

8.20

1.92

NA

NA

21.42

22.01

090 elbow joint. 24160......... ........ A

Remove elbow

7.82

NA

NA

5.82

6.62

1.30

NA

NA

14.94

15.74

090 joint implant. 24164......... ........ A

Remove radius

6.28

NA

NA

4.92

5.56

1.03

NA

NA

12.23

12.87

090 head implant. 24200......... ........ A

Removal of arm

1.76

2.78

3.25

1.38

1.57

0.20

4.74

5.21

3.34

3.53

010 foreign body. 24201......... ........ A

Removal of arm

4.55

7.92

9.34

3.71

4.10

0.72 13.19

14.61

8.98

9.37

090 foreign body. 24220......... ........ A

Injection for

1.31

2.64

3.38

0.43

0.44

0.08

4.03

4.77

1.82

1.83

000 elbow x-ray. 24300......... ........ A

Manipulate

3.74

NA

NA

5.18

5.58

0.65

NA

NA

9.57

9.97

090 elbow w/anesth. 24301......... ........ A

Muscle/tendon

10.18

NA

NA

6.85

7.85

1.66

NA

NA

18.69

19.69

090 transfer. 24305......... ........ A

Arm tendon

7.44

NA

NA

5.66

6.45

1.15

NA

NA

14.25

15.04

090 lengthening. 24310......... ........ A

Revision of arm 5.97

NA

NA

4.78

5.38

0.96

NA

NA

11.71

12.31

090 tendon. 24320......... ........ A

Repair of arm

10.66

NA

NA

7.11

7.43

1.73

NA

NA

19.50

19.82

090 tendon. 24330......... ........ A

Revision of arm 9.59

NA

NA

6.64

7.57

1.60

NA

NA

17.83

18.76

090 muscles. 24331......... ........ A

Revision of arm 10.75

NA

NA

6.52

8.13

1.77

NA

NA

19.04

20.65

090 muscles. 24332......... ........ A

Tenolysis,

7.69

NA

NA

5.75

6.52

1.23

NA

NA

14.67

15.44

090 triceps. 24340......... ........ A

Repair of

7.88

NA

NA

6.00

6.74

1.36

NA

NA

15.24

15.98

090 biceps tendon. 24341......... ........ A

Repair arm

9.14

NA

NA

7.52

7.82

1.36

NA

NA

18.02

18.32

090 tendon/muscle. 24342......... ........ A

Repair of

10.66

NA

NA

7.11

8.17

1.85

NA

NA

19.62

20.68

090 ruptured tendon. 24343......... ........ A

Repr elbow lat

8.89

NA

NA

7.02

7.87

1.43

NA

NA

17.34

18.19

090 ligmnt w/tiss.

[[Page 49104]]

24344......... ........ A

Reconstruct

14.85

NA

NA

10.06

11.16

2.36

NA

NA

27.27

28.37

090 elbow lat ligmnt. 24345......... ........ A

Repr elbw med

8.89

NA

NA

6.98

7.76

1.44

NA

NA

17.31

18.09

090 ligmnt w/tissu. 24346......... ........ A

Reconstruct

14.85

NA

NA

10.06

11.02

2.33

NA

NA

27.24

28.20

090 elbow med ligmnt. 24350......... ........ A

Repair of

5.24

NA

NA

4.89

5.41

0.87

NA

NA

11.00

11.52

090 tennis elbow. 24351......... ........ A

Repair of

5.90

NA

NA

5.01

5.69

1.02

NA

NA

11.93

12.61

090 tennis elbow. 24352......... ........ A

Repair of

6.42

NA

NA

5.23

5.94

1.10

NA

NA

12.75

13.46

090 tennis elbow. 24354......... ........ A

Repair of

6.47

NA

NA

5.25

5.93

1.07

NA

NA

12.79

13.47

090 tennis elbow. 24356......... ........ A

Revision of

6.67

NA

NA

5.32

6.06

1.11

NA

NA

13.10

13.84

090 tennis elbow. 24360......... ........ A

Reconstruct

12.44

NA

NA

7.97

9.10

2.05

NA

NA

22.46

23.59

090 elbow joint. 24361......... ........ A

Reconstruct

14.18

NA

NA

8.78

10.13

2.18

NA

NA

25.14

26.49

090 elbow joint. 24362......... ........ A

Reconstruct

15.09

NA

NA

9.30

9.86

2.60

NA

NA

26.99

27.55

090 elbow joint. 24363......... ........ A

Replace elbow

22.39

NA

NA

12.26

13.35

3.01

NA

NA

37.66

38.75

090 joint. 24365......... ........ A

Reconstruct

8.44

NA

NA

5.94

6.89

1.41

NA

NA

15.79

16.74

090 head of radius. 24366......... ........ A

Reconstruct

9.18

NA

NA

6.31

7.23

1.52

NA

NA

17.01

17.93

090 head of radius. 24400......... ........ A

Revision of

11.10

NA

NA

7.62

8.54

1.92

NA

NA

20.64

21.56

090 humerus. 24410......... ........ A

Revision of

14.86

NA

NA

9.32

10.06

2.57

NA

NA

26.75

27.49

090 humerus. 24420......... ........ A

Revision of

13.48

NA

NA

8.88

10.13

2.17

NA

NA

24.53

25.78

090 humerus. 24430......... ........ A

Repair of

14.99

NA

NA

9.30

9.63

2.21

NA

NA

26.50

26.83

090 humerus. 24435......... ........ A

Repair humerus 14.64

NA

NA

9.86

10.63

2.27

NA

NA

26.77

27.54

090 with graft. 24470......... ........ A

Revision of

8.73

NA

NA

6.43

7.40

1.48

NA

NA

16.64

17.61

090 elbow joint. 24495......... ........ A

Decompression

8.23

NA

NA

6.68

8.23

1.18

NA

NA

16.09

17.64

090 of forearm. 24498......... ........ A

Reinforce

12.08

NA

NA

7.75

8.88

2.06

NA

NA

21.89

23.02

090 humerus. 24500......... ........ A

Treat humerus

3.21

4.45

4.75

3.80

3.71

0.50

8.16

8.46

7.51

7.42

090 fracture. 24505......... ........ A

Treat humerus

5.16

5.87

6.42

4.90

5.27

0.89 11.92

12.47

10.95

11.32

090 fracture. 24515......... ........ A

Treat humerus

11.87

NA

NA

8.09

9.06

2.02

NA

NA

21.98

22.95

090 fracture. 24516......... ........ A

Treat humerus

11.99

NA

NA

7.71

8.76

2.02

NA

NA

21.72

22.77

090 fracture. 24530......... ........ A

Treat humerus

3.49

4.74

5.09

4.00

4.03

0.57

8.80

9.15

8.06

8.09

090 fracture. 24535......... ........ A

Treat humerus

6.86

6.82

7.59

5.86

6.43

1.18 14.86

15.63

13.90

14.47

090 fracture. 24538......... ........ A

Treat humerus

9.54

NA

NA

7.22

8.33

1.64

NA

NA

18.40

19.51

090 fracture. 24545......... ........ A

Treat humerus

10.80

NA

NA

7.24

8.15

1.82

NA

NA

19.86

20.77

090 fracture. 24546......... ........ A

Treat humerus

15.91

NA

NA

9.50

10.87

2.73

NA

NA

28.14

29.51

090 fracture. 24560......... ........ A

Treat humerus

2.80

4.05

4.37

3.38

3.24

0.44

7.29

7.61

6.62

6.48

090 fracture. 24565......... ........ A

Treat humerus

5.55

5.86

6.42

4.97

5.38

0.93 12.34

12.90

11.45

11.86

090 fracture. 24566......... ........ A

Treat humerus

8.78

NA

NA

6.97

7.86

1.30

NA

NA

17.05

17.94

090 fracture. 24575......... ........ A

Treat humerus

10.94

NA

NA

7.27

8.12

1.86

NA

NA

20.07

20.92

090 fracture. 24576......... ........ A

Treat humerus

2.86

4.45

4.68

3.74

3.72

0.46

7.77

8.00

7.06

7.04

090 fracture. 24577......... ........ A

Treat humerus

5.78

6.01

6.70

5.08

5.65

0.95 12.74

13.43

11.81

12.38

090 fracture. 24579......... ........ A

Treat humerus

11.88

NA

NA

7.87

8.59

2.02

NA

NA

21.77

22.49

090 fracture. 24582......... ........ A

Treat humerus

9.79

NA

NA

8.21

8.89

1.48

NA

NA

19.48

20.16

090 fracture. 24586......... ........ A

Treat elbow

15.55

NA

NA

9.36

10.76

2.64

NA

NA

27.55

28.95

090 fracture. 24587......... ........ A

Treat elbow

15.56

NA

NA

9.37

10.61

2.52

NA

NA

27.45

28.69

090 fracture. 24600......... ........ A

Treat elbow

4.22

3.87

4.61

3.29

3.45

0.50

8.59

9.33

8.01

8.17

090 dislocation. 24605......... ........ A

Treat elbow

5.41

NA

NA

4.96

5.26

0.89

NA

NA

11.26

11.56

090 dislocation. 24615......... ........ A

Treat elbow

9.65

NA

NA

6.59

7.51

1.60

NA

NA

17.84

18.76

090 dislocation. 24620......... ........ A

Treat elbow

6.97

NA

NA

5.48

6.06

1.07

NA

NA

13.52

14.10

090 fracture. 24635......... ........ A

Treat elbow

13.47

NA

NA

10.23

13.10

2.28

NA

NA

25.98

28.85

090 fracture. 24640......... ........ A

Treat elbow

1.20

1.48

1.75

0.80

0.80

0.12

2.80

3.07

2.12

2.12

010 dislocation. 24650......... ........ A

Treat radius

2.16

3.44

3.70

3.00

2.81

0.35

5.95

6.21

5.51

5.32

090 fracture. 24655......... ........ A

Treat radius

4.39

5.20

5.76

4.41

4.70

0.70 10.29

10.85

9.50

9.79

090 fracture. 24665......... ........ A

Treat radius

8.13

NA

NA

6.53

7.27

1.41

NA

NA

16.07

16.81

090 fracture. 24666......... ........ A

Treat radius

9.66

NA

NA

7.00

7.80

1.62

NA

NA

18.28

19.08

090 fracture. 24670......... ........ A

Treat ulnar

2.54

3.74

4.02

3.16

3.09

0.41

6.69

6.97

6.11

6.04

090 fracture. 24675......... ........ A

Treat ulnar

4.71

5.30

5.83

4.50

4.85

0.81 10.82

11.35

10.02

10.37

090 fracture. 24685......... ........ A

Treat ulnar

8.85

NA

NA

6.48

7.26

1.52

NA

NA

16.85

17.63

090 fracture. 24800......... ........ A

Fusion of elbow 11.18

NA

NA

7.66

8.47

1.63

NA

NA

20.47

21.28

090 joint. 24802......... ........ A

Fusion/graft of 14.09

NA

NA

8.56

9.93

2.37

NA

NA

25.02

26.39

090 elbow joint.

[[Page 49105]]

24900......... ........ A

Amputation of

9.95

NA

NA

6.47

6.91

1.53

NA

NA

17.95

18.39

090 upper arm. 24920......... ........ A

Amputation of

9.95

NA

NA

6.45

6.82

1.61

NA

NA

18.01

18.38

090 upper arm. 24925......... ........ A

Amputation

7.12

NA

NA

4.95

5.80

1.14

NA

NA

13.21

14.06

090 follow-up surgery. 24930......... ........ A

Amputation

10.65

NA

NA

5.90

6.91

1.67

NA

NA

18.22

19.23

090 follow-up surgery. 24931......... ........ A

Amputate upper 13.24

NA

NA

8.23

6.35

1.89

NA

NA

23.36

21.48

090 arm & implant. 24935......... ........ A

Revision of

16.20

NA

NA

8.90

8.24

2.13

NA

NA

27.23

26.57

090 amputation. 24940......... ........ C

Revision of

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 upper arm. 24999......... ........ C

Upper arm/elbow 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery. 25000......... ........ A

Incision of

3.37

NA

NA

5.06

6.42

0.55

NA

NA

8.98

10.34

090 tendon sheath. 25001......... ........ A

Incise flexor

3.62

NA

NA

3.85

4.14

0.55

NA

NA

8.02

8.31

090 carpi radialis. 25020......... ........ A

Decompress

5.91

NA

NA

6.90

8.90

0.93

NA

NA

13.74

15.74

090 forearm 1 space. 25023......... ........ A

Decompress

13.60

NA

NA

11.48

14.08

2.03

NA

NA

27.11

29.71

090 forearm 1 space. 25024......... ........ A

Decompress

10.52

NA

NA

7.20

7.40

1.36

NA

NA

19.08

19.28

090 forearm 2 spaces. 25025......... ........ A

Decompress

17.67

NA

NA

9.03

9.74

1.82

NA

NA

28.52

29.23

090 forearm 2 spaces. 25028......... ........ A

Drainage of

5.24

NA

NA

6.25

7.68

0.81

NA

NA

12.30

13.73

090 forearm lesion. 25031......... ........ A

Drainage of

4.13

NA

NA

5.47

7.31

0.63

NA

NA

10.23

12.07

090 forearm bursa. 25035......... ........ A

Treat forearm

7.47

NA

NA

8.88

12.41

1.24

NA

NA

17.59

21.12

090 bone lesion. 25040......... ........ A

Explore/treat

7.35

NA

NA

5.90

6.95

1.15

NA

NA

14.40

15.45

090 wrist joint. 25065......... ........ A

Biopsy forearm

1.99

4.19

3.46

1.90

1.90

0.15

6.33

5.60

4.04

4.04

010 soft tissues. 25066......... ........ A

Biopsy forearm

4.12

NA

NA

5.46

6.66

0.64

NA

NA

10.22

11.42

090 soft tissues. 25075......... ........ A

Removal forearm 3.73

NA

NA

4.90

5.64

0.55

NA

NA

9.18

9.92

090 lesion subcu. 25076......... ........ A

Removal forearm 4.91

NA

NA

6.92

8.89

0.74

NA

NA

12.57

14.54

090 lesion deep. 25077......... ........ A

Remove tumor,

9.81

NA

NA

8.95

11.30

1.42

NA

NA

20.18

22.53

090 forearm/wrist. 25085......... ........ A

Incision of

5.49

NA

NA

5.44

6.70

0.85

NA

NA

11.78

13.04

090 wrist capsule. 25100......... ........ A

Biopsy of wrist 3.89

NA

NA

4.28

5.02

0.59

NA

NA

8.76

9.50

090 joint. 25101......... ........ A

Explore/treat

4.68

NA

NA

4.83

5.63

0.75

NA

NA

10.26

11.06

090 wrist joint. 25105......... ........ A

Remove wrist

5.84

NA

NA

5.82

6.93

0.92

NA

NA

12.58

13.69

090 joint lining. 25107......... ........ A

Remove wrist

7.42

NA

NA

7.16

8.05

0.99

NA

NA

15.57

16.46

090 joint cartilage. 25110......... ........ A

Remove wrist

3.91

NA

NA

5.29

6.61

0.62

NA

NA

9.82

11.14

090 tendon lesion. 25111......... ........ A

Remove wrist

3.38

NA

NA

4.10

4.55

0.53

NA

NA

8.01

8.46

090 tendon lesion. 25112......... ........ A

Reremove wrist

4.52

NA

NA

4.54

5.07

0.70

NA

NA

9.76

10.29

090 tendon lesion. 25115......... ........ A

Remove wrist/

9.81

NA

NA

10.21

13.08

1.31

NA

NA

21.33

24.20

090 forearm lesion. 25116......... ........ A

Remove wrist/

7.28

NA

NA

9.08

12.13

1.11

NA

NA

17.47

20.52

090 forearm lesion. 25118......... ........ A

Excise wrist

4.36

NA

NA

4.63

5.46

0.68

NA

NA

9.67

10.50

090 tendon sheath. 25119......... ........ A

Partial removal 6.03

NA

NA

5.86

7.17

0.96

NA

NA

12.85

14.16

090 of ulna. 25120......... ........ A

Removal of

6.09

NA

NA

7.93

11.04

1.00

NA

NA

15.02

18.13

090 forearm lesion. 25125......... ........ A

Remove/graft

7.47

NA

NA

8.75

11.82

1.06

NA

NA

17.28

20.35

090 forearm lesion. 25126......... ........ A

Remove/graft

7.54

NA

NA

8.78

11.95

1.27

NA

NA

17.59

20.76

090 forearm lesion. 25130......... ........ A

Removal of

5.25

NA

NA

5.21

6.12

0.80

NA

NA

11.26

12.17

090 wrist lesion. 25135......... ........ A

Remove & graft

6.88

NA

NA

6.12

7.16

1.02

NA

NA

14.02

15.06

090 wrist lesion. 25136......... ........ A

Remove & graft

5.96

NA

NA

5.53

6.33

1.03

NA

NA

12.52

13.32

090 wrist lesion. 25145......... ........ A

Remove forearm

6.36

NA

NA

8.12

11.08

1.01

NA

NA

15.49

18.45

090 bone lesion. 25150......... ........ A

Partial removal 7.20

NA

NA

6.38

7.75

1.14

NA

NA

14.72

16.09

090 of ulna. 25151......... ........ A

Partial removal 7.50

NA

NA

8.52

11.67

1.18

NA

NA

17.20

20.35

090 of radius. 25170......... ........ A

Extensive

11.25

NA

NA

10.52

13.99

1.77

NA

NA

23.54

27.01

090 forearm surgery. 25210......... ........ A

Removal of

5.94

NA

NA

5.53

6.48

0.88

NA

NA

12.35

13.30

090 wrist bone. 25215......... ........ A

Removal of

7.94

NA

NA

6.83

8.27

1.19

NA

NA

15.96

17.40

090 wrist bones. 25230......... ........ A

Partial removal 5.22

NA

NA

4.96

5.85

0.79

NA

NA

10.97

11.86

090 of radius. 25240......... ........ A

Partial removal 5.16

NA

NA

5.27

6.53

0.81

NA

NA

11.24

12.50

090 of ulna. 25246......... ........ A

Injection for

1.45

2.70

3.26

0.48

0.48

0.09

4.24

4.80

2.02

2.02

000 wrist x-ray. 25248......... ........ A

Remove forearm

5.13

NA

NA

6.57

8.03

0.72

NA

NA

12.42

13.88

090 foreign body. 25250......... ........ A

Removal of

6.59

NA

NA

5.32

5.91

1.01

NA

NA

12.92

13.51

090 wrist prosthesis. 25251......... ........ A

Removal of

9.62

NA

NA

6.71

7.62

1.26

NA

NA

17.59

18.50

090 wrist prosthesis. 25259......... ........ A

Manipulate

3.74

NA

NA

5.14

5.58

0.62

NA

NA

9.50

9.94

090 wrist w/ anesthes. 25260......... ........ A

Repair forearm

7.79

NA

NA

9.22

12.29

1.19

NA

NA

18.20

21.27

090 tendon/muscle. 25263......... ........ A

Repair forearm

7.81

NA

NA

8.96

12.19

1.18

NA

NA

17.95

21.18

090 tendon/muscle. 25265......... ........ A

Repair forearm

9.87

NA

NA

10.00

13.23

1.47

NA

NA

21.34

24.57

090 tendon/muscle. 25270......... ........ A

Repair forearm

5.99

NA

NA

7.90

11.00

0.95

NA

NA

14.84

17.94

090 tendon/muscle. 25272......... ........ A

Repair forearm

7.03

NA

NA

8.37

11.69

1.11

NA

NA

16.51

19.83

090 tendon/muscle. 25274......... ........ A

Repair forearm

8.74

NA

NA

9.20

12.52

1.36

NA

NA

19.30

22.62

090 tendon/muscle. 25275......... ........ A

Repair forearm

8.74

NA

NA

6.50

7.31

1.31

NA

NA

16.55

17.36

090 tendon sheath. 25280......... ........ A

Revise wrist/

7.21

NA

NA

8.47

11.59

1.08

NA

NA

16.76

19.88

090 forearm tendon. 25290......... ........ A

Incise wrist/

5.28

NA

NA

9.17

13.54

0.82

NA

NA

15.27

19.64

090 forearm tendon. 25295......... ........ A

Release wrist/

6.54

NA

NA

8.14

11.15

1.00

NA

NA

15.68

18.69

090 forearm tendon. 25300......... ........ A

Fusion of

8.79

NA

NA

7.19

8.14

1.26

NA

NA

17.24

18.19

090 tendons at wrist. 25301......... ........ A

Fusion of

8.39

NA

NA

6.73

7.73

1.29

NA

NA

16.41

17.41

090 tendons at wrist.

[[Page 49106]]

25310......... ........ A

Transplant

8.19

NA

NA

8.82

11.98

1.21

NA

NA

18.22

21.38

090 forearm tendon. 25312......... ........ A

Transplant

9.62

NA

NA

9.60

12.86

1.41

NA

NA

20.63

23.89

090 forearm tendon. 25315......... ........ A

Revise palsy

10.48

NA

NA

10.00

13.30

1.58

NA

NA

22.06

25.36

090 hand tendon(s). 25316......... ........ A

Revise palsy

12.67

NA

NA

11.08

14.94

1.74

NA

NA

25.49

29.35

090 hand tendon(s). 25320......... ........ A

Repair/revise

12.28

NA

NA

10.38

11.14

1.61

NA

NA

24.27

25.03

090 wrist joint. 25332......... ........ A

Revise wrist

11.51

NA

NA

7.74

8.81

1.83

NA

NA

21.08

22.15

090 joint. 25335......... ........ A

Realignment of 13.16

NA

NA

7.01

10.45

1.92

NA

NA

22.09

25.53

090 hand. 25337......... ........ A

Reconstruct

11.36

NA

NA

9.39

10.66

1.61

NA

NA

22.36

23.63

090 ulna/ radioulnar. 25350......... ........ A

Revision of

8.89

NA

NA

9.27

12.80

1.46

NA

NA

19.62

23.15

090 radius. 25355......... ........ A

Revision of

10.33

NA

NA

10.03

13.47

1.73

NA

NA

22.09

25.53

090 radius. 25360......... ........ A

Revision of

8.54

NA

NA

9.13

12.69

1.41

NA

NA

19.08

22.64

090 ulna. 25365......... ........ A

Revise radius & 12.68

NA

NA

11.06

14.50

2.15

NA

NA

25.89

29.33

090 ulna. 25370......... ........ A

Revise radius

13.82

NA

NA

11.97

15.05

2.28

NA

NA

28.07

31.15

090 or ulna. 25375......... ........ A

Revise radius & 13.32

NA

NA

11.33

15.15

2.26

NA

NA

26.91

30.73

090 ulna. 25390......... ........ A

Shorten radius 10.50

NA

NA

9.94

13.42

1.65

NA

NA

22.09

25.57

090 or ulna. 25391......... ........ A

Lengthen radius 14.05

NA

NA

11.65

15.33

2.21

NA

NA

27.91

31.59

090 or ulna. 25392......... ........ A

Shorten radius 14.35

NA

NA

11.78

14.92

2.10

NA

NA

28.23

31.37

090 & ulna. 25393......... ........ A

Lengthen radius 16.33

NA

NA

13.18

16.48

2.76

NA

NA

32.27

35.57

090 & ulna. 25394......... ........ A

Repair carpal

10.63

NA

NA

6.80

7.75

1.59

NA

NA

19.02

19.97

090 bone, shorten. 25400......... ........ A

Repair radius

11.08

NA

NA

10.18

13.94

1.82

NA

NA

23.08

26.84

090 or ulna. 25405......... ........ A

Repair/graft

14.78

NA

NA

11.92

15.93

2.32

NA

NA

29.02

33.03

090 radius or ulna. 25415......... ........ A

Repair radius & 13.57

NA

NA

11.02

15.14

2.17

NA

NA

26.76

30.88

090 ulna. 25420......... ........ A

Repair/graft

16.79

NA

NA

12.79

16.90

2.61

NA

NA

32.19

36.30

090 radius & ulna. 25425......... ........ A

Repair/graft

13.49

NA

NA

14.14

19.58

2.08

NA

NA

29.71

35.15

090 radius or ulna. 25426......... ........ A

Repair/graft

16.22

NA

NA

12.50

15.54

2.54

NA

NA

31.26

34.30

090 radius & ulna. 25430......... ........ A

Vasc graft into 9.49

NA

NA

7.04

7.27

1.27

NA

NA

17.80

18.03

090 carpal bone. 25431......... ........ A

Repair nonunion 10.67

NA

NA

7.26

8.12

1.90

NA

NA

19.83

20.69

090 carpal bone. 25440......... ........ A

Repair/graft

10.48

NA

NA

7.53

8.93

1.63

NA

NA

19.64

21.04

090 wrist bone. 25441......... ........ A

Reconstruct

13.06

NA

NA

8.50

9.63

2.07

NA

NA

23.63

24.76

090 wrist joint. 25442......... ........ A

Reconstruct

10.89

NA

NA

7.32

8.49

1.53

NA

NA

19.74

20.91

090 wrist joint. 25443......... ........ A

Reconstruct

10.43

NA

NA

6.61

8.23

1.37

NA

NA

18.41

20.03

090 wrist joint. 25444......... ........ A

Reconstruct

11.19

NA

NA

7.65

8.69

1.71

NA

NA

20.55

21.59

090 wrist joint. 25445......... ........ A

Reconstruct

9.68

NA

NA

6.72

7.67

1.55

NA

NA

17.95

18.90

090 wrist joint. 25446......... ........ A

Wrist

17.07

NA

NA

9.88

11.41

2.47

NA

NA

29.42

30.95

090 replacement. 25447......... ........ A

Repair wrist

10.85

NA

NA

7.88

8.46

1.61

NA

NA

20.34

20.92

090 joint(s). 25449......... ........ A

Remove wrist

14.71

NA

NA

9.05

10.27

2.21

NA

NA

25.97

27.19

090 joint implant. 25450......... ........ A

Revision of

7.86

NA

NA

7.34

9.48

1.36

NA

NA

16.56

18.70

090 wrist joint. 25455......... ........ A

Revision of

9.48

NA

NA

6.50

9.77

0.96

NA

NA

16.94

20.21

090 wrist joint. 25490......... ........ A

Reinforce

9.53

NA

NA

9.47

12.67

1.43

NA

NA

20.43

23.63

090 radius. 25491......... ........ A

Reinforce ulna. 9.95

NA

NA

9.73

13.28

1.60

NA

NA

21.28

24.83

090 25492......... ........ A

Reinforce

12.43

NA

NA

10.59

14.12

2.14

NA

NA

25.16

28.69

090 radius and ulna. 25500......... ........ A

Treat fracture

2.45

3.33

3.51

2.89

2.76

0.35

6.13

6.31

5.69

5.56

090 of radius. 25505......... ........ A

Treat fracture

5.20

5.87

6.37

5.01

5.32

0.90 11.97

12.47

11.11

11.42

090 of radius. 25515......... ........ A

Treat fracture

9.29

NA

NA

6.75

7.28

1.59

NA

NA

17.63

18.16

090 of radius. 25520......... ........ A

Treat fracture

6.25

6.02

6.65

5.43

5.90

1.08 13.35

13.98

12.76

13.23

090 of radius. 25525......... ........ A

Treat fracture 12.59

NA

NA

8.74

9.68

2.12

NA

NA

23.45

24.39

090 of radius. 25526......... ........ A

Treat fracture 13.33

NA

NA

10.23

12.68

2.19

NA

NA

25.75

28.20

090 of radius. 25530......... ........ A

Treat fracture

2.09

3.48

3.69

2.97

2.89

0.34

5.91

6.12

5.40

5.32

090 of ulna. 25535......... ........ A

Treat fracture

5.13

5.68

5.93

4.93

5.20

0.89 11.70

11.95

10.95

11.22

090 of ulna. 25545......... ........ A

Treat fracture

9.01

NA

NA

6.64

7.41

1.53

NA

NA

17.18

17.95

090 of ulna. 25560......... ........ A

Treat fracture

2.44

3.40

3.62

2.87

2.67

0.35

6.19

6.41

5.66

5.46

090 radius & ulna. 25565......... ........ A

Treat fracture

5.62

5.97

6.52

4.99

5.31

0.93 12.52

13.07

11.54

11.86

090 radius & ulna. 25574......... ........ A

Treat fracture

7.37

NA

NA

6.64

7.06

1.21

NA

NA

15.22

15.64

090 radius & ulna. 25575......... ........ A

Treat fracture 11.92

NA

NA

9.00

9.38

1.81

NA

NA

22.73

23.11

090 radius/ulna. 25600......... ........ A

Treat fracture

2.63

3.69

3.99

3.18

3.02

0.42

6.74

7.04

6.23

6.07

090 radius/ulna. 25605......... ........ A

Treat fracture

6.93

6.91

7.15

6.18

6.21

1.00 14.84

15.08

14.11

14.14

090 radius/ulna.

[[Page 49107]]

25611......... ........ A

Treat fracture

9.14

NA

NA

8.34

8.81

1.34

NA

NA

18.82

19.29

090 radius/ulna. 25620......... ........ A

Treat fracture

8.54

NA

NA

6.27

7.01

1.42

NA

NA

16.23

16.97

090 radius/ulna. 25622......... ........ A

Treat wrist

2.61

3.91

4.18

3.36

3.17

0.41

6.93

7.20

6.38

6.19

090 bone fracture. 25624......... ........ A

Treat wrist

4.52

5.58

6.12

4.73

4.99

0.76 10.86

11.40

10.01

10.27

090 bone fracture. 25628......... ........ A

Treat wrist

9.42

NA

NA

7.34

7.70

1.37

NA

NA

18.13

18.49

090 bone fracture. 25630......... ........ A

Treat wrist

2.88

3.76

4.08

3.25

3.02

0.45

7.09

7.41

6.58

6.35

090 bone fracture. 25635......... ........ A

Treat wrist

4.38

5.38

5.80

4.56

4.07

0.74 10.50

10.92

9.68

9.19

090 bone fracture. 25645......... ........ A

Treat wrist

7.24

NA

NA

5.80

6.42

1.20

NA

NA

14.24

14.86

090 bone fracture. 25650......... ........ A

Treat wrist

3.05

3.86

4.20

3.46

3.24

0.45

7.36

7.70

6.96

6.74

090 bone fracture. 25651......... ........ A

Pin ulnar

5.60

NA

NA

5.13

5.39

0.86

NA

NA

11.59

11.85

090 styloid fracture. 25652......... ........ A

Treat fracture

7.84

NA

NA

6.21

6.80

1.21

NA

NA

15.26

15.85

090 ulnar styloid. 25660......... ........ A

Treat wrist

4.75

NA

NA

4.48

4.65

0.58

NA

NA

9.81

9.98

090 dislocation. 25670......... ........ A

Treat wrist

7.91

NA

NA

5.99

6.74

1.28

NA

NA

15.18

15.93

090 dislocation. 25671......... ........ A

Pin radioulnar

6.24

NA

NA

5.53

6.00

1.00

NA

NA

12.77

13.24

090 dislocation. 25675......... ........ A

Treat wrist

4.66

4.88

5.46

4.14

4.52

0.62 10.16

10.74

9.42

9.80

090 dislocation. 25676......... ........ A

Treat wrist

8.09

NA

NA

6.28

7.05

1.34

NA

NA

15.71

16.48

090 dislocation. 25680......... ........ A

Treat wrist

5.98

NA

NA

4.37

4.65

0.78

NA

NA

11.13

11.41

090 fracture. 25685......... ........ A

Treat wrist

9.89

NA

NA

6.70

7.53

1.60

NA

NA

18.19

19.02

090 fracture. 25690......... ........ A

Treat wrist

5.49

NA

NA

4.82

5.33

0.88

NA

NA

11.19

11.70

090 dislocation. 25695......... ........ A

Treat wrist

8.33

NA

NA

6.19

6.87

1.32

NA

NA

15.84

16.52

090 dislocation. 25800......... ........ A

Fusion of wrist 9.87

NA

NA

7.28

8.64

1.57

NA

NA

18.72

20.08

090 joint. 25805......... ........ A

Fusion/graft of 11.50

NA

NA

8.17

9.73

1.80

NA

NA

21.47

23.03

090 wrist joint. 25810......... ........ A

Fusion/graft of 11.67

NA

NA

8.56

9.57

1.67

NA

NA

21.90

22.91

090 wrist joint. 25820......... ........ A

Fusion of hand

7.44

NA

NA

6.28

7.46

1.22

NA

NA

14.94

16.12

090 bones. 25825......... ........ A

Fuse hand bones 9.44

NA

NA

7.56

8.81

1.41

NA

NA

18.41

19.66

090 with graft. 25830......... ........ A

Fusion,

10.61

NA

NA

10.46

13.42

1.55

NA

NA

22.62

25.58

090 radioulnar jnt/ ulna. 25900......... ........ A

Amputation of

9.36

NA

NA

9.27

11.74

1.30

NA

NA

19.93

22.40

090 forearm. 25905......... ........ A

Amputation of

9.41

NA

NA

8.44

11.33

1.40

NA

NA

19.25

22.14

090 forearm. 25907......... ........ A

Amputation

7.91

NA

NA

7.81

10.77

1.10

NA

NA

16.82

19.78

090 follow-up surgery. 25909......... ........ A

Amputation

9.13

NA

NA

9.04

11.46

1.44

NA

NA

19.61

22.03

090 follow-up surgery. 25915......... ........ A

Amputation of

17.30

NA

NA

8.23

16.22

2.93

NA

NA

28.46

36.45

090 forearm. 25920......... ........ A

Amputate hand

8.85

NA

NA

6.72

7.57

1.35

NA

NA

16.92

17.77

090 at wrist. 25922......... ........ A

Amputate hand

7.47

NA

NA

6.40

6.89

1.12

NA

NA

14.99

15.48

090 at wrist. 25924......... ........ A

Amputation

8.63

NA

NA

6.71

7.75

1.32

NA

NA

16.66

17.70

090 follow-up surgery. 25927......... ........ A

Amputation of

8.91

NA

NA

8.62

10.92

1.27

NA

NA

18.80

21.10

090 hand. 25929......... ........ A

Amputation

7.64

NA

NA

5.42

5.76

1.14

NA

NA

14.20

14.54

090 follow-up surgery. 25931......... ........ A

Amputation

7.86

NA

NA

8.53

10.73

1.15

NA

NA

17.54

19.74

090 follow-up surgery. 25999......... ........ C

Forearm or

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY wrist surgery. 26010......... ........ A

Drainage of

1.54

4.02

5.18

1.51

1.60

0.18

5.74

6.90

3.23

3.32

010 finger abscess. 26011......... ........ A

Drainage of

2.19

6.29

8.18

1.98

2.24

0.33

8.81

10.70

4.50

4.76

010 finger abscess. 26020......... ........ A

Drain hand

4.90

NA

NA

4.75

5.20

0.73

NA

NA

10.38

10.83

090 tendon sheath. 26025......... ........ A

Drainage of

4.93

NA

NA

4.46

4.96

0.76

NA

NA

10.15

10.65

090 palm bursa. 26030......... ........ A

Drainage of

6.10

NA

NA

4.99

5.54

0.92

NA

NA

12.01

12.56

090 palm bursa(s). 26034......... ........ A

Treat hand bone 6.40

NA

NA

5.55

6.15

1.01

NA

NA

12.96

13.56

090 lesion. 26035......... ........ A

Decompress

11.05

NA

NA

8.01

7.91

1.47

NA

NA

20.53

20.43

090 fingers/hand. 26037......... ........ A

Decompress

7.42

NA

NA

5.51

6.12

1.13

NA

NA

14.06

14.67

090 fingers/hand. 26040......... ........ A

Release palm

3.33

NA

NA

3.60

3.94

0.53

NA

NA

7.46

7.80

090 contracture. 26045......... ........ A

Release palm

5.55

NA

NA

4.88

5.45

0.93

NA

NA

11.36

11.93

090 contracture. 26055......... ........ A

Incise finger

2.94

9.07

13.03

3.83

3.91

0.43 12.44

16.40

7.20

7.28

090 tendon sheath. 26060......... ........ A

Incision of

2.81

NA

NA

3.06

3.40

0.45

NA

NA

6.32

6.66

090 finger tendon. 26070......... ........ A

Explore/treat

3.68

NA

NA

3.04

3.28

0.48

NA

NA

7.20

7.44

090 hand joint. 26075......... ........ A

Explore/treat

3.78

NA

NA

3.41

3.69

0.53

NA

NA

7.72

8.00

090 finger joint. 26080......... ........ A

Explore/treat

4.29

NA

NA

4.34

4.72

0.66

NA

NA

9.29

9.67

090 finger joint. 26100......... ........ A

Biopsy hand

3.66

NA

NA

3.56

3.99

0.54

NA

NA

7.76

8.19

090 joint lining. 26105......... ........ A

Biopsy finger

3.70

NA

NA

3.74

4.11

0.59

NA

NA

8.03

8.40

090 joint lining. 26110......... ........ A

Biopsy finger

3.52

NA

NA

3.60

3.93

0.53

NA

NA

7.65

7.98

090 joint lining. 26115......... ........ A

Removal hand

3.85

9.84

12.28

4.21

4.63

0.59 14.28

16.72

8.65

9.07

090 lesion subcut. 26116......... ........ A

Removal hand

5.52

NA

NA

5.29

5.82

0.84

NA

NA

11.65

12.18

090 lesion, deep. 26117......... ........ A

Remove tumor,

8.54

NA

NA

6.21

6.85

1.26

NA

NA

16.01

16.65

090 hand/finger. 26121......... ........ A

Release palm

7.53

NA

NA

5.94

6.71

1.17

NA

NA

14.64

15.41

090 contracture. 26123......... ........ A

Release palm

10.53

NA

NA

8.23

8.70

1.43

NA

NA

20.19

20.66

090 contracture. 26125......... ........ A

Release palm

4.60

NA

NA

1.89

2.30

0.70

NA

NA

7.19

7.60

ZZZ contracture. 26130......... ........ A

Remove wrist

5.41

NA

NA

4.85

5.22

0.94

NA

NA

11.20

11.57

090 joint lining. 26135......... ........ A

Revise finger

6.95

NA

NA

5.49

6.22

1.07

NA

NA

13.51

14.24

090 joint, each. 26140......... ........ A

Revise finger

6.16

NA

NA

5.17

5.82

0.92

NA

NA

12.25

12.90

090 joint, each. 26145......... ........ A

Tendon

6.31

NA

NA

5.19

5.84

0.97

NA

NA

12.47

13.12

090 excision, palm/ finger.

[[Page 49108]]

26160......... ........ A

Remove tendon

3.40

9.02

11.53

3.92

4.07

0.49 12.91

15.42

7.81

7.96

090 sheath lesion. 26170......... ........ A

Removal of palm 4.76

NA

NA

4.36

4.80

0.69

NA

NA

9.81

10.25

090 tendon, each. 26180......... ........ A

Removal of

5.17

NA

NA

4.77

5.25

0.78

NA

NA

10.72

11.20

090 finger tendon. 26185......... ........ A

Remove finger

6.24

NA

NA

5.81

5.98

0.81

NA

NA

12.86

13.03

090 bone. 26200......... ........ A

Remove hand

5.50

NA

NA

4.58

5.16

0.88

NA

NA

10.96

11.54

090 bone lesion. 26205......... ........ A

Remove/graft

7.75

NA

NA

5.85

6.63

1.20

NA

NA

14.80

15.58

090 bone lesion. 26210......... ........ A

Removal of

5.14

NA

NA

4.74

5.25

0.79

NA

NA

10.67

11.18

090 finger lesion. 26215......... ........ A

Remove/graft

7.09

NA

NA

5.53

6.12

0.98

NA

NA

13.60

14.19

090 finger lesion. 26230......... ........ A

Partial removal 6.32

NA

NA

5.01

5.69

1.01

NA

NA

12.34

13.02

090 of hand bone. 26235......... ........ A

Partial

6.18

NA

NA

4.96

5.60

0.95

NA

NA

12.09

12.73

090 removal, finger bone. 26236......... ........ A

Partial

5.31

NA

NA

4.55

5.13

0.81

NA

NA

10.67

11.25

090 removal, finger bone. 26250......... ........ A

Extensive hand

7.54

NA

NA

5.21

6.13

1.07

NA

NA

13.82

14.74

090 surgery. 26255......... ........ A

Extensive hand 12.71

NA

NA

8.39

9.13

1.68

NA

NA

22.78

23.52

090 surgery. 26260......... ........ A

Extensive

7.02

NA

NA

5.36

5.98

1.01

NA

NA

13.39

14.01

090 finger surgery. 26261......... ........ A

Extensive

9.20

NA

NA

6.88

6.35

1.14

NA

NA

17.22

16.69

090 finger surgery. 26262......... ........ A

Partial removal 5.66

NA

NA

4.66

5.16

0.88

NA

NA

11.20

11.70

090 of finger. 26320......... ........ A

Removal of

3.97

NA

NA

3.78

4.18

0.59

NA

NA

8.34

8.74

090 implant from hand. 26340......... ........ A

Manipulate

2.50

NA

NA

4.60

4.81

0.39

NA

NA

7.49

7.70

090 finger w/ anesth. 26350......... ........ A

Repair finger/

5.98

NA

NA

9.45

13.32

0.93

NA

NA

16.36

20.23

090 hand tendon. 26352......... ........ A

Repair/graft

7.67

NA

NA

10.04

14.03

1.13

NA

NA

18.84

22.83

090 hand tendon. 26356......... ........ A

Repair finger/ 10.06

NA

NA

13.68

17.20

1.21

NA

NA

24.95

28.47

090 hand tendon. 26357......... ........ A

Repair finger/

8.57

NA

NA

10.26

14.29

1.33

NA

NA

20.16

24.19

090 hand tendon. 26358......... ........ A

Repair/graft

9.13

NA

NA

10.81

15.18

1.38

NA

NA

21.32

25.69

090 hand tendon. 26370......... ........ A

Repair finger/

7.10

NA

NA

9.50

13.71

1.12

NA

NA

17.72

21.93

090 hand tendon. 26372......... ........ A

Repair/graft

8.81

NA

NA

10.48

15.02

1.40

NA

NA

20.69

25.23

090 hand tendon. 26373......... ........ A

Repair finger/

8.21

NA

NA

10.16

14.57

1.23

NA

NA

19.60

24.01

090 hand tendon. 26390......... ........ A

Revise hand/

9.24

NA

NA

9.08

12.23

1.40

NA

NA

19.72

22.87

090 finger tendon. 26392......... ........ A

Repair/graft

10.30

NA

NA

11.02

15.30

1.57

NA

NA

22.89

27.17

090 hand tendon. 26410......... ........ A

Repair hand

4.62

NA

NA

7.56

10.85

0.73

NA

NA

12.91

16.20

090 tendon. 26412......... ........ A

Repair/graft

6.30

NA

NA

8.57

12.10

0.97

NA

NA

15.84

19.37

090 hand tendon. 26415......... ........ A

Excision, hand/ 8.33

NA

NA

6.71

10.51

0.98

NA

NA

16.02

19.82

090 finger tendon. 26416......... ........ A

Graft hand or

9.36

NA

NA

8.70

13.12

0.79

NA

NA

18.85

23.27

090 finger tendon. 26418......... ........ A

Repair finger

4.24

NA

NA

8.07

11.26

0.67

NA

NA

12.98

16.17

090 tendon. 26420......... ........ A

Repair/graft

6.76

NA

NA

8.75

12.41

1.07

NA

NA

16.58

20.24

090 finger tendon. 26426......... ........ A

Repair finger/

6.14

NA

NA

8.52

12.00

0.95

NA

NA

15.61

19.09

090 hand tendon. 26428......... ........ A

Repair/graft

7.20

NA

NA

9.19

12.69

1.09

NA

NA

17.48

20.98

090 finger tendon. 26432......... ........ A

Repair finger

4.01

NA

NA

6.71

9.37

0.64

NA

NA

11.36

14.02

090 tendon. 26433......... ........ A

Repair finger

4.55

NA

NA

6.93

9.83

0.72

NA

NA

12.20

15.10

090 tendon. 26434......... ........ A

Repair/graft

6.08

NA

NA

7.87

10.62

0.93

NA

NA

14.88

17.63

090 finger tendon. 26437......... ........ A

Realignment of

5.81

NA

NA

7.71

10.61

0.89

NA

NA

14.41

17.31

090 tendons. 26440......... ........ A

Release palm/

5.01

NA

NA

8.43

12.18

0.75

NA

NA

14.19

17.94

090 finger tendon. 26442......... ........ A

Release palm &

9.40

NA

NA

11.61

14.86

1.20

NA

NA

22.21

25.46

090 finger tendon. 26445......... ........ A

Release hand/

4.30

NA

NA

8.10

11.88

0.65

NA

NA

13.05

16.83

090 finger tendon. 26449......... ........ A

Release forearm/ 8.24

NA

NA

11.30

14.65

1.06

NA

NA

20.60

23.95

090 hand tendon. 26450......... ........ A

Incision of

3.66

NA

NA

5.11

6.78

0.59

NA

NA

9.36

11.03

090 palm tendon. 26455......... ........ A

Incision of

3.63

NA

NA

5.07

6.73

0.58

NA

NA

9.28

10.94

090 finger tendon. 26460......... ........ A

Incise hand/

3.45

NA

NA

5.01

6.61

0.55

NA

NA

9.01

10.61

090 finger tendon. 26471......... ........ A

Fusion of

5.72

NA

NA

7.66

10.35

0.88

NA

NA

14.26

16.95

090 finger tendons. 26474......... ........ A

Fusion of

5.31

NA

NA

7.48

10.41

0.76

NA

NA

13.55

16.48

090 finger tendons. 26476......... ........ A

Tendon

5.17

NA

NA

7.39

10.05

0.79

NA

NA

13.35

16.01

090 lengthening. 26477......... ........ A

Tendon

5.14

NA

NA

7.47

10.16

0.81

NA

NA

13.42

16.11

090 shortening. 26478......... ........ A

Lengthening of

5.79

NA

NA

7.67

10.80

0.90

NA

NA

14.36

17.49

090 hand tendon. 26479......... ........ A

Shortening of

5.73

NA

NA

7.66

10.59

0.92

NA

NA

14.31

17.24

090 hand tendon. 26480......... ........ A

Transplant hand 6.68

NA

NA

9.57

13.67

1.02

NA

NA

17.27

21.37

090 tendon. 26483......... ........ A

Transplant/

8.28

NA

NA

10.22

14.18

1.26

NA

NA

19.76

23.72

090 graft hand tendon. 26485......... ........ A

Transplant palm 7.69

NA

NA

9.94

14.01

1.15

NA

NA

18.78

22.85

090 tendon.

[[Page 49109]]

26489......... ........ A

Transplant/

9.66

NA

NA

10.29

11.62

1.26

NA

NA

21.21

22.54

090 graft palm tendon. 26490......... ........ A

Revise thumb

8.40

NA

NA

8.89

11.84

1.21

NA

NA

18.50

21.45

090 tendon. 26492......... ........ A

Tendon transfer 9.61

NA

NA

9.77

12.64

1.40

NA

NA

20.78

23.65

090 with graft. 26494......... ........ A

Hand tendon/

8.46

NA

NA

9.01

11.98

1.28

NA

NA

18.75

21.72

090 muscle transfer. 26496......... ........ A

Revise thumb

9.58

NA

NA

9.46

12.29

1.45

NA

NA

20.49

23.32

090 tendon. 26497......... ........ A

Finger tendon

9.56

NA

NA

9.42

12.53

1.41

NA

NA

20.39

23.50

090 transfer. 26498......... ........ A

Finger tendon

13.98

NA

NA

11.48

14.99

2.10

NA

NA

27.56

31.07

090 transfer. 26499......... ........ A

Revision of

8.97

NA

NA

8.72

11.96

1.35

NA

NA

19.04

22.28

090 finger. 26500......... ........ A

Hand tendon

5.95

NA

NA

7.75

10.52

0.90

NA

NA

14.60

17.37

090 reconstruction. 26502......... ........ A

Hand tendon

7.13

NA

NA

8.34

11.10

1.13

NA

NA

16.60

19.36

090 reconstruction. 26504......... ........ A

Hand tendon

7.46

NA

NA

8.59

11.58

1.24

NA

NA

17.29

20.28

090 reconstruction. 26508......... ........ A

Release thumb

6.00

NA

NA

7.75

10.70

0.98

NA

NA

14.73

17.68

090 contracture. 26510......... ........ A

Thumb tendon

5.42

NA

NA

7.56

10.40

0.79

NA

NA

13.77

16.61

090 transfer. 26516......... ........ A

Fusion of

7.14

NA

NA

8.22

11.23

1.10

NA

NA

16.46

19.47

090 knuckle joint. 26517......... ........ A

Fusion of

8.88

NA

NA

9.21

12.43

1.41

NA

NA

19.50

22.72

090 knuckle joints. 26518......... ........ A

Fusion of

9.07

NA

NA

9.24

12.35

1.35

NA

NA

19.66

22.77

090 knuckle joints. 26520......... ........ A

Release knuckle 5.29

NA

NA

8.81

12.62

0.80

NA

NA

14.90

18.71

090 contracture. 26525......... ........ A

Release finger

5.32

NA

NA

8.82

12.68

0.81

NA

NA

14.95

18.81

090 contracture. 26530......... ........ A

Revise knuckle

6.68

NA

NA

5.43

5.96

1.04

NA

NA

13.15

13.68

090 joint. 26531......... ........ A

Revise knuckle

7.90

NA

NA

6.15

6.88

1.17

NA

NA

15.22

15.95

090 with implant. 26535......... ........ A

Revise finger

5.23

NA

NA

4.04

3.82

0.71

NA

NA

9.98

9.76

090 joint. 26536......... ........ A

Revise/implant

6.36

NA

NA

9.14

9.52

0.96

NA

NA

16.46

16.84

090 finger joint. 26540......... ........ A

Repair hand

6.42

NA

NA

7.98

10.90

0.99

NA

NA

15.39

18.31

090 joint. 26541......... ........ A

Repair hand

8.61

NA

NA

9.04

12.30

1.28

NA

NA

18.93

22.19

090 joint with graft. 26542......... ........ A

Repair hand

6.77

NA

NA

8.13

11.06

1.02

NA

NA

15.92

18.85

090 joint with graft. 26545......... ........ A

Reconstruct

6.91

NA

NA

8.32

11.18

1.05

NA

NA

16.28

19.14

090 finger joint. 26546......... ........ A

Repair nonunion 10.41

NA

NA

11.42

14.13

1.44

NA

NA

23.27

25.98

090 hand. 26548......... ........ A

Reconstruct

8.02

NA

NA

8.78

11.83

1.20

NA

NA

18.00

21.05

090 finger joint. 26550......... ........ A

Construct thumb 21.46

NA

NA

15.40

17.04

2.45

NA

NA

39.31

40.95

090 replacement. 26551......... ........ A

Great toe-hand 48.09

NA

NA

21.71

29.76

7.96

NA

NA

77.76

85.81

090 transfer. 26553......... ........ A

Single

47.78

NA

NA

20.29

22.08

2.41

NA

NA

70.48

72.27

090 transfer, toe- hand. 26554......... ........ A

Double

56.57

NA

NA

19.56

33.04

9.41

NA

NA

85.54

99.02

090 transfer, toe- hand. 26555......... ........ A

Positional

16.86

NA

NA

13.88

17.11

2.48

NA

NA

33.22

36.45

090 change of finger. 26556......... ........ A

Toe joint

49.27

NA

NA

17.86

29.46

2.57

NA

NA

69.70

81.30

090 transfer. 26560......... ........ A

Repair of web

5.37

NA

NA

7.09

9.12

0.85

NA

NA

13.31

15.34

090 finger. 26561......... ........ A

Repair of web

10.90

NA

NA

9.41

11.61

1.45

NA

NA

21.76

23.96

090 finger. 26562......... ........ A

Repair of web

16.30

NA

NA

13.88

16.33

2.23

NA

NA

32.41

34.86

090 finger. 26565......... ........ A

Correct

6.73

NA

NA

7.90

10.98

1.00

NA

NA

15.63

18.71

090 metacarpal flaw. 26567......... ........ A

Correct finger

6.81

NA

NA

8.15

11.00

1.04

NA

NA

16.00

18.85

090 deformity. 26568......... ........ A

Lengthen

9.07

NA

NA

10.13

14.11

1.49

NA

NA

20.69

24.67

090 metacarpal/ finger. 26580......... ........ A

Repair hand

19.40

NA

NA

11.01

12.98

2.28

NA

NA

32.69

34.66

090 deformity. 26587......... ........ A

Reconstruct

14.28

NA

NA

8.43

9.02

1.53

NA

NA

24.24

24.83

090 extra finger. 26590......... ........ A

Repair finger

18.43

NA

NA

10.52

13.09

2.77

NA

NA

31.72

34.29

090 deformity. 26591......... ........ A

Repair muscles

3.25

NA

NA

6.26

8.78

0.48

NA

NA

9.99

12.51

090 of hand. 26593......... ........ A

Release muscles 5.30

NA

NA

7.73

10.28

0.78

NA

NA

13.81

16.36

090 of hand. 26596......... ........ A

Excision

8.94

NA

NA

7.48

8.49

1.43

NA

NA

17.85

18.86

090 constricting tissue. 26600......... ........ A

Treat

2.40

3.83

3.67

3.48

2.86

0.30

6.53

6.37

6.18

5.56

090 metacarpal fracture. 26605......... ........ A

Treat

2.85

4.09

4.44

3.50

3.61

0.49

7.43

7.78

6.84

6.95

090 metacarpal fracture. 26607......... ........ A

Treat

5.35

NA

NA

4.88

5.92

0.87

NA

NA

11.10

12.14

090 metacarpal fracture. 26608......... ........ A

Treat

5.35

NA

NA

5.25

6.00

0.88

NA

NA

11.48

12.23

090 metacarpal fracture. 26615......... ........ A

Treat

5.32

NA

NA

4.75

5.16

0.86

NA

NA

10.93

11.34

090 metacarpal fracture. 26641......... ........ A

Treat thumb

3.93

4.17

4.47

3.52

3.53

0.39

8.49

8.79

7.84

7.85

090 dislocation. 26645......... ........ A

Treat thumb

4.40

4.62

5.03

3.93

4.13

0.67

9.69

10.10

9.00

9.20

090 fracture. 26650......... ........ A

Treat thumb

5.71

NA

NA

5.62

6.42

0.94

NA

NA

12.27

13.07

090 fracture. 26665......... ........ A

Treat thumb

7.65

NA

NA

5.87

6.43

0.90

NA

NA

14.42

14.98

090 fracture. 26670......... ........ A

Treat hand

3.68

3.55

4.08

2.96

2.95

0.39

7.62

8.15

7.03

7.02

090 dislocation. 26675......... ........ A

Treat hand

4.63

4.85

5.32

4.15

4.39

0.77 10.25

10.72

9.55

9.79

090 dislocation. 26676......... ........ A

Pin hand

5.51

NA

NA

5.57

6.41

0.91

NA

NA

11.99

12.83

090 dislocation. 26685......... ........ A

Treat hand

7.03

NA

NA

5.44

5.97

1.09

NA

NA

13.56

14.09

090 dislocation. 26686......... ........ A

Treat hand

7.99

NA

NA

6.12

6.71

1.24

NA

NA

15.35

15.94

090 dislocation. 26700......... ........ A

Treat knuckle

3.68

3.32

3.65

2.95

2.88

0.35

7.35

7.68

6.98

6.91

090 dislocation. 26705......... ........ A

Treat knuckle

4.18

4.82

5.20

4.10

4.25

0.66

9.66

10.04

8.94

9.09

090 dislocation. 26706......... ........ A

Pin knuckle

5.11

NA

NA

4.69

4.99

0.81

NA

NA

10.61

10.91

090 dislocation. 26715......... ........ A

Treat knuckle

5.73

NA

NA

4.92

5.36

0.91

NA

NA

11.56

12.00

090 dislocation. 26720......... ........ A

Treat finger

1.66

2.59

2.73

2.31

2.12

0.24

4.49

4.63

4.21

4.02

090 fracture, each. 26725......... ........ A

Treat finger

3.33

4.10

4.60

3.42

3.48

0.53

7.96

8.46

7.28

7.34

090 fracture, each.

[[Page 49110]]

26727......... ........ A

Treat finger

5.22

NA

NA

5.21

5.98

0.84

NA

NA

11.27

12.04

090 fracture, each. 26735......... ........ A

Treat finger

5.97

NA

NA

5.00

5.41

0.95

NA

NA

11.92

12.33

090 fracture, each. 26740......... ........ A

Treat finger

1.94

2.95

3.09

2.66

2.69

0.31

5.20

5.34

4.91

4.94

090 fracture, each. 26742......... ........ A

Treat finger

3.84

4.33

4.83

3.62

3.82

0.58

8.75

9.25

8.04

8.24

090 fracture, each. 26746......... ........ A

Treat finger

5.80

NA

NA

4.96

5.41

0.91

NA

NA

11.67

12.12

090 fracture, each. 26750......... ........ A

Treat finger

1.70

2.25

2.42

2.26

2.07

0.22

4.17

4.34

4.18

3.99

090 fracture, each. 26755......... ........ A

Treat finger

3.10

3.79

4.26

2.98

3.00

0.42

7.31

7.78

6.50

6.52

090 fracture, each. 26756......... ........ A

Pin finger

4.38

NA

NA

4.86

5.51

0.71

NA

NA

9.95

10.60

090 fracture, each. 26765......... ........ A

Treat finger

4.16

NA

NA

4.02

4.30

0.66

NA

NA

8.84

9.12

090 fracture, each. 26770......... ........ A

Treat finger

3.02

2.91

3.30

2.53

2.44

0.27

6.20

6.59

5.82

5.73

090 dislocation. 26775......... ........ A

Treat finger

3.70

4.54

5.03

3.81

3.81

0.54

8.78

9.27

8.05

8.05

090 dislocation. 26776......... ........ A

Pin finger

4.79

NA

NA

5.01

5.75

0.77

NA

NA

10.57

11.31

090 dislocation. 26785......... ........ A

Treat finger

4.20

NA

NA

4.08

4.42

0.68

NA

NA

8.96

9.30

090 dislocation. 26820......... ........ A

Thumb fusion

8.25

NA

NA

8.71

12.12

1.30

NA

NA

18.26

21.67

090 with graft. 26841......... ........ A

Fusion of thumb 7.12

NA

NA

8.69

12.10

1.18

NA

NA

16.99

20.40

090 26842......... ........ A

Thumb fusion

8.29

NA

NA

8.95

12.27

1.32

NA

NA

18.56

21.88

090 with graft. 26843......... ........ A

Fusion of hand

7.60

NA

NA

8.17

11.31

1.15

NA

NA

16.92

20.06

090 joint. 26844......... ........ A

Fusion/graft of 8.78

NA

NA

9.14

12.31

1.33

NA

NA

19.25

22.42

090 hand joint. 26850......... ........ A

Fusion of

6.96

NA

NA

8.29

11.22

1.06

NA

NA

16.31

19.24

090 knuckle. 26852......... ........ A

Fusion of

8.51

NA

NA

9.12

11.95

1.22

NA

NA

18.85

21.68

090 knuckle with graft. 26860......... ........ A

Fusion of

4.68

NA

NA

7.54

10.28

0.73

NA

NA

12.95

15.69

090 finger joint. 26861......... ........ A

Fusion of

1.74

NA

NA

0.71

0.88

0.27

NA

NA

2.72

2.89

ZZZ finger jnt, add-on. 26862......... ........ A

Fusion/graft of 7.36

NA

NA

8.68

11.43

1.10

NA

NA

17.14

19.89

090 finger joint. 26863......... ........ A

Fuse/graft

3.89

NA

NA

1.58

1.98

0.56

NA

NA

6.03

6.43

ZZZ added joint. 26910......... ........ A

Amputate

7.59

NA

NA

8.30

10.49

1.16

NA

NA

17.05

19.24

090 metacarpal bone. 26951......... ........ A

Amputation of

5.75

NA

NA

8.39

9.71

0.71

NA

NA

14.85

16.17

090 finger/thumb. 26952......... ........ A

Amputation of

6.30

NA

NA

7.94

10.73

0.95

NA

NA

15.19

17.98

090 finger/thumb. 26989......... ........ C

Hand/finger

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery. 26990......... ........ A

Drainage of

7.77

NA

NA

6.29

6.98

1.22

NA

NA

15.28

15.97

090 pelvis lesion. 26991......... ........ A

Drainage of

6.91

8.60

10.52

4.85

5.29

1.11 16.62

18.54

12.87

13.31

090 pelvis bursa. 26992......... ........ A

Drainage of

13.30

NA

NA

8.64

9.95

2.16

NA

NA

24.10

25.41

090 bone lesion. 27000......... ........ A

Incision of hip 5.61

NA

NA

4.55

5.10

0.98

NA

NA

11.14

11.69

090 tendon. 27001......... ........ A

Incision of hip 6.99

NA

NA

5.23

5.88

1.24

NA

NA

13.46

14.11

090 tendon. 27003......... ........ A

Incision of hip 7.63

NA

NA

5.82

6.32

1.12

NA

NA

14.57

15.07

090 tendon. 27005......... ........ A

Incision of hip 9.89

NA

NA

6.79

7.56

1.72

NA

NA

18.40

19.17

090 tendon. 27006......... ........ A

Incision of hip 9.91

NA

NA

6.84

7.70

1.69

NA

NA

18.44

19.30

090 tendons. 27025......... ........ A

Incision of hip/ 12.57

NA

NA

8.10

8.44

1.84

NA

NA

22.51

22.85

090 thigh fascia. 27030......... ........ A

Drainage of hip 13.47

NA

NA

8.10

9.26

2.26

NA

NA

23.83

24.99

090 joint. 27033......... ........ A

Exploration of 13.91

NA

NA

8.45

9.55

2.32

NA

NA

24.68

25.78

090 hip joint. 27035......... ........ A

Denervation of 17.14

NA

NA

9.53

10.81

2.15

NA

NA

28.82

30.10

090 hip joint. 27036......... ........ A

Excision of hip 14.10

NA

NA

8.98

9.75

2.26

NA

NA

25.34

26.11

090 joint/muscle. 27040......... ........ A

Biopsy of soft

2.87

5.14

5.21

1.81

1.96

0.27

8.28

8.35

4.95

5.10

010 tissues. 27041......... ........ A

Biopsy of soft 10.00

NA

NA

5.79

6.43

1.35

NA

NA

17.14

17.78

090 tissues. 27047......... ........ A

Remove hip/

7.44

7.12

7.11

4.57

4.72

1.03 15.59

15.58

13.04

13.19

090 pelvis lesion. 27048......... ........ A

Remove hip/

6.36

NA

NA

4.65

4.76

0.92

NA

NA

11.93

12.04

090 pelvis lesion. 27049......... ........ A

Remove tumor,

15.12

NA

NA

8.24

8.36

2.06

NA

NA

25.42

25.54

090 hip/pelvis. 27050......... ........ A

Biopsy of

4.59

NA

NA

3.79

4.26

0.60

NA

NA

8.98

9.45

090 sacroiliac joint. 27052......... ........ A

Biopsy of hip

7.21

NA

NA

5.68

5.83

1.08

NA

NA

13.97

14.12

090 joint. 27054......... ........ A

Removal of hip

9.01

NA

NA

6.49

7.13

1.47

NA

NA

16.97

17.61

090 joint lining. 27060......... ........ A

Removal of

5.72

NA

NA

4.38

4.37

0.80

NA

NA

10.90

10.89

090 ischial bursa. 27062......... ........ A

Remove femur

5.60

NA

NA

4.63

5.05

0.93

NA

NA

11.16

11.58

090 lesion/bursa. 27065......... ........ A

Removal of hip

6.37

NA

NA

5.12

5.36

1.01

NA

NA

12.50

12.74

090 bone lesion. 27066......... ........ A

Removal of hip 10.97

NA

NA

7.46

8.20

1.79

NA

NA

20.22

20.96

090 bone lesion. 27067......... ........ A

Remove/graft

14.47

NA

NA

8.80

10.20

1.84

NA

NA

25.11

26.51

090 hip bone lesion. 27070......... ........ A

Partial removal 11.36

NA

NA

7.94

8.83

1.74

NA

NA

21.04

21.93

090 of hip bone. 27071......... ........ A

Partial removal 12.16

NA

NA

8.54

9.73

1.92

NA

NA

22.62

23.81

090 of hip bone.

[[Page 49111]]

27075......... ........ A

Extensive hip

36.71

NA

NA

16.62

18.56

5.64

NA

NA

58.97

60.91

090 surgery. 27076......... ........ A

Extensive hip

24.17

NA

NA

12.75

14.07

3.70

NA

NA

40.62

41.94

090 surgery. 27077......... ........ A

Extensive hip

42.48

NA

NA

19.99

21.99

6.12

NA

NA

68.59

70.59

090 surgery. 27078......... ........ A

Extensive hip

14.44

NA

NA

8.79

9.65

2.22

NA

NA

25.45

26.31

090 surgery. 27079......... ........ A

Extensive hip

14.81

NA

NA

7.52

9.04

1.94

NA

NA

24.27

25.79

090 surgery. 27080......... ........ A

Removal of tail 6.74

NA

NA

4.72

4.80

0.93

NA

NA

12.39

12.47

090 bone. 27086......... ........ A

Remove hip

1.87

3.78

4.36

1.54

1.75

0.25

5.90

6.48

3.66

3.87

010 foreign body. 27087......... ........ A

Remove hip

8.65

NA

NA

5.66

6.41

1.35

NA

NA

15.66

16.41

090 foreign body. 27090......... ........ A

Removal of hip 11.49

NA

NA

7.44

8.45

1.94

NA

NA

20.87

21.88

090 prosthesis. 27091......... ........ A

Removal of hip 24.07

NA

NA

13.05

13.76

3.84

NA

NA

40.96

41.67

090 prosthesis. 27093......... ........ A

Injection for

1.30

3.09

4.12

0.44

0.47

0.13

4.52

5.55

1.87

1.90

000 hip x-ray. 27095......... ........ A

Injection for

1.50

3.73

5.22

0.50

0.52

0.14

5.37

6.86

2.14

2.16

000 hip x-ray. 27096......... ........ A

Inject

1.40

2.54

3.90

0.33

0.33

0.08

4.02

5.38

1.81

1.81

000 sacroiliac joint. 27097......... ........ A

Revision of hip 9.09

NA

NA

6.35

6.40

1.57

NA

NA

17.01

17.06

090 tendon. 27098......... ........ A

Transfer tendon 9.12

NA

NA

4.96

6.51

0.95

NA

NA

15.03

16.58

090 to pelvis. 27100......... ........ A

Transfer of

11.12

NA

NA

7.39

8.34

1.85

NA

NA

20.36

21.31

090 abdominal muscle. 27105......... ........ A

Transfer of

11.81

NA

NA

7.93

8.85

1.72

NA

NA

21.46

22.38

090 spinal muscle. 27110......... ........ A

Transfer of

13.54

NA

NA

8.61

8.99

2.18

NA

NA

24.33

24.71

090 iliopsoas muscle. 27111......... ........ A

Transfer of

12.37

NA

NA

8.13

8.88

1.94

NA

NA

22.44

23.19

090 iliopsoas muscle. 27120......... ........ A

Reconstruction 19.00

NA

NA

10.79

11.58

3.08

NA

NA

32.87

33.66

090 of hip socket. 27122......... ........ A

Reconstruction 15.86

NA

NA

9.49

10.65

2.61

NA

NA

27.96

29.12

090 of hip socket. 27125......... ........ A

Partial hip

16.39

NA

NA

9.69

10.39

2.54

NA

NA

28.62

29.32

090 replacement. 27130......... ........ A

Total hip

17.40

NA

NA

10.24

12.54

3.50

NA

NA

31.14

33.44

090 arthroplasty. 27132......... ........ A

Total hip

25.41

NA

NA

13.57

15.12

4.04

NA

NA

43.02

44.57

090 arthroplasty. 27134......... ........ A

Revise hip

30.07

NA

NA

14.86

17.06

4.94

NA

NA

49.87

52.07

090 joint replacement. 27137......... ........ A

Revise hip

22.49

NA

NA

11.85

13.41

3.67

NA

NA

38.01

39.57

090 joint replacement. 27138......... ........ A

Revise hip

23.49

NA

NA

12.24

13.85

3.84

NA

NA

39.57

41.18

090 joint replacement. 27140......... ........ A

Transplant

12.58

NA

NA

7.81

9.01

2.11

NA

NA

22.50

23.70

090 femur ridge. 27146......... ........ A

Incision of hip 18.64

NA

NA

10.74

11.78

2.96

NA

NA

32.34

33.38

090 bone. 27147......... ........ A

Revision of hip 21.79

NA

NA

11.94

12.92

3.57

NA

NA

37.30

38.28

090 bone. 27151......... ........ A

Incision of hip 23.84

NA

NA

12.44

9.07

3.91

NA

NA

40.19

36.82

090 bones. 27156......... ........ A

Revision of hip 25.95

NA

NA

13.54

15.43

4.21

NA

NA

43.70

45.59

090 bones. 27158......... ........ A

Revision of

20.79

NA

NA

7.19

10.03

3.16

NA

NA

31.14

33.98

090 pelvis. 27161......... ........ A

Incision of

17.64

NA

NA

10.42

11.68

2.94

NA

NA

31.00

32.26

090 neck of femur. 27165......... ........ A

Incision/

19.97

NA

NA

11.73

12.62

3.10

NA

NA

34.80

35.69

090 fixation of femur. 27170......... ........ A

Repair/graft

17.40

NA

NA

9.82

10.93

2.81

NA

NA

30.03

31.14

090 femur head/ neck. 27175......... ........ A

Treat slipped

9.23

NA

NA

5.80

6.45

1.46

NA

NA

16.49

17.14

090 epiphysis. 27176......... ........ A

Treat slipped

12.69

NA

NA

8.26

8.82

2.22

NA

NA

23.17

23.73

090 epiphysis. 27177......... ........ A

Treat slipped

15.84

NA

NA

9.69

10.59

2.61

NA

NA

28.14

29.04

090 epiphysis. 27178......... ........ A

Treat slipped

12.69

NA

NA

8.26

8.38

2.08

NA

NA

23.03

23.15

090 epiphysis. 27179......... ........ A

Revise head/

13.74

NA

NA

8.56

9.63

2.25

NA

NA

24.55

25.62

090 neck of femur. 27181......... ........ A

Treat slipped

15.90

NA

NA

9.83

10.11

1.57

NA

NA

27.30

27.58

090 epiphysis. 27185......... ........ A

Revision of

9.59

NA

NA

6.69

7.31

2.39

NA

NA

18.67

19.29

090 femur epiphysis. 27187......... ........ A

Reinforce hip

14.00

NA

NA

8.72

9.92

2.37

NA

NA

25.09

26.29

090 bones. 27193......... ........ A

Treat pelvic

5.92

4.65

4.98

4.78

5.01

0.96 11.53

11.86

11.66

11.89

090 ring fracture. 27194......... ........ A

Treat pelvic

10.00

NA

NA

6.62

7.39

1.65

NA

NA

18.27

19.04

090 ring fracture. 27200......... ........ A

Treat tail bone 1.84

2.09

2.19

2.24

2.17

0.28

4.21

4.31

4.36

4.29

090 fracture. 27202......... ........ A

Treat tail bone 7.21

NA

NA

11.28

15.47

1.06

NA

NA

19.55

23.74

090 fracture. 27215......... ........ A

Treat pelvic

10.39

NA

NA

6.53

6.94

1.97

NA

NA

18.89

19.30

090 fracture(s). 27216......... ........ A

Treat pelvic

15.65

NA

NA

9.25

9.51

2.63

NA

NA

27.53

27.79

090 ring fracture. 27217......... ........ A

Treat pelvic

14.57

NA

NA

8.70

9.78

2.41

NA

NA

25.68

26.76

090 ring fracture. 27218......... ........ A

Treat pelvic

20.85

NA

NA

11.41

11.40

3.48

NA

NA

35.74

35.73

090 ring fracture. 27220......... ........ A

Treat hip

6.65

5.28

5.61

5.18

5.52

1.07 13.00

13.33

12.90

13.24

090 socket fracture. 27222......... ........ A

Treat hip

13.88

NA

NA

8.50

9.60

2.19

NA

NA

24.57

25.67

090 socket fracture. 27226......... ........ A

Treat hip wall 15.37

NA

NA

9.00

8.11

2.48

NA

NA

26.85

25.96

090 fracture. 27227......... ........ A

Treat hip

25.13

NA

NA

13.44

14.91

4.05

NA

NA

42.62

44.09

090 fracture(s). 27228......... ........ A

Treat hip

29.05

NA

NA

15.03

16.97

4.66

NA

NA

48.74

50.68

090 fracture(s). 27230......... ........ A

Treat thigh

5.61

4.98

5.38

4.91

5.05

0.95 11.54

11.94

11.47

11.61

090 fracture. 27232......... ........ A

Treat thigh

11.62

NA

NA

6.00

6.88

1.85

NA

NA

19.47

20.35

090 fracture. 27235......... ........ A

Treat thigh

12.80

NA

NA

8.05

9.10

2.11

NA

NA

22.96

24.01

090 fracture. 27236......... ........ A

Treat thigh

14.54

NA

NA

9.10

10.56

2.71

NA

NA

26.35

27.81

090 fracture. 27238......... ........ A

Treat thigh

5.57

NA

NA

4.69

5.03

0.89

NA

NA

11.15

11.49

090 fracture. 27240......... ........ A

Treat thigh

13.56

NA

NA

8.10

9.13

2.16

NA

NA

23.82

24.85

090 fracture. 27244......... ........ A

Treat thigh

17.00

NA

NA

9.71

10.90

2.77

NA

NA

29.48

30.67

090 fracture. 27245......... ........ A

Treat thigh

21.01

NA

NA

11.46

13.17

3.52

NA

NA

35.99

37.70

090 fracture. 27246......... ........ A

Treat thigh

4.70

3.93

4.33

3.97

4.31

0.81

9.44

9.84

9.48

9.82

090 fracture.

[[Page 49112]]

27248......... ........ A

Treat thigh

10.73

NA

NA

7.01

7.91

1.81

NA

NA

19.55

20.45

090 fracture. 27250......... ........ A

Treat hip

7.12

NA

NA

4.27

4.53

0.62

NA

NA

12.01

12.27

090 dislocation. 27252......... ........ A

Treat hip

10.85

NA

NA

6.52

7.20

1.66

NA

NA

19.03

19.71

090 dislocation. 27253......... ........ A

Treat hip

13.38

NA

NA

8.26

9.40

2.24

NA

NA

23.88

25.02

090 dislocation. 27254......... ........ A

Treat hip

18.71

NA

NA

10.56

11.66

3.17

NA

NA

32.44

33.54

090 dislocation. 27256......... ........ A

Treat hip

4.23

2.39

3.24

1.39

1.91

0.46

7.08

7.93

6.08

6.60

010 dislocation. 27257......... ........ A

Treat hip

5.33

NA

NA

2.57

2.75

0.69

NA

NA

8.59

8.77

010 dislocation. 27258......... ........ A

Treat hip

15.95

NA

NA

9.45

10.52

2.64

NA

NA

28.04

29.11

090 dislocation. 27259......... ........ A

Treat hip

22.95

NA

NA

12.91

13.82

3.74

NA

NA

39.60

40.51

090 dislocation. 27265......... ........ A

Treat hip

5.04

NA

NA

3.98

4.59

0.63

NA

NA

9.65

10.26

090 dislocation. 27266......... ........ A

Treat hip

7.60

NA

NA

5.55

6.14

1.29

NA

NA

14.44

15.03

090 dislocation. 27275......... ........ A

Manipulation of 2.27

NA

NA

1.89

2.05

0.39

NA

NA

4.55

4.71

010 hip joint. 27280......... ........ A

Fusion of

14.39

NA

NA

9.05

9.96

2.53

NA

NA

25.97

26.88

090 sacroiliac joint. 27282......... ........ A

Fusion of pubic 11.62

NA

NA

7.83

7.96

1.86

NA

NA

21.31

21.44

090 bones. 27284......... ........ A

Fusion of hip

24.85

NA

NA

12.86

14.29

3.92

NA

NA

41.63

43.06

090 joint. 27286......... ........ A

Fusion of hip

24.89

NA

NA

13.47

15.21

3.12

NA

NA

41.48

43.22

090 joint. 27290......... ........ A

Amputation of

24.27

NA

NA

12.53

13.68

3.43

NA

NA

40.23

41.38

090 leg at hip. 27295......... ........ A

Amputation of

19.46

NA

NA

9.79

10.93

2.95

NA

NA

32.20

33.34

090 leg at hip. 27299......... ........ C

Pelvis/hip

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY joint surgery. 27301......... ........ A

Drain thigh/

6.60

8.23

9.61

4.66

5.02

1.04 15.87

17.25

12.30

12.66

090 knee lesion. 27303......... ........ A

Drainage of

8.45

NA

NA

6.07

6.75

1.43

NA

NA

15.95

16.63

090 bone lesion. 27305......... ........ A

Incise thigh

6.03

NA

NA

4.63

5.04

1.01

NA

NA

11.67

12.08

090 tendon & fascia. 27306......... ........ A

Incision of

4.61

NA

NA

4.07

4.56

0.85

NA

NA

9.53

10.02

090 thigh tendon. 27307......... ........ A

Incision of

5.91

NA

NA

4.81

5.24

1.04

NA

NA

11.76

12.19

090 thigh tendons. 27310......... ........ A

Exploration of

9.80

NA

NA

6.83

7.39

1.61

NA

NA

18.24

18.80

090 knee joint. 27315......... ........ A

Partial

7.02

NA

NA

5.44

5.07

1.09

NA

NA

13.55

13.18

090 removal, thigh nerve. 27320......... ........ A

Partial

6.29

NA

NA

4.75

5.11

1.06

NA

NA

12.10

12.46

090 removal, thigh nerve. 27323......... ........ A

Biopsy, thigh

2.28

4.09

3.66

1.87

1.88

0.24

6.61

6.18

4.39

4.40

010 soft tissues. 27324......... ........ A

Biopsy, thigh

4.89

NA

NA

3.85

4.10

0.75

NA

NA

9.49

9.74

090 soft tissues. 27327......... ........ A

Removal of

4.46

6.08

6.01

3.61

3.69

0.64 11.18

11.11

8.71

8.79

090 thigh lesion. 27328......... ........ A

Removal of

5.56

NA

NA

4.07

4.30

0.84

NA

NA

10.47

10.70

090 thigh lesion. 27329......... ........ A

Remove tumor,

15.60

NA

NA

8.58

8.91

2.14

NA

NA

26.32

26.65

090 thigh/knee. 27330......... ........ A

Biopsy, knee

4.96

NA

NA

4.12

4.46

0.86

NA

NA

9.94

10.28

090 joint lining. 27331......... ........ A

Explore/treat

5.87

NA

NA

4.84

5.35

1.02

NA

NA

11.73

12.24

090 knee joint. 27332......... ........ A

Removal of knee 8.26

NA

NA

6.15

6.88

1.43

NA

NA

15.84

16.57

090 cartilage. 27333......... ........ A

Removal of knee 7.35

NA

NA

5.73

6.44

1.26

NA

NA

14.34

15.05

090 cartilage. 27334......... ........ A

Remove knee

8.99

NA

NA

6.49

7.18

1.51

NA

NA

16.99

17.68

090 joint lining. 27335......... ........ A

Remove knee

10.35

NA

NA

7.06

7.93

1.74

NA

NA

19.15

20.02

090 joint lining. 27340......... ........ A

Removal of

4.17

NA

NA

4.05

4.43

0.72

NA

NA

8.94

9.32

090 kneecap bursa. 27345......... ........ A

Removal of knee 5.91

NA

NA

4.89

5.44

1.00

NA

NA

11.80

12.35

090 cyst. 27347......... ........ A

Remove knee

6.52

NA

NA

5.26

5.38

0.98

NA

NA

12.76

12.88

090 cyst. 27350......... ........ A

Removal of

8.46

NA

NA

6.29

7.00

1.41

NA

NA

16.16

16.87

090 kneecap. 27355......... ........ A

Remove femur

7.82

NA

NA

5.87

6.55

1.32

NA

NA

15.01

15.69

090 lesion. 27356......... ........ A

Remove femur

9.89

NA

NA

6.86

7.60

1.65

NA

NA

18.40

19.14

090 lesion/graft. 27357......... ........ A

Remove femur

10.93

NA

NA

7.54

8.41

1.95

NA

NA

20.42

21.29

090 lesion/graft. 27358......... ........ A

Remove femur

4.73

NA

NA

1.90

2.37

0.82

NA

NA

7.45

7.92

ZZZ lesion/ fixation. 27360......... ........ A

Partial

11.26

NA

NA

8.13

9.20

1.83

NA

NA

21.22

22.29

090 removal, leg bone(s). 27365......... ........ A

Extensive leg

17.85

NA

NA

10.52

11.39

2.79

NA

NA

31.16

32.03

090 surgery. 27370......... ........ A

Injection for

0.96

2.82

3.50

0.33

0.32

0.08

3.86

4.54

1.37

1.36

000 knee x-ray. 27372......... ........ A

Removal of

5.06

8.34

9.62

4.05

4.53

0.84 14.24

15.52

9.95

10.43

090 foreign body. 27380......... ........ A

Repair of

7.27

NA

NA

6.08

6.98

1.24

NA

NA

14.59

15.49

090 kneecap tendon. 27381......... ........ A

Repair/graft

10.56

NA

NA

7.56

8.71

1.79

NA

NA

19.91

21.06

090 kneecap tendon. 27385......... ........ A

Repair of thigh 7.93

NA

NA

6.36

7.31

1.36

NA

NA

15.65

16.60

090 muscle. 27386......... ........ A

Repair/graft of 10.90

NA

NA

7.98

9.13

1.85

NA

NA

20.73

21.88

090 thigh muscle. 27390......... ........ A

Incision of

5.38

NA

NA

4.57

4.98

0.92

NA

NA

10.87

11.28

090 thigh tendon. 27391......... ........ A

Incision of

7.31

NA

NA

5.52

6.30

1.23

NA

NA

14.06

14.84

090 thigh tendons.

[[Page 49113]]

27392......... ........ A

Incision of

9.43

NA

NA

6.72

7.37

1.57

NA

NA

17.72

18.37

090 thigh tendons. 27393......... ........ A

Lengthening of

6.44

NA

NA

5.01

5.63

1.10

NA

NA

12.55

13.17

090 thigh tendon. 27394......... ........ A

Lengthening of

8.61

NA

NA

6.19

6.96

1.47

NA

NA

16.27

17.04

090 thigh tendons. 27395......... ........ A

Lengthening of 12.01

NA

NA

7.99

8.99

2.04

NA

NA

22.04

23.04

090 thigh tendons. 27396......... ........ A

Transplant of

7.97

NA

NA

5.93

6.73

1.34

NA

NA

15.24

16.04

090 thigh tendon. 27397......... ........ A

Transplants of 12.38

NA

NA

8.42

8.89

1.82

NA

NA

22.62

23.09

090 thigh tendons. 27400......... ........ A

Revise thigh

9.13

NA

NA

6.17

6.98

1.31

NA

NA

16.61

17.42

090 muscles/ tendons. 27403......... ........ A

Repair of knee

8.44

NA

NA

6.09

6.91

1.44

NA

NA

15.97

16.79

090 cartilage. 27405......... ........ A

Repair of knee

8.88

NA

NA

6.44

7.23

1.51

NA

NA

16.83

17.62

090 ligament. 27407......... ........ A

Repair of knee 10.62

NA

NA

6.67

7.91

1.78

NA

NA

19.07

20.31

090 ligament. 27409......... ........ A

Repair of knee 13.48

NA

NA

8.44

9.57

2.24

NA

NA

24.16

25.29

090 ligaments. 27412......... ........ A

Autochondrocyte 24.43

NA

NA

13.66

14.52

4.35

NA

NA

42.44

43.30

090 implant knee. 27415......... ........ A

Osteochondral

19.69

NA

NA

11.86

12.38

4.35

NA

NA

35.90

36.42

090 knee allograft. 27418......... ........ A

Repair

11.37

NA

NA

7.61

8.58

1.88

NA

NA

20.86

21.83

090 degenerated kneecap. 27420......... ........ A

Revision of

10.06

NA

NA

6.96

7.82

1.71

NA

NA

18.73

19.59

090 unstable kneecap. 27422......... ........ A

Revision of

10.01

NA

NA

6.91

7.82

1.70

NA

NA

18.62

19.53

090 unstable kneecap. 27424......... ........ A

Revision/

10.04

NA

NA

6.92

7.80

1.70

NA

NA

18.66

19.54

090 removal of kneecap. 27425......... ........ A

Lat retinacular 5.21

NA

NA

4.71

5.32

0.90

NA

NA

10.82

11.43

090 release open. 27427......... ........ A

Reconstruction, 9.59

NA

NA

6.70

7.53

1.63

NA

NA

17.92

18.75

090 knee. 27428......... ........ A

Reconstruction, 15.23

NA

NA

10.13

10.96

2.42

NA

NA

27.78

28.61

090 knee. 27429......... ........ A

Reconstruction, 17.12

NA

NA

11.33

12.14

2.70

NA

NA

31.15

31.96

090 knee. 27430......... ........ A

Revision of

9.96

NA

NA

6.89

7.72

1.69

NA

NA

18.54

19.37

090 thigh muscles. 27435......... ........ A

Incision of

10.60

NA

NA

7.69

8.28

1.69

NA

NA

19.98

20.57

090 knee joint. 27437......... ........ A

Revise kneecap. 8.75

NA

NA

6.24

6.99

1.49

NA

NA

16.48

17.23

090 27438......... ........ A

Revise kneecap 11.69

NA

NA

7.57

8.30

1.95

NA

NA

21.21

21.94

090 with implant. 27440......... ........ A

Revision of

10.89

NA

NA

7.16

6.28

1.81

NA

NA

19.86

18.98

090 knee joint. 27441......... ........ A

Revision of

11.34

NA

NA

7.50

6.91

1.88

NA

NA

20.72

20.13

090 knee joint. 27442......... ........ A

Revision of

12.17

NA

NA

7.78

8.63

2.09

NA

NA

22.04

22.89

090 knee joint. 27443......... ........ A

Revision of

11.21

NA

NA

7.40

8.39

1.90

NA

NA

20.51

21.50

090 knee joint. 27445......... ........ A

Revision of

18.43

NA

NA

10.53

11.90

3.08

NA

NA

32.04

33.41

090 knee joint. 27446......... ........ A

Revision of

16.18

NA

NA

9.37

10.80

2.80

NA

NA

28.35

29.78

090 knee joint. 27447......... ........ A

Total knee

20.81

NA

NA

11.84

13.91

3.79

NA

NA

36.44

38.51

090 arthroplasty. 27448......... ........ A

Incision of

11.40

NA

NA

7.43

8.31

1.94

NA

NA

20.77

21.65

090 thigh. 27450......... ........ A

Incision of

14.38

NA

NA

8.85

10.15

2.42

NA

NA

25.65

26.95

090 thigh. 27454......... ........ A

Realignment of 18.89

NA

NA

10.74

12.06

3.12

NA

NA

32.75

34.07

090 thigh bone. 27455......... ........ A

Realignment of 13.16

NA

NA

8.40

9.51

2.24

NA

NA

23.80

24.91

090 knee. 27457......... ........ A

Realignment of 13.85

NA

NA

8.26

9.51

2.34

NA

NA

24.45

25.70

090 knee. 27465......... ........ A

Shortening of

18.36

NA

NA

10.30

10.24

2.47

NA

NA

31.13

31.07

090 thigh bone. 27466......... ........ A

Lengthening of 17.03

NA

NA

10.15

11.41

2.77

NA

NA

29.95

31.21

090 thigh bone. 27468......... ........ A

Shorten/

19.72

NA

NA

11.28

12.08

3.30

NA

NA

34.30

35.10

090 lengthen thighs. 27470......... ........ A

Repair of thigh 16.87

NA

NA

10.22

11.40

2.79

NA

NA

29.88

31.06

090 27472......... ........ A

Repair/graft of 18.47

NA

NA

10.72

12.19

3.07

NA

NA

32.26

33.73

090 thigh. 27475......... ........ A

Surgery to stop 8.75

NA

NA

6.65

7.07

1.36

NA

NA

16.76

17.18

090 leg growth. 27477......... ........ A

Surgery to stop 9.96

NA

NA

6.65

7.46

1.73

NA

NA

18.34

19.15

090 leg growth. 27479......... ........ A

Surgery to stop 12.96

NA

NA

5.11

8.51

2.78

NA

NA

20.85

24.25

090 leg growth. 27485......... ........ A

Surgery to stop 8.95

NA

NA

6.24

7.11

1.53

NA

NA

16.72

17.59

090 leg growth. 27486......... ........ A

Revise/replace 20.84

NA

NA

11.74

13.05

3.36

NA

NA

35.94

37.25

090 knee joint. 27487......... ........ A

Revise/replace 26.83

NA

NA

14.14

15.95

4.39

NA

NA

45.36

47.17

090 knee joint. 27488......... ........ A

Removal of knee 17.32

NA

NA

10.34

11.36

2.74

NA

NA

30.40

31.42

090 prosthesis. 27495......... ........ A

Reinforce thigh 16.31

NA

NA

9.70

10.98

2.71

NA

NA

28.72

30.00

090 27496......... ........ A

Decompression

6.58

NA

NA

5.02

5.46

0.99

NA

NA

12.59

13.03

090 of thigh/knee. 27497......... ........ A

Decompression

7.64

NA

NA

4.68

5.24

1.15

NA

NA

13.47

14.03

090 of thigh/knee. 27498......... ........ A

Decompression

8.46

NA

NA

5.37

5.81

1.24

NA

NA

15.07

15.51

090 of thigh/knee. 27499......... ........ A

Decompression

9.23

NA

NA

5.83

6.57

1.47

NA

NA

16.53

17.27

090 of thigh/knee. 27500......... ........ A

Treatment of

6.15

5.44

5.95

4.65

4.91

1.02 12.61

13.12

11.82

12.08

090 thigh fracture. 27501......... ........ A

Treatment of

6.28

5.04

5.60

4.95

5.27

1.03 12.35

12.91

12.26

12.58

090 thigh fracture. 27502......... ........ A

Treatment of

11.16

NA

NA

6.92

7.81

1.78

NA

NA

19.86

20.75

090 thigh fracture. 27503......... ........ A

Treatment of

11.05

NA

NA

7.26

8.03

1.84

NA

NA

20.15

20.92

090 thigh fracture. 27506......... ........ A

Treatment of

19.33

NA

NA

11.21

12.39

3.03

NA

NA

33.57

34.75

090 thigh fracture. 27507......... ........ A

Treatment of

14.33

NA

NA

8.20

9.43

2.42

NA

NA

24.95

26.18

090 thigh fracture. 27508......... ........ A

Treatment of

6.00

5.71

6.27

5.07

5.38

0.97 12.68

13.24

12.04

12.35

090 thigh fracture. 27509......... ........ A

Treatment of

7.94

NA

NA

6.57

7.61

1.34

NA

NA

15.85

16.89

090 thigh fracture. 27510......... ........ A

Treatment of

9.60

NA

NA

6.34

7.08

1.53

NA

NA

17.47

18.21

090 thigh fracture. 27511......... ........ A

Treatment of

13.86

NA

NA

9.11

10.68

2.37

NA

NA

25.34

26.91

090 thigh fracture. 27513......... ........ A

Treatment of

19.37

NA

NA

11.85

13.37

3.12

NA

NA

34.34

35.86

090 thigh fracture. 27514......... ........ A

Treatment of

19.00

NA

NA

11.98

13.01

3.00

NA

NA

33.98

35.01

090 thigh fracture.

[[Page 49114]]

27516......... ........ A

Treat thigh fx

5.36

5.69

6.19

5.05

5.40

0.81 11.86

12.36

11.22

11.57

090 growth plate. 27517......... ........ A

Treat thigh fx

8.89

NA

NA

6.04

7.10

1.22

NA

NA

16.15

17.21

090 growth plate. 27519......... ........ A

Treat thigh fx 15.72

NA

NA

9.88

11.16

2.55

NA

NA

28.15

29.43

090 growth plate. 27520......... ........ A

Treat kneecap

2.86

4.11

4.43

3.53

3.46

0.47

7.44

7.76

6.86

6.79

090 fracture. 27524......... ........ A

Treat kneecap

10.17

NA

NA

6.98

7.92

1.74

NA

NA

18.89

19.83

090 fracture. 27530......... ........ A

Treat knee

3.89

4.83

5.19

4.27

4.38

0.65

9.37

9.73

8.81

8.92

090 fracture. 27532......... ........ A

Treat knee

7.35

6.45

7.13

5.67

6.26

1.26 15.06

15.74

14.28

14.87

090 fracture. 27535......... ........ A

Treat knee

11.72

NA

NA

8.26

9.65

2.00

NA

NA

21.98

23.37

090 fracture. 27536......... ........ A

Treat knee

17.11

NA

NA

10.29

11.28

2.73

NA

NA

30.13

31.12

090 fracture. 27538......... ........ A

Treat knee

4.86

5.54

5.98

4.92

5.12

0.84 11.24

11.68

10.62

10.82

090 fracture(s). 27540......... ........ A

Treat knee

13.38

NA

NA

8.02

9.14

2.27

NA

NA

23.67

24.79

090 fracture. 27550......... ........ A

Treat knee

5.75

5.31

5.84

4.59

4.85

0.76 11.82

12.35

11.10

11.36

090 dislocation. 27552......... ........ A

Treat knee

7.95

NA

NA

6.12

6.74

1.36

NA

NA

15.43

16.05

090 dislocation. 27556......... ........ A

Treat knee

14.87

NA

NA

9.31

11.07

2.50

NA

NA

26.68

28.44

090 dislocation. 27557......... ........ A

Treat knee

17.22

NA

NA

10.58

12.49

2.97

NA

NA

30.77

32.68

090 dislocation. 27558......... ........ A

Treat knee

17.93

NA

NA

10.62

12.44

3.08

NA

NA

31.63

33.45

090 dislocation. 27560......... ........ A

Treat kneecap

3.81

3.93

4.61

3.41

3.24

0.40

8.14

8.82

7.62

7.45

090 dislocation. 27562......... ........ A

Treat kneecap

5.78

NA

NA

4.45

4.69

0.94

NA

NA

11.17

11.41

090 dislocation. 27566......... ........ A

Treat kneecap

12.51

NA

NA

7.85

8.95

2.12

NA

NA

22.48

23.58

090 dislocation. 27570......... ........ A

Fixation of

1.74

NA

NA

1.62

1.73

0.30

NA

NA

3.66

3.77

010 knee joint. 27580......... ........ A

Fusion of knee. 20.82

NA

NA

12.34

14.19

3.37

NA

NA

36.53

38.38

090 27590......... ........ A

Amputate leg at 13.27

NA

NA

6.14

6.54

1.74

NA

NA

21.15

21.55

090 thigh. 27591......... ........ A

Amputate leg at 13.74

NA

NA

7.43

8.34

2.02

NA

NA

23.19

24.10

090 thigh. 27592......... ........ A

Amputate leg at 10.78

NA

NA

5.50

6.00

1.45

NA

NA

17.73

18.23

090 thigh. 27594......... ........ A

Amputation

7.09

NA

NA

4.76

5.07

1.02

NA

NA

12.87

13.18

090 follow-up surgery. 27596......... ........ A

Amputation

11.06

NA

NA

6.06

6.62

1.57

NA

NA

18.69

19.25

090 follow-up surgery. 27598......... ........ A

Amputate lower 10.99

NA

NA

6.34

6.85

1.65

NA

NA

18.98

19.49

090 leg at knee. 27599......... ........ C

Leg surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 27600......... ........ A

Decompression

5.88

NA

NA

3.85

4.36

0.86

NA

NA

10.59

11.10

090 of lower leg. 27601......... ........ A

Decompression

5.87

NA

NA

4.26

4.70

0.80

NA

NA

10.93

11.37

090 of lower leg. 27602......... ........ A

Decompression

7.64

NA

NA

4.39

4.95

1.10

NA

NA

13.13

13.69

090 of lower leg. 27603......... ........ A

Drain lower leg 5.05

7.05

7.38

3.90

4.10

0.74 12.84

13.17

9.69

9.89

090 lesion. 27604......... ........ A

Drain lower leg 4.46

6.47

6.18

3.42

3.83

0.69 11.62

11.33

8.57

8.98

090 bursa. 27605......... ........ A

Incision of

2.87

5.28

7.08

1.78

2.19

0.41

8.56

10.36

5.06

5.47

010 achilles tendon. 27606......... ........ A

Incision of

4.13

NA

NA

2.67

3.19

0.69

NA

NA

7.49

8.01

010 achilles tendon. 27607......... ........ A

Treat lower leg 8.44

NA

NA

5.76

6.07

1.31

NA

NA

15.51

15.82

090 bone lesion. 27610......... ........ A

Explore/treat

8.93

NA

NA

6.17

6.79

1.40

NA

NA

16.50

17.12

090 ankle joint. 27612......... ........ A

Exploration of

7.92

NA

NA

5.35

5.91

1.13

NA

NA

14.40

14.96

090 ankle joint. 27613......... ........ A

Biopsy lower

2.17

3.81

3.38

1.72

1.78

0.20

6.18

5.75

4.09

4.15

010 leg soft tissue. 27614......... ........ A

Biopsy lower

5.65

7.88

7.32

4.00

4.33

0.78 14.31

13.75

10.43

10.76

090 leg soft tissue. 27615......... ........ A

Remove tumor,

12.84

NA

NA

8.04

9.05

1.83

NA

NA

22.71

23.72

090 lower leg. 27618......... ........ A

Remove lower

5.08

6.40

6.11

3.77

3.94

0.72 12.20

11.91

9.57

9.74

090 leg lesion. 27619......... ........ A

Remove lower

8.39 10.08

9.65

5.29

5.79

1.25 19.72

19.29

14.93

15.43

090 leg lesion. 27620......... ........ A

Explore/treat

5.97

NA

NA

4.61

5.25

0.97

NA

NA

11.55

12.19

090 ankle joint. 27625......... ........ A

Remove ankle

8.29

NA

NA

5.59

6.24

1.28

NA

NA

15.16

15.81

090 joint lining. 27626......... ........ A

Remove ankle

8.90

NA

NA

5.95

6.68

1.48

NA

NA

16.33

17.06

090 joint lining. 27630......... ........ A

Removal of

4.79

7.98

7.67

3.80

4.24

0.74 13.51

13.20

9.33

9.77

090 tendon lesion. 27635......... ........ A

Remove lower

7.83

NA

NA

5.67

6.47

1.31

NA

NA

14.81

15.61

090 leg bone lesion. 27637......... ........ A

Remove/graft

10.08

NA

NA

7.16

8.01

1.66

NA

NA

18.90

19.75

090 leg bone lesion. 27638......... ........ A

Remove/graft

10.79

NA

NA

6.98

7.96

1.84

NA

NA

19.61

20.59

090 leg bone lesion. 27640......... ........ A

Partial removal 12.01

NA

NA

8.19

9.78

1.88

NA

NA

22.08

23.67

090 of tibia. 27641......... ........ A

Partial removal 9.65

NA

NA

6.78

7.95

1.46

NA

NA

17.89

19.06

090 of fibula. 27645......... ........ A

Extensive lower 14.69

NA

NA

9.51

11.42

2.41

NA

NA

26.61

28.52

090 leg surgery. 27646......... ........ A

Extensive lower 13.12

NA

NA

8.41

10.38

2.05

NA

NA

23.58

25.55

090 leg surgery. 27647......... ........ A

Extensive ankle/ 12.76

NA

NA

6.61

7.36

1.75

NA

NA

21.12

21.87

090 heel surgery. 27648......... ........ A

Injection for

0.96

2.71

3.32

0.31

0.33

0.08

3.75

4.36

1.35

1.37

000 ankle x-ray.

[[Page 49115]]

27650......... ........ A

Repair achilles 9.86

NA

NA

6.30

7.21

1.59

NA

NA

17.75

18.66

090 tendon. 27652......... ........ A

Repair/graft

10.55

NA

NA

6.45

7.64

1.71

NA

NA

18.71

19.90

090 achilles tendon. 27654......... ........ A

Repair of

10.24

NA

NA

5.96

6.85

1.58

NA

NA

17.78

18.67

090 achilles tendon. 27656......... ........ A

Repair leg

4.56

8.06

8.41

3.65

3.74

0.69 13.31

13.66

8.90

8.99

090 fascia defect. 27658......... ........ A

Repair of leg

4.97

NA

NA

3.91

4.40

0.79

NA

NA

9.67

10.16

090 tendon, each. 27659......... ........ A

Repair of leg

6.92

NA

NA

4.87

5.45

1.09

NA

NA

12.88

13.46

090 tendon, each. 27664......... ........ A

Repair of leg

4.58

NA

NA

3.95

4.40

0.76

NA

NA

9.29

9.74

090 tendon, each. 27665......... ........ A

Repair of leg

5.39

NA

NA

4.50

4.85

0.89

NA

NA

10.78

11.13

090 tendon, each. 27675......... ........ A

Repair lower

7.17

NA

NA

4.75

5.49

1.11

NA

NA

13.03

13.77

090 leg tendons. 27676......... ........ A

Repair lower

8.53

NA

NA

5.79

6.51

1.37

NA

NA

15.69

16.41

090 leg tendons. 27680......... ........ A

Release of

5.73

NA

NA

4.37

4.93

0.93

NA

NA

11.03

11.59

090 lower leg tendon. 27681......... ........ A

Release of

6.87

NA

NA

4.77

5.63

1.15

NA

NA

12.79

13.65

090 lower leg tendons. 27685......... ........ A

Revision of

6.49

8.82

7.67

4.59

5.24

0.97 16.28

15.13

12.05

12.70

090 lower leg tendon. 27686......... ........ A

Revise lower

7.57

NA

NA

5.38

6.21

1.24

NA

NA

14.19

15.02

090 leg tendons. 27687......... ........ A

Revision of

6.23

NA

NA

4.54

5.12

1.00

NA

NA

11.77

12.35

090 calf tendon. 27690......... ........ A

Revise lower

8.88

NA

NA

5.47

6.13

1.33

NA

NA

15.68

16.34

090 leg tendon. 27691......... ........ A

Revise lower

10.19

NA

NA

6.72

7.50

1.64

NA

NA

18.55

19.33

090 leg tendon. 27692......... ........ A

Revise

1.87

NA

NA

0.73

0.88

0.32

NA

NA

2.92

3.07

ZZZ additional leg tendon. 27695......... ........ A

Repair of ankle 6.50

NA

NA

5.00

5.65

1.05

NA

NA

12.55

13.20

090 ligament. 27696......... ........ A

Repair of ankle 8.38

NA

NA

5.39

6.17

1.28

NA

NA

15.05

15.83

090 ligaments. 27698......... ........ A

Repair of ankle 9.41

NA

NA

5.93

6.69

1.47

NA

NA

16.81

17.57

090 ligament. 27700......... ........ A

Revision of

9.46

NA

NA

5.14

5.55

1.30

NA

NA

15.90

16.31

090 ankle joint. 27702......... ........ A

Reconstruct

14.19

NA

NA

8.73

10.03

2.37

NA

NA

25.29

26.59

090 ankle joint. 27703......... ........ A

Reconstruction, 16.69

NA

NA

9.89

10.90

2.76

NA

NA

29.34

30.35

090 ankle joint. 27704......... ........ A

Removal of

7.61

NA

NA

5.70

5.62

1.27

NA

NA

14.58

14.50

090 ankle implant. 27705......... ........ A

Incision of

10.66

NA

NA

6.91

7.86

1.80

NA

NA

19.37

20.32

090 tibia. 27707......... ........ A

Incision of

4.60

NA

NA

4.50

4.83

0.76

NA

NA

9.86

10.19

090 fibula. 27709......... ........ A

Incision of

17.24

NA

NA

9.94

8.58

1.73

NA

NA

28.91

27.55

090 tibia & fibula. 27712......... ........ A

Realignment of 15.59

NA

NA

9.18

10.35

2.47

NA

NA

27.24

28.41

090 lower leg. 27715......... ........ A

Revision of

15.27

NA

NA

9.07

10.35

2.49

NA

NA

26.83

28.11

090 lower leg. 27720......... ........ A

Repair of tibia 12.13

NA

NA

7.97

9.04

2.04

NA

NA

22.14

23.21

090 27722......... ........ A

Repair/graft of 12.22

NA

NA

8.07

8.87

2.05

NA

NA

22.34

23.14

090 tibia. 27724......... ........ A

Repair/graft of 19.12

NA

NA

10.34

11.86

3.16

NA

NA

32.62

34.14

090 tibia. 27725......... ........ A

Repair of lower 17.07

NA

NA

10.61

11.59

2.71

NA

NA

30.39

31.37

090 leg. 27727......... ........ A

Repair of lower 14.59

NA

NA

8.59

9.90

2.43

NA

NA

25.61

26.92

090 leg. 27730......... ........ A

Repair of tibia 7.52

NA

NA

5.30

6.14

1.72

NA

NA

14.54

15.38

090 epiphysis. 27732......... ........ A

Repair of

5.31

NA

NA

4.68

4.87

0.77

NA

NA

10.76

10.95

090 fibula epiphysis. 27734......... ........ A

Repair lower

8.65

NA

NA

6.20

6.26

1.35

NA

NA

16.20

16.26

090 leg epiphyses. 27740......... ........ A

Repair of leg

9.41

NA

NA

6.65

7.66

1.62

NA

NA

17.68

18.69

090 epiphyses. 27742......... ........ A

Repair of leg

10.40

NA

NA

5.20

5.47

1.79

NA

NA

17.39

17.66

090 epiphyses. 27745......... ........ A

Reinforce tibia 10.29

NA

NA

7.01

7.88

1.75

NA

NA

19.05

19.92

090 27750......... ........ A

Treatment of

3.19

4.33

4.65

3.74

3.82

0.55

8.07

8.39

7.48

7.56

090 tibia fracture. 27752......... ........ A

Treatment of

6.07

5.98

6.48

5.14

5.54

1.01 13.06

13.56

12.22

12.62

090 tibia fracture. 27756......... ........ A

Treatment of

7.25

NA

NA

5.77

6.29

1.17

NA

NA

14.19

14.71

090 tibia fracture. 27758......... ........ A

Treatment of

12.31

NA

NA

8.07

8.90

2.03

NA

NA

22.41

23.24

090 tibia fracture. 27759......... ........ A

Treatment of

14.23

NA

NA

8.73

9.92

2.38

NA

NA

25.34

26.53

090 tibia fracture. 27760......... ........ A

Treatment of

3.01

4.29

4.58

3.68

3.61

0.48

7.78

8.07

7.17

7.10

090 ankle fracture. 27762......... ........ A

Treatment of

5.24

5.58

6.14

4.75

5.14

0.85 11.67

12.23

10.84

11.23

090 ankle fracture. 27766......... ........ A

Treatment of

8.65

NA

NA

6.29

6.99

1.44

NA

NA

16.38

17.08

090 ankle fracture. 27780......... ........ A

Treatment of

2.65

3.89

4.11

3.33

3.24

0.41

6.95

7.17

6.39

6.30

090 fibula fracture. 27781......... ........ A

Treatment of

4.39

4.97

5.36

4.34

4.57

0.73 10.09

10.48

9.46

9.69

090 fibula fracture. 27784......... ........ A

Treatment of

7.34

NA

NA

5.62

6.26

1.23

NA

NA

14.19

14.83

090 fibula fracture. 27786......... ........ A

Treatment of

2.84

4.07

4.36

3.44

3.36

0.46

7.37

7.66

6.74

6.66

090 ankle fracture. 27788......... ........ A

Treatment of

4.44

5.00

5.48

4.26

4.55

0.74 10.18

10.66

9.44

9.73

090 ankle fracture. 27792......... ........ A

Treatment of

7.83

NA

NA

5.95

6.71

1.32

NA

NA

15.10

15.86

090 ankle fracture. 27808......... ........ A

Treatment of

2.83

4.40

4.70

3.70

3.70

0.46

7.69

7.99

6.99

6.99

090 ankle fracture. 27810......... ........ A

Treatment of

5.12

5.46

6.05

4.60

5.01

0.82 11.40

11.99

10.54

10.95

090 ankle fracture. 27814......... ........ A

Treatment of

11.02

NA

NA

7.28

8.24

1.85

NA

NA

20.15

21.11

090 ankle fracture. 27816......... ........ A

Treatment of

2.89

4.03

4.29

3.36

3.40

0.43

7.35

7.61

6.68

6.72

090 ankle fracture. 27818......... ........ A

Treatment of

5.49

5.44

6.14

4.47

5.00

0.82 11.75

12.45

10.78

11.31

090 ankle fracture. 27822......... ........ A

Treatment of

12.04

NA

NA

8.87

10.21

1.91

NA

NA

22.82

24.16

090 ankle fracture. 27823......... ........ A

Treatment of

14.18

NA

NA

9.51

10.98

2.25

NA

NA

25.94

27.41

090 ankle fracture. 27824......... ........ A

Treat lower leg 3.14

3.74

3.98

3.55

3.56

0.45

7.33

7.57

7.14

7.15

090 fracture. 27825......... ........ A

Treat lower leg 6.54

5.88

6.42

4.84

5.25

1.02 13.44

13.98

12.40

12.81

090 fracture. 27826......... ........ A

Treat lower leg 8.89

NA

NA

7.01

8.37

1.47

NA

NA

17.37

18.73

090 fracture. 27827......... ........ A

Treat lower leg 15.65

NA

NA

10.82

12.28

2.43

NA

NA

28.90

30.36

090 fracture.

[[Page 49116]]

27828......... ........ A

Treat lower leg 18.07

NA

NA

12.36

13.54

2.81

NA

NA

33.24

34.42

090 fracture. 27829......... ........ A

Treat lower leg 5.60

NA

NA

5.53

6.47

0.95

NA

NA

12.08

13.02

090 joint. 27830......... ........ A

Treat lower leg 3.78

4.32

4.37

3.76

3.83

0.54

8.64

8.69

8.08

8.15

090 dislocation. 27831......... ........ A

Treat lower leg 4.55

NA

NA

3.99

4.34

0.73

NA

NA

9.27

9.62

090 dislocation. 27832......... ........ A

Treat lower leg 6.60

NA

NA

4.75

5.82

1.03

NA

NA

12.38

13.45

090 dislocation. 27840......... ........ A

Treat ankle

4.57

NA

NA

3.62

3.73

0.46

NA

NA

8.65

8.76

090 dislocation. 27842......... ........ A

Treat ankle

6.26

NA

NA

4.90

5.07

1.00

NA

NA

12.16

12.33

090 dislocation. 27846......... ........ A

Treat ankle

10.08

NA

NA

6.87

7.67

1.70

NA

NA

18.65

19.45

090 dislocation. 27848......... ........ A

Treat ankle

11.48

NA

NA

7.72

9.21

1.94

NA

NA

21.14

22.63

090 dislocation. 27860......... ........ A

Fixation of

2.34

NA

NA

1.70

1.91

0.39

NA

NA

4.43

4.64

010 ankle joint. 27870......... ........ A

Fusion of ankle 15.13

NA

NA

9.19

10.19

2.36

NA

NA

26.68

27.68

090 joint, open. 27871......... ........ A

Fusion of

9.34

NA

NA

6.54

7.32

1.59

NA

NA

17.47

18.25

090 tibiofibular joint. 27880......... ........ A

Amputation of

15.18

NA

NA

6.78

7.04

1.75

NA

NA

23.71

23.97

090 lower leg. 27881......... ........ A

Amputation of

13.22

NA

NA

7.45

8.49

1.98

NA

NA

22.65

23.69

090 lower leg. 27882......... ........ A

Amputation of

9.59

NA

NA

5.55

6.25

1.29

NA

NA

16.43

17.13

090 lower leg. 27884......... ........ A

Amputation

8.56

NA

NA

5.11

5.59

1.22

NA

NA

14.89

15.37

090 follow-up surgery. 27886......... ........ A

Amputation

9.79

NA

NA

5.75

6.32

1.40

NA

NA

16.94

17.51

090 follow-up surgery. 27888......... ........ A

Amputation of

10.14

NA

NA

6.25

7.19

1.51

NA

NA

17.90

18.84

090 foot at ankle. 27889......... ........ A

Amputation of

10.63

NA

NA

5.35

6.19

1.46

NA

NA

17.44

18.28

090 foot at ankle. 27892......... ........ A

Decompression

7.74

NA

NA

4.88

5.41

1.10

NA

NA

13.72

14.25

090 of leg. 27893......... ........ A

Decompression

7.70

NA

NA

5.14

5.38

1.10

NA

NA

13.94

14.18

090 of leg. 27894......... ........ A

Decompression

12.32

NA

NA

7.36

7.67

1.65

NA

NA

21.33

21.64

090 of leg. 27899......... ........ C

Leg/ankle

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure. 28001......... ........ A

Drainage of

2.73

4.04

3.25

1.63

1.87

0.33

7.10

6.31

4.69

4.93

010 bursa of foot. 28002......... ........ A

Treatment of

5.72

6.77

5.44

3.62

3.73

0.61 13.10

11.77

9.95

10.06

010 foot infection. 28003......... ........ A

Treatment of

8.88

7.86

6.64

4.61

5.07

1.12 17.86

16.64

14.61

15.07

090 foot infection. 28005......... ........ A

Treat foot bone 9.21

NA

NA

5.48

5.90

1.16

NA

NA

15.85

16.27

090 lesion. 28008......... ........ A

Incision of

4.44

6.22

4.97

3.02

3.16

0.57 11.23

9.98

8.03

8.17

090 foot fascia. 28010......... ........ A

Incision of toe 2.84

2.87

2.50

2.35

2.37

0.36

6.07

5.70

5.55

5.57

090 tendon. 28011......... ........ A

Incision of toe 4.13

3.83

3.43

3.05

3.24

0.59

8.55

8.15

7.77

7.96

090 tendons. 28020......... ........ A

Exploration of

5.00

7.57

6.40

3.68

4.02

0.72 13.29

12.12

9.40

9.74

090 foot joint. 28022......... ........ A

Exploration of

4.66

6.94

5.63

3.33

3.72

0.62 12.22

10.91

8.61

9.00

090 foot joint. 28024......... ........ A

Exploration of

4.37

6.71

5.59

3.19

3.74

0.58 11.66

10.54

8.14

8.69

090 toe joint. 28030......... ........ A

Removal of foot 6.14

NA

NA

3.47

3.61

0.74

NA

NA

10.35

10.49

090 nerve. 28035......... ........ A

Decompression

5.08

7.52

6.27

3.68

3.99

0.70 13.30

12.05

9.46

9.77

090 of tibia nerve. 28043......... ........ A

Excision of

3.53

4.84

4.07

2.76

3.07

0.46

8.83

8.06

6.75

7.06

090 foot lesion. 28045......... ........ A

Excision of

4.71

7.12

5.81

3.29

3.52

0.63 12.46

11.15

8.63

8.86

090 foot lesion. 28046......... ........ A

Resection of

10.46 10.49

9.19

5.84

6.31

1.36 22.31

21.01

17.66

18.13

090 tumor, foot. 28050......... ........ A

Biopsy of foot

4.24

6.93

5.40

3.28

3.51

0.60 11.77

10.24

8.12

8.35

090 joint lining. 28052......... ........ A

Biopsy of foot

3.93

6.49

5.31

2.96

3.31

0.53 10.95

9.77

7.42

7.77

090 joint lining. 28054......... ........ A

Biopsy of toe

3.44

6.25

5.10

2.78

3.12

0.46 10.15

9.00

6.68

7.02

090 joint lining. 28060......... ........ A

Partial

5.22

7.19

5.90

3.60

3.80

0.70 13.11

11.82

9.52

9.72

090 removal, foot fascia. 28062......... ........ A

Removal of foot 6.51

7.91

6.86

3.86

3.97

0.83 15.25

14.20

11.20

11.31

090 fascia. 28070......... ........ A

Removal of foot 5.09

7.27

5.73

3.48

3.73

0.73 13.09

11.55

9.30

9.55

090 joint lining. 28072......... ........ A

Removal of foot 4.57

7.66

6.06

3.65

4.14

0.68 12.91

11.31

8.90

9.39

090 joint lining. 28080......... ........ A

Removal of foot 4.57

7.73

5.77

4.22

3.82

0.47 12.77

10.81

9.26

8.86

090 lesion. 28086......... ........ A

Excise foot

4.77

7.85

7.95

3.80

4.46

0.76 13.38

13.48

9.33

9.99

090 tendon sheath. 28088......... ........ A

Excise foot

3.85

7.00

6.06

3.18

3.71

0.61 11.46

10.52

7.64

8.17

090 tendon sheath. 28090......... ........ A

Removal of foot 4.40

6.84

5.57

3.21

3.39

0.59 11.83

10.56

8.20

8.38

090 lesion. 28092......... ........ A

Removal of toe

3.63

6.55

5.55

3.02

3.40

0.49 10.67

9.67

7.14

7.52

090 lesions. 28100......... ........ A

Removal of

5.65

8.29

8.04

4.10

4.54

0.82 14.76

14.51

10.57

11.01

090 ankle/heel lesion. 28102......... ........ A

Remove/graft

7.72

NA

NA

4.97

5.70

1.14

NA

NA

13.83

14.56

090 foot lesion. 28103......... ........ A

Remove/graft

6.49

NA

NA

4.17

4.50

0.91

NA

NA

11.57

11.90

090 foot lesion. 28104......... ........ A

Removal of foot 5.11

7.31

5.94

3.50

3.82

0.70 13.12

11.75

9.31

9.63

090 lesion. 28106......... ........ A

Remove/graft

7.15

NA

NA

4.46

4.44

0.97

NA

NA

12.58

12.56

090 foot lesion. 28107......... ........ A

Remove/graft

5.55

7.90

6.87

3.76

4.09

0.74 14.19

13.16

10.05

10.38

090 foot lesion.

[[Page 49117]]

28108......... ........ A

Removal of toe

4.15

6.42

5.05

3.01

3.19

0.53 11.10

9.73

7.69

7.87

090 lesions. 28110......... ........ A

Part removal of 4.07

7.02

5.66

3.10

3.19

0.54 11.63

10.27

7.71

7.80

090 metatarsal. 28111......... ........ A

Part removal of 5.00

7.37

6.55

3.33

3.57

0.67 13.04

12.22

9.00

9.24

090 metatarsal. 28112......... ........ A

Part removal of 4.48

7.31

6.18

3.30

3.50

0.61 12.40

11.27

8.39

8.59

090 metatarsal. 28113......... ........ A

Part removal of 5.78

8.48

6.66

4.67

4.40

0.63 14.89

13.07

11.08

10.81

090 metatarsal. 28114......... ........ A

Removal of

11.49 13.43

12.07

8.31

8.36

1.42 26.34

24.98

21.22

21.27

090 metatarsal heads. 28116......... ........ A

Revision of

8.86

9.58

7.49

5.41

5.23

1.03 19.47

17.38

15.30

15.12

090 foot. 28118......... ........ A

Removal of heel 5.95

8.00

6.68

4.05

4.27

0.84 14.79

13.47

10.84

11.06

090 bone. 28119......... ........ A

Removal of heel 5.38

7.28

5.89

3.60

3.69

0.70 13.36

11.97

9.68

9.77

090 spur. 28120......... ........ A

Part removal of 5.57

8.14

7.50

3.98

4.30

0.77 14.48

13.84

10.32

10.64

090 ankle/heel. 28122......... ........ A

Partial removal 7.46

8.57

7.27

4.83

5.15

0.98 17.01

15.71

13.27

13.59

090 of foot bone. 28124......... ........ A

Partial removal 4.80

6.82

5.45

3.47

3.61

0.60 12.22

10.85

8.87

9.01

090 of toe. 28126......... ........ A

Partial removal 3.51

6.00

4.66

2.67

2.91

0.45

9.96

8.62

6.63

6.87

090 of toe. 28130......... ........ A

Removal of

9.22

NA

NA

5.91

6.51

1.26

NA

NA

16.39

16.99

090 ankle bone. 28140......... ........ A

Removal of

6.96

7.91

7.39

4.16

4.61

0.92 15.79

15.27

12.04

12.49

090 metatarsal. 28150......... ........ A

Removal of toe. 4.08

6.46

5.24

3.03

3.22

0.53 11.07

9.85

7.64

7.83

090 28153......... ........ A

Partial removal 3.65

6.23

4.79

2.89

2.73

0.47 10.35

8.91

7.01

6.85

090 of toe. 28160......... ........ A

Partial removal 3.73

6.41

5.02

2.97

3.24

0.49 10.63

9.24

7.19

7.46

090 of toe. 28171......... ........ A

Extensive foot

9.77

NA

NA

5.34

5.40

1.33

NA

NA

16.44

16.50

090 surgery. 28173......... ........ A

Extensive foot

8.97

8.85

7.91

4.68

5.06

1.12 18.94

18.00

14.77

15.15

090 surgery. 28175......... ........ A

Extensive foot

6.10

7.18

6.07

3.64

3.69

0.73 14.01

12.90

10.47

10.52

090 surgery. 28190......... ........ A

Removal of foot 1.96

4.04

3.55

1.34

1.45

0.22

6.22

5.73

3.52

3.63

010 foreign body. 28192......... ........ A

Removal of foot 4.63

6.79

5.80

3.22

3.54

0.61 12.03

11.04

8.46

8.78

090 foreign body. 28193......... ........ A

Removal of foot 5.72

7.38

6.05

3.64

3.85

0.73 13.83

12.50

10.09

10.30

090 foreign body. 28200......... ........ A

Repair of foot

4.59

6.95

5.56

3.26

3.48

0.61 12.15

10.76

8.46

8.68

090 tendon. 28202......... ........ A

Repair/graft of 6.89

8.03

7.42

4.09

4.39

0.91 15.83

15.22

11.89

12.19

090 foot tendon. 28208......... ........ A

Repair of foot

4.36

6.73

5.29

3.19

3.27

0.58 11.67

10.23

8.13

8.21

090 tendon. 28210......... ........ A

Repair/graft of 6.34

7.59

6.56

3.91

3.99

0.81 14.74

13.71

11.06

11.14

090 foot tendon. 28220......... ........ A

Release of foot 4.52

6.45

5.12

3.09

3.34

0.57 11.54

10.21

8.18

8.43

090 tendon. 28222......... ........ A

Release of foot 5.61

6.93

5.66

3.34

3.93

0.69 13.23

11.96

9.64

10.23

090 tendons. 28225......... ........ A

Release of foot 3.65

6.09

4.73

2.75

2.86

0.46 10.20

8.84

6.86

6.97

090 tendon. 28226......... ........ A

Release of foot 4.52

7.01

5.35

3.32

3.64

0.58 12.11

10.45

8.42

8.74

090 tendons. 28230......... ........ A

Incision of

4.23

6.34

5.09

2.91

3.48

0.55 11.12

9.87

7.69

8.26

090 foot tendon(s). 28232......... ........ A

Incision of toe 3.38

5.99

4.89

2.70

3.16

0.44

9.81

8.71

6.52

6.98

090 tendon. 28234......... ........ A

Incision of

3.36

6.32

5.08

3.06

3.28

0.44 10.12

8.88

6.86

7.08

090 foot tendon. 28238......... ........ A

Revision of

7.78

8.40

7.53

4.37

4.79

1.06 17.24

16.37

13.21

13.63

090 foot tendon. 28240......... ........ A

Release of big

4.35

6.47

5.09

3.00

3.36

0.58 11.40

10.02

7.93

8.29

090 toe. 28250......... ........ A

Revision of

5.91

7.49

6.09

3.78

4.04

0.82 14.22

12.82

10.51

10.77

090 foot fascia. 28260......... ........ A

Release of

8.01

8.65

6.90

4.73

4.93

1.14 17.80

16.05

13.88

14.08

090 midfoot joint. 28261......... ........ A

Revision of

12.83 10.79

9.16

6.40

7.08

1.57 25.19

23.56

20.80

21.48

090 foot tendon. 28262......... ........ A

Revision of

16.93 15.68

14.08

9.83

10.64

2.59 35.20

33.60

29.35

30.16

090 foot and ankle. 28264......... ........ A

Release of

10.45 10.45

8.41

6.03

6.97

1.54 22.44

20.40

18.02

18.96

090 midfoot joint. 28270......... ........ A

Release of foot 4.75

6.97

5.41

3.46

3.66

0.62 12.34

10.78

8.83

9.03

090 contracture. 28272......... ........ A

Release of toe

3.79

5.87

4.60

2.66

2.80

0.46 10.12

8.85

6.91

7.05

090 joint, each. 28280......... ........ A

Fusion of toes. 5.18

7.41

6.53

3.60

4.26

0.73 13.32

12.44

9.51

10.17

090 28285......... ........ A

Repair of

4.58

6.77

5.34

3.37

3.41

0.59 11.94

10.51

8.54

8.58

090 hammertoe. 28286......... ........ A

Repair of

4.55

6.54

5.23

3.05

3.20

0.57 11.66

10.35

8.17

8.32

090 hammertoe. 28288......... ........ A

Partial removal 5.73

8.69

6.62

4.74

4.85

0.65 15.07

13.00

11.12

11.23

090 of foot bone. 28289......... ........ A

Repair hallux

8.03

9.52

8.37

5.39

5.67

1.02 18.57

17.42

14.44

14.72

090 rigidus. 28290......... ........ A

Correction of

5.65

8.24

6.75

3.98

4.54

0.82 14.71

13.22

10.45

11.01

090 bunion. 28292......... ........ A

Correction of

8.60 10.42

8.20

6.19

5.70

0.91 19.93

17.71

15.70

15.21

090 bunion. 28293......... ........ A

Correction of

10.96 14.60

11.71

6.97

6.32

1.13 26.69

23.80

19.06

18.41

090 bunion. 28294......... ........ A

Correction of

8.55

9.19

7.87

4.61

4.69

1.09 18.83

17.51

14.25

14.33

090 bunion. 28296......... ........ A

Correction of

9.23

9.66

8.53

4.83

5.27

1.19 20.08

18.95

15.25

15.69

090 bunion. 28297......... ........ A

Correction of

9.23 10.54

9.34

5.36

6.03

1.32 21.09

19.89

15.91

16.58

090 bunion. 28298......... ........ A

Correction of

7.93

9.30

7.73

4.58

4.90

1.05 18.28

16.71

13.56

13.88

090 bunion. 28299......... ........ A

Correction of

11.31 10.63

9.23

5.77

5.99

1.37 23.31

21.91

18.45

18.67

090 bunion. 28300......... ........ A

Incision of

9.53

NA

NA

6.11

6.80

1.54

NA

NA

17.18

17.87

090 heel bone. 28302......... ........ A

Incision of

9.54

NA

NA

5.72

6.59

1.42

NA

NA

16.68

17.55

090 ankle bone. 28304......... ........ A

Incision of

9.21

9.57

8.35

5.09

5.57

1.27 20.05

18.83

15.57

16.05

090 midfoot bones. 28305......... ........ A

Incise/graft

10.54

NA

NA

5.61

6.44

1.27

NA

NA

17.42

18.25

090 midfoot bones. 28306......... ........ A

Incision of

5.85

8.39

7.22

3.87

4.10

0.84 15.08

13.91

10.56

10.79

090 metatarsal. 28307......... ........ A

Incision of

6.32

9.57

10.66

4.48

5.08

0.90 16.79

17.88

11.70

12.30

090 metatarsal. 28308......... ........ A

Incision of

5.28

7.95

6.29

3.83

3.72

0.70 13.93

12.27

9.81

9.70

090 metatarsal. 28309......... ........ A

Incision of

13.88

NA

NA

7.79

7.91

2.04

NA

NA

23.71

23.83

090 metatarsals. 28310......... ........ A

Revision of big 5.42

7.56

6.20

3.42

3.52

0.70 13.68

12.32

9.54

9.64

090 toe.

[[Page 49118]]

28312......... ........ A

Revision of toe 4.54

7.41

5.93

3.24

3.53

0.63 12.58

11.10

8.41

8.70

090 28313......... ........ A

Repair

5.00

7.39

5.80

3.67

4.54

0.73 13.12

11.53

9.40

10.27

090 deformity of toe. 28315......... ........ A

Removal of

4.85

6.74

5.35

3.25

3.31

0.63 12.22

10.83

8.73

8.79

090 sesamoid bone. 28320......... ........ A

Repair of foot

9.17

NA

NA

5.78

6.48

1.43

NA

NA

16.38

17.08

090 bones. 28322......... ........ A

Repair of

8.33 10.03

9.39

5.48

6.12

1.27 19.63

18.99

15.08

15.72

090 metatarsals. 28340......... ........ A

Resect enlarged 6.97

8.08

6.85

4.07

4.20

0.84 15.89

14.66

11.88

12.01

090 toe tissue. 28341......... ........ A

Resect enlarged 8.52

8.70

7.37

4.47

4.73

1.01 18.23

16.90

14.00

14.26

090 toe. 28344......... ........ A

Repair extra

4.25

6.83

6.01

3.19

3.52

0.51 11.59

10.77

7.95

8.28

090 toe(s). 28345......... ........ A

Repair webbed

5.91

7.82

6.60

3.89

4.48

0.80 14.53

13.31

10.60

11.19

090 toe(s). 28360......... ........ A

Reconstruct

14.57

NA

NA

6.39

9.47

2.28

NA

NA

23.24

26.32

090 cleft foot. 28400......... ........ A

Treatment of

2.16

3.39

3.57

2.93

3.02

0.35

5.90

6.08

5.44

5.53

090 heel fracture. 28405......... ........ A

Treatment of

4.56

4.53

4.76

3.76

4.41

0.73

9.82

10.05

9.05

9.70

090 heel fracture. 28406......... ........ A

Treatment of

6.36

NA

NA

5.69

6.52

1.11

NA

NA

13.16

13.99

090 heel fracture. 28415......... ........ A

Treat heel

17.44

NA

NA

10.92

12.69

2.66

NA

NA

31.02

32.79

090 fracture. 28420......... ........ A

Treat/graft

16.98

NA

NA

10.21

12.24

2.80

NA

NA

29.99

32.02

090 heel fracture. 28430......... ........ A

Treatment of

2.09

3.15

3.33

2.59

2.57

0.31

5.55

5.73

4.99

4.97

090 ankle fracture. 28435......... ........ A

Treatment of

3.39

3.76

3.85

3.07

3.57

0.55

7.70

7.79

7.01

7.51

090 ankle fracture. 28436......... ........ A

Treatment of

4.70

NA

NA

5.00

5.68

0.81

NA

NA

10.51

11.19

090 ankle fracture. 28445......... ........ A

Treat ankle

16.99

NA

NA

9.79

10.72

2.58

NA

NA

29.36

30.29

090 fracture. 28450......... ........ A

Treat midfoot

1.90

2.95

3.07

2.44

2.46

0.28

5.13

5.25

4.62

4.64

090 fracture, each. 28455......... ........ A

Treat midfoot

3.09

3.68

3.49

3.05

3.33

0.44

7.21

7.02

6.58

6.86

090 fracture, each. 28456......... ........ A

Treat midfoot

2.68

NA

NA

3.63

4.02

0.44

NA

NA

6.75

7.14

090 fracture. 28465......... ........ A

Treat midfoot

7.06

NA

NA

5.09

6.01

1.10

NA

NA

13.25

14.17

090 fracture, each. 28470......... ........ A

Treat

1.99

2.84

3.05

2.40

2.43

0.30

5.13

5.34

4.69

4.72

090 metatarsal fracture. 28475......... ........ A

Treat

2.97

3.18

3.29

2.56

3.05

0.44

6.59

6.70

5.97

6.46

090 metatarsal fracture. 28476......... ........ A

Treat

3.37

NA

NA

4.35

4.82

0.54

NA

NA

8.26

8.73

090 metatarsal fracture. 28485......... ........ A

Treat

5.70

NA

NA

4.57

5.22

0.83

NA

NA

11.10

11.75

090 metatarsal fracture. 28490......... ........ A

Treat big toe

1.09

2.11

2.04

1.69

1.65

0.14

3.34

3.27

2.92

2.88

090 fracture. 28495......... ........ A

Treat big toe

1.58

2.48

2.25

1.88

2.02

0.20

4.26

4.03

3.66

3.80

090 fracture. 28496......... ........ A

Treat big toe

2.33

7.22

7.99

2.90

3.12

0.36

9.91

10.68

5.59

5.81

090 fracture. 28505......... ........ A

Treat big toe

3.80

7.53

7.96

3.28

3.75

0.56 11.89

12.32

7.64

8.11

090 fracture. 28510......... ........ A

Treatment of

1.09

1.68

1.57

1.61

1.55

0.14

2.91

2.80

2.84

2.78

090 toe fracture. 28515......... ........ A

Treatment of

1.46

2.25

1.98

1.84

1.88

0.18

3.89

3.62

3.48

3.52

090 toe fracture. 28525......... ........ A

Treat toe

3.32

6.93

7.37

2.92

3.30

0.49 10.74

11.18

6.73

7.11

090 fracture. 28530......... ........ A

Treat sesamoid

1.06

1.65

1.49

1.36

1.42

0.14

2.85

2.69

2.56

2.62

090 bone fracture. 28531......... ........ A

Treat sesamoid

2.47

5.84

6.91

2.13

2.08

0.34

8.65

9.72

4.94

4.89

090 bone fracture. 28540......... ........ A

Treat foot

2.04

2.78

2.50

2.33

2.38

0.26

5.08

4.80

4.63

4.68

090 dislocation. 28545......... ........ A

Treat foot

2.45

3.25

2.57

2.66

2.42

0.37

6.07

5.39

5.48

5.24

090 dislocation. 28546......... ........ A

Treat foot

3.20

7.69

7.11

3.45

4.15

0.52 11.41

10.83

7.17

7.87

090 dislocation. 28555......... ........ A

Repair foot

6.35

9.82

9.88

4.96

5.49

1.04 17.21

17.27

12.35

12.88

090 dislocation. 28570......... ........ A

Treat foot

1.66

2.59

2.46

2.00

2.25

0.23

4.48

4.35

3.89

4.14

090 dislocation. 28575......... ........ A

Treat foot

3.31

4.38

3.89

3.68

3.71

0.56

8.25

7.76

7.55

7.58

090 dislocation. 28576......... ........ A

Treat foot

4.40

NA

NA

4.01

4.13

0.69

NA

NA

9.10

9.22

090 dislocation. 28585......... ........ A

Repair foot

8.10

9.98

7.99

5.29

5.70

1.25 19.33

17.34

14.64

15.05

090 dislocation. 28600......... ........ A

Treat foot

1.89

3.06

2.87

2.40

2.61

0.27

5.22

5.03

4.56

4.77

090 dislocation. 28605......... ........ A

Treat foot

2.71

3.76

3.28

3.16

3.13

0.40

6.87

6.39

6.27

6.24

090 dislocation. 28606......... ........ A

Treat foot

4.89

NA

NA

4.31

4.60

0.82

NA

NA

10.02

10.31

090 dislocation. 28615......... ........ A

Repair foot

8.88

NA

NA

7.00

7.78

1.30

NA

NA

17.18

17.96

090 dislocation. 28630......... ........ A

Treat toe

1.70

1.96

1.67

0.95

0.99

0.20

3.86

3.57

2.85

2.89

010 dislocation. 28635......... ........ A

Treat toe

1.91

2.27

2.08

1.33

1.48

0.26

4.44

4.25

3.50

3.65

010 dislocation. 28636......... ........ A

Treat toe

2.77

4.38

4.00

2.05

2.48

0.43

7.58

7.20

5.25

5.68

010 dislocation. 28645......... ........ A

Repair toe

4.21

6.90

5.44

3.20

3.25

0.57 11.68

10.22

7.98

8.03

090 dislocation. 28660......... ........ A

Treat toe

1.23

1.31

1.27

0.79

0.79

0.13

2.67

2.63

2.15

2.15

010 dislocation. 28665......... ........ A

Treat toe

1.92

1.85

1.54

1.34

1.41

0.26

4.03

3.72

3.52

3.59

010 dislocation. 28666......... ........ A

Treat toe

2.66

NA

NA

1.92

2.42

0.43

NA

NA

5.01

5.51

010 dislocation. 28675......... ........ A

Repair of toe

2.92

6.72

7.04

2.87

3.23

0.45 10.09

10.41

6.24

6.60

090 dislocation.

[[Page 49119]]

28705......... ........ A

Fusion of foot 20.04

NA

NA

10.77

12.02

3.08

NA

NA

33.89

35.14

090 bones. 28715......... ........ A

Fusion of foot 14.32

NA

NA

8.54

9.45

2.16

NA

NA

25.02

25.93

090 bones. 28725......... ........ A

Fusion of foot 11.89

NA

NA

6.95

7.92

1.86

NA

NA

20.70

21.67

090 bones. 28730......... ........ A

Fusion of foot 12.11

NA

NA

7.79

8.31

1.70

NA

NA

21.60

22.12

090 bones. 28735......... ........ A

Fusion of foot 11.95

NA

NA

6.99

7.61

1.68

NA

NA

20.62

21.24

090 bones. 28737......... ........ A

Revision of

10.75

NA

NA

6.13

6.63

1.47

NA

NA

18.35

18.85

090 foot bones. 28740......... ........ A

Fusion of foot

9.01 10.96

10.89

6.04

6.36

1.22 21.19

21.12

16.27

16.59

090 bones. 28750......... ........ A

Fusion of big

8.29 10.90

11.66

5.95

6.48

1.13 20.32

21.08

15.37

15.90

090 toe joint. 28755......... ........ A

Fusion of big

4.73

7.30

6.40

3.37

3.66

0.65 12.68

11.78

8.75

9.04

090 toe joint. 28760......... ........ A

Fusion of big

8.86 10.01

8.48

5.34

5.47

1.05 19.92

18.39

15.25

15.38

090 toe joint. 28800......... ........ A

Amputation of

8.56

NA

NA

5.08

5.61

1.15

NA

NA

14.79

15.32

090 midfoot. 28805......... ........ A

Amputation thru 12.47

NA

NA

6.02

5.74

1.18

NA

NA

19.67

19.39

090 metatarsal. 28810......... ........ A

Amputation toe

6.44

NA

NA

4.13

4.39

0.86

NA

NA

11.43

11.69

090 & metatarsal. 28820......... ........ A

Amputation of

4.82

7.78

7.61

3.60

3.74

0.61 13.21

13.04

9.03

9.17

090 toe. 28825......... ........ A

Partial

3.64

7.23

7.05

3.16

3.40

0.50 11.37

11.19

7.30

7.54

090 amputation of toe. 28890......... ........ A

High energy

3.30

4.65

5.45

2.31

2.14

0.41

8.36

9.16

6.02

5.85

090 eswt, plantar f. 28899......... ........ C

Foot/toes

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure. 29000......... ........ A

Application of

2.25

4.76

3.41

1.85

1.76

0.41

7.42

6.07

4.51

4.42

000 body cast. 29010......... ........ A

Application of

2.06

3.37

3.30

1.33

1.66

0.45

5.88

5.81

3.84

4.17

000 body cast. 29015......... ........ A

Application of

2.41

3.37

3.07

1.48

1.57

0.28

6.06

5.76

4.17

4.26

000 body cast. 29020......... ........ A

Application of

2.11

3.79

3.33

1.48

1.43

0.28

6.18

5.72

3.87

3.82

000 body cast. 29025......... ........ A

Application of

2.40

3.62

3.26

1.59

1.79

0.44

6.46

6.10

4.43

4.63

000 body cast. 29035......... ........ A

Application of

1.77

3.71

3.64

1.48

1.56

0.28

5.76

5.69

3.53

3.61

000 body cast. 29040......... ........ A

Application of

2.22

3.63

2.75

1.50

1.51

0.36

6.21

5.33

4.08

4.09

000 body cast. 29044......... ........ A

Application of

2.12

3.98

3.97

1.66

1.84

0.35

6.45

6.44

4.13

4.31

000 body cast. 29046......... ........ A

Application of

2.41

4.21

3.48

1.80

2.02

0.42

7.04

6.31

4.63

4.85

000 body cast. 29049......... ........ A

Application of

0.89

1.13

1.26

0.60

0.55

0.13

2.15

2.28

1.62

1.57

000 figure eight. 29055......... ........ A

Application of

1.78

2.92

2.97

1.31

1.43

0.30

5.00

5.05

3.39

3.51

000 shoulder cast. 29058......... ........ A

Application of

1.31

1.25

1.48

0.68

0.71

0.17

2.73

2.96

2.16

2.19

000 shoulder cast. 29065......... ........ A

Application of

0.87

1.28

1.32

0.71

0.74

0.15

2.30

2.34

1.73

1.76

000 long arm cast. 29075......... ........ A

Application of

0.77

1.24

1.26

0.67

0.68

0.13

2.14

2.16

1.57

1.58

000 forearm cast. 29085......... ........ A

Apply hand/

0.87

1.26

1.28

0.69

0.65

0.14

2.27

2.29

1.70

1.66

000 wrist cast. 29086......... ........ A

Apply finger

0.62

1.03

0.98

0.53

0.50

0.07

1.72

1.67

1.22

1.19

000 cast. 29105......... ........ A

Apply long arm

0.87

1.10

1.20

0.53

0.52

0.12

2.09

2.19

1.52

1.51

000 splint. 29125......... ........ A

Apply forearm

0.59

0.97

1.01

0.43

0.40

0.07

1.63

1.67

1.09

1.06

000 splint. 29126......... ........ A

Apply forearm

0.77

1.02

1.16

0.48

0.47

0.07

1.86

2.00

1.32

1.31

000 splint. 29130......... ........ A

Application of

0.50

0.43

0.46

0.18

0.17

0.06

0.99

1.02

0.74

0.73

000 finger splint. 29131......... ........ A

Application of

0.55

0.63

0.71

0.26

0.25

0.03

1.21

1.29

0.84

0.83

000 finger splint. 29200......... ........ A

Strapping of

0.65

0.62

0.70

0.35

0.34

0.04

1.31

1.39

1.04

1.03

000 chest. 29220......... ........ A

Strapping of

0.64

0.62

0.70

0.35

0.38

0.04

1.30

1.38

1.03

1.06

000 low back. 29240......... ........ A

Strapping of

0.71

0.67

0.81

0.39

0.37

0.06

1.44

1.58

1.16

1.14

000 shoulder. 29260......... ........ A

Strapping of

0.55

0.65

0.72

0.36

0.33

0.05

1.25

1.32

0.96

0.93

000 elbow or wrist. 29280......... ........ A

Strapping of

0.51

0.66

0.77

0.37

0.33

0.03

1.20

1.31

0.91

0.87

000 hand or finger. 29305......... ........ A

Application of

2.03

3.40

3.36

1.61

1.72

0.35

5.78

5.74

3.99

4.10

000 hip cast. 29325......... ........ A

Application of

2.32

3.70

3.57

1.75

1.90

0.40

6.42

6.29

4.47

4.62

000 hip casts. 29345......... ........ A

Application of

1.40

1.67

1.74

0.95

1.03

0.24

3.31

3.38

2.59

2.67

000 long leg cast. 29355......... ........ A

Application of

1.53

1.64

1.69

0.95

1.08

0.26

3.43

3.48

2.74

2.87

000 long leg cast. 29358......... ........ A

Apply long leg

1.43

2.06

2.06

0.94

1.05

0.25

3.74

3.74

2.62

2.73

000 cast brace. 29365......... ........ A

Application of

1.18

1.58

1.64

0.86

0.93

0.20

2.96

3.02

2.24

2.31

000 long leg cast. 29405......... ........ A

Apply short leg 0.86

1.21

1.22

0.66

0.70

0.14

2.21

2.22

1.66

1.70

000 cast. 29425......... ........ A

Apply short leg 1.01

1.24

1.23

0.67

0.72

0.15

2.40

2.39

1.83

1.88

000 cast. 29435......... ........ A

Apply short leg 1.18

1.54

1.56

0.82

0.90

0.20

2.92

2.94

2.20

2.28

000 cast. 29440......... ........ A

Addition of

0.57

0.62

0.67

0.25

0.27

0.08

1.27

1.32

0.90

0.92

000 walker to cast. 29445......... ........ A

Apply rigid leg 1.78

1.62

1.76

0.93

0.95

0.27

3.67

3.81

2.98

3.00

000 cast. 29450......... ........ A

Application of

2.08

1.53

1.49

0.86

1.03

0.27

3.88

3.84

3.21

3.38

000 leg cast. 29505......... ........ A

Application,

0.69

1.06

1.15

0.45

0.45

0.08

1.83

1.92

1.22

1.22

000 long leg splint. 29515......... ........ A

Application

0.73

0.96

0.89

0.46

0.46

0.09

1.78

1.71

1.28

1.28

000 lower leg splint. 29520......... ........ A

Strapping of

0.54

0.68

0.81

0.38

0.45

0.03

1.25

1.38

0.95

1.02

000 hip. 29530......... ........ A

Strapping of

0.57

0.65

0.76

0.36

0.34

0.05

1.27

1.38

0.98

0.96

000 knee. 29540......... ........ A

Strapping of

0.51

0.55

0.45

0.31

0.31

0.06

1.12

1.02

0.88

0.88

000 ankle and/or ft. 29550......... ........ A

Strapping of

0.47

0.57

0.46

0.30

0.29

0.06

1.10

0.99

0.83

0.82

000 toes. 29580......... ........ A

Application of

0.55

0.73

0.67

0.34

0.35

0.07

1.35

1.29

0.96

0.97

000 paste boot. 29590......... ........ A

Application of

0.76

0.60

0.53

0.26

0.28

0.09

1.45

1.38

1.11

1.13

000 foot splint. 29700......... ........ A

Removal/

0.57

0.97

0.91

0.26

0.28

0.08

1.62

1.56

0.91

0.93

000 revision of cast. 29705......... ........ A

Removal/

0.76

0.77

0.81

0.37

0.38

0.13

1.66

1.70

1.26

1.27

000 revision of cast. 29710......... ........ A

Removal/

1.34

1.45

1.51

0.63

0.68

0.20

2.99

3.05

2.17

2.22

000 revision of cast.

[[Page 49120]]

29715......... ........ A

Removal/

0.94

1.14

1.16

0.41

0.40

0.09

2.17

2.19

1.44

1.43

000 revision of cast. 29720......... ........ A

Repair of body

0.68

1.15

1.16

0.34

0.38

0.12

1.95

1.96

1.14

1.18

000 cast. 29730......... ........ A

Windowing of

0.75

0.76

0.80

0.35

0.35

0.12

1.63

1.67

1.22

1.22

000 cast. 29740......... ........ A

Wedging of cast 1.12

1.05

1.13

0.49

0.49

0.18

2.35

2.43

1.79

1.79

000 29750......... ........ A

Wedging of

1.26

0.91

1.02

0.44

0.55

0.21

2.38

2.49

1.91

2.02

000 clubfoot cast. 29799......... ........ C

Casting/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY strapping procedure. 29800......... ........ A

Jaw arthroscopy/ 6.67

NA

NA

5.72

6.66

0.99

NA

NA

13.38

14.32

090 surgery. 29804......... ........ A

Jaw arthroscopy/ 8.63

NA

NA

7.34

7.55

1.38

NA

NA

17.35

17.56

090 surgery. 29805......... ........ A

Shoulder

5.88

NA

NA

4.74

5.44

1.02

NA

NA

11.64

12.34

090 arthroscopy, dx. 29806......... ........ A

Shoulder

14.85

NA

NA

9.41

10.72

2.49

NA

NA

26.75

28.06

090 arthroscopy/ surgery. 29807......... ........ A

Shoulder

14.38

NA

NA

9.28

10.56

2.41

NA

NA

26.07

27.35

090 arthroscopy/ surgery. 29819......... ........ A

Shoulder

7.61

NA

NA

5.66

6.51

1.32

NA

NA

14.59

15.44

090 arthroscopy/ surgery. 29820......... ........ A

Shoulder

7.06

NA

NA

5.21

5.97

1.22

NA

NA

13.49

14.25

090 arthroscopy/ surgery. 29821......... ........ A

Shoulder

7.71

NA

NA

5.68

6.52

1.33

NA

NA

14.72

15.56

090 arthroscopy/ surgery. 29822......... ........ A

Shoulder

7.42

NA

NA

5.61

6.42

1.28

NA

NA

14.31

15.12

090 arthroscopy/ surgery. 29823......... ........ A

Shoulder

8.16

NA

NA

6.07

6.93

1.41

NA

NA

15.64

16.50

090 arthroscopy/ surgery. 29824......... ........ A

Shoulder

8.74

NA

NA

6.57

7.29

1.42

NA

NA

16.73

17.45

090 arthroscopy/ surgery. 29825......... ........ A

Shoulder

7.61

NA

NA

5.67

6.49

1.32

NA

NA

14.60

15.42

090 arthroscopy/ surgery. 29826......... ........ A

Shoulder

8.98

NA

NA

6.22

7.20

1.55

NA

NA

16.75

17.73

090 arthroscopy/ surgery. 29827......... ........ A

Arthroscop

15.34

NA

NA

9.38

10.99

2.66

NA

NA

27.38

28.99

090 rotator cuff repr. 29830......... ........ A

Elbow

5.75

NA

NA

4.52

5.14

0.99

NA

NA

11.26

11.88

090 arthroscopy. 29834......... ........ A

Elbow

6.27

NA

NA

4.87

5.59

1.08

NA

NA

12.22

12.94

090 arthroscopy/ surgery. 29835......... ........ A

Elbow

6.47

NA

NA

4.99

5.66

1.13

NA

NA

12.59

13.26

090 arthroscopy/ surgery. 29836......... ........ A

Elbow

7.54

NA

NA

5.59

6.49

1.22

NA

NA

14.35

15.25

090 arthroscopy/ surgery. 29837......... ........ A

Elbow

6.86

NA

NA

5.15

5.89

1.19

NA

NA

13.20

13.94

090 arthroscopy/ surgery. 29838......... ........ A

Elbow

7.70

NA

NA

5.70

6.59

1.30

NA

NA

14.70

15.59

090 arthroscopy/ surgery. 29840......... ........ A

Wrist

5.53

NA

NA

4.62

5.15

0.84

NA

NA

10.99

11.52

090 arthroscopy. 29843......... ........ A

Wrist

6.00

NA

NA

4.92

5.45

0.92

NA

NA

11.84

12.37

090 arthroscopy/ surgery. 29844......... ........ A

Wrist

6.36

NA

NA

4.96

5.61

1.04

NA

NA

12.36

13.01

090 arthroscopy/ surgery. 29845......... ........ A

Wrist

7.51

NA

NA

5.51

6.23

0.99

NA

NA

14.01

14.73

090 arthroscopy/ surgery. 29846......... ........ A

Wrist

6.74

NA

NA

5.10

5.81

1.07

NA

NA

12.91

13.62

090 arthroscopy/ surgery. 29847......... ........ A

Wrist

7.07

NA

NA

5.17

5.94

1.08

NA

NA

13.32

14.09

090 arthroscopy/ surgery. 29848......... ........ A

Wrist endoscopy/ 6.18

NA

NA

5.29

5.52

0.86

NA

NA

12.33

12.56

090 surgery. 29850......... ........ A

Knee

8.18

NA

NA

5.13

5.07

1.25

NA

NA

14.56

14.50

090 arthroscopy/ surgery. 29851......... ........ A

Knee

13.08

NA

NA

8.32

9.42

2.34

NA

NA

23.74

24.84

090 arthroscopy/ surgery. 29855......... ........ A

Tibial

10.60

NA

NA

7.39

8.42

1.84

NA

NA

19.83

20.86

090 arthroscopy/ surgery. 29856......... ........ A

Tibial

14.12

NA

NA

8.76

10.19

2.39

NA

NA

25.27

26.70

090 arthroscopy/ surgery. 29860......... ........ A

Hip

8.79

NA

NA

6.23

6.77

1.36

NA

NA

16.38

16.92

090 arthroscopy, dx. 29861......... ........ A

Hip arthroscopy/ 9.89

NA

NA

6.64

7.17

1.59

NA

NA

18.12

18.65

090 surgery. 29862......... ........ A

Hip arthroscopy/ 10.89

NA

NA

7.62

8.33

1.62

NA

NA

20.13

20.84

090 surgery. 29863......... ........ A

Hip arthroscopy/ 10.89

NA

NA

7.53

8.27

1.42

NA

NA

19.84

20.58

090 surgery. 29866......... ........ A

Autgrft implnt, 14.38

NA

NA

9.54

10.90

2.39

NA

NA

26.31

27.67

090 knee w/scope. 29867......... ........ A

Allgrft implnt, 18.08

NA

NA

11.24

12.73

2.78

NA

NA

32.10

33.59

090 knee w/scope. 29868......... ........ A

Meniscal

24.79

NA

NA

13.94

16.08

4.35

NA

NA

43.08

45.22

090 trnspl, knee w/ scpe. 29870......... ........ A

Knee

5.06

NA

NA

4.18

4.71

0.85

NA

NA

10.09

10.62

090 arthroscopy, dx. 29871......... ........ A

Knee

6.54

NA

NA

5.03

5.66

1.14

NA

NA

12.71

13.34

090 arthroscopy/ drainage. 29873......... ........ A

Knee

5.99

NA

NA

5.61

6.33

1.04

NA

NA

12.64

13.36

090 arthroscopy/ surgery. 29874......... ........ A

Knee

7.04

NA

NA

5.18

5.85

1.11

NA

NA

13.33

14.00

090 arthroscopy/ surgery. 29875......... ........ A

Knee

6.30

NA

NA

4.92

5.62

1.09

NA

NA

12.31

13.01

090 arthroscopy/ surgery. 29876......... ........ A

Knee

8.66

NA

NA

6.23

6.82

1.37

NA

NA

16.26

16.85

090 arthroscopy/ surgery. 29877......... ........ A

Knee

8.09

NA

NA

5.99

6.55

1.28

NA

NA

15.36

15.92

090 arthroscopy/ surgery. 29879......... ........ A

Knee

8.78

NA

NA

6.28

6.91

1.39

NA

NA

16.45

17.08

090 arthroscopy/ surgery. 29880......... ........ A

Knee

9.24

NA

NA

6.48

7.14

1.47

NA

NA

17.19

17.85

090 arthroscopy/ surgery. 29881......... ........ A

Knee

8.50

NA

NA

6.18

6.77

1.34

NA

NA

16.02

16.61

090 arthroscopy/ surgery. 29882......... ........ A

Knee

9.39

NA

NA

6.52

7.06

1.50

NA

NA

17.41

17.95

090 arthroscopy/ surgery. 29883......... ........ A

Knee

11.53

NA

NA

7.65

8.71

1.92

NA

NA

21.10

22.16

090 arthroscopy/ surgery.

[[Page 49121]]

29884......... ........ A

Knee

8.07

NA

NA

6.01

6.53

1.27

NA

NA

15.35

15.87

090 arthroscopy/ surgery. 29885......... ........ A

Knee

9.96

NA

NA

7.05

7.74

1.58

NA

NA

18.58

19.28

090 arthroscopy/ surgery. 29886......... ........ A

Knee

8.28

NA

NA

6.08

6.66

1.30

NA

NA

15.66

16.24

090 arthroscopy/ surgery. 29887......... ........ A

Knee

9.91

NA

NA

7.04

7.71

1.57

NA

NA

18.52

19.19

090 arthroscopy/ surgery. 29888......... ........ A

Knee

14.06

NA

NA

8.34

9.74

2.41

NA

NA

24.81

26.21

090 arthroscopy/ surgery. 29889......... ........ A

Knee

17.05

NA

NA

10.75

12.01

2.78

NA

NA

30.58

31.84

090 arthroscopy/ surgery. 29891......... ........ A

Ankle

9.39

NA

NA

6.69

7.31

1.39

NA

NA

17.47

18.09

090 arthroscopy/ surgery. 29892......... ........ A

Ankle

9.99

NA

NA

6.58

7.45

1.41

NA

NA

17.98

18.85

090 arthroscopy/ surgery. 29893......... ........ A

Scope, plantar

5.96

8.86

6.93

4.67

4.16

0.63 15.45

13.52

11.26

10.75

090 fasciotomy. 29894......... ........ A

Ankle

7.20

NA

NA

4.72

5.28

1.15

NA

NA

13.07

13.63

090 arthroscopy/ surgery. 29895......... ........ A

Ankle

6.98

NA

NA

4.54

5.24

1.11

NA

NA

12.63

13.33

090 arthroscopy/ surgery. 29897......... ........ A

Ankle

7.17

NA

NA

4.96

5.65

1.17

NA

NA

13.30

13.99

090 arthroscopy/ surgery. 29898......... ........ A

Ankle

8.31

NA

NA

5.29

5.97

1.28

NA

NA

14.88

15.56

090 arthroscopy/ surgery. 29899......... ........ A

Ankle

15.13

NA

NA

9.30

10.23

2.40

NA

NA

26.83

27.76

090 arthroscopy/ surgery. 29900......... ........ A

Mcp joint

5.66

NA

NA

4.74

5.58

0.94

NA

NA

11.34

12.18

090 arthroscopy, dx. 29901......... ........ A

Mcp joint

6.37

NA

NA

5.50

6.07

1.06

NA

NA

12.93

13.50

090 arthroscopy, surg. 29902......... ........ A

Mcp joint

6.94

NA

NA

3.68

5.83

1.12

NA

NA

11.74

13.89

090 arthroscopy, surg. 29999......... ........ C

Arthroscopy of

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY joint. 30000......... ........ A

Drainage of

1.43

3.73

3.99

1.23

1.35

0.12

5.28

5.54

2.78

2.90

010 nose lesion. 30020......... ........ A

Drainage of

1.43

3.86

3.42

1.26

1.42

0.12

5.41

4.97

2.81

2.97

010 nose lesion. 30100......... ........ A

Intranasal

0.94

2.40

2.08

0.68

0.79

0.07

3.41

3.09

1.69

1.80

000 biopsy. 30110......... ........ A

Removal of nose 1.63

3.62

3.34

1.32

1.51

0.14

5.39

5.11

3.09

3.28

010 polyp(s). 30115......... ........ A

Removal of nose 4.34

NA

NA

5.47

5.69

0.41

NA

NA

10.22

10.44

090 polyp(s). 30117......... ........ A

Removal of

3.16 16.90

14.08

4.51

4.60

0.26 20.32

17.50

7.93

8.02

090 intranasal lesion. 30118......... ........ A

Removal of

9.74

NA

NA

7.73

8.83

0.78

NA

NA

18.25

19.35

090 intranasal lesion. 30120......... ........ A

Revision of

5.26

6.78

6.56

4.84

5.71

0.52 12.56

12.34

10.62

11.49

090 nose. 30124......... ........ A

Removal of nose 3.10

NA

NA

3.59

3.61

0.25

NA

NA

6.94

6.96

090 lesion. 30125......... ........ A

Removal of nose 7.15

NA

NA

7.00

7.99

0.63

NA

NA

14.78

15.77

090 lesion. 30130......... ........ A

Excise inferior 3.37

NA

NA

5.28

5.51

0.31

NA

NA

8.96

9.19

090 turbinate. 30140......... ........ A

Resect inferior 3.42

NA

NA

6.54

6.28

0.35

NA

NA

10.31

10.05

090 turbinate. 30150......... ........ A

Partial removal 9.37

NA

NA

8.50

10.38

0.93

NA

NA

18.80

20.68

090 of nose. 30160......... ........ A

Removal of nose 9.81

NA

NA

8.12

9.69

0.88

NA

NA

18.81

20.38

090 30200......... ........ A

Injection

0.78

1.87

1.68

0.61

0.71

0.06

2.71

2.52

1.45

1.55

000 treatment of nose. 30210......... ........ A

Nasal sinus

1.08

2.31

2.15

1.15

1.27

0.09

3.48

3.32

2.32

2.44

010 therapy. 30220......... ........ A

Insert nasal

1.54

5.41

4.53

1.29

1.47

0.12

7.07

6.19

2.95

3.13

010 septal button. 30300......... ........ A

Remove nasal

1.04

4.14

4.51

1.79

1.88

0.08

5.26

5.63

2.91

3.00

010 foreign body. 30310......... ........ A

Remove nasal

1.96

NA

NA

2.71

3.00

0.16

NA

NA

4.83

5.12

010 foreign body. 30320......... ........ A

Remove nasal

4.51

NA

NA

5.93

6.76

0.39

NA

NA

10.83

11.66

090 foreign body. 30400......... ........ R

Reconstruction 10.46

NA

NA

13.64

15.03

1.04

NA

NA

25.14

26.53

090 of nose. 30410......... ........ R

Reconstruction 13.60

NA

NA

14.27

17.35

1.42

NA

NA

29.29

32.37

090 of nose. 30420......... ........ R

Reconstruction 16.50

NA

NA

14.69

17.11

1.46

NA

NA

32.65

35.07

090 of nose. 30430......... ........ R

Revision of

7.84

NA

NA

12.76

15.20

0.77

NA

NA

21.37

23.81

090 nose. 30435......... ........ R

Revision of

12.33

NA

NA

14.67

18.18

1.22

NA

NA

28.22

31.73

090 nose. 30450......... ........ R

Revision of

19.26

NA

NA

16.12

20.45

1.96

NA

NA

37.34

41.67

090 nose. 30460......... ........ A

Revision of

10.20

NA

NA

7.13

9.24

1.03

NA

NA

18.36

20.47

090 nose. 30462......... ........ A

Revision of

20.04

NA

NA

14.29

18.75

2.53

NA

NA

36.86

41.32

090 nose. 30465......... ........ A

Repair nasal

12.12

NA

NA

10.25

11.54

1.06

NA

NA

23.43

24.72

090 stenosis. 30520......... ........ A

Repair of nasal 7.63

NA

NA

7.58

6.89

0.46

NA

NA

15.67

14.98

090 septum. 30540......... ........ A

Repair nasal

7.74

NA

NA

7.01

8.71

0.67

NA

NA

15.42

17.12

090 defect. 30545......... ........ A

Repair nasal

11.42

NA

NA

10.02

11.43

1.70

NA

NA

23.14

24.55

090 defect. 30560......... ........ A

Release of

1.26

4.93

4.81

1.87

2.07

0.10

6.29

6.17

3.23

3.43

010 nasal adhesions. 30580......... ........ A

Repair upper

6.68

8.15

7.87

4.69

5.52

0.89 15.72

15.44

12.26

13.09

090 jaw fistula. 30600......... ........ A

Repair mouth/

6.01

7.47

7.51

4.04

4.78

0.70 14.18

14.22

10.75

11.49

090 nose fistula. 30620......... ........ A

Intranasal

5.96

NA

NA

8.08

8.64

0.57

NA

NA

14.61

15.17

090 reconstruction. 30630......... ........ A

Repair nasal

7.11

NA

NA

7.05

7.73

0.61

NA

NA

14.77

15.45

090 septum defect. 30801......... ........ A

Ablate inf

1.09

4.03

4.11

1.97

1.93

0.09

5.21

5.29

3.15

3.11

010 turbinate, superf. 30802......... ........ A

Cauterization,

2.03

4.60

4.61

2.30

2.35

0.16

6.79

6.80

4.49

4.54

010 inner nose. 30901......... ........ A

Control of

1.21

1.20

1.32

0.28

0.31

0.11

2.52

2.64

1.60

1.63

000 nosebleed. 30903......... ........ A

Control of

1.54

3.07

2.80

0.38

0.47

0.13

4.74

4.47

2.05

2.14

000 nosebleed. 30905......... ........ A

Control of

1.97

3.73

3.57

0.46

0.69

0.17

5.87

5.71

2.60

2.83

000 nosebleed. 30906......... ........ A

Repeat control

2.45

3.96

3.91

0.66

1.07

0.20

6.61

6.56

3.31

3.72

000 of nosebleed. 30915......... ........ A

Ligation, nasal 7.31

NA

NA

5.80

6.47

0.58

NA

NA

13.69

14.36

090 sinus artery. 30920......... ........ A

Ligation, upper 10.97

NA

NA

8.11

8.76

0.80

NA

NA

19.88

20.53

090 jaw artery. 30930......... ........ A

Ther fx, nasal

1.26

NA

NA

1.52

1.60

0.12

NA

NA

2.90

2.98

010 inf turbinate. 30999......... ........ C

Nasal surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 31000......... ........ A

Irrigation,

1.15

3.00

2.88

1.23

1.36

0.09

4.24

4.12

2.47

2.60

010 maxillary sinus.

[[Page 49122]]

31002......... ........ A

Irrigation,

1.91

NA

NA

2.51

3.06

0.15

NA

NA

4.57

5.12

010 sphenoid sinus. 31020......... ........ A

Exploration,

2.94

8.06

8.41

5.16

5.18

0.29 11.29

11.64

8.39

8.41

090 maxillary sinus. 31030......... ........ A

Exploration,

5.91

9.77

11.07

6.01

6.50

0.60 16.28

17.58

12.52

13.01

090 maxillary sinus. 31032......... ........ A

Explore sinus,

6.56

NA

NA

6.46

7.04

0.59

NA

NA

13.61

14.19

090 remove polyps. 31040......... ........ A

Exploration

9.59

NA

NA

7.26

9.18

0.87

NA

NA

17.72

19.64

090 behind upper jaw. 31050......... ........ A

Exploration,

5.27

NA

NA

6.12

6.29

0.49

NA

NA

11.88

12.05

090 sphenoid sinus. 31051......... ........ A

Sphenoid sinus

7.10

NA

NA

7.68

8.10

0.62

NA

NA

15.40

15.82

090 surgery. 31070......... ........ A

Exploration of

4.27

NA

NA

5.68

5.87

0.38

NA

NA

10.33

10.52

090 frontal sinus. 31075......... ........ A

Exploration of

9.33

NA

NA

8.49

9.42

0.75

NA

NA

18.57

19.50

090 frontal sinus. 31080......... ........ A

Removal of

12.46

NA

NA

10.39

12.75

1.23

NA

NA

24.08

26.44

090 frontal sinus. 31081......... ........ A

Removal of

13.91

NA

NA

14.59

14.15

2.46

NA

NA

30.96

30.52

090 frontal sinus. 31084......... ........ A

Removal of

14.67

NA

NA

11.82

13.08

1.19

NA

NA

27.68

28.94

090 frontal sinus. 31085......... ........ A

Removal of

15.36

NA

NA

12.90

13.70

1.72

NA

NA

29.98

30.78

090 frontal sinus. 31086......... ........ A

Removal of

14.08

NA

NA

11.66

12.88

1.07

NA

NA

26.81

28.03

090 frontal sinus. 31087......... ........ A

Removal of

14.32

NA

NA

10.69

12.07

1.44

NA

NA

26.45

27.83

090 frontal sinus. 31090......... ........ A

Exploration of 10.78

NA

NA

12.26

12.48

0.94

NA

NA

23.98

24.20

090 sinuses. 31200......... ........ A

Removal of

4.96

NA

NA

7.42

8.76

0.29

NA

NA

12.67

14.01

090 ethmoid sinus. 31201......... ........ A

Removal of

8.42

NA

NA

8.22

8.93

0.82

NA

NA

17.46

18.17

090 ethmoid sinus. 31205......... ........ A

Removal of

10.40

NA

NA

9.52

11.29

0.67

NA

NA

20.59

22.36

090 ethmoid sinus. 31225......... ........ A

Removal of

26.34

NA

NA

16.28

17.44

1.59

NA

NA

44.21

45.37

090 upper jaw. 31230......... ........ A

Removal of

30.46

NA

NA

16.95

18.76

1.77

NA

NA

49.18

50.99

090 upper jaw. 31231......... ........ A

Nasal

1.10

3.34

3.37

0.69

0.83

0.09

4.53

4.56

1.88

2.02

000 endoscopy, dx. 31233......... ........ A

Nasal/sinus

2.18

3.94

4.21

0.99

1.36

0.20

6.32

6.59

3.37

3.74

000 endoscopy, dx. 31235......... ........ A

Nasal/sinus

2.64

4.28

4.75

1.12

1.57

0.26

7.18

7.65

4.02

4.47

000 endoscopy, dx. 31237......... ........ A

Nasal/sinus

2.98

4.51

5.02

1.22

1.72

0.28

7.77

8.28

4.48

4.98

000 endoscopy, surg. 31238......... ........ A

Nasal/sinus

3.26

4.43

5.03

1.30

1.89

0.27

7.96

8.56

4.83

5.42

000 endoscopy, surg. 31239......... ........ A

Nasal/sinus

9.19

NA

NA

6.27

7.57

0.62

NA

NA

16.08

17.38

010 endoscopy, surg. 31240......... ........ A

Nasal/sinus

2.61

NA

NA

1.12

1.58

0.24

NA

NA

3.97

4.43

000 endoscopy, surg. 31254......... ........ A

Revision of

4.64

NA

NA

1.70

2.56

0.45

NA

NA

6.79

7.65

000 ethmoid sinus. 31255......... ........ A

Removal of

6.95

NA

NA

2.34

3.67

0.73

NA

NA

10.02

11.35

000 ethmoid sinus. 31256......... ........ A

Exploration

3.29

NA

NA

1.31

1.91

0.33

NA

NA

4.93

5.53

000 maxillary sinus. 31267......... ........ A

Endoscopy,

5.45

NA

NA

1.92

2.95

0.55

NA

NA

7.92

8.95

000 maxillary sinus. 31276......... ........ A

Sinus

8.84

NA

NA

2.87

4.56

0.92

NA

NA

12.63

14.32

000 endoscopy, surgical. 31287......... ........ A

Nasal/sinus

3.91

NA

NA

1.48

2.21

0.39

NA

NA

5.78

6.51

000 endoscopy, surg. 31288......... ........ A

Nasal/sinus

4.57

NA

NA

1.67

2.53

0.46

NA

NA

6.70

7.56

000 endoscopy, surg. 31290......... ........ A

Nasal/sinus

18.46

NA

NA

7.99

11.04

1.40

NA

NA

27.85

30.90

010 endoscopy, surg. 31291......... ........ A

Nasal/sinus

19.41

NA

NA

8.60

11.50

1.68

NA

NA

29.69

32.59

010 endoscopy, surg. 31292......... ........ A

Nasal/sinus

15.75

NA

NA

7.20

9.76

1.21

NA

NA

24.16

26.72

010 endoscopy, surg. 31293......... ........ A

Nasal/sinus

17.32

NA

NA

7.82

10.49

1.28

NA

NA

26.42

29.09

010 endoscopy, surg. 31294......... ........ A

Nasal/sinus

20.16

NA

NA

8.72

11.83

1.53

NA

NA

30.41

33.52

010 endoscopy, surg. 31299......... ........ C

Sinus surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 31300......... ........ A

Removal of

15.63

NA

NA

13.43

14.59

1.17

NA

NA

30.23

31.39

090 larynx lesion. 31320......... ........ A

Diagnostic

5.55

NA

NA

9.17

10.02

0.46

NA

NA

15.18

16.03

090 incision, larynx. 31360......... ........ A

Removal of

27.23

NA

NA

17.39

16.89

1.38

NA

NA

46.00

45.50

090 larynx. 31365......... ........ A

Removal of

34.85

NA

NA

19.55

20.16

1.97

NA

NA

56.37

56.98

090 larynx. 31367......... ........ A

Partial removal 27.11

NA

NA

19.32

21.25

1.78

NA

NA

48.21

50.14

090 of larynx. 31368......... ........ A

Partial removal 33.73

NA

NA

22.12

24.65

2.20

NA

NA

58.05

60.58

090 of larynx. 31370......... ........ A

Partial removal 27.11

NA

NA

20.11

21.72

1.74

NA

NA

48.96

50.57

090 of larynx. 31375......... ........ A

Partial removal 25.61

NA

NA

19.22

20.09

1.63

NA

NA

46.46

47.33

090 of larynx. 31380......... ........ A

Partial removal 25.11

NA

NA

18.90

20.18

1.70

NA

NA

45.71

46.99

090 of larynx. 31382......... ........ A

Partial removal 28.11

NA

NA

20.41

21.31

1.67

NA

NA

50.19

51.09

090 of larynx. 31390......... ........ A

Removal of

38.72

NA

NA

22.29

23.86

2.23

NA

NA

63.24

64.81

090 larynx & pharynx. 31395......... ........ A

Reconstruct

43.34

NA

NA

25.53

27.61

2.48

NA

NA

71.35

73.43

090 larynx & pharynx. 31400......... ........ A

Revision of

11.40

NA

NA

11.42

13.18

0.83

NA

NA

23.65

25.41

090 larynx. 31420......... ........ A

Removal of

11.25

NA

NA

7.82

9.11

0.83

NA

NA

19.90

21.19

090 epiglottis. 31500......... ........ A

Insert

2.33

NA

NA

0.43

0.52

0.17

NA

NA

2.93

3.02

000 emergency airway.

[[Page 49123]]

31502......... ........ A

Change of

0.65

NA

NA

0.20

0.26

0.05

NA

NA

0.90

0.96

000 windpipe airway. 31505......... ........ A

Diagnostic

0.61

1.33

1.42

0.54

0.59

0.05

1.99

2.08

1.20

1.25

000 laryngoscopy. 31510......... ........ A

Laryngoscopy

1.92

2.98

3.22

0.91

1.17

0.16

5.06

5.30

2.99

3.25

000 with biopsy. 31511......... ........ A

Remove foreign

2.16

2.75

3.03

0.93

1.03

0.19

5.10

5.38

3.28

3.38

000 body, larynx. 31512......... ........ A

Removal of

2.07

2.73

3.08

0.95

1.26

0.18

4.98

5.33

3.20

3.51

000 larynx lesion. 31513......... ........ A

Injection into

2.10

NA

NA

0.97

1.34

0.17

NA

NA

3.24

3.61

000 vocal cord. 31515......... ........ A

Laryngoscopy

1.80

3.06

3.42

0.83

1.00

0.14

5.00

5.36

2.77

2.94

000 for aspiration. 31520......... ........ A

Dx

2.56

NA

NA

1.09

1.44

0.20

NA

NA

3.85

4.20

000 laryngoscopy, newborn. 31525......... ........ A

Dx laryngoscopy 2.63

3.22

3.54

1.10

1.52

0.21

6.06

6.38

3.94

4.36

000 excl nb. 31526......... ........ A

Dx laryngoscopy 2.57

NA

NA

1.10

1.57

0.21

NA

NA

3.88

4.35

000 w/oper scope. 31527......... ........ A

Laryngoscopy

3.27

NA

NA

1.29

1.73

0.26

NA

NA

4.82

5.26

000 for treatment. 31528......... ........ A

Laryngoscopy

2.37

NA

NA

0.97

1.34

0.19

NA

NA

3.53

3.90

000 and dilation. 31529......... ........ A

Laryngoscopy

2.68

NA

NA

1.09

1.56

0.22

NA

NA

3.99

4.46

000 and dilation. 31530......... ........ A

Laryngoscopy w/ 3.38

NA

NA

1.29

1.79

0.29

NA

NA

4.96

5.46

000 fb removal. 31531......... ........ A

Laryngoscopy w/ 3.58

NA

NA

1.39

2.05

0.29

NA

NA

5.26

5.92

000 fb & op scope. 31535......... ........ A

Laryngoscopy w/ 3.16

NA

NA

1.27

1.81

0.26

NA

NA

4.69

5.23

000 biopsy. 31536......... ........ A

Laryngoscopy w/ 3.55

NA

NA

1.38

2.03

0.29

NA

NA

5.22

5.87

000 bx & op scope. 31540......... ........ A

Laryngoscopy w/ 4.12

NA

NA

1.54

2.29

0.33

NA

NA

5.99

6.74

000 exc of tumor. 31541......... ........ A

Larynscop w/

4.52

NA

NA

1.66

2.50

0.37

NA

NA

6.55

7.39

000 tumr exc + scope. 31545......... ........ A

Remove vc

6.30

NA

NA

2.19

3.15

0.37

NA

NA

8.86

9.82

000 lesion w/scope. 31546......... ........ A

Remove vc

9.73

NA

NA

3.71

4.66

0.78

NA

NA

14.22

15.17

000 lesion scope/ graft. 31560......... ........ A

Laryngoscop w/

5.45

NA

NA

1.87

2.83

0.43

NA

NA

7.75

8.71

000 arytenoidectom. 31561......... ........ A

Larynscop,

5.99

NA

NA

2.02

3.03

0.49

NA

NA

8.50

9.51

000 remve cart + scop. 31570......... ........ A

Laryngoscope w/ 3.86

3.93

5.24

1.46

2.15

0.31

8.10

9.41

5.63

6.32

000 vc inj. 31571......... ........ A

Laryngoscop w/

4.26

NA

NA

1.58

2.35

0.35

NA

NA

6.19

6.96

000 vc inj + scope. 31575......... ........ A

Diagnostic

1.10

1.56

1.82

0.69

0.84

0.09

2.75

3.01

1.88

2.03

000 laryngoscopy. 31576......... ........ A

Laryngoscopy

1.97

3.26

3.56

0.94

1.20

0.14

5.37

5.67

3.05

3.31

000 with biopsy. 31577......... ........ A

Remove foreign

2.47

3.22

3.63

1.09

1.42

0.21

5.90

6.31

3.77

4.10

000 body, larynx. 31578......... ........ A

Removal of

2.84

3.66

4.13

1.18

1.44

0.23

6.73

7.20

4.25

4.51

000 larynx lesion. 31579......... ........ A

Diagnostic

2.26

2.63

3.49

1.02

1.37

0.18

5.07

5.93

3.46

3.81

000 laryngoscopy. 31580......... ........ A

Revision of

14.38

NA

NA

13.35

15.27

1.00

NA

NA

28.73

30.65

090 larynx. 31582......... ........ A

Revision of

22.73

NA

NA

20.27

24.42

1.75

NA

NA

44.75

48.90

090 larynx. 31584......... ........ A

Treat larynx

20.27

NA

NA

14.11

17.14

1.71

NA

NA

36.09

39.12

090 fracture. 31587......... ........ A

Revision of

15.06

NA

NA

7.88

8.92

0.97

NA

NA

23.91

24.95

090 larynx. 31588......... ........ A

Revision of

14.48

NA

NA

11.28

13.03

1.06

NA

NA

26.82

28.57

090 larynx. 31590......... ........ A

Reinnervate

7.53

NA

NA

11.98

14.64

0.84

NA

NA

20.35

23.01

090 larynx. 31595......... ........ A

Larynx nerve

8.69

NA

NA

8.86

10.13

0.68

NA

NA

18.23

19.50

090 surgery. 31599......... ........ C

Larynx surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 31600......... ........ A

Incision of

7.17

NA

NA

2.19

2.94

0.80

NA

NA

10.16

10.91

000 windpipe. 31601......... ........ A

Incision of

4.44

NA

NA

1.61

2.20

0.40

NA

NA

6.45

7.04

000 windpipe. 31603......... ........ A

Incision of

4.14

NA

NA

1.11

1.56

0.44

NA

NA

5.69

6.14

000 windpipe. 31605......... ........ A

Incision of

3.57

NA

NA

0.82

1.10

0.40

NA

NA

4.79

5.07

000 windpipe. 31610......... ........ A

Incision of

9.23

NA

NA

7.12

7.98

0.79

NA

NA

17.14

18.00

090 windpipe. 31611......... ........ A

Surgery/speech

5.87

NA

NA

6.44

6.91

0.46

NA

NA

12.77

13.24

090 prosthesis. 31612......... ........ A

Puncture/clear

0.91

1.07

1.09

0.24

0.32

0.08

2.06

2.08

1.23

1.31

000 windpipe. 31613......... ........ A

Repair windpipe 4.58

NA

NA

5.79

5.94

0.42

NA

NA

10.79

10.94

090 opening. 31614......... ........ A

Repair windpipe 8.39

NA

NA

8.81

8.74

0.58

NA

NA

17.78

17.71

090 opening. 31615......... ........ A

Visualization

2.09

2.21

2.50

0.95

1.14

0.16

4.46

4.75

3.20

3.39

000 of windpipe. 31620......... ........ A

Endobronchial

1.40

6.04

5.74

0.34

0.50

0.11

7.55

7.25

1.85

2.01

ZZZ us add-on. 31622......... ........ A

Dx bronchoscope/ 2.78

5.26

5.55

0.90

1.02

0.18

8.22

8.51

3.86

3.98

000 wash. 31623......... ........ A

Dx bronchoscope/ 2.88

6.03

6.32

0.90

1.01

0.13

9.04

9.33

3.91

4.02

000 brush. 31624......... ........ A

Dx bronchoscope/ 2.88

5.38

5.67

0.90

1.01

0.13

8.39

8.68

3.91

4.02

000 lavage. 31625......... ........ A

Bronchoscopy w/ 3.36

5.52

5.74

1.02

1.16

0.18

9.06

9.28

4.56

4.70

000 biopsy(s). 31628......... ........ A

Bronchoscopy/

3.80

7.02

7.02

1.11

1.25

0.18 11.00

11.00

5.09

5.23

000 lung bx, each. 31629......... ........ A

Bronchoscopy/

4.09 12.10

13.71

1.19

1.35

0.16 16.35

17.96

5.44

5.60

000 needle bx, each. 31630......... ........ A

Bronchoscopy

3.81

NA

NA

1.25

1.60

0.32

NA

NA

5.38

5.73

000 dilate/fx repr. 31631......... ........ A

Bronchoscopy,

4.36

NA

NA

1.39

1.67

0.34

NA

NA

6.09

6.37

000 dilate w/stent. 31632......... ........ A

Bronchoscopy/

1.03

0.86

0.82

0.24

0.29

0.18

2.07

2.03

1.45

1.50

ZZZ lung bx, addIl. 31633......... ........ A

Bronchoscopy/

1.32

0.99

0.94

0.31

0.38

0.16

2.47

2.42

1.79

1.86

ZZZ needle bx addIl. 31635......... ........ A

Bronchoscopy w/ 3.67

5.20

5.88

1.13

1.36

0.24

9.11

9.79

5.04

5.27

000 fb removal. 31636......... ........ A

Bronchoscopy,

4.30

NA

NA

1.37

1.66

0.31

NA

NA

5.98

6.27

000 bronch stents. 31637......... ........ A

Bronchoscopy,

1.58

NA

NA

0.42

0.53

0.13

NA

NA

2.13

2.24

ZZZ stent add-on. 31638......... ........ A

Bronchoscopy,

4.88

NA

NA

1.55

1.87

0.22

NA

NA

6.65

6.97

000 revise stent. 31640......... ........ A

Bronchoscopy w/ 4.93

NA

NA

1.52

1.93

0.46

NA

NA

6.91

7.32

000 tumor excise. 31641......... ........ A

Bronchoscopy,

5.02

NA

NA

1.49

1.78

0.35

NA

NA

6.86

7.15

000 treat blockage. 31643......... ........ A

Diag

3.49

NA

NA

1.05

1.19

0.20

NA

NA

4.74

4.88

000 bronchoscope/ catheter.

[[Page 49124]]

31645......... ........ A

Bronchoscopy,

3.16

4.77

5.05

0.97

1.08

0.16

8.09

8.37

4.29

4.40

000 clear airways. 31646......... ........ A

Bronchoscopy,

2.72

4.48

4.77

0.86

0.97

0.14

7.34

7.63

3.72

3.83

000 reclear airway. 31656......... ........ A

Bronchoscopy,

2.17

5.31

6.80

0.65

0.79

0.15

7.63

9.12

2.97

3.11

000 inj for x-ray. 31700......... ........ A

Insertion of

1.34

2.30

2.19

0.68

0.68

0.08

3.72

3.61

2.10

2.10

000 airway catheter. 31708......... ........ A

Instill airway

1.41

NA

NA

0.40

0.45

0.07

NA

NA

1.88

1.93

000 contrast dye. 31710......... ........ A

Insertion of

1.30

NA

NA

0.42

0.41

0.12

NA

NA

1.84

1.83

000 airway catheter. 31715......... ........ A

Injection for

1.11

NA

NA

0.29

0.33

0.07

NA

NA

1.47

1.51

000 bronchus x-ray. 31717......... ........ A

Bronchial brush 2.12

5.86

7.65

0.76

0.78

0.14

8.12

9.91

3.02

3.04

000 biopsy. 31720......... ........ A

Clearance of

1.06

NA

NA

0.25

0.31

0.07

NA

NA

1.38

1.44

000 airways. 31725......... ........ A

Clearance of

1.96

NA

NA

0.45

0.55

0.14

NA

NA

2.55

2.65

000 airways. 31730......... ........ A

Intro, windpipe 2.85 25.67

8.06

0.72

0.93

0.21 28.73

11.12

3.78

3.99

000 wire/tube. 31750......... ........ A

Repair of

15.11

NA

NA

16.11

17.19

1.05

NA

NA

32.27

33.35

090 windpipe. 31755......... ........ A

Repair of

17.05

NA

NA

22.15

23.93

1.29

NA

NA

40.49

42.27

090 windpipe. 31760......... ........ A

Repair of

23.28

NA

NA

9.76

10.47

2.94

NA

NA

35.98

36.69

090 windpipe. 31766......... ........ A

Reconstruction 31.52

NA

NA

11.44

13.10

4.52

NA

NA

47.48

49.14

090 of windpipe. 31770......... ........ A

Repair/graft of 23.44

NA

NA

8.83

9.89

2.83

NA

NA

35.10

36.16

090 bronchus. 31775......... ........ A

Reconstruct

24.46

NA

NA

9.07

11.11

3.01

NA

NA

36.54

38.58

090 bronchus. 31780......... ........ A

Reconstruct

19.62

NA

NA

7.98

10.28

1.65

NA

NA

29.25

31.55

090 windpipe. 31781......... ........ A

Reconstruct

24.72

NA

NA

9.17

11.38

2.24

NA

NA

36.13

38.34

090 windpipe. 31785......... ........ A

Remove windpipe 18.25

NA

NA

5.49

9.01

1.59

NA

NA

25.33

28.85

090 lesion. 31786......... ........ A

Remove windpipe 25.29

NA

NA

9.74

12.25

3.29

NA

NA

38.32

40.83

090 lesion. 31800......... ........ A

Repair of

8.05

NA

NA

8.35

9.02

0.79

NA

NA

17.19

17.86

090 windpipe injury. 31805......... ........ A

Repair of

13.29

NA

NA

6.24

6.97

1.82

NA

NA

21.35

22.08

090 windpipe injury. 31820......... ........ A

Closure of

4.54

5.43

5.60

2.98

3.48

0.38 10.35

10.52

7.90

8.40

090 windpipe lesion. 31825......... ........ A

Repair of

6.92

6.78

7.44

4.00

5.03

0.53 14.23

14.89

11.45

12.48

090 windpipe defect. 31830......... ........ A

Revise windpipe 4.49

5.60

5.72

3.33

3.82

0.44 10.53

10.65

8.26

8.75

090 scar. 31899......... ........ C

Airways

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgical procedure. 32000......... ........ A

Drainage of

1.54

2.39

2.89

0.43

0.47

0.08

4.01

4.51

2.05

2.09

000 chest. 32002......... ........ A

Treatment of

2.19

2.85

3.12

0.99

1.04

0.12

5.16

5.43

3.30

3.35

000 collapsed lung. 32005......... ........ A

Treat lung

2.19

5.11

6.12

0.59

0.67

0.23

7.53

8.54

3.01

3.09

000 lining chemically. 32019......... ........ A

Insert pleural

4.17 15.54

18.86

1.45

1.60

0.42 20.13

23.45

6.04

6.19

000 catheter. 32020......... ........ A

Insertion of

3.97

NA

NA

1.14

1.30

0.43

NA

NA

5.54

5.70

000 chest tube. 32035......... ........ A

Exploration of 11.14

NA

NA

6.11

5.92

1.26

NA

NA

18.50

18.32

090 chest. 32036......... ........ A

Exploration of 12.15

NA

NA

6.43

6.43

1.43

NA

NA

20.01

20.01

090 chest. 32095......... ........ A

Biopsy through 10.03

NA

NA

5.22

5.33

1.22

NA

NA

16.47

16.58

090 chest wall. 32100......... ........ A

Exploration/

16.04

NA

NA

7.09

7.64

2.23

NA

NA

25.36

25.91

090 biopsy of chest. 32110......... ........ A

Explore/repair 25.11

NA

NA

10.03

10.56

3.21

NA

NA

38.35

38.88

090 chest. 32120......... ........ A

Re-exploration 14.24

NA

NA

6.91

7.03

1.63

NA

NA

22.78

22.90

090 of chest. 32124......... ........ A

Explore chest

15.30

NA

NA

7.09

7.18

1.89

NA

NA

24.28

24.37

090 free adhesions. 32140......... ........ A

Removal of lung 16.51

NA

NA

7.48

7.63

1.96

NA

NA

25.95

26.10

090 lesion(s). 32141......... ........ A

Remove/treat

17.14

NA

NA

7.69

7.59

2.00

NA

NA

26.83

26.73

090 lung lesions. 32150......... ........ A

Removal of lung 16.67

NA

NA

7.54

7.59

2.00

NA

NA

26.21

26.26

090 lesion(s). 32151......... ........ A

Remove lung

16.79

NA

NA

8.73

8.18

2.03

NA

NA

27.55

27.00

090 foreign body. 32160......... ........ A

Open chest

13.00

NA

NA

5.89

5.42

1.31

NA

NA

20.20

19.73

090 heart massage. 32200......... ........ A

Drain, open,

18.43

NA

NA

8.91

8.69

2.13

NA

NA

29.47

29.25

090 lung lesion. 32201......... ........ A

Drain, percut,

3.99 19.87

20.49

1.26

1.29

0.24 24.10

24.72

5.49

5.52

000 lung lesion. 32215......... ........ A

Treat chest

12.90

NA

NA

6.43

6.78

1.68

NA

NA

21.01

21.36

090 lining. 32220......... ........ A

Release of lung 26.31

NA

NA

12.11

12.74

3.56

NA

NA

41.98

42.61

090 32225......... ........ A

Partial release 16.60

NA

NA

7.54

7.62

2.06

NA

NA

26.20

26.28

090 of lung. 32310......... ........ A

Removal of

15.13

NA

NA

6.98

7.29

1.99

NA

NA

24.10

24.41

090 chest lining. 32320......... ........ A

Free/remove

26.96

NA

NA

11.63

12.02

3.51

NA

NA

42.10

42.49

090 chest lining. 32400......... ........ A

Needle biopsy

1.76

2.12

2.12

0.52

0.54

0.10

3.98

3.98

2.38

2.40

000 chest lining. 32402......... ........ A

Open biopsy

8.86

NA

NA

4.81

5.04

1.07

NA

NA

14.74

14.97

090 chest lining. 32405......... ........ A

Biopsy, lung or 1.93

0.61

0.66

0.61

0.63

0.11

2.65

2.70

2.65

2.67

000 mediastinum. 32420......... ........ A

Puncture/clear

2.18

NA

NA

0.68

0.68

0.12

NA

NA

2.98

2.98

000 lung. 32440......... ........ A

Removal of lung 27.11

NA

NA

11.11

12.45

3.68

NA

NA

41.90

43.24

090

[[Page 49125]]

32442......... ........ A

Sleeve

37.74

NA

NA

13.28

14.39

3.84

NA

NA

54.86

55.97

090 pneumonectomy. 32445......... ........ A

Removal of lung 40.73

NA

NA

16.31

14.62

3.71

NA

NA

60.75

59.06

090 32480......... ........ A

Partial removal 25.65

NA

NA

10.37

11.64

3.49

NA

NA

39.51

40.78

090 of lung. 32482......... ........ A

Bilobectomy.... 27.22

NA

NA

11.22

12.49

3.66

NA

NA

42.10

43.37

090 32484......... ........ A

Segmentectomy.. 22.67

NA

NA

8.92

10.77

3.03

NA

NA

34.62

36.47

090 32486......... ........ A

Sleeve

31.72

NA

NA

11.89

12.90

3.51

NA

NA

47.12

48.13

090 lobectomy. 32488......... ........ A

Completion

32.69

NA

NA

12.78

13.53

3.80

NA

NA

49.27

50.02

090 pneumonectomy. 32491......... ........ R

Lung volume

25.03

NA

NA

10.69

12.14

2.98

NA

NA

38.70

40.15

090 reduction. 32500......... ........ A

Partial removal 24.42

NA

NA

10.43

11.87

3.25

NA

NA

38.10

39.54

090 of lung. 32501......... ........ A

Repair bronchus 4.68

NA

NA

1.37

1.50

0.65

NA

NA

6.70

6.83

ZZZ add-on. 32503......... ........ A

Resect apical

31.55

NA

NA

12.31

14.38

4.37

NA

NA

48.23

50.30

090 lung tumor. 32504......... ........ A

Resect apical

36.35

NA

NA

13.73

15.94

5.07

NA

NA

55.15

57.36

090 lung tum/chest. 32540......... ........ A

Removal of lung 23.68

NA

NA

10.25

9.79

2.07

NA

NA

36.00

35.54

090 lesion. 32601......... ........ A

Thoracoscopy,

5.45

NA

NA

2.11

2.29

0.80

NA

NA

8.36

8.54

000 diagnostic. 32602......... ........ A

Thoracoscopy,

5.95

NA

NA

2.25

2.45

0.87

NA

NA

9.07

9.27

000 diagnostic. 32603......... ........ A

Thoracoscopy,

7.80

NA

NA

2.99

3.02

1.14

NA

NA

11.93

11.96

000 diagnostic. 32604......... ........ A

Thoracoscopy,

8.77

NA

NA

3.08

3.36

1.25

NA

NA

13.10

13.38

000 diagnostic. 32605......... ........ A

Thoracoscopy,

6.92

NA

NA

2.56

2.82

1.00

NA

NA

10.48

10.74

000 diagnostic. 32606......... ........ A

Thoracoscopy,

8.39

NA

NA

3.02

3.25

1.22

NA

NA

12.63

12.86

000 diagnostic. 32650......... ........ A

Thoracoscopy,

10.73

NA

NA

5.32

6.40

1.58

NA

NA

17.63

18.71

090 surgical. 32651......... ........ A

Thoracoscopy,

16.28

NA

NA

7.09

7.20

1.86

NA

NA

25.23

25.34

090 surgical. 32652......... ........ A

Thoracoscopy,

23.34

NA

NA

9.65

10.02

2.72

NA

NA

35.71

36.08

090 surgical. 32653......... ........ A

Thoracoscopy,

19.86

NA

NA

8.01

7.23

1.88

NA

NA

29.75

28.97

090 surgical. 32654......... ........ A

Thoracoscopy,

18.49

NA

NA

7.47

7.52

1.63

NA

NA

27.59

27.64

090 surgical. 32655......... ........ A

Thoracoscopy,

14.95

NA

NA

6.74

7.12

1.89

NA

NA

23.58

23.96

090 surgical. 32656......... ........ A

Thoracoscopy,

13.14

NA

NA

6.04

7.47

1.89

NA

NA

21.07

22.50

090 surgical. 32657......... ........ A

Thoracoscopy,

14.54

NA

NA

6.47

7.38

1.99

NA

NA

23.00

23.91

090 surgical. 32658......... ........ A

Thoracoscopy,

11.61

NA

NA

5.64

6.92

1.69

NA

NA

18.94

20.22

090 surgical. 32659......... ........ A

Thoracoscopy,

11.82

NA

NA

5.95

7.08

1.62

NA

NA

19.39

20.52

090 surgical. 32660......... ........ A

Thoracoscopy,

17.65

NA

NA

7.52

8.99

2.08

NA

NA

27.25

28.72

090 surgical. 32661......... ........ A

Thoracoscopy,

13.23

NA

NA

6.22

7.40

1.92

NA

NA

21.37

22.55

090 surgical. 32662......... ........ A

Thoracoscopy,

17.00

NA

NA

7.23

8.42

2.17

NA

NA

26.40

27.59

090 surgical. 32663......... ........ A

Thoracoscopy,

19.96

NA

NA

8.91

10.30

2.72

NA

NA

31.59

32.98

090 surgical. 32664......... ........ A

Thoracoscopy,

14.18

NA

NA

6.42

7.33

2.32

NA

NA

22.92

23.83

090 surgical. 32665......... ........ A

Thoracoscopy,

17.37

NA

NA

7.66

8.01

2.15

NA

NA

27.18

27.53

090 surgical. 32800......... ........ A

Repair lung

15.56

NA

NA

7.13

7.34

1.98

NA

NA

24.67

24.88

090 hernia. 32810......... ........ A

Close chest

14.80

NA

NA

7.12

7.42

1.93

NA

NA

23.85

24.15

090 after drainage. 32815......... ........ A

Close bronchial 37.94

NA

NA

15.43

12.09

3.27

NA

NA

56.64

53.30

090 fistula. 32820......... ........ A

Reconstruct

22.27

NA

NA

11.75

12.06

2.52

NA

NA

36.54

36.85

090 injured chest. 32851......... ........ A

Lung

40.72

NA

NA

20.99

25.99

5.56

NA

NA

67.27

72.27

090 transplant, single. 32852......... ........ A

Lung transplant 44.37

NA

NA

23.82

30.83

6.00

NA

NA

74.19

81.20

090 with bypass. 32853......... ........ A

Lung

49.89

NA

NA

23.39

29.66

7.05

NA

NA

80.33

86.60

090 transplant, double. 32854......... ........ A

Lung transplant 53.60

NA

NA

26.62

32.70

7.20

NA

NA

87.42

93.50

090 with bypass. 32855......... ........ C

Prepare donor

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX lung, single. 32856......... ........ C

Prepare donor

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX lung, double. 32900......... ........ A

Removal of

23.66

NA

NA

9.81

9.86

2.93

NA

NA

36.40

36.45

090 rib(s). 32905......... ........ A

Revise & repair 23.14

NA

NA

9.64

10.01

3.15

NA

NA

35.93

36.30

090 chest wall. 32906......... ........ A

Revise & repair 29.15

NA

NA

11.34

11.88

3.97

NA

NA

44.46

45.00

090 chest wall. 32940......... ........ A

Revision of

21.19

NA

NA

8.66

9.27

2.88

NA

NA

32.73

33.34

090 lung. 32960......... ........ A

Therapeutic

1.84

1.59

1.70

0.67

0.59

0.16

3.59

3.70

2.67

2.59

000 pneumothorax. 32997......... ........ A

Total lung

5.99

NA

NA

1.51

1.81

0.55

NA

NA

8.05

8.35

000 lavage. 32999......... ........ C

Chest surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 33010......... ........ A

Drainage of

2.24

NA

NA

1.02

0.84

0.14

NA

NA

3.40

3.22

000 heart sac. 33011......... ........ A

Repeat drainage 2.24

NA

NA

1.10

0.88

0.15

NA

NA

3.49

3.27

000 of heart sac. 33015......... ........ A

Incision of

8.41

NA

NA

5.08

4.98

0.65

NA

NA

14.14

14.04

090 heart sac. 33020......... ........ A

Incision of

14.85

NA

NA

6.54

6.72

1.79

NA

NA

23.18

23.36

090 heart sac. 33025......... ........ A

Incision of

13.63

NA

NA

5.98

6.26

1.80

NA

NA

21.41

21.69

090 heart sac. 33030......... ........ A

Partial removal 22.24

NA

NA

9.26

9.46

2.83

NA

NA

34.33

34.53

090 of heart sac. 33031......... ........ A

Partial removal 25.28

NA

NA

9.96

10.01

3.13

NA

NA

38.37

38.42

090 of heart sac. 33050......... ........ A

Removal of

16.82

NA

NA

7.63

7.79

2.14

NA

NA

26.59

26.75

090 heart sac lesion. 33120......... ........ A

Removal of

27.30

NA

NA

10.79

11.38

3.69

NA

NA

41.78

42.37

090 heart lesion. 33130......... ........ A

Removal of

24.02

NA

NA

9.48

9.95

3.00

NA

NA

36.50

36.97

090 heart lesion. 33140......... ........ A

Heart

22.72

NA

NA

10.09

10.68

2.85

NA

NA

35.66

36.25

090 revascularize (tmr). 33141......... ........ A

Heart tmr w/

4.83

NA

NA

1.52

1.57

0.69

NA

NA

7.04

7.09

ZZZ other procedure. 33200......... ........ A

Insertion of

14.70

NA

NA

7.45

6.99

1.70

NA

NA

23.85

23.39

090 heart pacemaker. 33201......... ........ A

Insertion of

12.08

NA

NA

6.40

6.54

1.36

NA

NA

19.84

19.98

090 heart pacemaker.

[[Page 49126]]

33206......... ........ A

Insertion of

7.28

NA

NA

5.13

4.63

0.52

NA

NA

12.92

12.42

090 heart pacemaker. 33207......... ........ A

Insertion of

9.03

NA

NA

5.78

4.94

0.59

NA

NA

15.40

14.56

090 heart pacemaker. 33208......... ........ A

Insertion of

8.12

NA

NA

5.43

4.94

0.56

NA

NA

14.11

13.62

090 heart pacemaker. 33210......... ........ A

Insertion of

3.30

NA

NA

1.70

1.36

0.18

NA

NA

5.18

4.84

000 heart electrode. 33211......... ........ A

Insertion of

3.39

NA

NA

1.67

1.40

0.21

NA

NA

5.27

5.00

000 heart electrode. 33212......... ........ A

Insertion of

5.51

NA

NA

3.75

3.46

0.43

NA

NA

9.69

9.40

090 pulse generator. 33213......... ........ A

Insertion of

6.36

NA

NA

4.17

3.83

0.45

NA

NA

10.98

10.64

090 pulse generator. 33214......... ........ A

Upgrade of

7.74

NA

NA

5.38

5.01

0.58

NA

NA

13.70

13.33

090 pacemaker system. 33215......... ........ A

Reposition

4.87

NA

NA

3.52

3.27

0.37

NA

NA

8.76

8.51

090 pacing-defib lead. 33216......... ........ A

Insert lead

5.77

NA

NA

4.58

4.30

0.36

NA

NA

10.71

10.43

090 pace-defib, one. 33217......... ........ A

Insert lead

5.74

NA

NA

4.50

4.30

0.39

NA

NA

10.63

10.43

090 pace-defib, dual. 33218......... ........ A

Repair lead

5.93

NA

NA

4.83

4.43

0.37

NA

NA

11.13

10.73

090 pace-defib, one. 33220......... ........ A

Repair lead

6.01

NA

NA

4.89

4.43

0.37

NA

NA

11.27

10.81

090 pace-defib, dual. 33222......... ........ A

Revise pocket,

4.95

NA

NA

4.33

4.30

0.42

NA

NA

9.70

9.67

090 pacemaker. 33223......... ........ A

Revise pocket,

6.45

NA

NA

4.97

4.69

0.45

NA

NA

11.87

11.59

090 pacing-defib. 33224......... ........ A

Insert pacing

9.04

NA

NA

5.03

4.26

0.54

NA

NA

14.61

13.84

000 lead & connect. 33225......... ........ A

L ventric

8.33

NA

NA

4.45

3.55

0.45

NA

NA

13.23

12.33

ZZZ pacing lead add-on. 33226......... ........ A

Reposition l

8.68

NA

NA

4.87

4.08

0.59

NA

NA

14.14

13.35

000 ventric lead. 33233......... ........ A

Removal of

3.29

NA

NA

3.29

3.28

0.22

NA

NA

6.80

6.79

090 pacemaker system. 33234......... ........ A

Removal of

7.81

NA

NA

5.52

5.06

0.56

NA

NA

13.89

13.43

090 pacemaker system. 33235......... ........ A

Removal

9.85

NA

NA

7.32

6.94

0.73

NA

NA

17.90

17.52

090 pacemaker electrode. 33236......... ........ A

Remove

12.58

NA

NA

6.70

7.25

1.68

NA

NA

20.96

21.51

090 electrode/ thoracotomy. 33237......... ........ A

Remove

13.69

NA

NA

7.68

7.76

1.59

NA

NA

22.96

23.04

090 electrode/ thoracotomy. 33238......... ........ A

Remove

15.20

NA

NA

8.35

8.24

2.02

NA

NA

25.57

25.46

090 electrode/ thoracotomy. 33240......... ........ A

Insert pulse

7.59

NA

NA

5.34

4.77

0.41

NA

NA

13.34

12.77

090 generator. 33241......... ........ A

Remove pulse

3.24

NA

NA

3.04

2.98

0.18

NA

NA

6.46

6.40

090 generator. 33243......... ........ A

Remove eltrd/

23.36

NA

NA

11.00

11.35

2.09

NA

NA

36.45

36.80

090 thoracotomy. 33244......... ........ A

Remove eltrd,

13.74

NA

NA

9.53

9.05

0.99

NA

NA

24.26

23.78

090 transven. 33245......... ........ A

Insert epic

16.82

NA

NA

7.96

7.92

2.01

NA

NA

26.79

26.75

090 eltrd pace- defib. 33246......... ........ A

Insert epic

23.11

NA

NA

10.73

10.39

2.63

NA

NA

36.47

36.13

090 eltrd/ generator. 33249......... ........ A

Eltrd/insert

14.96

NA

NA

10.33

8.85

0.77

NA

NA

26.06

24.58

090 pace-defib. 33250......... ........ A

Ablate heart

25.75

NA

NA

10.16

10.81

3.18

NA

NA

39.09

39.74

090 dysrhythm focus. 33251......... ........ A

Ablate heart

28.77

NA

NA

11.15

11.53

3.59

NA

NA

43.51

43.89

090 dysrhythm focus. 33253......... ........ A

Reconstruct

31.33

NA

NA

12.15

13.40

4.52

NA

NA

48.00

49.25

090 atria. 33261......... ........ A

Ablate heart

28.77

NA

NA

11.33

11.66

3.45

NA

NA

43.55

43.88

090 dysrhythm focus. 33282......... ........ A

Implant pat-

4.66

NA

NA

4.29

4.09

0.23

NA

NA

9.18

8.98

090 active ht record. 33284......... ........ A

Remove pat-

3.00

NA

NA

3.40

3.50

0.14

NA

NA

6.54

6.64

090 active ht record. 33300......... ........ A

Repair of heart 29.93

NA

NA

11.14

9.71

2.65

NA

NA

43.72

42.29

090 wound. 33305......... ........ A

Repair of heart 33.67

NA

NA

12.24

11.02

3.12

NA

NA

49.03

47.81

090 wound. 33310......... ........ A

Exploratory

20.19

NA

NA

8.83

9.39

2.58

NA

NA

31.60

32.16

090 heart surgery. 33315......... ........ A

Exploratory

26.02

NA

NA

10.46

10.78

3.27

NA

NA

39.75

40.07

090 heart surgery. 33320......... ........ A

Repair major

18.43

NA

NA

8.69

8.34

2.07

NA

NA

29.19

28.84

090 blood vessel(s). 33321......... ........ A

Repair major

20.67

NA

NA

10.28

9.91

2.90

NA

NA

33.85

33.48

090 vessel. 33322......... ........ A

Repair major

24.27

NA

NA

9.83

10.23

2.85

NA

NA

36.95

37.35

090 blood vessel(s). 33330......... ........ A

Insert major

25.14

NA

NA

9.80

10.15

2.81

NA

NA

37.75

38.10

090 vessel graft. 33332......... ........ A

Insert major

24.42

NA

NA

9.65

10.30

3.02

NA

NA

37.09

37.74

090 vessel graft. 33335......... ........ A

Insert major

33.76

NA

NA

12.97

13.24

4.27

NA

NA

51.00

51.27

090 vessel graft. 33400......... ........ A

Repair of

39.23

NA

NA

14.57

15.39

4.10

NA

NA

57.90

58.72

090 aortic valve. 33401......... ........ A

Valvuloplasty, 24.33

NA

NA

9.83

12.58

3.56

NA

NA

37.72

40.47

090 open. 33403......... ........ A

Valvuloplasty, 25.31

NA

NA

10.53

13.36

3.54

NA

NA

39.38

42.21

090 w/cp bypass. 33404......... ........ A

Prepare heart- 31.22

NA

NA

12.26

13.97

4.32

NA

NA

47.80

49.51

090 aorta conduit. 33405......... ........ A

Replacement of 39.97

NA

NA

15.12

17.50

5.31

NA

NA

60.40

62.78

090 aortic valve. 33406......... ........ A

Replacement of 48.87

NA

NA

17.72

18.77

5.43

NA

NA

72.02

73.07

090 aortic valve. 33410......... ........ A

Replacement of 38.69

NA

NA

14.63

16.09

4.68

NA

NA

58.00

59.46

090 aortic valve. 33411......... ........ A

Replacement of 57.11

NA

NA

20.12

19.09

5.46

NA

NA

82.69

81.66

090 aortic valve. 33412......... ........ A

Replacement of 43.71

NA

NA

16.57

19.44

6.37

NA

NA

66.65

69.52

090 aortic valve.

[[Page 49127]]

33413......... ........ A

Replacement of 55.27

NA

NA

19.33

20.44

6.51

NA

NA

81.11

82.22

090 aortic valve. 33414......... ........ A

Repair of

39.27

NA

NA

15.20

14.40

4.56

NA

NA

59.03

58.23

090 aortic valve. 33415......... ........ A

Revision,

29.70

NA

NA

11.14

11.80

4.13

NA

NA

44.97

45.63

090 subvalvular tissue. 33416......... ........ A

Revise

36.39

NA

NA

13.63

13.53

4.56

NA

NA

54.58

54.48

090 ventricle muscle. 33417......... ........ A

Repair of

29.13

NA

NA

12.14

13.24

4.09

NA

NA

45.36

46.46

090 aortic valve. 33420......... ........ A

Revision of

25.64

NA

NA

8.85

9.38

1.81

NA

NA

36.30

36.83

090 mitral valve. 33422......... ........ A

Revision of

29.58

NA

NA

12.50

13.36

3.93

NA

NA

46.01

46.87

090 mitral valve. 33425......... ........ A

Repair of

38.37

NA

NA

14.50

13.41

4.06

NA

NA

56.93

55.84

090 mitral valve. 33426......... ........ A

Repair of

41.28

NA

NA

15.51

16.73

5.01

NA

NA

61.80

63.02

090 mitral valve. 33427......... ........ A

Repair of

42.78

NA

NA

16.33

18.60

6.07

NA

NA

65.18

67.45

090 mitral valve. 33430......... ........ A

Replacement of 49.81

NA

NA

18.75

17.66

5.08

NA

NA

73.64

72.55

090 mitral valve. 33460......... ........ A

Revision of

27.97

NA

NA

10.98

11.22

3.44

NA

NA

42.39

42.63

090 tricuspid valve. 33463......... ........ A

Valvuloplasty, 42.57

NA

NA

15.50

13.56

3.86

NA

NA

61.93

59.99

090 tricuspid. 33464......... ........ A

Valvuloplasty, 30.93

NA

NA

12.13

13.17

4.14

NA

NA

47.20

48.24

090 tricuspid. 33465......... ........ A

Replace

33.58

NA

NA

12.60

12.87

4.38

NA

NA

50.56

50.83

090 tricuspid valve. 33468......... ........ A

Revision of

32.79

NA

NA

15.30

14.06

4.06

NA

NA

52.15

50.91

090 tricuspid valve. 33470......... ........ A

Revision of

21.24

NA

NA

8.74

10.20

1.03

NA

NA

31.01

32.47

090 pulmonary valve. 33471......... ........ A

Valvotomy,

22.79

NA

NA

7.77

9.26

3.38

NA

NA

33.94

35.43

090 pulmonary valve. 33472......... ........ A

Revision of

22.86

NA

NA

7.28

10.72

3.54

NA

NA

33.68

37.12

090 pulmonary valve. 33474......... ........ A

Revision of

25.85

NA

NA

12.10

11.19

3.21

NA

NA

41.16

40.25

090 pulmonary valve. 33475......... ........ A

Replacement,

44.81

NA

NA

16.54

15.66

4.92

NA

NA

66.27

65.39

090 pulmonary valve. 33476......... ........ A

Revision of

26.37

NA

NA

11.78

11.92

2.41

NA

NA

40.56

40.70

090 heart chamber. 33478......... ........ A

Revision of

27.34

NA

NA

11.04

12.55

3.88

NA

NA

42.26

43.77

090 heart chamber. 33496......... ........ A

Repair, prosth 29.67

NA

NA

11.51

12.43

4.12

NA

NA

45.30

46.22

090 valve clot. 33500......... ........ A

Repair heart

27.79

NA

NA

11.08

11.37

3.86

NA

NA

42.73

43.02

090 vessel fistula. 33501......... ........ A

Repair heart

19.39

NA

NA

8.25

8.27

1.90

NA

NA

29.54

29.56

090 vessel fistula. 33502......... ........ A

Coronary artery 21.65

NA

NA

9.32

10.63

2.99

NA

NA

33.96

35.27

090 correction. 33503......... ........ A

Coronary artery 22.21

NA

NA

10.61

9.95

1.77

NA

NA

34.59

33.93

090 graft. 33504......... ........ A

Coronary artery 25.26

NA

NA

10.18

11.40

3.35

NA

NA

38.79

40.01

090 graft. 33505......... ........ A

Repair artery w/ 38.33

NA

NA

12.33

12.76

2.18

NA

NA

52.84

53.27

090 tunnel. 33506......... ........ A

Repair artery, 37.78

NA

NA

15.51

14.80

4.65

NA

NA

57.94

57.23

090 translocation. 33507......... ........ A

Repair art,

31.33

NA

NA

11.78

13.18

4.05

NA

NA

47.16

48.56

090 intramural. 33508......... ........ A

Endoscopic vein 0.31

NA

NA

0.10

0.10

0.04

NA

NA

0.45

0.45

ZZZ harvest. 33510......... ........ A

CABG, vein,

33.45

NA

NA

12.81

15.45

4.40

NA

NA

50.66

53.30

090 single. 33511......... ........ A

CABG, vein, two 34.59

NA

NA

13.37

16.15

4.55

NA

NA

52.51

55.29

090 33512......... ........ A

CABG, vein,

38.73

NA

NA

14.72

16.88

4.66

NA

NA

58.11

60.27

090 three. 33513......... ........ A

CABG, vein,

39.69

NA

NA

15.13

17.12

4.87

NA

NA

59.69

61.68

090 four. 33514......... ........ A

CABG, vein,

40.50

NA

NA

15.38

17.38

4.76

NA

NA

60.64

62.64

090 five. 33516......... ........ A

Cabg, vein, six 41.96

NA

NA

16.16

18.14

5.11

NA

NA

63.23

65.21

090 or more. 33517......... ........ A

CABG, artery-

2.57

NA

NA

0.79

0.83

0.39

NA

NA

3.75

3.79

ZZZ vein, single. 33518......... ........ A

CABG, artery-

4.84

NA

NA

1.48

1.56

0.73

NA

NA

7.05

7.13

ZZZ vein, two. 33519......... ........ A

CABG, artery-

7.11

NA

NA

2.18

2.29

1.04

NA

NA

10.33

10.44

ZZZ vein, three. 33521......... ........ A

CABG, artery-

9.39

NA

NA

2.89

3.03

1.37

NA

NA

13.65

13.79

ZZZ vein, four. 33522......... ........ A

CABG, artery-

11.65

NA

NA

3.56

3.75

1.77

NA

NA

16.98

17.17

ZZZ vein, five. 33523......... ........ A

Cabg, art-vein, 13.93

NA

NA

4.29

4.47

2.12

NA

NA

20.34

20.52

ZZZ six or more. 33530......... ........ A

Coronary

5.85

NA

NA

1.79

1.88

0.88

NA

NA

8.52

8.61

ZZZ artery, bypass/ reop. 33533......... ........ A

CABG, arterial, 37.38

NA

NA

14.00

15.85

4.55

NA

NA

55.93

57.78

090 single. 33534......... ........ A

CABG, arterial, 38.81

NA

NA

14.74

16.97

4.69

NA

NA

58.24

60.47

090 two. 33535......... ........ A

CABG, arterial, 41.48

NA

NA

15.68

17.52

5.01

NA

NA

62.17

64.01

090 three. 33536......... ........ A

Cabg, arterial, 40.79

NA

NA

15.30

17.54

5.42

NA

NA

61.51

63.75

090 four or more. 33542......... ........ A

Removal of

32.65

NA

NA

12.64

12.90

4.37

NA

NA

49.66

49.92

090 heart lesion. 33545......... ........ A

Repair of heart 41.12

NA

NA

15.46

15.58

5.19

NA

NA

61.77

61.89

090 damage. 33548......... ........ A

Restore/

42.46

NA

NA

16.52

18.60

5.51

NA

NA

64.49

66.57

090 remodel, ventricle. 33572......... ........ A

Open coronary

4.44

NA

NA

1.34

1.42

0.65

NA

NA

6.43

6.51

ZZZ endarterectomy. 33600......... ........ A

Closure of

30.11

NA

NA

12.44

12.49

4.41

NA

NA

46.96

47.01

090 valve. 33602......... ........ A

Closure of

29.14

NA

NA

13.30

12.66

3.81

NA

NA

46.25

45.61

090 valve. 33606......... ........ A

Anastomosis/

31.33

NA

NA

12.17

13.30

4.40

NA

NA

47.90

49.03

090 artery-aorta. 33608......... ........ A

Repair anomaly 31.68

NA

NA

13.41

13.93

4.73

NA

NA

49.82

50.34

090 w/conduit. 33610......... ........ A

Repair by

31.20

NA

NA

11.20

13.00

4.55

NA

NA

46.95

48.75

090 enlargement. 33611......... ........ A

Repair double

35.47

NA

NA

12.37

13.69

4.36

NA

NA

52.20

53.52

090 ventricle. 33612......... ........ A

Repair double

36.47

NA

NA

12.97

14.61

5.28

NA

NA

54.72

56.36

090 ventricle. 33615......... ........ A

Repair,

35.72

NA

NA

12.49

12.98

4.31

NA

NA

52.52

53.01

090 modified fontan. 33617......... ........ A

Repair single

38.92

NA

NA

16.37

16.09

5.64

NA

NA

60.93

60.65

090 ventricle. 33619......... ........ A

Repair single

48.56

NA

NA

18.36

20.19

6.44

NA

NA

73.36

75.19

090 ventricle. 33641......... ........ A

Repair heart

28.47

NA

NA

10.73

9.86

3.22

NA

NA

42.42

41.55

090 septum defect. 33645......... ........ A

Revision of

27.95

NA

NA

11.02

11.58

3.78

NA

NA

42.75

43.31

090 heart veins.

[[Page 49128]]

33647......... ........ A

Repair heart

29.33

NA

NA

12.34

13.41

3.31

NA

NA

44.98

46.05

090 septum defects. 33660......... ........ A

Repair of heart 31.73

NA

NA

11.49

12.98

4.48

NA

NA

47.70

49.19

090 defects. 33665......... ........ A

Repair of heart 34.75

NA

NA

12.45

13.49

3.99

NA

NA

51.19

52.23

090 defects. 33670......... ........ A

Repair of heart 36.56

NA

NA

12.28

12.95

4.64

NA

NA

53.48

54.15

090 chambers. 33681......... ........ A

Repair heart

32.10

NA

NA

13.28

14.33

4.44

NA

NA

49.82

50.87

090 septum defect. 33684......... ........ A

Repair heart

34.27

NA

NA

19.40

15.07

3.38

NA

NA

57.05

52.72

090 septum defect. 33688......... ........ A

Repair heart

34.65

NA

NA

9.50

10.23

4.72

NA

NA

48.87

49.60

090 septum defect. 33690......... ........ A

Reinforce

20.16

NA

NA

8.63

9.78

1.96

NA

NA

30.75

31.90

090 pulmonary artery. 33692......... ........ A

Repair of heart 31.34

NA

NA

9.29

12.76

4.57

NA

NA

45.20

48.67

090 defects. 33694......... ........ A

Repair of heart 35.47

NA

NA

10.16

13.21

5.26

NA

NA

50.89

53.94

090 defects. 33697......... ........ A

Repair of heart 37.47

NA

NA

21.66

16.57

4.08

NA

NA

63.21

58.12

090 defects. 33702......... ........ A

Repair of heart 27.07

NA

NA

11.48

12.29

3.67

NA

NA

42.22

43.03

090 defects. 33710......... ........ A

Repair of heart 30.24

NA

NA

11.69

13.39

4.42

NA

NA

46.35

48.05

090 defects. 33720......... ........ A

Repair of heart 27.09

NA

NA

11.17

12.00

3.83

NA

NA

42.09

42.92

090 defect. 33722......... ........ A

Repair of heart 29.01

NA

NA

8.75

12.58

1.30

NA

NA

39.06

42.89

090 defect. 33730......... ........ A

Repair heart-

35.97

NA

NA

13.35

13.93

5.01

NA

NA

54.33

54.91

090 vein defect(s). 33732......... ........ A

Repair heart-

28.76

NA

NA

14.75

13.72

3.67

NA

NA

47.18

46.15

090 vein defect. 33735......... ........ A

Revision of

22.00

NA

NA

9.50

9.09

1.91

NA

NA

33.41

33.00

090 heart chamber. 33736......... ........ A

Revision of

24.12

NA

NA

10.80

11.59

3.08

NA

NA

38.00

38.79

090 heart chamber. 33737......... ........ A

Revision of

22.30

NA

NA

7.62

10.10

3.24

NA

NA

33.16

35.64

090 heart chamber. 33750......... ........ A

Major vessel

22.02

NA

NA

11.30

10.48

1.16

NA

NA

34.48

33.66

090 shunt. 33755......... ........ A

Major vessel

22.40

NA

NA

7.87

8.57

3.25

NA

NA

33.52

34.22

090 shunt. 33762......... ........ A

Major vessel

22.40

NA

NA

7.21

9.42

3.13

NA

NA

32.74

34.95

090 shunt. 33764......... ........ A

Major vessel

22.40

NA

NA

9.29

9.99

3.00

NA

NA

34.69

35.39

090 shunt & graft. 33766......... ........ A

Major vessel

23.37

NA

NA

8.58

10.90

3.69

NA

NA

35.64

37.96

090 shunt. 33767......... ........ A

Major vessel

25.10

NA

NA

9.47

11.16

3.81

NA

NA

38.38

40.07

090 shunt. 33768......... ........ A

Cavopulmonary

8.00

NA

NA

2.22

2.55

1.19

NA

NA

11.41

11.74

ZZZ shunting. 33770......... ........ A

Repair great

39.00

NA

NA

10.67

13.68

5.72

NA

NA

55.39

58.40

090 vessels defect. 33771......... ........ A

Repair great

40.56

NA

NA

10.65

11.95

5.66

NA

NA

56.87

58.17

090 vessels defect. 33774......... ........ A

Repair great

31.48

NA

NA

12.45

14.11

4.80

NA

NA

48.73

50.39

090 vessels defect. 33775......... ........ A

Repair great

32.79

NA

NA

10.21

13.80

4.98

NA

NA

47.98

51.57

090 vessels defect. 33776......... ........ A

Repair great

34.45

NA

NA

13.39

15.20

5.07

NA

NA

52.91

54.72

090 vessels defect. 33777......... ........ A

Repair great

33.87

NA

NA

10.02

14.21

5.47

NA

NA

49.36

53.55

090 vessels defect. 33778......... ........ A

Repair great

42.58

NA

NA

15.26

16.48

6.18

NA

NA

64.02

65.24

090 vessels defect. 33779......... ........ A

Repair great

43.13

NA

NA

11.48

14.40

2.91

NA

NA

57.52

60.44

090 vessels defect. 33780......... ........ A

Repair great

43.83

NA

NA

11.79

17.26

3.67

NA

NA

59.29

64.76

090 vessels defect. 33781......... ........ A

Repair great

43.14

NA

NA

14.18

13.54

5.95

NA

NA

63.27

62.63

090 vessels defect. 33786......... ........ A

Repair arterial 41.70

NA

NA

11.53

15.42

5.69

NA

NA

58.92

62.81

090 trunk. 33788......... ........ A

Revision of

27.22

NA

NA

9.69

11.39

4.02

NA

NA

40.93

42.63

090 pulmonary artery. 33800......... ........ A

Aortic

17.21

NA

NA

7.32

7.91

2.45

NA

NA

26.98

27.57

090 suspension. 33802......... ........ A

Repair vessel

18.20

NA

NA

7.50

8.79

2.26

NA

NA

27.96

29.25

090 defect. 33803......... ........ A

Repair vessel

20.14

NA

NA

7.95

9.31

3.19

NA

NA

31.28

32.64

090 defect. 33813......... ........ A

Repair septal

21.19

NA

NA

9.00

10.43

3.12

NA

NA

33.31

34.74

090 defect. 33814......... ........ A

Repair septal

26.37

NA

NA

10.48

12.10

3.84

NA

NA

40.69

42.31

090 defect. 33820......... ........ A

Revise major

16.59

NA

NA

8.39

8.37

2.34

NA

NA

27.32

27.30

090 vessel. 33822......... ........ A

Revise major

17.61

NA

NA

6.00

8.21

2.67

NA

NA

26.28

28.49

090 vessel. 33824......... ........ A

Revise major

20.06

NA

NA

8.62

9.64

2.88

NA

NA

31.56

32.58

090 vessel. 33840......... ........ A

Remove aorta

21.17

NA

NA

8.99

9.97

2.15

NA

NA

32.31

33.29

090 constriction. 33845......... ........ A

Remove aorta

22.73

NA

NA

9.64

10.92

3.21

NA

NA

35.58

36.86

090 constriction. 33851......... ........ A

Remove aorta

21.81

NA

NA

9.17

10.30

3.17

NA

NA

34.15

35.28

090 constriction. 33852......... ........ A

Repair septal

24.24

NA

NA

9.90

11.00

2.15

NA

NA

36.29

37.39

090 defect. 33853......... ........ A

Repair septal

32.31

NA

NA

13.03

14.37

4.47

NA

NA

49.81

51.15

090 defect. 33860......... ........ A

Ascending

43.13

NA

NA

15.73

16.27

5.74

NA

NA

64.60

65.14

090 aortic graft. 33861......... ........ A

Ascending

43.88

NA

NA

16.12

17.31

6.35

NA

NA

66.35

67.54

090 aortic graft. 33863......... ........ A

Ascending

48.52

NA

NA

17.69

18.44

6.57

NA

NA

72.78

73.53

090 aortic graft. 33870......... ........ A

Transverse

45.87

NA

NA

16.67

17.95

6.60

NA

NA

69.14

70.42

090 aortic arch graft.

[[Page 49129]]

33875......... ........ A

Thoracic aortic 35.64

NA

NA

13.16

13.86

4.88

NA

NA

53.68

54.38

090 graft. 33877......... ........ A

Thoracoabdomina 57.75

NA

NA

18.83

16.94

5.92

NA

NA

82.50

80.61

090 l graft. 33880......... ........ A

Endovasc taa

34.44

NA

NA

10.59

12.75

2.74

NA

NA

47.77

49.93

090 repr incl subcl. 33881......... ........ A

Endovasc taa

29.44

NA

NA

9.35

11.31

2.32

NA

NA

41.11

43.07

090 repr w/o subcl. 33883......... ........ A

Insert endovasc 20.95

NA

NA

7.01

8.64

2.10

NA

NA

30.06

31.69

090 prosth, taa. 33884......... ........ A

Endovasc

8.20

NA

NA

2.01

2.43

0.86

NA

NA

11.07

11.49

ZZZ prosth, taa, add-on. 33886......... ........ A

Endovasc

17.95

NA

NA

6.25

7.74

1.79

NA

NA

25.99

27.48

090 prosth, delayed. 33889......... ........ A

Artery

15.92

NA

NA

4.17

4.92

2.17

NA

NA

22.26

23.01

000 transpose/ endovas taa. 33891......... ........ A

Car-car bp grft/ 20.00

NA

NA

6.45

6.83

2.72

NA

NA

29.17

29.55

000 endovas taa. 33910......... ........ A

Remove lung

29.56

NA

NA

11.34

11.41

3.69

NA

NA

44.59

44.66

090 artery emboli. 33915......... ........ A

Remove lung

24.80

NA

NA

10.04

9.73

1.44

NA

NA

36.28

35.97

090 artery emboli. 33916......... ........ A

Surgery of

28.27

NA

NA

10.92

11.24

3.66

NA

NA

42.85

43.17

090 great vessel. 33917......... ........ A

Repair

25.10

NA

NA

10.43

11.74

3.69

NA

NA

39.22

40.53

090 pulmonary artery. 33920......... ........ A

Repair

32.54

NA

NA

11.39

13.21

4.37

NA

NA

48.30

50.12

090 pulmonary atresia. 33922......... ........ A

Transect

24.05

NA

NA

11.44

11.04

3.09

NA

NA

38.58

38.18

090 pulmonary artery. 33924......... ........ A

Remove

5.49

NA

NA

2.12

1.91

0.82

NA

NA

8.43

8.22

ZZZ pulmonary shunt. 33925......... ........ A

Rpr pul art

31.23

NA

NA

10.21

13.55

4.60

NA

NA

46.04

49.38

090 unifocal w/o cpb. 33926......... ........ A

Repr pul art,

44.66

NA

NA

14.38

16.86

6.20

NA

NA

65.24

67.72

090 unifocal w/cpb. 33933......... ........ C

Prepare donor

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart/lung. 33935......... ........ R

Transplantation 61.56

NA

NA

23.37

27.42

9.03

NA

NA

93.96

98.01

090 , heart/lung. 33944......... ........ C

Prepare donor

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart. 33945......... ........ R

Transplantation 50.14

NA

NA

19.01

20.80

6.24

NA

NA

75.39

77.18

090 of heart. 33960......... ........ A

External

19.33

NA

NA

5.60

5.08

2.66

NA

NA

27.59

27.07

000 circulation assist. 33961......... ........ A

External

10.91

NA

NA

2.91

3.44

0.88

NA

NA

14.70

15.23

ZZZ circulation assist. 33967......... ........ A

Insert ia

4.84

NA

NA

2.44

1.99

0.35

NA

NA

7.63

7.18

000 percut device. 33968......... ........ A

Remove aortic

0.64

NA

NA

0.27

0.24

0.07

NA

NA

0.98

0.95

000 assist device. 33970......... ........ A

Aortic

6.74

NA

NA

2.54

2.35

0.82

NA

NA

10.10

9.91

000 circulation assist. 33971......... ........ A

Aortic

11.89

NA

NA

6.09

6.02

1.25

NA

NA

19.23

19.16

090 circulation assist. 33973......... ........ A

Insert balloon

9.75

NA

NA

3.88

3.45

1.26

NA

NA

14.89

14.46

000 device. 33974......... ........ A

Remove intra-

14.89

NA

NA

7.79

7.86

1.73

NA

NA

24.41

24.48

090 aortic balloon. 33975......... ........ A

Implant

20.97

NA

NA

6.63

6.37

3.06

NA

NA

30.66

30.40

XXX ventricular device. 33976......... ........ A

Implant

22.97

NA

NA

7.92

7.64

3.25

NA

NA

34.14

33.86

XXX ventricular device. 33977......... ........ A

Remove

19.99

NA

NA

9.37

10.65

2.80

NA

NA

32.16

33.44

090 ventricular device. 33978......... ........ A

Remove

22.43

NA

NA

10.52

11.44

3.30

NA

NA

36.25

37.17

090 ventricular device. 33979......... ........ A

Insert

45.93

NA

NA

14.38

14.79

6.95

NA

NA

67.26

67.67

XXX intracorporeal device. 33980......... ........ A

Remove

64.76

NA

NA

25.09

25.20

8.56

NA

NA

98.41

98.52

090 intracorporeal device. 33999......... ........ C

Cardiac surgery 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 34001......... ........ A

Removal of

17.74

NA

NA

6.68

6.70

1.84

NA

NA

26.26

26.28

090 artery clot. 34051......... ........ A

Removal of

16.86

NA

NA

6.93

7.57

2.20

NA

NA

25.99

26.63

090 artery clot. 34101......... ........ A

Removal of

10.81

NA

NA

4.44

5.12

1.41

NA

NA

16.66

17.34

090 artery clot. 34111......... ........ A

Removal of arm 10.81

NA

NA

4.50

5.14

1.40

NA

NA

16.71

17.35

090 artery clot. 34151......... ........ A

Removal of

26.35

NA

NA

8.87

10.02

3.55

NA

NA

38.77

39.92

090 artery clot. 34201......... ........ A

Removal of

18.40

NA

NA

6.57

5.70

1.45

NA

NA

26.42

25.55

090 artery clot. 34203......... ........ A

Removal of leg 17.67

NA

NA

6.57

7.69

2.35

NA

NA

26.59

27.71

090 artery clot. 34401......... ........ A

Removal of vein 26.35

NA

NA

9.64

10.41

3.09

NA

NA

39.08

39.85

090 clot. 34421......... ........ A

Removal of vein 13.25

NA

NA

5.36

6.06

1.55

NA

NA

20.16

20.86

090 clot. 34451......... ........ A

Removal of vein 28.35

NA

NA

9.71

11.01

3.83

NA

NA

41.89

43.19

090 clot. 34471......... ........ A

Removal of vein 20.94

NA

NA

7.73

5.91

1.18

NA

NA

29.85

28.03

090 clot. 34490......... ........ A

Removal of vein 10.79

NA

NA

4.54

5.20

1.41

NA

NA

16.74

17.40

090 clot. 34501......... ........ A

Repair valve,

16.68

NA

NA

6.96

8.11

2.34

NA

NA

25.98

27.13

090 femoral vein. 34502......... ........ A

Reconstruct

27.80

NA

NA

10.78

11.91

3.62

NA

NA

42.20

43.33

090 vena cava. 34510......... ........ A

Transposition

19.74

NA

NA

7.25

8.87

2.32

NA

NA

29.31

30.93

090 of vein valve. 34520......... ........ A

Cross-over vein 18.99

NA

NA

9.19

8.64

2.28

NA

NA

30.46

29.91

090 graft. 34530......... ........ A

Leg vein fusion 17.69

NA

NA

7.88

8.43

1.73

NA

NA

27.30

27.85

090 34800......... ........ A

Endovas aaa

21.42

NA

NA

7.49

8.74

2.45

NA

NA

31.36

32.61

090 repr w/sm tube. 34802......... ........ A

Endovas aaa

23.67

NA

NA

8.32

9.42

2.32

NA

NA

34.31

35.41

090 repr w/2-p part. 34803......... ........ A

Endovas aaa

24.70

NA

NA

8.25

9.72

2.00

NA

NA

34.95

36.42

090 repr w/3-p part. 34804......... ........ A

Endovas aaa

23.67

NA

NA

8.18

9.40

2.29

NA

NA

34.14

35.36

090 repr w/1-p part. 34805......... ........ A

Endovas aaa

22.55

NA

NA

7.34

9.07

2.00

NA

NA

31.89

33.62

090 repr w/long tube. 34808......... ........ A

Endovas iliac a 4.12

NA

NA

1.11

1.31

0.59

NA

NA

5.82

6.02

ZZZ device addon. 34812......... ........ A

Xpose for

6.74

NA

NA

1.73

2.11

1.18

NA

NA

9.65

10.03

000 endoprosth, femorl. 34813......... ........ A

Femoral endovas 4.79

NA

NA

1.21

1.48

0.67

NA

NA

6.67

6.94

ZZZ graft add-on. 34820......... ........ A

Xpose for

9.74

NA

NA

2.47

3.04

1.50

NA

NA

13.71

14.28

000 endoprosth, iliac. 34825......... ........ A

Endovasc extend 12.68

NA

NA

5.23

5.91

1.28

NA

NA

19.19

19.87

090 prosth, init. 34826......... ........ A

Endovasc exten

4.12

NA

NA

1.16

1.32

0.44

NA

NA

5.72

5.88

ZZZ prosth, addIl. 34830......... ........ A

Open aortic

35.04

NA

NA

10.82

12.97

4.54

NA

NA

50.40

52.55

090 tube prosth repr.

[[Page 49130]]

34831......... ........ A

Open aortoiliac 37.79

NA

NA

12.15

11.84

4.88

NA

NA

54.82

54.51

090 prosth repr. 34832......... ........ A

Open aortofemor 37.79

NA

NA

11.68

13.89

4.84

NA

NA

54.31

56.52

090 prosth repr. 34833......... ........ A

Xpose for

11.98

NA

NA

3.32

4.15

1.69

NA

NA

16.99

17.82

000 endoprosth, iliac. 34834......... ........ A

Xpose,

5.34

NA

NA

1.62

2.05

0.76

NA

NA

7.72

8.15

000 endoprosth, brachial. 34900......... ........ A

Endovasc iliac 16.73

NA

NA

6.34

7.27

1.99

NA

NA

25.06

25.99

090 repr w/graft. 35001......... ........ A

Repair defect

20.63

NA

NA

7.64

9.07

2.80

NA

NA

31.07

32.50

090 of artery. 35002......... ........ A

Repair artery

22.05

NA

NA

7.82

9.22

2.99

NA

NA

32.86

34.26

090 rupture, neck. 35005......... ........ A

Repair defect

19.11

NA

NA

8.14

8.67

1.76

NA

NA

29.01

29.54

090 of artery. 35011......... ........ A

Repair defect

18.46

NA

NA

6.43

7.59

2.54

NA

NA

27.43

28.59

090 of artery. 35013......... ........ A

Repair artery

23.04

NA

NA

7.96

9.24

3.09

NA

NA

34.09

35.37

090 rupture, arm. 35021......... ........ A

Repair defect

22.04

NA

NA

8.70

9.23

2.86

NA

NA

33.60

34.13

090 of artery. 35022......... ........ A

Repair artery

25.57

NA

NA

9.50

9.76

3.16

NA

NA

38.23

38.49

090 rupture, chest. 35045......... ........ A

Repair defect

17.91

NA

NA

6.42

7.23

2.44

NA

NA

26.77

27.58

090 of arm artery. 35081......... ........ A

Repair defect

33.31

NA

NA

11.10

11.37

4.00

NA

NA

48.41

48.68

090 of artery. 35082......... ........ A

Repair artery

41.87

NA

NA

13.19

14.77

5.42

NA

NA

60.48

62.06

090 rupture, aorta. 35091......... ........ A

Repair defect

35.35

NA

NA

10.46

12.79

5.12

NA

NA

50.93

53.26

090 of artery. 35092......... ........ A

Repair artery

50.75

NA

NA

15.09

17.00

6.38

NA

NA

72.22

74.13

090 rupture, aorta. 35102......... ........ A

Repair defect

36.31

NA

NA

11.68

12.18

4.47

NA

NA

52.46

52.96

090 of artery. 35103......... ........ A

Repair artery

43.43

NA

NA

13.31

15.21

5.74

NA

NA

62.48

64.38

090 rupture, groin. 35111......... ........ A

Repair defect

26.11

NA

NA

8.62

10.00

3.46

NA

NA

38.19

39.57

090 of artery. 35112......... ........ A

Repair artery

32.38

NA

NA

10.53

11.60

4.07

NA

NA

46.98

48.05

090 rupture,spleen. 35121......... ........ A

Repair defect

31.35

NA

NA

10.51

11.90

4.29

NA

NA

46.15

47.54

090 of artery. 35122......... ........ A

Repair artery

37.70

NA

NA

12.17

13.39

4.74

NA

NA

54.61

55.83

090 rupture, belly. 35131......... ........ A

Repair defect

26.23

NA

NA

8.92

10.29

3.79

NA

NA

38.94

40.31

090 of artery. 35132......... ........ A

Repair artery

32.38

NA

NA

10.33

11.86

4.29

NA

NA

47.00

48.53

090 rupture, groin. 35141......... ........ A

Repair defect

20.79

NA

NA

7.15

8.47

2.89

NA

NA

30.83

32.15

090 of artery. 35142......... ........ A

Repair artery

24.97

NA

NA

8.46

9.89

3.35

NA

NA

36.78

38.21

090 rupture, thigh. 35151......... ........ A

Repair defect

23.55

NA

NA

7.96

9.48

3.23

NA

NA

34.74

36.26

090 of artery. 35152......... ........ A

Repair artery

27.47

NA

NA

9.15

10.82

3.60

NA

NA

40.22

41.89

090 rupture, knee. 35180......... ........ A

Repair blood

14.95

NA

NA

6.15

6.74

1.00

NA

NA

22.10

22.69

090 vessel lesion. 35182......... ........ A

Repair blood

31.52

NA

NA

11.82

12.55

4.35

NA

NA

47.69

48.42

090 vessel lesion. 35184......... ........ A

Repair blood

18.67

NA

NA

6.96

7.96

2.52

NA

NA

28.15

29.15

090 vessel lesion. 35188......... ........ A

Repair blood

14.98

NA

NA

6.23

7.28

2.15

NA

NA

23.36

24.41

090 vessel lesion. 35189......... ........ A

Repair blood

29.79

NA

NA

10.15

11.50

4.00

NA

NA

43.94

45.29

090 vessel lesion. 35190......... ........ A

Repair blood

13.27

NA

NA

5.34

6.19

1.79

NA

NA

20.40

21.25

090 vessel lesion. 35201......... ........ A

Repair blood

16.78

NA

NA

6.45

7.61

2.33

NA

NA

25.56

26.72

090 vessel lesion. 35206......... ........ A

Repair blood

13.72

NA

NA

5.42

6.27

1.86

NA

NA

21.00

21.85

090 vessel lesion. 35207......... ........ A

Repair blood

10.79

NA

NA

6.60

7.16

1.48

NA

NA

18.87

19.43

090 vessel lesion. 35211......... ........ A

Repair blood

24.45

NA

NA

10.11

10.49

3.19

NA

NA

37.75

38.13

090 vessel lesion. 35216......... ........ A

Repair blood

36.43

NA

NA

13.90

10.20

2.64

NA

NA

52.97

49.27

090 vessel lesion. 35221......... ........ A

Repair blood

26.50

NA

NA

8.59

9.60

3.36

NA

NA

38.45

39.46

090 vessel lesion. 35226......... ........ A

Repair blood

15.18

NA

NA

5.91

7.05

2.01

NA

NA

23.10

24.24

090 vessel lesion. 35231......... ........ A

Repair blood

21.04

NA

NA

7.70

9.25

2.88

NA

NA

31.62

33.17

090 vessel lesion. 35236......... ........ A

Repair blood

17.90

NA

NA

6.50

7.54

2.42

NA

NA

26.82

27.86

090 vessel lesion. 35241......... ........ A

Repair blood

25.45

NA

NA

9.97

10.83

3.52

NA

NA

38.94

39.80

090 vessel lesion. 35246......... ........ A

Repair blood

28.11

NA

NA

11.95

11.55

3.85

NA

NA

43.91

43.51

090 vessel lesion. 35251......... ........ A

Repair blood

31.79

NA

NA

9.83

11.30

4.12

NA

NA

45.74

47.21

090 vessel lesion. 35256......... ........ A

Repair blood

18.94

NA

NA

6.65

7.93

2.62

NA

NA

28.21

29.49

090 vessel lesion. 35261......... ........ A

Repair blood

18.84

NA

NA

7.26

7.82

2.60

NA

NA

28.70

29.26

090 vessel lesion. 35266......... ........ A

Repair blood

15.71

NA

NA

5.72

6.68

2.09

NA

NA

23.52

24.48

090 vessel lesion. 35271......... ........ A

Repair blood

24.45

NA

NA

9.69

10.31

3.15

NA

NA

37.29

37.91

090 vessel lesion. 35276......... ........ A

Repair blood

25.67

NA

NA

9.66

10.82

3.48

NA

NA

38.81

39.97

090 vessel lesion. 35281......... ........ A

Repair blood

29.87

NA

NA

9.81

11.23

3.96

NA

NA

43.64

45.06

090 vessel lesion. 35286......... ........ A

Repair blood

17.00

NA

NA

6.47

7.66

2.34

NA

NA

25.81

27.00

090 vessel lesion. 35301......... ........ A

Rechanneling of 19.49

NA

NA

6.90

8.05

2.67

NA

NA

29.06

30.21

090 artery. 35311......... ........ A

Rechanneling of 28.48

NA

NA

9.69

11.23

3.41

NA

NA

41.58

43.12

090 artery.

[[Continued on page 49131]]

From the Federal Register Online via GPO Access [wais.access.gpo.gov] ]

[[pp. 49131-49180]] Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2007 and Other Changes to Payment Under Part B

[[Continued from page 49130]]

[[Page 49131]]

35321......... ........ A

Rechanneling of 16.47

NA

NA

6.00

7.04

2.24

NA

NA

24.71

25.75

090 artery. 35331......... ........ A

Rechanneling of 27.55

NA

NA

9.04

10.68

3.82

NA

NA

40.41

42.05

090 artery. 35341......... ........ A

Rechanneling of 26.03

NA

NA

8.58

10.29

3.77

NA

NA

38.38

40.09

090 artery. 35351......... ........ A

Rechanneling of 24.49

NA

NA

7.98

9.19

3.34

NA

NA

35.81

37.02

090 artery. 35355......... ........ A

Rechanneling of 19.74

NA

NA

6.57

7.70

2.66

NA

NA

28.97

30.10

090 artery. 35361......... ........ A

Rechanneling of 30.05

NA

NA

9.75

11.21

4.14

NA

NA

43.94

45.40

090 artery. 35363......... ........ A

Rechanneling of 32.16

NA

NA

10.60

12.09

4.32

NA

NA

47.08

48.57

090 artery. 35371......... ........ A

Rechanneling of 15.19

NA

NA

5.51

6.59

2.13

NA

NA

22.83

23.91

090 artery. 35372......... ........ A

Rechanneling of 18.46

NA

NA

6.33

7.61

2.62

NA

NA

27.41

28.69

090 artery. 35381......... ........ A

Rechanneling of 16.63

NA

NA

6.33

7.44

2.25

NA

NA

25.21

26.32

090 artery. 35390......... ........ A

Reoperation,

3.19

NA

NA

0.85

1.01

0.46

NA

NA

4.50

4.66

ZZZ carotid add-on. 35400......... ........ A

Angioscopy..... 3.00

NA

NA

0.75

1.02

0.43

NA

NA

4.18

4.45

ZZZ 35450......... ........ A

Repair arterial 10.05

NA

NA

3.22

3.48

1.25

NA

NA

14.52

14.78

000 blockage. 35452......... ........ A

Repair arterial 6.90

NA

NA

2.12

2.48

0.94

NA

NA

9.96

10.32

000 blockage. 35454......... ........ A

Repair arterial 6.03

NA

NA

1.83

2.19

0.87

NA

NA

8.73

9.09

000 blockage. 35456......... ........ A

Repair arterial 7.34

NA

NA

2.30

2.65

1.04

NA

NA

10.68

11.03

000 blockage. 35458......... ........ A

Repair arterial 9.48

NA

NA

2.91

3.33

1.26

NA

NA

13.65

14.07

000 blockage. 35459......... ........ A

Repair arterial 8.62

NA

NA

2.53

3.01

1.21

NA

NA

12.36

12.84

000 blockage. 35460......... ........ A

Repair venous

6.03

NA

NA

1.79

2.15

0.83

NA

NA

8.65

9.01

000 blockage. 35470......... ........ A

Repair arterial 8.62 62.11

82.17

3.47

3.38

0.69 71.42

91.48

12.78

12.69

000 blockage. 35471......... ........ A

Repair arterial 10.05 66.97

91.94

4.70

4.14

0.67 77.69

102.7

15.42

14.86

000 blockage. 35472......... ........ A

Repair arterial 6.90 48.34

60.35

2.81

2.76

0.58 55.82

67.83

10.29

10.24

000 blockage. 35473......... ........ A

Repair arterial 6.03 47.23

56.69

2.51

2.44

0.51 53.77

63.23

9.05

8.98

000 blockage. 35474......... ........ A

Repair arterial 7.35 61.24

81.11

3.00

2.92

0.57 69.16

89.03

10.92

10.84

000 blockage. 35475......... ........ R

Repair arterial 9.48 49.26

54.39

3.40

3.52

0.62 59.36

64.49

13.50

13.62

000 blockage. 35476......... ........ A

Repair venous

6.03 37.43

42.91

2.13

2.30

0.34 43.80

49.28

8.50

8.67

000 blockage. 35480......... ........ A

Atherectomy,

11.06

NA

NA

3.96

4.02

1.28

NA

NA

16.30

16.36

000 open. 35481......... ........ A

Atherectomy,

7.60

NA

NA

2.50

2.78

1.13

NA

NA

11.23

11.51

000 open. 35482......... ........ A

Atherectomy,

6.64

NA

NA

2.13

2.45

0.89

NA

NA

9.66

9.98

000 open. 35483......... ........ A

Atherectomy,

8.09

NA

NA

2.79

2.96

1.15

NA

NA

12.03

12.20

000 open. 35484......... ........ A

Atherectomy,

10.42

NA

NA

3.08

3.60

1.27

NA

NA

14.77

15.29

000 open. 35485......... ........ A

Atherectomy,

9.48

NA

NA

3.00

3.40

1.35

NA

NA

13.83

14.23

000 open. 35490......... ........ A

Atherectomy,

11.06

NA

NA

6.27

5.09

0.71

NA

NA

18.04

16.86

000 percutaneous. 35491......... ........ A

Atherectomy,

7.60

NA

NA

3.97

3.46

0.74

NA

NA

12.31

11.80

000 percutaneous. 35492......... ........ A

Atherectomy,

6.64

NA

NA

3.63

3.30

0.43

NA

NA

10.70

10.37

000 percutaneous. 35493......... ........ A

Atherectomy,

8.09

NA

NA

4.15

3.89

0.56

NA

NA

12.80

12.54

000 percutaneous. 35494......... ........ A

Atherectomy,

10.42

NA

NA

5.23

4.65

0.59

NA

NA

16.24

15.66

000 percutaneous. 35495......... ........ A

Atherectomy,

9.48

NA

NA

4.64

4.45

0.69

NA

NA

14.81

14.62

000 percutaneous. 35500......... ........ A

Harvest vein

6.44

NA

NA

1.69

1.94

0.93

NA

NA

9.06

9.31

ZZZ for bypass. 35501......... ........ A

Artery bypass

19.70

NA

NA

7.29

8.17

2.80

NA

NA

29.79

30.67

090 graft. 35506......... ........ A

Artery bypass

25.19

NA

NA

8.48

9.22

2.86

NA

NA

36.53

37.27

090 graft. 35507......... ........ A

Artery bypass

20.60

NA

NA

7.54

8.95

2.84

NA

NA

30.98

32.39

090 graft. 35508......... ........ A

Artery bypass

25.95

NA

NA

9.15

9.37

2.77

NA

NA

37.87

38.09

090 graft. 35509......... ........ A

Artery bypass

18.94

NA

NA

6.78

8.27

2.61

NA

NA

28.33

29.82

090 graft. 35510......... ........ A

Artery bypass

24.25

NA

NA

7.80

9.58

2.11

NA

NA

34.16

35.94

090 graft. 35511......... ........ A

Artery bypass

22.08

NA

NA

7.33

8.85

2.90

NA

NA

32.31

33.83

090 graft. 35512......... ........ A

Artery bypass

23.75

NA

NA

7.53

9.38

2.11

NA

NA

33.39

35.24

090 graft. 35515......... ........ A

Artery bypass

25.95

NA

NA

8.45

9.07

2.77

NA

NA

37.17

37.79

090 graft. 35516......... ........ A

Artery bypass

24.07

NA

NA

7.80

7.05

2.33

NA

NA

34.20

33.45

090 graft. 35518......... ........ A

Artery bypass

22.53

NA

NA

7.54

8.61

3.02

NA

NA

33.09

34.16

090 graft. 35521......... ........ A

Artery bypass

23.94

NA

NA

8.15

9.41

3.12

NA

NA

35.21

36.47

090 graft. 35522......... ........ A

Artery bypass

23.01

NA

NA

7.51

9.19

2.11

NA

NA

32.63

34.31

090 graft. 35525......... ........ A

Artery bypass

21.55

NA

NA

7.19

8.83

2.11

NA

NA

30.85

32.49

090 graft. 35526......... ........ A

Artery bypass

31.43

NA

NA

18.22

13.93

3.62

NA

NA

53.27

48.98

090 graft. 35531......... ........ A

Artery bypass

38.92

NA

NA

11.95

13.84

5.16

NA

NA

56.03

57.92

090 graft. 35533......... ........ A

Artery bypass

29.73

NA

NA

9.99

11.29

3.84

NA

NA

43.56

44.86

090 graft. 35536......... ........ A

Artery bypass

33.54

NA

NA

10.69

12.38

4.61

NA

NA

48.84

50.53

090 graft. 35541......... ........ A

Artery bypass

26.90

NA

NA

9.26

10.72

3.70

NA

NA

39.86

41.32

090 graft. 35546......... ........ A

Artery bypass

26.40

NA

NA

9.07

10.41

3.69

NA

NA

39.16

40.50

090 graft. 35548......... ........ A

Artery bypass

22.50

NA

NA

7.97

9.06

2.97

NA

NA

33.44

34.53

090 graft. 35549......... ........ A

Artery bypass

24.27

NA

NA

9.18

10.07

3.29

NA

NA

36.74

37.63

090 graft. 35551......... ........ A

Artery bypass

27.65

NA

NA

9.90

11.09

3.74

NA

NA

41.29

42.48

090 graft. 35556......... ........ A

Artery bypass

26.56

NA

NA

8.93

9.52

3.09

NA

NA

38.58

39.17

090 graft. 35558......... ........ A

Artery bypass

22.94

NA

NA

8.09

9.18

2.99

NA

NA

34.02

35.11

090 graft. 35560......... ........ A

Artery bypass

33.84

NA

NA

10.79

12.68

4.74

NA

NA

49.37

51.26

090 graft. 35563......... ........ A

Artery bypass

25.93

NA

NA

8.62

10.05

3.51

NA

NA

38.06

39.49

090 graft.

[[Page 49132]]

35565......... ........ A

Artery bypass

24.94

NA

NA

8.51

9.73

3.29

NA

NA

36.74

37.96

090 graft. 35566......... ........ A

Artery bypass

32.16

NA

NA

10.20

11.09

3.82

NA

NA

46.18

47.07

090 graft. 35571......... ........ A

Artery bypass

25.33

NA

NA

8.45

10.24

3.42

NA

NA

37.20

38.99

090 graft. 35572......... ........ A

Harvest

6.81

NA

NA

1.88

2.15

0.99

NA

NA

9.68

9.95

ZZZ femoropoplitea l vein. 35583......... ........ A

Vein bypass

27.56

NA

NA

9.01

9.87

3.16

NA

NA

39.73

40.59

090 graft. 35585......... ........ A

Vein bypass

32.16

NA

NA

10.15

11.70

4.01

NA

NA

46.32

47.87

090 graft. 35587......... ........ A

Vein bypass

26.02

NA

NA

8.69

10.76

3.51

NA

NA

38.22

40.29

090 graft. 35600......... ........ A

Harvest artery

4.94

NA

NA

1.54

1.60

0.73

NA

NA

7.21

7.27

ZZZ for cabg. 35601......... ........ A

Artery bypass

18.31

NA

NA

6.63

8.12

2.49

NA

NA

27.43

28.92

090 graft. 35606......... ........ A

Artery bypass

22.32

NA

NA

7.68

8.68

2.69

NA

NA

32.69

33.69

090 graft. 35612......... ........ A

Artery bypass

16.64

NA

NA

6.40

7.51

2.08

NA

NA

25.12

26.23

090 graft. 35616......... ........ A

Artery bypass

21.70

NA

NA

7.14

7.86

2.19

NA

NA

31.03

31.75

090 graft. 35621......... ........ A

Artery bypass

20.91

NA

NA

7.04

8.26

2.91

NA

NA

30.86

32.08

090 graft. 35623......... ........ A

Bypass graft,

25.73

NA

NA

8.65

10.03

3.45

NA

NA

37.83

39.21

090 not vein. 35626......... ........ A

Artery bypass

29.02

NA

NA

10.25

11.54

4.07

NA

NA

43.34

44.63

090 graft. 35631......... ........ A

Artery bypass

35.84

NA

NA

11.04

13.13

4.95

NA

NA

51.83

53.92

090 graft. 35636......... ........ A

Artery bypass

31.56

NA

NA

9.94

11.70

4.09

NA

NA

45.59

47.35

090 graft. 35641......... ........ A

Artery bypass

26.24

NA

NA

9.23

10.60

3.53

NA

NA

39.00

40.37

090 graft. 35642......... ........ A

Artery bypass

18.79

NA

NA

7.70

8.44

2.27

NA

NA

28.76

29.50

090 graft. 35645......... ........ A

Artery bypass

18.28

NA

NA

7.32

8.03

2.49

NA

NA

28.09

28.80

090 graft. 35646......... ........ A

Artery bypass

32.78

NA

NA

10.78

12.52

4.43

NA

NA

47.99

49.73

090 graft. 35647......... ........ A

Artery bypass

29.56

NA

NA

9.79

11.28

3.98

NA

NA

43.33

44.82

090 graft. 35650......... ........ A

Artery bypass

20.04

NA

NA

6.80

7.97

2.71

NA

NA

29.55

30.72

090 graft. 35651......... ........ A

Artery bypass

25.90

NA

NA

8.84

10.25

3.35

NA

NA

38.09

39.50

090 graft. 35654......... ........ A

Artery bypass

26.11

NA

NA

8.59

10.14

3.52

NA

NA

38.22

39.77

090 graft. 35656......... ........ A

Artery bypass

20.35

NA

NA

7.05

8.21

2.79

NA

NA

30.19

31.35

090 graft. 35661......... ........ A

Artery bypass

20.16

NA

NA

7.30

8.52

2.71

NA

NA

30.17

31.39

090 graft. 35663......... ........ A

Artery bypass

23.74

NA

NA

8.13

9.51

3.10

NA

NA

34.97

36.35

090 graft. 35665......... ........ A

Artery bypass

22.16

NA

NA

7.65

8.99

3.00

NA

NA

32.81

34.15

090 graft. 35666......... ........ A

Artery bypass

23.47

NA

NA

8.78

10.18

3.15

NA

NA

35.40

36.80

090 graft. 35671......... ........ A

Artery bypass

20.58

NA

NA

7.98

9.02

2.77

NA

NA

31.33

32.37

090 graft. 35681......... ........ A

Composite

1.60

NA

NA

0.42

0.50

0.23

NA

NA

2.25

2.33

ZZZ bypass graft. 35682......... ........ A

Composite

7.19

NA

NA

1.78

2.23

1.03

NA

NA

10.00

10.45

ZZZ bypass graft. 35683......... ........ A

Composite

8.49

NA

NA

2.12

2.65

1.20

NA

NA

11.81

12.34

ZZZ bypass graft. 35685......... ........ A

Bypass graft

4.04

NA

NA

1.01

1.27

0.58

NA

NA

5.63

5.89

ZZZ patency/patch. 35686......... ........ A

Bypass graft/av 3.34

NA

NA

0.85

1.06

0.47

NA

NA

4.66

4.87

ZZZ fist patency. 35691......... ........ A

Arterial

18.26

NA

NA

6.33

7.88

2.58

NA

NA

27.17

28.72

090 transposition. 35693......... ........ A

Arterial

15.58

NA

NA

6.09

7.31

2.21

NA

NA

23.88

25.10

090 transposition. 35694......... ........ A

Arterial

19.13

NA

NA

6.59

8.10

2.69

NA

NA

28.41

29.92

090 transposition. 35695......... ........ A

Arterial

19.91

NA

NA

6.64

8.07

2.73

NA

NA

29.28

30.71

090 transposition. 35697......... ........ A

Reimplant

3.00

NA

NA

0.77

0.96

0.41

NA

NA

4.18

4.37

ZZZ artery each. 35700......... ........ A

Reoperation,

3.08

NA

NA

0.80

0.97

0.44

NA

NA

4.32

4.49

ZZZ bypass graft. 35701......... ........ A

Exploration,

9.07

NA

NA

4.26

4.93

1.12

NA

NA

14.45

15.12

090 carotid artery. 35721......... ........ A

Exploration,

7.62

NA

NA

3.76

4.26

1.03

NA

NA

12.41

12.91

090 femoral artery. 35741......... ........ A

Exploration

8.57

NA

NA

3.98

4.49

1.12

NA

NA

13.67

14.18

090 popliteal artery. 35761......... ........ A

Exploration of

5.78

NA

NA

3.49

3.88

0.75

NA

NA

10.02

10.41

090 artery/vein. 35800......... ........ A

Explore neck

7.94

NA

NA

3.96

4.48

0.95

NA

NA

12.85

13.37

090 vessels. 35820......... ........ A

Explore chest

30.08

NA

NA

11.17

8.19

1.94

NA

NA

43.19

40.21

090 vessels. 35840......... ........ A

Explore

10.81

NA

NA

4.89

5.18

1.34

NA

NA

17.04

17.33

090 abdominal vessels. 35860......... ........ A

Explore limb

6.67

NA

NA

3.49

3.90

0.78

NA

NA

10.94

11.35

090 vessels. 35870......... ........ A

Repair vessel

24.32

NA

NA

8.25

9.38

3.00

NA

NA

35.57

36.70

090 graft defect. 35875......... ........ A

Removal of clot 10.60

NA

NA

4.43

4.99

1.41

NA

NA

16.44

17.00

090 in graft. 35876......... ........ A

Removal of clot 17.70

NA

NA

6.16

7.17

2.39

NA

NA

26.25

27.26

090 in graft. 35879......... ........ A

Revise graft w/ 17.24

NA

NA

6.17

7.31

2.27

NA

NA

25.68

26.82

090 vein. 35881......... ........ A

Revise graft w/ 19.16

NA

NA

6.72

8.18

2.55

NA

NA

28.43

29.89

090 vein. 35901......... ........ A

Excision,

8.18

NA

NA

4.32

5.06

1.15

NA

NA

13.65

14.39

090 graft, neck.

[[Page 49133]]

35903......... ........ A

Excision,

9.38

NA

NA

4.72

5.79

1.30

NA

NA

15.40

16.47

090 graft, extremity. 35905......... ........ A

Excision,

33.33

NA

NA

10.76

12.58

4.43

NA

NA

48.52

50.34

090 graft, thorax. 35907......... ........ A

Excision,

37.08

NA

NA

11.35

13.46

4.91

NA

NA

53.34

55.45

090 graft, abdomen. 36000......... ........ A

Place needle in 0.18

0.46

0.54

0.06

0.05

0.01

0.65

0.73

0.25

0.24

XXX vein. 36002......... ........ A

Pseudoaneurysm

1.96

2.23

2.70

0.82

0.93

0.17

4.36

4.83

2.95

3.06

000 injection trt. 36005......... ........ A

Injection ext

0.95

8.54

7.87

0.37

0.33

0.05

9.54

8.87

1.37

1.33

000 venography. 36010......... ........ A

Place catheter

2.43 11.23

17.28

0.75

0.78

0.20 13.86

19.91

3.38

3.41

XXX in vein. 36011......... ........ A

Place catheter

3.14 19.70

25.79

0.97

1.04

0.27 23.11

29.20

4.38

4.45

XXX in vein. 36012......... ........ A

Place catheter

3.51 20.46

19.33

1.20

1.19

0.23 24.20

23.07

4.94

4.93

XXX in vein. 36013......... ........ A

Place catheter

2.52 19.36

20.86

0.96

0.76

0.25 22.13

23.63

3.73

3.53

XXX in artery. 36014......... ........ A

Place catheter

3.02 19.16

19.88

1.03

1.03

0.19 22.37

23.09

4.24

4.24

XXX in artery. 36015......... ........ A

Place catheter

3.51 18.23

22.30

0.94

1.13

0.21 21.95

26.02

4.66

4.85

XXX in artery. 36100......... ........ A

Establish

3.02 11.30

11.88

1.20

1.13

0.26 14.58

15.16

4.48

4.41

XXX access to artery. 36120......... ........ A

Establish

2.01

9.35

10.36

0.58

0.63

0.14 11.50

12.51

2.73

2.78

XXX access to artery. 36140......... ........ A

Establish

2.01 10.55

12.22

0.70

0.66

0.16 12.72

14.39

2.87

2.83

XXX access to artery. 36145......... ........ A

Artery to vein

2.01 10.36

12.00

0.62

0.65

0.11 12.48

14.12

2.74

2.77

XXX shunt. 36160......... ........ A

Establish

2.52 11.88

13.08

0.76

0.82

0.26 14.66

15.86

3.54

3.60

XXX access to aorta. 36200......... ........ A

Place catheter

3.02 13.76

15.82

1.00

1.01

0.24 17.02

19.08

4.26

4.27

XXX in aorta. 36215......... ........ A

Place catheter

4.67 26.10

26.80

1.83

1.67

0.27 31.04

31.74

6.77

6.61

XXX in artery. 36216......... ........ A

Place catheter

5.27 28.11

28.84

1.99

1.84

0.31 33.69

34.42

7.57

7.42

XXX in artery. 36217......... ........ A

Place catheter

6.29 46.29

53.15

2.30

2.20

0.44 53.02

59.88

9.03

8.93

XXX in artery. 36218......... ........ A

Place catheter

1.01

3.78

4.76

0.36

0.35

0.07

4.86

5.84

1.44

1.43

ZZZ in artery. 36245......... ........ A

Place catheter

4.67 29.09

31.34

2.09

1.78

0.31 34.07

36.32

7.07

6.76

XXX in artery. 36246......... ........ A

Place catheter

5.27 27.75

29.41

1.96

1.86

0.38 33.40

35.06

7.61

7.51

XXX in artery. 36247......... ........ A

Place catheter

6.29 45.77

48.58

2.34

2.19

0.47 52.53

55.34

9.10

8.95

XXX in artery. 36248......... ........ A

Place catheter

1.01

3.21

3.83

0.37

0.35

0.07

4.29

4.91

1.45

1.43

ZZZ in artery. 36260......... ........ A

Insertion of

9.76

NA

NA

4.86

4.88

1.29

NA

NA

15.91

15.93

090 infusion pump. 36261......... ........ A

Revision of

5.50

NA

NA

3.25

3.56

0.70

NA

NA

9.45

9.76

090 infusion pump. 36262......... ........ A

Removal of

4.01

NA

NA

2.69

2.74

0.54

NA

NA

7.24

7.29

090 infusion pump. 36299......... ........ C

Vessel

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY injection procedure. 36400......... ........ A

Bl draw 3 yrs. 36420......... ........ A

Vein access

1.01

NA

NA

0.21

0.26

0.07

NA

NA

1.29

1.34

XXX cutdown 1 yr. 36430......... ........ A

Blood

0.00

0.93

0.99

0.00

0.76

0.06

0.99

1.05

0.06

0.82

XXX transfusion service. 36440......... ........ A

Bl push

1.03

NA

NA

0.43

0.33

0.10

NA

NA

1.56

1.46

XXX transfuse, 2 yr or 5 yr. 49507......... ........ A

Prp i/hern init 9.93

NA

NA

4.50

4.46

1.27

NA

NA

15.70

15.66

090 block >5 yr. 49520......... ........ A

Rerepair ing

9.87

NA

NA

4.42

4.43

1.28

NA

NA

15.57

15.58

090 hernia, reduce. 49521......... ........ A

Rerepair ing

12.32

NA

NA

5.04

5.18

1.59

NA

NA

18.95

19.09

090 hernia, blocked. 49525......... ........ A

Repair ing

8.81

NA

NA

4.17

4.10

1.13

NA

NA

14.11

14.04

090 hernia, sliding. 49540......... ........ A

Repair lumbar

10.62

NA

NA

4.67

4.72

1.37

NA

NA

16.66

16.71

090 hernia. 49550......... ........ A

Rpr rem hernia, 8.87

NA

NA

4.15

4.13

1.14

NA

NA

14.16

14.14

090 init, reduce. 49553......... ........ A

Rpr fem hernia, 9.80

NA

NA

4.45

4.42

1.24

NA

NA

15.49

15.46

090 init blocked. 49555......... ........ A

Rerepair fem

9.27

NA

NA

4.26

4.26

1.20

NA

NA

14.73

14.73

090 hernia, reduce. 49557......... ........ A

Rerepair fem

11.50

NA

NA

4.90

4.96

1.47

NA

NA

17.87

17.93

090 hernia, blocked. 49560......... ........ A

Rpr ventral

11.80

NA

NA

4.93

5.09

1.52

NA

NA

18.25

18.41

090 hern init, reduc. 49561......... ........ A

Rpr ventral

15.26

NA

NA

5.86

6.00

1.88

NA

NA

23.00

23.14

090 hern init, block. 49565......... ........ A

Rerepair ventrl 12.25

NA

NA

5.17

5.20

1.52

NA

NA

18.94

18.97

090 hern, reduce. 49566......... ........ A

Rerepair ventrl 15.41

NA

NA

5.92

6.07

1.90

NA

NA

23.23

23.38

090 hern, block. 49568......... ........ A

Hernia repair w/ 4.88

NA

NA

1.26

1.57

0.64

NA

NA

6.78

7.09

ZZZ mesh. 49570......... ........ A

Rpr epigastric

5.93

NA

NA

3.36

3.21

0.75

NA

NA

10.04

9.89

090 hern, reduce. 49572......... ........ A

Rpr epigastric

7.75

NA

NA

3.87

3.56

0.88

NA

NA

12.50

12.19

090 hern, blocked. 49580......... ........ A

Rpr umbil hern, 4.35

NA

NA

3.03

2.70

0.54

NA

NA

7.92

7.59

090 reduc 5 yr. 49587......... ........ A

Rpr umbil hern, 7.92

NA

NA

3.90

3.77

0.99

NA

NA

12.81

12.68

090 block > 5 yr. 49590......... ........ A

Repair

8.78

NA

NA

4.14

4.10

1.13

NA

NA

14.05

14.01

090 spigelian hernia. 49600......... ........ A

Repair

11.42

NA

NA

5.20

5.29

1.32

NA

NA

17.94

18.03

090 umbilical lesion. 49605......... ........ A

Repair

86.79

NA

NA

26.58

28.02

9.36

NA

NA 122.73

124.17

090 umbilical lesion. 49606......... ........ A

Repair

18.87

NA

NA

6.66

7.43

2.45

NA

NA

27.98

28.75

090 umbilical lesion. 49610......... ........ A

Repair

10.78

NA

NA

4.73

5.08

1.07

NA

NA

16.58

16.93

090 umbilical lesion. 49611......... ........ A

Repair

9.21

NA

NA

3.66

6.14

0.78

NA

NA

13.65

16.13

090 umbilical lesion. 49650......... ........ A

Laparo hernia

6.26

NA

NA

3.37

3.24

0.93

NA

NA

10.56

10.43

090 repair initial. 49651......... ........ A

Laparo hernia

8.23

NA

NA

4.26

4.10

1.14

NA

NA

13.63

13.47

090 repair recur. 49659......... ........ C

Laparo proc,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY hernia repair. 49900......... ........ A

Repair of

12.26

NA

NA

6.35

6.25

1.62

NA

NA

20.23

20.13

090 abdominal wall. 49904......... ........ A

Omental flap,

22.06

NA

NA

12.17

14.45

2.69

NA

NA

36.92

39.20

090 extra-abdom. 49905......... ........ A

Omental flap,

6.54

NA

NA

1.74

2.15

0.75

NA

NA

9.03

9.44

ZZZ intra-abdom. 49906......... ........ C

Free omental

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 flap, microvasc.

[[Page 49150]]

49999......... ........ C

Abdomen surgery 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 50010......... ........ A

Exploration of 12.07

NA

NA

6.90

5.63

0.93

NA

NA

19.90

18.63

090 kidney. 50020......... ........ A

Renal abscess, 17.80

NA

NA

8.63

7.96

1.34

NA

NA

27.77

27.10

090 open drain. 50021......... ........ A

Renal abscess,

3.37 21.26

21.55

1.09

1.10

0.20 24.83

25.12

4.66

4.67

000 percut drain. 50040......... ........ A

Drainage of

16.40

NA

NA

8.91

7.33

1.03

NA

NA

26.34

24.76

090 kidney. 50045......... ........ A

Exploration of 16.61

NA

NA

8.55

7.08

1.24

NA

NA

26.40

24.93

090 kidney. 50060......... ........ A

Removal of

20.74

NA

NA

11.10

8.64

1.36

NA

NA

33.20

30.74

090 kidney stone. 50065......... ........ A

Incision of

22.11

NA

NA

11.69

7.48

1.59

NA

NA

35.39

31.18

090 kidney. 50070......... ........ A

Incision of

21.64

NA

NA

11.49

9.03

1.44

NA

NA

34.57

32.11

090 kidney. 50075......... ........ A

Removal of

26.84

NA

NA

13.79

10.87

1.80

NA

NA

42.43

39.51

090 kidney stone. 50080......... ........ A

Removal of

15.56

NA

NA

8.64

6.86

1.04

NA

NA

25.24

23.46

090 kidney stone. 50081......... ........ A

Removal of

23.25

NA

NA

12.32

9.64

1.54

NA

NA

37.11

34.43

090 kidney stone. 50100......... ........ A

Revise kidney

17.24

NA

NA

7.34

7.67

2.06

NA

NA

26.64

26.97

090 blood vessels. 50120......... ........ A

Exploration of 17.00

NA

NA

8.80

7.27

1.21

NA

NA

27.01

25.48

090 kidney. 50125......... ........ A

Explore and

17.61

NA

NA

9.85

7.68

1.43

NA

NA

28.89

26.72

090 drain kidney. 50130......... ........ A

Removal of

18.61

NA

NA

10.12

7.90

1.22

NA

NA

29.95

27.73

090 kidney stone. 50135......... ........ A

Exploration of 20.38

NA

NA

10.81

8.53

1.33

NA

NA

32.52

30.24

090 kidney. 50200......... ........ A

Biopsy of

2.63

NA

NA

1.13

1.25

0.16

NA

NA

3.92

4.04

000 kidney. 50205......... ........ A

Biopsy of

12.15

NA

NA

5.62

5.16

1.30

NA

NA

19.07

18.61

090 kidney. 50220......... ........ A

Remove kidney, 18.47

NA

NA

9.64

7.83

1.35

NA

NA

29.46

27.65

090 open. 50225......... ........ A

Removal kidney 21.67

NA

NA

11.14

8.89

1.50

NA

NA

34.31

32.06

090 open, complex. 50230......... ........ A

Removal kidney 23.63

NA

NA

11.81

9.38

1.55

NA

NA

36.99

34.56

090 open, radical. 50234......... ........ A

Removal of

23.84

NA

NA

12.20

9.67

1.59

NA

NA

37.63

35.10

090 kidney & ureter. 50236......... ........ A

Removal of

26.66

NA

NA

14.10

11.21

1.76

NA

NA

42.52

39.63

090 kidney & ureter. 50240......... ........ A

Partial removal 23.93

NA

NA

12.78

9.95

1.55

NA

NA

38.26

35.43

090 of kidney. 50250......... ........ A

Cryoablate

21.98

NA

NA

11.01

9.62

1.39

NA

NA

34.38

32.99

090 renal mass open. 50280......... ........ A

Removal of

16.88

NA

NA

9.35

7.35

1.19

NA

NA

27.42

25.42

090 kidney lesion. 50290......... ........ A

Removal of

15.94

NA

NA

8.19

6.89

1.41

NA

NA

25.54

24.24

090 kidney lesion. 50320......... ........ A

Remove kidney, 22.18

NA

NA

12.52

11.12

2.35

NA

NA

37.05

35.65

090 living donor. 50323......... ........ C

Prep cadaver

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX renal allograft. 50325......... ........ C

Prep donor

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX renal graft. 50327......... ........ A

Prep renal

4.00

NA

NA

1.10

1.29

0.29

NA

NA

5.39

5.58

XXX graft/venous. 50328......... ........ A

Prep renal

3.50

NA

NA

0.98

1.13

0.26

NA

NA

4.74

4.89

XXX graft/arterial. 50329......... ........ A

Prep renal

3.34

NA

NA

0.97

1.09

0.25

NA

NA

4.56

4.68

XXX graft/ureteral. 50340......... ........ A

Removal of

13.79

NA

NA

7.70

6.79

1.65

NA

NA

23.14

22.23

090 kidney. 50360......... ........ A

Transplantation 40.27

NA

NA

18.95

16.34

3.81

NA

NA

63.03

60.42

090 of kidney. 50365......... ........ A

Transplantation 45.50

NA

NA

19.63

18.55

4.42

NA

NA

69.55

68.47

090 of kidney. 50370......... ........ A

Remove

18.60

NA

NA

9.35

7.69

1.67

NA

NA

29.62

27.96

090 transplanted kidney. 50380......... ........ A

Reimplantation 29.48

NA

NA

16.43

13.12

2.50

NA

NA

48.41

45.10

090 of kidney. 50382......... ........ A

Change ureter

5.50 26.41

33.69

1.86

1.86

0.34 32.25

39.53

7.70

7.70

000 stent, percut. 50384......... ........ A

Remove ureter

5.00 20.77

31.61

1.69

1.71

0.31 26.08

36.92

7.00

7.02

000 stent, percut. 50387......... ........ A

Change ext/int

2.00 12.75

16.85

0.66

0.67

0.12 14.87

18.97

2.78

2.79

000 ureter stent. 50389......... ........ A

Remove renal

1.10

6.75

11.24

0.36

0.37

0.07

7.92

12.41

1.53

1.54

000 tube w/fluoro. 50390......... ........ A

Drainage of

1.96

NA

NA

0.64

0.64

0.12

NA

NA

2.72

2.72

000 kidney lesion. 50391......... ........ A

Instll rx agnt

1.96

1.51

1.56

0.79

0.67

0.14

3.61

3.66

2.89

2.77

000 into rnal tub. 50392......... ........ A

Insert kidney

3.37

NA

NA

1.40

1.49

0.20

NA

NA

4.97

5.06

000 drain. 50393......... ........ A

Insert ureteral 4.15

NA

NA

1.66

1.75

0.25

NA

NA

6.06

6.15

000 tube. 50394......... ........ A

Injection for

0.76

1.88

2.48

0.56

0.64

0.05

2.69

3.29

1.37

1.45

000 kidney x-ray. 50395......... ........ A

Create passage

3.37

NA

NA

1.48

1.50

0.21

NA

NA

5.06

5.08

000 to kidney. 50396......... ........ A

Measure kidney

2.09

NA

NA

1.02

1.07

0.13

NA

NA

3.24

3.29

000 pressure. 50398......... ........ A

Change kidney

1.46 11.99

15.23

0.52

0.52

0.09 13.54

16.78

2.07

2.07

000 tube. 50400......... ........ A

Revision of

21.06

NA

NA

11.12

8.68

1.38

NA

NA

33.56

31.12

090 kidney/ureter. 50405......... ........ A

Revision of

25.61

NA

NA

13.16

10.06

1.78

NA

NA

40.55

37.45

090 kidney/ureter. 50500......... ........ A

Repair of

21.01

NA

NA

9.29

8.61

2.01

NA

NA

32.31

31.63

090 kidney wound. 50520......... ........ A

Close kidney-

18.67

NA

NA

9.40

7.92

1.49

NA

NA

29.56

28.08

090 skin fistula. 50525......... ........ A

Repair renal-

24.14

NA

NA

10.99

9.49

1.83

NA

NA

36.96

35.46

090 abdomen fistula.

[[Page 49151]]

50526......... ........ A

Repair renal-

26.06

NA

NA

8.23

9.45

1.96

NA

NA

36.25

37.47

090 abdomen fistula. 50540......... ........ A

Revision of

20.89

NA

NA

10.79

8.94

1.36

NA

NA

33.04

31.19

090 horseshoe kidney. 50541......... ........ A

Laparo ablate

16.72

NA

NA

8.81

7.06

1.13

NA

NA

26.66

24.91

090 renal cyst. 50542......... ........ A

Laparo ablate

21.12

NA

NA

11.24

8.91

1.39

NA

NA

33.75

31.42

090 renal mass. 50543......... ........ A

Laparo partial 27.10

NA

NA

14.20

11.19

1.80

NA

NA

43.10

40.09

090 nephrectomy. 50544......... ........ A

Laparoscopy,

23.23

NA

NA

11.51

9.27

1.58

NA

NA

36.32

34.08

090 pyeloplasty. 50545......... ........ A

Laparo radical 24.89

NA

NA

12.35

9.97

1.70

NA

NA

38.94

36.56

090 nephrectomy. 50546......... ........ A

Laparoscopic

21.63

NA

NA

11.39

9.12

1.57

NA

NA

34.59

32.32

090 nephrectomy. 50547......... ........ A

Laparo removal 26.20

NA

NA

12.68

11.50

2.76

NA

NA

41.64

40.46

090 donor kidney. 50548......... ........ A

Laparo remove w/ 25.22

NA

NA

12.27

9.95

1.72

NA

NA

39.21

36.89

090 ureter. 50549......... ........ C

Laparoscope

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY proc, renal. 50551......... ........ A

Kidney

5.59

4.61

4.26

2.66

2.14

0.40 10.60

10.25

8.65

8.13

000 endoscopy. 50553......... ........ A

Kidney

5.98

4.45

4.38

2.55

2.27

0.39 10.82

10.75

8.92

8.64

000 endoscopy. 50555......... ........ A

Kidney

6.52

5.12

4.89

3.03

2.51

0.45 12.09

11.86

10.00

9.48

000 endoscopy & biopsy. 50557......... ........ A

Kidney

6.61

5.28

4.76

3.07

2.49

0.47 12.36

11.84

10.15

9.57

000 endoscopy & treatment. 50561......... ........ A

Kidney

7.58

5.80

5.26

3.42

2.84

0.54 13.92

13.38

11.54

10.96

000 endoscopy & treatment. 50562......... ........ A

Renal scope w/ 10.90

NA

NA

5.42

4.59

0.73

NA

NA

17.05

16.22

090 tumor resect. 50570......... ........ A

Kidney

9.53

NA

NA

4.27

3.48

0.68

NA

NA

14.48

13.69

000 endoscopy. 50572......... ........ A

Kidney

10.33

NA

NA

4.60

3.78

0.85

NA

NA

15.78

14.96

000 endoscopy. 50574......... ........ A

Kidney

11.00

NA

NA

4.78

4.00

0.77

NA

NA

16.55

15.77

000 endoscopy & biopsy. 50575......... ........ A

Kidney

13.96

NA

NA

6.06

4.99

0.99

NA

NA

21.01

19.94

000 endoscopy. 50576......... ........ A

Kidney

10.97

NA

NA

4.86

3.96

0.78

NA

NA

16.61

15.71

000 endoscopy & treatment. 50580......... ........ A

Kidney

11.84

NA

NA

5.17

4.26

0.83

NA

NA

17.84

16.93

000 endoscopy & treatment. 50590......... ........ A

Fragmenting of

9.58 17.26

13.61

6.19

4.63

0.65 27.49

23.84

16.42

14.86

090 kidney stone. 50592......... ........ A

Perc rf ablate

6.75 77.05

131.0

2.81

2.94

0.43 84.23

138.2

9.99

10.12

010 renal tumor. 50600......... ........ A

Exploration of 16.99

NA

NA

8.60

7.15

1.13

NA

NA

26.72

25.27

090 ureter. 50605......... ........ A

Insert ureteral 16.61

NA

NA

8.00

7.05

1.45

NA

NA

26.06

25.11

090 support. 50610......... ........ A

Removal of

17.07

NA

NA

9.12

7.50

1.43

NA

NA

27.62

26.00

090 ureter stone. 50620......... ........ A

Removal of

16.25

NA

NA

8.97

6.99

1.07

NA

NA

26.29

24.31

090 ureter stone. 50630......... ........ A

Removal of

16.03

NA

NA

8.30

6.78

1.09

NA

NA

25.42

23.90

090 ureter stone. 50650......... ........ A

Removal of

18.61

NA

NA

10.15

7.95

1.23

NA

NA

29.99

27.79

090 ureter. 50660......... ........ A

Removal of

20.81

NA

NA

10.87

8.68

1.38

NA

NA

33.06

30.87

090 ureter. 50684......... ........ A

Injection for

0.76

4.12

4.76

0.64

0.51

0.05

4.93

5.57

1.45

1.32

000 ureter x-ray. 50686......... ........ A

Measure ureter

1.51

2.07

3.10

0.71

0.79

0.11

3.69

4.72

2.33

2.41

000 pressure. 50688......... ........ A

Change of

1.17

NA

NA

0.92

1.03

0.07

NA

NA

2.16

2.27

010 ureter tube/ stent. 50690......... ........ A

Injection for

1.16

1.43

1.72

0.72

0.72

0.07

2.66

2.95

1.95

1.95

000 ureter x-ray. 50700......... ........ A

Revision of

16.48

NA

NA

8.46

7.45

1.27

NA

NA

26.21

25.20

090 ureter. 50715......... ........ A

Release of

20.43

NA

NA

8.65

8.71

2.13

NA

NA

31.21

31.27

090 ureter. 50722......... ........ A

Release of

17.74

NA

NA

8.02

7.86

1.90

NA

NA

27.66

27.50

090 ureter. 50725......... ........ A

Release/revise 19.99

NA

NA

9.70

8.46

1.52

NA

NA

31.21

29.97

090 ureter. 50727......... ........ A

Revise ureter.. 8.17

NA

NA

5.78

4.65

0.61

NA

NA

14.56

13.43

090 50728......... ........ A

Revise ureter.. 12.00

NA

NA

7.21

5.97

1.00

NA

NA

20.21

18.97

090 50740......... ........ A

Fusion of

19.86

NA

NA

9.03

8.06

1.96

NA

NA

30.85

29.88

090 ureter & kidney. 50750......... ........ A

Fusion of

21.01

NA

NA

9.84

8.45

1.38

NA

NA

32.23

30.84

090 ureter & kidney. 50760......... ........ A

Fusion of

19.86

NA

NA

9.84

8.21

1.55

NA

NA

31.25

29.62

090 ureters. 50770......... ........ A

Splicing of

21.01

NA

NA

10.70

8.65

1.45

NA

NA

33.16

31.11

090 ureters. 50780......... ........ A

Reimplant

19.74

NA

NA

10.14

8.22

1.51

NA

NA

31.39

29.47

090 ureter in bladder. 50782......... ........ A

Reimplant

19.51

NA

NA

8.30

8.65

1.61

NA

NA

29.42

29.77

090 ureter in bladder. 50783......... ........ A

Reimplant

20.52

NA

NA

10.07

8.68

1.98

NA

NA

32.57

31.18

090 ureter in bladder. 50785......... ........ A

Reimplant

22.02

NA

NA

11.19

9.02

1.45

NA

NA

34.66

32.49

090 ureter in bladder. 50800......... ........ A

Implant ureter 16.16

NA

NA

9.32

7.18

1.19

NA

NA

26.67

24.53

090 in bowel. 50810......... ........ A

Fusion of

22.29

NA

NA

9.65

9.22

2.31

NA

NA

34.25

33.82

090 ureter & bowel. 50815......... ........ A

Urine shunt to 21.98

NA

NA

11.63

9.24

1.54

NA

NA

35.15

32.76

090 intestine. 50820......... ........ A

Construct bowel 23.82

NA

NA

12.00

9.47

1.89

NA

NA

37.71

35.18

090 bladder. 50825......... ........ A

Construct bowel 30.40

NA

NA

15.09

12.11

2.07

NA

NA

47.56

44.58

090 bladder. 50830......... ........ A

Revise urine

33.49

NA

NA

15.92

13.10

2.37

NA

NA

51.78

48.96

090 flow. 50840......... ........ A

Replace ureter 22.11

NA

NA

11.93

9.30

1.47

NA

NA

35.51

32.88

090 by bowel. 50845......... ........ A

Appendico-

22.11

NA

NA

12.42

9.77

1.57

NA

NA

36.10

33.45

090 vesicostomy. 50860......... ........ A

Transplant

16.87

NA

NA

9.05

7.22

1.29

NA

NA

27.21

25.38

090 ureter to skin. 50900......... ........ A

Repair of

14.83

NA

NA

8.10

6.62

1.14

NA

NA

24.07

22.59

090 ureter. 50920......... ........ A

Closure ureter/ 15.60

NA

NA

8.54

7.06

1.01

NA

NA

25.15

23.67

090 skin fistula. 50930......... ........ A

Closure ureter/ 19.98

NA

NA

10.29

8.54

1.28

NA

NA

31.55

29.80

090 bowel fistula. 50940......... ........ A

Release of

15.72

NA

NA

8.27

6.86

1.26

NA

NA

25.25

23.84

090 ureter. 50945......... ........ A

Laparoscopy

17.83

NA

NA

8.78

7.47

1.36

NA

NA

27.97

26.66

090 ureterolithoto my. 50947......... ........ A

Laparo new

25.57

NA

NA

12.50

10.39

2.16

NA

NA

40.23

38.12

090 ureter/bladder. 50948......... ........ A

Laparo new

23.65

NA

NA

12.02

9.52

1.70

NA

NA

37.37

34.87

090 ureter/bladder.

[[Page 49152]]

50949......... ........ C

Laparoscope

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY proc, ureter. 50951......... ........ A

Endoscopy of

5.83

4.87

4.44

2.79

2.24

0.41 11.11

10.68

9.03

8.48

000 ureter. 50953......... ........ A

Endoscopy of

6.23

5.05

4.56

3.31

2.60

0.43 11.71

11.22

9.97

9.26

000 ureter. 50955......... ........ A

Ureter

6.74

5.28

6.13

3.52

2.89

0.48 12.50

13.35

10.74

10.11

000 endoscopy & biopsy. 50957......... ........ A

Ureter

6.78

5.37

4.76

3.15

2.57

0.48 12.63

12.02

10.41

9.83

000 endoscopy & treatment. 50961......... ........ A

Ureter

6.04

4.85

4.48

2.82

2.34

0.41 11.30

10.93

9.27

8.79

000 endoscopy & treatment. 50970......... ........ A

Ureter

7.13

NA

NA

3.30

2.67

0.52

NA

NA

10.95

10.32

000 endoscopy. 50972......... ........ A

Ureter

6.88

NA

NA

3.14

2.63

0.49

NA

NA

10.51

10.00

000 endoscopy & catheter. 50974......... ........ A

Ureter

9.16

NA

NA

3.97

3.32

0.64

NA

NA

13.77

13.12

000 endoscopy & biopsy. 50976......... ........ A

Ureter

9.03

NA

NA

3.76

3.24

0.66

NA

NA

13.45

12.93

000 endoscopy & treatment. 50980......... ........ A

Ureter

6.84

NA

NA

3.13

2.56

0.48

NA

NA

10.45

9.88

000 endoscopy & treatment. 51000......... ........ A

Drainage of

0.78

0.94

1.69

0.28

0.25

0.05

1.77

2.52

1.11

1.08

000 bladder. 51005......... ........ A

Drainage of

1.02

2.43

4.13

0.30

0.33

0.10

3.55

5.25

1.42

1.45

000 bladder. 51010......... ........ A

Drainage of

4.25

4.78

5.40

2.38

2.00

0.28

9.31

9.93

6.91

6.53

010 bladder. 51020......... ........ A

Incise & treat

7.51

NA

NA

5.35

4.23

0.47

NA

NA

13.33

12.21

090 bladder. 51030......... ........ A

Incise & treat

7.63

NA

NA

4.80

4.18

0.58

NA

NA

13.01

12.39

090 bladder. 51040......... ........ A

Incise & drain

4.39

NA

NA

3.72

3.00

0.31

NA

NA

8.42

7.70

090 bladder. 51045......... ........ A

Incise bladder/ 7.63

NA

NA

5.23

4.25

0.52

NA

NA

13.38

12.40

090 drain ureter. 51050......... ........ A

Removal of

7.83

NA

NA

5.38

4.08

0.49

NA

NA

13.70

12.40

090 bladder stone. 51060......... ........ A

Removal of

9.77

NA

NA

6.42

4.98

0.62

NA

NA

16.81

15.37

090 ureter stone. 51065......... ........ A

Remove ureter

9.77

NA

NA

6.35

4.85

0.63

NA

NA

16.75

15.25

090 calculus. 51080......... ........ A

Drainage of

6.57

NA

NA

4.35

3.74

0.43

NA

NA

11.35

10.74

090 bladder abscess. 51500......... ........ A

Removal of

10.87

NA

NA

5.85

5.21

1.03

NA

NA

17.75

17.11

090 bladder cyst. 51520......... ........ A

Removal of

10.03

NA

NA

6.51

5.13

0.69

NA

NA

17.23

15.85

090 bladder lesion. 51525......... ........ A

Removal of

15.24

NA

NA

8.66

6.76

0.99

NA

NA

24.89

22.99

090 bladder lesion. 51530......... ........ A

Removal of

13.53

NA

NA

7.33

6.14

1.05

NA

NA

21.91

20.72

090 bladder lesion. 51535......... ........ A

Repair of

13.72

NA

NA

7.54

6.46

1.23

NA

NA

22.49

21.41

090 ureter lesion. 51550......... ........ A

Partial removal 17.05

NA

NA

8.91

7.27

1.31

NA

NA

27.27

25.63

090 of bladder. 51555......... ........ A

Partial removal 22.97

NA

NA

11.51

9.37

1.69

NA

NA

36.17

34.03

090 of bladder. 51565......... ........ A

Revise bladder 23.43

NA

NA

12.07

9.73

1.63

NA

NA

37.13

34.79

090 & ureter(s). 51570......... ........ A

Removal of

27.25

NA

NA

13.39

10.65

1.71

NA

NA

42.35

39.61

090 bladder. 51575......... ........ A

Removal of

33.93

NA

NA

16.79

13.21

2.16

NA

NA

52.88

49.30

090 bladder & nodes. 51580......... ........ A

Remove bladder/ 35.05

NA

NA

17.64

13.77

2.24

NA

NA

54.93

51.06

090 revise tract. 51585......... ........ A

Removal of

39.32

NA

NA

19.63

15.18

2.48

NA

NA

61.43

56.98

090 bladder & nodes. 51590......... ........ A

Remove bladder/ 36.08

NA

NA

17.47

13.82

2.27

NA

NA

55.82

52.17

090 revise tract. 51595......... ........ A

Remove bladder/ 41.04

NA

NA

19.79

15.54

2.59

NA

NA

63.42

59.17

090 revise tract. 51596......... ........ A

Remove bladder/ 43.91

NA

NA

21.37

16.76

2.77

NA

NA

68.04

63.44

090 create pouch. 51597......... ........ A

Removal of

42.51

NA

NA

20.13

16.15

2.81

NA

NA

65.45

61.47

090 pelvic structures. 51600......... ........ A

Injection for

0.88

4.25

4.85

0.31

0.30

0.06

5.19

5.79

1.25

1.24

000 bladder x-ray. 51605......... ........ A

Preparation for 0.64

NA

NA

0.42

0.37

0.04

NA

NA

1.10

1.05

000 bladder xray. 51610......... ........ A

Injection for

1.05

1.93

2.19

0.70

0.63

0.07

3.05

3.31

1.82

1.75

000 bladder x-ray. 51700......... ........ A

Irrigation of

0.88

1.52

1.58

0.34

0.30

0.06

2.46

2.52

1.28

1.24

000 bladder. 51701......... ........ A

Insert bladder

0.50

1.05

1.45

0.25

0.21

0.04

1.59

1.99

0.79

0.75

000 catheter. 51702......... ........ A

Insert temp

0.50

1.54

1.95

0.34

0.27

0.04

2.08

2.49

0.88

0.81

000 bladder cath. 51703......... ........ A

Insert bladder

1.47

2.29

2.62

0.81

0.62

0.10

3.86

4.19

2.38

2.19

000 cath, complex. 51705......... ........ A

Change of

1.02

2.04

2.21

0.85

0.67

0.07

3.13

3.30

1.94

1.76

010 bladder tube. 51710......... ........ A

Change of

1.49

2.75

3.19

1.19

0.88

0.11

4.35

4.79

2.79

2.48

010 bladder tube. 51715......... ........ A

Endoscopic

3.73

4.47

4.04

1.76

1.45

0.29

8.49

8.06

5.78

5.47

000 injection/ implant. 51720......... ........ A

Treatment of

1.50

1.64

1.72

0.75

0.71

0.14

3.28

3.36

2.39

2.35

000 bladder lesion. 51725......... ........ A

Simple

1.51

4.32

5.27

4.32

5.27

0.16

5.99

6.94

5.99

6.94

000 cystometrogram. 51725......... 26...... A

Simple

1.51

0.57

0.51

0.57

0.51

0.12

2.20

2.14

2.20

2.14

000 cystometrogram. 51725......... TC...... A

Simple

0.00

3.75

4.76

3.75

4.76

0.04

3.79

4.80

3.79

4.80

000 cystometrogram. 51726......... ........ A

Complex

1.71

7.18

7.42

7.18

7.42

0.18

9.07

9.31

9.07

9.31

000 cystometrogram. 51726......... 26...... A

Complex

1.71

0.65

0.58

0.65

0.58

0.13

2.49

2.42

2.49

2.42

000 cystometrogram. 51726......... TC...... A

Complex

0.00

6.53

6.84

6.53

6.84

0.05

6.58

6.89

6.58

6.89

000 cystometrogram. 51736......... ........ A

Urine flow

0.61

0.91

0.66

0.91

0.66

0.06

1.58

1.33

1.58

1.33

000 measurement.

[[Page 49153]]

51736......... 26...... A

Urine flow

0.61

0.23

0.21

0.23

0.21

0.05

0.89

0.87

0.89

0.87

000 measurement. 51736......... TC...... A

Urine flow

0.00

0.68

0.46

0.68

0.46

0.01

0.69

0.47

0.69

0.47

000 measurement. 51741......... ........ A

Electro-

1.14

1.27

0.91

1.27

0.91

0.11

2.52

2.16

2.52

2.16

000 uroflowmetry, first. 51741......... 26...... A

Electro-

1.14

0.44

0.39

0.44

0.39

0.09

1.67

1.62

1.67

1.62

000 uroflowmetry, first. 51741......... TC...... A

Electro-

0.00

0.83

0.52

0.83

0.52

0.02

0.85

0.54

0.85

0.54

000 uroflowmetry, first. 51772......... ........ A

Urethra

1.61

5.09

5.45

5.09

5.45

0.20

6.90

7.26

6.90

7.26

000 pressure profile. 51772......... 26...... A

Urethra

1.61

0.55

0.55

0.55

0.55

0.15

2.31

2.31

2.31

2.31

000 pressure profile. 51772......... TC...... A

Urethra

0.00

4.54

4.91

4.54

4.91

0.05

4.59

4.96

4.59

4.96

000 pressure profile. 51784......... ........ A

Anal/urinary

1.53

3.85

3.95

3.85

3.95

0.16

5.54

5.64

5.54

5.64

000 muscle study. 51784......... 26...... A

Anal/urinary

1.53

0.52

0.51

0.52

0.51

0.12

2.17

2.16

2.17

2.16

000 muscle study. 51784......... TC...... A

Anal/urinary

0.00

3.33

3.44

3.33

3.44

0.04

3.37

3.48

3.37

3.48

000 muscle study. 51785......... ........ A

Anal/urinary

1.53

4.54

4.47

4.54

4.47

0.15

6.22

6.15

6.22

6.15

000 muscle study. 51785......... 26...... A

Anal/urinary

1.53

0.56

0.52

0.56

0.52

0.11

2.20

2.16

2.20

2.16

000 muscle study. 51785......... TC...... A

Anal/urinary

0.00

3.97

3.95

3.97

3.95

0.04

4.01

3.99

4.01

3.99

000 muscle study. 51792......... ........ A

Urinary reflex

1.10

5.01

5.75

5.01

5.75

0.20

6.31

7.05

6.31

7.05

000 study. 51792......... 26...... A

Urinary reflex

1.10

0.40

0.41

0.40

0.41

0.07

1.57

1.58

1.57

1.58

000 study. 51792......... TC...... A

Urinary reflex

0.00

4.61

5.34

4.61

5.34

0.13

4.74

5.47

4.74

5.47

000 study. 51795......... ........ A

Urine voiding

1.53

6.78

7.16

6.78

7.16

0.22

8.53

8.91

8.53

8.91

000 pressure study. 51795......... 26...... A

Urine voiding

1.53

0.58

0.52

0.58

0.52

0.12

2.23

2.17

2.23

2.17

000 pressure study. 51795......... TC...... A

Urine voiding

0.00

6.21

6.65

6.21

6.65

0.10

6.31

6.75

6.31

6.75

000 pressure study. 51797......... ........ A

Intraabdominal

1.60

4.88

5.56

4.88

5.56

0.17

6.65

7.33

6.65

7.33

000 pressure test. 51797......... 26...... A

Intraabdominal

1.60

0.60

0.55

0.60

0.55

0.12

2.32

2.27

2.32

2.27

000 pressure test. 51797......... TC...... A

Intraabdominal

0.00

4.28

5.01

4.28

5.01

0.05

4.33

5.06

4.33

5.06

000 pressure test. 51798......... ........ A

Us urine

0.00

0.60

0.41

NA

NA

0.08

0.68

0.49

NA

NA

XXX capacity measure. 51800......... ........ A

Revision of

18.68

NA

NA

10.11

8.20

1.32

NA

NA

30.11

28.20

090 bladder/ urethra. 51820......... ........ A

Revision of

19.34

NA

NA

10.54

8.85

1.74

NA

NA

31.62

29.93

090 urinary tract. 51840......... ........ A

Attach bladder/ 11.23

NA

NA

5.81

5.62

1.06

NA

NA

18.10

17.91

090 urethra. 51841......... ........ A

Attach bladder/ 13.55

NA

NA

6.85

6.49

1.24

NA

NA

21.64

21.28

090 urethra. 51845......... ........ A

Repair bladder 10.02

NA

NA

5.88

5.03

0.79

NA

NA

16.69

15.84

090 neck. 51860......... ........ A

Repair of

12.42

NA

NA

6.83

6.02

1.16

NA

NA

20.41

19.60

090 bladder wound. 51865......... ........ A

Repair of

15.62

NA

NA

8.47

7.12

1.23

NA

NA

25.32

23.97

090 bladder wound. 51880......... ........ A

Repair of

7.77

NA

NA

4.73

4.15

0.72

NA

NA

13.22

12.64

090 bladder opening. 51900......... ........ A

Repair bladder/ 14.42

NA

NA

8.04

6.56

1.21

NA

NA

23.67

22.19

090 vagina lesion. 51920......... ........ A

Close bladder- 13.20

NA

NA

7.77

6.17

1.18

NA

NA

22.15

20.55

090 uterus fistula. 51925......... ........ A

Hysterectomy/

17.28

NA

NA

10.27

9.03

2.03

NA

NA

29.58

28.34

090 bladder repair. 51940......... ........ A

Correction of

30.41

NA

NA

11.41

11.91

2.14

NA

NA

43.96

44.46

090 bladder defect. 51960......... ........ A

Revision of

25.12

NA

NA

13.18

10.52

1.63

NA

NA

39.93

37.27

090 bladder & bowel. 51980......... ........ A

Construct

12.39

NA

NA

7.29

5.85

0.86

NA

NA

20.54

19.10

090 bladder opening. 51990......... ........ A

Laparo urethral 13.22

NA

NA

5.99

6.10

1.39

NA

NA

20.60

20.71

090 suspension. 51992......... ........ A

Laparo sling

14.73

NA

NA

6.65

6.31

1.41

NA

NA

22.79

22.45

090 operation. 51999......... ........ C

Laparoscope

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY proc, bladder. 52000......... ........ A

Cystoscopy..... 2.23

3.70

3.40

1.33

0.90

0.14

6.07

5.77

3.70

3.27

000 52001......... ........ A

Cystoscopy,

5.44

5.14

5.09

2.62

2.05

0.39 10.97

10.92

8.45

7.88

000 removal of clots. 52005......... ........ A

Cystoscopy &

2.37

5.79

5.62

1.39

1.02

0.17

8.33

8.16

3.93

3.56

000 ureter catheter. 52007......... ........ A

Cystoscopy and

3.02 10.83

15.04

1.64

1.27

0.22 14.07

18.28

4.88

4.51

000 biopsy. 52010......... ........ A

Cystoscopy &

3.02

8.20

10.11

1.65

1.28

0.21 11.43

13.34

4.88

4.51

000 duct catheter. 52204......... ........ A

Cystoscopy..... 2.59

8.39

12.98

1.40

1.03

0.17 11.15

15.74

4.16

3.79

000 52214......... ........ A

Cystoscopy and

3.70 20.07

33.59

1.86

1.46

0.26 24.03

37.55

5.82

5.42

000 treatment. 52224......... ........ A

Cystoscopy and

3.14 19.25

32.15

1.63

1.27

0.22 22.61

35.51

4.99

4.63

000 treatment. 52234......... ........ A

Cystoscopy and

4.62

NA

NA

2.31

1.82

0.33

NA

NA

7.26

6.77

000 treatment. 52235......... ........ A

Cystoscopy and

5.44

NA

NA

2.68

2.12

0.39

NA

NA

8.51

7.95

000 treatment. 52240......... ........ A

Cystoscopy and

9.71

NA

NA

4.42

3.58

0.69

NA

NA

14.82

13.98

000 treatment. 52250......... ........ A

Cystoscopy and

4.49

NA

NA

2.35

1.83

0.32

NA

NA

7.16

6.64

000 radiotracer. 52260......... ........ A

Cystoscopy and

3.91

NA

NA

1.97

1.56

0.28

NA

NA

6.16

5.75

000 treatment. 52265......... ........ A

Cystoscopy and

2.94

7.74

11.94

1.53

1.22

0.22 10.90

15.10

4.69

4.38

000 treatment. 52270......... ........ A

Cystoscopy &

3.36

7.08

10.04

1.77

1.37

0.24 10.68

13.64

5.37

4.97

000 revise urethra. 52275......... ........ A

Cystoscopy &

4.69

9.39

14.01

2.31

1.82

0.33 14.41

19.03

7.33

6.84

000 revise urethra. 52276......... ........ A

Cystoscopy and

4.99

NA

NA

2.48

1.96

0.35

NA

NA

7.82

7.30

000 treatment. 52277......... ........ A

Cystoscopy and

6.16

NA

NA

2.91

2.39

0.44

NA

NA

9.51

8.99

000 treatment. 52281......... ........ A

Cystoscopy and

2.80

5.34

6.65

1.56

1.20

0.20

8.34

9.65

4.56

4.20

000 treatment. 52282......... ........ A

Cystoscopy,

6.39

NA

NA

3.01

2.43

0.45

NA

NA

9.85

9.27

000 implant stent. 52283......... ........ A

Cystoscopy and

3.73

4.14

3.99

1.90

1.51

0.26

8.13

7.98

5.89

5.50

000 treatment. 52285......... ........ A

Cystoscopy and

3.60

4.40

4.11

1.87

1.47

0.26

8.26

7.97

5.73

5.33

000 treatment. 52290......... ........ A

Cystoscopy and

4.58

NA

NA

2.30

1.81

0.32

NA

NA

7.20

6.71

000 treatment. 52300......... ........ A

Cystoscopy and

5.30

NA

NA

2.65

2.09

0.38

NA

NA

8.33

7.77

000 treatment. 52301......... ........ A

Cystoscopy and

5.50

NA

NA

2.13

2.02

0.46

NA

NA

8.09

7.98

000 treatment.

[[Page 49154]]

52305......... ........ A

Cystoscopy and

5.30

NA

NA

2.53

2.02

0.38

NA

NA

8.21

7.70

000 treatment. 52310......... ........ A

Cystoscopy and

2.81

4.05

4.53

1.45

1.14

0.20

7.06

7.54

4.46

4.15

000 treatment. 52315......... ........ A

Cystoscopy and

5.20

6.70

8.17

2.51

2.00

0.37 12.27

13.74

8.08

7.57

000 treatment. 52317......... ........ A

Remove bladder

6.71 17.25

26.02

3.04

2.47

0.48 24.44

33.21

10.23

9.66

000 stone. 52318......... ........ A

Remove bladder

9.18

NA

NA

4.11

3.35

0.65

NA

NA

13.94

13.18

000 stone. 52320......... ........ A

Cystoscopy and

4.69

NA

NA

2.24

1.78

0.33

NA

NA

7.26

6.80

000 treatment. 52325......... ........ A

Cystoscopy,

6.15

NA

NA

2.86

2.30

0.44

NA

NA

9.45

8.89

000 stone removal. 52327......... ........ A

Cystoscopy,

5.18 17.98

28.35

2.36

1.95

0.37 23.53

33.90

7.91

7.50

000 inject material. 52330......... ........ A

Cystoscopy and

5.03 20.61

34.27

2.38

1.91

0.36 26.00

39.66

7.77

7.30

000 treatment. 52332......... ........ A

Cystoscopy and

2.83 12.54

7.44

1.58

1.18

0.21 15.58

10.48

4.62

4.22

000 treatment. 52334......... ........ A

Create passage

4.82

NA

NA

2.34

1.88

0.35

NA

NA

7.51

7.05

000 to kidney. 52341......... ........ A

Cysto w/ureter

5.99

NA

NA

3.04

2.42

0.43

NA

NA

9.46

8.84

000 stricture tx. 52342......... ........ A

Cysto w/up

6.49

NA

NA

3.26

2.57

0.46

NA

NA

10.21

9.52

000 stricture tx. 52343......... ........ A

Cysto w/renal

7.19

NA

NA

3.54

2.82

0.51

NA

NA

11.24

10.52

000 stricture tx. 52344......... ........ A

Cysto/uretero,

7.69

NA

NA

3.91

3.07

0.55

NA

NA

12.15

11.31

000 stricture tx. 52345......... ........ A

Cysto/uretero w/ 8.19

NA

NA

4.12

3.24

0.58

NA

NA

12.89

12.01

000 up stricture. 52346......... ........ A

Cystouretero w/ 9.22

NA

NA

4.52

3.59

0.65

NA

NA

14.39

13.46

000 renal strict. 52351......... ........ A

Cystouretero &

5.85

NA

NA

3.00

2.36

0.41

NA

NA

9.26

8.62

000 or pyeloscope. 52352......... ........ A

Cystouretero w/ 6.87

NA

NA

3.52

2.76

0.49

NA

NA

10.88

10.12

000 stone remove. 52353......... ........ A

Cystouretero w/ 7.96

NA

NA

3.96

3.13

0.57

NA

NA

12.49

11.66

000 lithotripsy. 52354......... ........ A

Cystouretero w/ 7.33

NA

NA

3.71

2.93

0.52

NA

NA

11.56

10.78

000 biopsy. 52355......... ........ A

Cystouretero w/ 8.81

NA

NA

4.30

3.43

0.63

NA

NA

13.74

12.87

000 excise tumor. 52400......... ........ A

Cystouretero w/ 10.04

NA

NA

5.47

4.17

0.68

NA

NA

16.19

14.89

090 congen repr. 52402......... ........ A

Cystourethro

5.27

NA

NA

2.20

1.83

0.40

NA

NA

7.87

7.50

000 cut ejacul duct. 52450......... ........ A

Incision of

7.63

NA

NA

5.56

4.14

0.54

NA

NA

13.73

12.31

090 prostate. 52500......... ........ A

Revision of

9.33

NA

NA

6.24

4.50

0.60

NA

NA

16.17

14.43

090 bladder neck. 52510......... ........ A

Dilation

7.45

NA

NA

4.95

3.57

0.48

NA

NA

12.88

11.50

090 prostatic urethra. 52601......... ........ A

Prostatectomy

15.07

NA

NA

8.54

5.96

0.87

NA

NA

24.48

21.90

090 (TURP). 52606......... ........ A

Control postop

8.80

NA

NA

5.57

4.06

0.57

NA

NA

14.94

13.43

090 bleeding. 52612......... ........ A

Prostatectomy,

9.02

NA

NA

5.94

4.28

0.56

NA

NA

15.52

13.86

090 first stage. 52614......... ........ A

Prostatectomy,

7.76

NA

NA

5.44

3.87

0.48

NA

NA

13.68

12.11

090 second stage. 52620......... ........ A

Remove residual 7.16

NA

NA

4.64

3.40

0.47

NA

NA

12.27

11.03

090 prostate. 52630......... ........ A

Remove prostate 7.61

NA

NA

4.85

3.61

0.51

NA

NA

12.97

11.73

090 regrowth. 52640......... ........ A

Relieve bladder 6.85

NA

NA

4.45

3.33

0.47

NA

NA

11.77

10.65

090 contracture. 52647......... ........ A

Laser surgery

11.09 42.33

66.04

6.97

5.14

0.73 54.15

77.86

18.79

16.96

090 of prostate. 52648......... ........ A

Laser surgery

11.94 42.86

66.17

7.30

5.42

0.79 55.59

78.90

20.03

18.15

090 of prostate. 52700......... ........ A

Drainage of

7.35

NA

NA

5.00

3.64

0.48

NA

NA

12.83

11.47

090 prostate abscess. 53000......... ........ A

Incision of

2.28

NA

NA

1.81

1.61

0.16

NA

NA

4.25

4.05

010 urethra. 53010......... ........ A

Incision of

4.31

NA

NA

3.83

3.14

0.24

NA

NA

8.38

7.69

090 urethra. 53020......... ........ A

Incision of

1.77

NA

NA

0.96

0.74

0.13

NA

NA

2.86

2.64

000 urethra. 53025......... ........ A

Incision of

1.13

NA

NA

0.68

0.55

0.08

NA

NA

1.89

1.76

000 urethra. 53040......... ........ A

Drainage of

6.45

NA

NA

4.45

3.69

0.45

NA

NA

11.35

10.59

090 urethra abscess. 53060......... ........ A

Drainage of

2.63

2.01

2.06

1.47

1.40

0.28

4.92

4.97

4.38

4.31

010 urethra abscess. 53080......... ........ A

Drainage of

6.78

NA

NA

4.94

5.70

0.52

NA

NA

12.24

13.00

090 urinary leakage. 53085......... ........ A

Drainage of

11.00

NA

NA

4.54

6.69

0.92

NA

NA

16.46

18.60

090 urinary leakage. 53200......... ........ A

Biopsy of

2.59

1.71

1.42

1.30

1.06

0.20

4.50

4.21

4.09

3.85

000 urethra. 53210......... ........ A

Removal of

13.54

NA

NA

7.80

6.32

0.89

NA

NA

22.23

20.75

090 urethra. 53215......... ........ A

Removal of

16.67

NA

NA

9.22

7.27

1.10

NA

NA

26.99

25.04

090 urethra. 53220......... ........ A

Treatment of

7.49

NA

NA

5.04

4.04

0.49

NA

NA

13.02

12.02

090 urethra lesion. 53230......... ........ A

Removal of

10.26

NA

NA

6.49

5.16

0.73

NA

NA

17.48

16.15

090 urethra lesion. 53235......... ........ A

Removal of

10.81

NA

NA

6.96

5.42

0.72

NA

NA

18.49

16.95

090 urethra lesion. 53240......... ........ A

Surgery for

6.94

NA

NA

4.80

3.84

0.52

NA

NA

12.26

11.30

090 urethra pouch. 53250......... ........ A

Removal of

6.38

NA

NA

4.72

3.65

0.49

NA

NA

11.59

10.52

090 urethra gland. 53260......... ........ A

Treatment of

2.98

2.48

2.30

1.86

1.53

0.25

5.71

5.53

5.09

4.76

010 urethra lesion. 53265......... ........ A

Treatment of

3.12

2.98

2.78

2.02

1.57

0.24

6.34

6.14

5.38

4.93

010 urethra lesion. 53270......... ........ A

Removal of

3.09

2.31

2.23

1.72

1.59

0.30

5.70

5.62

5.11

4.98

010 urethra gland.

[[Page 49155]]

53275......... ........ A

Repair of

4.52

NA

NA

2.79

2.39

0.32

NA

NA

7.63

7.23

010 urethra defect. 53400......... ........ A

Revise urethra, 13.92

NA

NA

8.23

6.57

0.98

NA

NA

23.13

21.47

090 stage 1. 53405......... ........ A

Revise urethra, 15.45

NA

NA

8.96

6.97

1.10

NA

NA

25.51

23.52

090 stage 2. 53410......... ........ A

Reconstruction 17.47

NA

NA

9.84

7.75

1.16

NA

NA

28.47

26.38

090 of urethra. 53415......... ........ A

Reconstruction 20.49

NA

NA

11.00

8.25

1.37

NA

NA

32.86

30.11

090 of urethra. 53420......... ........ A

Reconstruct

14.99

NA

NA

6.51

6.34

0.96

NA

NA

22.46

22.29

090 urethra, stage 1. 53425......... ........ A

Reconstruct

16.89

NA

NA

9.30

7.49

1.13

NA

NA

27.32

25.51

090 urethra, stage 2. 53430......... ........ A

Reconstruction 17.25

NA

NA

8.73

7.43

1.15

NA

NA

27.13

25.83

090 of urethra. 53431......... ........ A

Reconstruct

20.97

NA

NA

11.08

8.81

1.41

NA

NA

33.46

31.19

090 urethra/ bladder. 53440......... ........ A

Male sling

15.33

NA

NA

9.31

6.81

0.96

NA

NA

25.60

23.10

090 procedure. 53442......... ........ A

Remove/revise

13.28

NA

NA

8.50

6.20

0.82

NA

NA

22.60

20.30

090 male sling. 53444......... ........ A

Insert tandem

14.00

NA

NA

8.09

6.43

0.94

NA

NA

23.03

21.37

090 cuff. 53445......... ........ A

Insert uro/ves 15.15

NA

NA

8.86

7.53

0.99

NA

NA

25.00

23.67

090 nck sphincter. 53446......... ........ A

Remove uro

10.83

NA

NA

7.10

5.68

0.72

NA

NA

18.65

17.23

090 sphincter. 53447......... ........ A

Remove/replace 14.09

NA

NA

8.48

6.94

0.95

NA

NA

23.52

21.98

090 ur sphincter. 53448......... ........ A

Remov/replc ur 23.20

NA

NA

12.52

9.91

1.50

NA

NA

37.22

34.61

090 sphinctr comp. 53449......... ........ A

Repair uro

10.38

NA

NA

6.70

5.22

0.68

NA

NA

17.76

16.28

090 sphincter. 53450......... ........ A

Revision of

6.63

NA

NA

4.81

3.67

0.43

NA

NA

11.87

10.73

090 urethra. 53460......... ........ A

Revision of

7.61

NA

NA

5.17

4.06

0.50

NA

NA

13.28

12.17

090 urethra. 53500......... ........ A

Urethrlys,

12.81

NA

NA

7.47

6.52

0.90

NA

NA

21.18

20.23

090 transvag w/ scope. 53502......... ........ A

Repair of

8.12

NA

NA

5.06

4.25

0.62

NA

NA

13.80

12.99

090 urethra injury. 53505......... ........ A

Repair of

8.12

NA

NA

5.45

4.26

0.54

NA

NA

14.11

12.92

090 urethra injury. 53510......... ........ A

Repair of

10.78

NA

NA

6.78

5.57

0.74

NA

NA

18.30

17.08

090 urethra injury. 53515......... ........ A

Repair of

14.04

NA

NA

7.89

6.41

1.05

NA

NA

22.98

21.50

090 urethra injury. 53520......... ........ A

Repair of

9.30

NA

NA

6.17

4.90

0.61

NA

NA

16.08

14.81

090 urethra defect. 53600......... ........ A

Dilate urethra

1.21

1.16

1.15

0.57

0.47

0.09

2.46

2.45

1.87

1.77

000 stricture. 53601......... ........ A

Dilate urethra

0.98

1.38

1.30

0.53

0.41

0.07

2.43

2.35

1.58

1.46

000 stricture. 53605......... ........ A

Dilate urethra

1.28

NA

NA

0.52

0.44

0.09

NA

NA

1.89

1.81

000 stricture. 53620......... ........ A

Dilate urethra

1.62

1.72

1.92

0.84

0.65

0.11

3.45

3.65

2.57

2.38

000 stricture. 53621......... ........ A

Dilate urethra

1.35

1.83

2.01

0.68

0.54

0.10

3.28

3.46

2.13

1.99

000 stricture. 53660......... ........ A

Dilation of

0.71

1.33

1.32

0.46

0.35

0.05

2.09

2.08

1.22

1.11

000 urethra. 53661......... ........ A

Dilation of

0.72

1.31

1.30

0.42

0.32

0.05

2.08

2.07

1.19

1.09

000 urethra. 53665......... ........ A

Dilation of

0.76

NA

NA

0.27

0.26

0.06

NA

NA

1.09

1.08

000 urethra. 53850......... ........ A

Prostatic

9.94 49.68

82.97

5.94

4.44

0.67 60.29

93.58

16.55

15.05

090 microwave thermotx. 53852......... ........ A

Prostatic rf

10.62 46.82

78.28

6.74

4.96

0.70 58.14

89.60

18.06

16.28

090 thermotx. 53853......... ........ A

Prostatic water 5.48 29.37

48.85

4.39

3.24

0.37 35.22

54.70

10.24

9.09

090 thermother. 53899......... ........ C

Urology surgery 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 54000......... ........ A

Slitting of

1.54

2.72

2.86

1.49

1.07

0.11

4.37

4.51

3.14

2.72

010 prepuce. 54001......... ........ A

Slitting of

2.19

3.07

3.15

1.67

1.25

0.15

5.41

5.49

4.01

3.59

010 prepuce. 54015......... ........ A

Drain penis

5.31

NA

NA

3.22

2.72

0.38

NA

NA

8.91

8.41

010 lesion. 54050......... ........ A

Destruction,

1.24

2.05

1.76

1.35

1.11

0.08

3.37

3.08

2.67

2.43

010 penis lesion(s). 54055......... ........ A

Destruction,

1.22

1.97

1.67

1.23

0.91

0.08

3.27

2.97

2.53

2.21

010 penis lesion(s). 54056......... ........ A

Cryosurgery,

1.24

2.29

1.84

1.48

1.22

0.06

3.59

3.14

2.78

2.52

010 penis lesion(s). 54057......... ........ A

Laser surg,

1.24

2.61

2.31

1.36

0.96

0.09

3.94

3.64

2.69

2.29

010 penis lesion(s). 54060......... ........ A

Excision of

1.93

3.11

3.10

1.64

1.21

0.13

5.17

5.16

3.70

3.27

010 penis lesion(s). 54065......... ........ A

Destruction,

2.42

3.22

2.78

1.94

1.41

0.13

5.77

5.33

4.49

3.96

010 penis lesion(s). 54100......... ........ A

Biopsy of penis 1.90

3.30

2.93

1.34

0.95

0.10

5.30

4.93

3.34

2.95

000 54105......... ........ A

Biopsy of penis 3.49

4.03

4.22

2.47

2.07

0.25

7.77

7.96

6.21

5.81

010 54110......... ........ A

Treatment of

10.74

NA

NA

6.58

5.21

0.72

NA

NA

18.03

16.67

090 penis lesion. 54111......... ........ A

Treat penis

14.24

NA

NA

8.13

6.35

0.96

NA

NA

23.33

21.55

090 lesion, graft. 54112......... ........ A

Treat penis

16.77

NA

NA

9.42

7.45

1.11

NA

NA

27.30

25.33

090 lesion, graft. 54115......... ........ A

Treatment of

6.77

5.87

4.75

5.03

3.85

0.43 13.07

11.95

12.23

11.05

090 penis lesion. 54120......... ........ A

Partial removal 10.83

NA

NA

6.81

5.21

0.68

NA

NA

18.32

16.72

090 of penis. 54125......... ........ A

Removal of

14.38

NA

NA

8.25

6.43

0.95

NA

NA

23.58

21.76

090 penis. 54130......... ........ A

Remove penis & 21.59

NA

NA

11.40

8.98

1.52

NA

NA

34.51

32.09

090 nodes. 54135......... ........ A

Remove penis & 27.92

NA

NA

14.31

11.20

1.87

NA

NA

44.10

40.99

090 nodes. 54150......... ........ A

Circumcision... 1.81

2.56

3.90

0.57

0.67

0.16

4.53

5.87

2.54

2.64

000 54152......... ........ A

Circumcision... 2.31

NA

NA

1.72

1.33

0.19

NA

NA

4.22

3.83

010 54160......... ........ A

Circumcision... 2.48

3.69

4.03

1.45

1.18

0.19

6.36

6.70

4.12

3.85

010 54161......... ........ A

Circumcision... 3.27

NA

NA

2.22

1.73

0.23

NA

NA

5.72

5.23

010 54162......... ........ A

Lysis penil

3.25

4.02

4.49

2.27

1.65

0.21

7.48

7.95

5.73

5.11

010 circumic lesion. 54163......... ........ A

Repair of

3.25

NA

NA

2.89

2.22

0.21

NA

NA

6.35

5.68

010 circumcision. 54164......... ........ A

Frenulotomy of

2.75

NA

NA

2.65

2.04

0.18

NA

NA

5.58

4.97

010 penis. 54200......... ........ A

Treatment of

1.06

2.03

1.85

1.31

1.06

0.08

3.17

2.99

2.45

2.20

010 penis lesion. 54205......... ........ A

Treatment of

8.79

NA

NA

6.12

5.04

0.56

NA

NA

15.47

14.39

090 penis lesion. 54220......... ........ A

Treatment of

2.42

3.35

3.72

1.37

1.06

0.17

5.94

6.31

3.96

3.65

000 penis lesion.

[[Page 49156]]

54230......... ........ A

Prepare penis

1.34

1.41

1.16

0.91

0.70

0.09

2.84

2.59

2.34

2.13

000 study. 54231......... ........ A

Dynamic

2.04

1.87

1.50

1.18

0.95

0.16

4.07

3.70

3.38

3.15

000 cavernosometry. 54235......... ........ A

Penile

1.19

1.40

1.07

0.90

0.66

0.08

2.67

2.34

2.17

1.93

000 injection. 54240......... ........ A

Penis study.... 1.31

1.55

1.16

1.55

1.16

0.17

3.03

2.64

3.03

2.64

000 54240......... 26...... A

Penis study.... 1.31

0.50

0.45

0.50

0.45

0.11

1.92

1.87

1.92

1.87

000 54240......... TC...... A

Penis study.... 0.00

1.05

0.71

1.05

0.71

0.06

1.11

0.77

1.11

0.77

000 54250......... ........ A

Penis study.... 2.22

1.25

1.00

1.25

1.00

0.18

3.65

3.40

3.65

3.40

000 54250......... 26...... A

Penis study.... 2.22

0.88

0.75

0.88

0.75

0.16

3.26

3.13

3.26

3.13

000 54250......... TC...... A

Penis study.... 0.00

0.37

0.24

0.37

0.24

0.02

0.39

0.26

0.39

0.26

000 54300......... ........ A

Revision of

11.02

NA

NA

6.80

5.87

0.76

NA

NA

18.58

17.65

090 penis. 54304......... ........ A

Revision of

13.10

NA

NA

7.89

6.71

0.88

NA

NA

21.87

20.69

090 penis. 54308......... ........ A

Reconstruction 12.44

NA

NA

7.58

6.36

0.84

NA

NA

20.86

19.64

090 of urethra. 54312......... ........ A

Reconstruction 14.30

NA

NA

8.58

7.38

1.24

NA

NA

24.12

22.92

090 of urethra. 54316......... ........ A

Reconstruction 17.84

NA

NA

10.07

8.47

1.21

NA

NA

29.12

27.52

090 of urethra. 54318......... ........ A

Reconstruction 12.22

NA

NA

6.25

5.90

1.39

NA

NA

19.86

19.51

090 of urethra. 54322......... ........ A

Reconstruction 13.80

NA

NA

7.94

6.82

0.92

NA

NA

22.66

21.54

090 of urethra. 54324......... ........ A

Reconstruction 17.34

NA

NA

9.83

8.42

1.14

NA

NA

28.31

26.90

090 of urethra. 54326......... ........ A

Reconstruction 16.81

NA

NA

9.65

8.24

1.11

NA

NA

27.57

26.16

090 of urethra. 54328......... ........ A

Revise penis/

16.68

NA

NA

9.73

7.86

0.98

NA

NA

27.39

25.52

090 urethra. 54332......... ........ A

Revise penis/

18.16

NA

NA

10.20

8.34

1.21

NA

NA

29.57

27.71

090 urethra. 54336......... ........ A

Revise penis/

21.37

NA

NA

11.88

10.68

2.20

NA

NA

35.45

34.25

090 urethra. 54340......... ........ A

Secondary

9.53

NA

NA

6.43

5.38

0.63

NA

NA

16.58

15.54

090 urethral surgery. 54344......... ........ A

Secondary

16.85

NA

NA

9.79

8.25

1.54

NA

NA

28.18

26.64

090 urethral surgery. 54348......... ........ A

Secondary

18.11

NA

NA

6.40

7.86

1.23

NA

NA

25.74

27.20

090 urethral surgery. 54352......... ........ A

Reconstruct

25.88

NA

NA

13.72

11.81

2.24

NA

NA

41.84

39.93

090 urethra/penis. 54360......... ........ A

Penis plastic

12.60

NA

NA

7.54

6.40

0.84

NA

NA

20.98

19.84

090 surgery. 54380......... ........ A

Repair penis... 13.97

NA

NA

5.59

6.35

0.93

NA

NA

20.49

21.25

090 54385......... ........ A

Repair penis... 16.31

NA

NA

8.37

8.28

0.86

NA

NA

25.54

25.45

090 54390......... ........ A

Repair penis

22.52

NA

NA

7.49

8.92

1.54

NA

NA

31.55

32.98

090 and bladder. 54400......... ........ A

Insert semi-

9.04

NA

NA

5.80

4.71

0.64

NA

NA

15.48

14.39

090 rigid prosthesis. 54401......... ........ A

Insert self-

10.26

NA

NA

8.26

6.36

0.73

NA

NA

19.25

17.35

090 contd prosthesis. 54405......... ........ A

Insert multi-

14.34

NA

NA

8.22

6.49

0.95

NA

NA

23.51

21.78

090 comp penis pros. 54406......... ........ A

Remove muti-

12.70

NA

NA

7.70

5.98

0.86

NA

NA

21.26

19.54

090 comp penis pros. 54408......... ........ A

Repair multi-

13.67

NA

NA

8.31

6.37

0.90

NA

NA

22.88

20.94

090 comp penis pros. 54410......... ........ A

Remove/replace 16.42

NA

NA

9.45

7.32

1.10

NA

NA

26.97

24.84

090 penis prosth. 54411......... ........ A

Remov/replc

18.06

NA

NA

10.50

7.90

1.13

NA

NA

29.69

27.09

090 penis pros, comp. 54415......... ........ A

Remove self-

8.69

NA

NA

6.06

4.66

0.58

NA

NA

15.33

13.93

090 contd penis pros. 54416......... ........ A

Remv/repl penis 11.79

NA

NA

7.96

6.01

0.77

NA

NA

20.52

18.57

090 contain pros. 54417......... ........ A

Remv/replc

15.88

NA

NA

9.22

6.93

1.00

NA

NA

26.10

23.81

090 penis pros, compl. 54420......... ........ A

Revision of

12.21

NA

NA

7.61

6.07

0.81

NA

NA

20.63

19.08

090 penis. 54430......... ........ A

Revision of

10.88

NA

NA

6.99

5.57

0.72

NA

NA

18.58

17.17

090 penis. 54435......... ........ A

Revision of

6.67

NA

NA

4.98

3.95

0.43

NA

NA

12.08

11.05

090 penis. 54440......... ........ C

Repair of penis 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 54450......... ........ A

Preputial

1.12

0.86

0.93

0.49

0.45

0.08

2.06

2.13

1.69

1.65

000 stretching. 54500......... ........ A

Biopsy of

1.31

NA

NA

0.80

0.62

0.10

NA

NA

2.21

2.03

000 testis. 54505......... ........ A

Biopsy of

3.45

NA

NA

2.41

2.04

0.27

NA

NA

6.13

5.76

010 testis. 54512......... ........ A

Excise lesion

9.19

NA

NA

5.72

4.52

0.67

NA

NA

15.58

14.38

090 testis. 54520......... ........ A

Removal of

5.22

NA

NA

3.76

3.03

0.50

NA

NA

9.48

8.75

090 testis. 54522......... ........ A

Orchiectomy,

10.11

NA

NA

5.80

5.10

0.89

NA

NA

16.80

16.10

090 partial. 54530......... ........ A

Removal of

9.26

NA

NA

6.13

4.71

0.66

NA

NA

16.05

14.63

090 testis. 54535......... ........ A

Extensive

13.01

NA

NA

7.59

6.05

0.95

NA

NA

21.55

20.01

090 testis surgery. 54550......... ........ A

Exploration for 8.27

NA

NA

5.38

4.20

0.59

NA

NA

14.24

13.06

090 testis. 54560......... ........ A

Exploration for 11.92

NA

NA

6.32

5.44

0.90

NA

NA

19.14

18.26

090 testis. 54600......... ........ A

Reduce testis

7.50

NA

NA

5.18

3.95

0.51

NA

NA

13.19

11.96

090 torsion. 54620......... ........ A

Suspension of

5.14

NA

NA

3.28

2.64

0.37

NA

NA

8.79

8.15

010 testis. 54640......... ........ A

Suspension of

7.53

NA

NA

5.50

4.17

0.62

NA

NA

13.65

12.32

090 testis.

[[Page 49157]]

54650......... ........ A

Orchiopexy

12.18

NA

NA

7.72

5.97

1.16

NA

NA

21.06

19.31

090 (Fowler- Stephens). 54660......... ........ A

Revision of

5.60

NA

NA

4.44

3.35

0.44

NA

NA

10.48

9.39

090 testis. 54670......... ........ A

Repair testis

6.52

NA

NA

4.84

3.86

0.47

NA

NA

11.83

10.85

090 injury. 54680......... ........ A

Relocation of

13.86

NA

NA

7.78

6.55

1.16

NA

NA

22.80

21.57

090 testis(es). 54690......... ........ A

Laparoscopy,

11.56

NA

NA

6.20

5.25

1.02

NA

NA

18.78

17.83

090 orchiectomy. 54692......... ........ A

Laparoscopy,

13.60

NA

NA

7.66

5.98

1.30

NA

NA

22.56

20.88

090 orchiopexy. 54699......... ........ C

Laparoscope

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY proc, testis. 54700......... ........ A

Drainage of

3.42

NA

NA

2.40

2.05

0.28

NA

NA

6.10

5.75

010 scrotum. 54800......... ........ A

Biopsy of

2.33

NA

NA

1.00

0.93

0.23

NA

NA

3.56

3.49

000 epididymis. 54820......... ........ A

Exploration of

5.63

NA

NA

4.32

3.28

0.40

NA

NA

10.35

9.31

090 epididymis. 54830......... ........ A

Remove

5.87

NA

NA

4.48

3.38

0.41

NA

NA

10.76

9.66

090 epididymis lesion. 54840......... ........ A

Remove

5.19

NA

NA

3.84

3.04

0.37

NA

NA

9.40

8.60

090 epididymis lesion. 54860......... ........ A

Removal of

6.81

NA

NA

4.92

3.71

0.45

NA

NA

12.18

10.97

090 epididymis. 54861......... ........ A

Removal of

9.52

NA

NA

6.32

4.81

0.63

NA

NA

16.47

14.96

090 epididymis. 54900......... ........ A

Fusion of

13.99

NA

NA

5.29

5.66

0.93

NA

NA

20.21

20.58

090 spermatic ducts. 54901......... ........ A

Fusion of

18.85

NA

NA

6.64

7.29

1.82

NA

NA

27.31

27.96

090 spermatic ducts. 55000......... ........ A

Drainage of

1.43

1.86

2.01

0.92

0.72

0.11

3.40

3.55

2.46

2.26

000 hydrocele. 55040......... ........ A

Removal of

5.35

NA

NA

3.98

3.16

0.43

NA

NA

9.76

8.94

090 hydrocele. 55041......... ........ A

Removal of

8.36

NA

NA

5.74

4.41

0.60

NA

NA

14.70

13.37

090 hydroceles. 55060......... ........ A

Repair of

6.01

NA

NA

4.47

3.42

0.46

NA

NA

10.94

9.89

090 hydrocele. 55100......... ........ A

Drainage of

2.38

3.52

3.63

2.12

1.70

0.17

6.07

6.18

4.67

4.25

010 scrotum abscess. 55110......... ........ A

Explore scrotum 6.19

NA

NA

4.52

3.47

0.43

NA

NA

11.14

10.09

090 55120......... ........ A

Removal of

5.58

NA

NA

4.30

3.28

0.39

NA

NA

10.27

9.25

090 scrotum lesion. 55150......... ........ A

Removal of

7.96

NA

NA

5.49

4.25

0.56

NA

NA

14.01

12.77

090 scrotum. 55175......... ........ A

Revision of

5.73

NA

NA

4.38

3.35

0.37

NA

NA

10.48

9.45

090 scrotum. 55180......... ........ A

Revision of

11.57

NA

NA

7.32

5.84

0.90

NA

NA

19.79

18.31

090 scrotum. 55200......... ........ A

Incision of

4.48

8.27

11.30

3.38

2.62

0.33 13.08

16.11

8.19

7.43

090 sperm duct. 55250......... ........ A

Removal of

3.29

7.74

10.54

3.00

2.41

0.25 11.28

14.08

6.54

5.95

090 sperm duct(s). 55300......... ........ A

Prepare, sperm

3.50

NA

NA

1.63

1.39

0.25

NA

NA

5.38

5.14

000 duct x-ray. 55400......... ........ A

Repair of sperm 8.48

NA

NA

5.50

4.41

0.64

NA

NA

14.62

13.53

090 duct. 55450......... ........ A

Ligation of

4.36

6.00

6.74

2.86

2.11

0.29 10.65

11.39

7.51

6.76

010 sperm duct. 55500......... ........ A

Removal of

6.08

NA

NA

4.26

3.38

0.55

NA

NA

10.89

10.01

090 hydrocele. 55520......... ........ A

Removal of

6.52

NA

NA

3.86

3.40

0.75

NA

NA

11.13

10.67

090 sperm cord lesion. 55530......... ........ A

Revise

5.65

NA

NA

4.16

3.29

0.45

NA

NA

10.26

9.39

090 spermatic cord veins. 55535......... ........ A

Revise

7.05

NA

NA

4.88

3.76

0.47

NA

NA

12.40

11.28

090 spermatic cord veins. 55540......... ........ A

Revise hernia & 8.16

NA

NA

4.32

3.92

0.94

NA

NA

13.42

13.02

090 sperm veins. 55550......... ........ A

Laparo ligate

7.06

NA

NA

4.58

3.61

0.57

NA

NA

12.21

11.24

090 spermatic vein. 55559......... ........ C

Laparo proc,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY spermatic cord. 55600......... ........ A

Incise sperm

6.87

NA

NA

4.95

3.73

0.62

NA

NA

12.44

11.22

090 duct pouch. 55605......... ........ A

Incise sperm

8.58

NA

NA

4.94

4.45

0.64

NA

NA

14.16

13.67

090 duct pouch. 55650......... ........ A

Remove sperm

12.47

NA

NA

7.31

5.77

0.92

NA

NA

20.70

19.16

090 duct pouch. 55680......... ........ A

Remove sperm

5.56

NA

NA

3.90

3.20

0.47

NA

NA

9.93

9.23

090 pouch lesion. 55700......... ........ A

Biopsy of

2.58

3.75

4.08

1.34

0.82

0.11

6.44

6.77

4.03

3.51

000 prostate. 55705......... ........ A

Biopsy of

4.56

NA

NA

2.89

2.44

0.32

NA

NA

7.77

7.32

010 prostate. 55720......... ........ A

Drainage of

7.63

NA

NA

4.84

4.07

0.95

NA

NA

13.42

12.65

090 prostate abscess. 55725......... ........ A

Drainage of

9.84

NA

NA

6.41

4.96

0.70

NA

NA

16.95

15.50

090 prostate abscess. 55801......... ........ A

Removal of

19.55

NA

NA

10.68

8.37

1.34

NA

NA

31.57

29.26

090 prostate. 55810......... ........ A

Extensive

24.08

NA

NA

12.49

9.81

1.60

NA

NA

38.17

35.49

090 prostate surgery. 55812......... ........ A

Extensive

29.61

NA

NA

15.07

11.99

2.04

NA

NA

46.72

43.64

090 prostate surgery. 55815......... ........ A

Extensive

32.67

NA

NA

16.50

13.03

2.16

NA

NA

51.33

47.86

090 prostate surgery. 55821......... ........ A

Removal of

15.58

NA

NA

8.79

6.84

1.01

NA

NA

25.38

23.43

090 prostate. 55831......... ........ A

Removal of

17.01

NA

NA

9.37

7.32

1.10

NA

NA

27.48

25.43

090 prostate. 55840......... ........ A

Extensive

24.38

NA

NA

12.82

10.15

1.61

NA

NA

38.81

36.14

090 prostate surgery. 55842......... ........ A

Extensive

26.24

NA

NA

13.67

10.78

1.72

NA

NA

41.63

38.74

090 prostate surgery. 55845......... ........ A

Extensive

30.46

NA

NA

14.90

11.91

2.02

NA

NA

47.38

44.39

090 prostate surgery. 55859......... ........ A

Percut/needle

13.25

NA

NA

7.90

6.35

0.89

NA

NA

22.04

20.49

090 insert, pros. 55860......... ........ A

Surgical

15.66

NA

NA

8.73

6.98

1.02

NA

NA

25.41

23.66

090 exposure, prostate. 55862......... ........ A

Extensive

19.83

NA

NA

10.84

8.58

1.49

NA

NA

32.16

29.90

090 prostate surgery. 55865......... ........ A

Extensive

24.32

NA

NA

12.97

10.17

1.63

NA

NA

38.92

36.12

090 prostate surgery. 55866......... ........ A

Laparo radical 32.17

NA

NA

16.15

12.81

2.16

NA

NA

50.48

47.14

090 prostatectomy. 55870......... ........ A

Electroejaculat 2.58

2.47

1.77

1.44

1.17

0.16

5.21

4.51

4.18

3.91

000 ion. 55873......... ........ A

Cryoablate

20.19

NA

NA

11.44

9.56

1.38

NA

NA

33.01

31.13

090 prostate. 55899......... ........ C

Genital surgery 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 56405......... ........ A

I & D of vulva/ 1.44

1.18

1.29

1.16

1.15

0.17

2.79

2.90

2.77

2.76

010 perineum. 56420......... ........ A

Drainage of

1.39

1.52

2.08

0.78

0.98

0.16

3.07

3.63

2.33

2.53

010 gland abscess. 56440......... ........ A

Surgery for

2.84

NA

NA

1.54

1.67

0.34

NA

NA

4.72

4.85

010 vulva lesion.

[[Page 49158]]

56441......... ........ A

Lysis of labial 1.97

1.71

1.79

1.56

1.45

0.20

3.88

3.96

3.73

3.62

010 lesion(s). 56501......... ........ A

Destroy, vulva

1.53

1.64

1.75

1.22

1.24

0.18

3.35

3.46

2.93

2.95

010 lesions, sim. 56515......... ........ A

Destroy vulva

3.01

2.37

2.50

1.73

1.79

0.33

5.71

5.84

5.07

5.13

010 lesion/s compl. 56605......... ........ A

Biopsy of vulva/ 1.10

0.91

1.03

0.35

0.43

0.13

2.14

2.26

1.58

1.66

000 perineum. 56606......... ........ A

Biopsy of vulva/ 0.55

0.36

0.46

0.16

0.21

0.07

0.98

1.08

0.78

0.83

ZZZ perineum. 56620......... ........ A

Partial removal 8.39

NA

NA

4.41

4.70

0.90

NA

NA

13.70

13.99

090 of vulva. 56625......... ........ A

Complete

9.50

NA

NA

4.77

5.18

1.02

NA

NA

15.28

15.70

090 removal of vulva. 56630......... ........ A

Extensive vulva 14.62

NA

NA

6.28

6.69

1.49

NA

NA

22.39

22.80

090 surgery. 56631......... ........ A

Extensive vulva 18.75

NA

NA

7.74

8.54

1.95

NA

NA

28.44

29.24

090 surgery. 56632......... ........ A

Extensive vulva 21.51

NA

NA

9.30

9.46

2.38

NA

NA

33.19

33.35

090 surgery. 56633......... ........ A

Extensive vulva 19.41

NA

NA

7.79

8.39

1.97

NA

NA

29.17

29.77

090 surgery. 56634......... ........ A

Extensive vulva 20.42

NA

NA

8.18

9.11

2.16

NA

NA

30.76

31.69

090 surgery. 56637......... ........ A

Extensive vulva 24.51

NA

NA

9.20

10.60

2.60

NA

NA

36.31

37.71

090 surgery. 56640......... ........ A

Extensive vulva 24.60

NA

NA

9.07

10.23

2.88

NA

NA

36.55

37.71

090 surgery. 56700......... ........ A

Partial removal 2.77

NA

NA

1.77

1.82

0.30

NA

NA

4.84

4.89

010 of hymen. 56720......... ........ A

Incision of

0.68

NA

NA

0.52

0.51

0.08

NA

NA

1.28

1.27

000 hymen. 56740......... ........ A

Remove vagina

4.81

NA

NA

2.32

2.50

0.56

NA

NA

7.69

7.87

010 gland lesion. 56800......... ........ A

Repair of

3.88

NA

NA

2.00

2.14

0.44

NA

NA

6.32

6.46

010 vagina. 56805......... ........ A

Repair clitoris 19.69

NA

NA

9.28

9.38

2.14

NA

NA

31.11

31.21

090 56810......... ........ A

Repair of

4.24

NA

NA

2.06

2.23

0.49

NA

NA

6.79

6.96

010 perineum. 56820......... ........ A

Exam of vulva w/ 1.50

1.20

1.28

0.53

0.62

0.18

2.88

2.96

2.21

2.30

000 scope. 56821......... ........ A

Exam/biopsy of

2.05

1.55

1.70

0.69

0.86

0.25

3.85

4.00

2.99

3.16

000 vulva w/scope. 57000......... ........ A

Exploration of

2.97

NA

NA

1.72

1.72

0.31

NA

NA

5.00

5.00

010 vagina. 57010......... ........ A

Drainage of

6.70

NA

NA

3.85

3.81

0.71

NA

NA

11.26

11.22

090 pelvic abscess. 57020......... ........ A

Drainage of

1.50

0.76

0.90

0.45

0.56

0.18

2.44

2.58

2.13

2.24

000 pelvic fluid. 57022......... ........ A

I & d vaginal

2.68

NA

NA

1.44

1.48

0.26

NA

NA

4.38

4.42

010 hematoma, pp. 57023......... ........ A

I & d vag

5.11

NA

NA

2.40

2.53

0.58

NA

NA

8.09

8.22

010 hematoma, non- ob. 57061......... ........ A

Destroy vag

1.25

1.52

1.62

1.12

1.12

0.15

2.92

3.02

2.52

2.52

010 lesions, simple. 57065......... ........ A

Destroy vag

2.61

2.03

2.23

1.49

1.63

0.31

4.95

5.15

4.41

4.55

010 lesions, complex. 57100......... ........ A

Biopsy of

1.20

0.93

1.04

0.37

0.45

0.14

2.27

2.38

1.71

1.79

000 vagina. 57105......... ........ A

Biopsy of

1.69

1.59

1.74

1.34

1.40

0.20

3.48

3.63

3.23

3.29

010 vagina. 57106......... ........ A

Remove vagina

7.29

NA

NA

4.26

4.20

0.73

NA

NA

12.28

12.22

090 wall, partial. 57107......... ........ A

Remove vagina

24.37

NA

NA

9.11

10.12

2.71

NA

NA

36.19

37.20

090 tissue, part. 57109......... ........ A

Vaginectomy

28.19

NA

NA

10.34

11.02

3.21

NA

NA

41.74

42.42

090 partial w/ nodes. 57110......... ........ A

Remove vagina

15.34

NA

NA

6.27

7.02

1.73

NA

NA

23.34

24.09

090 wall, complete. 57111......... ........ A

Remove vagina

28.19

NA

NA

10.26

12.02

3.17

NA

NA

41.62

43.38

090 tissue, compl. 57112......... ........ A

Vaginectomy w/ 30.31

NA

NA

11.58

11.96

3.07

NA

NA

44.96

45.34

090 nodes, compl. 57120......... ........ A

Closure of

8.14

NA

NA

4.21

4.50

0.89

NA

NA

13.24

13.53

090 vagina. 57130......... ........ A

Remove vagina

2.43

1.99

2.11

1.49

1.53

0.29

4.71

4.83

4.21

4.25

010 lesion. 57135......... ........ A

Remove vagina

2.67

2.03

2.20

1.54

1.62

0.31

5.01

5.18

4.52

4.60

010 lesion. 57150......... ........ A

Treat vagina

0.55

0.58

0.97

0.16

0.20

0.07

1.20

1.59

0.78

0.82

000 infection. 57155......... ........ A

Insert uteri

6.75

NA

NA

3.11

4.20

0.43

NA

NA

10.29

11.38

090 tandems/ovoids. 57160......... ........ A

Insert pessary/ 0.89

1.05

1.02

0.26

0.32

0.10

2.04

2.01

1.25

1.31

000 other device. 57170......... ........ A

Fitting of

0.91

0.57

1.25

0.25

0.31

0.11

1.59

2.27

1.27

1.33

000 diaphragm/cap. 57180......... ........ A

Treat vaginal

1.58

1.85

2.08

0.92

1.18

0.19

3.62

3.85

2.69

2.95

010 bleeding. 57200......... ........ A

Repair of

4.31

NA

NA

2.95

2.91

0.46

NA

NA

7.72

7.68

090 vagina. 57210......... ........ A

Repair vagina/

5.60

NA

NA

3.28

3.39

0.62

NA

NA

9.50

9.61

090 perineum. 57220......... ........ A

Revision of

4.74

NA

NA

3.03

3.08

0.51

NA

NA

8.28

8.33

090 urethra. 57230......... ........ A

Repair of

6.19

NA

NA

3.78

3.50

0.54

NA

NA

10.51

10.23

090 urethral lesion. 57240......... ........ A

Repair bladder 11.38

NA

NA

5.47

4.23

0.62

NA

NA

17.47

16.23

090 & vagina. 57250......... ........ A

Repair rectum & 11.38

NA

NA

5.04

3.94

0.65

NA

NA

17.07

15.97

090 vagina. 57260......... ........ A

Repair of

14.32

NA

NA

5.86

5.09

0.97

NA

NA

21.15

20.38

090 vagina. 57265......... ........ A

Extensive

15.82

NA

NA

6.33

6.11

1.32

NA

NA

23.47

23.25

090 repair of vagina. 57267......... ........ A

Insert mesh/

4.88

NA

NA

1.52

1.86

0.64

NA

NA

7.04

7.38

ZZZ pelvic flr addon. 57268......... ........ A

Repair of bowel 7.43

NA

NA

4.31

4.22

0.79

NA

NA

12.53

12.44

090 bulge. 57270......... ........ A

Repair of bowel 13.53

NA

NA

5.71

6.11

1.42

NA

NA

20.66

21.06

090 pouch.

[[Page 49159]]

57280......... ........ A

Suspension of

16.58

NA

NA

7.02

7.28

1.67

NA

NA

25.27

25.53

090 vagina. 57282......... ........ A

Colpopexy,

7.79

NA

NA

4.43

4.48

1.02

NA

NA

13.24

13.29

090 extraperitonea l. 57283......... ........ A

Colpopexy,

11.54

NA

NA

5.24

5.74

1.02

NA

NA

17.80

18.30

090 intraperitonea l. 57284......... ........ A

Repair

13.43

NA

NA

6.77

7.05

1.41

NA

NA

21.61

21.89

090 paravaginal defect. 57287......... ........ A

Revise/remove

11.43

NA

NA

6.47

5.72

0.90

NA

NA

18.80

18.05

090 sling repair. 57288......... ........ A

Repair bladder 13.95

NA

NA

7.09

6.20

1.12

NA

NA

22.16

21.27

090 defect. 57289......... ........ A

Repair bladder 12.63

NA

NA

6.23

6.08

1.21

NA

NA

20.07

19.92

090 & vagina. 57291......... ........ A

Construction of 8.50

NA

NA

4.39

4.79

0.93

NA

NA

13.82

14.22

090 vagina. 57292......... ........ A

Construct

13.87

NA

NA

5.99

6.70

1.58

NA

NA

21.44

22.15

090 vagina with graft. 57295......... ........ A

Change vaginal

7.70

NA

NA

3.77

4.27

0.91

NA

NA

12.38

12.88

090 graft. 57300......... ........ A

Repair rectum-

8.53

NA

NA

4.48

4.33

0.87

NA

NA

13.88

13.73

090 vagina fistula. 57305......... ........ A

Repair rectum- 15.18

NA

NA

6.20

6.25

1.72

NA

NA

23.10

23.15

090 vagina fistula. 57307......... ........ A

Fistula repair 16.96

NA

NA

7.04

7.00

2.01

NA

NA

26.01

25.97

090 & colostomy. 57308......... ........ A

Fistula repair, 10.42

NA

NA

4.88

5.04

1.14

NA

NA

16.44

16.60

090 transperine. 57310......... ........ A

Repair

7.51

NA

NA

5.05

4.14

0.54

NA

NA

13.10

12.19

090 urethrovaginal lesion. 57311......... ........ A

Repair

8.77

NA

NA

5.16

4.37

0.65

NA

NA

14.58

13.79

090 urethrovaginal lesion. 57320......... ........ A

Repair bladder- 8.74

NA

NA

5.34

4.61

0.69

NA

NA

14.77

14.04

090 vagina lesion. 57330......... ........ A

Repair bladder- 13.07

NA

NA

7.18

6.07

1.06

NA

NA

21.31

20.20

090 vagina lesion. 57335......... ........ A

Repair vagina.. 19.81

NA

NA

8.80

8.97

1.91

NA

NA

30.52

30.69

090 57400......... ........ A

Dilation of

2.27

NA

NA

0.99

1.08

0.26

NA

NA

3.52

3.61

000 vagina. 57410......... ........ A

Pelvic

1.75

NA

NA

0.92

0.90

0.18

NA

NA

2.85

2.83

000 examination. 57415......... ........ A

Remove vaginal

2.42

NA

NA

1.51

1.44

0.24

NA

NA

4.17

4.10

010 foreign body. 57420......... ........ A

Exam of vagina

1.60

1.24

1.32

0.57

0.65

0.19

3.03

3.11

2.36

2.44

000 w/scope. 57421......... ........ A

Exam/biopsy of

2.20

1.60

1.78

0.73

0.90

0.27

4.07

4.25

3.20

3.37

000 vag w/scope. 57425......... ........ A

Laparoscopy,

16.89

NA

NA

7.00

6.72

1.75

NA

NA

25.64

25.36

090 surg, colpopexy. 57452......... ........ A

Exam of cervix

1.50

1.19

1.26

0.75

0.76

0.18

2.87

2.94

2.43

2.44

000 w/scope. 57454......... ........ A

Bx/curett of

2.33

1.41

1.58

0.97

1.11

0.28

4.02

4.19

3.58

3.72

000 cervix w/scope. 57455......... ........ A

Biopsy of

1.99

1.51

1.67

0.67

0.82

0.24

3.74

3.90

2.90

3.05

000 cervix w/scope. 57456......... ........ A

Endocerv

1.85

1.47

1.61

0.63

0.77

0.22

3.54

3.68

2.70

2.84

000 curettage w/ scope. 57460......... ........ A

Bx of cervix w/ 2.83

4.33

5.46

1.11

1.31

0.34

7.50

8.63

4.28

4.48

000 scope, leep. 57461......... ........ A

Conz of cervix

3.43

4.63

5.73

1.08

1.37

0.41

8.47

9.57

4.92

5.21

000 w/scope, leep. 57500......... ........ A

Biopsy of

1.20

2.03

2.41

0.65

0.64

0.12

3.35

3.73

1.97

1.96

000 cervix. 57505......... ........ A

Endocervical

1.14

1.32

1.43

1.07

1.09

0.14

2.60

2.71

2.35

2.37

010 curettage. 57510......... ........ A

Cauterization

1.90

1.32

1.50

0.91

1.01

0.23

3.45

3.63

3.04

3.14

010 of cervix. 57511......... ........ A

Cryocautery of

1.90

1.61

1.77

1.27

1.35

0.23

3.74

3.90

3.40

3.48

010 cervix. 57513......... ........ A

Laser surgery

1.90

1.57

1.68

1.28

1.37

0.23

3.70

3.81

3.41

3.50

010 of cervix. 57520......... ........ A

Conization of

4.03

3.39

3.80

2.52

2.78

0.49

7.91

8.32

7.04

7.30

090 cervix. 57522......... ........ A

Conization of

3.60

2.79

3.06

2.27

2.41

0.41

6.80

7.07

6.28

6.42

090 cervix. 57530......... ........ A

Removal of

5.16

NA

NA

3.12

3.32

0.58

NA

NA

8.86

9.06

090 cervix. 57531......... ........ A

Removal of

29.71

NA

NA

10.66

12.54

3.34

NA

NA

43.71

45.59

090 cervix, radical. 57540......... ........ A

Removal of

13.15

NA

NA

5.61

6.08

1.49

NA

NA

20.25

20.72

090 residual cervix. 57545......... ........ A

Remove cervix/ 13.96

NA

NA

6.23

6.56

1.52

NA

NA

21.71

22.04

090 repair pelvis. 57550......... ........ A

Removal of

6.20

NA

NA

3.65

3.78

0.67

NA

NA

10.52

10.65

090 residual cervix. 57555......... ........ A

Remove cervix/

9.80

NA

NA

4.80

5.01

1.09

NA

NA

15.69

15.90

090 repair vagina. 57556......... ........ A

Remove cervix,

9.22

NA

NA

4.68

4.81

0.92

NA

NA

14.82

14.95

090 repair bowel. 57700......... ........ A

Revision of

4.17

NA

NA

3.31

3.15

0.41

NA

NA

7.89

7.73

090 cervix. 57720......... ........ A

Revision of

4.50

NA

NA

2.92

3.06

0.49

NA

NA

7.91

8.05

090 cervix. 57800......... ........ A

Dilation of

0.77

0.71

0.75

0.42

0.46

0.09

1.57

1.61

1.28

1.32

000 cervical canal. 57820......... ........ A

D & c of

1.67

1.35

1.44

1.05

1.12

0.20

3.22

3.31

2.92

2.99

010 residual cervix. 58100......... ........ A

Biopsy of

1.53

1.14

1.28

0.59

0.69

0.18

2.85

2.99

2.30

2.40

000 uterus lining. 58110......... ........ A

Bx done w/

0.77

0.40

0.51

0.21

0.29

0.09

1.26

1.37

1.07

1.15

ZZZ colposcopy add- on. 58120......... ........ A

Dilation and

3.52

2.72

2.41

1.67

1.82

0.39

6.63

6.32

5.58

5.73

010 curettage. 58140......... ........ A

Myomectomy

15.65

NA

NA

6.25

6.89

1.81

NA

NA

23.71

24.35

090 abdom method. 58145......... ........ A

Myomectomy vag

8.77

NA

NA

4.28

4.66

0.97

NA

NA

14.02

14.40

090 method. 58146......... ........ A

Myomectomy

20.20

NA

NA

7.36

8.59

2.32

NA

NA

29.88

31.11

090 abdom complex. 58150......... ........ A

Total

17.17

NA

NA

6.59

7.26

1.84

NA

NA

25.60

26.27

090 hysterectomy. 58152......... ........ A

Total

21.68

NA

NA

8.18

9.43

2.47

NA

NA

32.33

33.58

090 hysterectomy. 58180......... ........ A

Partial

16.46

NA

NA

6.38

7.18

1.64

NA

NA

24.48

25.28

090 hysterectomy. 58200......... ........ A

Extensive

22.96

NA

NA

8.15

9.53

2.54

NA

NA

33.65

35.03

090 hysterectomy. 58210......... ........ A

Extensive

30.70

NA

NA

10.71

12.57

3.37

NA

NA

44.78

46.64

090 hysterectomy. 58240......... ........ A

Removal of

43.13

NA

NA

15.92

17.19

4.22

NA

NA

63.27

64.54

090 pelvis contents. 58260......... ........ A

Vaginal

13.98

NA

NA

5.83

6.48

1.57

NA

NA

21.38

22.03

090 hysterectomy. 58262......... ........ A

Vag hyst

15.77

NA

NA

6.31

7.11

1.79

NA

NA

23.87

24.67

090 including t/o. 58263......... ........ A

Vag hyst w/t/o 17.06

NA

NA

6.67

7.58

1.94

NA

NA

25.67

26.58

090 & vag repair. 58267......... ........ A

Vag hyst w/

18.18

NA

NA

7.06

8.04

2.06

NA

NA

27.30

28.28

090 urinary repair. 58270......... ........ A

Vag hyst w/

15.16

NA

NA

5.99

6.79

1.73

NA

NA

22.88

23.68

090 enterocele repair.

[[Page 49160]]

58275......... ........ A

Hysterectomy/

16.85

NA

NA

6.70

7.50

1.91

NA

NA

25.46

26.26

090 revise vagina. 58280......... ........ A

Hysterectomy/

18.15

NA

NA

7.08

7.96

2.06

NA

NA

27.28

28.17

090 revise vagina. 58285......... ........ A

Extensive

23.26

NA

NA

7.96

9.45

2.70

NA

NA

33.92

35.41

090 hysterectomy. 58290......... ........ A

Vag hyst

20.13

NA

NA

7.44

8.70

2.29

NA

NA

29.86

31.12

090 complex. 58291......... ........ A

Vag hyst incl t/ 21.92

NA

NA

7.87

9.37

2.52

NA

NA

32.31

33.81

090 o, complex. 58292......... ........ A

Vag hyst t/o & 23.21

NA

NA

8.34

9.86

2.67

NA

NA

34.22

35.74

090 repair, compl. 58293......... ........ A

Vag hyst w/uro 24.19

NA

NA

8.55

10.13

2.78

NA

NA

35.52

37.10

090 repair, compl. 58294......... ........ A

Vag hyst w/

21.41

NA

NA

7.22

8.97

2.39

NA

NA

31.02

32.77

090 enterocele, compl. 58300......... ........ N

Insert

1.01

0.63

1.22

0.24

0.35

0.12

1.76

2.35

1.37

1.48

XXX intrauterine device. 58301......... ........ A

Remove

1.27

1.06

1.26

0.35

0.45

0.15

2.48

2.68

1.77

1.87

000 intrauterine device. 58321......... ........ A

Artificial

0.92

0.98

1.11

0.25

0.34

0.10

2.00

2.13

1.27

1.36

000 insemination. 58322......... ........ A

Artificial

1.10

1.05

1.16

0.31

0.39

0.13

2.28

2.39

1.54

1.62

000 insemination. 58323......... ........ A

Sperm washing.. 0.23

0.15

0.44

0.07

0.09

0.03

0.41

0.70

0.33

0.35

000 58340......... ........ A

Catheter for

0.88

2.17

2.91

0.57

0.63

0.09

3.14

3.88

1.54

1.60

000 hysterography. 58345......... ........ A

Reopen

4.65

NA

NA

2.08

2.34

0.41

NA

NA

7.14

7.40

010 fallopian tube. 58346......... ........ A

Insert heyman

7.44

NA

NA

3.34

3.78

0.56

NA

NA

11.34

11.78

090 uteri capsule. 58350......... ........ A

Reopen

1.01

1.34

1.45

0.87

0.91

0.12

2.47

2.58

2.00

2.04

010 fallopian tube. 58353......... ........ A

Endometr

3.55 23.12

32.53

1.72

1.97

0.43 27.10

36.51

5.70

5.95

010 ablate, thermal. 58356......... ........ A

Endometrial

6.36 43.78

57.02

1.86

2.48

0.82 50.96

64.20

9.04

9.66

010 cryoablation. 58400......... ........ A

Suspension of

7.03

NA

NA

3.85

3.91

0.75

NA

NA

11.63

11.69

090 uterus. 58410......... ........ A

Suspension of

13.66

NA

NA

5.91

6.30

1.45

NA

NA

21.02

21.41

090 uterus. 58520......... ........ A

Repair of

13.34

NA

NA

5.48

5.89

1.47

NA

NA

20.29

20.70

090 ruptured uterus. 58540......... ........ A

Revision of

15.57

NA

NA

6.25

6.78

1.78

NA

NA

23.60

24.13

090 uterus. 58545......... ........ A

Laparoscopic

15.65

NA

NA

6.03

6.89

1.77

NA

NA

23.45

24.31

090 myomectomy. 58546......... ........ A

Laparo-

20.20

NA

NA

7.26

8.50

2.30

NA

NA

29.76

31.00

090 myomectomy, complex. 58550......... ........ A

Laparo-asst vag 14.91

NA

NA

6.20

7.02

1.72

NA

NA

22.83

23.65

090 hysterectomy. 58552......... ........ A

Laparo-vag hyst 16.23

NA

NA

6.49

7.63

1.72

NA

NA

24.44

25.58

090 incl t/o. 58553......... ........ A

Laparo-vag

20.13

NA

NA

7.24

8.49

2.30

NA

NA

29.67

30.92

090 hyst, complex. 58554......... ........ A

Laparo-vag hyst 23.13

NA

NA

8.41

9.90

2.27

NA

NA

33.81

35.30

090 w/t/o, compl. 58555......... ........ A

Hysteroscopy,

3.33

2.76

2.33

1.25

1.48

0.40

6.49

6.06

4.98

5.21

000 dx, sep proc. 58558......... ........ A

Hysteroscopy,

4.74

3.63

2.54

1.68

2.05

0.57

8.94

7.85

6.99

7.36

000 biopsy. 58559......... ........ A

Hysteroscopy,

6.16

NA

NA

2.07

2.57

0.74

NA

NA

8.97

9.47

000 lysis. 58560......... ........ A

Hysteroscopy,

6.99

NA

NA

2.31

2.89

0.84

NA

NA

10.14

10.72

000 resect septum. 58561......... ........ A

Hysteroscopy,

9.99

NA

NA

3.16

4.00

1.21

NA

NA

14.36

15.20

000 remove myoma. 58562......... ........ A

Hysteroscopy,

5.20

3.53

2.65

1.78

2.21

0.63

9.36

8.48

7.61

8.04

000 remove fb. 58563......... ........ A

Hysteroscopy,

6.16 37.70

51.57

2.08

2.58

0.74 44.60

58.47

8.98

9.48

000 ablation. 58565......... ........ A

Hysteroscopy,

7.02 34.73

45.85

3.39

3.77

1.19 42.94

54.06

11.60

11.98

090 sterilization. 58578......... ........ C

Laparo proc,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY uterus. 58579......... ........ C

Hysteroscope

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 58600......... ........ A

Division of

5.84

NA

NA

2.94

3.23

0.66

NA

NA

9.44

9.73

090 fallopian tube. 58605......... ........ A

Division of

5.23

NA

NA

2.69

3.01

0.59

NA

NA

8.51

8.83

090 fallopian tube. 58611......... ........ A

Ligate

1.45

NA

NA

0.40

0.53

0.18

NA

NA

2.03

2.16

ZZZ oviduct(s) add- on. 58615......... ........ A

Occlude

3.89

NA

NA

2.00

2.53

0.47

NA

NA

6.36

6.89

010 fallopian tube(s). 58660......... ........ A

Laparoscopy,

11.52

NA

NA

4.56

5.08

1.40

NA

NA

17.48

18.00

090 lysis. 58661......... ........ A

Laparoscopy,

11.28

NA

NA

4.04

4.85

1.34

NA

NA

16.66

17.47

010 remove adnexa. 58662......... ........ A

Laparoscopy,

12.06

NA

NA

4.83

5.54

1.43

NA

NA

18.32

19.03

090 excise lesions. 58670......... ........ A

Laparoscopy,

5.84

NA

NA

2.98

3.20

0.67

NA

NA

9.49

9.71

090 tubal cautery. 58671......... ........ A

Laparoscopy,

5.84

NA

NA

2.97

3.20

0.68

NA

NA

9.49

9.72

090 tubal block. 58672......... ........ A

Laparoscopy,

12.86

NA

NA

4.79

5.83

1.60

NA

NA

19.25

20.29

090 fimbrioplasty. 58673......... ........ A

Laparoscopy,

13.97

NA

NA

5.23

6.24

1.69

NA

NA

20.89

21.90

090 salpingostomy. 58679......... ........ C

Laparo proc,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY oviduct-ovary. 58700......... ........ A

Removal of

12.80

NA

NA

5.56

5.88

1.51

NA

NA

19.87

20.19

090 fallopian tube. 58720......... ........ A

Removal of

12.04

NA

NA

5.13

5.61

1.39

NA

NA

18.56

19.04

090 ovary/tube(s). 58740......... ........ A

Revise

14.75

NA

NA

6.11

6.88

1.71

NA

NA

22.57

23.34

090 fallopian tube(s). 58750......... ........ A

Repair oviduct. 15.52

NA

NA

6.14

7.06

1.84

NA

NA

23.50

24.42

090 58752......... ........ A

Revise ovarian 15.52

NA

NA

6.04

6.72

1.80

NA

NA

23.36

24.04

090 tube(s).

[[Page 49161]]

58760......... ........ A

Remove tubal

13.81

NA

NA

5.66

6.45

1.79

NA

NA

21.26

22.05

090 obstruction. 58770......... ........ A

Create new

14.65

NA

NA

5.81

6.63

1.73

NA

NA

22.19

23.01

090 tubal opening. 58800......... ........ A

Drainage of

4.51

3.20

3.53

2.68

2.85

0.43

8.14

8.47

7.62

7.79

090 ovarian cyst(s). 58805......... ........ A

Drainage of

6.31

NA

NA

3.49

3.50

0.69

NA

NA

10.49

10.50

090 ovarian cyst(s). 58820......... ........ A

Drain ovary

4.59

NA

NA

2.89

3.19

0.52

NA

NA

8.00

8.30

090 abscess, open. 58822......... ........ A

Drain ovary

11.67

NA

NA

5.18

5.20

1.16

NA

NA

18.01

18.03

090 abscess, percut. 58823......... ........ A

Drain pelvic

3.37 20.10

21.02

1.04

1.10

0.24 23.71

24.63

4.65

4.71

000 abscess, percut. 58825......... ........ A

Transposition, 11.66

NA

NA

4.98

5.59

1.32

NA

NA

17.96

18.57

090 ovary(s). 58900......... ........ A

Biopsy of

6.48

NA

NA

3.49

3.55

0.69

NA

NA

10.66

10.72

090 ovary(s). 58920......... ........ A

Partial removal 11.84

NA

NA

5.24

5.49

1.43

NA

NA

18.51

18.76

090 of ovary(s). 58925......... ........ A

Removal of

12.29

NA

NA

5.31

5.59

1.41

NA

NA

19.01

19.29

090 ovarian cyst(s). 58940......... ........ A

Removal of

8.08

NA

NA

4.07

4.09

0.91

NA

NA

13.06

13.08

090 ovary(s). 58943......... ........ A

Removal of

19.38

NA

NA

7.25

8.29

2.22

NA

NA

28.85

29.89

090 ovary(s). 58950......... ........ A

Resect ovarian 18.18

NA

NA

7.29

8.12

2.04

NA

NA

27.51

28.34

090 malignancy. 58951......... ........ A

Resect ovarian 24.11

NA

NA

8.61

9.98

2.63

NA

NA

35.35

36.72

090 malignancy. 58952......... ........ A

Resect ovarian 27.09

NA

NA

9.81

11.27

3.02

NA

NA

39.92

41.38

090 malignancy. 58953......... ........ A

Tah, rad

33.91

NA

NA

11.63

13.81

3.83

NA

NA

49.37

51.55

090 dissect for debulk. 58954......... ........ A

Tah rad debulk/ 36.91

NA

NA

12.49

14.90

4.17

NA

NA

53.57

55.98

090 lymph remove. 58956......... ........ A

Bso,

22.59

NA

NA

8.59

9.88

4.00

NA

NA

35.18

36.47

090 omentectomy w/ tah. 58960......... ........ A

Exploration of 15.64

NA

NA

6.29

7.09

1.79

NA

NA

23.72

24.52

090 abdomen. 58970......... ........ A

Retrieval of

3.52

1.83

2.19

1.26

1.43

0.43

5.78

6.14

5.21

5.38

000 oocyte. 58974......... ........ C

Transfer of

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 embryo. 58976......... ........ A

Transfer of

3.82

1.96

2.50

1.22

1.67

0.47

6.25

6.79

5.51

5.96

000 embryo. 58999......... ........ C

Genital surgery 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 59000......... ........ A

Amniocentesis,

1.30

1.75

1.99

0.56

0.64

0.31

3.36

3.60

2.17

2.25

000 diagnostic. 59001......... ........ A

Amniocentesis,

3.00

NA

NA

1.09

1.33

0.71

NA

NA

4.80

5.04

000 therapeutic. 59012......... ........ A

Fetal cord

3.44

NA

NA

1.16

1.45

0.82

NA

NA

5.42

5.71

000 puncture,prena tal. 59015......... ........ A

Chorion biopsy. 2.20

1.43

1.52

0.81

0.98

0.52

4.15

4.24

3.53

3.70

000 59020......... ........ A

Fetal contract

0.66

1.08

0.86

1.08

0.86

0.26

2.00

1.78

2.00

1.78

000 stress test. 59020......... 26...... A

Fetal contract

0.66

0.19

0.24

0.19

0.24

0.16

1.01

1.06

1.01

1.06

000 stress test. 59020......... TC...... A

Fetal contract

0.00

0.90

0.62

0.90

0.62

0.10

1.00

0.72

1.00

0.72

000 stress test. 59025......... ........ A

Fetal non-

0.53

0.63

0.49

0.63

0.49

0.15

1.31

1.17

1.31

1.17

000 stress test. 59025......... 26...... A

Fetal non-

0.53

0.15

0.20

0.15

0.20

0.13

0.81

0.86

0.81

0.86

000 stress test. 59025......... TC...... A

Fetal non-

0.00

0.49

0.30

0.49

0.30

0.02

0.51

0.32

0.51

0.32

000 stress test. 59030......... ........ A

Fetal scalp

1.99

NA

NA

0.56

0.72

0.47

NA

NA

3.02

3.18

000 blood sample. 59050......... ........ A

Fetal monitor w/ 0.89

NA

NA

0.26

0.33

0.21

NA

NA

1.36

1.43

XXX report. 59051......... ........ A

Fetal monitor/

0.74

NA

NA

0.21

0.27

0.17

NA

NA

1.12

1.18

XXX interpret only. 59070......... ........ A

Transabdom

5.24

4.48

4.98

1.83

2.19

0.28 10.00

10.50

7.35

7.71

000 amnioinfus w/ us. 59072......... ........ A

Umbilical cord

8.99

NA

NA

2.88

3.06

0.16

NA

NA

12.03

12.21

000 occlud w/us. 59074......... ........ A

Fetal fluid

5.24

3.91

4.41

1.71

2.16

0.28

9.43

9.93

7.23

7.68

000 drainage w/us. 59076......... ........ A

Fetal shunt

8.99

NA

NA

2.42

2.95

0.16

NA

NA

11.57

12.10

000 placement, w/ us. 59100......... ........ A

Remove uterus

13.22

NA

NA

5.80

6.29

2.94

NA

NA

21.96

22.45

090 lesion. 59120......... ........ A

Treat ectopic

12.52

NA

NA

5.47

6.05

2.72

NA

NA

20.71

21.29

090 pregnancy. 59121......... ........ A

Treat ectopic

12.60

NA

NA

5.42

6.10

2.78

NA

NA

20.80

21.48

090 pregnancy. 59130......... ........ A

Treat ectopic

14.94

NA

NA

6.09

5.12

3.38

NA

NA

24.41

23.44

090 pregnancy. 59135......... ........ A

Treat ectopic

14.78

NA

NA

5.12

6.70

3.30

NA

NA

23.20

24.78

090 pregnancy. 59136......... ........ A

Treat ectopic

14.11

NA

NA

5.77

6.39

3.13

NA

NA

23.01

23.63

090 pregnancy. 59140......... ........ A

Treat ectopic

5.83

NA

NA

2.91

2.39

1.29

NA

NA

10.03

9.51

090 pregnancy. 59150......... ........ A

Treat ectopic

12.15

NA

NA

5.26

5.81

2.78

NA

NA

20.19

20.74

090 pregnancy. 59151......... ........ A

Treat ectopic

11.97

NA

NA

4.93

5.77

2.73

NA

NA

19.63

20.47

090 pregnancy. 59160......... ........ A

D & c after

2.71

2.00

2.97

1.19

1.90

0.64

5.35

6.32

4.54

5.25

010 delivery. 59200......... ........ A

Insert cervical 0.79

0.95

1.13

0.22

0.28

0.19

1.93

2.11

1.20

1.26

000 dilator. 59300......... ........ A

Episiotomy or

2.41

2.21

2.18

1.03

0.98

0.57

5.19

5.16

4.01

3.96

000 vaginal repair. 59320......... ........ A

Revision of

2.48

NA

NA

1.02

1.19

0.59

NA

NA

4.09

4.26

000 cervix. 59325......... ........ A

Revision of

4.06

NA

NA

1.24

1.73

0.88

NA

NA

6.18

6.67

000 cervix. 59350......... ........ A

Repair of

4.94

NA

NA

1.41

1.76

1.17

NA

NA

7.52

7.87

000 uterus. 59400......... ........ A

Obstetrical

26.53

NA

NA

14.36

15.08

5.48

NA

NA

46.37

47.09

MMM care. 59409......... ........ A

Obstetrical

13.48

NA

NA

3.76

4.92

3.21

NA

NA

20.45

21.61

MMM care. 59410......... ........ A

Obstetrical

15.26

NA

NA

4.97

5.97

3.51

NA

NA

23.74

24.74

MMM care. 59412......... ........ A

Antepartum

1.71

NA

NA

0.65

0.77

0.40

NA

NA

2.76

2.88

MMM manipulation. 59414......... ........ A

Deliver

1.61

NA

NA

0.44

0.59

0.38

NA

NA

2.43

2.58

MMM placenta. 59425......... ........ A

Antepartum care 6.12

4.25

4.21

1.68

1.81

1.14 11.51

11.47

8.94

9.07

MMM only. 59426......... ........ A

Antepartum care 10.84

7.82

7.61

2.97

3.16

1.97 20.63

20.42

15.78

15.97

MMM only. 59430......... ........ A

Care after

2.13

1.04

1.18

0.66

0.87

0.50

3.67

3.81

3.29

3.50

MMM delivery. 59510......... ........ A

Cesarean

30.05

NA

NA

16.03

16.95

6.23

NA

NA

52.31

53.23

MMM delivery. 59514......... ........ A

Cesarean

15.95

NA

NA

4.51

5.79

3.79

NA

NA

24.25

25.53

MMM delivery only.

[[Page 49162]]

59515......... ........ A

Cesarean

18.21

NA

NA

6.25

7.44

4.12

NA

NA

28.58

29.77

MMM delivery. 59525......... ........ A

Remove uterus

8.53

NA

NA

2.40

3.08

1.94

NA

NA

12.87

13.55

ZZZ after cesarean. 59610......... ........ A

Vbac delivery.. 27.95

NA

NA

14.66

15.56

5.85

NA

NA

48.46

49.36

MMM 59612......... ........ A

Vbac delivery

15.04

NA

NA

4.28

5.61

3.58

NA

NA

22.90

24.23

MMM only. 59614......... ........ A

Vbac care after 16.57

NA

NA

5.19

6.50

3.88

NA

NA

25.64

26.95

MMM delivery. 59618......... ........ A

Attempted vbac 31.48

NA

NA

16.38

17.77

6.59

NA

NA

54.45

55.84

MMM delivery. 59620......... ........ A

Attempted vbac 17.50

NA

NA

4.80

6.27

4.16

NA

NA

26.46

27.93

MMM delivery only. 59622......... ........ A

Attempted vbac 19.64

NA

NA

6.69

8.15

4.49

NA

NA

30.82

32.28

MMM after care. 59812......... ........ A

Treatment of

4.37

3.12

2.69

2.38

2.50

0.95

8.44

8.01

7.70

7.82

090 miscarriage. 59820......... ........ A

Care of

4.64

4.10

4.34

3.49

3.54

0.95

9.69

9.93

9.08

9.13

090 miscarriage. 59821......... ........ A

Treatment of

4.94

3.85

4.17

3.19

3.35

1.06

9.85

10.17

9.19

9.35

090 miscarriage. 59830......... ........ A

Treat uterus

6.48

NA

NA

3.47

3.85

1.44

NA

NA

11.39

11.77

090 infection. 59840......... ........ R

Abortion....... 3.01

2.04

2.10

1.81

2.04

0.71

5.76

5.82

5.53

5.76

010 59841......... ........ R

Abortion....... 5.55

3.19

3.42

2.61

2.88

1.24

9.98

10.21

9.40

9.67

010 59850......... ........ R

Abortion....... 5.90

NA

NA

2.66

3.10

1.28

NA

NA

9.84

10.28

090 59851......... ........ R

Abortion....... 5.92

NA

NA

3.33

3.64

1.28

NA

NA

10.53

10.84

090 59852......... ........ R

Abortion....... 8.23

NA

NA

3.84

4.74

1.80

NA

NA

13.87

14.77

090 59855......... ........ R

Abortion....... 6.36

NA

NA

3.00

3.41

1.45

NA

NA

10.81

11.22

090 59856......... ........ R

Abortion....... 7.72

NA

NA

3.85

4.01

1.78

NA

NA

13.35

13.51

090 59857......... ........ R

Abortion....... 9.28

NA

NA

3.17

4.33

2.01

NA

NA

14.46

15.62

090 59866......... ........ R

Abortion (mpr). 3.99

NA

NA

1.26

1.73

0.87

NA

NA

6.12

6.59

000 59870......... ........ A

Evacuate mole

6.32

NA

NA

4.31

4.44

1.42

NA

NA

12.05

12.18

090 of uterus. 59871......... ........ A

Remove cerclage 2.13

NA

NA

0.94

1.08

0.50

NA

NA

3.57

3.71

000 suture. 59897......... ........ C

Fetal invas px

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY w/us. 59898......... ........ C

Laparo proc, ob 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY care/deliver. 59899......... ........ C

Maternity care

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 60000......... ........ A

Drain thyroid/

1.76

2.06

1.96

1.67

1.70

0.15

3.97

3.87

3.58

3.61

010 tongue cyst. 60001......... ........ A

Aspirate/inject 0.97

1.93

1.54

0.28

0.32

0.07

2.97

2.58

1.32

1.36

000 thyriod cyst. 60100......... ........ A

Biopsy of

1.56

1.27

1.37

0.47

0.52

0.10

2.93

3.03

2.13

2.18

000 thyroid. 60200......... ........ A

Remove thyroid

9.84

NA

NA

5.20

5.79

1.01

NA

NA

16.05

16.64

090 lesion. 60210......... ........ A

Partial thyroid 11.11

NA

NA

5.04

5.48

1.23

NA

NA

17.38

17.82

090 excision. 60212......... ........ A

Partial thyroid 16.26

NA

NA

6.55

7.39

1.94

NA

NA

24.75

25.59

090 excision. 60220......... ........ A

Partial removal 12.25

NA

NA

5.37

5.95

1.32

NA

NA

18.94

19.52

090 of thyroid. 60225......... ........ A

Partial removal 14.59

NA

NA

6.65

7.21

1.64

NA

NA

22.88

23.44

090 of thyroid. 60240......... ........ A

Removal of

16.16

NA

NA

6.14

7.22

1.85

NA

NA

24.15

25.23

090 thyroid. 60252......... ........ A

Removal of

21.82

NA

NA

8.38

9.66

2.29

NA

NA

32.49

33.77

090 thyroid. 60254......... ........ A

Extensive

28.23

NA

NA

10.28

13.18

2.60

NA

NA

41.11

44.01

090 thyroid surgery. 60260......... ........ A

Repeat thyroid 18.14

NA

NA

6.96

8.22

1.93

NA

NA

27.03

28.29

090 surgery. 60270......... ........ A

Removal of

23.01

NA

NA

8.90

10.06

2.32

NA

NA

34.23

35.39

090 thyroid. 60271......... ........ A

Removal of

17.50

NA

NA

6.77

8.13

1.74

NA

NA

26.01

27.37

090 thyroid. 60280......... ........ A

Remove thyroid

5.98

NA

NA

4.07

4.51

0.54

NA

NA

10.59

11.03

090 duct lesion. 60281......... ........ A

Remove thyroid

8.64

NA

NA

4.63

5.53

0.73

NA

NA

14.00

14.90

090 duct lesion. 60500......... ........ A

Explore

16.63

NA

NA

6.74

7.24

2.00

NA

NA

25.37

25.87

090 parathyroid glands. 60502......... ........ A

Re-explore

20.92

NA

NA

8.47

9.13

2.53

NA

NA

31.92

32.58

090 parathyroids. 60505......... ........ A

Explore

22.81

NA

NA

9.23

10.50

2.64

NA

NA

34.68

35.95

090 parathyroid glands. 60512......... ........ A

Autotransplant

4.44

NA

NA

1.18

1.51

0.53

NA

NA

6.15

6.48

ZZZ parathyroid. 60520......... ........ A

Removal of

17.03

NA

NA

6.97

7.96

2.19

NA

NA

26.19

27.18

090 thymus gland. 60521......... ........ A

Removal of

19.09

NA

NA

8.31

9.23

2.81

NA

NA

30.21

31.13

090 thymus gland. 60522......... ........ A

Removal of

23.31

NA

NA

9.80

10.90

3.26

NA

NA

36.37

37.47

090 thymus gland. 60540......... ........ A

Explore adrenal 17.84

NA

NA

8.14

7.72

1.74

NA

NA

27.72

27.30

090 gland. 60545......... ........ A

Explore adrenal 20.75

NA

NA

8.92

8.63

2.07

NA

NA

31.74

31.45

090 gland. 60600......... ........ A

Remove carotid 24.95

NA

NA

8.78

10.42

2.19

NA

NA

35.92

37.56

090 body lesion. 60605......... ........ A

Remove carotid 31.82

NA

NA

12.29

12.26

2.49

NA

NA

46.60

46.57

090 body lesion. 60650......... ........ A

Laparoscopy

20.59

NA

NA

8.20

8.04

2.28

NA

NA

31.07

30.91

090 adrenalectomy. 60659......... ........ C

Laparo proc,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY endocrine. 60699......... ........ C

Endocrine

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure.

[[Page 49163]]

61000......... ........ A

Remove cranial

1.58

NA

NA

1.23

1.02

0.13

NA

NA

2.94

2.73

000 cavity fluid. 61001......... ........ A

Remove cranial

1.49

NA

NA

1.20

1.10

0.16

NA

NA

2.85

2.75

000 cavity fluid. 61020......... ........ A

Remove brain

1.51

NA

NA

1.58

1.40

0.34

NA

NA

3.43

3.25

000 cavity fluid. 61026......... ........ A

Injection into

1.69

NA

NA

1.49

1.42

0.33

NA

NA

3.51

3.44

000 brain canal. 61050......... ........ A

Remove brain

1.51

NA

NA

1.13

1.24

0.11

NA

NA

2.75

2.86

000 canal fluid. 61055......... ........ A

Injection into

2.10

NA

NA

1.29

1.39

0.17

NA

NA

3.56

3.66

000 brain canal. 61070......... ........ A

Brain canal

0.89

NA

NA

1.17

1.05

0.17

NA

NA

2.23

2.11

000 shunt procedure. 61105......... ........ A

Twist drill

5.38

NA

NA

4.89

4.17

1.32

NA

NA

11.59

10.87

090 hole. 61107......... ........ A

Drill skull for 4.99

NA

NA

1.85

2.36

1.29

NA

NA

8.13

8.64

000 implantation. 61108......... ........ A

Drill skull for 11.46

NA

NA

8.43

7.46

2.63

NA

NA

22.52

21.55

090 drainage. 61120......... ........ A

Burr hole for

9.49

NA

NA

6.69

6.17

2.09

NA

NA

18.27

17.75

090 puncture. 61140......... ........ A

Pierce skull

17.05

NA

NA

10.39

10.01

4.11

NA

NA

31.55

31.17

090 for biopsy. 61150......... ........ A

Pierce skull

18.76

NA

NA

10.73

10.46

4.31

NA

NA

33.80

33.53

090 for drainage. 61151......... ........ A

Pierce skull

13.38

NA

NA

8.49

7.98

3.00

NA

NA

24.87

24.36

090 for drainage. 61154......... ........ A

Pierce skull & 16.86

NA

NA

10.76

9.80

4.20

NA

NA

31.82

30.86

090 remove clot. 61156......... ........ A

Pierce skull

17.34

NA

NA

9.88

9.84

4.22

NA

NA

31.44

31.40

090 for drainage. 61210......... ........ A

Pierce skull,

5.83

NA

NA

2.18

2.73

1.50

NA

NA

9.51

10.06

000 implant device. 61215......... ........ A

Insert brain-

5.74

NA

NA

5.44

4.36

1.26

NA

NA

12.44

11.36

090 fluid device. 61250......... ........ A

Pierce skull & 11.38

NA

NA

7.49

7.01

2.76

NA

NA

21.63

21.15

090 explore. 61253......... ........ A

Pierce skull & 13.38

NA

NA

7.80

7.74

2.61

NA

NA

23.79

23.73

090 explore. 61304......... ........ A

Open skull for 23.27

NA

NA

12.61

12.78

5.61

NA

NA

41.49

41.66

090 exploration. 61305......... ........ A

Open skull for 28.46

NA

NA

15.07

15.25

6.07

NA

NA

49.60

49.78

090 exploration. 61312......... ........ A

Open skull for 30.03

NA

NA

15.34

15.12

6.34

NA

NA

51.71

51.49

090 drainage. 61313......... ........ A

Open skull for 27.88

NA

NA

15.48

14.97

6.43

NA

NA

49.79

49.28

090 drainage. 61314......... ........ A

Open skull for 25.72

NA

NA

14.22

13.33

6.26

NA

NA

46.20

45.31

090 drainage. 61315......... ........ A

Open skull for 29.47

NA

NA

15.56

15.90

7.14

NA

NA

52.17

52.51

090 drainage. 61316......... ........ A

Implt cran bone 1.39

NA

NA

0.52

0.58

0.35

NA

NA

2.26

2.32

ZZZ flap to abdo. 61320......... ........ A

Open skull for 27.28

NA

NA

14.29

14.64

6.60

NA

NA

48.17

48.52

090 drainage. 61321......... ........ A

Open skull for 30.35

NA

NA

14.29

15.66

7.12

NA

NA

51.76

53.13

090 drainage. 61322......... ........ A

Decompressive

34.00

NA

NA

17.78

16.19

7.61

NA

NA

59.39

57.80

090 craniotomy. 61323......... ........ A

Decompressive

34.87

NA

NA

17.00

16.31

8.01

NA

NA

59.88

59.19

090 lobectomy. 61330......... ........ A

Decompress eye 25.12

NA

NA

11.88

13.26

2.31

NA

NA

39.31

40.69

090 socket. 61332......... ........ A

Explore/biopsy 28.46

NA

NA

13.45

15.06

4.82

NA

NA

46.73

48.34

090 eye socket. 61333......... ........ A

Explore orbit/ 29.13

NA

NA

13.31

15.01

3.91

NA

NA

46.35

48.05

090 remove lesion. 61334......... ........ A

Explore orbit/ 19.46

NA

NA

9.11

10.25

1.74

NA

NA

30.31

31.45

090 remove object. 61340......... ........ A

Subtemporal

19.97

NA

NA

11.40

11.19

4.83

NA

NA

36.20

35.99

090 decompression. 61343......... ........ A

Incise skull

31.68

NA

NA

16.14

16.64

7.62

NA

NA

55.44

55.94

090 (press relief). 61345......... ........ A

Relieve cranial 29.05

NA

NA

15.24

15.35

7.02

NA

NA

51.31

51.42

090 pressure. 61440......... ........ A

Incise skull

28.48

NA

NA

14.06

14.17

6.88

NA

NA

49.42

49.53

090 for surgery. 61450......... ........ A

Incise skull

27.55

NA

NA

12.70

13.89

5.77

NA

NA

46.02

47.21

090 for surgery. 61458......... ........ A

Incise skull

28.66

NA

NA

15.01

15.39

7.01

NA

NA

50.68

51.06

090 for brain wound. 61460......... ........ A

Incise skull

30.06

NA

NA

15.14

16.09

6.02

NA

NA

51.22

52.17

090 for surgery. 61470......... ........ A

Incise skull

27.48

NA

NA

13.11

13.67

5.88

NA

NA

46.47

47.03

090 for surgery. 61480......... ........ A

Incise skull

27.91

NA

NA

8.23

13.51

6.71

NA

NA

42.85

48.13

090 for surgery. 61490......... ........ A

Incise skull

27.08

NA

NA

14.34

14.33

6.90

NA

NA

48.32

48.31

090 for surgery. 61500......... ........ A

Removal of

19.00

NA

NA

10.64

10.76

4.10

NA

NA

33.74

33.86

090 skull lesion. 61501......... ........ A

Remove infected 16.17

NA

NA

9.52

9.28

3.21

NA

NA

28.90

28.66

090 skull bone. 61510......... ........ A

Removal of

30.55

NA

NA

17.08

16.79

7.33

NA

NA

54.96

54.67

090 brain lesion. 61512......... ........ A

Remove brain

36.93

NA

NA

18.56

19.39

9.05

NA

NA

64.54

65.37

090 lining lesion. 61514......... ........ A

Removal of

27.05

NA

NA

14.53

14.46

6.52

NA

NA

48.10

48.03

090 brain abscess. 61516......... ........ A

Removal of

26.40

NA

NA

14.28

14.27

6.33

NA

NA

47.01

47.00

090 brain lesion. 61517......... ........ A

Implt brain

1.38

NA

NA

0.51

0.61

0.35

NA

NA

2.24

2.34

ZZZ chemotx add-on. 61518......... ........ A

Removal of

39.61

NA

NA

20.45

20.93

9.62

NA

NA

69.68

70.16

090 brain lesion. 61519......... ........ A

Remove brain

43.22

NA

NA

20.82

22.19 10.60

NA

NA

74.64

76.01

090 lining lesion. 61520......... ........ A

Removal of

56.81

NA

NA

25.64

29.15 11.18

NA

NA

93.63

97.14

090 brain lesion. 61521......... ........ A

Removal of

46.78

NA

NA

22.16

23.70 11.36

NA

NA

80.30

81.84

090 brain lesion. 61522......... ........ A

Removal of

31.36

NA

NA

15.56

16.20

7.60

NA

NA

54.52

55.16

090 brain abscess. 61524......... ........ A

Removal of

29.71

NA

NA

15.78

15.69

7.14

NA

NA

52.63

52.54

090 brain lesion. 61526......... ........ A

Removal of

53.84

NA

NA

21.66

27.53

7.05

NA

NA

82.55

88.42

090 brain lesion. 61530......... ........ A

Removal of

45.38

NA

NA

18.18

23.33

6.13

NA

NA

69.69

74.84

090 brain lesion. 61531......... ........ A

Implant brain

16.24

NA

NA

10.26

9.41

3.78

NA

NA

30.28

29.43

090 electrodes. 61533......... ........ A

Implant brain

21.32

NA

NA

11.76

11.59

5.10

NA

NA

38.18

38.01

090 electrodes. 61534......... ........ A

Removal of

22.83

NA

NA

13.21

12.36

5.42

NA

NA

41.46

40.61

090 brain lesion. 61535......... ........ A

Remove brain

13.01

NA

NA

8.93

7.80

3.01

NA

NA

24.95

23.82

090 electrodes. 61536......... ........ A

Removal of

37.54

NA

NA

18.46

19.45

9.18

NA

NA

65.18

66.17

090 brain lesion. 61537......... ........ A

Removal of

36.31

NA

NA

17.52

15.44

6.92

NA

NA

60.75

58.67

090 brain tissue.

[[Page 49164]]

61538......... ........ A

Removal of

39.31

NA

NA

18.80

16.18

6.92

NA

NA

65.03

62.41

090 brain tissue. 61539......... ........ A

Removal of

34.10

NA

NA

15.51

17.20

8.30

NA

NA

57.91

59.60

090 brain tissue. 61540......... ........ A

Removal of

31.24

NA

NA

15.91

16.91

8.30

NA

NA

55.45

56.45

090 brain tissue. 61541......... ........ A

Incision of

30.76

NA

NA

16.10

16.18

6.58

NA

NA

53.44

53.52

090 brain tissue. 61542......... ........ A

Removal of

32.98

NA

NA

16.23

17.42

8.01

NA

NA

57.22

58.41

090 brain tissue. 61543......... ........ A

Removal of

31.13

NA

NA

16.35

16.37

7.54

NA

NA

55.02

55.04

090 brain tissue. 61544......... ........ A

Remove & treat 27.22

NA

NA

14.39

13.96

5.95

NA

NA

47.56

47.13

090 brain lesion. 61545......... ........ A

Excision of

46.15

NA

NA

22.36

23.75 10.60

NA

NA

79.11

80.50

090 brain tumor. 61546......... ........ A

Removal of

33.26

NA

NA

16.62

17.27

7.65

NA

NA

57.53

58.17

090 pituitary gland. 61548......... ........ A

Removal of

23.23

NA

NA

11.37

12.43

3.42

NA

NA

38.02

39.08

090 pituitary gland. 61550......... ........ A

Release of

15.38

NA

NA

5.70

6.62

0.98

NA

NA

22.06

22.98

090 skull seams. 61552......... ........ A

Release of

20.22

NA

NA

6.71

8.51

1.06

NA

NA

27.99

29.78

090 skull seams. 61556......... ........ A

Incise skull/

23.96

NA

NA

12.76

11.71

4.64

NA

NA

41.36

40.31

090 sutures. 61557......... ........ A

Incise skull/

23.10

NA

NA

13.73

13.65

5.78

NA

NA

42.61

42.53

090 sutures. 61558......... ........ A

Excision of

26.29

NA

NA

8.24

12.70

1.36

NA

NA

35.89

40.35

090 skull/sutures. 61559......... ........ A

Excision of

33.74

NA

NA

18.83

19.19

8.48

NA

NA

61.05

61.41

090 skull/sutures. 61563......... ........ A

Excision of

28.31

NA

NA

14.31

15.01

5.15

NA

NA

47.77

48.47

090 skull tumor. 61564......... ........ A

Excision of

34.53

NA

NA

16.25

17.77

8.75

NA

NA

59.53

61.05

090 skull tumor. 61566......... ........ A

Removal of

32.26

NA

NA

16.65

17.49

6.92

NA

NA

55.83

56.67

090 brain tissue. 61567......... ........ A

Incision of

36.76

NA

NA

16.84

19.71

6.52

NA

NA

60.12

62.99

090 brain tissue. 61570......... ........ A

Remove foreign 26.33

NA

NA

14.16

13.97

5.86

NA

NA

46.35

46.16

090 body, brain. 61571......... ........ A

Incise skull

28.24

NA

NA

15.21

15.16

6.77

NA

NA

50.22

50.17

090 for brain wound. 61575......... ........ A

Skull base/

36.38

NA

NA

15.53

18.61

5.32

NA

NA

57.23

60.31

090 brainstem surgery. 61576......... ........ A

Skull base/

55.03

NA

NA

25.88

32.52

5.56

NA

NA

86.47

93.11

090 brainstem surgery. 61580......... ........ A

Craniofacial

34.26

NA

NA

20.69

24.36

3.36

NA

NA

58.31

61.98

090 approach, skull. 61581......... ........ A

Craniofacial

38.78

NA

NA

24.86

23.80

3.91

NA

NA

67.55

66.49

090 approach, skull. 61582......... ........ A

Craniofacial

34.83

NA

NA

30.37

28.07

7.19

NA

NA

72.39

70.09

090 approach, skull. 61583......... ........ A

Craniofacial

38.37

NA

NA

25.79

25.28

9.18

NA

NA

73.34

72.83

090 approach, skull. 61584......... ........ A

Orbitocranial

37.57

NA

NA

25.56

24.78

8.16

NA

NA

71.29

70.51

090 approach/skull. 61585......... ........ A

Orbitocranial

42.40

NA

NA

24.83

26.08

7.01

NA

NA

74.24

75.49

090 approach/skull. 61586......... ........ A

Resect

27.20

NA

NA

23.97

22.93

4.36

NA

NA

55.53

54.49

090 nasopharynx, skull. 61590......... ........ A

Infratemporal

46.79

NA

NA

23.16

27.26

5.29

NA

NA

75.24

79.34

090 approach/skull. 61591......... ........ A

Infratemporal

46.81

NA

NA

23.73

28.07

5.64

NA

NA

76.18

80.52

090 approach/skull. 61592......... ........ A

Orbitocranial

42.94

NA

NA

27.58

26.77 10.04

NA

NA

80.56

79.75

090 approach/skull. 61595......... ........ A

Transtemporal

33.49

NA

NA

19.29

21.59

3.97

NA

NA

56.75

59.05

090 approach/skull. 61596......... ........ A

Transcochlear

39.25

NA

NA

18.52

22.96

3.39

NA

NA

61.16

65.60

090 approach/skull. 61597......... ........ A

Transcondylar

40.67

NA

NA

22.86

22.96

8.81

NA

NA

72.34

72.44

090 approach/skull. 61598......... ........ A

Transpetrosal

36.35

NA

NA

20.81

22.63

5.68

NA

NA

62.84

64.66

090 approach/skull. 61600......... ........ A

Resect/excise

29.76

NA

NA

18.31

19.41

3.78

NA

NA

51.85

52.95

090 cranial lesion. 61601......... ........ A

Resect/excise

31.00

NA

NA

22.32

20.95

6.61

NA

NA

59.93

58.56

090 cranial lesion. 61605......... ........ A

Resect/excise

32.32

NA

NA

17.57

20.86

2.85

NA

NA

52.74

56.03

090 cranial lesion. 61606......... ........ A

Resect/excise

41.88

NA

NA

24.31

24.94

8.94

NA

NA

75.13

75.76

090 cranial lesion. 61607......... ........ A

Resect/excise

40.76

NA

NA

20.51

22.96

6.88

NA

NA

68.15

70.60

090 cranial lesion. 61608......... ........ A

Resect/excise

45.39

NA

NA

26.51

26.56 10.72

NA

NA

82.62

82.67

090 cranial lesion. 61609......... ........ A

Transect

9.88

NA

NA

3.73

4.57

2.55

NA

NA

16.16

17.00

ZZZ artery, sinus. 61610......... ........ A

Transect

29.63

NA

NA

11.19

12.65

7.66

NA

NA

48.48

49.94

ZZZ artery, sinus. 61611......... ........ A

Transect

7.41

NA

NA

2.80

3.57

1.88

NA

NA

12.09

12.86

ZZZ artery, sinus. 61612......... ........ A

Transect

27.84

NA

NA

8.15

12.02

4.30

NA

NA

40.29

44.16

ZZZ artery, sinus. 61613......... ........ A

Remove

44.88

NA

NA

27.54

26.58

8.42

NA

NA

80.84

79.88

090 aneurysm, sinus. 61615......... ........ A

Resect/excise

35.57

NA

NA

19.35

21.88

4.72

NA

NA

59.64

62.17

090 lesion, skull. 61616......... ........ A

Resect/excise

46.54

NA

NA

26.45

28.10

8.24

NA

NA

81.23

82.88

090 lesion, skull. 61618......... ........ A

Repair dura.... 18.52

NA

NA

10.11

10.36

3.71

NA

NA

32.34

32.59

090 61619......... ........ A

Repair dura.... 21.95

NA

NA

10.97

11.92

3.94

NA

NA

36.86

37.81

090 61623......... ........ A

Endovasc

9.95

NA

NA

3.40

3.91

1.05

NA

NA

14.40

14.91

000 tempory vessel occl. 61624......... ........ A

Transcath

20.12

NA

NA

6.80

6.87

1.95

NA

NA

28.87

28.94

000 occlusion, cns. 61626......... ........ A

Transcath

16.60

NA

NA

5.43

5.49

1.24

NA

NA

23.27

23.33

000 occlusion, non- cns.

[[Page 49165]]

61630......... ........ N

Intracranial

22.03

NA

NA

6.50

10.99

2.01

NA

NA

30.54

35.03

090 angioplasty. 61635......... ........ N

Intracran

24.24

NA

NA

7.02

11.91

2.20

NA

NA

33.46

38.35

090 angioplsty w/ stent. 61680......... ........ A

Intracranial

32.34

NA

NA

16.85

17.29

7.93

NA

NA

57.12

57.56

090 vessel surgery. 61682......... ........ A

Intracranial

63.27

NA

NA

27.31

30.99 15.85

NA

NA 106.43

110.11

090 vessel surgery. 61684......... ........ A

Intracranial

41.43

NA

NA

20.46

21.62 10.28

NA

NA

72.17

73.33

090 vessel surgery. 61686......... ........ A

Intracranial

67.26

NA

NA

30.29

33.61 16.66

NA

NA 114.21

117.53

090 vessel surgery. 61690......... ........ A

Intracranial

31.14

NA

NA

15.88

16.51

6.92

NA

NA

53.94

54.57

090 vessel surgery. 61692......... ........ A

Intracranial

54.39

NA

NA

24.71

26.78 13.39

NA

NA

92.49

94.56

090 vessel surgery. 61697......... ........ A

Brain aneurysm 63.16

NA

NA

28.85

28.22 12.81

NA

NA 104.82

104.19

090 repr, complx. 61698......... ........ A

Brain aneurysm 69.39

NA

NA

30.92

27.75 12.50

NA

NA 112.81

109.64

090 repr, complx. 61700......... ........ A

Brain aneurysm 50.44

NA

NA

24.03

26.86 12.98

NA

NA

87.45

90.28

090 repr, simple. 61702......... ........ A

Inner skull

59.80

NA

NA

27.94

26.51 10.76

NA

NA

98.50

97.07

090 vessel surgery. 61703......... ........ A

Clamp neck

18.66

NA

NA

10.84

10.56

4.05

NA

NA

33.55

33.27

090 artery. 61705......... ........ A

Revise

37.92

NA

NA

17.61

18.84

8.84

NA

NA

64.37

65.60

090 circulation to head. 61708......... ........ A

Revise

37.02

NA

NA

13.19

14.66

2.50

NA

NA

52.71

54.18

090 circulation to head. 61710......... ........ A

Revise

31.15

NA

NA

13.35

13.57

4.51

NA

NA

49.01

49.23

090 circulation to head. 61711......... ........ A

Fusion of skull 38.05

NA

NA

18.57

19.49

9.39

NA

NA

66.01

66.93

090 arteries. 61720......... ........ A

Incise skull/

17.48

NA

NA

8.13

9.51

2.78

NA

NA

28.39

29.77

090 brain surgery. 61735......... ........ A

Incise skull/

22.17

NA

NA

11.32

11.95

2.72

NA

NA

36.21

36.84

090 brain surgery. 61750......... ........ A

Incise skull/

19.69

NA

NA

10.97

10.70

4.71

NA

NA

35.37

35.10

090 brain biopsy. 61751......... ........ A

Brain biopsy w/ 18.58

NA

NA

11.42

10.97

4.55

NA

NA

34.55

34.10

090 ct/mr guide. 61760......... ........ A

Implant brain

22.24

NA

NA

11.94

9.52

5.40

NA

NA

39.58

37.16

090 electrodes. 61770......... ........ A

Incise skull

23.05

NA

NA

9.87

11.66

3.54

NA

NA

36.46

38.25

090 for treatment. 61790......... ........ A

Treat

11.46

NA

NA

7.79

6.38

2.81

NA

NA

22.06

20.65

090 trigeminal nerve. 61791......... ........ A

Treat

15.27

NA

NA

7.61

8.59

3.39

NA

NA

26.27

27.25

090 trigeminal tract. 61793......... ........ A

Focus radiation 17.71

NA

NA

9.79

10.04

4.45

NA

NA

31.95

32.20

090 beam. 61795......... ........ A

Brain surgery

4.03

NA

NA

1.37

1.87

0.79

NA

NA

6.19

6.69

ZZZ using computer. 61850......... ........ A

Implant

13.23

NA

NA

5.56

7.14

3.21

NA

NA

22.00

23.58

090 neuroelectrode s. 61860......... ........ A

Implant

22.12

NA

NA

11.19

11.84

4.94

NA

NA

38.25

38.90

090 neuroelectrode s. 61863......... ........ A

Implant

20.50

NA

NA

12.48

11.95

5.41

NA

NA

38.39

37.86

090 neuroelectrode. 61864......... ........ A

Implant

4.49

NA

NA

1.70

2.14

5.41

NA

NA

11.60

12.04

ZZZ neuroelectrde, addl. 61867......... ........ A

Implant

32.82

NA

NA

16.69

17.69

5.41

NA

NA

54.92

55.92

090 neuroelectrode. 61868......... ........ A

Implant

7.91

NA

NA

2.96

3.75

5.41

NA

NA

16.28

17.07

ZZZ neuroelectrde, addIl. 61870......... ........ A

Implant

16.20

NA

NA

8.63

9.43

3.86

NA

NA

28.69

29.49

090 neuroelectrode s. 61875......... ........ A

Implant

16.32

NA

NA

5.38

7.77

2.94

NA

NA

24.64

27.03

090 neuroelectrode s. 61880......... ........ A

Revise/remove

6.84

NA

NA

5.47

4.80

1.66

NA

NA

13.97

13.30

090 neuroelectrode. 61885......... ........ A

Insrt/redo

7.29

NA

NA

7.42

5.83

1.59

NA

NA

16.30

14.71

090 neurostim 1 array. 61886......... ........ A

Implant

9.65

NA

NA

8.74

6.95

1.96

NA

NA

20.35

18.56

090 neurostim arrays. 61888......... ........ A

Revise/remove

5.18

NA

NA

3.59

3.65

1.33

NA

NA

10.10

10.16

010 neuroreceiver. 62000......... ........ A

Treat skull

13.79

NA

NA

7.21

5.94

1.06

NA

NA

22.06

20.79

090 fracture. 62005......... ........ A

Treat skull

17.49

NA

NA

9.47

8.96

3.86

NA

NA

30.82

30.31

090 fracture. 62010......... ........ A

Treatment of

21.25

NA

NA

11.91

11.76

5.12

NA

NA

38.28

38.13

090 head injury. 62100......... ........ A

Repair brain

23.35

NA

NA

11.84

12.55

4.83

NA

NA

40.02

40.73

090 fluid leakage. 62115......... ........ A

Reduction of

22.63

NA

NA

13.97

12.22

5.49

NA

NA

42.09

40.34

090 skull defect. 62116......... ........ A

Reduction of

24.82

NA

NA

13.12

13.30

6.09

NA

NA

44.03

44.21

090 skull defect. 62117......... ........ A

Reduction of

28.20

NA

NA

14.69

15.20

4.52

NA

NA

47.41

47.92

090 skull defect. 62120......... ........ A

Repair skull

24.31

NA

NA

15.76

17.80

2.99

NA

NA

43.06

45.10

090 cavity lesion. 62121......... ........ A

Incise skull

22.89

NA

NA

14.03

15.10

4.16

NA

NA

41.08

42.15

090 repair. 62140......... ........ A

Repair of skull 14.41

NA

NA

8.60

8.39

3.46

NA

NA

26.47

26.26

090 defect. 62141......... ........ A

Repair of skull 15.93

NA

NA

9.30

9.11

3.75

NA

NA

28.98

28.79

090 defect. 62142......... ........ A

Remove skull

11.69

NA

NA

7.72

7.17

2.72

NA

NA

22.13

21.58

090 plate/flap. 62143......... ........ A

Replace skull

14.01

NA

NA

8.79

8.23

3.36

NA

NA

26.16

25.60

090 plate/flap. 62145......... ........ A

Repair of skull 19.95

NA

NA

10.20

10.72

4.49

NA

NA

34.64

35.16

090 & brain. 62146......... ........ A

Repair of skull 17.14

NA

NA

9.04

9.48

3.61

NA

NA

29.79

30.23

090 with graft. 62147......... ........ A

Repair of skull 20.53

NA

NA

10.59

11.12

4.31

NA

NA

35.43

35.96

090 with graft. 62148......... ........ A

Retr bone flap

2.00

NA

NA

0.76

0.84

0.48

NA

NA

3.24

3.32

ZZZ to fix skull. 62160......... ........ A

Neuroendoscopy

3.00

NA

NA

1.12

1.43

0.77

NA

NA

4.89

5.20

ZZZ add-on. 62161......... ........ A

Dissect brain w/ 21.04

NA

NA

12.12

12.10

5.17

NA

NA

38.33

38.31

090 scope. 62162......... ........ A

Remove colloid 26.61

NA

NA

13.85

14.60

5.89

NA

NA

46.35

47.10

090 cyst w/scope. 62163......... ........ A

Neuroendoscopy 16.34

NA

NA

10.53

10.07

4.00

NA

NA

30.87

30.41

090 w/fb removal. 62164......... ........ A

Remove brain

29.19

NA

NA

14.93

14.95

5.36

NA

NA

49.48

49.50

090 tumor w/scope. 62165......... ........ A

Remove pituit

23.04

NA

NA

11.46

12.90

3.00

NA

NA

37.50

38.94

090 tumor w/scope. 62180......... ........ A

Establish brain 22.41

NA

NA

12.00

12.21

4.97

NA

NA

39.38

39.59

090 cavity shunt. 62190......... ........ A

Establish brain 12.03

NA

NA

7.67

7.23

2.79

NA

NA

22.49

22.05

090 cavity shunt. 62192......... ........ A

Establish brain 13.21

NA

NA

8.40

7.82

3.01

NA

NA

24.62

24.04

090 cavity shunt. 62194......... ........ A

Replace/

5.64

NA

NA

3.81

2.78

0.92

NA

NA

10.37

9.34

010 irrigate catheter.

[[Page 49166]]

62200......... ........ A

Establish brain 19.15

NA

NA

10.69

10.80

4.64

NA

NA

34.48

34.59

090 cavity shunt. 62201......... ........ A

Brain cavity

15.83

NA

NA

10.52

9.71

3.67

NA

NA

30.02

29.21

090 shunt w/scope. 62220......... ........ A

Establish brain 13.96

NA

NA

8.39

8.08

3.34

NA

NA

25.69

25.38

090 cavity shunt. 62223......... ........ A

Establish brain 13.84

NA

NA

9.42

8.54

3.13

NA

NA

26.39

25.51

090 cavity shunt. 62225......... ........ A

Replace/

6.08

NA

NA

5.49

4.44

1.39

NA

NA

12.96

11.91

090 irrigate catheter. 62230......... ........ A

Replace/revise 11.32

NA

NA

7.28

6.68

2.70

NA

NA

21.30

20.70

090 brain shunt. 62252......... ........ A

Csf shunt

0.74

1.78

1.55

NA

NA

0.21

2.73

2.50

NA

NA

XXX reprogram. 62252......... 26...... A

Csf shunt

0.74

0.27

0.35

0.27

0.35

0.19

1.20

1.28

1.20

1.28

XXX reprogram. 62252......... TC...... A

Csf shunt

0.00

1.51

1.20

NA

NA

0.02

1.53

1.22

NA

NA

XXX reprogram. 62256......... ........ A

Remove brain

7.27

NA

NA

5.88

4.99

1.71

NA

NA

14.86

13.97

090 cavity shunt. 62258......... ........ A

Replace brain

15.50

NA

NA

9.25

8.85

3.73

NA

NA

28.48

28.08

090 cavity shunt. 62263......... ........ A

Epidural lysis

6.37

9.18

11.81

2.88

3.11

0.41 15.96

18.59

9.66

9.89

010 mult sessions. 62264......... ........ A

Epidural lysis

4.42

5.78

7.24

1.31

1.39

0.27 10.47

11.93

6.00

6.08

010 on single day. 62268......... ........ A

Drain spinal

4.73

6.76

10.34

1.74

2.04

0.43 11.92

15.50

6.90

7.20

000 cord cyst. 62269......... ........ A

Needle biopsy,

5.01

6.84

12.72

1.67

1.90

0.37 12.22

18.10

7.05

7.28

000 spinal cord. 62270......... ........ A

Spinal fluid

1.37

2.38

2.84

0.55

0.56

0.08

3.83

4.29

2.00

2.01

000 tap, diagnostic. 62272......... ........ A

Drain cerebro

1.35

3.14

3.49

0.61

0.69

0.18

4.67

5.02

2.14

2.22

000 spinal fluid. 62273......... ........ A

Inject epidural 2.15

1.70

2.46

0.58

0.68

0.13

3.98

4.74

2.86

2.96

000 patch. 62280......... ........ A

Treat spinal

2.63

4.30

6.27

1.07

1.03

0.30

7.23

9.20

4.00

3.96

010 cord lesion. 62281......... ........ A

Treat spinal

2.66

3.79

5.19

0.91

0.90

0.19

6.64

8.04

3.76

3.75

010 cord lesion. 62282......... ........ A

Treat spinal

2.33

3.97

7.26

1.07

0.96

0.17

6.47

9.76

3.57

3.46

010 canal lesion. 62284......... ........ A

Injection for

1.54

3.79

4.67

0.67

0.68

0.13

5.46

6.34

2.34

2.35

000 myelogram. 62287......... ........ A

Percutaneous

8.82

NA

NA

4.24

5.22

0.58

NA

NA

13.64

14.62

090 diskectomy. 62290......... ........ A

Inject for

3.00

4.46

6.46

1.13

1.32

0.23

7.69

9.69

4.36

4.55

000 spine disk x- ray. 62291......... ........ A

Inject for

2.91

4.25

5.51

1.07

1.19

0.26

7.42

8.68

4.24

4.36

000 spine disk x- ray. 62292......... ........ A

Injection into

9.10

NA

NA

3.19

4.15

0.82

NA

NA

13.11

14.07

090 disk lesion. 62294......... ........ A

Injection into 12.73

NA

NA

5.63

5.59

1.24

NA

NA

19.60

19.56

090 spinal artery. 62310......... ........ A

Inject spine c/ 1.91

3.06

4.37

0.58

0.63

0.12

5.09

6.40

2.61

2.66

000 t. 62311......... ........ A

Inject spine l/ 1.54

2.70

4.37

0.54

0.58

0.09

4.33

6.00

2.17

2.21

000 s (cd). 62318......... ........ A

Inject spine w/ 2.04

3.24

5.10

0.48

0.61

0.12

5.40

7.26

2.64

2.77

000 cath, c/t. 62319......... ........ A

Inject spine w/ 1.87

2.90

4.46

0.47

0.58

0.11

4.88

6.44

2.45

2.56

000 cath l/s (cd). 62350......... ........ A

Implant spinal

7.96

NA

NA

4.19

4.00

1.02

NA

NA

13.17

12.98

090 canal cath. 62351......... ........ A

Implant spinal 11.46

NA

NA

7.73

7.27

2.24

NA

NA

21.43

20.97

090 canal cath. 62355......... ........ A

Remove spinal

6.54

NA

NA

3.61

3.27

0.71

NA

NA

10.86

10.52

090 canal catheter. 62360......... ........ A

Insert spine

3.60

NA

NA

3.46

2.88

0.34

NA

NA

7.40

6.82

090 infusion device. 62361......... ........ A

Implant spine

6.51

NA

NA

4.00

3.94

0.80

NA

NA

11.31

11.25

090 infusion pump. 62362......... ........ A

Implant spine

8.50

NA

NA

4.78

4.47

1.18

NA

NA

14.46

14.15

090 infusion pump. 62365......... ........ A

Remove spine

6.51

NA

NA

3.85

3.65

0.86

NA

NA

11.22

11.02

090 infusion device. 62367......... ........ A

Analyze spine

0.48

0.41

0.56

0.11

0.10

0.03

0.92

1.07

0.62

0.61

XXX infusion pump. 62368......... ........ A

Analyze spine

0.75

0.60

0.67

0.19

0.18

0.06

1.41

1.48

1.00

0.99

XXX infusion pump. 63001......... ........ A

Removal of

17.47

NA

NA

9.89

9.61

3.76

NA

NA

31.12

30.84

090 spinal lamina. 63003......... ........ A

Removal of

17.60

NA

NA

9.80

9.85

3.72

NA

NA

31.12

31.17

090 spinal lamina. 63005......... ........ A

Removal of

16.22

NA

NA

9.78

9.92

3.34

NA

NA

29.34

29.48

090 spinal lamina. 63011......... ........ A

Removal of

15.73

NA

NA

9.22

8.51

3.37

NA

NA

28.32

27.61

090 spinal lamina. 63012......... ........ A

Removal of

16.67

NA

NA

9.84

10.05

3.48

NA

NA

29.99

30.20

090 spinal lamina. 63015......... ........ A

Removal of

20.64

NA

NA

12.01

11.91

4.75

NA

NA

37.40

37.30

090 spinal lamina. 63016......... ........ A

Removal of

21.85

NA

NA

11.95

11.82

4.58

NA

NA

38.38

38.25

090 spinal lamina. 63017......... ........ A

Removal of

17.12

NA

NA

10.43

10.40

3.63

NA

NA

31.18

31.15

090 spinal lamina. 63020......... ........ A

Neck spine disk 15.99

NA

NA

9.99

9.75

3.71

NA

NA

29.69

29.45

090 surgery. 63030......... ........ A

Low back disk

12.97

NA

NA

8.67

8.48

3.00

NA

NA

24.64

24.45

090 surgery. 63035......... ........ A

Spinal disk

3.15

NA

NA

1.21

1.50

0.79

NA

NA

5.15

5.44

ZZZ surgery add-on. 63040......... ........ A

Laminotomy,

20.13

NA

NA

11.08

11.40

4.67

NA

NA

35.88

36.20

090 single cervical. 63042......... ........ A

Laminotomy,

18.55

NA

NA

10.68

11.18

4.25

NA

NA

33.48

33.98

090 single lumbar. 63043......... ........ C

Laminotomy,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ addIl cervical. 63044......... ........ C

Laminotomy,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ addIl lumbar. 63045......... ........ A

Removal of

17.77

NA

NA

10.41

10.37

3.98

NA

NA

32.16

32.12

090 spinal lamina.

[[Page 49167]]

63046......... ........ A

Removal of

17.07

NA

NA

9.88

10.11

3.55

NA

NA

30.50

30.73

090 spinal lamina. 63047......... ........ A

Removal of

15.16

NA

NA

9.41

9.77

3.23

NA

NA

27.80

28.16

090 spinal lamina. 63048......... ........ A

Remove spinal

3.26

NA

NA

1.25

1.56

0.72

NA

NA

5.23

5.54

ZZZ lamina add-on. 63050......... ........ A

Cervical

21.82

NA

NA

8.87

11.10

4.66

NA

NA

35.35

37.58

090 laminoplasty. 63051......... ........ A

C-laminoplasty 25.32

NA

NA

11.71

13.03

4.66

NA

NA

41.69

43.01

090 w/graft/plate. 63055......... ........ A

Decompress

23.37

NA

NA

12.40

12.95

5.27

NA

NA

41.04

41.59

090 spinal cord. 63056......... ........ A

Decompress

21.68

NA

NA

11.41

12.27

4.75

NA

NA

37.84

38.70

090 spinal cord. 63057......... ........ A

Decompress

5.25

NA

NA

1.97

2.47

1.22

NA

NA

8.44

8.94

ZZZ spine cord add- on. 63064......... ........ A

Decompress

26.04

NA

NA

13.41

14.17

5.69

NA

NA

45.14

45.90

090 spinal cord. 63066......... ........ A

Decompress

3.26

NA

NA

1.24

1.56

0.69

NA

NA

5.19

5.51

ZZZ spine cord add- on. 63075......... ........ A

Neck spine disk 19.41

NA

NA

11.11

11.84

4.62

NA

NA

35.14

35.87

090 surgery. 63076......... ........ A

Neck spine disk 4.04

NA

NA

1.53

1.92

0.96

NA

NA

6.53

6.92

ZZZ surgery. 63077......... ........ A

Spine disk

22.70

NA

NA

11.20

12.39

3.98

NA

NA

37.88

39.07

090 surgery, thorax. 63078......... ........ A

Spine disk

3.28

NA

NA

1.20

1.53

0.66

NA

NA

5.14

5.47

ZZZ surgery, thorax. 63081......... ........ A

Removal of

25.92

NA

NA

13.62

14.15

5.54

NA

NA

45.08

45.61

090 vertebral body. 63082......... ........ A

Remove

4.36

NA

NA

1.66

2.08

1.02

NA

NA

7.04

7.46

ZZZ vertebral body add-on. 63085......... ........ A

Removal of

29.29

NA

NA

13.77

15.05

4.48

NA

NA

47.54

48.82

090 vertebral body. 63086......... ........ A

Remove

3.19

NA

NA

1.17

1.49

0.59

NA

NA

4.95

5.27

ZZZ vertebral body add-on. 63087......... ........ A

Removal of

37.32

NA

NA

16.85

18.80

6.20

NA

NA

60.37

62.32

090 vertebral body. 63088......... ........ A

Remove

4.32

NA

NA

1.64

2.04

0.82

NA

NA

6.78

7.18

ZZZ vertebral body add-on. 63090......... ........ A

Removal of

30.72

NA

NA

14.16

15.56

4.21

NA

NA

49.09

50.49

090 vertebral body. 63091......... ........ A

Remove

3.03

NA

NA

1.13

1.38

0.48

NA

NA

4.64

4.89

ZZZ vertebral body add-on. 63101......... ........ A

Removal of

33.84

NA

NA

17.18

18.75

5.69

NA

NA

56.71

58.28

090 vertebral body. 63102......... ........ A

Removal of

33.84

NA

NA

16.90

18.68

5.69

NA

NA

56.43

58.21

090 vertebral body. 63103......... ........ A

Remove

4.82

NA

NA

1.78

2.32

0.69

NA

NA

7.29

7.83

ZZZ vertebral body add-on. 63170......... ........ A

Incise spinal

22.03

NA

NA

12.64

12.06

4.86

NA

NA

39.53

38.95

090 cord tract(s). 63172......... ........ A

Drainage of

19.62

NA

NA

11.31

10.81

4.48

NA

NA

35.41

34.91

090 spinal cyst. 63173......... ........ A

Drainage of

24.13

NA

NA

13.38

12.95

5.68

NA

NA

43.19

42.76

090 spinal cyst. 63180......... ........ A

Revise spinal

20.35

NA

NA

10.94

10.97

3.95

NA

NA

35.24

35.27

090 cord ligaments. 63182......... ........ A

Revise spinal

22.64

NA

NA

7.25

10.03

5.30

NA

NA

35.19

37.97

090 cord ligaments. 63185......... ........ A

Incise spinal

16.31

NA

NA

10.11

8.60

2.79

NA

NA

29.21

27.70

090 column/nerves. 63190......... ........ A

Incise spinal

18.71

NA

NA

10.16

10.14

3.24

NA

NA

32.11

32.09

090 column/nerves. 63191......... ........ A

Incise spinal

18.74

NA

NA

10.78

10.55

6.34

NA

NA

35.86

35.63

090 column/nerves. 63194......... ........ A

Incise spinal

21.92

NA

NA

8.65

10.95

3.26

NA

NA

33.83

36.13

090 column & cord. 63195......... ........ A

Incise spinal

21.50

NA

NA

12.18

11.33

4.87

NA

NA

38.55

37.70

090 column & cord. 63196......... ........ A

Incise spinal

25.09

NA

NA

13.88

13.51

5.76

NA

NA

44.73

44.36

090 column & cord. 63197......... ........ A

Incise spinal

23.90

NA

NA

13.43

12.51

5.36

NA

NA

42.69

41.77

090 column & cord. 63198......... ........ A

Incise spinal

29.69

NA

NA

9.01

8.58

6.43

NA

NA

45.13

44.70

090 column & cord. 63199......... ........ A

Incise spinal

31.26

NA

NA

9.38

13.62

1.40

NA

NA

42.04

46.28

090 column & cord. 63200......... ........ A

Release of

21.26

NA

NA

11.74

11.40

4.96

NA

NA

37.96

37.62

090 spinal cord. 63250......... ........ A

Revise spinal

43.68

NA

NA

21.09

20.21

9.01

NA

NA

73.78

72.90

090 cord vessels. 63251......... ........ A

Revise spinal

44.43

NA

NA

21.36

22.28 10.41

NA

NA

76.20

77.12

090 cord vessels. 63252......... ........ A

Revise spinal

44.42

NA

NA

21.41

22.03 10.64

NA

NA

76.47

77.09

090 cord vessels. 63265......... ........ A

Excise

23.64

NA

NA

13.10

12.85

5.43

NA

NA

42.17

41.92

090 intraspinal lesion. 63266......... ........ A

Excise

24.50

NA

NA

13.27

13.20

5.54

NA

NA

43.31

43.24

090 intraspinal lesion. 63267......... ........ A

Excise

19.27

NA

NA

11.22

11.11

4.37

NA

NA

34.86

34.75

090 intraspinal lesion. 63268......... ........ A

Excise

19.84

NA

NA

10.84

10.48

3.69

NA

NA

34.37

34.01

090 intraspinal lesion. 63270......... ........ A

Excise

29.62

NA

NA

15.73

15.53

6.82

NA

NA

52.17

51.97

090 intraspinal lesion. 63271......... ........ A

Excise

29.74

NA

NA

15.34

15.51

6.90

NA

NA

51.98

52.15

090 intraspinal lesion. 63272......... ........ A

Excise

27.32

NA

NA

14.33

14.59

6.18

NA

NA

47.83

48.09

090 intraspinal lesion. 63273......... ........ A

Excise

26.29

NA

NA

13.84

14.21

5.74

NA

NA

45.87

46.24

090 intraspinal lesion. 63275......... ........ A

Biopsy/excise

25.68

NA

NA

13.51

13.70

5.80

NA

NA

44.99

45.18

090 spinal tumor. 63276......... ........ A

Biopsy/excise

25.51

NA

NA

13.73

13.69

5.83

NA

NA

45.07

45.03

090 spinal tumor. 63277......... ........ A

Biopsy/excise

22.21

NA

NA

12.17

12.43

5.01

NA

NA

39.39

39.65

090 spinal tumor. 63278......... ........ A

Biopsy/excise

21.94

NA

NA

12.07

12.30

4.55

NA

NA

38.56

38.79

090 spinal tumor. 63280......... ........ A

Biopsy/excise

30.08

NA

NA

16.02

16.23

7.27

NA

NA

53.37

53.58

090 spinal tumor. 63281......... ........ A

Biopsy/excise

29.78

NA

NA

15.82

16.08

7.17

NA

NA

52.77

53.03

090 spinal tumor. 63282......... ........ A

Biopsy/excise

27.94

NA

NA

15.14

15.28

6.76

NA

NA

49.84

49.98

090 spinal tumor. 63283......... ........ A

Biopsy/excise

26.55

NA

NA

14.20

14.54

6.26

NA

NA

47.01

47.35

090 spinal tumor. 63285......... ........ A

Biopsy/excise

37.84

NA

NA

19.05

19.71

9.18

NA

NA

66.07

66.73

090 spinal tumor. 63286......... ........ A

Biopsy/excise

37.41

NA

NA

18.80

19.62

9.21

NA

NA

65.42

66.24

090 spinal tumor. 63287......... ........ A

Biopsy/excise

39.87

NA

NA

19.48

20.18

9.39

NA

NA

68.74

69.43

090 spinal tumor. 63290......... ........ A

Biopsy/excise

40.61

NA

NA

20.06

20.45

9.02

NA

NA

69.68

70.07

090 spinal tumor. 63295......... ........ A

Repair of

5.25

NA

NA

1.33

1.94

1.03

NA

NA

7.61

8.22

ZZZ laminectomy defect. 63300......... ........ A

Removal of

26.62

NA

NA

13.54

14.10

5.97

NA

NA

46.13

46.69

090 vertebral body. 63301......... ........ A

Removal of

31.36

NA

NA

15.06

15.42

5.39

NA

NA

51.81

52.17

090 vertebral body.

[[Page 49168]]

63302......... ........ A

Removal of

30.94

NA

NA

14.83

15.59

5.53

NA

NA

51.30

52.06

090 vertebral body. 63303......... ........ A

Removal of

33.37

NA

NA

14.68

16.35

4.68

NA

NA

52.73

54.40

090 vertebral body. 63304......... ........ A

Removal of

33.64

NA

NA

17.05

17.21

6.41

NA

NA

57.10

57.26

090 vertebral body. 63305......... ........ A

Removal of

36.03

NA

NA

17.60

17.93

5.71

NA

NA

59.34

59.67

090 vertebral body. 63306......... ........ A

Removal of

35.34

NA

NA

15.77

17.29

8.33

NA

NA

59.43

60.96

090 vertebral body. 63307......... ........ A

Removal of

34.75

NA

NA

17.66

17.02

4.46

NA

NA

56.87

56.23

090 vertebral body. 63308......... ........ A

Remove

5.24

NA

NA

1.93

2.43

1.29

NA

NA

8.46

8.96

ZZZ vertebral body add-on. 63600......... ........ A

Remove spinal

14.98

NA

NA

4.61

5.20

1.52

NA

NA

21.11

21.70

090 cord lesion. 63610......... ........ A

Stimulation of

8.72 14.20

48.31

1.58

2.08

0.86 23.78

57.89

11.16

11.66

000 spinal cord. 63615......... ........ A

Remove lesion

17.18

NA

NA

5.98

8.44

2.84

NA

NA

26.00

28.46

090 of spinal cord. 63650......... ........ A

Implant

7.53

NA

NA

2.98

3.12

0.53

NA

NA

11.04

11.18

090 neuroelectrode s. 63655......... ........ A

Implant

11.38

NA

NA

7.84

7.13

2.43

NA

NA

21.65

20.94

090 neuroelectrode s. 63660......... ........ A

Revise/remove

6.83

NA

NA

3.36

3.55

0.78

NA

NA

10.97

11.16

090 neuroelectrode. 63685......... ........ A

Insrt/redo

7.83

NA

NA

3.74

4.04

1.05

NA

NA

12.62

12.92

090 spine n generator. 63688......... ........ A

Revise/remove

6.06

NA

NA

3.60

3.56

0.89

NA

NA

10.55

10.51

090 neuroreceiver. 63700......... ........ A

Repair of

17.26

NA

NA

9.78

10.17

3.52

NA

NA

30.56

30.95

090 spinal herniation. 63702......... ........ A

Repair of

19.20

NA

NA

10.93

11.01

4.12

NA

NA

34.25

34.33

090 spinal herniation. 63704......... ........ A

Repair of

22.15

NA

NA

12.60

12.83

4.57

NA

NA

39.32

39.55

090 spinal herniation. 63706......... ........ A

Repair of

25.07

NA

NA

15.07

13.95

6.23

NA

NA

46.37

45.25

090 spinal herniation. 63707......... ........ A

Repair spinal

12.47

NA

NA

7.90

7.75

2.51

NA

NA

22.88

22.73

090 fluid leakage. 63709......... ........ A

Repair spinal

15.47

NA

NA

9.06

9.31

3.09

NA

NA

27.62

27.87

090 fluid leakage. 63710......... ........ A

Graft repair of 15.22

NA

NA

9.26

9.09

3.40

NA

NA

27.88

27.71

090 spine defect. 63740......... ........ A

Install spinal 12.45

NA

NA

8.25

7.57

2.93

NA

NA

23.63

22.95

090 shunt. 63741......... ........ A

Install spinal

8.98

NA

NA

4.85

4.78

1.66

NA

NA

15.49

15.42

090 shunt. 63744......... ........ A

Revision of

8.83

NA

NA

6.06

5.45

1.89

NA

NA

16.78

16.17

090 spinal shunt. 63746......... ........ A

Removal of

7.22

NA

NA

4.75

4.02

1.53

NA

NA

13.50

12.77

090 spinal shunt. 64400......... ........ A

N block inj,

1.11

1.41

1.77

0.45

0.44

0.07

2.59

2.95

1.63

1.62

000 trigeminal. 64402......... ........ A

N block inj,

1.25

1.46

1.57

0.53

0.58

0.09

2.80

2.91

1.87

1.92

000 facial. 64405......... ........ A

N block inj,

1.32

1.17

1.39

0.51

0.47

0.08

2.57

2.79

1.91

1.87

000 occipital. 64408......... ........ A

N block inj,

1.41

1.45

1.55

0.70

0.81

0.10

2.96

3.06

2.21

2.32

000 vagus. 64410......... ........ A

N block inj,

1.43

1.82

2.33

0.52

0.48

0.09

3.34

3.85

2.04

2.00

000 phrenic. 64412......... ........ A

N block inj,

1.18

2.05

2.50

0.55

0.46

0.08

3.31

3.76

1.81

1.72

000 spinal accessor. 64413......... ........ A

N block inj,

1.40

1.30

1.71

0.47

0.49

0.08

2.78

3.19

1.95

1.97

000 cervical plexus. 64415......... ........ A

N block inj,

1.48

1.50

2.48

0.34

0.43

0.09

3.07

4.05

1.91

2.00

000 brachial plexus. 64416......... ........ A

N block cont

3.85

NA

NA

0.57

0.74

0.31

NA

NA

4.73

4.90

010 infuse, b plex. 64417......... ........ A

N block inj,

1.44

1.51

2.65

0.35

0.46

0.11

3.06

4.20

1.90

2.01

000 axillary. 64418......... ........ A

N block inj,

1.32

1.90

2.44

0.52

0.46

0.07

3.29

3.83

1.91

1.85

000 suprascapular. 64420......... ........ A

N block inj,

1.18

2.40

3.51

0.44

0.43

0.08

3.66

4.77

1.70

1.69

000 intercost, sng. 64421......... ........ A

N block inj,

1.68

3.55

5.45

0.53

0.52

0.11

5.34

7.24

2.32

2.31

000 intercost, mlt. 64425......... ........ A

N block inj,

1.75

1.34

1.57

0.56

0.55

0.13

3.22

3.45

2.44

2.43

000 ilio-ing/ hypogi. 64430......... ........ A

N block inj,

1.46

2.41

2.49

0.78

0.61

0.10

3.97

4.05

2.34

2.17

000 pudendal. 64435......... ........ A

N block inj,

1.45

2.00

2.39

0.56

0.66

0.16

3.61

4.00

2.17

2.27

000 paracervical. 64445......... ........ A

N block inj,

1.48

1.67

2.42

0.52

0.51

0.10

3.25

4.00

2.10

2.09

000 sciatic, sng. 64446......... ........ A

N blk inj,

3.61

NA

NA

0.59

0.90

0.20

NA

NA

4.40

4.71

010 sciatic, cont inf. 64447......... ........ A

N block inj

1.50

NA

NA

0.21

0.38

0.09

NA

NA

1.80

1.97

000 fem, single. 64448......... ........ A

N block inj

3.36

NA

NA

0.47

0.73

0.18

NA

NA

4.01

4.27

010 fem, cont inf. 64449......... ........ A

N block inj,

3.24

NA

NA

0.49

0.84

0.15

NA

NA

3.88

4.23

010 lumbar plexus. 64450......... ........ A

N block, other

1.27

1.29

1.25

0.50

0.49

0.13

2.69

2.65

1.90

1.89

000 peripheral. 64470......... ........ A

Inj

1.85

3.87

6.39

0.71

0.71

0.11

5.83

8.35

2.67

2.67

000 paravertebral c/t. 64472......... ........ A

Inj

1.29

1.23

2.06

0.34

0.34

0.08

2.60

3.43

1.71

1.71

ZZZ paravertebral c/t add-on. 64475......... ........ A

Inj

1.41

3.72

6.09

0.60

0.62

0.10

5.23

7.60

2.11

2.13

000 paravertebral l/s. 64476......... ........ A

Inj

0.98

1.12

1.87

0.23

0.24

0.07

2.17

2.92

1.28

1.29

ZZZ paravertebral l/s add-on. 64479......... ........ A

Inj foramen

2.20

3.81

6.57

0.82

0.87

0.12

6.13

8.89

3.14

3.19

000 epidural c/t. 64480......... ........ A

Inj foramen

1.54

1.50

2.51

0.38

0.45

0.10

3.14

4.15

2.02

2.09

ZZZ epidural add- on. 64483......... ........ A

Inj foramen

1.90

3.85

6.88

0.76

0.81

0.11

5.86

8.89

2.77

2.82

000 epidural l/s. 64484......... ........ A

Inj foramen

1.33

1.63

2.87

0.32

0.36

0.08

3.04

4.28

1.73

1.77

ZZZ epidural add- on.

[[Page 49169]]

64505......... ........ A

N block,

1.36

1.11

1.21

0.73

0.68

0.10

2.57

2.67

2.19

2.14

000 spenopalatine gangl. 64508......... ........ A

N block,

1.12

1.89

2.96

0.48

0.68

0.07

3.08

4.15

1.67

1.87

000 carotid sinus s/p. 64510......... ........ A

N block,

1.22

1.92

3.07

0.44

0.49

0.07

3.21

4.36

1.73

1.78

000 stellate ganglion. 64517......... ........ A

N block inj,

2.20

1.70

2.47

0.67

0.82

0.11

4.01

4.78

2.98

3.13

000 hypogas plxs. 64520......... ........ A

N block, lumbar/ 1.35

2.62

4.51

0.52

0.54

0.08

4.05

5.94

1.95

1.97

000 thoracic. 64530......... ........ A

N block inj,

1.58

2.65

4.00

0.60

0.64

0.10

4.33

5.68

2.28

2.32

000 celiac pelus. 64550......... ........ A

Apply

0.18

0.20

0.26

0.06

0.05

0.01

0.39

0.45

0.25

0.24

000 neurostimulato r. 64553......... ........ A

Implant

2.31

2.50

2.75

1.35

1.73

0.18

4.99

5.24

3.84

4.22

010 neuroelectrode s. 64555......... ........ A

Implant

2.27

2.57

2.97

1.36

1.23

0.19

5.03

5.43

3.82

3.69

010 neuroelectrode s. 64560......... ........ A

Implant

2.36

2.49

2.60

1.33

1.29

0.22

5.07

5.18

3.91

3.87

010 neuroelectrode s. 64561......... ........ A

Implant

7.05 20.04

27.55

3.87

3.05

0.51 27.60

35.11

11.43

10.61

010 neuroelectrode s. 64565......... ........ A

Implant

1.76

2.47

3.08

1.28

1.27

0.13

4.36

4.97

3.17

3.16

010 neuroelectrode s. 64573......... ........ A

Implant

8.11

NA

NA

5.44

5.29

1.60

NA

NA

15.15

15.00

090 neuroelectrode s. 64575......... ........ A

Implant

4.34

NA

NA

2.00

2.50

0.61

NA

NA

6.95

7.45

090 neuroelectrode s. 64577......... ........ A

Implant

4.61

NA

NA

2.87

3.18

1.04

NA

NA

8.52

8.83

090 neuroelectrode s. 64580......... ........ A

Implant

4.11

NA

NA

2.69

3.34

0.36

NA

NA

7.16

7.81

090 neuroelectrode s. 64581......... ........ A

Implant

14.13

NA

NA

6.72

5.71

1.05

NA

NA

21.90

20.89

090 neuroelectrode s. 64585......... ........ A

Revise/remove

2.06

5.79

9.91

2.24

2.16

0.20

8.05

12.17

4.50

4.42

010 neuroelectrode. 64590......... ........ A

Insrt/redo

2.40

6.44

6.97

2.47

2.33

0.19

9.03

9.56

5.06

4.92

010 perph n generator. 64595......... ........ A

Revise/remove

1.73

6.52

9.42

2.20

1.99

0.19

8.44

11.34

4.12

3.91

010 neuroreceiver. 64600......... ........ A

Injection

3.44

5.28

8.33

1.58

1.63

0.34

9.06

12.11

5.36

5.41

010 treatment of nerve. 64605......... ........ A

Injection

5.60

7.65

9.08

2.39

2.23

0.79 14.04

15.47

8.78

8.62

010 treatment of nerve. 64610......... ........ A

Injection

7.15

9.41

9.00

3.52

3.66

1.58 18.14

17.73

12.25

12.39

010 treatment of nerve. 64612......... ........ A

Destroy nerve,

1.96

1.61

2.26

1.36

1.33

0.11

3.68

4.33

3.43

3.40

010 face muscle. 64613......... ........ A

Destroy nerve,

1.96

1.36

2.54

1.13

1.20

0.11

3.43

4.61

3.20

3.27

010 neck muscle. 64614......... ........ A

Destroy nerve,

2.20

1.62

2.82

1.31

1.31

0.10

3.92

5.12

3.61

3.61

010 extrem musc. 64620......... ........ A

Injection

2.84

3.44

4.66

1.17

1.29

0.20

6.48

7.70

4.21

4.33

010 treatment of nerve. 64622......... ........ A

Destr

3.00

4.10

6.85

1.27

1.35

0.18

7.28

10.03

4.45

4.53

010 paravertebrl nerve l/s. 64623......... ........ A

Destr

0.99

1.65

2.63

0.22

0.22

0.06

2.70

3.68

1.27

1.27

ZZZ paravertebral n add-on. 64626......... ........ A

Destr

3.78

4.74

7.02

1.87

1.94

0.20

8.72

11.00

5.85

5.92

010 paravertebrl nerve c/t. 64627......... ........ A

Destr

1.16

2.38

3.99

0.25

0.27

0.07

3.61

5.22

1.48

1.50

ZZZ paravertebral n add-on. 64630......... ........ A

Injection

3.00

2.81

2.75

1.88

1.53

0.22

6.03

5.97

5.10

4.75

010 treatment of nerve. 64640......... ........ A

Injection

2.76

2.45

3.75

1.44

1.74

0.29

5.50

6.80

4.49

4.79

010 treatment of nerve. 64650......... ........ A

Chemodenerv

0.70

0.78

0.85

0.18

0.27

0.06

1.54

1.61

0.94

1.03

000 eccrine glands. 64653......... ........ A

Chemodenerv

0.88

0.83

0.90

0.22

0.34

0.08

1.79

1.86

1.18

1.30

000 eccrine glands. 64680......... ........ A

Injection

2.62

4.01

6.04

1.09

1.35

0.18

6.81

8.84

3.89

4.15

010 treatment of nerve. 64681......... ........ A

Injection

3.78

4.92

8.20

1.32

1.88

0.28

8.98

12.26

5.38

5.94

010 treatment of nerve. 64702......... ........ A

Revise finger/

6.02

NA

NA

5.27

4.21

0.61

NA

NA

11.90

10.84

090 toe nerve. 64704......... ........ A

Revise hand/

4.56

NA

NA

3.20

3.28

0.61

NA

NA

8.37

8.45

090 foot nerve. 64708......... ........ A

Revise arm/leg

6.17

NA

NA

4.29

4.72

0.96

NA

NA

11.42

11.85

090 nerve. 64712......... ........ A

Revision of

7.92

NA

NA

4.55

4.86

0.95

NA

NA

13.42

13.73

090 sciatic nerve. 64713......... ........ A

Revision of arm 11.22

NA

NA

6.47

6.02

1.82

NA

NA

19.51

19.06

090 nerve(s). 64714......... ........ A

Revise low back 10.37

NA

NA

4.91

4.38

1.19

NA

NA

16.47

15.94

090 nerve(s). 64716......... ........ A

Revision of

6.80

NA

NA

5.15

5.77

0.63

NA

NA

12.58

13.20

090 cranial nerve. 64718......... ........ A

Revise ulnar

6.98

NA

NA

6.23

6.05

1.05

NA

NA

14.26

14.08

090 nerve at elbow. 64719......... ........ A

Revise ulnar

4.84

NA

NA

4.16

4.43

0.77

NA

NA

9.77

10.04

090 nerve at wrist. 64721......... ........ A

Carpal tunnel

4.78

4.72

5.20

4.66

5.19

0.73 10.23

10.71

10.17

10.70

090 surgery. 64722......... ........ A

Relieve

4.69

NA

NA

2.83

2.99

0.48

NA

NA

8.00

8.16

090 pressure on nerve(s). 64726......... ........ A

Release foot/

4.17

NA

NA

2.73

2.78

0.54

NA

NA

7.44

7.49

090 toe nerve. 64727......... ........ A

Internal nerve

3.10

NA

NA

1.23

1.43

0.48

NA

NA

4.81

5.01

ZZZ revision. 64732......... ........ A

Incision of

4.78

NA

NA

4.27

3.69

0.98

NA

NA

10.03

9.45

090 brow nerve. 64734......... ........ A

Incision of

5.41

NA

NA

4.64

4.20

0.89

NA

NA

10.94

10.50

090 cheek nerve. 64736......... ........ A

Incision of

5.09

NA

NA

3.87

3.98

0.52

NA

NA

9.48

9.59

090 chin nerve. 64738......... ........ A

Incision of jaw 6.22

NA

NA

4.22

4.51

1.08

NA

NA

11.52

11.81

090 nerve. 64740......... ........ A

Incision of

6.08

NA

NA

4.41

4.94

0.69

NA

NA

11.18

11.71

090 tongue nerve. 64742......... ........ A

Incision of

6.71

NA

NA

4.35

4.61

0.73

NA

NA

11.79

12.05

090 facial nerve. 64744......... ........ A

Incise nerve,

5.61

NA

NA

4.59

3.98

1.16

NA

NA

11.36

10.75

090 back of head. 64746......... ........ A

Incise

6.42

NA

NA

3.88

4.35

0.82

NA

NA

11.12

11.59

090 diaphragm nerve. 64752......... ........ A

Incision of

7.55

NA

NA

4.06

4.23

0.93

NA

NA

12.54

12.71

090 vagus nerve. 64755......... ........ A

Incision of

14.93

NA

NA

5.84

5.68

1.83

NA

NA

22.60

22.44

090 stomach nerves. 64760......... ........ A

Incision of

7.45

NA

NA

3.85

3.55

0.81

NA

NA

12.11

11.81

090 vagus nerve. 64761......... ........ A

Incision of

6.90

NA

NA

3.99

3.64

0.53

NA

NA

11.42

11.07

090 pelvis nerve. 64763......... ........ A

Incise hip/

7.42

NA

NA

5.07

5.16

0.94

NA

NA

13.43

13.52

090 thigh nerve. 64766......... ........ A

Incise hip/

9.29

NA

NA

5.31

5.26

1.06

NA

NA

15.66

15.61

090 thigh nerve. 64771......... ........ A

Sever cranial

7.97

NA

NA

5.28

5.48

1.23

NA

NA

14.48

14.68

090 nerve. 64772......... ........ A

Incision of

7.70

NA

NA

5.32

5.02

1.40

NA

NA

14.42

14.12

090 spinal nerve.

[[Page 49170]]

64774......... ........ A

Remove skin

5.66

NA

NA

3.97

3.87

0.74

NA

NA

10.37

10.27

090 nerve lesion. 64776......... ........ A

Remove digit

5.49

NA

NA

3.73

3.69

0.76

NA

NA

9.98

9.94

090 nerve lesion. 64778......... ........ A

Digit nerve

3.11

NA

NA

1.19

1.42

0.46

NA

NA

4.76

4.99

ZZZ surgery add-on. 64782......... ........ A

Remove limb

6.72

NA

NA

4.11

3.86

0.86

NA

NA

11.69

11.44

090 nerve lesion. 64783......... ........ A

Limb nerve

3.71

NA

NA

1.41

1.73

0.51

NA

NA

5.63

5.95

ZZZ surgery add-on. 64784......... ........ A

Remove nerve

10.44

NA

NA

6.20

6.49

1.38

NA

NA

18.01

18.30

090 lesion. 64786......... ........ A

Remove sciatic 16.07

NA

NA

8.97

9.62

2.60

NA

NA

27.64

28.29

090 nerve lesion. 64787......... ........ A

Implant nerve

4.29

NA

NA

1.60

1.99

0.58

NA

NA

6.47

6.86

ZZZ end. 64788......... ........ A

Remove skin

5.10

NA

NA

3.87

3.56

0.73

NA

NA

9.70

9.39

090 nerve lesion. 64790......... ........ A

Removal of

11.92

NA

NA

6.81

7.10

2.10

NA

NA

20.83

21.12

090 nerve lesion. 64792......... ........ A

Removal of

15.65

NA

NA

8.40

8.72

2.48

NA

NA

26.53

26.85

090 nerve lesion. 64795......... ........ A

Biopsy of nerve 3.01

NA

NA

1.44

1.53

0.52

NA

NA

4.97

5.06

000 64802......... ........ A

Remove

10.19

NA

NA

4.22

4.90

1.29

NA

NA

15.70

16.38

090 sympathetic nerves. 64804......... ........ A

Remove

15.73

NA

NA

6.10

6.90

2.14

NA

NA

23.97

24.77

090 sympathetic nerves. 64809......... ........ A

Remove

14.57

NA

NA

6.60

5.97

1.50

NA

NA

22.67

22.04

090 sympathetic nerves. 64818......... ........ A

Remove

11.20

NA

NA

4.36

5.05

1.33

NA

NA

16.89

17.58

090 sympathetic nerves. 64820......... ........ A

Remove

10.60

NA

NA

7.04

7.10

1.49

NA

NA

19.13

19.19

090 sympathetic nerves. 64821......... ........ A

Remove

9.11

NA

NA

6.64

7.17

1.24

NA

NA

16.99

17.52

090 sympathetic nerves. 64822......... ........ A

Remove

9.11

NA

NA

6.45

7.04

1.30

NA

NA

16.86

17.45

090 sympathetic nerves. 64823......... ........ A

Remove

10.72

NA

NA

7.11

7.88

1.57

NA

NA

19.40

20.17

090 sympathetic nerves. 64831......... ........ A

Repair of digit 10.18

NA

NA

6.67

6.97

1.41

NA

NA

18.26

18.56

090 nerve. 64832......... ........ A

Repair nerve

5.65

NA

NA

2.36

2.79

0.85

NA

NA

8.86

9.29

ZZZ add-on. 64834......... ........ A

Repair of hand 10.67

NA

NA

6.57

6.96

1.54

NA

NA

18.78

19.17

090 or foot nerve. 64835......... ........ A

Repair of hand 11.55

NA

NA

7.32

7.60

1.73

NA

NA

20.60

20.88

090 or foot nerve. 64836......... ........ A

Repair of hand 11.55

NA

NA

7.04

7.51

1.67

NA

NA

20.26

20.73

090 or foot nerve. 64837......... ........ A

Repair nerve

6.25

NA

NA

2.67

3.09

0.97

NA

NA

9.89

10.31

ZZZ add-on. 64840......... ........ A

Repair of leg

13.81

NA

NA

5.07

7.46

1.37

NA

NA

20.25

22.64

090 nerve. 64856......... ........ A

Repair/

14.89

NA

NA

8.60

9.04

2.12

NA

NA

25.61

26.05

090 transpose nerve. 64857......... ........ A

Repair arm/leg 15.64

NA

NA

8.93

9.46

2.21

NA

NA

26.78

27.31

090 nerve. 64858......... ........ A

Repair sciatic 17.64

NA

NA

10.15

10.62

3.33

NA

NA

31.12

31.58

090 nerve. 64859......... ........ A

Nerve surgery.. 4.25

NA

NA

1.88

2.11

0.67

NA

NA

6.80

7.03

ZZZ 64861......... ........ A

Repair of arm

20.68

NA

NA

10.04

11.34

4.08

NA

NA

34.80

36.10

090 nerves. 64862......... ........ A

Repair of low

20.88

NA

NA

6.83

10.66

4.31

NA

NA

32.02

35.85

090 back nerves. 64864......... ........ A

Repair of

13.27

NA

NA

7.03

8.33

1.26

NA

NA

21.56

22.86

090 facial nerve. 64865......... ........ A

Repair of

15.91

NA

NA

9.89

12.61

1.50

NA

NA

27.30

30.02

090 facial nerve. 64866......... ........ A

Fusion of

16.65

NA

NA

12.27

12.94

2.04

NA

NA

30.96

31.63

090 facial/other nerve. 64868......... ........ A

Fusion of

14.76

NA

NA

9.07

10.84

1.43

NA

NA

25.26

27.03

090 facial/other nerve. 64870......... ........ A

Fusion of

16.90

NA

NA

8.42

8.65

1.30

NA

NA

26.62

26.85

090 facial/other nerve. 64872......... ........ A

Subsequent

1.99

NA

NA

0.81

1.01

0.29

NA

NA

3.09

3.29

ZZZ repair of nerve. 64874......... ........ A

Repair & revise 2.98

NA

NA

1.21

1.45

0.42

NA

NA

4.61

4.85

ZZZ nerve add-on. 64876......... ........ A

Repair nerve/

3.37

NA

NA

0.78

1.50

0.47

NA

NA

4.62

5.34

ZZZ shorten bone. 64885......... ........ A

Nerve graft,

17.50

NA

NA

8.84

10.91

1.63

NA

NA

27.97

30.04

090 head or neck. 64886......... ........ A

Nerve graft,

20.72

NA

NA

9.68

12.58

2.08

NA

NA

32.48

35.38

090 head or neck. 64890......... ........ A

Nerve graft,

16.06

NA

NA

9.05

9.76

2.29

NA

NA

27.40

28.11

090 hand or foot. 64891......... ........ A

Nerve graft,

17.17

NA

NA

9.87

8.15

1.63

NA

NA

28.67

26.95

090 hand or foot. 64892......... ........ A

Nerve graft,

15.56

NA

NA

8.95

8.88

2.47

NA

NA

26.98

26.91

090 arm or leg. 64893......... ........ A

Nerve graft,

16.69

NA

NA

9.67

9.81

2.61

NA

NA

28.97

29.11

090 arm or leg. 64895......... ........ A

Nerve graft,

20.21

NA

NA

10.02

9.74

2.57

NA

NA

32.80

32.52

090 hand or foot. 64896......... ........ A

Nerve graft,

21.75

NA

NA

11.89

11.21

3.16

NA

NA

36.80

36.12

090 hand or foot. 64897......... ........ A

Nerve graft,

19.20

NA

NA

10.43

10.63

2.54

NA

NA

32.17

32.37

090 arm or leg. 64898......... ........ A

Nerve graft,

20.76

NA

NA

11.28

11.66

2.77

NA

NA

34.81

35.19

090 arm or leg. 64901......... ........ A

Nerve graft add- 10.20

NA

NA

3.82

4.90

1.37

NA

NA

15.39

16.47

ZZZ on. 64902......... ........ A

Nerve graft add- 11.81

NA

NA

4.25

5.53

1.55

NA

NA

17.61

18.89

ZZZ on. 64905......... ........ A

Nerve pedicle

14.93

NA

NA

6.84

8.08

2.00

NA

NA

23.77

25.01

090 transfer. 64907......... ........ A

Nerve pedicle

19.85

NA

NA

6.41

10.99

3.16

NA

NA

29.42

34.00

090 transfer. 64999......... ........ C

Nervous system

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery.

[[Page 49171]]

65091......... ........ A

Revise eye..... 7.08

NA

NA

6.91

7.99

0.32

NA

NA

14.31

15.39

090 65093......... ........ A

Revise eye with 6.86

NA

NA

7.00

8.28

0.34

NA

NA

14.20

15.48

090 implant. 65101......... ........ A

Removal of eye. 8.02

NA

NA

8.15

9.18

0.35

NA

NA

16.52

17.55

090 65103......... ........ A

Remove eye/

8.56

NA

NA

8.37

9.39

0.37

NA

NA

17.30

18.32

090 insert implant. 65105......... ........ A

Remove eye/

9.61

NA

NA

9.06

10.11

0.42

NA

NA

19.09

20.14

090 attach implant. 65110......... ........ A

Removal of eye. 15.31

NA

NA

11.58

13.15

0.81

NA

NA

27.70

29.27

090 65112......... ........ A

Remove eye/

18.05

NA

NA

13.05

15.36

1.30

NA

NA

32.40

34.71

090 revise socket. 65114......... ........ A

Remove eye/

19.19

NA

NA

13.69

15.68

1.02

NA

NA

33.90

35.89

090 revise socket. 65125......... ........ A

Revise ocular

3.12

6.82

8.31

3.18

3.50

0.19 10.13

11.62

6.49

6.81

090 implant. 65130......... ........ A

Insert ocular

8.14

NA

NA

7.92

8.85

0.35

NA

NA

16.41

17.34

090 implant. 65135......... ........ A

Insert ocular

8.32

NA

NA

7.97

8.98

0.36

NA

NA

16.65

17.66

090 implant. 65140......... ........ A

Attach ocular

9.14

NA

NA

8.59

9.55

0.40

NA

NA

18.13

19.09

090 implant. 65150......... ........ A

Revise ocular

6.25

NA

NA

6.47

7.60

0.31

NA

NA

13.03

14.16

090 implant. 65155......... ........ A

Reinsert ocular 9.78

NA

NA

8.85

10.07

0.50

NA

NA

19.13

20.35

090 implant. 65175......... ........ A

Removal of

7.15

NA

NA

7.27

8.18

0.31

NA

NA

14.73

15.64

090 ocular implant. 65205......... ........ A

Remove foreign

0.71

0.59

0.63

0.33

0.30

0.03

1.33

1.37

1.07

1.04

000 body from eye. 65210......... ........ A

Remove foreign

0.84

0.74

0.79

0.41

0.39

0.04

1.62

1.67

1.29

1.27

000 body from eye. 65220......... ........ A

Remove foreign

0.71

0.60

0.63

0.29

0.28

0.05

1.36

1.39

1.05

1.04

000 body from eye. 65222......... ........ A

Remove foreign

0.93

0.81

0.87

0.43

0.39

0.04

1.78

1.84

1.40

1.36

000 body from eye. 65235......... ........ A

Remove foreign

8.69

NA

NA

6.99

6.80

0.37

NA

NA

16.05

15.86

090 body from eye. 65260......... ........ A

Remove foreign 12.19

NA

NA

9.03

9.50

0.57

NA

NA

21.79

22.26

090 body from eye. 65265......... ........ A

Remove foreign 13.95

NA

NA

9.90

10.44

0.62

NA

NA

24.47

25.01

090 body from eye. 65270......... ........ A

Repair of eye

1.90

3.88

4.89

1.22

1.35

0.09

5.87

6.88

3.21

3.34

010 wound. 65272......... ........ A

Repair of eye

4.44

6.50

7.41

3.27

3.29

0.19 11.13

12.04

7.90

7.92

090 wound. 65273......... ........ A

Repair of eye

4.98

NA

NA

3.43

3.54

0.22

NA

NA

8.63

8.74

090 wound. 65275......... ........ A

Repair of eye

6.08

6.43

6.34

3.99

3.95

0.26 12.77

12.68

10.33

10.29

090 wound. 65280......... ........ A

Repair of eye

8.78

NA

NA

6.02

6.18

0.38

NA

NA

15.18

15.34

090 wound. 65285......... ........ A

Repair of eye

14.32

NA

NA

8.70

9.08

0.64

NA

NA

23.66

24.04

090 wound. 65286......... ........ A

Repair of eye

6.38

8.96

10.60

4.53

4.60

0.27 15.61

17.25

11.18

11.25

090 wound. 65290......... ........ A

Repair of eye

6.28

NA

NA

4.55

4.69

0.31

NA

NA

11.14

11.28

090 socket wound. 65400......... ........ A

Removal of eye

7.18

7.66

8.16

6.03

6.10

0.30 15.14

15.64

13.51

13.58

090 lesion. 65410......... ........ A

Biopsy of

1.47

1.72

2.01

0.90

0.95

0.07

3.26

3.55

2.44

2.49

000 cornea. 65420......... ........ A

Removal of eye

4.16

7.03

8.40

4.07

4.35

0.21 11.40

12.77

8.44

8.72

090 lesion. 65426......... ........ A

Removal of eye

5.85

8.41

9.73

4.71

4.87

0.25 14.51

15.83

10.81

10.97

090 lesion. 65430......... ........ A

Corneal smear.. 1.47

1.13

1.25

0.90

0.96

0.07

2.67

2.79

2.44

2.50

000 65435......... ........ A

Curette/treat

0.92

0.89

0.97

0.67

0.70

0.04

1.85

1.93

1.63

1.66

000 cornea. 65436......... ........ A

Curette/treat

4.68

3.88

4.04

3.55

3.64

0.21

8.77

8.93

8.44

8.53

090 cornea. 65450......... ........ A

Treatment of

3.27

3.76

3.99

3.68

3.88

0.16

7.19

7.42

7.11

7.31

090 corneal lesion. 65600......... ........ A

Revision of

4.02

4.58

4.90

3.51

3.39

0.17

8.77

9.09

7.70

7.58

090 cornea. 65710......... ........ A

Corneal

13.97

NA

NA

10.49

11.02

0.61

NA

NA

25.07

25.60

090 transplant. 65730......... ........ A

Corneal

15.87

NA

NA

11.29

11.84

0.70

NA

NA

27.86

28.41

090 transplant. 65750......... ........ A

Corneal

16.48

NA

NA

11.00

11.73

0.74

NA

NA

28.22

28.95

090 transplant. 65755......... ........ A

Corneal

16.37

NA

NA

10.97

11.66

0.73

NA

NA

28.07

28.76

090 transplant. 65770......... ........ A

Revise cornea

19.28

NA

NA

12.09

12.92

0.87

NA

NA

32.24

33.07

090 with implant. 65772......... ........ A

Correction of

4.91

4.99

5.40

4.04

4.11

0.21 10.11

10.52

9.16

9.23

090 astigmatism. 65775......... ........ A

Correction of

6.66

NA

NA

5.46

5.83

0.28

NA

NA

12.40

12.77

090 astigmatism. 65780......... ........ A

Ocular reconst, 10.23

NA

NA

9.18

10.01

0.44

NA

NA

19.85

20.68

090 transplant. 65781......... ........ A

Ocular reconst, 17.64

NA

NA

11.94

13.24

0.44

NA

NA

30.02

31.32

090 transplant. 65782......... ........ A

Ocular reconst, 14.98

NA

NA

10.53

11.63

0.44

NA

NA

25.95

27.05

090 transplant. 65800......... ........ A

Drainage of eye 1.91

1.45

1.71

1.07

1.15

0.09

3.45

3.71

3.07

3.15

000 65805......... ........ A

Drainage of eye 1.91

1.76

2.07

1.07

1.16

0.09

3.76

4.07

3.07

3.16

000 65810......... ........ A

Drainage of eye 5.61

NA

NA

4.82

4.73

0.24

NA

NA

10.67

10.58

090 65815......... ........ A

Drainage of eye 5.79

8.14

9.54

4.72

4.79

0.25 14.18

15.58

10.76

10.83

090 65820......... ........ A

Relieve inner

8.62

NA

NA

7.88

8.76

0.40

NA

NA

16.90

17.78

090 eye pressure. 65850......... ........ A

Incision of eye 11.14

NA

NA

7.56

8.22

0.52

NA

NA

19.22

19.88

090 65855......... ........ A

Laser surgery

3.84

3.59

4.13

2.71

3.00

0.19

7.62

8.16

6.74

7.03

010 of eye. 65860......... ........ A

Incise inner

3.54

3.37

3.87

2.16

2.42

0.18

7.09

7.59

5.88

6.14

090 eye adhesions. 65865......... ........ A

Incise inner

5.59

NA

NA

4.84

5.43

0.28

NA

NA

10.71

11.30

090 eye adhesions. 65870......... ........ A

Incise inner

7.14

NA

NA

5.88

6.28

0.31

NA

NA

13.33

13.73

090 eye adhesions. 65875......... ........ A

Incise inner

7.53

NA

NA

6.33

6.68

0.32

NA

NA

14.18

14.53

090 eye adhesions. 65880......... ........ A

Incise inner

8.08

NA

NA

6.54

6.91

0.35

NA

NA

14.97

15.34

090 eye adhesions. 65900......... ........ A

Remove eye

12.16

NA

NA

9.15

9.98

0.54

NA

NA

21.85

22.68

090 lesion. 65920......... ........ A

Remove implant

9.64

NA

NA

7.72

8.06

0.41

NA

NA

17.77

18.11

090 of eye. 65930......... ........ A

Remove blood

8.18

NA

NA

5.98

6.62

0.37

NA

NA

14.53

15.17

090 clot from eye. 66020......... ........ A

Injection

1.59

2.49

2.96

1.31

1.41

0.08

4.16

4.63

2.98

3.08

010 treatment of eye. 66030......... ........ A

Injection

1.25

2.36

2.81

1.18

1.26

0.06

3.67

4.12

2.49

2.57

010 treatment of eye.

[[Page 49172]]

66130......... ........ A

Remove eye

7.68

7.75

9.15

5.04

5.47

0.38 15.81

17.21

13.10

13.53

090 lesion. 66150......... ........ A

Glaucoma

10.04

NA

NA

9.04

9.31

0.46

NA

NA

19.54

19.81

090 surgery. 66155......... ........ A

Glaucoma

10.03

NA

NA

9.02

9.27

0.41

NA

NA

19.46

19.71

090 surgery. 66160......... ........ A

Glaucoma

11.90

NA

NA

9.78

10.09

0.50

NA

NA

22.18

22.49

090 surgery. 66165......... ........ A

Glaucoma

9.75

NA

NA

8.97

9.17

0.40

NA

NA

19.12

19.32

090 surgery. 66170......... ........ A

Glaucoma

14.39

NA

NA

11.90

12.14

0.60

NA

NA

26.89

27.13

090 surgery. 66172......... ........ A

Incision of eye 18.02

NA

NA

15.09

15.17

0.74

NA

NA

33.85

33.93

090 66180......... ........ A

Implant eye

15.91

NA

NA

10.05

10.58

0.71

NA

NA

26.67

27.20

090 shunt. 66185......... ........ A

Revise eye

9.26

NA

NA

7.28

7.36

0.40

NA

NA

16.94

17.01

090 shunt. 66220......... ........ A

Repair eye

8.89

NA

NA

7.21

7.13

0.40

NA

NA

16.50

16.42

090 lesion. 66225......... ........ A

Repair/graft

12.28

NA

NA

8.41

8.65

0.55

NA

NA

21.24

21.48

090 eye lesion. 66250......... ........ A

Follow-up

6.85

9.51

11.15

5.42

5.47

0.30 16.66

18.30

12.57

12.62

090 surgery of eye. 66500......... ........ A

Incision of

3.70

NA

NA

4.07

4.50

0.18

NA

NA

7.95

8.38

090 iris. 66505......... ........ A

Incision of

4.07

NA

NA

4.43

4.85

0.20

NA

NA

8.70

9.12

090 iris. 66600......... ........ A

Remove iris and 9.80

NA

NA

8.55

8.30

0.43

NA

NA

18.78

18.53

090 lesion. 66605......... ........ A

Removal of iris 13.90

NA

NA

9.43

9.87

0.77

NA

NA

24.10

24.54

090 66625......... ........ A

Removal of iris 5.12

NA

NA

4.34

4.63

0.26

NA

NA

9.72

10.01

090 66630......... ........ A

Removal of iris 7.03

NA

NA

5.52

5.66

0.31

NA

NA

12.86

13.00

090 66635......... ........ A

Removal of iris 7.12

NA

NA

5.55

5.69

0.31

NA

NA

12.98

13.12

090 66680......... ........ A

Repair iris &

6.18

NA

NA

5.23

5.26

0.27

NA

NA

11.68

11.71

090 ciliary body. 66682......... ........ A

Repair iris &

7.08

NA

NA

6.92

6.69

0.31

NA

NA

14.31

14.08

090 ciliary body. 66700......... ........ A

Destruction,

5.02

4.96

5.17

3.73

3.88

0.24 10.22

10.43

8.99

9.14

090 ciliary body. 66710......... ........ A

Ciliary

5.02

4.73

5.06

3.71

3.81

0.23

9.98

10.31

8.96

9.06

090 transsleral therapy. 66711......... ........ A

Ciliary

7.60

NA

NA

6.49

6.48

0.30

NA

NA

14.39

14.38

090 endoscopic ablation. 66720......... ........ A

Destruction,

4.77

5.47

5.71

4.40

4.64

0.26 10.50

10.74

9.43

9.67

090 ciliary body. 66740......... ........ A

Destruction,

5.02

4.68

4.99

3.73

3.91

0.23

9.93

10.24

8.98

9.16

090 ciliary body. 66761......... ........ A

Revision of

4.81

5.17

5.49

4.32

4.31

0.20 10.18

10.50

9.33

9.32

090 iris. 66762......... ........ A

Revision of

5.20

5.26

5.55

4.20

4.27

0.23 10.69

10.98

9.63

9.70

090 iris. 66770......... ........ A

Removal of

5.92

5.71

5.99

4.74

4.79

0.26 11.89

12.17

10.92

10.97

090 inner eye lesion. 66820......... ........ A

Incision,

3.88

NA

NA

4.76

5.55

0.19

NA

NA

8.83

9.62

090 secondary cataract. 66821......... ........ A

After cataract

3.28

3.93

4.05

3.51

3.59

0.11

7.32

7.44

6.90

6.98

090 laser surgery. 66825......... ........ A

Reposition

8.72

NA

NA

8.01

8.80

0.40

NA

NA

17.13

17.92

090 intraocular lens. 66830......... ........ A

Removal of lens 9.19

NA

NA

6.57

6.86

0.36

NA

NA

16.12

16.41

090 lesion. 66840......... ........ A

Removal of lens 8.90

NA

NA

6.51

6.77

0.39

NA

NA

15.80

16.06

090 material. 66850......... ........ A

Removal of lens 10.23

NA

NA

7.31

7.56

0.45

NA

NA

17.99

18.24

090 material. 66852......... ........ A

Removal of lens 11.09

NA

NA

7.65

7.99

0.49

NA

NA

19.23

19.57

090 material. 66920......... ........ A

Extraction of

9.85

NA

NA

6.87

7.19

0.44

NA

NA

17.16

17.48

090 lens. 66930......... ........ A

Extraction of

11.29

NA

NA

7.73

8.04

0.49

NA

NA

19.51

19.82

090 lens. 66940......... ........ A

Extraction of

10.05

NA

NA

7.25

7.51

0.43

NA

NA

17.73

17.99

090 lens. 66982......... ........ A

Cataract

14.73

NA

NA

9.28

9.72

0.63

NA

NA

24.64

25.08

090 surgery, complex. 66983......... ........ A

Cataract surg w/ 10.11

NA

NA

6.30

6.16

0.14

NA

NA

16.55

16.41

090 iol, 1 stage. 66984......... ........ A

Cataract surg w/ 10.28

NA

NA

6.62

7.22

0.39

NA

NA

17.29

17.89

090 iol, 1 stage. 66985......... ........ A

Insert lens

9.63

NA

NA

7.33

7.42

0.36

NA

NA

17.32

17.41

090 prosthesis. 66986......... ........ A

Exchange lens

12.26

NA

NA

8.38

8.97

0.60

NA

NA

21.24

21.83

090 prosthesis. 66990......... ........ A

Ophthalmic

1.51

NA

NA

0.57

0.66

0.07

NA

NA

2.15

2.24

ZZZ endoscope add- on. 66999......... ........ C

Eye surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 67005......... ........ A

Partial removal 5.69

NA

NA

4.72

4.83

0.28

NA

NA

10.69

10.80

090 of eye fluid. 67010......... ........ A

Partial removal 6.86

NA

NA

5.16

5.35

0.34

NA

NA

12.36

12.55

090 of eye fluid. 67015......... ........ A

Release of eye

6.91

NA

NA

5.88

6.31

0.34

NA

NA

13.13

13.56

090 fluid. 67025......... ........ A

Replace eye

7.83

8.11

8.94

6.11

6.19

0.34 16.28

17.11

14.28

14.36

090 fluid. 67027......... ........ A

Implant eye

11.33

NA

NA

7.61

7.90

0.54

NA

NA

19.48

19.77

090 drug system. 67028......... ........ A

Injection eye

2.52

2.23

2.58

1.30

1.42

0.12

4.87

5.22

3.94

4.06

000 drug. 67030......... ........ A

Incise inner

5.83

NA

NA

5.77

5.83

0.24

NA

NA

11.84

11.90

090 eye strands. 67031......... ........ A

Laser surgery,

4.29

4.21

4.50

3.53

3.61

0.18

8.68

8.97

8.00

8.08

090 eye strands. 67036......... ........ A

Removal of

13.00

NA

NA

8.35

8.93

0.58

NA

NA

21.93

22.51

090 inner eye fluid. 67038......... ........ A

Strip retinal

23.15

NA

NA

13.97

15.11

1.04

NA

NA

38.16

39.30

090 membrane.

[[Page 49173]]

67039......... ........ A

Laser treatment 16.25

NA

NA

11.08

11.91

0.71

NA

NA

28.04

28.87

090 of retina. 67040......... ........ A

Laser treatment 19.08

NA

NA

12.45

13.37

0.85

NA

NA

32.38

33.30

090 of retina. 67101......... ........ A

Repair detached 8.52

8.75

9.03

6.38

6.49

0.37 17.64

17.92

15.27

15.38

090 retina. 67105......... ........ A

Repair detached 8.28

7.65

7.97

5.99

6.11

0.37 16.30

16.62

14.64

14.75

090 retina. 67107......... ........ A

Repair detached 16.26

NA

NA

10.74

11.16

0.73

NA

NA

27.73

28.15

090 retina. 67108......... ........ A

Repair detached 22.39

NA

NA

13.45

14.18

1.02

NA

NA

36.86

37.59

090 retina. 67110......... ........ A

Repair detached 9.93

9.22

9.98

7.20

7.34

0.44 19.59

20.35

17.57

17.71

090 retina. 67112......... ........ A

Rerepair

18.33

NA

NA

11.27

11.68

0.83

NA

NA

30.43

30.84

090 detached retina. 67115......... ........ A

Release

5.86

NA

NA

5.07

5.08

0.25

NA

NA

11.18

11.19

090 encircling material. 67120......... ........ A

Remove eye

6.85

7.57

8.33

5.45

5.51

0.29 14.71

15.47

12.59

12.65

090 implant material. 67121......... ........ A

Remove eye

11.90

NA

NA

8.25

8.46

0.53

NA

NA

20.68

20.89

090 implant material. 67141......... ........ A

Treatment of

5.94

5.59

5.79

4.81

4.85

0.26 11.79

11.99

11.01

11.05

090 retina. 67145......... ........ A

Treatment of

6.11

5.51

5.67

4.87

4.92

0.27 11.89

12.05

11.25

11.30

090 retina. 67208......... ........ A

Treatment of

7.44

5.84

6.05

5.38

5.48

0.33 13.61

13.82

13.15

13.25

090 retinal lesion. 67210......... ........ A

Treatment of

9.31

6.14

6.46

5.65

5.82

0.44 15.89

16.21

15.40

15.57

090 retinal lesion. 67218......... ........ A

Treatment of

20.14

NA

NA

11.08

11.88

0.92

NA

NA

32.14

32.94

090 retinal lesion. 67220......... ........ A

Treatment of

14.11

9.55

10.20

8.47

8.88

0.65 24.31

24.96

23.23

23.64

090 choroid lesion. 67221......... ........ R

Ocular

3.45

3.03

4.01

1.45

1.71

0.20

6.68

7.66

5.10

5.36

000 photodynamic ther. 67225......... ........ A

Eye

0.47

0.24

0.25

0.18

0.20

0.02

0.73

0.74

0.67

0.69

ZZZ photodynamic ther add-on. 67227......... ........ A

Treatment of

7.32

6.19

6.48

5.33

5.47

0.33 13.84

14.13

12.98

13.12

090 retinal lesion. 67228......... ........ A

Treatment of

13.60 10.27

11.18

7.98

8.40

0.63 24.50

25.41

22.21

22.63

090 retinal lesion. 67250......... ........ A

Reinforce eye

9.40

NA

NA

7.90

8.85

0.47

NA

NA

17.77

18.72

090 wall. 67255......... ........ A

Reinforce/graft 9.89

NA

NA

8.71

9.60

0.44

NA

NA

19.04

19.93

090 eye wall. 67299......... ........ C

Eye surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 67311......... ........ A

Revise eye

7.52

NA

NA

5.68

5.94

0.37

NA

NA

13.57

13.83

090 muscle. 67312......... ........ A

Revise two eye

9.41

NA

NA

6.42

6.67

0.43

NA

NA

16.26

16.51

090 muscles. 67314......... ........ A

Revise eye

8.51

NA

NA

6.37

6.51

0.39

NA

NA

15.27

15.41

090 muscle. 67316......... ........ A

Revise two eye 10.65

NA

NA

7.18

7.42

0.49

NA

NA

18.32

18.56

090 muscles. 67318......... ........ A

Revise eye

8.84

NA

NA

6.76

6.89

0.41

NA

NA

16.01

16.14

090 muscle(s). 67320......... ........ A

Revise eye

4.32

NA

NA

1.62

1.87

0.22

NA

NA

6.16

6.41

ZZZ muscle(s) add- on. 67331......... ........ A

Eye surgery

4.05

NA

NA

1.51

1.75

0.21

NA

NA

5.77

6.01

ZZZ follow-up add- on. 67332......... ........ A

Rerevise eye

4.48

NA

NA

1.68

1.94

0.23

NA

NA

6.39

6.65

ZZZ muscles add-on. 67334......... ........ A

Revise eye

3.97

NA

NA

1.48

1.71

0.20

NA

NA

5.65

5.88

ZZZ muscle w/ suture. 67335......... ........ A

Eye suture

2.49

NA

NA

0.93

1.07

0.13

NA

NA

3.55

3.69

ZZZ during surgery. 67340......... ........ A

Revise eye

4.92

NA

NA

1.84

2.11

0.25

NA

NA

7.01

7.28

ZZZ muscle add-on. 67343......... ........ A

Release eye

8.22

NA

NA

6.25

6.45

0.37

NA

NA

14.84

15.04

090 tissue. 67345......... ........ A

Destroy nerve

2.96

2.27

2.50

1.77

1.95

0.17

5.40

5.63

4.90

5.08

010 of eye muscle. 67350......... ........ A

Biopsy eye

2.87

NA

NA

1.69

1.83

0.15

NA

NA

4.71

4.85

000 muscle. 67399......... ........ C

Eye muscle

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure. 67400......... ........ A

Explore/biopsy 10.88

NA

NA

9.71

10.87

0.56

NA

NA

21.15

22.31

090 eye socket. 67405......... ........ A

Explore/drain

8.92

NA

NA

8.48

9.45

0.44

NA

NA

17.84

18.81

090 eye socket. 67412......... ........ A

Explore/treat

10.12

NA

NA

8.81

10.40

0.48

NA

NA

19.41

21.00

090 eye socket. 67413......... ........ A

Explore/treat

9.99

NA

NA

8.94

10.31

0.50

NA

NA

19.43

20.80

090 eye socket. 67414......... ........ A

Explr/

17.72

NA

NA

11.99

12.03

0.65

NA

NA

30.36

30.40

090 decompress eye socket. 67415......... ........ A

Aspiration,

1.76

NA

NA

0.63

0.73

0.09

NA

NA

2.48

2.58

000 orbital contents. 67420......... ........ A

Explore/treat

21.52

NA

NA

14.59

16.69

1.15

NA

NA

37.26

39.36

090 eye socket. 67430......... ........ A

Explore/treat

14.87

NA

NA

12.66

14.33

0.86

NA

NA

28.39

30.06

090 eye socket. 67440......... ........ A

Explore/drain

14.45

NA

NA

12.12

13.73

0.70

NA

NA

27.27

28.88

090 eye socket. 67445......... ........ A

Explr/

18.90

NA

NA

12.58

13.58

0.90

NA

NA

32.38

33.38

090 decompress eye socket. 67450......... ........ A

Explore/biopsy 14.99

NA

NA

12.63

14.18

0.68

NA

NA

28.30

29.85

090 eye socket. 67500......... ........ A

Inject/treat

1.44

0.61

0.66

0.48

0.34

0.05

2.10

2.15

1.97

1.83

000 eye socket. 67505......... ........ A

Inject/treat

1.27

0.53

0.65

0.40

0.33

0.05

1.85

1.97

1.72

1.65

000 eye socket. 67515......... ........ A

Inject/treat

1.40

0.81

0.65

0.64

0.45

0.03

2.24

2.08

2.07

1.88

000 eye socket. 67550......... ........ A

Insert eye

11.42

NA

NA

10.04

10.99

0.72

NA

NA

22.18

23.13

090 socket implant. 67560......... ........ A

Revise eye

11.83

NA

NA

10.07

11.05

0.60

NA

NA

22.50

23.48

090 socket implant. 67570......... ........ A

Decompress

14.13

NA

NA

11.33

13.02

0.68

NA

NA

26.14

27.83

090 optic nerve. 67599......... ........ C

Orbit surgery

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY procedure. 67700......... ........ A

Drainage of

1.35

4.42

5.62

1.21

1.26

0.07

5.84

7.04

2.63

2.68

010 eyelid abscess. 67710......... ........ A

Incision of

1.02

3.79

4.98

1.10

1.18

0.05

4.86

6.05

2.17

2.25

010 eyelid. 67715......... ........ A

Incision of

1.22

3.91

5.01

1.18

1.26

0.06

5.19

6.29

2.46

2.54

010 eyelid fold. 67800......... ........ A

Remove eyelid

1.38

1.44

1.58

0.93

1.01

0.07

2.89

3.03

2.38

2.46

010 lesion. 67801......... ........ A

Remove eyelid

1.88

1.73

1.90

1.12

1.23

0.09

3.70

3.87

3.09

3.20

010 lesions. 67805......... ........ A

Remove eyelid

2.22

2.25

2.45

1.46

1.60

0.11

4.58

4.78

3.79

3.93

010 lesions. 67808......... ........ A

Remove eyelid

4.42

NA

NA

3.70

3.75

0.19

NA

NA

8.31

8.36

090 lesion(s). 67810......... ........ A

Biopsy of

1.48

3.87

3.47

0.66

0.68

0.06

5.41

5.01

2.20

2.22

000 eyelid. 67820......... ........ A

Revise

0.71

0.45

0.56

0.52

0.55

0.04

1.20

1.31

1.27

1.30

000 eyelashes.

[[Page 49174]]

67825......... ........ A

Revise

1.38

1.44

1.66

1.30

1.38

0.07

2.89

3.11

2.75

2.83

010 eyelashes. 67830......... ........ A

Revise

1.70

4.10

5.17

1.36

1.47

0.08

5.88

6.95

3.14

3.25

010 eyelashes. 67835......... ........ A

Revise

5.55

NA

NA

4.18

4.51

0.28

NA

NA

10.01

10.34

090 eyelashes. 67840......... ........ A

Remove eyelid

2.04

4.01

5.11

1.50

1.61

0.10

6.15

7.25

3.64

3.75

010 lesion. 67850......... ........ A

Treat eyelid

1.69

3.26

3.34

1.43

1.46

0.07

5.02

5.10

3.19

3.22

010 lesion. 67875......... ........ A

Closure of

1.35

2.45

3.09

0.86

0.92

0.07

3.87

4.51

2.28

2.34

000 eyelid by suture. 67880......... ........ A

Revision of

4.42

5.58

6.35

3.67

3.77

0.19 10.19

10.96

8.28

8.38

090 eyelid. 67882......... ........ A

Revision of

5.81

6.56

7.36

4.62

4.76

0.25 12.62

13.42

10.68

10.82

090 eyelid. 67900......... ........ A

Repair brow

6.63

7.52

8.68

4.72

5.12

0.38 14.53

15.69

11.73

12.13

090 defect. 67901......... ........ A

Repair eyelid

7.39

9.25

6.36

5.46

5.42

0.54 17.18

14.29

13.39

13.35

090 defect. 67902......... ........ A

Repair eyelid

9.60

NA

NA

6.58

5.74

0.60

NA

NA

16.78

15.94

090 defect. 67903......... ........ A

Repair eyelid

6.36

6.82

8.88

4.48

5.25

0.47 13.65

15.71

11.31

12.08

090 defect. 67904......... ........ A

Repair eyelid

7.75

8.47

9.34

5.54

5.31

0.41 16.63

17.50

13.70

13.47

090 defect. 67906......... ........ A

Repair eyelid

6.78

NA

NA

4.63

4.93

0.46

NA

NA

11.87

12.17

090 defect. 67908......... ........ A

Repair eyelid

5.12

5.71

6.40

4.25

5.07

0.28 11.11

11.80

9.65

10.47

090 defect. 67909......... ........ A

Revise eyelid

5.39

6.39

7.62

4.31

4.79

0.31 12.09

13.32

10.01

10.49

090 defect. 67911......... ........ A

Revise eyelid

7.30

NA

NA

5.21

4.89

0.31

NA

NA

12.82

12.50

090 defect. 67912......... ........ A

Correction

6.17 13.18

17.49

4.74

5.33

0.28 19.63

23.94

11.19

11.78

090 eyelid w/ implant. 67914......... ........ A

Repair eyelid

3.67

4.88

5.98

2.76

2.98

0.19

8.74

9.84

6.62

6.84

090 defect. 67915......... ........ A

Repair eyelid

3.18

4.54

5.62

2.57

2.74

0.16

7.88

8.96

5.91

6.08

090 defect. 67916......... ........ A

Repair eyelid

5.30

6.53

7.67

4.26

4.64

0.28 12.11

13.25

9.84

10.22

090 defect. 67917......... ........ A

Repair eyelid

6.01

6.91

8.07

4.54

4.94

0.36 13.28

14.44

10.91

11.31

090 defect. 67921......... ........ A

Repair eyelid

3.39

4.75

5.83

2.64

2.83

0.17

8.31

9.39

6.20

6.39

090 defect. 67922......... ........ A

Repair eyelid

3.06

4.44

5.54

2.51

2.69

0.15

7.65

8.75

5.72

5.90

090 defect. 67923......... ........ A

Repair eyelid

5.87

6.63

7.75

4.46

4.84

0.30 12.80

13.92

10.63

11.01

090 defect. 67924......... ........ A

Repair eyelid

5.78

7.11

8.47

4.19

4.56

0.30 13.19

14.55

10.27

10.64

090 defect. 67930......... ........ A

Repair eyelid

3.60

4.50

5.41

1.85

2.09

0.19

8.29

9.20

5.64

5.88

010 wound. 67935......... ........ A

Repair eyelid

6.21

6.95

8.13

3.70

4.23

0.39 13.55

14.73

10.30

10.83

090 wound. 67938......... ........ A

Remove eyelid

1.33

3.95

5.02

1.27

1.26

0.06

5.34

6.41

2.66

2.65

010 foreign body. 67950......... ........ A

Revision of

5.81

6.80

8.17

4.47

5.03

0.36 12.97

14.34

10.64

11.20

090 eyelid. 67961......... ........ A

Revision of

5.68

7.00

8.26

4.43

4.88

0.33 13.01

14.27

10.44

10.89

090 eyelid. 67966......... ........ A

Revision of

8.75

8.29

8.92

5.93

5.65

0.37 17.41

18.04

15.05

14.77

090 eyelid. 67971......... ........ A

Reconstruction

9.78

NA

NA

6.40

7.06

0.53

NA

NA

16.71

17.37

090 of eyelid. 67973......... ........ A

Reconstruction 12.85

NA

NA

8.02

8.99

0.75

NA

NA

21.62

22.59

090 of eyelid. 67974......... ........ A

Reconstruction 12.82

NA

NA

8.04

8.93

0.75

NA

NA

21.61

22.50

090 of eyelid. 67975......... ........ A

Reconstruction

9.12

NA

NA

6.16

6.75

0.50

NA

NA

15.78

16.37

090 of eyelid. 67999......... ........ C

Revision of

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY eyelid. 68020......... ........ A

Incise/drain

1.37

1.28

1.38

1.09

1.18

0.06

2.71

2.81

2.52

2.61

010 eyelid lining. 68040......... ........ A

Treatment of

0.85

0.62

0.69

0.37

0.42

0.04

1.51

1.58

1.26

1.31

000 eyelid lesions. 68100......... ........ A

Biopsy of

1.35

2.41

3.04

0.88

0.93

0.07

3.83

4.46

2.30

2.35

000 eyelid lining. 68110......... ........ A

Remove eyelid

1.77

3.15

3.86

1.52

1.62

0.09

5.01

5.72

3.38

3.48

010 lining lesion. 68115......... ........ A

Remove eyelid

2.36

4.44

5.58

1.74

1.87

0.12

6.92

8.06

4.22

4.35

010 lining lesion. 68130......... ........ A

Remove eyelid

4.92

6.84

8.24

4.16

4.49

0.24 12.00

13.40

9.32

9.65

090 lining lesion. 68135......... ........ A

Remove eyelid

1.84

1.63

1.77

1.51

1.62

0.09

3.56

3.70

3.44

3.55

010 lining lesion. 68200......... ........ A

Treat eyelid by 0.49

0.47

0.52

0.30

0.32

0.02

0.98

1.03

0.81

0.83

000 injection. 68320......... ........ A

Revise/graft

6.36

9.42

10.82

5.47

5.51

0.27 16.05

17.45

12.10

12.14

090 eyelid lining. 68325......... ........ A

Revise/graft

8.35

NA

NA

6.16

6.45

0.44

NA

NA

14.95

15.24

090 eyelid lining. 68326......... ........ A

Revise/graft

8.14

NA

NA

6.12

6.34

0.35

NA

NA

14.61

14.83

090 eyelid lining. 68328......... ........ A

Revise/graft

9.17

NA

NA

6.66

7.13

0.54

NA

NA

16.37

16.84

090 eyelid lining. 68330......... ........ A

Revise eyelid

5.57

7.64

8.97

4.59

4.69

0.24 13.45

14.78

10.40

10.50

090 lining. 68335......... ........ A

Revise/graft

8.18

NA

NA

6.13

6.32

0.36

NA

NA

14.67

14.86

090 eyelid lining. 68340......... ........ A

Separate eyelid 4.79

7.07

8.42

3.99

4.07

0.21 12.07

13.42

8.99

9.07

090 adhesions. 68360......... ........ A

Revise eyelid

4.99

6.60

7.68

4.07

4.15

0.22 11.81

12.89

9.28

9.36

090 lining. 68362......... ........ A

Revise eyelid

8.33

NA

NA

6.18

6.35

0.36

NA

NA

14.87

15.04

090 lining. 68371......... ........ A

Harvest eye

4.89

NA

NA

4.18

4.59

0.44

NA

NA

9.51

9.92

010 tissue, alograft. 68399......... ........ C

Eyelid lining

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery.

[[Page 49175]]

68400......... ........ A

Incise/drain

1.69

4.44

5.54

1.22

1.67

0.08

6.21

7.31

2.99

3.44

010 tear gland. 68420......... ........ A

Incise/drain

2.30

4.70

5.82

1.46

1.94

0.11

7.11

8.23

3.87

4.35

010 tear sac. 68440......... ........ A

Incise tear

0.94

1.28

1.88

1.21

1.26

0.05

2.27

2.87

2.20

2.25

010 duct opening. 68500......... ........ A

Removal of tear 12.38

NA

NA

8.97

9.54

0.55

NA

NA

21.90

22.47

090 gland. 68505......... ........ A

Partial

12.30

NA

NA

9.11

10.27

0.55

NA

NA

21.96

23.12

090 removal, tear gland. 68510......... ........ A

Biopsy of tear

4.60

5.37

6.84

2.11

2.10

0.23 10.20

11.67

6.94

6.93

000 gland. 68520......... ........ A

Removal of tear 8.50

NA

NA

6.68

7.24

0.37

NA

NA

15.55

16.11

090 sac. 68525......... ........ A

Biopsy of tear

4.42

NA

NA

1.64

1.93

0.22

NA

NA

6.28

6.57

000 sac. 68530......... ........ A

Clearance of

3.65

5.75

7.57

2.14

2.52

0.18

9.58

11.40

5.97

6.35

010 tear duct. 68540......... ........ A

Remove tear

11.83

NA

NA

8.71

9.22

0.52

NA

NA

21.06

21.57

090 gland lesion. 68550......... ........ A

Remove tear

14.74

NA

NA

10.52

11.14

0.80

NA

NA

26.06

26.68

090 gland lesion. 68700......... ........ A

Repair tear

7.59

NA

NA

5.74

5.92

0.32

NA

NA

13.65

13.83

090 ducts. 68705......... ........ A

Revise tear

2.06

3.12

3.91

1.63

1.75

0.10

5.28

6.07

3.79

3.91

010 duct opening. 68720......... ........ A

Create tear sac 9.70

NA

NA

7.10

7.67

0.44

NA

NA

17.24

17.81

090 drain. 68745......... ........ A

Create tear

9.62

NA

NA

7.45

7.76

0.52

NA

NA

17.59

17.90

090 duct drain. 68750......... ........ A

Create tear

9.78

NA

NA

7.64

8.11

0.43

NA

NA

17.85

18.32

090 duct drain. 68760......... ........ A

Close tear duct 1.73

2.66

3.32

1.50

1.60

0.09

4.48

5.14

3.32

3.42

010 opening. 68761......... ........ A

Close tear duct 1.36

1.88

2.17

1.28

1.31

0.06

3.30

3.59

2.70

2.73

010 opening. 68770......... ........ A

Close tear

8.01

NA

NA

5.88

3.86

0.35

NA

NA

14.24

12.22

090 system fistula. 68801......... ........ A

Dilate tear

0.94

1.82

1.91

1.45

1.47

0.05

2.81

2.90

2.44

2.46

010 duct opening. 68810......... ........ A

Probe

2.59

3.49

3.62

2.76

2.69

0.10

6.18

6.31

5.45

5.38

010 nasolacrimal duct. 68811......... ........ A

Probe

2.35

NA

NA

2.17

2.35

0.13

NA

NA

4.65

4.83

010 nasolacrimal duct. 68815......... ........ A

Probe

3.20

6.57

7.82

2.49

2.73

0.17

9.94

11.19

5.86

6.10

010 nasolacrimal duct. 68840......... ........ A

Explore/

1.25

1.56

1.59

1.32

1.17

0.06

2.87

2.90

2.63

2.48

010 irrigate tear ducts. 68850......... ........ A

Injection for

0.80

0.72

0.84

0.60

0.66

0.04

1.56

1.68

1.44

1.50

000 tear sac x-ray. 68899......... ........ C

Tear duct

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY system surgery. 69000......... ........ A

Drain external

1.45

2.70

2.84

1.24

1.33

0.12

4.27

4.41

2.81

2.90

010 ear lesion. 69005......... ........ A

Drain external

2.11

2.74

2.88

1.45

1.74

0.17

5.02

5.16

3.73

4.02

010 ear lesion. 69020......... ........ A

Drain outer ear 1.48

3.84

3.95

1.76

1.99

0.12

5.44

5.55

3.36

3.59

010 canal lesion. 69100......... ........ A

Biopsy of

0.81

1.80

1.73

0.38

0.39

0.03

2.64

2.57

1.22

1.23

000 external ear. 69105......... ........ A

Biopsy of

0.85

2.47

2.37

0.65

0.74

0.07

3.39

3.29

1.57

1.66

000 external ear canal. 69110......... ........ A

Remove external 3.43

7.50

6.93

4.23

4.41

0.30 11.23

10.66

7.96

8.14

090 ear, partial. 69120......... ........ A

Removal of

4.04

NA

NA

5.09

5.91

0.38

NA

NA

9.51

10.33

090 external ear. 69140......... ........ A

Remove ear

7.96

NA

NA

12.30

13.04

0.65

NA

NA

20.91

21.65

090 canal lesion(s). 69145......... ........ A

Remove ear

2.62

6.53

5.97

3.10

3.25

0.21

9.36

8.80

5.93

6.08

090 canal lesion(s). 69150......... ........ A

Extensive ear

13.41

NA

NA

10.55

12.69

1.22

NA

NA

25.18

27.32

090 canal surgery. 69155......... ........ A

Extensive ear/ 22.96

NA

NA

15.01

18.41

1.92

NA

NA

39.89

43.29

090 neck surgery. 69200......... ........ A

Clear outer ear 0.77

2.03

2.29

0.57

0.56

0.06

2.86

3.12

1.40

1.39

000 canal. 69205......... ........ A

Clear outer ear 1.20

NA

NA

1.14

1.31

0.10

NA

NA

2.44

2.61

010 canal. 69210......... ........ A

Remove impacted 0.61

0.55

0.61

0.16

0.21

0.05

1.21

1.27

0.82

0.87

000 ear wax. 69220......... ........ A

Clean out

0.83

2.37

2.36

0.61

0.70

0.07

3.27

3.26

1.51

1.60

000 mastoid cavity. 69222......... ........ A

Clean out

1.40

3.66

3.80

1.73

1.98

0.12

5.18

5.32

3.25

3.50

010 mastoid cavity. 69300......... ........ R

Revise external 6.35

9.61

5.57

4.51

4.29

0.72 16.68

12.64

11.58

11.36

YYY ear. 69310......... ........ A

Rebuild outer

10.77

NA

NA

14.19

15.76

0.85

NA

NA

25.81

27.38

090 ear canal. 69320......... ........ A

Rebuild outer

16.93

NA

NA

18.16

20.92

1.37

NA

NA

36.46

39.22

090 ear canal. 69399......... ........ C

Outer ear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure. 69400......... ........ A

Inflate middle

0.83

2.60

2.27

0.61

0.66

0.07

3.50

3.17

1.51

1.56

000 ear canal. 69401......... ........ A

Inflate middle

0.63

1.46

1.30

0.56

0.63

0.05

2.14

1.98

1.24

1.31

000 ear canal. 69405......... ........ A

Catheterize

2.63

3.38

3.47

1.78

2.18

0.21

6.22

6.31

4.62

5.02

010 middle ear canal. 69420......... ........ A

Incision of

1.33

3.05

3.13

1.41

1.55

0.11

4.49

4.57

2.85

2.99

010 eardrum. 69421......... ........ A

Incision of

1.73

NA

NA

1.68

2.04

0.15

NA

NA

3.56

3.92

010 eardrum. 69424......... ........ A

Remove

0.85

2.18

2.18

0.62

0.67

0.07

3.10

3.10

1.54

1.59

000 ventilating tube. 69433......... ........ A

Create eardrum

1.52

3.06

3.08

1.44

1.59

0.13

4.71

4.73

3.09

3.24

010 opening. 69436......... ........ A

Create eardrum

1.96

NA

NA

1.72

2.15

0.19

NA

NA

3.87

4.30

010 opening. 69440......... ........ A

Exploration of

7.56

NA

NA

8.31

8.66

0.61

NA

NA

16.48

16.83

090 middle ear. 69450......... ........ A

Eardrum

5.56

NA

NA

6.96

7.01

0.45

NA

NA

12.97

13.02

090 revision. 69501......... ........ A

Mastoidectomy.. 9.06

NA

NA

7.80

8.70

0.73

NA

NA

17.59

18.49

090 69502......... ........ A

Mastoidectomy.. 12.36

NA

NA

10.02

11.20

1.00

NA

NA

23.38

24.56

090 69505......... ........ A

Remove mastoid 12.97

NA

NA

14.81

16.60

1.05

NA

NA

28.83

30.62

090 structures. 69511......... ........ A

Extensive

13.50

NA

NA

14.89

16.83

1.09

NA

NA

29.48

31.42

090 mastoid surgery. 69530......... ........ A

Extensive

20.15

NA

NA

17.97

20.72

1.54

NA

NA

39.66

42.41

090 mastoid surgery. 69535......... ........ A

Remove part of 37.17

NA

NA

24.19

30.02

2.92

NA

NA

64.28

70.11

090 temporal bone. 69540......... ........ A

Remove ear

1.20

3.62

3.71

1.70

1.90

0.10

4.92

5.01

3.00

3.20

010 lesion. 69550......... ........ A

Remove ear

10.97

NA

NA

13.06

14.41

0.89

NA

NA

24.92

26.27

090 lesion. 69552......... ........ A

Remove ear

19.61

NA

NA

16.55

19.64

1.59

NA

NA

37.75

40.84

090 lesion. 69554......... ........ A

Remove ear

35.63

NA

NA

22.41

28.35

2.91

NA

NA

60.95

66.89

090 lesion.

[[Page 49176]]

69601......... ........ A

Mastoid surgery 13.22

NA

NA

10.84

12.21

1.07

NA

NA

25.13

26.50

090 revision. 69602......... ........ A

Mastoid surgery 13.56

NA

NA

11.56

12.81

1.10

NA

NA

26.22

27.47

090 revision. 69603......... ........ A

Mastoid surgery 14.00

NA

NA

15.03

17.53

1.14

NA

NA

30.17

32.67

090 revision. 69604......... ........ A

Mastoid surgery 14.00

NA

NA

11.67

13.19

1.14

NA

NA

26.81

28.33

090 revision. 69605......... ........ A

Mastoid surgery 18.46

NA

NA

17.50

20.09

1.50

NA

NA

37.46

40.05

090 revision. 69610......... ........ A

Repair of

4.42

4.47

5.28

2.30

3.03

0.36

9.25

10.06

7.08

7.81

010 eardrum. 69620......... ........ A

Repair of

5.88 10.04

10.85

5.29

6.04

0.48 16.40

17.21

11.65

12.40

090 eardrum. 69631......... ........ A

Repair eardrum

9.85

NA

NA

10.50

11.03

0.80

NA

NA

21.15

21.68

090 structures. 69632......... ........ A

Rebuild eardrum 12.73

NA

NA

12.08

13.12

1.03

NA

NA

25.84

26.88

090 structures. 69633......... ........ A

Rebuild eardrum 12.08

NA

NA

11.91

12.77

0.98

NA

NA

24.97

25.83

090 structures. 69635......... ........ A

Repair eardrum 13.31

NA

NA

14.83

16.26

1.08

NA

NA

29.22

30.65

090 structures. 69636......... ........ A

Rebuild eardrum 15.20

NA

NA

16.60

18.63

1.23

NA

NA

33.03

35.06

090 structures. 69637......... ........ A

Rebuild eardrum 15.09

NA

NA

16.58

18.56

1.22

NA

NA

32.89

34.87

090 structures. 69641......... ........ A

Revise middle

12.69

NA

NA

11.31

12.41

1.03

NA

NA

25.03

26.13

090 ear & mastoid. 69642......... ........ A

Revise middle

16.81

NA

NA

14.05

15.72

1.36

NA

NA

32.22

33.89

090 ear & mastoid. 69643......... ........ A

Revise middle

15.36

NA

NA

12.81

14.32

1.24

NA

NA

29.41

30.92

090 ear & mastoid. 69644......... ........ A

Revise middle

17.00

NA

NA

17.09

19.57

1.37

NA

NA

35.46

37.94

090 ear & mastoid. 69645......... ........ A

Revise middle

16.48

NA

NA

17.01

19.27

1.33

NA

NA

34.82

37.08

090 ear & mastoid. 69646......... ........ A

Revise middle

18.14

NA

NA

17.42

19.93

1.46

NA

NA

37.02

39.53

090 ear & mastoid. 69650......... ........ A

Release middle

9.65

NA

NA

8.64

9.59

0.78

NA

NA

19.07

20.02

090 ear bone. 69660......... ........ A

Revise middle

11.88

NA

NA

9.52

10.77

0.96

NA

NA

22.36

23.61

090 ear bone. 69661......... ........ A

Revise middle

15.72

NA

NA

12.17

14.07

1.27

NA

NA

29.16

31.06

090 ear bone. 69662......... ........ A

Revise middle

15.42

NA

NA

11.29

13.14

1.25

NA

NA

27.96

29.81

090 ear bone. 69666......... ........ A

Repair middle

9.74

NA

NA

8.92

9.71

0.79

NA

NA

19.45

20.24

090 ear structures. 69667......... ........ A

Repair middle

9.75

NA

NA

8.83

9.69

0.79

NA

NA

19.37

20.23

090 ear structures. 69670......... ........ A

Remove mastoid 11.55

NA

NA

10.15

11.32

0.93

NA

NA

22.63

23.80

090 air cells. 69676......... ........ A

Remove middle

9.51

NA

NA

9.63

10.47

0.81

NA

NA

19.95

20.79

090 ear nerve. 69700......... ........ A

Close mastoid

8.22

NA

NA

7.65

8.84

0.67

NA

NA

16.54

17.73

090 fistula. 69711......... ........ A

Remove/repair

10.42

NA

NA

9.42

10.45

0.83

NA

NA

20.67

21.70

090 hearing aid. 69714......... ........ A

Implant temple 14.23

NA

NA

10.56

12.14

1.13

NA

NA

25.92

27.50

090 bone w/stimul. 69715......... ........ A

Temple bne

18.72

NA

NA

11.94

14.26

1.48

NA

NA

32.14

34.46

090 implnt w/ stimulat. 69717......... ........ A

Temple bone

15.21

NA

NA

11.31

13.68

0.90

NA

NA

27.42

29.79

090 implant revision. 69718......... ........ A

Revise temple

18.97

NA

NA

20.26

16.54

3.21

NA

NA

42.44

38.72

090 bone implant. 69720......... ........ A

Release facial 14.48

NA

NA

12.75

14.08

1.16

NA

NA

28.39

29.72

090 nerve. 69725......... ........ A

Release facial 27.36

NA

NA

16.30

19.17

2.44

NA

NA

46.10

48.97

090 nerve. 69740......... ........ A

Repair facial

16.12

NA

NA

11.17

12.85

1.27

NA

NA

28.56

30.24

090 nerve. 69745......... ........ A

Repair facial

16.84

NA

NA

11.87

14.20

1.14

NA

NA

29.85

32.18

090 nerve. 69799......... ........ C

Middle ear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure. 69801......... ........ A

Incise inner

8.55

NA

NA

8.75

9.28

0.69

NA

NA

17.99

18.52

090 ear. 69802......... ........ A

Incise inner

13.32

NA

NA

10.54

11.88

1.06

NA

NA

24.92

26.26

090 ear. 69805......... ........ A

Explore inner

14.49

NA

NA

9.80

11.36

1.12

NA

NA

25.41

26.97

090 ear. 69806......... ........ A

Explore inner

12.45

NA

NA

9.37

10.62

1.00

NA

NA

22.82

24.07

090 ear. 69820......... ........ A

Establish inner 10.32

NA

NA

9.83

10.87

0.90

NA

NA

21.05

22.09

090 ear window. 69840......... ........ A

Revise inner

10.24

NA

NA

11.67

12.80

0.79

NA

NA

22.70

23.83

090 ear window. 69905......... ........ A

Remove inner

11.08

NA

NA

10.08

11.03

0.90

NA

NA

22.06

23.01

090 ear. 69910......... ........ A

Remove inner

13.73

NA

NA

9.79

11.39

1.07

NA

NA

24.59

26.19

090 ear & mastoid. 69915......... ........ A

Incise inner

22.57

NA

NA

13.38

15.69

1.69

NA

NA

37.64

39.95

090 ear nerve. 69930......... ........ A

Implant

17.54

NA

NA

11.81

14.02

1.36

NA

NA

30.71

32.92

090 cochlear device. 69949......... ........ C

Inner ear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery procedure. 69950......... ........ A

Incise inner

27.38

NA

NA

15.12

17.96

2.28

NA

NA

44.78

47.62

090 ear nerve. 69955......... ........ A

Release facial 29.14

NA

NA

17.30

20.36

2.48

NA

NA

48.92

51.98

090 nerve. 69960......... ........ A

Release inner

29.14

NA

NA

15.41

18.89

2.17

NA

NA

46.72

50.20

090 ear canal. 69970......... ........ A

Remove inner

32.13

NA

NA

17.78

21.90

2.41

NA

NA

52.32

56.44

090 ear lesion. 69979......... ........ C

Temporal bone

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

YYY surgery. 69990......... ........ R

Microsurgery

3.46

NA

NA

1.29

1.67

0.89

NA

NA

5.64

6.02

ZZZ add-on. 70010......... ........ A

Contrast x-ray

1.19

2.77

4.23

NA

NA

0.27

4.23

5.69

NA

NA

XXX of brain.

[[Page 49177]]

70010......... 26...... A

Contrast x-ray

1.19

0.37

0.39

0.37

0.39

0.05

1.61

1.63

1.61

1.63

XXX of brain. 70010......... TC...... A

Contrast x-ray

0.00

2.40

3.85

NA

NA

0.22

2.62

4.07

NA

NA

XXX of brain. 70015......... ........ A

Contrast x-ray

1.19

2.85

2.01

NA

NA

0.16

4.20

3.36

NA

NA

XXX of brain. 70015......... 26...... A

Contrast x-ray

1.19

0.38

0.39

0.38

0.39

0.08

1.65

1.66

1.65

1.66

XXX of brain. 70015......... TC...... A

Contrast x-ray

0.00

2.47

1.63

NA

NA

0.08

2.55

1.71

NA

NA

XXX of brain. 70030......... ........ A

X-ray eye for

0.17

0.60

0.51

NA

NA

0.03

0.80

0.71

NA

NA

XXX foreign body. 70030......... 26...... A

X-ray eye for

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX foreign body. 70030......... TC...... A

X-ray eye for

0.00

0.55

0.45

NA

NA

0.02

0.57

0.47

NA

NA

XXX foreign body. 70100......... ........ A

X-ray exam of

0.18

0.63

0.59

NA

NA

0.03

0.84

0.80

NA

NA

XXX jaw. 70100......... 26...... A

X-ray exam of

0.18

0.05

0.06

0.05

0.06

0.01

0.24

0.25

0.24

0.25

XXX jaw. 70100......... TC...... A

X-ray exam of

0.00

0.58

0.54

NA

NA

0.02

0.60

0.56

NA

NA

XXX jaw. 70110......... ........ A

X-ray exam of

0.25

0.80

0.73

NA

NA

0.05

1.10

1.03

NA

NA

XXX jaw. 70110......... 26...... A

X-ray exam of

0.25

0.08

0.08

0.08

0.08

0.01

0.34

0.34

0.34

0.34

XXX jaw. 70110......... TC...... A

X-ray exam of

0.00

0.72

0.65

NA

NA

0.04

0.76

0.69

NA

NA

XXX jaw. 70120......... ........ A

X-ray exam of

0.18

0.69

0.68

NA

NA

0.05

0.92

0.91

NA

NA

XXX mastoids. 70120......... 26...... A

X-ray exam of

0.18

0.05

0.06

0.05

0.06

0.01

0.24

0.25

0.24

0.25

XXX mastoids. 70120......... TC...... A

X-ray exam of

0.00

0.64

0.63

NA

NA

0.04

0.68

0.67

NA

NA

XXX mastoids. 70130......... ........ A

X-ray exam of

0.34

1.16

0.96

NA

NA

0.07

1.57

1.37

NA

NA

XXX mastoids. 70130......... 26...... A

X-ray exam of

0.34

0.10

0.11

0.10

0.11

0.02

0.46

0.47

0.46

0.47

XXX mastoids. 70130......... TC...... A

X-ray exam of

0.00

1.06

0.85

NA

NA

0.05

1.11

0.90

NA

NA

XXX mastoids. 70134......... ........ A

X-ray exam of

0.34

0.92

0.86

NA

NA

0.07

1.33

1.27

NA

NA

XXX middle ear. 70134......... 26...... A

X-ray exam of

0.34

0.11

0.11

0.11

0.11

0.02

0.47

0.47

0.47

0.47

XXX middle ear. 70134......... TC...... A

X-ray exam of

0.00

0.82

0.75

NA

NA

0.05

0.87

0.80

NA

NA

XXX middle ear. 70140......... ........ A

X-ray exam of

0.19

0.55

0.65

NA

NA

0.05

0.79

0.89

NA

NA

XXX facial bones. 70140......... 26...... A

X-ray exam of

0.19

0.05

0.06

0.05

0.06

0.01

0.25

0.26

0.25

0.26

XXX facial bones. 70140......... TC...... A

X-ray exam of

0.00

0.50

0.59

NA

NA

0.04

0.54

0.63

NA

NA

XXX facial bones. 70150......... ........ A

X-ray exam of

0.26

0.85

0.86

NA

NA

0.06

1.17

1.18

NA

NA

XXX facial bones. 70150......... 26...... A

X-ray exam of

0.26

0.07

0.08

0.07

0.08

0.01

0.34

0.35

0.34

0.35

XXX facial bones. 70150......... TC...... A

X-ray exam of

0.00

0.77

0.78

NA

NA

0.05

0.82

0.83

NA

NA

XXX facial bones. 70160......... ........ A

X-ray exam of

0.17

0.70

0.61

NA

NA

0.03

0.90

0.81

NA

NA

XXX nasal bones. 70160......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX nasal bones. 70160......... TC...... A

X-ray exam of

0.00

0.65

0.55

NA

NA

0.02

0.67

0.57

NA

NA

XXX nasal bones. 70170......... ........ A

X-ray exam of

0.30

NA

NA

NA

NA

0.07

NA

NA

NA

NA

XXX tear duct. 70170......... 26...... A

X-ray exam of

0.30

0.09

0.10

0.09

0.10

0.01

0.40

0.41

0.40

0.41

XXX tear duct. 70170......... TC...... A

X-ray exam of

0.00

NA

NA

NA

NA

0.06

NA

NA

NA

NA

XXX tear duct. 70190......... ........ A

X-ray exam of

0.21

0.72

0.70

NA

NA

0.05

0.98

0.96

NA

NA

XXX eye sockets. 70190......... 26...... A

X-ray exam of

0.21

0.06

0.07

0.06

0.07

0.01

0.28

0.29

0.28

0.29

XXX eye sockets. 70190......... TC...... A

X-ray exam of

0.00

0.66

0.63

NA

NA

0.04

0.70

0.67

NA

NA

XXX eye sockets. 70200......... ........ A

X-ray exam of

0.28

0.87

0.87

NA

NA

0.06

1.21

1.21

NA

NA

XXX eye sockets. 70200......... 26...... A

X-ray exam of

0.28

0.08

0.09

0.08

0.09

0.01

0.37

0.38

0.37

0.38

XXX eye sockets. 70200......... TC...... A

X-ray exam of

0.00

0.79

0.78

NA

NA

0.05

0.84

0.83

NA

NA

XXX eye sockets. 70210......... ........ A

X-ray exam of

0.17

0.57

0.65

NA

NA

0.05

0.79

0.87

NA

NA

XXX sinuses. 70210......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX sinuses. 70210......... TC...... A

X-ray exam of

0.00

0.52

0.60

NA

NA

0.04

0.56

0.64

NA

NA

XXX sinuses. 70220......... ........ A

X-ray exam of

0.25

0.72

0.83

NA

NA

0.06

1.03

1.14

NA

NA

XXX sinuses. 70220......... 26...... A

X-ray exam of

0.25

0.07

0.08

0.07

0.08

0.01

0.33

0.34

0.33

0.34

XXX sinuses. 70220......... TC...... A

X-ray exam of

0.00

0.65

0.75

NA

NA

0.05

0.70

0.80

NA

NA

XXX sinuses. 70240......... ........ A

X-ray exam,

0.19

0.61

0.51

NA

NA

0.03

0.83

0.73

NA

NA

XXX pituitary saddle. 70240......... 26...... A

X-ray exam,

0.19

0.06

0.06

0.06

0.06

0.01

0.26

0.26

0.26

0.26

XXX pituitary saddle. 70240......... TC...... A

X-ray exam,

0.00

0.55

0.45

NA

NA

0.02

0.57

0.47

NA

NA

XXX pituitary saddle. 70250......... ........ A

X-ray exam of

0.24

0.70

0.70

NA

NA

0.05

0.99

0.99

NA

NA

XXX skull. 70250......... 26...... A

X-ray exam of

0.24

0.07

0.08

0.07

0.08

0.01

0.32

0.33

0.32

0.33

XXX skull. 70250......... TC...... A

X-ray exam of

0.00

0.64

0.63

NA

NA

0.04

0.68

0.67

NA

NA

XXX skull. 70260......... ........ A

X-ray exam of

0.34

0.88

0.97

NA

NA

0.08

1.30

1.39

NA

NA

XXX skull. 70260......... 26...... A

X-ray exam of

0.34

0.10

0.11

0.10

0.11

0.02

0.46

0.47

0.46

0.47

XXX skull. 70260......... TC...... A

X-ray exam of

0.00

0.78

0.86

NA

NA

0.06

0.84

0.92

NA

NA

XXX skull. 70300......... ........ A

X-ray exam of

0.10

0.24

0.29

NA

NA

0.03

0.37

0.42

NA

NA

XXX teeth. 70300......... 26...... A

X-ray exam of

0.10

0.03

0.05

0.03

0.05

0.01

0.14

0.16

0.14

0.16

XXX teeth. 70300......... TC...... A

X-ray exam of

0.00

0.21

0.25

NA

NA

0.02

0.23

0.27

NA

NA

XXX teeth. 70310......... ........ A

X-ray exam of

0.16

0.82

0.58

NA

NA

0.03

1.01

0.77

NA

NA

XXX teeth. 70310......... 26...... A

X-ray exam of

0.16

0.05

0.07

0.05

0.07

0.01

0.22

0.24

0.22

0.24

XXX teeth. 70310......... TC...... A

X-ray exam of

0.00

0.77

0.51

NA

NA

0.02

0.79

0.53

NA

NA

XXX teeth. 70320......... ........ A

Full mouth x-

0.22

0.98

0.89

NA

NA

0.06

1.26

1.17

NA

NA

XXX ray of teeth. 70320......... 26...... A

Full mouth x-

0.22

0.06

0.08

0.06

0.08

0.01

0.29

0.31

0.29

0.31

XXX ray of teeth. 70320......... TC...... A

Full mouth x-

0.00

0.91

0.81

NA

NA

0.05

0.96

0.86

NA

NA

XXX ray of teeth. 70328......... ........ A

X-ray exam of

0.18

0.62

0.57

NA

NA

0.03

0.83

0.78

NA

NA

XXX jaw joint.

[[Page 49178]]

70328......... 26...... A

X-ray exam of

0.18

0.05

0.06

0.05

0.06

0.01

0.24

0.25

0.24

0.25

XXX jaw joint. 70328......... TC...... A

X-ray exam of

0.00

0.57

0.51

NA

NA

0.02

0.59

0.53

NA

NA

XXX jaw joint. 70330......... ........ A

X-ray exam of

0.24

1.01

0.94

NA

NA

0.06

1.31

1.24

NA

NA

XXX jaw joints. 70330......... 26...... A

X-ray exam of

0.24

0.07

0.08

0.07

0.08

0.01

0.32

0.33

0.32

0.33

XXX jaw joints. 70330......... TC...... A

X-ray exam of

0.00

0.94

0.87

NA

NA

0.05

0.99

0.92

NA

NA

XXX jaw joints. 70332......... ........ A

X-ray exam of

0.54

1.46

2.09

NA

NA

0.14

2.14

2.77

NA

NA

XXX jaw joint. 70332......... 26...... A

X-ray exam of

0.54

0.16

0.19

0.16

0.19

0.02

0.72

0.75

0.72

0.75

XXX jaw joint. 70332......... TC...... A

X-ray exam of

0.00

1.30

1.90

NA

NA

0.12

1.42

2.02

NA

NA

XXX jaw joint. 70336......... ........ A

Magnetic image, 1.48 12.60

11.92

NA

NA

0.66 14.74

14.06

NA

NA

XXX jaw joint. 70336......... 26...... A

Magnetic image, 1.48

0.50

0.49

0.50

0.49

0.07

2.05

2.04

2.05

2.04

XXX jaw joint. 70336......... TC...... A

Magnetic image, 0.00 12.10

11.43

NA

NA

0.59 12.69

12.02

NA

NA

XXX jaw joint. 70350......... ........ A

X-ray head for

0.17

0.33

0.42

NA

NA

0.03

0.53

0.62

NA

NA

XXX orthodontia. 70350......... 26...... A

X-ray head for

0.17

0.05

0.07

0.05

0.07

0.01

0.23

0.25

0.23

0.25

XXX orthodontia. 70350......... TC...... A

X-ray head for

0.00

0.27

0.35

NA

NA

0.02

0.29

0.37

NA

NA

XXX orthodontia. 70355......... ........ A

Panoramic x-ray 0.20

0.30

0.56

NA

NA

0.05

0.55

0.81

NA

NA

XXX of jaws. 70355......... 26...... A

Panoramic x-ray 0.20

0.06

0.07

0.06

0.07

0.01

0.27

0.28

0.27

0.28

XXX of jaws. 70355......... TC...... A

Panoramic x-ray 0.00

0.24

0.49

NA

NA

0.04

0.28

0.53

NA

NA

XXX of jaws. 70360......... ........ A

X-ray exam of

0.17

0.58

0.51

NA

NA

0.03

0.78

0.71

NA

NA

XXX neck. 70360......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX neck. 70360......... TC...... A

X-ray exam of

0.00

0.52

0.45

NA

NA

0.02

0.54

0.47

NA

NA

XXX neck. 70370......... ........ A

Throat x-ray &

0.32

1.65

1.47

NA

NA

0.08

2.05

1.87

NA

NA

XXX fluoroscopy. 70370......... 26...... A

Throat x-ray &

0.32

0.09

0.10

0.09

0.10

0.01

0.42

0.43

0.42

0.43

XXX fluoroscopy. 70370......... TC...... A

Throat x-ray &

0.00

1.56

1.37

NA

NA

0.07

1.63

1.44

NA

NA

XXX fluoroscopy. 70371......... ........ A

Speech

0.84

1.50

2.16

NA

NA

0.16

2.50

3.16

NA

NA

XXX evaluation, complex. 70371......... 26...... A

Speech

0.84

0.26

0.28

0.26

0.28

0.04

1.14

1.16

1.14

1.16

XXX evaluation, complex. 70371......... TC...... A

Speech

0.00

1.24

1.89

NA

NA

0.12

1.36

2.01

NA

NA

XXX evaluation, complex. 70373......... ........ A

Contrast x-ray

0.44

1.71

1.87

NA

NA

0.13

2.28

2.44

NA

NA

XXX of larynx. 70373......... 26...... A

Contrast x-ray

0.44

0.13

0.14

0.13

0.14

0.02

0.59

0.60

0.59

0.60

XXX of larynx. 70373......... TC...... A

Contrast x-ray

0.00

1.58

1.73

NA

NA

0.11

1.69

1.84

NA

NA

XXX of larynx. 70380......... ........ A

X-ray exam of

0.17

0.82

0.75

NA

NA

0.05

1.04

0.97

NA

NA

XXX salivary gland. 70380......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX salivary gland. 70380......... TC...... A

X-ray exam of

0.00

0.76

0.69

NA

NA

0.04

0.80

0.73

NA

NA

XXX salivary gland. 70390......... ........ A

X-ray exam of

0.38

2.34

2.01

NA

NA

0.13

2.85

2.52

NA

NA

XXX salivary duct. 70390......... 26...... A

X-ray exam of

0.38

0.12

0.12

0.12

0.12

0.02

0.52

0.52

0.52

0.52

XXX salivary duct. 70390......... TC...... A

X-ray exam of

0.00

2.22

1.89

NA

NA

0.11

2.33

2.00

NA

NA

XXX salivary duct. 70450......... ........ A

Ct head/brain w/ 0.85

4.90

4.98

NA

NA

0.29

6.04

6.12

NA

NA

XXX o dye. 70450......... 26...... A

Ct head/brain w/ 0.85

0.27

0.28

0.27

0.28

0.04

1.16

1.17

1.16

1.17

XXX o dye. 70450......... TC...... A

Ct head/brain w/ 0.00

4.64

4.70

NA

NA

0.25

4.89

4.95

NA

NA

XXX o dye. 70460......... ........ A

Ct head/brain w/ 1.13

6.52

6.15

NA

NA

0.35

8.00

7.63

NA

NA

XXX dye. 70460......... 26...... A

Ct head/brain w/ 1.13

0.36

0.37

0.36

0.37

0.05

1.54

1.55

1.54

1.55

XXX dye. 70460......... TC...... A

Ct head/brain w/ 0.00

6.16

5.79

NA

NA

0.30

6.46

6.09

NA

NA

XXX dye. 70470......... ........ A

Ct head/brain w/ 1.27

7.96

7.61

NA

NA

0.43

9.66

9.31

NA

NA

XXX o & w/dye. 70470......... 26...... A

Ct head/brain w/ 1.27

0.40

0.42

0.40

0.42

0.06

1.73

1.75

1.73

1.75

XXX o & w/dye. 70470......... TC...... A

Ct head/brain w/ 0.00

7.56

7.19

NA

NA

0.37

7.93

7.56

NA

NA

XXX o & w/dye. 70480......... ........ A

Ct orbit/ear/

1.28

8.52

5.99

NA

NA

0.31 10.11

7.58

NA

NA

XXX fossa w/o dye. 70480......... 26...... A

Ct orbit/ear/

1.28

0.41

0.42

0.41

0.42

0.06

1.75

1.76

1.75

1.76

XXX fossa w/o dye. 70480......... TC...... A

Ct orbit/ear/

0.00

8.11

5.57

NA

NA

0.25

8.36

5.82

NA

NA

XXX fossa w/o dye. 70481......... ........ A

Ct orbit/ear/

1.38 10.04

7.09

NA

NA

0.36 11.78

8.83

NA

NA

XXX fossa w/dye. 70481......... 26...... A

Ct orbit/ear/

1.38

0.44

0.45

0.44

0.45

0.06

1.88

1.89

1.88

1.89

XXX fossa w/dye. 70481......... TC...... A

Ct orbit/ear/

0.00

9.60

6.65

NA

NA

0.30

9.90

6.95

NA

NA

XXX fossa w/dye. 70482......... ........ A

Ct orbit/ear/

1.45 11.56

8.55

NA

NA

0.43 13.44

10.43

NA

NA

XXX fossa w/o&w/ dye. 70482......... 26...... A

Ct orbit/ear/

1.45

0.47

0.48

0.47

0.48

0.06

1.98

1.99

1.98

1.99

XXX fossa w/o&w/ dye. 70482......... TC...... A

Ct orbit/ear/

0.00 11.09

8.08

NA

NA

0.37 11.46

8.45

NA

NA

XXX fossa w/o&w/ dye. 70486......... ........ A

Ct

1.14

6.81

5.52

NA

NA

0.30

8.25

6.96

NA

NA

XXX maxillofacial w/o dye. 70486......... 26...... A

Ct

1.14

0.36

0.37

0.36

0.37

0.05

1.55

1.56

1.55

1.56

XXX maxillofacial w/o dye. 70486......... TC...... A

Ct

0.00

6.44

5.15

NA

NA

0.25

6.69

5.40

NA

NA

XXX maxillofacial w/o dye.

[[Page 49179]]

70487......... ........ A

Ct

1.30

8.39

6.67

NA

NA

0.36 10.05

8.33

NA

NA

XXX maxillofacial w/dye. 70487......... 26...... A

Ct

1.30

0.42

0.43

0.42

0.43

0.06

1.78

1.79

1.78

1.79

XXX maxillofacial w/dye. 70487......... TC...... A

Ct

0.00

7.97

6.24

NA

NA

0.30

8.27

6.54

NA

NA

XXX maxillofacial w/dye. 70488......... ........ A

Ct

1.42 10.48

8.27

NA

NA

0.43 12.33

10.12

NA

NA

XXX maxillofacial w/o & w/dye. 70488......... 26...... A

Ct

1.42

0.46

0.46

0.46

0.46

0.06

1.94

1.94

1.94

1.94

XXX maxillofacial w/o & w/dye. 70488......... TC...... A

Ct

0.00 10.03

7.81

NA

NA

0.37 10.40

8.18

NA

NA

XXX maxillofacial w/o & w/dye. 70490......... ........ A

Ct soft tissue

1.28

6.52

5.49

NA

NA

0.31

8.11

7.08

NA

NA

XXX neck w/o dye. 70490......... 26...... A

Ct soft tissue

1.28

0.41

0.42

0.41

0.42

0.06

1.75

1.76

1.75

1.76

XXX neck w/o dye. 70490......... TC...... A

Ct soft tissue

0.00

6.11

5.07

NA

NA

0.25

6.36

5.32

NA

NA

XXX neck w/o dye. 70491......... ........ A

Ct soft tissue

1.38

8.06

6.60

NA

NA

0.36

9.80

8.34

NA

NA

XXX neck w/dye. 70491......... 26...... A

Ct soft tissue

1.38

0.44

0.45

0.44

0.45

0.06

1.88

1.89

1.88

1.89

XXX neck w/dye. 70491......... TC...... A

Ct soft tissue

0.00

7.62

6.15

NA

NA

0.30

7.92

6.45

NA

NA

XXX neck w/dye. 70492......... ........ A

Ct sft tsue nck 1.45 10.18

8.20

NA

NA

0.43 12.06

10.08

NA

NA

XXX w/o & w/dye. 70492......... 26...... A

Ct sft tsue nck 1.45

0.47

0.47

0.47

0.47

0.06

1.98

1.98

1.98

1.98

XXX w/o & w/dye. 70492......... TC...... A

Ct sft tsue nck 0.00

9.71

7.73

NA

NA

0.37 10.08

8.10

NA

NA

XXX w/o & w/dye. 70496......... ........ A

Ct angiography, 1.75 17.16

12.67

NA

NA

0.66 19.57

15.08

NA

NA

XXX head. 70496......... 26...... A

Ct angiography, 1.75

0.57

0.57

0.57

0.57

0.08

2.40

2.40

2.40

2.40

XXX head. 70496......... TC...... A

Ct angiography, 0.00 16.59

12.10

NA

NA

0.58 17.17

12.68

NA

NA

XXX head. 70498......... ........ A

Ct angiography, 1.75 17.26

12.69

NA

NA

0.66 19.67

15.10

NA

NA

XXX neck. 70498......... 26...... A

Ct angiography, 1.75

0.58

0.57

0.58

0.57

0.08

2.41

2.40

2.41

2.40

XXX neck. 70498......... TC...... A

Ct angiography, 0.00 16.68

12.12

NA

NA

0.58 17.26

12.70

NA

NA

XXX neck. 70540......... ........ A

Mri orbit/face/ 1.35 14.58

12.38

NA

NA

0.45 16.38

14.18

NA

NA

XXX neck w/o dye. 70540......... 26...... A

Mri orbit/face/ 1.35

0.45

0.44

0.45

0.44

0.06

1.86

1.85

1.86

1.85

XXX neck w/o dye. 70540......... TC...... A

Mri orbit/face/ 0.00 14.13

11.93

NA

NA

0.39 14.52

12.32

NA

NA

XXX neck w/o dye. 70542......... ........ A

Mri orbit/face/ 1.62 15.53

14.36

NA

NA

0.54 17.69

16.52

NA

NA

XXX neck w/dye. 70542......... 26...... A

Mri orbit/face/ 1.62

0.53

0.53

0.53

0.53

0.07

2.22

2.22

2.22

2.22

XXX neck w/dye. 70542......... TC...... A

Mri orbit/face/ 0.00 15.00

13.83

NA

NA

0.47 15.47

14.30

NA

NA

XXX neck w/dye. 70543......... ........ A

Mri orbt/fac/

2.15 19.26

24.01

NA

NA

0.94 22.35

27.10

NA

NA

XXX nck w/o & w/ dye. 70543......... 26...... A

Mri orbt/fac/

2.15

0.72

0.71

0.72

0.71

0.10

2.97

2.96

2.97

2.96

XXX nck w/o & w/ dye. 70543......... TC...... A

Mri orbt/fac/

0.00 18.54

23.30

NA

NA

0.84 19.38

24.14

NA

NA

XXX nck w/o & w/ dye. 70544......... ........ A

Mr angiography

1.20 16.05

12.71

NA

NA

0.64 17.89

14.55

NA

NA

XXX head w/o dye. 70544......... 26...... A

Mr angiography

1.20

0.39

0.40

0.39

0.40

0.05

1.64

1.65

1.64

1.65

XXX head w/o dye. 70544......... TC...... A

Mr angiography

0.00 15.67

12.32

NA

NA

0.59 16.26

12.91

NA

NA

XXX head w/o dye. 70545......... ........ A

Mr angiography

1.20 15.97

12.69

NA

NA

0.64 17.81

14.53

NA

NA

XXX head w/dye. 70545......... 26...... A

Mr angiography

1.20

0.38

0.39

0.38

0.39

0.05

1.63

1.64

1.63

1.64

XXX head w/dye. 70545......... TC...... A

Mr angiography

0.00 15.59

12.30

NA

NA

0.59 16.18

12.89

NA

NA

XXX head w/dye. 70546......... ........ A

Mr angiograph

1.80 24.49

23.37

NA

NA

0.67 26.96

25.84

NA

NA

XXX head w/o&w/dye. 70546......... 26...... A

Mr angiograph

1.80

0.58

0.59

0.58

0.59

0.08

2.46

2.47

2.46

2.47

XXX head w/o&w/dye. 70546......... TC...... A

Mr angiograph

0.00 23.91

22.79

NA

NA

0.59 24.50

23.38

NA

NA

XXX head w/o&w/dye. 70547......... ........ A

Mr angiography

1.20 16.09

12.72

NA

NA

0.64 17.93

14.56

NA

NA

XXX neck w/o dye. 70547......... 26...... A

Mr angiography

1.20

0.39

0.39

0.39

0.39

0.05

1.64

1.64

1.64

1.64

XXX neck w/o dye. 70547......... TC...... A

Mr angiography

0.00 15.70

12.33

NA

NA

0.59 16.29

12.92

NA

NA

XXX neck w/o dye. 70548......... ........ A

Mr angiography

1.20 16.79

12.89

NA

NA

0.64 18.63

14.73

NA

NA

XXX neck w/dye. 70548......... 26...... A

Mr angiography

1.20

0.38

0.39

0.38

0.39

0.05

1.63

1.64

1.63

1.64

XXX neck w/dye. 70548......... TC...... A

Mr angiography

0.00 16.41

12.50

NA

NA

0.59 17.00

13.09

NA

NA

XXX neck w/dye. 70549......... ........ A

Mr angiograph

1.80 24.41

23.35

NA

NA

0.67 26.88

25.82

NA

NA

XXX neck w/o&w/dye. 70549......... 26...... A

Mr angiograph

1.80

0.58

0.59

0.58

0.59

0.08

2.46

2.47

2.46

2.47

XXX neck w/o&w/dye. 70549......... TC...... A

Mr angiograph

0.00 23.83

22.77

NA

NA

0.59 24.42

23.36

NA

NA

XXX neck w/o&w/dye. 70551......... ........ A

Mri brain w/o

1.48 14.69

12.44

NA

NA

0.66 16.83

14.58

NA

NA

XXX dye. 70551......... 26...... A

Mri brain w/o

1.48

0.48

0.49

0.48

0.49

0.07

2.03

2.04

2.03

2.04

XXX dye. 70551......... TC...... A

Mri brain w/o

0.00 14.22

11.96

NA

NA

0.59 14.81

12.55

NA

NA

XXX dye. 70552......... ........ A

Mri brain w/dye 1.78 15.73

14.46

NA

NA

0.78 18.29

17.02

NA

NA

XXX 70552......... 26...... A

Mri brain w/dye 1.78

0.57

0.59

0.57

0.59

0.08

2.43

2.45

2.43

2.45

XXX 70552......... TC...... A

Mri brain w/dye 0.00 15.16

13.87

NA

NA

0.70 15.86

14.57

NA

NA

XXX 70553......... ........ A

Mri brain w/o & 2.36 18.37

23.84

NA

NA

1.41 22.14

27.61

NA

NA

XXX w/dye. 70553......... 26...... A

Mri brain w/o & 2.36

0.76

0.78

0.76

0.78

0.10

3.22

3.24

3.22

3.24

XXX w/dye. 70553......... TC...... A

Mri brain w/o & 0.00 17.61

23.06

NA

NA

1.31 18.92

24.37

NA

NA

XXX w/dye. 70557......... ........ C

Mri brain w/o

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dye. 70557......... 26...... A

Mri brain w/o

2.90

0.92

1.08

0.92

1.08

0.08

3.90

4.06

3.90

4.06

XXX dye. 70557......... TC...... C

Mri brain w/o

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dye. 70558......... ........ C

Mri brain w/dye 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 70558......... 26...... A

Mri brain w/dye 3.20

1.15

1.22

1.15

1.22

0.10

4.45

4.52

4.45

4.52

XXX 70558......... TC...... C

Mri brain w/dye 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 70559......... ........ C

Mri brain w/o & 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX w/dye. 70559......... 26...... A

Mri brain w/o & 3.20

1.03

1.19

1.03

1.19

0.12

4.35

4.51

4.35

4.51

XXX w/dye. 70559......... TC...... C

Mri brain w/o & 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX w/dye.

[[Page 49180]]

71010......... ........ A

Chest x-ray.... 0.18

0.43

0.51

NA

NA

0.03

0.64

0.72

NA

NA

XXX 71010......... 26...... A

Chest x-ray.... 0.18

0.05

0.06

0.05

0.06

0.01

0.24

0.25

0.24

0.25

XXX 71010......... TC...... A

Chest x-ray.... 0.00

0.37

0.45

NA

NA

0.02

0.39

0.47

NA

NA

XXX 71015......... ........ A

Chest x-ray.... 0.21

0.57

0.59

NA

NA

0.03

0.81

0.83

NA

NA

XXX 71015......... 26...... A

Chest x-ray.... 0.21

0.07

0.07

0.07

0.07

0.01

0.29

0.29

0.29

0.29

XXX 71015......... TC...... A

Chest x-ray.... 0.00

0.51

0.52

NA

NA

0.02

0.53

0.54

NA

NA

XXX 71020......... ........ A

Chest x-ray.... 0.22

0.57

0.66

NA

NA

0.05

0.84

0.93

NA

NA

XXX 71020......... 26...... A

Chest x-ray.... 0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX 71020......... TC...... A

Chest x-ray.... 0.00

0.50

0.59

NA

NA

0.04

0.54

0.63

NA

NA

XXX 71021......... ........ A

Chest x-ray.... 0.27

0.71

0.79

NA

NA

0.06

1.04

1.12

NA

NA

XXX 71021......... 26...... A

Chest x-ray.... 0.27

0.08

0.09

0.08

0.09

0.01

0.36

0.37

0.36

0.37

XXX 71021......... TC...... A

Chest x-ray.... 0.00

0.63

0.71

NA

NA

0.05

0.68

0.76

NA

NA

XXX 71022......... ........ A

Chest x-ray.... 0.31

0.89

0.85

NA

NA

0.06

1.26

1.22

NA

NA

XXX 71022......... 26...... A

Chest x-ray.... 0.31

0.09

0.10

0.09

0.10

0.01

0.41

0.42

0.41

0.42

XXX 71022......... TC...... A

Chest x-ray.... 0.00

0.80

0.75

NA

NA

0.05

0.85

0.80

NA

NA

XXX 71023......... ........ A

Chest x-ray and 0.38

1.57

1.08

NA

NA

0.06

2.01

1.52

NA

NA

XXX fluoroscopy. 71023......... 26...... A

Chest x-ray and 0.38

0.14

0.13

0.14

0.13

0.01

0.53

0.52

0.53

0.52

XXX fluoroscopy. 71023......... TC...... A

Chest x-ray and 0.00

1.42

0.94

NA

NA

0.05

1.47

0.99

NA

NA

XXX fluoroscopy. 71030......... ........ A

Chest x-ray.... 0.31

0.91

0.89

NA

NA

0.06

1.28

1.26

NA

NA

XXX 71030......... 26...... A

Chest x-ray.... 0.31

0.09

0.10

0.09

0.10

0.01

0.41

0.42

0.41

0.42

XXX 71030......... TC...... A

Chest x-ray.... 0.00

0.82

0.79

NA

NA

0.05

0.87

0.84

NA

NA

XXX 71034......... ........ A

Chest x-ray and 0.46

2.04

1.71

NA

NA

0.10

2.60

2.27

NA

NA

XXX fluoroscopy. 71034......... 26...... A

Chest x-ray and 0.46

0.18

0.17

0.18

0.17

0.02

0.66

0.65

0.66

0.65

XXX fluoroscopy. 71034......... TC...... A

Chest x-ray and 0.00

1.86

1.55

NA

NA

0.08

1.94

1.63

NA

NA

XXX fluoroscopy. 71035......... ........ A

Chest x-ray.... 0.18

0.77

0.63

NA

NA

0.03

0.98

0.84

NA

NA

XXX 71035......... 26...... A

Chest x-ray.... 0.18

0.06

0.06

0.06

0.06

0.01

0.25

0.25

0.25

0.25

XXX 71035......... TC...... A

Chest x-ray.... 0.00

0.72

0.57

NA

NA

0.02

0.74

0.59

NA

NA

XXX 71040......... ........ A

Contrast x-ray

0.58

2.08

1.76

NA

NA

0.11

2.77

2.45

NA

NA

XXX of bronchi. 71040......... 26...... A

Contrast x-ray

0.58

0.16

0.18

0.16

0.18

0.03

0.77

0.79

0.77

0.79

XXX of bronchi. 71040......... TC...... A

Contrast x-ray

0.00

1.92

1.58

NA

NA

0.08

2.00

1.66

NA

NA

XXX of bronchi. 71060......... ........ A

Contrast x-ray

0.74

3.07

2.60

NA

NA

0.16

3.97

3.50

NA

NA

XXX of bronchi. 71060......... 26...... A

Contrast x-ray

0.74

0.23

0.24

0.23

0.24

0.03

1.00

1.01

1.00

1.01

XXX of bronchi. 71060......... TC...... A

Contrast x-ray

0.00

2.84

2.36

NA

NA

0.13

2.97

2.49

NA

NA

XXX of bronchi. 71090......... ........ A

X-ray &

0.54

NA

NA

NA

NA

0.13

NA

NA

NA

NA

XXX pacemaker insertion. 71090......... 26...... A

X-ray &

0.54

0.28

0.23

0.28

0.23

0.02

0.84

0.79

0.84

0.79

XXX pacemaker insertion. 71090......... TC...... A

X-ray &

0.00

NA

NA

NA

NA

0.11

NA

NA

NA

NA

XXX pacemaker insertion. 71100......... ........ A

X-ray exam of

0.22

0.62

0.64

NA

NA

0.05

0.89

0.91

NA

NA

XXX ribs. 71100......... 26...... A

X-ray exam of

0.22

0.06

0.07

0.06

0.07

0.01

0.29

0.30

0.29

0.30

XXX ribs. 71100......... TC...... A

X-ray exam of

0.00

0.55

0.57

NA

NA

0.04

0.59

0.61

NA

NA

XXX ribs. 71101......... ........ A

X-ray exam of

0.27

0.76

0.76

NA

NA

0.05

1.08

1.08

NA

NA

XXX ribs/chest. 71101......... 26...... A

X-ray exam of

0.27

0.08

0.09

0.08

0.09

0.01

0.36

0.37

0.36

0.37

XXX ribs/chest. 71101......... TC...... A

X-ray exam of

0.00

0.68

0.67

NA

NA

0.04

0.72

0.71

NA

NA

XXX ribs/chest. 71110......... ........ A

X-ray exam of

0.27

0.78

0.85

NA

NA

0.06

1.11

1.18

NA

NA

XXX ribs. 71110......... 26...... A

X-ray exam of

0.27

0.08

0.09

0.08

0.09

0.01

0.36

0.37

0.36

0.37

XXX ribs. 71110......... TC...... A

X-ray exam of

0.00

0.70

0.76

NA

NA

0.05

0.75

0.81

NA

NA

XXX ribs. 71111......... ........ A

X-ray exam of

0.32

1.06

1.01

NA

NA

0.07

1.45

1.40

NA

NA

XXX ribs/chest. 71111......... 26...... A

X-ray exam of

0.32

0.09

0.10

0.09

0.10

0.01

0.42

0.43

0.42

0.43

XXX ribs/chest. 71111......... TC...... A

X-ray exam of

0.00

0.97

0.91

NA

NA

0.06

1.03

0.97

NA

NA

XXX ribs/chest. 71120......... ........ A

X-ray exam of

0.20

0.62

0.70

NA

NA

0.05

0.87

0.95

NA

NA

XXX breastbone. 71120......... 26...... A

X-ray exam of

0.20

0.06

0.07

0.06

0.07

0.01

0.27

0.28

0.27

0.28

XXX breastbone. 71120......... TC...... A

X-ray exam of

0.00

0.56

0.63

NA

NA

0.04

0.60

0.67

NA

NA

XXX breastbone. 71130......... ........ A

X-ray exam of

0.22

0.75

0.77

NA

NA

0.05

1.02

1.04

NA

NA

XXX breastbone. 71130......... 26...... A

X-ray exam of

0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX breastbone. 71130......... TC...... A

X-ray exam of

0.00

0.68

0.70

NA

NA

0.04

0.72

0.74

NA

NA

XXX breastbone. 71250......... ........ A

Ct thorax w/o

1.16

6.47

6.34

NA

NA

0.36

7.99

7.86

NA

NA

XXX dye. 71250......... 26...... A

Ct thorax w/o

1.16

0.37

0.38

0.37

0.38

0.05

1.58

1.59

1.58

1.59

XXX dye.

[[Continued on page 49181]]

From the Federal Register Online via GPO Access [wais.access.gpo.gov] ]

[[pp. 49181-49230]] Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2007 and Other Changes to Payment Under Part B

[[Continued from page 49180]]

[[Page 49181]]

71250......... TC...... A

Ct thorax w/o

0.00

6.10

5.96

NA

NA

0.31

6.41

6.27

NA

NA

XXX dye. 71260......... ........ A

Ct thorax w/dye 1.24

8.01

7.61

NA

NA

0.42

9.67

9.27

NA

NA

XXX 71260......... 26...... A

Ct thorax w/dye 1.24

0.39

0.41

0.39

0.41

0.05

1.68

1.70

1.68

1.70

XXX 71260......... TC...... A

Ct thorax w/dye 0.00

7.61

7.21

NA

NA

0.37

7.98

7.58

NA

NA

XXX 71270......... ........ A

Ct thorax w/o & 1.38 10.15

9.51

NA

NA

0.52 12.05

11.41

NA

NA

XXX w/dye. 71270......... 26...... A

Ct thorax w/o & 1.38

0.44

0.45

0.44

0.45

0.06

1.88

1.89

1.88

1.89

XXX w/dye. 71270......... TC...... A

Ct thorax w/o & 0.00

9.71

9.07

NA

NA

0.46 10.17

9.53

NA

NA

XXX w/dye. 71275......... ........ A

Ct angiography, 1.92 11.77

12.70

NA

NA

0.48 14.17

15.10

NA

NA

XXX chest. 71275......... 26...... A

Ct angiography, 1.92

0.62

0.63

0.62

0.63

0.09

2.63

2.64

2.63

2.64

XXX chest. 71275......... TC...... A

Ct angiography, 0.00 11.14

12.07

NA

NA

0.39 11.53

12.46

NA

NA

XXX chest. 71550......... ........ A

Mri chest w/o

1.46 16.75

12.95

NA

NA

0.51 18.72

14.92

NA

NA

XXX dye. 71550......... 26...... A

Mri chest w/o

1.46

0.48

0.48

0.48

0.48

0.06

2.00

2.00

2.00

2.00

XXX dye. 71550......... TC...... A

Mri chest w/o

0.00 16.27

12.47

NA

NA

0.45 16.72

12.92

NA

NA

XXX dye. 71551......... ........ A

Mri chest w/dye 1.73 18.16

15.05

NA

NA

0.60 20.49

17.38

NA

NA

XXX 71551......... 26...... A

Mri chest w/dye 1.73

0.56

0.57

0.56

0.57

0.08

2.37

2.38

2.37

2.38

XXX 71551......... TC...... A

Mri chest w/dye 0.00 17.59

14.48

NA

NA

0.52 18.11

15.00

NA

NA

XXX 71552......... ........ A

Mri chest w/o & 2.26 22.91

24.94

NA

NA

0.78 25.95

27.98

NA

NA

XXX w/dye. 71552......... 26...... A

Mri chest w/o & 2.26

0.75

0.74

0.75

0.74

0.10

3.11

3.10

3.11

3.10

XXX w/dye. 71552......... TC...... A

Mri chest w/o & 0.00 22.16

24.20

NA

NA

0.68 22.84

24.88

NA

NA

XXX w/dye. 71555......... ........ R

Mri angio chest 1.81 15.55

12.74

NA

NA

0.67 18.03

15.22

NA

NA

XXX w or w/o dye. 71555......... 26...... R

Mri angio chest 1.81

0.62

0.61

0.62

0.61

0.08

2.51

2.50

2.51

2.50

XXX w or w/o dye. 71555......... TC...... R

Mri angio chest 0.00 14.94

12.14

NA

NA

0.59 15.53

12.73

NA

NA

XXX w or w/o dye. 72010......... ........ A

X-ray exam of

0.45

1.45

1.24

NA

NA

0.08

1.98

1.77

NA

NA

XXX spine. 72010......... 26...... A

X-ray exam of

0.45

0.13

0.15

0.13

0.15

0.02

0.60

0.62

0.60

0.62

XXX spine. 72010......... TC...... A

X-ray exam of

0.00

1.32

1.10

NA

NA

0.06

1.38

1.16

NA

NA

XXX spine. 72020......... ........ A

X-ray exam of

0.15

0.46

0.47

NA

NA

0.03

0.64

0.65

NA

NA

XXX spine. 72020......... 26...... A

X-ray exam of

0.15

0.05

0.05

0.05

0.05

0.01

0.21

0.21

0.21

0.21

XXX spine. 72020......... TC...... A

X-ray exam of

0.00

0.42

0.42

NA

NA

0.02

0.44

0.44

NA

NA

XXX spine. 72040......... ........ A

X-ray exam of

0.22

0.77

0.70

NA

NA

0.05

1.04

0.97

NA

NA

XXX neck spine. 72040......... 26...... A

X-ray exam of

0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX neck spine. 72040......... TC...... A

X-ray exam of

0.00

0.70

0.63

NA

NA

0.04

0.74

0.67

NA

NA

XXX neck spine. 72050......... ........ A

X-ray exam of

0.31

1.07

1.01

NA

NA

0.07

1.45

1.39

NA

NA

XXX neck spine. 72050......... 26...... A

X-ray exam of

0.31

0.10

0.10

0.10

0.10

0.01

0.42

0.42

0.42

0.42

XXX neck spine. 72050......... TC...... A

X-ray exam of

0.00

0.97

0.91

NA

NA

0.06

1.03

0.97

NA

NA

XXX neck spine. 72052......... ........ A

X-ray exam of

0.36

1.39

1.29

NA

NA

0.08

1.83

1.73

NA

NA

XXX neck spine. 72052......... 26...... A

X-ray exam of

0.36

0.11

0.12

0.11

0.12

0.02

0.49

0.50

0.49

0.50

XXX neck spine. 72052......... TC...... A

X-ray exam of

0.00

1.27

1.17

NA

NA

0.06

1.33

1.23

NA

NA

XXX neck spine. 72069......... ........ A

X-ray exam of

0.22

0.77

0.62

NA

NA

0.03

1.02

0.87

NA

NA

XXX trunk spine. 72069......... 26...... A

X-ray exam of

0.22

0.08

0.08

0.08

0.08

0.01

0.31

0.31

0.31

0.31

XXX trunk spine. 72069......... TC...... A

X-ray exam of

0.00

0.69

0.54

NA

NA

0.02

0.71

0.56

NA

NA

XXX trunk spine. 72070......... ........ A

X-ray exam of

0.22

0.64

0.70

NA

NA

0.05

0.91

0.97

NA

NA

XXX thoracic spine. 72070......... 26...... A

X-ray exam of

0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX thoracic spine. 72070......... TC...... A

X-ray exam of

0.00

0.57

0.63

NA

NA

0.04

0.61

0.67

NA

NA

XXX thoracic spine. 72072......... ........ A

X-ray exam of

0.22

0.77

0.79

NA

NA

0.06

1.05

1.07

NA

NA

XXX thoracic spine. 72072......... 26...... A

X-ray exam of

0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX thoracic spine. 72072......... TC...... A

X-ray exam of

0.00

0.70

0.72

NA

NA

0.05

0.75

0.77

NA

NA

XXX thoracic spine. 72074......... ........ A

X-ray exam of

0.22

0.95

0.97

NA

NA

0.07

1.24

1.26

NA

NA

XXX thoracic spine. 72074......... 26...... A

X-ray exam of

0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX thoracic spine. 72074......... TC...... A

X-ray exam of

0.00

0.88

0.90

NA

NA

0.06

0.94

0.96

NA

NA

XXX thoracic spine. 72080......... ........ A

X-ray exam of

0.22

0.70

0.73

NA

NA

0.05

0.97

1.00

NA

NA

XXX trunk spine. 72080......... 26...... A

X-ray exam of

0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX trunk spine. 72080......... TC...... A

X-ray exam of

0.00

0.62

0.66

NA

NA

0.04

0.66

0.70

NA

NA

XXX trunk spine. 72090......... ........ A

X-ray exam of

0.28

1.01

0.82

NA

NA

0.05

1.34

1.15

NA

NA

XXX trunk spine. 72090......... 26...... A

X-ray exam of

0.28

0.10

0.09

0.10

0.09

0.01

0.39

0.38

0.39

0.38

XXX trunk spine. 72090......... TC...... A

X-ray exam of

0.00

0.92

0.73

NA

NA

0.04

0.96

0.77

NA

NA

XXX trunk spine. 72100......... ........ A

X-ray exam of

0.22

0.81

0.76

NA

NA

0.05

1.08

1.03

NA

NA

XXX lower spine. 72100......... 26...... A

X-ray exam of

0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX lower spine. 72100......... TC...... A

X-ray exam of

0.00

0.74

0.69

NA

NA

0.04

0.78

0.73

NA

NA

XXX lower spine. 72110......... ........ A

X-ray exam of

0.31

1.14

1.04

NA

NA

0.07

1.52

1.42

NA

NA

XXX lower spine. 72110......... 26...... A

X-ray exam of

0.31

0.10

0.10

0.10

0.10

0.01

0.42

0.42

0.42

0.42

XXX lower spine. 72110......... TC...... A

X-ray exam of

0.00

1.04

0.94

NA

NA

0.06

1.10

1.00

NA

NA

XXX lower spine. 72114......... ........ A

X-ray exam of

0.36

1.57

1.38

NA

NA

0.08

2.01

1.82

NA

NA

XXX lower spine. 72114......... 26...... A

X-ray exam of

0.36

0.12

0.12

0.12

0.12

0.02

0.50

0.50

0.50

0.50

XXX lower spine. 72114......... TC...... A

X-ray exam of

0.00

1.45

1.26

NA

NA

0.06

1.51

1.32

NA

NA

XXX lower spine. 72120......... ........ A

X-ray exam of

0.22

1.07

0.99

NA

NA

0.07

1.36

1.28

NA

NA

XXX lower spine. 72120......... 26...... A

X-ray exam of

0.22

0.08

0.07

0.08

0.07

0.01

0.31

0.30

0.31

0.30

XXX lower spine.

[[Page 49182]]

72120......... TC...... A

X-ray exam of

0.00

1.00

0.92

NA

NA

0.06

1.06

0.98

NA

NA

XXX lower spine. 72125......... ........ A

Ct neck spine w/ 1.16

6.46

6.33

NA

NA

0.36

7.98

7.85

NA

NA

XXX o dye. 72125......... 26...... A

Ct neck spine w/ 1.16

0.37

0.38

0.37

0.38

0.05

1.58

1.59

1.58

1.59

XXX o dye. 72125......... TC...... A

Ct neck spine w/ 0.00

6.09

5.96

NA

NA

0.31

6.40

6.27

NA

NA

XXX o dye. 72126......... ........ A

Ct neck spine w/ 1.22

8.04

7.61

NA

NA

0.42

9.68

9.25

NA

NA

XXX dye. 72126......... 26...... A

Ct neck spine w/ 1.22

0.39

0.40

0.39

0.40

0.05

1.66

1.67

1.66

1.67

XXX dye. 72126......... TC...... A

Ct neck spine w/ 0.00

7.65

7.22

NA

NA

0.37

8.02

7.59

NA

NA

XXX dye. 72127......... ........ A

Ct neck spine w/ 1.27 10.17

9.50

NA

NA

0.52 11.96

11.29

NA

NA

XXX o & w/dye. 72127......... 26...... A

Ct neck spine w/ 1.27

0.43

0.42

0.43

0.42

0.06

1.76

1.75

1.76

1.75

XXX o & w/dye. 72127......... TC...... A

Ct neck spine w/ 0.00

9.73

9.07

NA

NA

0.46 10.19

9.53

NA

NA

XXX o & w/dye. 72128......... ........ A

Ct chest spine

1.16

6.47

6.34

NA

NA

0.36

7.99

7.86

NA

NA

XXX w/o dye. 72128......... 26...... A

Ct chest spine

1.16

0.37

0.38

0.37

0.38

0.05

1.58

1.59

1.58

1.59

XXX w/o dye. 72128......... TC...... A

Ct chest spine

0.00

6.10

5.96

NA

NA

0.31

6.41

6.27

NA

NA

XXX w/o dye. 72129......... ........ A

Ct chest spine

1.22

8.03

7.61

NA

NA

0.42

9.67

9.25

NA

NA

XXX w/dye. 72129......... 26...... A

Ct chest spine

1.22

0.39

0.40

0.39

0.40

0.05

1.66

1.67

1.66

1.67

XXX w/dye. 72129......... TC...... A

Ct chest spine

0.00

7.64

7.21

NA

NA

0.37

8.01

7.58

NA

NA

XXX w/dye. 72130......... ........ A

Ct chest spine

1.27 10.14

9.49

NA

NA

0.52 11.93

11.28

NA

NA

XXX w/o & w/dye. 72130......... 26...... A

Ct chest spine

1.27

0.43

0.42

0.43

0.42

0.06

1.76

1.75

1.76

1.75

XXX w/o & w/dye. 72130......... TC...... A

Ct chest spine

0.00

9.70

9.06

NA

NA

0.46 10.16

9.52

NA

NA

XXX w/o & w/dye. 72131......... ........ A

Ct lumbar spine 1.16

6.47

6.34

NA

NA

0.36

7.99

7.86

NA

NA

XXX w/o dye. 72131......... 26...... A

Ct lumbar spine 1.16

0.37

0.38

0.37

0.38

0.05

1.58

1.59

1.58

1.59

XXX w/o dye. 72131......... TC...... A

Ct lumbar spine 0.00

6.10

5.96

NA

NA

0.31

6.41

6.27

NA

NA

XXX w/o dye. 72132......... ........ A

Ct lumbar spine 1.22

8.03

7.61

NA

NA

0.42

9.67

9.25

NA

NA

XXX w/dye. 72132......... 26...... A

Ct lumbar spine 1.22

0.39

0.40

0.39

0.40

0.05

1.66

1.67

1.66

1.67

XXX w/dye. 72132......... TC...... A

Ct lumbar spine 0.00

7.64

7.21

NA

NA

0.37

8.01

7.58

NA

NA

XXX w/dye. 72133......... ........ A

Ct lumbar spine 1.27 10.21

9.51

NA

NA

0.52 12.00

11.30

NA

NA

XXX w/o & w/dye. 72133......... 26...... A

Ct lumbar spine 1.27

0.41

0.42

0.41

0.42

0.06

1.74

1.75

1.74

1.75

XXX w/o & w/dye. 72133......... TC...... A

Ct lumbar spine 0.00

9.79

9.09

NA

NA

0.46 10.25

9.55

NA

NA

XXX w/o & w/dye. 72141......... ........ A

Mri neck spine

1.60 12.80

12.00

NA

NA

0.66 15.06

14.26

NA

NA

XXX w/o dye. 72141......... 26...... A

Mri neck spine

1.60

0.53

0.53

0.53

0.53

0.07

2.20

2.20

2.20

2.20

XXX w/o dye. 72141......... TC...... A

Mri neck spine

0.00 12.26

11.47

NA

NA

0.59 12.85

12.06

NA

NA

XXX w/o dye. 72142......... ........ A

Mri neck spine

1.92 15.86

14.53

NA

NA

0.79 18.57

17.24

NA

NA

XXX w/dye. 72142......... 26...... A

Mri neck spine

1.92

0.63

0.64

0.63

0.64

0.09

2.64

2.65

2.64

2.65

XXX w/dye. 72142......... TC...... A

Mri neck spine

0.00 15.24

13.89

NA

NA

0.70 15.94

14.59

NA

NA

XXX w/dye. 72146......... ........ A

Mri chest spine 1.60 12.77

12.92

NA

NA

0.71 15.08

15.23

NA

NA

XXX w/o dye. 72146......... 26...... A

Mri chest spine 1.60

0.53

0.53

0.53

0.53

0.07

2.20

2.20

2.20

2.20

XXX w/o dye. 72146......... TC...... A

Mri chest spine 0.00 12.24

12.39

NA

NA

0.64 12.88

13.03

NA

NA

XXX w/o dye. 72147......... ........ A

Mri chest spine 1.92 13.70

13.98

NA

NA

0.79 16.41

16.69

NA

NA

XXX w/dye. 72147......... 26...... A

Mri chest spine 1.92

0.62

0.63

0.62

0.63

0.09

2.63

2.64

2.63

2.64

XXX w/dye. 72147......... TC...... A

Mri chest spine 0.00 13.08

13.35

NA

NA

0.70 13.78

14.05

NA

NA

XXX w/dye. 72148......... ........ A

Mri lumbar

1.48 12.77

12.89

NA

NA

0.71 14.96

15.08

NA

NA

XXX spine w/o dye. 72148......... 26...... A

Mri lumbar

1.48

0.50

0.49

0.50

0.49

0.07

2.05

2.04

2.05

2.04

XXX spine w/o dye. 72148......... TC...... A

Mri lumbar

0.00 12.28

12.40

NA

NA

0.64 12.92

13.04

NA

NA

XXX spine w/o dye. 72149......... ........ A

Mri lumbar

1.78 15.83

14.49

NA

NA

0.78 18.39

17.05

NA

NA

XXX spine w/dye. 72149......... 26...... A

Mri lumbar

1.78

0.59

0.60

0.59

0.60

0.08

2.45

2.46

2.45

2.46

XXX spine w/dye. 72149......... TC...... A

Mri lumbar

0.00 15.25

13.89

NA

NA

0.70 15.95

14.59

NA

NA

XXX spine w/dye. 72156......... ........ A

Mri neck spine

2.57 18.13

23.83

NA

NA

1.42 22.12

27.82

NA

NA

XXX w/o & w/dye. 72156......... 26...... A

Mri neck spine

2.57

0.84

0.85

0.84

0.85

0.11

3.52

3.53

3.52

3.53

XXX w/o & w/dye. 72156......... TC...... A

Mri neck spine

0.00 17.29

22.98

NA

NA

1.31 18.60

24.29

NA

NA

XXX w/o & w/dye. 72157......... ........ A

Mri chest spine 2.57 16.43

23.40

NA

NA

1.42 20.42

27.39

NA

NA

XXX w/o & w/dye. 72157......... 26...... A

Mri chest spine 2.57

0.83

0.84

0.83

0.84

0.11

3.51

3.52

3.51

3.52

XXX w/o & w/dye. 72157......... TC...... A

Mri chest spine 0.00 15.60

22.56

NA

NA

1.31 16.91

23.87

NA

NA

XXX w/o & w/dye. 72158......... ........ A

Mri lumbar

2.36 18.10

23.77

NA

NA

1.41 21.87

27.54

NA

NA

XXX spine w/o & w/ dye. 72158......... 26...... A

Mri lumbar

2.36

0.78

0.78

0.78

0.78

0.10

3.24

3.24

3.24

3.24

XXX spine w/o & w/ dye. 72158......... TC...... A

Mri lumbar

0.00 17.32

22.99

NA

NA

1.31 18.63

24.30

NA

NA

XXX spine w/o & w/ dye. 72159......... ........ N

Mr angio spine

1.80 14.79

13.39

NA

NA

0.74 17.33

15.93

NA

NA

XXX w/o&w/dye.

[[Page 49183]]

72159......... 26...... N

Mr angio spine

1.80

0.42

0.62

0.42

0.62

0.10

2.32

2.52

2.32

2.52

XXX w/o&w/dye. 72159......... TC...... N

Mr angio spine

0.00 14.37

12.77

NA

NA

0.64 15.01

13.41

NA

NA

XXX w/o&w/dye. 72170......... ........ A

X-ray exam of

0.17

0.50

0.56

NA

NA

0.03

0.70

0.76

NA

NA

XXX pelvis. 72170......... 26...... A

X-ray exam of

0.17

0.06

0.06

0.06

0.06

0.01

0.24

0.24

0.24

0.24

XXX pelvis. 72170......... TC...... A

X-ray exam of

0.00

0.44

0.50

NA

NA

0.02

0.46

0.52

NA

NA

XXX pelvis. 72190......... ........ A

X-ray exam of

0.21

0.85

0.77

NA

NA

0.05

1.11

1.03

NA

NA

XXX pelvis. 72190......... 26...... A

X-ray exam of

0.21

0.07

0.07

0.07

0.07

0.01

0.29

0.29

0.29

0.29

XXX pelvis. 72190......... TC...... A

X-ray exam of

0.00

0.78

0.70

NA

NA

0.04

0.82

0.74

NA

NA

XXX pelvis. 72191......... ........ A

Ct angiograph

1.81 11.43

12.32

NA

NA

0.47 13.71

14.60

NA

NA

XXX pelv w/o&w/dye. 72191......... 26...... A

Ct angiograph

1.81

0.60

0.60

0.60

0.60

0.08

2.49

2.49

2.49

2.49

XXX pelv w/o&w/dye. 72191......... TC...... A

Ct angiograph

0.00 10.83

11.73

NA

NA

0.39 11.22

12.12

NA

NA

XXX pelv w/o&w/dye. 72192......... ........ A

Ct pelvis w/o

1.09

6.02

6.21

NA

NA

0.36

7.47

7.66

NA

NA

XXX dye. 72192......... 26...... A

Ct pelvis w/o

1.09

0.34

0.36

0.34

0.36

0.05

1.48

1.50

1.48

1.50

XXX dye. 72192......... TC...... A

Ct pelvis w/o

0.00

5.68

5.85

NA

NA

0.31

5.99

6.16

NA

NA

XXX dye. 72193......... ........ A

Ct pelvis w/dye 1.16

7.55

7.30

NA

NA

0.41

9.12

8.87

NA

NA

XXX 72193......... 26...... A

Ct pelvis w/dye 1.16

0.37

0.38

0.37

0.38

0.05

1.58

1.59

1.58

1.59

XXX 72193......... TC...... A

Ct pelvis w/dye 0.00

7.18

6.93

NA

NA

0.36

7.54

7.29

NA

NA

XXX 72194......... ........ A

Ct pelvis w/o & 1.22 10.18

9.21

NA

NA

0.48 11.88

10.91

NA

NA

XXX w/dye. 72194......... 26...... A

Ct pelvis w/o & 1.22

0.39

0.40

0.39

0.40

0.05

1.66

1.67

1.66

1.67

XXX w/dye. 72194......... TC...... A

Ct pelvis w/o & 0.00

9.78

8.81

NA

NA

0.43 10.21

9.24

NA

NA

XXX w/dye. 72195......... ........ A

Mri pelvis w/o

1.46 14.74

12.45

NA

NA

0.51 16.71

14.42

NA

NA

XXX dye. 72195......... 26...... A

Mri pelvis w/o

1.46

0.48

0.48

0.48

0.48

0.06

2.00

2.00

2.00

2.00

XXX dye. 72195......... TC...... A

Mri pelvis w/o

0.00 14.25

11.96

NA

NA

0.45 14.70

12.41

NA

NA

XXX dye. 72196......... ........ A

Mri pelvis w/

1.73 15.67

14.43

NA

NA

0.60 18.00

16.76

NA

NA

XXX dye. 72196......... 26...... A

Mri pelvis w/

1.73

0.56

0.57

0.56

0.57

0.08

2.37

2.38

2.37

2.38

XXX dye. 72196......... TC...... A

Mri pelvis w/

0.00 15.11

13.86

NA

NA

0.52 15.63

14.38

NA

NA

XXX dye. 72197......... ........ A

Mri pelvis w/o

2.26 19.28

24.04

NA

NA

1.02 22.56

27.32

NA

NA

XXX & w/dye. 72197......... 26...... A

Mri pelvis w/o

2.26

0.74

0.74

0.74

0.74

0.10

3.10

3.10

3.10

3.10

XXX & w/dye. 72197......... TC...... A

Mri pelvis w/o

0.00 18.54

23.30

NA

NA

0.92 19.46

24.22

NA

NA

XXX & w/dye. 72198......... ........ A

Mr angio pelvis 1.80 15.34

12.68

NA

NA

0.67 17.81

15.15

NA

NA

XXX w/o & w/dye. 72198......... 26...... A

Mr angio pelvis 1.80

0.60

0.59

0.60

0.59

0.08

2.48

2.47

2.48

2.47

XXX w/o & w/dye. 72198......... TC...... A

Mr angio pelvis 0.00 14.75

12.09

NA

NA

0.59 15.34

12.68

NA

NA

XXX w/o & w/dye. 72200......... ........ A

X-ray exam

0.17

0.60

0.59

NA

NA

0.03

0.80

0.79

NA

NA

XXX sacroiliac joints. 72200......... 26...... A

X-ray exam

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX sacroiliac joints. 72200......... TC...... A

X-ray exam

0.00

0.55

0.53

NA

NA

0.02

0.57

0.55

NA

NA

XXX sacroiliac joints. 72202......... ........ A

X-ray exam

0.19

0.74

0.70

NA

NA

0.05

0.98

0.94

NA

NA

XXX sacroiliac joints. 72202......... 26...... A

X-ray exam

0.19

0.06

0.06

0.06

0.06

0.01

0.26

0.26

0.26

0.26

XXX sacroiliac joints. 72202......... TC...... A

X-ray exam

0.00

0.68

0.64

NA

NA

0.04

0.72

0.68

NA

NA

XXX sacroiliac joints. 72220......... ........ A

X-ray exam of

0.17

0.58

0.62

NA

NA

0.05

0.80

0.84

NA

NA

XXX tailbone. 72220......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX tailbone. 72220......... TC...... A

X-ray exam of

0.00

0.53

0.56

NA

NA

0.04

0.57

0.60

NA

NA

XXX tailbone. 72240......... ........ A

Contrast x-ray

0.91

2.53

4.41

NA

NA

0.29

3.73

5.61

NA

NA

XXX of neck spine. 72240......... 26...... A

Contrast x-ray

0.91

0.28

0.29

0.28

0.29

0.04

1.23

1.24

1.23

1.24

XXX of neck spine. 72240......... TC...... A

Contrast x-ray

0.00

2.25

4.13

NA

NA

0.25

2.50

4.38

NA

NA

XXX of neck spine. 72255......... ........ A

Contrast x-ray, 0.91

2.27

4.02

NA

NA

0.26

3.44

5.19

NA

NA

XXX thorax spine. 72255......... 26...... A

Contrast x-ray, 0.91

0.27

0.27

0.27

0.27

0.04

1.22

1.22

1.22

1.22

XXX thorax spine. 72255......... TC...... A

Contrast x-ray, 0.00

2.00

3.75

NA

NA

0.22

2.22

3.97

NA

NA

XXX thorax spine. 72265......... ........ A

Contrast x-ray, 0.83

2.50

3.87

NA

NA

0.26

3.59

4.96

NA

NA

XXX lower spine. 72265......... 26...... A

Contrast x-ray, 0.83

0.26

0.25

0.26

0.25

0.04

1.13

1.12

1.13

1.12

XXX lower spine. 72265......... TC...... A

Contrast x-ray, 0.00

2.24

3.61

NA

NA

0.22

2.46

3.83

NA

NA

XXX lower spine. 72270......... ........ A

Contrast x-ray, 1.33

3.95

5.88

NA

NA

0.39

5.67

7.60

NA

NA

XXX spine. 72270......... 26...... A

Contrast x-ray, 1.33

0.43

0.42

0.43

0.42

0.06

1.82

1.81

1.82

1.81

XXX spine. 72270......... TC...... A

Contrast x-ray, 0.00

3.52

5.46

NA

NA

0.33

3.85

5.79

NA

NA

XXX spine. 72275......... ........ A

Epidurography.. 0.76

1.71

2.15

NA

NA

0.26

2.73

3.17

NA

NA

XXX 72275......... 26...... A

Epidurography.. 0.76

0.19

0.20

0.19

0.20

0.04

0.99

1.00

0.99

1.00

XXX 72275......... TC...... A

Epidurography.. 0.00

1.52

1.96

NA

NA

0.22

1.74

2.18

NA

NA

XXX 72285......... ........ A

X-ray c/t spine 1.16

1.42

6.90

NA

NA

0.50

3.08

8.56

NA

NA

XXX disk. 72285......... 26...... A

X-ray c/t spine 1.16

0.29

0.34

0.29

0.34

0.07

1.52

1.57

1.52

1.57

XXX disk. 72285......... TC...... A

X-ray c/t spine 0.00

1.13

6.57

NA

NA

0.43

1.56

7.00

NA

NA

XXX disk. 72295......... ........ A

X-ray of lower

0.83

1.41

6.45

NA

NA

0.46

2.70

7.74

NA

NA

XXX spine disk. 72295......... 26...... A

X-ray of lower

0.83

0.23

0.26

0.23

0.26

0.06

1.12

1.15

1.12

1.15

XXX spine disk. 72295......... TC...... A

X-ray of lower

0.00

1.18

6.19

NA

NA

0.40

1.58

6.59

NA

NA

XXX spine disk. 73000......... ........ A

X-ray exam of

0.16

0.56

0.57

NA

NA

0.03

0.75

0.76

NA

NA

XXX collar bone. 73000......... 26...... A

X-ray exam of

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX collar bone. 73000......... TC...... A

X-ray exam of

0.00

0.50

0.52

NA

NA

0.02

0.52

0.54

NA

NA

XXX collar bone. 73010......... ........ A

X-ray exam of

0.17

0.58

0.58

NA

NA

0.03

0.78

0.78

NA

NA

XXX shoulder blade.

[[Page 49184]]

73010......... 26...... A

X-ray exam of

0.17

0.06

0.06

0.06

0.06

0.01

0.24

0.24

0.24

0.24

XXX shoulder blade. 73010......... TC...... A

X-ray exam of

0.00

0.53

0.52

NA

NA

0.02

0.55

0.54

NA

NA

XXX shoulder blade. 73020......... ........ A

X-ray exam of

0.15

0.45

0.50

NA

NA

0.03

0.63

0.68

NA

NA

XXX shoulder. 73020......... 26...... A

X-ray exam of

0.15

0.05

0.05

0.05

0.05

0.01

0.21

0.21

0.21

0.21

XXX shoulder. 73020......... TC...... A

X-ray exam of

0.00

0.40

0.45

NA

NA

0.02

0.42

0.47

NA

NA

XXX shoulder. 73030......... ........ A

X-ray exam of

0.18

0.57

0.62

NA

NA

0.05

0.80

0.85

NA

NA

XXX shoulder. 73030......... 26...... A

X-ray exam of

0.18

0.06

0.06

0.06

0.06

0.01

0.25

0.25

0.25

0.25

XXX shoulder. 73030......... TC...... A

X-ray exam of

0.00

0.51

0.56

NA

NA

0.04

0.55

0.60

NA

NA

XXX shoulder. 73040......... ........ A

Contrast x-ray

0.54

2.24

2.27

NA

NA

0.14

2.92

2.95

NA

NA

XXX of shoulder. 73040......... 26...... A

Contrast x-ray

0.54

0.17

0.18

0.17

0.18

0.02

0.73

0.74

0.73

0.74

XXX of shoulder. 73040......... TC...... A

Contrast x-ray

0.00

2.06

2.09

NA

NA

0.12

2.18

2.21

NA

NA

XXX of shoulder. 73050......... ........ A

X-ray exam of

0.20

0.74

0.74

NA

NA

0.05

0.99

0.99

NA

NA

XXX shoulders. 73050......... 26...... A

X-ray exam of

0.20

0.07

0.07

0.07

0.07

0.01

0.28

0.28

0.28

0.28

XXX shoulders. 73050......... TC...... A

X-ray exam of

0.00

0.66

0.67

NA

NA

0.04

0.70

0.71

NA

NA

XXX shoulders. 73060......... ........ A

X-ray exam of

0.17

0.57

0.62

NA

NA

0.05

0.79

0.84

NA

NA

XXX humerus. 73060......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX humerus. 73060......... TC...... A

X-ray exam of

0.00

0.52

0.56

NA

NA

0.04

0.56

0.60

NA

NA

XXX humerus. 73070......... ........ A

X-ray exam of

0.15

0.56

0.57

NA

NA

0.03

0.74

0.75

NA

NA

XXX elbow. 73070......... 26...... A

X-ray exam of

0.15

0.05

0.05

0.05

0.05

0.01

0.21

0.21

0.21

0.21

XXX elbow. 73070......... TC...... A

X-ray exam of

0.00

0.51

0.52

NA

NA

0.02

0.53

0.54

NA

NA

XXX elbow. 73080......... ........ A

X-ray exam of

0.17

0.75

0.66

NA

NA

0.05

0.97

0.88

NA

NA

XXX elbow. 73080......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX elbow. 73080......... TC...... A

X-ray exam of

0.00

0.70

0.60

NA

NA

0.04

0.74

0.64

NA

NA

XXX elbow. 73085......... ........ A

Contrast x-ray

0.54

1.82

2.17

NA

NA

0.14

2.50

2.85

NA

NA

XXX of elbow. 73085......... 26...... A

Contrast x-ray

0.54

0.17

0.19

0.17

0.19

0.02

0.73

0.75

0.73

0.75

XXX of elbow. 73085......... TC...... A

Contrast x-ray

0.00

1.65

1.99

NA

NA

0.12

1.77

2.11

NA

NA

XXX of elbow. 73090......... ........ A

X-ray exam of

0.16

0.55

0.57

NA

NA

0.03

0.74

0.76

NA

NA

XXX forearm. 73090......... 26...... A

X-ray exam of

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX forearm. 73090......... TC...... A

X-ray exam of

0.00

0.50

0.52

NA

NA

0.02

0.52

0.54

NA

NA

XXX forearm. 73092......... ........ A

X-ray exam of

0.16

0.59

0.55

NA

NA

0.03

0.78

0.74

NA

NA

XXX arm, infant. 73092......... 26...... A

X-ray exam of

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX arm, infant. 73092......... TC...... A

X-ray exam of

0.00

0.54

0.50

NA

NA

0.02

0.56

0.52

NA

NA

XXX arm, infant. 73100......... ........ A

X-ray exam of

0.16

0.61

0.56

NA

NA

0.03

0.80

0.75

NA

NA

XXX wrist. 73100......... 26...... A

X-ray exam of

0.16

0.06

0.05

0.06

0.05

0.01

0.23

0.22

0.23

0.22

XXX wrist. 73100......... TC...... A

X-ray exam of

0.00

0.55

0.51

NA

NA

0.02

0.57

0.53

NA

NA

XXX wrist. 73110......... ........ A

X-ray exam of

0.17

0.78

0.64

NA

NA

0.03

0.98

0.84

NA

NA

XXX wrist. 73110......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX wrist. 73110......... TC...... A

X-ray exam of

0.00

0.72

0.58

NA

NA

0.02

0.74

0.60

NA

NA

XXX wrist. 73115......... ........ A

Contrast x-ray

0.54

2.38

1.91

NA

NA

0.12

3.04

2.57

NA

NA

XXX of wrist. 73115......... 26...... A

Contrast x-ray

0.54

0.18

0.18

0.18

0.18

0.02

0.74

0.74

0.74

0.74

XXX of wrist. 73115......... TC...... A

Contrast x-ray

0.00

2.20

1.74

NA

NA

0.10

2.30

1.84

NA

NA

XXX of wrist. 73120......... ........ A

X-ray exam of

0.16

0.56

0.55

NA

NA

0.03

0.75

0.74

NA

NA

XXX hand. 73120......... 26...... A

X-ray exam of

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX hand. 73120......... TC...... A

X-ray exam of

0.00

0.51

0.50

NA

NA

0.02

0.53

0.52

NA

NA

XXX hand. 73130......... ........ A

X-ray exam of

0.17

0.66

0.61

NA

NA

0.03

0.86

0.81

NA

NA

XXX hand. 73130......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX hand. 73130......... TC...... A

X-ray exam of

0.00

0.61

0.55

NA

NA

0.02

0.63

0.57

NA

NA

XXX hand. 73140......... ........ A

X-ray exam of

0.13

0.68

0.52

NA

NA

0.03

0.84

0.68

NA

NA

XXX finger(s). 73140......... 26...... A

X-ray exam of

0.13

0.04

0.04

0.04

0.04

0.01

0.18

0.18

0.18

0.18

XXX finger(s). 73140......... TC...... A

X-ray exam of

0.00

0.64

0.48

NA

NA

0.02

0.66

0.50

NA

NA

XXX finger(s). 73200......... ........ A

Ct upper

1.09

6.45

5.60

NA

NA

0.30

7.84

6.99

NA

NA

XXX extremity w/o dye. 73200......... 26...... A

Ct upper

1.09

0.35

0.36

0.35

0.36

0.05

1.49

1.50

1.49

1.50

XXX extremity w/o dye. 73200......... TC...... A

Ct upper

0.00

6.10

5.25

NA

NA

0.25

6.35

5.50

NA

NA

XXX extremity w/o dye. 73201......... ........ A

Ct upper

1.16

7.97

6.71

NA

NA

0.36

9.49

8.23

NA

NA

XXX extremity w/ dye. 73201......... 26...... A

Ct upper

1.16

0.37

0.38

0.37

0.38

0.05

1.58

1.59

1.58

1.59

XXX extremity w/ dye. 73201......... TC...... A

Ct upper

0.00

7.60

6.33

NA

NA

0.31

7.91

6.64

NA

NA

XXX extremity w/ dye.

[[Page 49185]]

73202......... ........ A

Ct uppr

1.22 10.74

8.55

NA

NA

0.44 12.40

10.21

NA

NA

XXX extremity w/ o&w/dye. 73202......... 26...... A

Ct uppr

1.22

0.39

0.40

0.39

0.40

0.05

1.66

1.67

1.66

1.67

XXX extremity w/ o&w/dye. 73202......... TC...... A

Ct uppr

0.00 10.35

8.15

NA

NA

0.39 10.74

8.54

NA

NA

XXX extremity w/ o&w/dye. 73206......... ........ A

Ct angio upr

1.81 10.85

11.38

NA

NA

0.47 13.13

13.66

NA

NA

XXX extrm w/o&w/ dye. 73206......... 26...... A

Ct angio upr

1.81

0.60

0.59

0.60

0.59

0.08

2.49

2.48

2.49

2.48

XXX extrm w/o&w/ dye. 73206......... TC...... A

Ct angio upr

0.00 10.25

10.78

NA

NA

0.39 10.64

11.17

NA

NA

XXX extrm w/o&w/ dye. 73218......... ........ A

Mri upper

1.35 15.03

12.49

NA

NA

0.45 16.83

14.29

NA

NA

XXX extremity w/o dye. 73218......... 26...... A

Mri upper

1.35

0.45

0.44

0.45

0.44

0.06

1.86

1.85

1.86

1.85

XXX extremity w/o dye. 73218......... TC...... A

Mri upper

0.00 14.58

12.05

NA

NA

0.39 14.97

12.44

NA

NA

XXX extremity w/o dye. 73219......... ........ A

Mri upper

1.62 15.68

14.41

NA

NA

0.54 17.84

16.57

NA

NA

XXX extremity w/ dye. 73219......... 26...... A

Mri upper

1.62

0.53

0.54

0.53

0.54

0.07

2.22

2.23

2.22

2.23

XXX extremity w/ dye. 73219......... TC...... A

Mri upper

0.00 15.15

13.87

NA

NA

0.47 15.62

14.34

NA

NA

XXX extremity w/ dye. 73220......... ........ A

Mri uppr

2.15 19.37

24.04

NA

NA

0.94 22.46

27.13

NA

NA

XXX extremity w/ o&w/dye. 73220......... 26...... A

Mri uppr

2.15

0.70

0.71

0.70

0.71

0.10

2.95

2.96

2.95

2.96

XXX extremity w/ o&w/dye. 73220......... TC...... A

Mri uppr

0.00 18.67

23.33

NA

NA

0.84 19.51

24.17

NA

NA

XXX extremity w/ o&w/dye. 73221......... ........ A

Mri joint upr

1.35 13.95

12.22

NA

NA

0.45 15.75

14.02

NA

NA

XXX extrem w/o dye. 73221......... 26...... A

Mri joint upr

1.35

0.46

0.45

0.46

0.45

0.06

1.87

1.86

1.87

1.86

XXX extrem w/o dye. 73221......... TC...... A

Mri joint upr

0.00 13.49

11.77

NA

NA

0.39 13.88

12.16

NA

NA

XXX extrem w/o dye. 73222......... ........ A

Mri joint upr

1.62 14.71

14.16

NA

NA

0.54 16.87

16.32

NA

NA

XXX extrem w/dye. 73222......... 26...... A

Mri joint upr

1.62

0.55

0.54

0.55

0.54

0.07

2.24

2.23

2.24

2.23

XXX extrem w/dye. 73222......... TC...... A

Mri joint upr

0.00 14.16

13.62

NA

NA

0.47 14.63

14.09

NA

NA

XXX extrem w/dye. 73223......... ........ A

Mri joint upr

2.15 18.04

23.70

NA

NA

0.94 21.13

26.79

NA

NA

XXX extr w/o&w/dye. 73223......... 26...... A

Mri joint upr

2.15

0.71

0.71

0.71

0.71

0.10

2.96

2.96

2.96

2.96

XXX extr w/o&w/dye. 73223......... TC...... A

Mri joint upr

0.00 17.33

22.99

NA

NA

0.84 18.17

23.83

NA

NA

XXX extr w/o&w/dye. 73225......... ........ N

Mr angio upr

1.73 14.77

12.45

NA

NA

0.69 17.19

14.87

NA

NA

XXX extr w/o&w/dye. 73225......... 26...... N

Mr angio upr

1.73

0.40

0.60

0.40

0.60

0.10

2.23

2.43

2.23

2.43

XXX extr w/o&w/dye. 73225......... TC...... N

Mr angio upr

0.00 14.37

11.85

NA

NA

0.59 14.96

12.44

NA

NA

XXX extr w/o&w/dye. 73500......... ........ A

X-ray exam of

0.17

0.49

0.52

NA

NA

0.03

0.69

0.72

NA

NA

XXX hip. 73500......... 26...... A

X-ray exam of

0.17

0.06

0.06

0.06

0.06

0.01

0.24

0.24

0.24

0.24

XXX hip. 73500......... TC...... A

X-ray exam of

0.00

0.43

0.46

NA

NA

0.02

0.45

0.48

NA

NA

XXX hip. 73510......... ........ A

X-ray exam of

0.21

0.78

0.68

NA

NA

0.05

1.04

0.94

NA

NA

XXX hip. 73510......... 26...... A

X-ray exam of

0.21

0.07

0.07

0.07

0.07

0.01

0.29

0.29

0.29

0.29

XXX hip. 73510......... TC...... A

X-ray exam of

0.00

0.71

0.61

NA

NA

0.04

0.75

0.65

NA

NA

XXX hip. 73520......... ........ A

X-ray exam of

0.26

0.79

0.77

NA

NA

0.05

1.10

1.08

NA

NA

XXX hips. 73520......... 26...... A

X-ray exam of

0.26

0.08

0.09

0.08

0.09

0.01

0.35

0.36

0.35

0.36

XXX hips. 73520......... TC...... A

X-ray exam of

0.00

0.71

0.68

NA

NA

0.04

0.75

0.72

NA

NA

XXX hips. 73525......... ........ A

Contrast x-ray

0.54

1.79

2.16

NA

NA

0.15

2.48

2.85

NA

NA

XXX of hip. 73525......... 26...... A

Contrast x-ray

0.54

0.17

0.18

0.17

0.18

0.03

0.74

0.75

0.74

0.75

XXX of hip. 73525......... TC...... A

Contrast x-ray

0.00

1.62

1.98

NA

NA

0.12

1.74

2.10

NA

NA

XXX of hip. 73530......... ........ A

X-ray exam of

0.29

NA

NA

NA

NA

0.03

NA

NA

NA

NA

XXX hip. 73530......... 26...... A

X-ray exam of

0.29

0.09

0.10

0.09

0.10

0.01

0.39

0.40

0.39

0.40

XXX hip. 73530......... TC...... A

X-ray exam of

0.00

NA

NA

NA

NA

0.02

NA

NA

NA

NA

XXX hip. 73540......... ........ A

X-ray exam of

0.20

0.80

0.68

NA

NA

0.05

1.05

0.93

NA

NA

XXX pelvis & hips. 73540......... 26...... A

X-ray exam of

0.20

0.07

0.07

0.07

0.07

0.01

0.28

0.28

0.28

0.28

XXX pelvis & hips. 73540......... TC...... A

X-ray exam of

0.00

0.73

0.61

NA

NA

0.04

0.77

0.65

NA

NA

XXX pelvis & hips. 73542......... ........ A

X-ray exam,

0.59

1.12

1.98

NA

NA

0.15

1.86

2.72

NA

NA

XXX sacroiliac joint. 73542......... 26...... A

X-ray exam,

0.59

0.14

0.16

0.14

0.16

0.03

0.76

0.78

0.76

0.78

XXX sacroiliac joint. 73542......... TC...... A

X-ray exam,

0.00

0.98

1.82

NA

NA

0.12

1.10

1.94

NA

NA

XXX sacroiliac joint. 73550......... ........ A

X-ray exam of

0.17

0.54

0.61

NA

NA

0.05

0.76

0.83

NA

NA

XXX thigh. 73550......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX thigh. 73550......... TC...... A

X-ray exam of

0.00

0.49

0.55

NA

NA

0.04

0.53

0.59

NA

NA

XXX thigh. 73560......... ........ A

X-ray exam of

0.17

0.59

0.58

NA

NA

0.03

0.79

0.78

NA

NA

XXX knee, 1 or 2. 73560......... 26...... A

X-ray exam of

0.17

0.06

0.06

0.06

0.06

0.01

0.24

0.24

0.24

0.24

XXX knee, 1 or 2. 73560......... TC...... A

X-ray exam of

0.00

0.53

0.52

NA

NA

0.02

0.55

0.54

NA

NA

XXX knee, 1 or 2. 73562......... ........ A

X-ray exam of

0.18

0.73

0.66

NA

NA

0.05

0.96

0.89

NA

NA

XXX knee, 3. 73562......... 26...... A

X-ray exam of

0.18

0.06

0.06

0.06

0.06

0.01

0.25

0.25

0.25

0.25

XXX knee, 3. 73562......... TC...... A

X-ray exam of

0.00

0.67

0.60

NA

NA

0.04

0.71

0.64

NA

NA

XXX knee, 3. 73564......... ........ A

X-ray exam,

0.22

0.87

0.74

NA

NA

0.05

1.14

1.01

NA

NA

XXX knee, 4 or more. 73564......... 26...... A

X-ray exam,

0.22

0.08

0.07

0.08

0.07

0.01

0.31

0.30

0.31

0.30

XXX knee, 4 or more. 73564......... TC...... A

X-ray exam,

0.00

0.79

0.66

NA

NA

0.04

0.83

0.70

NA

NA

XXX knee, 4 or more. 73565......... ........ A

X-ray exam of

0.17

0.65

0.58

NA

NA

0.03

0.85

0.78

NA

NA

XXX knees. 73565......... 26...... A

X-ray exam of

0.17

0.06

0.06

0.06

0.06

0.01

0.24

0.24

0.24

0.24

XXX knees. 73565......... TC...... A

X-ray exam of

0.00

0.59

0.52

NA

NA

0.02

0.61

0.54

NA

NA

XXX knees. 73580......... ........ A

Contrast x-ray

0.54

2.40

2.69

NA

NA

0.17

3.11

3.40

NA

NA

XXX of knee joint. 73580......... 26...... A

Contrast x-ray

0.54

0.18

0.17

0.18

0.17

0.03

0.75

0.74

0.75

0.74

XXX of knee joint. 73580......... TC...... A

Contrast x-ray

0.00

2.22

2.52

NA

NA

0.14

2.36

2.66

NA

NA

XXX of knee joint.

[[Page 49186]]

73590......... ........ A

X-ray exam of

0.17

0.54

0.57

NA

NA

0.03

0.74

0.77

NA

NA

XXX lower leg. 73590......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX lower leg. 73590......... TC...... A

X-ray exam of

0.00

0.49

0.51

NA

NA

0.02

0.51

0.53

NA

NA

XXX lower leg. 73592......... ........ A

X-ray exam of

0.16

0.60

0.56

NA

NA

0.03

0.79

0.75

NA

NA

XXX leg, infant. 73592......... 26...... A

X-ray exam of

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX leg, infant. 73592......... TC...... A

X-ray exam of

0.00

0.55

0.51

NA

NA

0.02

0.57

0.53

NA

NA

XXX leg, infant. 73600......... ........ A

X-ray exam of

0.16

0.57

0.55

NA

NA

0.03

0.76

0.74

NA

NA

XXX ankle. 73600......... 26...... A

X-ray exam of

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX ankle. 73600......... TC...... A

X-ray exam of

0.00

0.51

0.50

NA

NA

0.02

0.53

0.52

NA

NA

XXX ankle. 73610......... ........ A

X-ray exam of

0.17

0.67

0.61

NA

NA

0.03

0.87

0.81

NA

NA

XXX ankle. 73610......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX ankle. 73610......... TC...... A

X-ray exam of

0.00

0.62

0.55

NA

NA

0.02

0.64

0.57

NA

NA

XXX ankle. 73615......... ........ A

Contrast x-ray

0.54

1.89

2.18

NA

NA

0.15

2.58

2.87

NA

NA

XXX of ankle. 73615......... 26...... A

Contrast x-ray

0.54

0.17

0.18

0.17

0.18

0.03

0.74

0.75

0.74

0.75

XXX of ankle. 73615......... TC...... A

Contrast x-ray

0.00

1.72

2.01

NA

NA

0.12

1.84

2.13

NA

NA

XXX of ankle. 73620......... ........ A

X-ray exam of

0.16

0.53

0.54

NA

NA

0.03

0.72

0.73

NA

NA

XXX foot. 73620......... 26...... A

X-ray exam of

0.16

0.04

0.05

0.04

0.05

0.01

0.21

0.22

0.21

0.22

XXX foot. 73620......... TC...... A

X-ray exam of

0.00

0.49

0.49

NA

NA

0.02

0.51

0.51

NA

NA

XXX foot. 73630......... ........ A

X-ray exam of

0.17

0.66

0.61

NA

NA

0.03

0.86

0.81

NA

NA

XXX foot. 73630......... 26...... A

X-ray exam of

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX foot. 73630......... TC...... A

X-ray exam of

0.00

0.60

0.55

NA

NA

0.02

0.62

0.57

NA

NA

XXX foot. 73650......... ........ A

X-ray exam of

0.16

0.56

0.53

NA

NA

0.03

0.75

0.72

NA

NA

XXX heel. 73650......... 26...... A

X-ray exam of

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX heel. 73650......... TC...... A

X-ray exam of

0.00

0.51

0.48

NA

NA

0.02

0.53

0.50

NA

NA

XXX heel. 73660......... ........ A

X-ray exam of

0.13

0.64

0.51

NA

NA

0.03

0.80

0.67

NA

NA

XXX toe(s). 73660......... 26...... A

X-ray exam of

0.13

0.04

0.04

0.04

0.04

0.01

0.18

0.18

0.18

0.18

XXX toe(s). 73660......... TC...... A

X-ray exam of

0.00

0.60

0.47

NA

NA

0.02

0.62

0.49

NA

NA

XXX toe(s). 73700......... ........ A

Ct lower

1.09

6.44

5.59

NA

NA

0.30

7.83

6.98

NA

NA

XXX extremity w/o dye. 73700......... 26...... A

Ct lower

1.09

0.35

0.36

0.35

0.36

0.05

1.49

1.50

1.49

1.50

XXX extremity w/o dye. 73700......... TC...... A

Ct lower

0.00

6.09

5.24

NA

NA

0.25

6.34

5.49

NA

NA

XXX extremity w/o dye. 73701......... ........ A

Ct lower

1.16

7.95

6.71

NA

NA

0.36

9.47

8.23

NA

NA

XXX extremity w/ dye. 73701......... 26...... A

Ct lower

1.16

0.36

0.38

0.36

0.38

0.05

1.57

1.59

1.57

1.59

XXX extremity w/ dye. 73701......... TC...... A

Ct lower

0.00

7.59

6.33

NA

NA

0.31

7.90

6.64

NA

NA

XXX extremity w/ dye. 73702......... ........ A

Ct lwr

1.22 10.81

8.57

NA

NA

0.44 12.47

10.23

NA

NA

XXX extremity w/ o&w/dye. 73702......... 26...... A

Ct lwr

1.22

0.40

0.40

0.40

0.40

0.05

1.67

1.67

1.67

1.67

XXX extremity w/ o&w/dye. 73702......... TC...... A

Ct lwr

0.00 10.41

8.17

NA

NA

0.39 10.80

8.56

NA

NA

XXX extremity w/ o&w/dye. 73706......... ........ A

Ct angio lwr

1.90 12.39

11.78

NA

NA

0.47 14.76

14.15

NA

NA

XXX extr w/o&w/dye. 73706......... 26...... A

Ct angio lwr

1.90

0.66

0.63

0.66

0.63

0.08

2.64

2.61

2.64

2.61

XXX extr w/o&w/dye. 73706......... TC...... A

Ct angio lwr

0.00 11.73

11.15

NA

NA

0.39 12.12

11.54

NA

NA

XXX extr w/o&w/dye. 73718......... ........ A

Mri lower

1.35 14.74

12.42

NA

NA

0.45 16.54

14.22

NA

NA

XXX extremity w/o dye. 73718......... 26...... A

Mri lower

1.35

0.46

0.45

0.46

0.45

0.06

1.87

1.86

1.87

1.86

XXX extremity w/o dye. 73718......... TC...... A

Mri lower

0.00 14.28

11.97

NA

NA

0.39 14.67

12.36

NA

NA

XXX extremity w/o dye. 73719......... ........ A

Mri lower

1.62 15.59

14.38

NA

NA

0.54 17.75

16.54

NA

NA

XXX extremity w/ dye. 73719......... 26...... A

Mri lower

1.62

0.52

0.53

0.52

0.53

0.07

2.21

2.22

2.21

2.22

XXX extremity w/ dye. 73719......... TC...... A

Mri lower

0.00 15.07

13.85

NA

NA

0.47 15.54

14.32

NA

NA

XXX extremity w/ dye. 73720......... ........ A

Mri lwr

2.15 19.28

24.01

NA

NA

0.94 22.37

27.10

NA

NA

XXX extremity w/ o&w/dye. 73720......... 26...... A

Mri lwr

2.15

0.69

0.70

0.69

0.70

0.10

2.94

2.95

2.94

2.95

XXX extremity w/ o&w/dye. 73720......... TC...... A

Mri lwr

0.00 18.59

23.31

NA

NA

0.84 19.43

24.15

NA

NA

XXX extremity w/ o&w/dye. 73721......... ........ A

Mri jnt of lwr

1.35 14.27

12.30

NA

NA

0.45 16.07

14.10

NA

NA

XXX extre w/o dye. 73721......... 26...... A

Mri jnt of lwr

1.35

0.46

0.45

0.46

0.45

0.06

1.87

1.86

1.87

1.86

XXX extre w/o dye. 73721......... TC...... A

Mri jnt of lwr

0.00 13.81

11.85

NA

NA

0.39 14.20

12.24

NA

NA

XXX extre w/o dye. 73722......... ........ A

Mri joint of

1.62 14.86

14.19

NA

NA

0.54 17.02

16.35

NA

NA

XXX lwr extr w/dye. 73722......... 26...... A

Mri joint of

1.62

0.54

0.53

0.54

0.53

0.07

2.23

2.22

2.23

2.22

XXX lwr extr w/dye. 73722......... TC...... A

Mri joint of

0.00 14.32

13.66

NA

NA

0.47 14.79

14.13

NA

NA

XXX lwr extr w/dye. 73723......... ........ A

Mri joint lwr

2.15 17.91

23.67

NA

NA

0.94 21.00

26.76

NA

NA

XXX extr w/o&w/dye. 73723......... 26...... A

Mri joint lwr

2.15

0.70

0.71

0.70

0.71

0.10

2.95

2.96

2.95

2.96

XXX extr w/o&w/dye.

[[Page 49187]]

73723......... TC...... A

Mri joint lwr

0.00 17.21

22.96

NA

NA

0.84 18.05

23.80

NA

NA

XXX extr w/o&w/dye. 73725......... ........ R

Mr ang lwr ext

1.82 15.34

12.69

NA

NA

0.67 17.83

15.18

NA

NA

XXX w or w/o dye. 73725......... 26...... R

Mr ang lwr ext

1.82

0.60

0.60

0.60

0.60

0.08

2.50

2.50

2.50

2.50

XXX w or w/o dye. 73725......... TC...... R

Mr ang lwr ext

0.00 14.75

12.09

NA

NA

0.59 15.34

12.68

NA

NA

XXX w or w/o dye. 74000......... ........ A

X-ray exam of

0.18

0.46

0.55

NA

NA

0.03

0.67

0.76

NA

NA

XXX abdomen. 74000......... 26...... A

X-ray exam of

0.18

0.05

0.06

0.05

0.06

0.01

0.24

0.25

0.24

0.25

XXX abdomen. 74000......... TC...... A

X-ray exam of

0.00

0.40

0.49

NA

NA

0.02

0.42

0.51

NA

NA

XXX abdomen. 74010......... ........ A

X-ray exam of

0.23

0.79

0.69

NA

NA

0.05

1.07

0.97

NA

NA

XXX abdomen. 74010......... 26...... A

X-ray exam of

0.23

0.07

0.08

0.07

0.08

0.01

0.31

0.32

0.31

0.32

XXX abdomen. 74010......... TC...... A

X-ray exam of

0.00

0.72

0.61

NA

NA

0.04

0.76

0.65

NA

NA

XXX abdomen. 74020......... ........ A

X-ray exam of

0.27

0.80

0.73

NA

NA

0.05

1.12

1.05

NA

NA

XXX abdomen. 74020......... 26...... A

X-ray exam of

0.27

0.08

0.09

0.08

0.09

0.01

0.36

0.37

0.36

0.37

XXX abdomen. 74020......... TC...... A

X-ray exam of

0.00

0.71

0.64

NA

NA

0.04

0.75

0.68

NA

NA

XXX abdomen. 74022......... ........ A

X-ray exam

0.32

0.97

0.87

NA

NA

0.06

1.35

1.25

NA

NA

XXX series, abdomen. 74022......... 26...... A

X-ray exam

0.32

0.10

0.10

0.10

0.10

0.01

0.43

0.43

0.43

0.43

XXX series, abdomen. 74022......... TC...... A

X-ray exam

0.00

0.87

0.77

NA

NA

0.05

0.92

0.82

NA

NA

XXX series, abdomen. 74150......... ........ A

Ct abdomen w/o

1.19

6.06

6.05

NA

NA

0.35

7.60

7.59

NA

NA

XXX dye. 74150......... 26...... A

Ct abdomen w/o

1.19

0.38

0.39

0.38

0.39

0.05

1.62

1.63

1.62

1.63

XXX dye. 74150......... TC...... A

Ct abdomen w/o

0.00

5.68

5.67

NA

NA

0.30

5.98

5.97

NA

NA

XXX dye. 74160......... ........ A

Ct abdomen w/

1.27

8.83

7.65

NA

NA

0.42 10.52

9.34

NA

NA

XXX dye. 74160......... 26...... A

Ct abdomen w/

1.27

0.40

0.42

0.40

0.42

0.06

1.73

1.75

1.73

1.75

XXX dye. 74160......... TC...... A

Ct abdomen w/

0.00

8.43

7.24

NA

NA

0.36

8.79

7.60

NA

NA

XXX dye. 74170......... ........ A

Ct abdomen w/o

1.40 12.27

9.77

NA

NA

0.49 14.16

11.66

NA

NA

XXX & w/dye. 74170......... 26...... A

Ct abdomen w/o

1.40

0.45

0.46

0.45

0.46

0.06

1.91

1.92

1.91

1.92

XXX & w/dye. 74170......... TC...... A

Ct abdomen w/o

0.00 11.82

9.32

NA

NA

0.43 12.25

9.75

NA

NA

XXX & w/dye. 74175......... ........ A

Ct angio abdom

1.90 12.34

12.57

NA

NA

0.47 14.71

14.94

NA

NA

XXX w/o & w/dye. 74175......... 26...... A

Ct angio abdom

1.90

0.63

0.62

0.63

0.62

0.08

2.61

2.60

2.61

2.60

XXX w/o & w/dye. 74175......... TC...... A

Ct angio abdom

0.00 11.71

11.95

NA

NA

0.39 12.10

12.34

NA

NA

XXX w/o & w/dye. 74181......... ........ A

Mri abdomen w/o 1.46 12.60

11.91

NA

NA

0.51 14.57

13.88

NA

NA

XXX dye. 74181......... 26...... A

Mri abdomen w/o 1.46

0.47

0.48

0.47

0.48

0.06

1.99

2.00

1.99

2.00

XXX dye. 74181......... TC...... A

Mri abdomen w/o 0.00 12.13

11.43

NA

NA

0.45 12.58

11.88

NA

NA

XXX dye. 74182......... ........ A

Mri abdomen w/

1.73 17.59

14.91

NA

NA

0.60 19.92

17.24

NA

NA

XXX dye. 74182......... 26...... A

Mri abdomen w/

1.73

0.55

0.57

0.55

0.57

0.08

2.36

2.38

2.36

2.38

XXX dye. 74182......... TC...... A

Mri abdomen w/

0.00 17.04

14.34

NA

NA

0.52 17.56

14.86

NA

NA

XXX dye. 74183......... ........ A

Mri abdomen w/o 2.26 19.27

24.03

NA

NA

1.02 22.55

27.31

NA

NA

XXX & w/dye. 74183......... 26...... A

Mri abdomen w/o 2.26

0.73

0.74

0.73

0.74

0.10

3.09

3.10

3.09

3.10

XXX & w/dye. 74183......... TC...... A

Mri abdomen w/o 0.00 18.54

23.30

NA

NA

0.92 19.46

24.22

NA

NA

XXX & w/dye. 74185......... ........ R

Mri angio,

1.80 15.31

12.67

NA

NA

0.67 17.78

15.14

NA

NA

XXX abdom w orw/o dye. 74185......... 26...... R

Mri angio,

1.80

0.59

0.59

0.59

0.59

0.08

2.47

2.47

2.47

2.47

XXX abdom w orw/o dye. 74185......... TC...... R

Mri angio,

0.00 14.72

12.08

NA

NA

0.59 15.31

12.67

NA

NA

XXX abdom w orw/o dye. 74190......... ........ A

X-ray exam of

0.48

NA

NA

NA

NA

0.09

NA

NA

NA

NA

XXX peritoneum. 74190......... 26...... A

X-ray exam of

0.48

0.15

0.16

0.15

0.16

0.02

0.65

0.66

0.65

0.66

XXX peritoneum. 74190......... TC...... A

X-ray exam of

0.00

NA

NA

NA

NA

0.07

NA

NA

NA

NA

XXX peritoneum. 74210......... ........ A

Contrst x-ray

0.36

1.76

1.42

NA

NA

0.08

2.20

1.86

NA

NA

XXX exam of throat. 74210......... 26...... A

Contrst x-ray

0.36

0.11

0.12

0.11

0.12

0.02

0.49

0.50

0.49

0.50

XXX exam of throat. 74210......... TC...... A

Contrst x-ray

0.00

1.65

1.31

NA

NA

0.06

1.71

1.37

NA

NA

XXX exam of throat. 74220......... ........ A

Contrast x-ray, 0.46

2.01

1.51

NA

NA

0.08

2.55

2.05

NA

NA

XXX esophagus. 74220......... 26...... A

Contrast x-ray, 0.46

0.14

0.15

0.14

0.15

0.02

0.62

0.63

0.62

0.63

XXX esophagus. 74220......... TC...... A

Contrast x-ray, 0.00

1.87

1.36

NA

NA

0.06

1.93

1.42

NA

NA

XXX esophagus. 74230......... ........ A

Cine/vid x-ray, 0.53

1.93

1.59

NA

NA

0.09

2.55

2.21

NA

NA

XXX throat/esoph. 74230......... 26...... A

Cine/vid x-ray, 0.53

0.17

0.17

0.17

0.17

0.02

0.72

0.72

0.72

0.72

XXX throat/esoph. 74230......... TC...... A

Cine/vid x-ray, 0.00

1.76

1.42

NA

NA

0.07

1.83

1.49

NA

NA

XXX throat/esoph. 74235......... ........ C

Remove

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX esophagus obstruction. 74235......... 26...... A

Remove

1.19

0.40

0.39

0.40

0.39

0.05

1.64

1.63

1.64

1.63

XXX esophagus obstruction. 74235......... TC...... C

Remove

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX esophagus obstruction. 74240......... ........ A

X-ray exam,

0.69

2.28

1.84

NA

NA

0.11

3.08

2.64

NA

NA

XXX upper gi tract. 74240......... 26...... A

X-ray exam,

0.69

0.22

0.23

0.22

0.23

0.03

0.94

0.95

0.94

0.95

XXX upper gi tract. 74240......... TC...... A

X-ray exam,

0.00

2.07

1.61

NA

NA

0.08

2.15

1.69

NA

NA

XXX upper gi tract. 74241......... ........ A

X-ray exam,

0.69

2.55

1.93

NA

NA

0.11

3.35

2.73

NA

NA

XXX upper gi tract. 74241......... 26...... A

X-ray exam,

0.69

0.21

0.23

0.21

0.23

0.03

0.93

0.95

0.93

0.95

XXX upper gi tract. 74241......... TC...... A

X-ray exam,

0.00

2.34

1.70

NA

NA

0.08

2.42

1.78

NA

NA

XXX upper gi tract. 74245......... ........ A

X-ray exam,

0.91

3.94

3.00

NA

NA

0.17

5.02

4.08

NA

NA

XXX upper gi tract. 74245......... 26...... A

X-ray exam,

0.91

0.29

0.30

0.29

0.30

0.04

1.24

1.25

1.24

1.25

XXX upper gi tract. 74245......... TC...... A

X-ray exam,

0.00

3.65

2.70

NA

NA

0.13

3.78

2.83

NA

NA

XXX upper gi tract. 74246......... ........ A

Contrst x-ray

0.69

2.78

2.09

NA

NA

0.13

3.60

2.91

NA

NA

XXX uppr gi tract. 74246......... 26...... A

Contrst x-ray

0.69

0.22

0.23

0.22

0.23

0.03

0.94

0.95

0.94

0.95

XXX uppr gi tract.

[[Page 49188]]

74246......... TC...... A

Contrst x-ray

0.00

2.57

1.87

NA

NA

0.10

2.67

1.97

NA

NA

XXX uppr gi tract. 74247......... ........ A

Contrst x-ray

0.69

3.21

2.23

NA

NA

0.14

4.04

3.06

NA

NA

XXX uppr gi tract. 74247......... 26...... A

Contrst x-ray

0.69

0.22

0.23

0.22

0.23

0.03

0.94

0.95

0.94

0.95

XXX uppr gi tract. 74247......... TC...... A

Contrst x-ray

0.00

2.99

2.01

NA

NA

0.11

3.10

2.12

NA

NA

XXX uppr gi tract. 74249......... ........ A

Contrst x-ray

0.91

4.33

3.24

NA

NA

0.18

5.42

4.33

NA

NA

XXX uppr gi tract. 74249......... 26...... A

Contrst x-ray

0.91

0.29

0.30

0.29

0.30

0.04

1.24

1.25

1.24

1.25

XXX uppr gi tract. 74249......... TC...... A

Contrst x-ray

0.00

4.05

2.94

NA

NA

0.14

4.19

3.08

NA

NA

XXX uppr gi tract. 74250......... ........ A

X-ray exam of

0.47

2.48

1.72

NA

NA

0.09

3.04

2.28

NA

NA

XXX small bowel. 74250......... 26...... A

X-ray exam of

0.47

0.15

0.15

0.15

0.15

0.02

0.64

0.64

0.64

0.64

XXX small bowel. 74250......... TC...... A

X-ray exam of

0.00

2.33

1.57

NA

NA

0.07

2.40

1.64

NA

NA

XXX small bowel. 74251......... ........ A

X-ray exam of

0.69 10.01

3.66

NA

NA

0.10 10.80

4.45

NA

NA

XXX small bowel. 74251......... 26...... A

X-ray exam of

0.69

0.22

0.23

0.22

0.23

0.03

0.94

0.95

0.94

0.95

XXX small bowel. 74251......... TC...... A

X-ray exam of

0.00

9.80

3.43

NA

NA

0.07

9.87

3.50

NA

NA

XXX small bowel. 74260......... ........ A

X-ray exam of

0.50

8.32

3.32

NA

NA

0.10

8.92

3.92

NA

NA

XXX small bowel. 74260......... 26...... A

X-ray exam of

0.50

0.15

0.16

0.15

0.16

0.02

0.67

0.68

0.67

0.68

XXX small bowel. 74260......... TC...... A

X-ray exam of

0.00

8.17

3.16

NA

NA

0.08

8.25

3.24

NA

NA

XXX small bowel. 74270......... ........ A

Contrast x-ray

0.69

3.57

2.33

NA

NA

0.14

4.40

3.16

NA

NA

XXX exam of colon. 74270......... 26...... A

Contrast x-ray

0.69

0.22

0.23

0.22

0.23

0.03

0.94

0.95

0.94

0.95

XXX exam of colon. 74270......... TC...... A

Contrast x-ray

0.00

3.35

2.11

NA

NA

0.11

3.46

2.22

NA

NA

XXX exam of colon. 74280......... ........ A

Contrast x-ray

0.99

4.94

3.15

NA

NA

0.17

6.10

4.31

NA

NA

XXX exam of colon. 74280......... 26...... A

Contrast x-ray

0.99

0.31

0.32

0.31

0.32

0.04

1.34

1.35

1.34

1.35

XXX exam of colon. 74280......... TC...... A

Contrast x-ray

0.00

4.63

2.83

NA

NA

0.13

4.76

2.96

NA

NA

XXX exam of colon. 74283......... ........ A

Contrast x-ray

2.02

3.42

3.27

NA

NA

0.23

5.67

5.52

NA

NA

XXX exam of colon. 74283......... 26...... A

Contrast x-ray

2.02

0.61

0.65

0.61

0.65

0.09

2.72

2.76

2.72

2.76

XXX exam of colon. 74283......... TC...... A

Contrast x-ray

0.00

2.80

2.62

NA

NA

0.14

2.94

2.76

NA

NA

XXX exam of colon. 74290......... ........ A

Contrast x-ray, 0.32

1.56

1.01

NA

NA

0.06

1.94

1.39

NA

NA

XXX gallbladder. 74290......... 26...... A

Contrast x-ray, 0.32

0.10

0.10

0.10

0.10

0.01

0.43

0.43

0.43

0.43

XXX gallbladder. 74290......... TC...... A

Contrast x-ray, 0.00

1.46

0.91

NA

NA

0.05

1.51

0.96

NA

NA

XXX gallbladder. 74291......... ........ A

Contrast x-

0.20

1.60

0.77

NA

NA

0.03

1.83

1.00

NA

NA

XXX rays, gallbladder. 74291......... 26...... A

Contrast x-

0.20

0.06

0.07

0.06

0.07

0.01

0.27

0.28

0.27

0.28

XXX rays, gallbladder. 74291......... TC...... A

Contrast x-

0.00

1.54

0.70

NA

NA

0.02

1.56

0.72

NA

NA

XXX rays, gallbladder. 74300......... ........ C

X-ray bile

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ducts/pancreas. 74300......... 26...... A

X-ray bile

0.36

0.11

0.12

0.11

0.12

0.02

0.49

0.50

0.49

0.50

XXX ducts/pancreas. 74300......... TC...... C

X-ray bile

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ducts/pancreas. 74301......... ........ C

X-rays at

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ surgery add-on. 74301......... 26...... A

X-rays at

0.21

0.07

0.07

0.07

0.07

0.01

0.29

0.29

0.29

0.29

ZZZ surgery add-on. 74301......... TC...... C

X-rays at

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ surgery add-on. 74305......... ........ A

X-ray bile

0.42

NA

NA

NA

NA

0.07

NA

NA

NA

NA

XXX ducts/pancreas. 74305......... 26...... A

X-ray bile

0.42

0.14

0.14

0.14

0.14

0.02

0.58

0.58

0.58

0.58

XXX ducts/pancreas. 74305......... TC...... A

X-ray bile

0.00

NA

NA

NA

NA

0.05

NA

NA

NA

NA

XXX ducts/pancreas. 74320......... ........ A

Contrast x-ray

0.54

2.13

3.03

NA

NA

0.19

2.86

3.76

NA

NA

XXX of bile ducts. 74320......... 26...... A

Contrast x-ray

0.54

0.17

0.18

0.17

0.18

0.02

0.73

0.74

0.73

0.74

XXX of bile ducts. 74320......... TC...... A

Contrast x-ray

0.00

1.95

2.85

NA

NA

0.17

2.12

3.02

NA

NA

XXX of bile ducts. 74327......... ........ A

X-ray bile

0.70

2.99

2.24

NA

NA

0.14

3.83

3.08

NA

NA

XXX stone removal. 74327......... 26...... A

X-ray bile

0.70

0.23

0.23

0.23

0.23

0.03

0.96

0.96

0.96

0.96

XXX stone removal. 74327......... TC...... A

X-ray bile

0.00

2.76

2.01

NA

NA

0.11

2.87

2.12

NA

NA

XXX stone removal. 74328......... ........ A

X-ray bile duct 0.70

NA

NA

NA

NA

0.20

NA

NA

NA

NA

XXX endoscopy. 74328......... 26...... A

X-ray bile duct 0.70

0.23

0.23

0.23

0.23

0.03

0.96

0.96

0.96

0.96

XXX endoscopy. 74328......... TC...... A

X-ray bile duct 0.00

NA

NA

NA

NA

0.17

NA

NA

NA

NA

XXX endoscopy. 74329......... ........ C

X-ray for

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX pancreas endoscopy. 74329......... 26...... A

X-ray for

0.70

0.23

0.23

0.23

0.23

0.03

0.96

0.96

0.96

0.96

XXX pancreas endoscopy. 74329......... TC...... C

X-ray for

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX pancreas endoscopy. 74330......... ........ A

X-ray bile/panc 0.90

NA

NA

NA

NA

0.21

NA

NA

NA

NA

XXX endoscopy. 74330......... 26...... A

X-ray bile/panc 0.90

0.30

0.29

0.30

0.29

0.04

1.24

1.23

1.24

1.23

XXX endoscopy. 74330......... TC...... A

X-ray bile/panc 0.00

NA

NA

NA

NA

0.17

NA

NA

NA

NA

XXX endoscopy. 74340......... ........ A

X-ray guide for 0.54

NA

NA

NA

NA

0.16

NA

NA

NA

NA

XXX GI tube.

[[Page 49189]]

74340......... 26...... A

X-ray guide for 0.54

0.17

0.18

0.17

0.18

0.02

0.73

0.74

0.73

0.74

XXX GI tube. 74340......... TC...... A

X-ray guide for 0.00

NA

NA

NA

NA

0.14

NA

NA

NA

NA

XXX GI tube. 74350......... ........ A

X-ray guide,

0.76

2.22

3.11

NA

NA

0.20

3.18

4.07

NA

NA

XXX stomach tube. 74350......... 26...... A

X-ray guide,

0.76

0.25

0.25

0.25

0.25

0.03

1.04

1.04

1.04

1.04

XXX stomach tube. 74350......... TC...... A

X-ray guide,

0.00

1.97

2.86

NA

NA

0.17

2.14

3.03

NA

NA

XXX stomach tube. 74355......... ........ A

X-ray guide,

0.76

NA

NA

NA

NA

0.17

NA

NA

NA

NA

XXX intestinal tube. 74355......... 26...... A

X-ray guide,

0.76

0.25

0.25

0.25

0.25

0.03

1.04

1.04

1.04

1.04

XXX intestinal tube. 74355......... TC...... A

X-ray guide,

0.00

NA

NA

NA

NA

0.14

NA

NA

NA

NA

XXX intestinal tube. 74360......... ........ A

X-ray guide, GI 0.54

NA

NA

NA

NA

0.19

NA

NA

NA

NA

XXX dilation. 74360......... 26...... A

X-ray guide, GI 0.54

0.24

0.20

0.24

0.20

0.02

0.80

0.76

0.80

0.76

XXX dilation. 74360......... TC...... A

X-ray guide, GI 0.00

NA

NA

NA

NA

0.17

NA

NA

NA

NA

XXX dilation. 74363......... ........ C

X-ray, bile

0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX duct dilation. 74363......... 26...... A

X-ray, bile

0.88

0.29

0.29

0.29

0.29

0.04

1.21

1.21

1.21

1.21

XXX duct dilation. 74363......... TC...... C

X-ray, bile

0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX duct dilation. 74400......... ........ A

Contrst x-ray,

0.49

2.60

2.02

NA

NA

0.13

3.22

2.64

NA

NA

XXX urinary tract. 74400......... 26...... A

Contrst x-ray,

0.49

0.16

0.16

0.16

0.16

0.02

0.67

0.67

0.67

0.67

XXX urinary tract. 74400......... TC...... A

Contrst x-ray,

0.00

2.44

1.87

NA

NA

0.11

2.55

1.98

NA

NA

XXX urinary tract. 74410......... ........ A

Contrst x-ray,

0.49

2.73

2.27

NA

NA

0.13

3.35

2.89

NA

NA

XXX urinary tract. 74410......... 26...... A

Contrst x-ray,

0.49

0.17

0.16

0.17

0.16

0.02

0.68

0.67

0.68

0.67

XXX urinary tract. 74410......... TC...... A

Contrst x-ray,

0.00

2.56

2.10

NA

NA

0.11

2.67

2.21

NA

NA

XXX urinary tract. 74415......... ........ A

Contrst x-ray,

0.49

3.29

2.53

NA

NA

0.14

3.92

3.16

NA

NA

XXX urinary tract. 74415......... 26...... A

Contrst x-ray,

0.49

0.16

0.16

0.16

0.16

0.02

0.67

0.67

0.67

0.67

XXX urinary tract. 74415......... TC...... A

Contrst x-ray,

0.00

3.13

2.37

NA

NA

0.12

3.25

2.49

NA

NA

XXX urinary tract. 74420......... ........ A

Contrst x-ray,

0.36

NA

NA

NA

NA

0.16

NA

NA

NA

NA

XXX urinary tract. 74420......... 26...... A

Contrst x-ray,

0.36

0.13

0.12

0.13

0.12

0.02

0.51

0.50

0.51

0.50

XXX urinary tract. 74420......... TC...... A

Contrst x-ray,

0.00

NA

NA

NA

NA

0.14

NA

NA

NA

NA

XXX urinary tract. 74425......... ........ A

Contrst x-ray,

0.36

NA

NA

NA

NA

0.09

NA

NA

NA

NA

XXX urinary tract. 74425......... 26...... A

Contrst x-ray,

0.36

0.12

0.12

0.12

0.12

0.02

0.50

0.50

0.50

0.50

XXX urinary tract. 74425......... TC...... A

Contrst x-ray,

0.00

NA

NA

NA

NA

0.07

NA

NA

NA

NA

XXX urinary tract. 74430......... ........ A

Contrast x-ray, 0.32

1.96

1.35

NA

NA

0.08

2.36

1.75

NA

NA

XXX bladder. 74430......... 26...... A

Contrast x-ray, 0.32

0.11

0.10

0.11

0.10

0.02

0.45

0.44

0.45

0.44

XXX bladder. 74430......... TC...... A

Contrast x-ray, 0.00

1.85

1.25

NA

NA

0.06

1.91

1.31

NA

NA

XXX bladder. 74440......... ........ A

X-ray, male

0.38

2.20

1.49

NA

NA

0.08

2.66

1.95

NA

NA

XXX genital tract. 74440......... 26...... A

X-ray, male

0.38

0.15

0.13

0.15

0.13

0.02

0.55

0.53

0.55

0.53

XXX genital tract. 74440......... TC...... A

X-ray, male

0.00

2.06

1.36

NA

NA

0.06

2.12

1.42

NA

NA

XXX genital tract. 74445......... ........ A

X-ray exam of

1.14

NA

NA

NA

NA

0.13

NA

NA

NA

NA

XXX penis. 74445......... 26...... A

X-ray exam of

1.14

0.44

0.39

0.44

0.39

0.07

1.65

1.60

1.65

1.60

XXX penis. 74445......... TC...... A

X-ray exam of

0.00

NA

NA

NA

NA

0.06

NA

NA

NA

NA

XXX penis. 74450......... ........ A

X-ray, urethra/ 0.33

NA

NA

NA

NA

0.10

NA

NA

NA

NA

XXX bladder. 74450......... 26...... A

X-ray, urethra/ 0.33

0.11

0.11

0.11

0.11

0.02

0.46

0.46

0.46

0.46

XXX bladder. 74450......... TC...... A

X-ray, urethra/ 0.00

NA

NA

NA

NA

0.08

NA

NA

NA

NA

XXX bladder. 74455......... ........ A

X-ray, urethra/ 0.33

2.18

1.81

NA

NA

0.12

2.63

2.26

NA

NA

XXX bladder. 74455......... 26...... A

X-ray, urethra/ 0.33

0.12

0.11

0.12

0.11

0.02

0.47

0.46

0.47

0.46

XXX bladder. 74455......... TC...... A

X-ray, urethra/ 0.00

2.06

1.70

NA

NA

0.10

2.16

1.80

NA

NA

XXX bladder. 74470......... ........ A

X-ray exam of

0.54

NA

NA

NA

NA

0.09

NA

NA

NA

NA

XXX kidney lesion. 74470......... 26...... A

X-ray exam of

0.54

0.16

0.18

0.16

0.18

0.02

0.72

0.74

0.72

0.74

XXX kidney lesion. 74470......... TC...... A

X-ray exam of

0.00

NA

NA

NA

NA

0.07

NA

NA

NA

NA

XXX kidney lesion. 74475......... ........ A

X-ray control,

0.54

2.12

3.72

NA

NA

0.24

2.90

4.50

NA

NA

XXX cath insert. 74475......... 26...... A

X-ray control,

0.54

0.18

0.18

0.18

0.18

0.02

0.74

0.74

0.74

0.74

XXX cath insert. 74475......... TC...... A

X-ray control,

0.00

1.94

3.54

NA

NA

0.22

2.16

3.76

NA

NA

XXX cath insert. 74480......... ........ A

X-ray control,

0.54

2.13

3.72

NA

NA

0.24

2.91

4.50

NA

NA

XXX cath insert. 74480......... 26...... A

X-ray control,

0.54

0.18

0.18

0.18

0.18

0.02

0.74

0.74

0.74

0.74

XXX cath insert. 74480......... TC...... A

X-ray control,

0.00

1.95

3.54

NA

NA

0.22

2.17

3.76

NA

NA

XXX cath insert. 74485......... ........ A

X-ray guide, GU 0.54

2.29

3.06

NA

NA

0.20

3.03

3.80

NA

NA

XXX dilation. 74485......... 26...... A

X-ray guide, GU 0.54

0.19

0.18

0.19

0.18

0.03

0.76

0.75

0.76

0.75

XXX dilation. 74485......... TC...... A

X-ray guide, GU 0.00

2.10

2.89

NA

NA

0.17

2.27

3.06

NA

NA

XXX dilation. 74710......... ........ A

X-ray

0.34

0.64

1.03

NA

NA

0.08

1.06

1.45

NA

NA

XXX measurement of pelvis. 74710......... 26...... A

X-ray

0.34

0.11

0.11

0.11

0.11

0.02

0.47

0.47

0.47

0.47

XXX measurement of pelvis. 74710......... TC...... A

X-ray

0.00

0.53

0.92

NA

NA

0.06

0.59

0.98

NA

NA

XXX measurement of pelvis. 74740......... ........ A

X-ray, female

0.38

1.77

1.52

NA

NA

0.09

2.24

1.99

NA

NA

XXX genital tract. 74740......... 26...... A

X-ray, female

0.38

0.12

0.13

0.12

0.13

0.02

0.52

0.53

0.52

0.53

XXX genital tract. 74740......... TC...... A

X-ray, female

0.00

1.65

1.40

NA

NA

0.07

1.72

1.47

NA

NA

XXX genital tract. 74742......... ........ C

X-ray,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX fallopian tube. 74742......... 26...... A

X-ray,

0.61

0.17

0.19

0.17

0.19

0.03

0.81

0.83

0.81

0.83

XXX fallopian tube. 74742......... TC...... C

X-ray,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX fallopian tube. 74775......... ........ A

X-ray exam of

0.62

NA

NA

NA

NA

0.11

NA

NA

NA

NA

XXX perineum.

[[Page 49190]]

74775......... 26...... A

X-ray exam of

0.62

0.19

0.21

0.19

0.21

0.03

0.84

0.86

0.84

0.86

XXX perineum. 74775......... TC...... A

X-ray exam of

0.00

NA

NA

NA

NA

0.08

NA

NA

NA

NA

XXX perineum. 75552......... ........ A

Heart mri for

1.60 19.30

13.62

NA

NA

0.66 21.56

15.88

NA

NA

XXX morph w/o dye. 75552......... 26...... A

Heart mri for

1.60

0.57

0.54

0.57

0.54

0.07

2.24

2.21

2.24

2.21

XXX morph w/o dye. 75552......... TC...... A

Heart mri for

0.00 18.73

13.08

NA

NA

0.59 19.32

13.67

NA

NA

XXX morph w/o dye. 75553......... ........ A

Heart mri for

2.00 24.28

14.96

NA

NA

0.66 26.94

17.62

NA

NA

XXX morph w/dye. 75553......... 26...... A

Heart mri for

2.00

0.94

0.72

0.94

0.72

0.07

3.01

2.79

3.01

2.79

XXX morph w/dye. 75553......... TC...... A

Heart mri for

0.00 23.34

14.24

NA

NA

0.59 23.93

14.83

NA

NA

XXX morph w/dye. 75554......... ........ A

Cardiac MRI/

1.83 27.20

15.68

NA

NA

0.66 29.69

18.17

NA

NA

XXX function. 75554......... 26...... A

Cardiac MRI/

1.83

0.79

0.68

0.79

0.68

0.07

2.69

2.58

2.69

2.58

XXX function. 75554......... TC...... A

Cardiac MRI/

0.00 26.41

15.00

NA

NA

0.59 27.00

15.59

NA

NA

XXX function. 75555......... ........ A

Cardiac MRI/

1.74 27.64

15.79

NA

NA

0.66 30.04

18.19

NA

NA

XXX limited study. 75555......... 26...... A

Cardiac MRI/

1.74

0.84

0.69

0.84

0.69

0.07

2.65

2.50

2.65

2.50

XXX limited study. 75555......... TC...... A

Cardiac MRI/

0.00 26.80

15.10

NA

NA

0.59 27.39

15.69

NA

NA

XXX limited study. 75600......... ........ A

Contrast x-ray

0.49

6.49

11.22

NA

NA

0.67

7.65

12.38

NA

NA

XXX exam of aorta. 75600......... 26...... A

Contrast x-ray

0.49

0.25

0.21

0.25

0.21

0.02

0.76

0.72

0.76

0.72

XXX exam of aorta. 75600......... TC...... A

Contrast x-ray

0.00

6.24

11.01

NA

NA

0.65

6.89

11.66

NA

NA

XXX exam of aorta. 75605......... ........ A

Contrast x-ray

1.14

3.63

10.66

NA

NA

0.70

5.47

12.50

NA

NA

XXX exam of aorta. 75605......... 26...... A

Contrast x-ray

1.14

0.51

0.43

0.51

0.43

0.05

1.70

1.62

1.70

1.62

XXX exam of aorta. 75605......... TC...... A

Contrast x-ray

0.00

3.13

10.23

NA

NA

0.65

3.78

10.88

NA

NA

XXX exam of aorta. 75625......... ........ A

Contrast x-ray

1.14

3.38

10.58

NA

NA

0.71

5.23

12.43

NA

NA

XXX exam of aorta. 75625......... 26...... A

Contrast x-ray

1.14

0.42

0.39

0.42

0.39

0.06

1.62

1.59

1.62

1.59

XXX exam of aorta. 75625......... TC...... A

Contrast x-ray

0.00

2.96

10.19

NA

NA

0.65

3.61

10.84

NA

NA

XXX exam of aorta. 75630......... ........ A

X-ray aorta,

1.79

3.80

11.26

NA

NA

0.80

6.39

13.85

NA

NA

XXX leg arteries. 75630......... 26...... A

X-ray aorta,

1.79

0.72

0.64

0.72

0.64

0.11

2.62

2.54

2.62

2.54

XXX leg arteries. 75630......... TC...... A

X-ray aorta,

0.00

3.08

10.62

NA

NA

0.69

3.77

11.31

NA

NA

XXX leg arteries. 75635......... ........ A

Ct angio

2.40 12.87

15.74

NA

NA

0.50 15.77

18.64

NA

NA

XXX abdominal arteries. 75635......... 26...... A

Ct angio

2.40

0.83

0.80

0.83

0.80

0.11

3.34

3.31

3.34

3.31

XXX abdominal arteries. 75635......... TC...... A

Ct angio

0.00 12.04

14.94

NA

NA

0.39 12.43

15.33

NA

NA

XXX abdominal arteries. 75650......... ........ A

Artery x-rays,

1.49

3.53

10.70

NA

NA

0.72

5.74

12.91

NA

NA

XXX head & neck. 75650......... 26...... A

Artery x-rays,

1.49

0.55

0.51

0.55

0.51

0.07

2.11

2.07

2.11

2.07

XXX head & neck. 75650......... TC...... A

Artery x-rays,

0.00

2.97

10.19

NA

NA

0.65

3.62

10.84

NA

NA

XXX head & neck. 75658......... ........ A

Artery x-rays,

1.31

3.86

10.77

NA

NA

0.72

5.89

12.80

NA

NA

XXX arm. 75658......... 26...... A

Artery x-rays,

1.31

0.48

0.47

0.48

0.47

0.07

1.86

1.85

1.86

1.85

XXX arm. 75658......... TC...... A

Artery x-rays,

0.00

3.37

10.29

NA

NA

0.65

4.02

10.94

NA

NA

XXX arm. 75660......... ........ A

Artery x-rays,

1.31

3.94

10.77

NA

NA

0.71

5.96

12.79

NA

NA

XXX head & neck. 75660......... 26...... A

Artery x-rays,

1.31

0.49

0.45

0.49

0.45

0.06

1.86

1.82

1.86

1.82

XXX head & neck. 75660......... TC...... A

Artery x-rays,

0.00

3.45

10.31

NA

NA

0.65

4.10

10.96

NA

NA

XXX head & neck. 75662......... ........ A

Artery x-rays,

1.66

5.11

11.17

NA

NA

0.71

7.48

13.54

NA

NA

XXX head & neck. 75662......... 26...... A

Artery x-rays,

1.66

0.72

0.62

0.72

0.62

0.06

2.44

2.34

2.44

2.34

XXX head & neck. 75662......... TC...... A

Artery x-rays,

0.00

4.39

10.55

NA

NA

0.65

5.04

11.20

NA

NA

XXX head & neck. 75665......... ........ A

Artery x-rays,

1.31

4.10

10.81

NA

NA

0.74

6.15

12.86

NA

NA

XXX head & neck. 75665......... 26...... A

Artery x-rays,

1.31

0.46

0.45

0.46

0.45

0.09

1.86

1.85

1.86

1.85

XXX head & neck. 75665......... TC...... A

Artery x-rays,

0.00

3.64

10.36

NA

NA

0.65

4.29

11.01

NA

NA

XXX head & neck. 75671......... ........ A

Artery x-rays,

1.66

5.09

11.14

NA

NA

0.72

7.47

13.52

NA

NA

XXX head & neck. 75671......... 26...... A

Artery x-rays,

1.66

0.61

0.57

0.61

0.57

0.07

2.34

2.30

2.34

2.30

XXX head & neck. 75671......... TC...... A

Artery x-rays,

0.00

4.48

10.57

NA

NA

0.65

5.13

11.22

NA

NA

XXX head & neck. 75676......... ........ A

Artery x-rays,

1.31

3.86

10.75

NA

NA

0.72

5.89

12.78

NA

NA

XXX neck. 75676......... 26...... A

Artery x-rays,

1.31

0.47

0.45

0.47

0.45

0.07

1.85

1.83

1.85

1.83

XXX neck. 75676......... TC...... A

Artery x-rays,

0.00

3.40

10.30

NA

NA

0.65

4.05

10.95

NA

NA

XXX neck. 75680......... ........ A

Artery x-rays,

1.66

4.61

11.02

NA

NA

0.72

6.99

13.40

NA

NA

XXX neck. 75680......... 26...... A

Artery x-rays,

1.66

0.64

0.57

0.64

0.57

0.07

2.37

2.30

2.37

2.30

XXX neck. 75680......... TC...... A

Artery x-rays,

0.00

3.98

10.45

NA

NA

0.65

4.63

11.10

NA

NA

XXX neck. 75685......... ........ A

Artery x-rays,

1.31

3.90

10.75

NA

NA

0.71

5.92

12.77

NA

NA

XXX spine. 75685......... 26...... A

Artery x-rays,

1.31

0.49

0.45

0.49

0.45

0.06

1.86

1.82

1.86

1.82

XXX spine. 75685......... TC...... A

Artery x-rays,

0.00

3.41

10.30

NA

NA

0.65

4.06

10.95

NA

NA

XXX spine.

[[Page 49191]]

75705......... ........ A

Artery x-rays,

2.18

4.07

11.02

NA

NA

0.78

7.03

13.98

NA

NA

XXX spine. 75705......... 26...... A

Artery x-rays,

2.18

0.72

0.73

0.72

0.73

0.13

3.03

3.04

3.03

3.04

XXX spine. 75705......... TC...... A

Artery x-rays,

0.00

3.35

10.29

NA

NA

0.65

4.00

10.94

NA

NA

XXX spine. 75710......... ........ A

Artery x-rays,

1.14

3.99

10.74

NA

NA

0.72

5.85

12.60

NA

NA

XXX arm/leg. 75710......... 26...... A

Artery x-rays,

1.14

0.42

0.40

0.42

0.40

0.07

1.63

1.61

1.63

1.61

XXX arm/leg. 75710......... TC...... A

Artery x-rays,

0.00

3.57

10.34

NA

NA

0.65

4.22

10.99

NA

NA

XXX arm/leg. 75716......... ........ A

Artery x-rays,

1.31

4.94

11.01

NA

NA

0.72

6.97

13.04

NA

NA

XXX arms/legs. 75716......... 26...... A

Artery x-rays,

1.31

0.49

0.45

0.49

0.45

0.07

1.87

1.83

1.87

1.83

XXX arms/legs. 75716......... TC...... A

Artery x-rays,

0.00

4.45

10.56

NA

NA

0.65

5.10

11.21

NA

NA

XXX arms/legs. 75722......... ........ A

Artery x-rays,

1.14

3.89

10.72

NA

NA

0.70

5.73

12.56

NA

NA

XXX kidney. 75722......... 26...... A

Artery x-rays,

1.14

0.47

0.42

0.47

0.42

0.05

1.66

1.61

1.66

1.61

XXX kidney. 75722......... TC...... A

Artery x-rays,

0.00

3.42

10.31

NA

NA

0.65

4.07

10.96

NA

NA

XXX kidney. 75724......... ........ A

Artery x-rays,

1.49

5.20

11.17

NA

NA

0.70

7.39

13.36

NA

NA

XXX kidneys. 75724......... 26...... A

Artery x-rays,

1.49

0.75

0.61

0.75

0.61

0.05

2.29

2.15

2.29

2.15

XXX kidneys. 75724......... TC...... A

Artery x-rays,

0.00

4.44

10.56

NA

NA

0.65

5.09

11.21

NA

NA

XXX kidneys. 75726......... ........ A

Artery x-rays,

1.14

3.73

10.66

NA

NA

0.70

5.57

12.50

NA

NA

XXX abdomen. 75726......... 26...... A

Artery x-rays,

1.14

0.38

0.37

0.38

0.37

0.05

1.57

1.56

1.57

1.56

XXX abdomen. 75726......... TC...... A

Artery x-rays,

0.00

3.35

10.29

NA

NA

0.65

4.00

10.94

NA

NA

XXX abdomen. 75731......... ........ A

Artery x-rays,

1.14

3.90

10.70

NA

NA

0.71

5.75

12.55

NA

NA

XXX adrenal gland. 75731......... 26...... A

Artery x-rays,

1.14

0.42

0.38

0.42

0.38

0.06

1.62

1.58

1.62

1.58

XXX adrenal gland. 75731......... TC...... A

Artery x-rays,

0.00

3.48

10.32

NA

NA

0.65

4.13

10.97

NA

NA

XXX adrenal gland. 75733......... ........ A

Artery x-rays,

1.31

5.27

11.10

NA

NA

0.71

7.29

13.12

NA

NA

XXX adrenals. 75733......... 26...... A

Artery x-rays,

1.31

0.59

0.48

0.59

0.48

0.06

1.96

1.85

1.96

1.85

XXX adrenals. 75733......... TC...... A

Artery x-rays,

0.00

4.68

10.62

NA

NA

0.65

5.33

11.27

NA

NA

XXX adrenals. 75736......... ........ A

Artery x-rays,

1.14

3.87

10.70

NA

NA

0.71

5.72

12.55

NA

NA

XXX pelvis. 75736......... 26...... A

Artery x-rays,

1.14

0.41

0.39

0.41

0.39

0.06

1.61

1.59

1.61

1.59

XXX pelvis. 75736......... TC...... A

Artery x-rays,

0.00

3.46

10.32

NA

NA

0.65

4.11

10.97

NA

NA

XXX pelvis. 75741......... ........ A

Artery x-rays,

1.31

3.14

10.56

NA

NA

0.71

5.16

12.58

NA

NA

XXX lung. 75741......... 26...... A

Artery x-rays,

1.31

0.45

0.44

0.45

0.44

0.06

1.82

1.81

1.82

1.81

XXX lung. 75741......... TC...... A

Artery x-rays,

0.00

2.70

10.13

NA

NA

0.65

3.35

10.78

NA

NA

XXX lung. 75743......... ........ A

Artery x-rays,

1.66

3.53

10.74

NA

NA

0.72

5.91

13.12

NA

NA

XXX lungs. 75743......... 26...... A

Artery x-rays,

1.66

0.57

0.55

0.57

0.55

0.07

2.30

2.28

2.30

2.28

XXX lungs. 75743......... TC...... A

Artery x-rays,

0.00

2.96

10.19

NA

NA

0.65

3.61

10.84

NA

NA

XXX lungs. 75746......... ........ A

Artery x-rays,

1.14

3.46

10.60

NA

NA

0.70

5.30

12.44

NA

NA

XXX lung. 75746......... 26...... A

Artery x-rays,

1.14

0.36

0.38

0.36

0.38

0.05

1.55

1.57

1.55

1.57

XXX lung. 75746......... TC...... A

Artery x-rays,

0.00

3.10

10.23

NA

NA

0.65

3.75

10.88

NA

NA

XXX lung. 75756......... ........ A

Artery x-rays,

1.14

4.45

10.90

NA

NA

0.69

6.28

12.73

NA

NA

XXX chest. 75756......... 26...... A

Artery x-rays,

1.14

0.60

0.49

0.60

0.49

0.04

1.78

1.67

1.78

1.67

XXX chest. 75756......... TC...... A

Artery x-rays,

0.00

3.84

10.41

NA

NA

0.65

4.49

11.06

NA

NA

XXX chest. 75774......... ........ A

Artery x-ray,

0.36

2.53

10.17

2.53

10.17

0.67

3.56

11.20

3.56

11.20

ZZZ each vessel. 75774......... 26...... A

Artery x-ray,

0.36

0.13

0.12

0.13

0.12

0.02

0.51

0.50

0.51

0.50

ZZZ each vessel. 75774......... TC...... A

Artery x-ray,

0.00

2.40

10.05

2.40

10.05

0.65

3.05

10.70

3.05

10.70

ZZZ each vessel. 75790......... ........ A

Visualize A-V

1.84

3.11

2.23

NA

NA

0.17

5.12

4.24

NA

NA

XXX shunt. 75790......... 26...... A

Visualize A-V

1.84

0.57

0.59

0.57

0.59

0.09

2.50

2.52

2.50

2.52

XXX shunt. 75790......... TC...... A

Visualize A-V

0.00

2.54

1.65

NA

NA

0.08

2.62

1.73

NA

NA

XXX shunt. 75801......... ........ A

Lymph vessel x- 0.81

NA

NA

NA

NA

0.37

NA

NA

NA

NA

XXX ray, arm/leg. 75801......... 26...... A

Lymph vessel x- 0.81

0.22

0.26

0.22

0.26

0.08

1.11

1.15

1.11

1.15

XXX ray, arm/leg. 75801......... TC...... A

Lymph vessel x- 0.00

NA

NA

NA

NA

0.29

NA

NA

NA

NA

XXX ray, arm/leg. 75803......... ........ A

Lymph vessel x- 1.17

NA

NA

NA

NA

0.34

NA

NA

NA

NA

XXX ray,arms/legs. 75803......... 26...... A

Lymph vessel x- 1.17

0.35

0.37

0.35

0.37

0.05

1.57

1.59

1.57

1.59

XXX ray,arms/legs. 75803......... TC...... A

Lymph vessel x- 0.00

NA

NA

NA

NA

0.29

NA

NA

NA

NA

XXX ray,arms/legs. 75805......... ........ A

Lymph vessel x- 0.81

NA

NA

NA

NA

0.38

NA

NA

NA

NA

XXX ray, trunk. 75805......... 26...... A

Lymph vessel x- 0.81

0.23

0.26

0.23

0.26

0.05

1.09

1.12

1.09

1.12

XXX ray, trunk. 75805......... TC...... A

Lymph vessel x- 0.00

NA

NA

NA

NA

0.33

NA

NA

NA

NA

XXX ray, trunk. 75807......... ........ C

Lymph vessel x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX ray, trunk. 75807......... 26...... A

Lymph vessel x- 1.17

0.37

0.38

0.37

0.38

0.05

1.59

1.60

1.59

1.60

XXX ray, trunk. 75807......... TC...... C

Lymph vessel x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX ray, trunk. 75809......... ........ A

Nonvascular

0.47

2.18

1.24

NA

NA

0.07

2.72

1.78

NA

NA

XXX shunt, x-ray. 75809......... 26...... A

Nonvascular

0.47

0.15

0.15

0.15

0.15

0.02

0.64

0.64

0.64

0.64

XXX shunt, x-ray. 75809......... TC...... A

Nonvascular

0.00

2.03

1.09

NA

NA

0.05

2.08

1.14

NA

NA

XXX shunt, x-ray. 75810......... ........ A

Vein x-ray,

1.14

NA

NA

NA

NA

0.70

NA

NA

NA

NA

XXX spleen/liver. 75810......... 26...... A

Vein x-ray,

1.14

0.39

0.38

0.39

0.38

0.05

1.58

1.57

1.58

1.57

XXX spleen/liver. 75810......... TC...... A

Vein x-ray,

0.00

NA

NA

NA

NA

0.65

NA

NA

NA

NA

XXX spleen/liver. 75820......... ........ A

Vein x-ray, arm/ 0.70

3.02

1.64

NA

NA

0.09

3.81

2.43

NA

NA

XXX leg. 75820......... 26...... A

Vein x-ray, arm/ 0.70

0.28

0.24

0.28

0.24

0.03

1.01

0.97

1.01

0.97

XXX leg. 75820......... TC...... A

Vein x-ray, arm/ 0.00

2.74

1.40

NA

NA

0.06

2.80

1.46

NA

NA

XXX leg.

[[Page 49192]]

75822......... ........ A

Vein x-ray,

1.06

3.18

2.16

NA

NA

0.13

4.37

3.35

NA

NA

XXX arms/legs. 75822......... 26...... A

Vein x-ray,

1.06

0.35

0.35

0.35

0.35

0.05

1.46

1.46

1.46

1.46

XXX arms/legs. 75822......... TC...... A

Vein x-ray,

0.00

2.83

1.82

NA

NA

0.08

2.91

1.90

NA

NA

XXX arms/legs. 75825......... ........ A

Vein x-ray,

1.14

2.93

10.46

NA

NA

0.72

4.79

12.32

NA

NA

XXX trunk. 75825......... 26...... A

Vein x-ray,

1.14

0.36

0.37

0.36

0.37

0.07

1.57

1.58

1.57

1.58

XXX trunk. 75825......... TC...... A

Vein x-ray,

0.00

2.57

10.09

NA

NA

0.65

3.22

10.74

NA

NA

XXX trunk. 75827......... ........ A

Vein x-ray,

1.14

2.98

10.47

NA

NA

0.70

4.82

12.31

NA

NA

XXX chest. 75827......... 26...... A

Vein x-ray,

1.14

0.36

0.37

0.36

0.37

0.05

1.55

1.56

1.55

1.56

XXX chest. 75827......... TC...... A

Vein x-ray,

0.00

2.61

10.10

NA

NA

0.65

3.26

10.75

NA

NA

XXX chest. 75831......... ........ A

Vein x-ray,

1.14

3.05

10.49

NA

NA

0.71

4.90

12.34

NA

NA

XXX kidney. 75831......... 26...... A

Vein x-ray,

1.14

0.36

0.37

0.36

0.37

0.06

1.56

1.57

1.56

1.57

XXX kidney. 75831......... TC...... A

Vein x-ray,

0.00

2.69

10.12

NA

NA

0.65

3.34

10.77

NA

NA

XXX kidney. 75833......... ........ A

Vein x-ray,

1.49

3.71

10.75

NA

NA

0.74

5.94

12.98

NA

NA

XXX kidneys. 75833......... 26...... A

Vein x-ray,

1.49

0.48

0.49

0.48

0.49

0.09

2.06

2.07

2.06

2.07

XXX kidneys. 75833......... TC...... A

Vein x-ray,

0.00

3.23

10.26

NA

NA

0.65

3.88

10.91

NA

NA

XXX kidneys. 75840......... ........ A

Vein x-ray,

1.14

3.29

10.56

NA

NA

0.72

5.15

12.42

NA

NA

XXX adrenal gland. 75840......... 26...... A

Vein x-ray,

1.14

0.45

0.40

0.45

0.40

0.07

1.66

1.61

1.66

1.61

XXX adrenal gland. 75840......... TC...... A

Vein x-ray,

0.00

2.84

10.16

NA

NA

0.65

3.49

10.81

NA

NA

XXX adrenal gland. 75842......... ........ A

Vein x-ray,

1.49

3.68

10.73

NA

NA

0.72

5.89

12.94

NA

NA

XXX adrenal glands. 75842......... 26...... A

Vein x-ray,

1.49

0.49

0.48

0.49

0.48

0.07

2.05

2.04

2.05

2.04

XXX adrenal glands. 75842......... TC...... A

Vein x-ray,

0.00

3.19

10.25

NA

NA

0.65

3.84

10.90

NA

NA

XXX adrenal glands. 75860......... ........ A

Vein x-ray,

1.14

3.45

10.61

NA

NA

0.69

5.28

12.44

NA

NA

XXX neck. 75860......... 26...... A

Vein x-ray,

1.14

0.50

0.42

0.50

0.42

0.04

1.68

1.60

1.68

1.60

XXX neck. 75860......... TC...... A

Vein x-ray,

0.00

2.96

10.19

NA

NA

0.65

3.61

10.84

NA

NA

XXX neck. 75870......... ........ A

Vein x-ray,

1.14

3.23

10.55

NA

NA

0.70

5.07

12.39

NA

NA

XXX skull. 75870......... 26...... A

Vein x-ray,

1.14

0.39

0.39

0.39

0.39

0.05

1.58

1.58

1.58

1.58

XXX skull. 75870......... TC...... A

Vein x-ray,

0.00

2.84

10.16

NA

NA

0.65

3.49

10.81

NA

NA

XXX skull. 75872......... ........ A

Vein x-ray,

1.14

3.91

10.71

NA

NA

0.79

5.84

12.64

NA

NA

XXX skull. 75872......... 26...... A

Vein x-ray,

1.14

0.42

0.38

0.42

0.38

0.14

1.70

1.66

1.70

1.66

XXX skull. 75872......... TC...... A

Vein x-ray,

0.00

3.48

10.32

NA

NA

0.65

4.13

10.97

NA

NA

XXX skull. 75880......... ........ A

Vein x-ray, eye 0.70

2.99

1.63

NA

NA

0.09

3.78

2.42

NA

NA

XXX socket. 75880......... 26...... A

Vein x-ray, eye 0.70

0.23

0.23

0.23

0.23

0.03

0.96

0.96

0.96

0.96

XXX socket. 75880......... TC...... A

Vein x-ray, eye 0.00

2.76

1.40

NA

NA

0.06

2.82

1.46

NA

NA

XXX socket. 75885......... ........ A

Vein x-ray,

1.44

3.17

10.60

NA

NA

0.71

5.32

12.75

NA

NA

XXX liver. 75885......... 26...... A

Vein x-ray,

1.44

0.47

0.47

0.47

0.47

0.06

1.97

1.97

1.97

1.97

XXX liver. 75885......... TC...... A

Vein x-ray,

0.00

2.70

10.13

NA

NA

0.65

3.35

10.78

NA

NA

XXX liver. 75887......... ........ A

Vein x-ray,

1.44

3.35

10.64

NA

NA

0.71

5.50

12.79

NA

NA

XXX liver. 75887......... 26...... A

Vein x-ray,

1.44

0.51

0.48

0.51

0.48

0.06

2.01

1.98

2.01

1.98

XXX liver. 75887......... TC...... A

Vein x-ray,

0.00

2.84

10.16

NA

NA

0.65

3.49

10.81

NA

NA

XXX liver. 75889......... ........ A

Vein x-ray,

1.14

3.07

10.50

NA

NA

0.70

4.91

12.34

NA

NA

XXX liver. 75889......... 26...... A

Vein x-ray,

1.14

0.38

0.37

0.38

0.37

0.05

1.57

1.56

1.57

1.56

XXX liver. 75889......... TC...... A

Vein x-ray,

0.00

2.70

10.13

NA

NA

0.65

3.35

10.78

NA

NA

XXX liver. 75891......... ........ A

Vein x-ray,

1.14

3.05

10.49

NA

NA

0.70

4.89

12.33

NA

NA

XXX liver. 75891......... 26...... A

Vein x-ray,

1.14

0.37

0.37

0.37

0.37

0.05

1.56

1.56

1.56

1.56

XXX liver. 75891......... TC...... A

Vein x-ray,

0.00

2.68

10.12

NA

NA

0.65

3.33

10.77

NA

NA

XXX liver. 75893......... ........ A

Venous sampling 0.54

2.87

10.30

NA

NA

0.67

4.08

11.51

NA

NA

XXX by catheter. 75893......... 26...... A

Venous sampling 0.54

0.18

0.18

0.18

0.18

0.02

0.74

0.74

0.74

0.74

XXX by catheter. 75893......... TC...... A

Venous sampling 0.00

2.69

10.12

NA

NA

0.65

3.34

10.77

NA

NA

XXX by catheter. 75894......... ........ A

X-rays,

1.31

NA

NA

NA

NA

1.35

NA

NA

NA

NA

XXX transcath therapy. 75894......... 26...... A

X-rays,

1.31

0.42

0.43

0.42

0.43

0.08

1.81

1.82

1.81

1.82

XXX transcath therapy. 75894......... TC...... A

X-rays,

0.00

NA

NA

NA

NA

1.27

NA

NA

NA

NA

XXX transcath therapy. 75896......... ........ A

X-rays,

1.31

NA

NA

NA

NA

1.15

NA

NA

NA

NA

XXX transcath therapy. 75896......... 26...... A

X-rays,

1.31

0.51

0.47

0.51

0.47

0.05

1.87

1.83

1.87

1.83

XXX transcath therapy. 75896......... TC...... A

X-rays,

0.00

NA

NA

NA

NA

1.10

NA

NA

NA

NA

XXX transcath therapy. 75898......... ........ A

Follow-up

1.65

NA

NA

NA

NA

0.13

NA

NA

NA

NA

XXX angiography. 75898......... 26...... A

Follow-up

1.65

0.60

0.56

0.60

0.56

0.07

2.32

2.28

2.32

2.28

XXX angiography.

[[Page 49193]]

75898......... TC...... A

Follow-up

0.00

NA

NA

NA

NA

0.06

NA

NA

NA

NA

XXX angiography. 75900......... ........ C

Intravascular

0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX cath exchange. 75900......... 26...... A

Intravascular

0.49

0.16

0.16

0.16

0.16

0.03

0.68

0.68

0.68

0.68

XXX cath exchange. 75900......... TC...... C

Intravascular

0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX cath exchange. 75901......... ........ A

Remove cva

0.49

4.20

2.15

NA

NA

0.85

5.54

3.49

NA

NA

XXX device obstruct. 75901......... 26...... A

Remove cva

0.49

0.16

0.16

0.16

0.16

0.02

0.67

0.67

0.67

0.67

XXX device obstruct. 75901......... TC...... A

Remove cva

0.00

4.04

1.99

NA

NA

0.83

4.87

2.82

NA

NA

XXX device obstruct. 75902......... ........ A

Remove cva

0.39

1.64

1.49

NA

NA

0.85

2.88

2.73

NA

NA

XXX lumen obstruct. 75902......... 26...... A

Remove cva

0.39

0.13

0.13

0.13

0.13

0.02

0.54

0.54

0.54

0.54

XXX lumen obstruct. 75902......... TC...... A

Remove cva

0.00

1.52

1.36

NA

NA

0.83

2.35

2.19

NA

NA

XXX lumen obstruct. 75940......... ........ A

X-ray

0.54

NA

NA

NA

NA

0.69

NA

NA

NA

NA

XXX placement, vein filter. 75940......... 26...... A

X-ray

0.54

0.17

0.18

0.17

0.18

0.04

0.75

0.76

0.75

0.76

XXX placement, vein filter. 75940......... TC...... A

X-ray

0.00

NA

NA

NA

NA

0.65

NA

NA

NA

NA

XXX placement, vein filter. 75945......... ........ A

Intravascular

0.40

NA

NA

NA

NA

0.28

NA

NA

NA

NA

XXX us. 75945......... 26...... A

Intravascular

0.40

0.15

0.14

0.15

0.14

0.04

0.59

0.58

0.59

0.58

XXX us. 75945......... TC...... A

Intravascular

0.00

NA

NA

NA

NA

0.24

NA

NA

NA

NA

XXX us. 75946......... ........ C

Intravascular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ us add-on. 75946......... 26...... A

Intravascular

0.40

0.13

0.14

0.13

0.14

0.05

0.58

0.59

0.58

0.59

ZZZ us add-on. 75946......... TC...... C

Intravascular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ us add-on. 75952......... ........ C

Endovasc repair 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX abdom aorta. 75952......... 26...... A

Endovasc repair 4.49

1.31

1.45

1.31

1.45

0.43

6.23

6.37

6.23

6.37

XXX abdom aorta. 75952......... TC...... C

Endovasc repair 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX abdom aorta. 75953......... ........ C

Abdom aneurysm

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX endovas rpr. 75953......... 26...... A

Abdom aneurysm

1.36

0.40

0.44

0.40

0.44

0.13

1.89

1.93

1.89

1.93

XXX endovas rpr. 75953......... TC...... C

Abdom aneurysm

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX endovas rpr. 75954......... ........ C

Iliac aneurysm

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX endovas rpr. 75954......... 26...... A

Iliac aneurysm

2.25

0.66

0.75

0.66

0.75

0.15

3.06

3.15

3.06

3.15

XXX endovas rpr. 75954......... TC...... C

Iliac aneurysm

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX endovas rpr. 75956......... ........ C

Xray, endovasc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX thor ao repr. 75956......... 26...... A

Xray, endovasc

7.00

1.63

2.43

1.63

2.43

0.69

9.32

10.12

9.32

10.12

XXX thor ao repr. 75956......... TC...... C

Xray, endovasc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX thor ao repr. 75957......... ........ C

Xray, endovasc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX thor ao repr. 75957......... 26...... A

Xray, endovasc

6.00

1.40

2.08

1.40

2.08

0.59

7.99

8.67

7.99

8.67

XXX thor ao repr. 75957......... TC...... C

Xray, endovasc

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX thor ao repr. 75958......... ........ C

Xray, place

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX prox ext thor ao. 75958......... 26...... A

Xray, place

4.00

0.93

1.40

0.93

1.40

0.39

5.32

5.79

5.32

5.79

XXX prox ext thor ao. 75958......... TC...... C

Xray, place

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX prox ext thor ao. 75959......... ........ C

Xray, place

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dist ext thor ao. 75959......... 26...... A

Xray, place

3.50

0.82

1.23

0.82

1.23

0.34

4.66

5.07

4.66

5.07

XXX dist ext thor ao. 75959......... TC...... C

Xray, place

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX dist ext thor ao. 75960......... ........ A

Transcath iv

0.82

NA

NA

NA

NA

0.82

NA

NA

NA

NA

XXX stent rs&i. 75960......... 26...... A

Transcath iv

0.82

0.32

0.29

0.32

0.29

0.05

1.19

1.16

1.19

1.16

XXX stent rs&i. 75960......... TC...... A

Transcath iv

0.00

NA

NA

NA

NA

0.77

NA

NA

NA

NA

XXX stent rs&i. 75961......... ........ A

Retrieval,

4.24

4.59

10.07

NA

NA

0.73

9.56

15.04

NA

NA

XXX broken catheter. 75961......... 26...... A

Retrieval,

4.24

1.38

1.39

1.38

1.39

0.18

5.80

5.81

5.80

5.81

XXX broken catheter. 75961......... TC...... A

Retrieval,

0.00

3.20

8.68

NA

NA

0.55

3.75

9.23

NA

NA

XXX broken catheter. 75962......... ........ A

Repair arterial 0.54

3.54

12.83

NA

NA

0.86

4.94

14.23

NA

NA

XXX blockage. 75962......... 26...... A

Repair arterial 0.54

0.20

0.19

0.20

0.19

0.03

0.77

0.76

0.77

0.76

XXX blockage. 75962......... TC...... A

Repair arterial 0.00

3.34

12.64

NA

NA

0.83

4.17

13.47

NA

NA

XXX blockage. 75964......... ........ A

Repair artery

0.36

2.38

6.98

2.38

6.98

0.46

3.20

7.80

3.20

7.80

ZZZ blockage, each. 75964......... 26...... A

Repair artery

0.36

0.13

0.12

0.13

0.12

0.03

0.52

0.51

0.52

0.51

ZZZ blockage, each. 75964......... TC...... A

Repair artery

0.00

2.26

6.86

2.26

6.86

0.43

2.69

7.29

2.69

7.29

ZZZ blockage, each. 75966......... ........ A

Repair arterial 1.31

4.21

13.20

NA

NA

0.89

6.41

15.40

NA

NA

XXX blockage. 75966......... 26...... A

Repair arterial 1.31

0.57

0.49

0.57

0.49

0.06

1.94

1.86

1.94

1.86

XXX blockage. 75966......... TC...... A

Repair arterial 0.00

3.64

12.72

NA

NA

0.83

4.47

13.55

NA

NA

XXX blockage. 75968......... ........ A

Repair artery

0.36

2.44

7.00

2.44

7.00

0.45

3.25

7.81

3.25

7.81

ZZZ blockage, each. 75968......... 26...... A

Repair artery

0.36

0.16

0.14

0.16

0.14

0.02

0.54

0.52

0.54

0.52

ZZZ blockage, each. 75968......... TC...... A

Repair artery

0.00

2.29

6.87

2.29

6.87

0.43

2.72

7.30

2.72

7.30

ZZZ blockage, each. 75970......... ........ A

Vascular biopsy 0.83

NA

NA

NA

NA

0.64

NA

NA

NA

NA

XXX 75970......... 26...... A

Vascular biopsy 0.83

0.28

0.28

0.28

0.28

0.04

1.15

1.15

1.15

1.15

XXX 75970......... TC...... A

Vascular biopsy 0.00

NA

NA

NA

NA

0.60

NA

NA

NA

NA

XXX 75978......... ........ A

Repair venous

0.54

3.27

12.76

NA

NA

0.85

4.66

14.15

NA

NA

XXX blockage. 75978......... 26...... A

Repair venous

0.54

0.17

0.18

0.17

0.18

0.02

0.73

0.74

0.73

0.74

XXX blockage. 75978......... TC...... A

Repair venous

0.00

3.11

12.58

NA

NA

0.83

3.94

13.41

NA

NA

XXX blockage. 75980......... ........ A

Contrast xray

1.44

NA

NA

NA

NA

0.35

NA

NA

NA

NA

XXX exam bile duct. 75980......... 26...... A

Contrast xray

1.44

0.47

0.47

0.47

0.47

0.06

1.97

1.97

1.97

1.97

XXX exam bile duct.

[[Page 49194]]

75980......... TC...... A

Contrast xray

0.00

NA

NA

NA

NA

0.29

NA

NA

NA

NA

XXX exam bile duct. 75982......... ........ C

Contrast xray

0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX exam bile duct. 75982......... 26...... A

Contrast xray

1.44

0.47

0.47

0.47

0.47

0.06

1.97

1.97

1.97

1.97

XXX exam bile duct. 75982......... TC...... C

Contrast xray

0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX exam bile duct. 75984......... ........ A

Xray control

0.72

2.31

2.21

NA

NA

0.14

3.17

3.07

NA

NA

XXX catheter change. 75984......... 26...... A

Xray control

0.72

0.24

0.23

0.24

0.23

0.03

0.99

0.98

0.99

0.98

XXX catheter change. 75984......... TC...... A

Xray control

0.00

2.08

1.98

NA

NA

0.11

2.19

2.09

NA

NA

XXX catheter change. 75989......... ........ A

Abscess

1.19

2.21

3.21

NA

NA

0.22

3.62

4.62

NA

NA

XXX drainage under x-ray. 75989......... 26...... A

Abscess

1.19

0.38

0.39

0.38

0.39

0.05

1.62

1.63

1.62

1.63

XXX drainage under x-ray. 75989......... TC...... A

Abscess

0.00

1.83

2.82

NA

NA

0.17

2.00

2.99

NA

NA

XXX drainage under x-ray. 75992......... ........ A

Atherectomy, x- 0.54

NA

NA

NA

NA

0.86

NA

NA

NA

NA

XXX ray exam. 75992......... 26...... A

Atherectomy, x- 0.54

0.23

0.20

0.23

0.20

0.03

0.80

0.77

0.80

0.77

XXX ray exam. 75992......... TC...... A

Atherectomy, x- 0.00

NA

NA

NA

NA

0.83

NA

NA

NA

NA

XXX ray exam. 75993......... ........ C

Atherectomy, x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

ZZZ ray exam. 75993......... 26...... A

Atherectomy, x- 0.36

0.15

0.14

0.15

0.14

0.02

0.53

0.52

0.53

0.52

ZZZ ray exam. 75993......... TC...... C

Atherectomy, x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

ZZZ ray exam. 75994......... ........ C

Atherectomy, x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX ray exam. 75994......... 26...... A

Atherectomy, x- 1.31

0.62

0.50

0.62

0.50

0.07

2.00

1.88

2.00

1.88

XXX ray exam. 75994......... TC...... C

Atherectomy, x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX ray exam. 75995......... ........ C

Atherectomy, x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX ray exam. 75995......... 26...... A

Atherectomy, x- 1.31

0.51

0.48

0.51

0.48

0.05

1.87

1.84

1.87

1.84

XXX ray exam. 75995......... TC...... C

Atherectomy, x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

XXX ray exam. 75996......... ........ C

Atherectomy, x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

ZZZ ray exam. 75996......... 26...... A

Atherectomy, x- 0.36

0.15

0.13

0.15

0.13

0.02

0.53

0.51

0.53

0.51

ZZZ ray exam. 75996......... TC...... C

Atherectomy, x- 0.00

NA

NA

NA

NA

0.00

NA

NA

NA

NA

ZZZ ray exam. 75998......... ........ A

Fluoroguide for 0.38

2.73

1.76

NA

NA

0.11

3.22

2.25

NA

NA

ZZZ vein device. 75998......... 26...... A

Fluoroguide for 0.38

0.12

0.13

0.12

0.13

0.01

0.51

0.52

0.51

0.52

ZZZ vein device. 75998......... TC...... A

Fluoroguide for 0.00

2.61

1.64

NA

NA

0.10

2.71

1.74

NA

NA

ZZZ vein device. 76000......... ........ A

Fluoroscope

0.17

2.75

1.71

NA

NA

0.08

3.00

1.96

NA

NA

XXX examination. 76000......... 26...... A

Fluoroscope

0.17

0.06

0.05

0.06

0.05

0.01

0.24

0.23

0.24

0.23

XXX examination. 76000......... TC...... A

Fluoroscope

0.00

2.70

1.66

NA

NA

0.07

2.77

1.73

NA

NA

XXX examination. 76001......... ........ A

Fluoroscope

0.67

NA

NA

NA

NA

0.19

NA

NA

NA

NA

XXX exam, extensive. 76001......... 26...... A

Fluoroscope

0.67

0.22

0.22

0.22

0.22

0.05

0.94

0.94

0.94

0.94

XXX exam, extensive. 76001......... TC...... A

Fluoroscope

0.00

NA

NA

NA

NA

0.14

NA

NA

NA

NA

XXX exam, extensive. 76003......... ........ A

Needle

0.54

1.21

1.41

NA

NA

0.09

1.84

2.04

NA

NA

XXX localization by x-ray. 76003......... 26...... A

Needle

0.54

0.15

0.17

0.15

0.17

0.02

0.71

0.73

0.71

0.73

XXX localization by x-ray. 76003......... TC...... A

Needle

0.00

1.06

1.25

NA

NA

0.07

1.13

1.32

NA

NA

XXX localization by x-ray. 76005......... ........ A

Fluoroguide for 0.60

0.76

1.29

NA

NA

0.10

1.46

1.99

NA

NA

XXX spine inject. 76005......... 26...... A

Fluoroguide for 0.60

0.14

0.15

0.14

0.15

0.03

0.77

0.78

0.77

0.78

XXX spine inject. 76005......... TC...... A

Fluoroguide for 0.00

0.62

1.14

NA

NA

0.07

0.69

1.21

NA

NA

XXX spine inject. 76006......... ........ A

X-ray stress

0.41

0.77

0.33

0.77

0.33

0.06

1.24

0.80

1.24

0.80

XXX view. 76010......... ........ A

X-ray, nose to

0.18

0.55

0.57

NA

NA

0.03

0.76

0.78

NA

NA

XXX rectum. 76010......... 26...... A

X-ray, nose to

0.18

0.06

0.06

0.06

0.06

0.01

0.25

0.25

0.25

0.25

XXX rectum. 76010......... TC...... A

X-ray, nose to

0.00

0.49

0.51

NA

NA

0.02

0.51

0.53

NA

NA

XXX rectum. 76012......... ........ C

Percut

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX vertebroplasty fluor. 76012......... 26...... A

Percut

1.31

0.44

0.46

0.44

0.46

0.10

1.85

1.87

1.85

1.87

XXX vertebroplasty fluor. 76012......... TC...... C

Percut

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX vertebroplasty fluor. 76013......... ........ C

Percut

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX vertebroplasty , ct. 76013......... 26...... A

Percut

1.38

0.45

0.47

0.45

0.47

0.07

1.90

1.92

1.90

1.92

XXX vertebroplasty , ct. 76013......... TC...... C

Percut

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX vertebroplasty , ct. 76020......... ........ A

X-rays for bone 0.19

0.42

0.54

NA

NA

0.03

0.64

0.76

NA

NA

XXX age. 76020......... 26...... A

X-rays for bone 0.19

0.06

0.06

0.06

0.06

0.01

0.26

0.26

0.26

0.26

XXX age. 76020......... TC...... A

X-rays for bone 0.00

0.36

0.48

NA

NA

0.02

0.38

0.50

NA

NA

XXX age. 76040......... ........ A

X-rays, bone

0.27

0.67

0.82

NA

NA

0.06

1.00

1.15

NA

NA

XXX evaluation. 76040......... 26...... A

X-rays, bone

0.27

0.10

0.09

0.10

0.09

0.01

0.38

0.37

0.38

0.37

XXX evaluation. 76040......... TC...... A

X-rays, bone

0.00

0.57

0.73

NA

NA

0.05

0.62

0.78

NA

NA

XXX evaluation.

[[Page 49195]]

76061......... ........ A

X-rays, bone

0.45

1.43

1.22

NA

NA

0.08

1.96

1.75

NA

NA

XXX survey. 76061......... 26...... A

X-rays, bone

0.45

0.14

0.15

0.14

0.15

0.02

0.61

0.62

0.61

0.62

XXX survey. 76061......... TC...... A

X-rays, bone

0.00

1.28

1.07

NA

NA

0.06

1.34

1.13

NA

NA

XXX survey. 76062......... ........ A

X-rays, bone

0.54

2.28

1.79

NA

NA

0.10

2.92

2.43

NA

NA

XXX survey. 76062......... 26...... A

X-rays, bone

0.54

0.17

0.18

0.17

0.18

0.02

0.73

0.74

0.73

0.74

XXX survey. 76062......... TC...... A

X-rays, bone

0.00

2.10

1.61

NA

NA

0.08

2.18

1.69

NA

NA

XXX survey. 76065......... ........ A

X-rays, bone

0.70

2.01

1.22

NA

NA

0.08

2.79

2.00

NA

NA

XXX evaluation. 76065......... 26...... A

X-rays, bone

0.70

0.20

0.22

0.20

0.22

0.03

0.93

0.95

0.93

0.95

XXX evaluation. 76065......... TC...... A

X-rays, bone

0.00

1.81

1.00

NA

NA

0.05

1.86

1.05

NA

NA

XXX evaluation. 76066......... ........ A

Joint survey,

0.31

0.65

1.07

NA

NA

0.08

1.04

1.46

NA

NA

XXX single view. 76066......... 26...... A

Joint survey,

0.31

0.11

0.10

0.11

0.10

0.02

0.44

0.43

0.44

0.43

XXX single view. 76066......... TC...... A

Joint survey,

0.00

0.55

0.97

NA

NA

0.06

0.61

1.03

NA

NA

XXX single view. 76070......... ........ A

Ct bone

0.25

4.78

3.47

NA

NA

0.17

5.20

3.89

NA

NA

XXX density, axial. 76070......... 26...... A

Ct bone

0.25

0.08

0.08

0.08

0.08

0.01

0.34

0.34

0.34

0.34

XXX density, axial. 76070......... TC...... A

Ct bone

0.00

4.70

3.39

NA

NA

0.16

4.86

3.55

NA

NA

XXX density, axial. 76071......... ........ A

Ct bone

0.22

0.78

2.46

NA

NA

0.06

1.06

2.74

NA

NA

XXX density, peripheral. 76071......... 26...... A

Ct bone

0.22

0.07

0.07

0.07

0.07

0.01

0.30

0.30

0.30

0.30

XXX density, peripheral. 76071......... TC...... A

Ct bone

0.00

0.71

2.39

NA

NA

0.05

0.76

2.44

NA

NA

XXX density, peripheral. 76075......... ........ A

Dxa bone

0.20

0.53

2.53

NA

NA

0.18

0.91

2.91

NA

NA

XXX density, axial. 76075......... 26...... A

Dxa bone

0.20

0.06

0.09

0.06

0.09

0.01

0.27

0.30

0.27

0.30

XXX density, axial. 76075......... TC...... A

Dxa bone

0.00

0.47

2.44

NA

NA

0.17

0.64

2.61

NA

NA

XXX density, axial. 76076......... ........ A

Dxa bone

0.22

0.57

0.77

NA

NA

0.06

0.85

1.05

NA

NA

XXX density/ peripheral. 76076......... 26...... A

Dxa bone

0.22

0.06

0.08

0.06

0.08

0.01

0.29

0.31

0.29

0.31

XXX density/ peripheral. 76076......... TC...... A

Dxa bone

0.00

0.50

0.69

NA

NA

0.05

0.55

0.74

NA

NA

XXX density/ peripheral. 76077......... ........ A

Dxa bone

0.17

0.41

0.71

NA

NA

0.06

0.64

0.94

NA

NA

XXX density/v- fracture. 76077......... 26...... A

Dxa bone

0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX density/v- fracture. 76077......... TC...... A

Dxa bone

0.00

0.36

0.65

NA

NA

0.05

0.41

0.70

NA

NA

XXX density/v- fracture. 76078......... ........ A

Radiographic

0.20

0.38

0.71

NA

NA

0.06

0.64

0.97

NA

NA

XXX absorptiometry. 76078......... 26...... A

Radiographic

0.20

0.05

0.07

0.05

0.07

0.01

0.26

0.28

0.26

0.28

XXX absorptiometry. 76078......... TC...... A

Radiographic

0.00

0.33

0.65

NA

NA

0.05

0.38

0.70

NA

NA

XXX absorptiometry. 76080......... ........ A

X-ray exam of

0.54

1.08

1.19

NA

NA

0.08

1.70

1.81

NA

NA

XXX fistula. 76080......... 26...... A

X-ray exam of

0.54

0.17

0.18

0.17

0.18

0.02

0.73

0.74

0.73

0.74

XXX fistula. 76080......... TC...... A

X-ray exam of

0.00

0.90

1.01

NA

NA

0.06

0.96

1.07

NA

NA

XXX fistula. 76082......... ........ A

Computer

0.06

0.20

0.38

0.20

0.38

0.02

0.28

0.46

0.28

0.46

ZZZ mammogram add- on. 76082......... 26...... A

Computer

0.06

0.02

0.02

0.02

0.02

0.01

0.09

0.09

0.09

0.09

ZZZ mammogram add- on. 76082......... TC...... A

Computer

0.00

0.18

0.36

0.18

0.36

0.01

0.19

0.37

0.19

0.37

ZZZ mammogram add- on. 76083......... ........ A

Computer

0.06

0.20

0.38

0.20

0.38

0.02

0.28

0.46

0.28

0.46

ZZZ mammogram add- on. 76083......... 26...... A

Computer

0.06

0.02

0.02

0.02

0.02

0.01

0.09

0.09

0.09

0.09

ZZZ mammogram add- on. 76083......... TC...... A

Computer

0.00

0.18

0.36

0.18

0.36

0.01

0.19

0.37

0.19

0.37

ZZZ mammogram add- on. 76086......... ........ A

X-ray of

0.36

1.22

2.36

NA

NA

0.16

1.74

2.88

NA

NA

XXX mammary duct. 76086......... 26...... A

X-ray of

0.36

0.11

0.12

0.11

0.12

0.02

0.49

0.50

0.49

0.50

XXX mammary duct. 76086......... TC...... A

X-ray of

0.00

1.11

2.24

NA

NA

0.14

1.25

2.38

NA

NA

XXX mammary duct. 76088......... ........ A

X-ray of

0.45

1.66

3.27

NA

NA

0.21

2.32

3.93

NA

NA

XXX mammary ducts. 76088......... 26...... A

X-ray of

0.45

0.14

0.15

0.14

0.15

0.02

0.61

0.62

0.61

0.62

XXX mammary ducts. 76088......... TC...... A

X-ray of

0.00

1.52

3.13

NA

NA

0.19

1.71

3.32

NA

NA

XXX mammary ducts. 76090......... ........ A

Mammogram, one

0.70

1.62

1.37

NA

NA

0.09

2.41

2.16

NA

NA

XXX breast. 76090......... 26...... A

Mammogram, one

0.70

0.22

0.23

0.22

0.23

0.03

0.95

0.96

0.95

0.96

XXX breast. 76090......... TC...... A

Mammogram, one

0.00

1.40

1.14

NA

NA

0.06

1.46

1.20

NA

NA

XXX breast. 76091......... ........ A

Mammogram, both 0.87

2.11

1.72

NA

NA

0.11

3.09

2.70

NA

NA

XXX breasts. 76091......... 26...... A

Mammogram, both 0.87

0.27

0.28

0.27

0.28

0.04

1.18

1.19

1.18

1.19

XXX breasts. 76091......... TC...... A

Mammogram, both 0.00

1.84

1.44

NA

NA

0.07

1.91

1.51

NA

NA

XXX breasts. 76092......... ........ A

Mammogram,

0.70

1.42

1.45

NA

NA

0.10

2.22

2.25

NA

NA

XXX screening. 76092......... 26...... A

Mammogram,

0.70

0.22

0.23

0.22

0.23

0.03

0.95

0.96

0.95

0.96

XXX screening. 76092......... TC...... A

Mammogram,

0.00

1.20

1.22

NA

NA

0.07

1.27

1.29

NA

NA

XXX screening. 76093......... ........ A

Magnetic image, 1.63 22.03

19.12

NA

NA

0.99 24.65

21.74

NA

NA

XXX breast. 76093......... 26...... A

Magnetic image, 1.63

0.53

0.53

0.53

0.53

0.07

2.23

2.23

2.23

2.23

XXX breast. 76093......... TC...... A

Magnetic image, 0.00 21.50

18.59

NA

NA

0.92 22.42

19.51

NA

NA

XXX breast. 76094......... ........ A

Magnetic image, 1.63 22.03

23.84

NA

NA

1.31 24.97

26.78

NA

NA

XXX both breasts. 76094......... 26...... A

Magnetic image, 1.63

0.53

0.53

0.53

0.53

0.07

2.23

2.23

2.23

2.23

XXX both breasts. 76094......... TC...... A

Magnetic image, 0.00 21.50

23.31

NA

NA

1.24 22.74

24.55

NA

NA

XXX both breasts. 76095......... ........ A

Stereotactic

1.59

1.82

6.22

NA

NA

0.46

3.87

8.27

NA

NA

XXX breast biopsy. 76095......... 26...... A

Stereotactic

1.59

0.48

0.51

0.48

0.51

0.09

2.16

2.19

2.16

2.19

XXX breast biopsy. 76095......... TC...... A

Stereotactic

0.00

1.34

5.71

NA

NA

0.37

1.71

6.08

NA

NA

XXX breast biopsy. 76096......... ........ A

X-ray of needle 0.56

0.82

1.32

NA

NA

0.09

1.47

1.97

NA

NA

XXX wire, breast. 76096......... 26...... A

X-ray of needle 0.56

0.18

0.18

0.18

0.18

0.02

0.76

0.76

0.76

0.76

XXX wire, breast. 76096......... TC...... A

X-ray of needle 0.00

0.64

1.14

NA

NA

0.07

0.71

1.21

NA

NA

XXX wire, breast.

[[Page 49196]]

76098......... ........ A

X-ray exam,

0.16

0.32

0.43

NA

NA

0.03

0.51

0.62

NA

NA

XXX breast specimen. 76098......... 26...... A

X-ray exam,

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX breast specimen. 76098......... TC...... A

X-ray exam,

0.00

0.27

0.38

NA

NA

0.02

0.29

0.40

NA

NA

XXX breast specimen. 76100......... ........ A

X-ray exam of

0.58

3.54

1.97

NA

NA

0.10

4.22

2.65

NA

NA

XXX body section. 76100......... 26...... A

X-ray exam of

0.58

0.20

0.19

0.20

0.19

0.03

0.81

0.80

0.81

0.80

XXX body section. 76100......... TC...... A

X-ray exam of

0.00

3.35

1.78

NA

NA

0.07

3.42

1.85

NA

NA

XXX body section. 76101......... ........ A

Complex body

0.58

5.35

2.55

NA

NA

0.11

6.04

3.24

NA

NA

XXX section x-ray. 76101......... 26...... A

Complex body

0.58

0.19

0.19

0.19

0.19

0.03

0.80

0.80

0.80

0.80

XXX section x-ray. 76101......... TC...... A

Complex body

0.00

5.16

2.36

NA

NA

0.08

5.24

2.44

NA

NA

XXX section x-ray. 76102......... ........ A

Complex body

0.58

7.74

3.38

NA

NA

0.14

8.46

4.10

NA

NA

XXX section x-rays. 76102......... 26...... A

Complex body

0.58

0.18

0.19

0.18

0.19

0.03

0.79

0.80

0.79

0.80

XXX section x-rays. 76102......... TC...... A

Complex body

0.00

7.56

3.19

NA

NA

0.11

7.67

3.30

NA

NA

XXX section x-rays. 76120......... ........ A

Cine/video x-

0.38

2.00

1.39

NA

NA

0.08

2.46

1.85

NA

NA

XXX rays. 76120......... 26...... A

Cine/video x-

0.38

0.15

0.14

0.15

0.14

0.02

0.55

0.54

0.55

0.54

XXX rays. 76120......... TC...... A

Cine/video x-

0.00

1.85

1.25

NA

NA

0.06

1.91

1.31

NA

NA

XXX rays. 76125......... ........ A

Cine/video x-

0.27

NA

NA

NA

NA

0.06

NA

NA

NA

NA

ZZZ rays add-on. 76125......... 26...... A

Cine/video x-

0.27

0.10

0.09

0.10

0.09

0.01

0.38

0.37

0.38

0.37

ZZZ rays add-on. 76125......... TC...... A

Cine/video x-

0.00

NA

NA

NA

NA

0.05

NA

NA

NA

NA

ZZZ rays add-on. 76150......... ........ A

X-ray exam, dry 0.00

0.68

0.49

NA

NA

0.02

0.70

0.51

NA

NA

XXX process. 76350......... ........ C

Special x-ray

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX contrast study. 76355......... ........ A

Ct scan for

1.21 20.46

11.60

NA

NA

0.47 22.14

13.28

NA

NA

XXX localization. 76355......... 26...... A

Ct scan for

1.21

0.37

0.39

0.37

0.39

0.05

1.63

1.65

1.63

1.65

XXX localization. 76355......... TC...... A

Ct scan for

0.00 20.09

11.22

NA

NA

0.42 20.51

11.64

NA

NA

XXX localization. 76360......... ........ A

Ct scan for

1.16

2.30

7.05

NA

NA

0.47

3.93

8.68

NA

NA

XXX needle biopsy. 76360......... 26...... A

Ct scan for

1.16

0.37

0.38

0.37

0.38

0.05

1.58

1.59

1.58

1.59

XXX needle biopsy. 76360......... TC...... A

Ct scan for

0.00

1.93

6.68

NA

NA

0.42

2.35

7.10

NA

NA

XXX needle biopsy. 76362......... ........ A

Ct guide for

3.99

NA

NA

NA

NA

1.64

NA

NA

NA

NA

XXX tissue ablation. 76362......... 26...... A

Ct guide for

3.99

1.25

1.29

1.25

1.29

0.18

5.42

5.46

5.42

5.46

XXX tissue ablation. 76362......... TC...... A

Ct guide for

0.00

NA

NA

NA

NA

1.46

NA

NA

NA

NA

XXX tissue ablation. 76370......... ........ A

Ct scan for

0.85

4.43

3.53

NA

NA

0.20

5.48

4.58

NA

NA

XXX therapy guide. 76370......... 26...... A

Ct scan for

0.85

0.24

0.27

0.24

0.27

0.04

1.13

1.16

1.13

1.16

XXX therapy guide. 76370......... TC...... A

Ct scan for

0.00

4.19

3.26

NA

NA

0.16

4.35

3.42

NA

NA

XXX therapy guide. 76376......... ........ A

3d render w/o

0.20

1.40

2.97

NA

NA

0.10

1.70

3.27

NA

NA

XXX postprocess. 76376......... 26...... A

3d render w/o

0.20

0.06

0.07

0.06

0.07

0.02

0.28

0.29

0.28

0.29

XXX postprocess. 76376......... TC...... A

3d render w/o

0.00

1.34

2.90

NA

NA

0.08

1.42

2.98

NA

NA

XXX postprocess. 76377......... ........ A

3d rendering w/ 0.79

1.38

3.11

NA

NA

0.39

2.56

4.29

NA

NA

XXX postprocess. 76377......... 26...... A

3d rendering w/ 0.79

0.25

0.27

0.25

0.27

0.08

1.12

1.14

1.12

1.14

XXX postprocess. 76377......... TC...... A

3d rendering w/ 0.00

1.13

2.85

NA

NA

0.31

1.44

3.16

NA

NA

XXX postprocess. 76380......... ........ A

CAT scan follow- 0.98

4.72

4.05

NA

NA

0.22

5.92

5.25

NA

NA

XXX up study. 76380......... 26...... A

CAT scan follow- 0.98

0.31

0.32

0.31

0.32

0.04

1.33

1.34

1.33

1.34

XXX up study. 76380......... TC...... A

CAT scan follow- 0.00

4.42

3.73

NA

NA

0.18

4.60

3.91

NA

NA

XXX up study. 76390......... ........ N

Mr spectroscopy 1.40

9.51

10.99

NA

NA

0.66 11.57

13.05

NA

NA

XXX 76390......... 26...... N

Mr spectroscopy 1.40

0.33

0.44

0.33

0.44

0.07

1.80

1.91

1.80

1.91

XXX 76390......... TC...... N

Mr spectroscopy 0.00

9.19

10.56

NA

NA

0.59

9.78

11.15

NA

NA

XXX 76393......... ........ A

Mr guidance for 1.50

9.83

11.23

NA

NA

0.64 11.97

13.37

NA

NA

XXX needle place. 76393......... 26...... A

Mr guidance for 1.50

0.49

0.50

0.49

0.50

0.09

2.08

2.09

2.08

2.09

XXX needle place. 76393......... TC...... A

Mr guidance for 0.00

9.34

10.74

NA

NA

0.55

9.89

11.29

NA

NA

XXX needle place. 76394......... ........ A

Mri for tissue

4.24

NA

NA

NA

NA

1.81

NA

NA

NA

NA

XXX ablation. 76394......... 26...... A

Mri for tissue

4.24

1.34

1.37

1.34

1.37

0.24

5.82

5.85

5.82

5.85

XXX ablation. 76394......... TC...... A

Mri for tissue

0.00

NA

NA

NA

NA

1.57

NA

NA

NA

NA

XXX ablation. 76400......... ........ A

Magnetic image, 1.60 14.85

12.50

NA

NA

0.66 17.11

14.76

NA

NA

XXX bone marrow. 76400......... 26...... A

Magnetic image, 1.60

0.56

0.53

0.56

0.53

0.07

2.23

2.20

2.23

2.20

XXX bone marrow. 76400......... TC...... A

Magnetic image, 0.00 14.30

11.98

NA

NA

0.59 14.89

12.57

NA

NA

XXX bone marrow. 76496......... ........ C

Fluoroscopic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 76496......... 26...... C

Fluoroscopic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 76496......... TC...... C

Fluoroscopic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure.

[[Page 49197]]

76497......... ........ C

Ct procedure... 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 76497......... 26...... C

Ct procedure... 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 76497......... TC...... C

Ct procedure... 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 76498......... ........ C

Mri procedure.. 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 76498......... 26...... C

Mri procedure.. 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 76498......... TC...... C

Mri procedure.. 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 76499......... ........ C

Radiographic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 76499......... 26...... C

Radiographic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 76499......... TC...... C

Radiographic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 76506......... ........ A

Echo exam of

0.63

2.83

1.95

NA

NA

0.14

3.60

2.72

NA

NA

XXX head. 76506......... 26...... A

Echo exam of

0.63

0.20

0.23

0.20

0.23

0.06

0.89

0.92

0.89

0.92

XXX head. 76506......... TC...... A

Echo exam of

0.00

2.63

1.72

NA

NA

0.08

2.71

1.80

NA

NA

XXX head. 76510......... ........ A

Ophth us, b &

1.55

2.31

2.72

NA

NA

0.10

3.96

4.37

NA

NA

XXX quant a. 76510......... 26...... A

Ophth us, b &

1.55

0.58

0.66

0.58

0.66

0.03

2.16

2.24

2.16

2.24

XXX quant a. 76510......... TC...... A

Ophth us, b &

0.00

1.73

2.07

NA

NA

0.07

1.80

2.14

NA

NA

XXX quant a. 76511......... ........ A

Ophth us, quant 0.94

1.39

2.17

NA

NA

0.10

2.43

3.21

NA

NA

XXX a only. 76511......... 26...... A

Ophth us, quant 0.94

0.35

0.39

0.35

0.39

0.03

1.32

1.36

1.32

1.36

XXX a only. 76511......... TC...... A

Ophth us, quant 0.00

1.05

1.79

NA

NA

0.07

1.12

1.86

NA

NA

XXX a only. 76512......... ........ A

Ophth us, b w/

0.94

1.19

1.97

NA

NA

0.12

2.25

3.03

NA

NA

XXX non-quant a. 76512......... 26...... A

Ophth us, b w/

0.94

0.35

0.40

0.35

0.40

0.02

1.31

1.36

1.31

1.36

XXX non-quant a. 76512......... TC...... A

Ophth us, b w/

0.00

0.85

1.57

NA

NA

0.10

0.95

1.67

NA

NA

XXX non-quant a. 76513......... ........ A

Echo exam of

0.66

1.58

1.75

NA

NA

0.12

2.36

2.53

NA

NA

XXX eye, water bath. 76513......... 26...... A

Echo exam of

0.66

0.25

0.28

0.25

0.28

0.02

0.93

0.96

0.93

0.96

XXX eye, water bath. 76513......... TC...... A

Echo exam of

0.00

1.33

1.47

NA

NA

0.10

1.43

1.57

NA

NA

XXX eye, water bath. 76514......... ........ A

Echo exam of

0.17

0.17

0.14

NA

NA

0.02

0.36

0.33

NA

NA

XXX eye, thickness. 76514......... 26...... A

Echo exam of

0.17

0.06

0.08

0.06

0.08

0.01

0.24

0.26

0.24

0.26

XXX eye, thickness. 76514......... TC...... A

Echo exam of

0.00

0.11

0.07

NA

NA

0.01

0.12

0.08

NA

NA

XXX eye, thickness. 76516......... ........ A

Echo exam of

0.54

1.19

1.39

NA

NA

0.08

1.81

2.01

NA

NA

XXX eye. 76516......... 26...... A

Echo exam of

0.54

0.19

0.23

0.19

0.23

0.01

0.74

0.78

0.74

0.78

XXX eye. 76516......... TC...... A

Echo exam of

0.00

1.00

1.17

NA

NA

0.07

1.07

1.24

NA

NA

XXX eye. 76519......... ........ A

Echo exam of

0.54

1.33

1.50

NA

NA

0.08

1.95

2.12

NA

NA

XXX eye. 76519......... 26...... A

Echo exam of

0.54

0.20

0.23

0.20

0.23

0.01

0.75

0.78

0.75

0.78

XXX eye. 76519......... TC...... A

Echo exam of

0.00

1.12

1.26

NA

NA

0.07

1.19

1.33

NA

NA

XXX eye. 76529......... ........ A

Echo exam of

0.57

1.19

1.33

NA

NA

0.10

1.86

2.00

NA

NA

XXX eye. 76529......... 26...... A

Echo exam of

0.57

0.21

0.23

0.21

0.23

0.02

0.80

0.82

0.80

0.82

XXX eye. 76529......... TC...... A

Echo exam of

0.00

0.98

1.09

NA

NA

0.08

1.06

1.17

NA

NA

XXX eye. 76536......... ........ A

Us exam of head 0.56

2.69

1.87

NA

NA

0.10

3.35

2.53

NA

NA

XXX and neck. 76536......... 26...... A

Us exam of head 0.56

0.17

0.18

0.17

0.18

0.02

0.75

0.76

0.75

0.76

XXX and neck. 76536......... TC...... A

Us exam of head 0.00

2.52

1.70

NA

NA

0.08

2.60

1.78

NA

NA

XXX and neck. 76604......... ........ A

Us exam, chest, 0.55

1.81

1.57

NA

NA

0.09

2.45

2.21

NA

NA

XXX b-scan. 76604......... 26...... A

Us exam, chest, 0.55

0.17

0.18

0.17

0.18

0.02

0.74

0.75

0.74

0.75

XXX b-scan. 76604......... TC...... A

Us exam, chest, 0.00

1.64

1.39

NA

NA

0.07

1.71

1.46

NA

NA

XXX b-scan. 76645......... ........ A

Us exam,

0.54

2.11

1.45

NA

NA

0.08

2.73

2.07

NA

NA

XXX breast(s). 76645......... 26...... A

Us exam,

0.54

0.17

0.18

0.17

0.18

0.02

0.73

0.74

0.73

0.74

XXX breast(s). 76645......... TC...... A

Us exam,

0.00

1.94

1.27

NA

NA

0.06

2.00

1.33

NA

NA

XXX breast(s). 76700......... ........ A

Us exam, abdom, 0.81

3.04

2.44

NA

NA

0.15

4.00

3.40

NA

NA

XXX complete. 76700......... 26...... A

Us exam, abdom, 0.81

0.26

0.27

0.26

0.27

0.04

1.11

1.12

1.11

1.12

XXX complete. 76700......... TC...... A

Us exam, abdom, 0.00

2.78

2.17

NA

NA

0.11

2.89

2.28

NA

NA

XXX complete. 76705......... ........ A

Echo exam of

0.59

2.34

1.79

NA

NA

0.11

3.04

2.49

NA

NA

XXX abdomen. 76705......... 26...... A

Echo exam of

0.59

0.19

0.19

0.19

0.19

0.03

0.81

0.81

0.81

0.81

XXX abdomen. 76705......... TC...... A

Echo exam of

0.00

2.16

1.61

NA

NA

0.08

2.24

1.69

NA

NA

XXX abdomen. 76770......... ........ A

Us exam abdo

0.74

2.94

2.39

NA

NA

0.14

3.82

3.27

NA

NA

XXX back wall, comp. 76770......... 26...... A

Us exam abdo

0.74

0.24

0.24

0.24

0.24

0.03

1.01

1.01

1.01

1.01

XXX back wall, comp. 76770......... TC...... A

Us exam abdo

0.00

2.70

2.15

NA

NA

0.11

2.81

2.26

NA

NA

XXX back wall, comp. 76775......... ........ A

Us exam abdo

0.58

2.42

1.81

NA

NA

0.11

3.11

2.50

NA

NA

XXX back wall, lim. 76775......... 26...... A

Us exam abdo

0.58

0.19

0.19

0.19

0.19

0.03

0.80

0.80

0.80

0.80

XXX back wall, lim. 76775......... TC...... A

Us exam abdo

0.00

2.23

1.62

NA

NA

0.08

2.31

1.70

NA

NA

XXX back wall, lim. 76778......... ........ A

Us exam kidney

0.74

3.21

2.46

NA

NA

0.14

4.09

3.34

NA

NA

XXX transplant. 76778......... 26...... A

Us exam kidney

0.74

0.23

0.24

0.23

0.24

0.03

1.00

1.01

1.00

1.01

XXX transplant. 76778......... TC...... A

Us exam kidney

0.00

2.98

2.22

NA

NA

0.11

3.09

2.33

NA

NA

XXX transplant. 76800......... ........ A

Us exam, spinal 1.13

2.34

1.90

NA

NA

0.13

3.60

3.16

NA

NA

XXX canal. 76800......... 26...... A

Us exam, spinal 1.13

0.30

0.33

0.30

0.33

0.05

1.48

1.51

1.48

1.51

XXX canal. 76800......... TC...... A

Us exam, spinal 0.00

2.04

1.58

NA

NA

0.08

2.12

1.66

NA

NA

XXX canal. 76801......... ........ A

Ob us /= 14

0.99

3.05

2.59

NA

NA

0.16

4.20

3.74

NA

NA

XXX wks, sngl fetus. 76805......... 26...... A

Ob us >/= 14

0.99

0.29

0.33

0.29

0.33

0.04

1.32

1.36

1.32

1.36

XXX wks, sngl fetus. 76805......... TC...... A

Ob us >/= 14

0.00

2.75

2.26

NA

NA

0.12

2.87

2.38

NA

NA

XXX wks, sngl fetus. 76810......... ........ A

Ob us >/= 14

0.98

1.66

1.46

1.66

1.46

0.26

2.90

2.70

2.90

2.70

ZZZ wks, addl fetus. 76810......... 26...... A

Ob us >/= 14

0.98

0.29

0.33

0.29

0.33

0.04

1.31

1.35

1.31

1.35

ZZZ wks, addl fetus. 76810......... TC...... A

Ob us >/= 14

0.00

1.37

1.13

1.37

1.13

0.22

1.59

1.35

1.59

1.35

ZZZ wks, addl fetus. 76811......... ........ A

Ob us,

1.90

3.07

3.95

NA

NA

0.52

5.49

6.37

NA

NA

XXX detailed, sngl fetus. 76811......... 26...... A

Ob us,

1.90

0.54

0.67

0.54

0.67

0.09

2.53

2.66

2.53

2.66

XXX detailed, sngl fetus. 76811......... TC...... A

Ob us,

0.00

2.53

3.28

NA

NA

0.43

2.96

3.71

NA

NA

XXX detailed, sngl fetus. 76812......... ........ A

Ob us,

1.78

3.98

2.28

3.98

2.28

0.49

6.25

4.55

6.25

4.55

ZZZ detailed, addl fetus. 76812......... 26...... A

Ob us,

1.78

0.51

0.62

0.51

0.62

0.08

2.37

2.48

2.37

2.48

ZZZ detailed, addl fetus. 76812......... TC...... A

Ob us,

0.00

3.47

1.66

3.47

1.66

0.41

3.88

2.07

3.88

2.07

ZZZ detailed, addl fetus. 76815......... ........ A

Ob us, limited, 0.65

1.80

1.69

NA

NA

0.11

2.56

2.45

NA

NA

XXX fetus(s). 76815......... 26...... A

Ob us, limited, 0.65

0.19

0.22

0.19

0.22

0.03

0.87

0.90

0.87

0.90

XXX fetus(s). 76815......... TC...... A

Ob us, limited, 0.00

1.61

1.47

NA

NA

0.08

1.69

1.55

NA

NA

XXX fetus(s). 76816......... ........ A

Ob us, follow-

0.85

2.40

1.67

NA

NA

0.10

3.35

2.62

NA

NA

XXX up, per fetus. 76816......... 26...... A

Ob us, follow-

0.85

0.24

0.30

0.24

0.30

0.04

1.13

1.19

1.13

1.19

XXX up, per fetus. 76816......... TC...... A

Ob us, follow-

0.00

2.15

1.37

NA

NA

0.06

2.21

1.43

NA

NA

XXX up, per fetus. 76817......... ........ A

Transvaginal

0.75

2.02

1.83

NA

NA

0.09

2.86

2.67

NA

NA

XXX us, obstetric. 76817......... 26...... A

Transvaginal

0.75

0.22

0.25

0.22

0.25

0.03

1.00

1.03

1.00

1.03

XXX us, obstetric. 76817......... TC...... A

Transvaginal

0.00

1.80

1.59

NA

NA

0.06

1.86

1.65

NA

NA

XXX us, obstetric. 76818......... ........ A

Fetal biophys

1.05

2.22

2.05

NA

NA

0.15

3.42

3.25

NA

NA

XXX profile w/nst. 76818......... 26...... A

Fetal biophys

1.05

0.30

0.37

0.30

0.37

0.05

1.40

1.47

1.40

1.47

XXX profile w/nst. 76818......... TC...... A

Fetal biophys

0.00

1.92

1.69

NA

NA

0.10

2.02

1.79

NA

NA

XXX profile w/nst. 76819......... ........ A

Fetal biophys

0.77

1.63

1.82

NA

NA

0.13

2.53

2.72

NA

NA

XXX profil w/o nst. 76819......... 26...... A

Fetal biophys

0.77

0.23

0.27

0.23

0.27

0.03

1.03

1.07

1.03

1.07

XXX profil w/o nst. 76819......... TC...... A

Fetal biophys

0.00

1.41

1.56

NA

NA

0.10

1.51

1.66

NA

NA

XXX profil w/o nst. 76820......... ........ A

Umbilical

0.50

0.57

1.49

NA

NA

0.15

1.22

2.14

NA

NA

XXX artery echo. 76820......... 26...... A

Umbilical

0.50

0.14

0.18

0.14

0.18

0.03

0.67

0.71

0.67

0.71

XXX artery echo. 76820......... TC...... A

Umbilical

0.00

0.43

1.32

NA

NA

0.12

0.55

1.44

NA

NA

XXX artery echo. 76821......... ........ A

Middle cerebral 0.70

1.88

1.87

NA

NA

0.15

2.73

2.72

NA

NA

XXX artery echo. 76821......... 26...... A

Middle cerebral 0.70

0.20

0.25

0.20

0.25

0.03

0.93

0.98

0.93

0.98

XXX artery echo. 76821......... TC...... A

Middle cerebral 0.00

1.68

1.63

NA

NA

0.12

1.80

1.75

NA

NA

XXX artery echo. 76825......... ........ A

Echo exam of

1.67

4.37

3.02

NA

NA

0.18

6.22

4.87

NA

NA

XXX fetal heart. 76825......... 26...... A

Echo exam of

1.67

0.49

0.57

0.49

0.57

0.07

2.23

2.31

2.23

2.31

XXX fetal heart. 76825......... TC...... A

Echo exam of

0.00

3.88

2.45

NA

NA

0.11

3.99

2.56

NA

NA

XXX fetal heart. 76826......... ........ A

Echo exam of

0.83

2.75

1.44

NA

NA

0.08

3.66

2.35

NA

NA

XXX fetal heart. 76826......... 26...... A

Echo exam of

0.83

0.24

0.28

0.24

0.28

0.03

1.10

1.14

1.10

1.14

XXX fetal heart. 76826......... TC...... A

Echo exam of

0.00

2.51

1.16

NA

NA

0.05

2.56

1.21

NA

NA

XXX fetal heart. 76827......... ........ A

Echo exam of

0.58

1.07

1.71

NA

NA

0.14

1.79

2.43

NA

NA

XXX fetal heart. 76827......... 26...... A

Echo exam of

0.58

0.17

0.20

0.17

0.20

0.02

0.77

0.80

0.77

0.80

XXX fetal heart. 76827......... TC...... A

Echo exam of

0.00

0.90

1.52

NA

NA

0.12

1.02

1.64

NA

NA

XXX fetal heart. 76828......... ........ A

Echo exam of

0.56

0.64

1.16

NA

NA

0.11

1.31

1.83

NA

NA

XXX fetal heart. 76828......... 26...... A

Echo exam of

0.56

0.16

0.21

0.16

0.21

0.03

0.75

0.80

0.75

0.80

XXX fetal heart. 76828......... TC...... A

Echo exam of

0.00

0.48

0.95

NA

NA

0.08

0.56

1.03

NA

NA

XXX fetal heart. 76830......... ........ A

Transvaginal

0.69

2.77

2.00

NA

NA

0.13

3.59

2.82

NA

NA

XXX us, non-ob. 76830......... 26...... A

Transvaginal

0.69

0.21

0.23

0.21

0.23

0.03

0.93

0.95

0.93

0.95

XXX us, non-ob. 76830......... TC...... A

Transvaginal

0.00

2.56

1.78

NA

NA

0.10

2.66

1.88

NA

NA

XXX us, non-ob. 76831......... ........ A

Echo exam,

0.72

2.76

2.01

NA

NA

0.13

3.61

2.86

NA

NA

XXX uterus. 76831......... 26...... A

Echo exam,

0.72

0.21

0.24

0.21

0.24

0.03

0.96

0.99

0.96

0.99

XXX uterus. 76831......... TC...... A

Echo exam,

0.00

2.55

1.78

NA

NA

0.10

2.65

1.88

NA

NA

XXX uterus. 76856......... ........ A

Us exam,

0.69

2.81

2.01

NA

NA

0.13

3.63

2.83

NA

NA

XXX pelvic, complete. 76856......... 26...... A

Us exam,

0.69

0.22

0.23

0.22

0.23

0.03

0.94

0.95

0.94

0.95

XXX pelvic, complete.

[[Page 49199]]

76856......... TC...... A

Us exam,

0.00

2.59

1.79

NA

NA

0.10

2.69

1.89

NA

NA

XXX pelvic, complete. 76857......... ........ A

Us exam,

0.38

2.53

2.00

NA

NA

0.08

2.99

2.46

NA

NA

XXX pelvic, limited. 76857......... 26...... A

Us exam,

0.38

0.14

0.13

0.14

0.13

0.02

0.54

0.53

0.54

0.53

XXX pelvic, limited. 76857......... TC...... A

Us exam,

0.00

2.38

1.88

NA

NA

0.06

2.44

1.94

NA

NA

XXX pelvic, limited. 76870......... ........ A

Us exam,

0.64

2.83

2.00

NA

NA

0.13

3.60

2.77

NA

NA

XXX scrotum. 76870......... 26...... A

Us exam,

0.64

0.21

0.21

0.21

0.21

0.03

0.88

0.88

0.88

0.88

XXX scrotum. 76870......... TC...... A

Us exam,

0.00

2.62

1.80

NA

NA

0.10

2.72

1.90

NA

NA

XXX scrotum. 76872......... ........ A

Us, transrectal 0.69

3.43

2.54

NA

NA

0.14

4.26

3.37

NA

NA

XXX 76872......... 26...... A

Us, transrectal 0.69

0.27

0.23

0.27

0.23

0.04

1.00

0.96

1.00

0.96

XXX 76872......... TC...... A

Us, transrectal 0.00

3.16

2.31

NA

NA

0.10

3.26

2.41

NA

NA

XXX 76873......... ........ A

Echograp trans

1.55

3.39

2.80

NA

NA

0.25

5.19

4.60

NA

NA

XXX r, pros study. 76873......... 26...... A

Echograp trans

1.55

0.51

0.50

0.51

0.50

0.09

2.15

2.14

2.15

2.14

XXX r, pros study. 76873......... TC...... A

Echograp trans

0.00

2.87

2.29

NA

NA

0.16

3.03

2.45

NA

NA

XXX r, pros study. 76880......... ........ A

Us exam,

0.59

3.19

2.01

NA

NA

0.11

3.89

2.71

NA

NA

XXX extremity. 76880......... 26...... A

Us exam,

0.59

0.18

0.19

0.18

0.19

0.03

0.80

0.81

0.80

0.81

XXX extremity. 76880......... TC...... A

Us exam,

0.00

3.01

1.82

NA

NA

0.08

3.09

1.90

NA

NA

XXX extremity. 76885......... ........ A

Us exam infant

0.74

3.21

2.12

NA

NA

0.13

4.08

2.99

NA

NA

XXX hips, dynamic. 76885......... 26...... A

Us exam infant

0.74

0.22

0.24

0.22

0.24

0.03

0.99

1.01

0.99

1.01

XXX hips, dynamic. 76885......... TC...... A

Us exam infant

0.00

2.99

1.89

NA

NA

0.10

3.09

1.99

NA

NA

XXX hips, dynamic. 76886......... ........ A

Us exam infant

0.62

2.30

1.79

NA

NA

0.11

3.03

2.52

NA

NA

XXX hips, static. 76886......... 26...... A

Us exam infant

0.62

0.18

0.20

0.18

0.20

0.03

0.83

0.85

0.83

0.85

XXX hips, static. 76886......... TC...... A

Us exam infant

0.00

2.12

1.60

NA

NA

0.08

2.20

1.68

NA

NA

XXX hips, static. 76930......... ........ A

Echo guide,

0.67

2.11

1.85

NA

NA

0.12

2.90

2.64

NA

NA

XXX cardiocentesis. 76930......... 26...... A

Echo guide,

0.67

0.34

0.27

0.34

0.27

0.02

1.03

0.96

1.03

0.96

XXX cardiocentesis. 76930......... TC...... A

Echo guide,

0.00

1.76

1.58

NA

NA

0.10

1.86

1.68

NA

NA

XXX cardiocentesis. 76932......... ........ A

Echo guide for

0.67

NA

NA

NA

NA

0.12

NA

NA

NA

NA

XXX heart biopsy. 76932......... 26...... A

Echo guide for

0.67

0.35

0.28

0.35

0.28

0.02

1.04

0.97

1.04

0.97

XXX heart biopsy. 76932......... TC...... A

Echo guide for

0.00

NA

NA

NA

NA

0.10

NA

NA

NA

NA

XXX heart biopsy. 76936......... ........ A

Echo guide for

1.99

6.05

6.73

NA

NA

0.47

8.51

9.19

NA

NA

XXX artery repair. 76936......... 26...... A

Echo guide for

1.99

0.67

0.66

0.67

0.66

0.13

2.79

2.78

2.79

2.78

XXX artery repair. 76936......... TC...... A

Echo guide for

0.00

5.38

6.06

NA

NA

0.34

5.72

6.40

NA

NA

XXX artery repair. 76937......... ........ A

Us guide,

0.30

0.61

0.51

0.61

0.51

0.13

1.04

0.94

1.04

0.94

ZZZ vascular access. 76937......... 26...... A

Us guide,

0.30

0.09

0.10

0.09

0.10

0.03

0.42

0.43

0.42

0.43

ZZZ vascular access. 76937......... TC...... A

Us guide,

0.00

0.52

0.42

0.52

0.42

0.10

0.62

0.52

0.62

0.52

ZZZ vascular access. 76940......... ........ A

Us guide,

2.00

NA

NA

NA

NA

0.60

NA

NA

NA

NA

XXX tissue ablation. 76940......... 26...... A

Us guide,

2.00

0.60

0.64

0.60

0.64

0.31

2.91

2.95

2.91

2.95

XXX tissue ablation. 76940......... TC...... A

Us guide,

0.00

NA

NA

NA

NA

0.29

NA

NA

NA

NA

XXX tissue ablation. 76941......... ........ A

Echo guide for

1.34

NA

NA

NA

NA

0.15

NA

NA

NA

NA

XXX transfusion. 76941......... 26...... A

Echo guide for

1.34

0.44

0.46

0.44

0.46

0.07

1.85

1.87

1.85

1.87

XXX transfusion. 76941......... TC...... A

Echo guide for

0.00

NA

NA

NA

NA

0.08

NA

NA

NA

NA

XXX transfusion. 76942......... ........ A

Echo guide for

0.67

4.83

3.48

NA

NA

0.13

5.63

4.28

NA

NA

XXX biopsy. 76942......... 26...... A

Echo guide for

0.67

0.23

0.22

0.23

0.22

0.03

0.93

0.92

0.93

0.92

XXX biopsy. 76942......... TC...... A

Echo guide for

0.00

4.60

3.26

NA

NA

0.10

4.70

3.36

NA

NA

XXX biopsy. 76945......... ........ A

Echo guide,

0.67

NA

NA

NA

NA

0.11

NA

NA

NA

NA

XXX villus sampling. 76945......... 26...... A

Echo guide,

0.67

0.21

0.22

0.21

0.22

0.03

0.91

0.92

0.91

0.92

XXX villus sampling. 76945......... TC...... A

Echo guide,

0.00

NA

NA

NA

NA

0.08

NA

NA

NA

NA

XXX villus sampling. 76946......... ........ A

Echo guide for

0.38

0.45

1.36

NA

NA

0.12

0.95

1.86

NA

NA

XXX amniocentesis. 76946......... 26...... A

Echo guide for

0.38

0.11

0.13

0.11

0.13

0.02

0.51

0.53

0.51

0.53

XXX amniocentesis. 76946......... TC...... A

Echo guide for

0.00

0.34

1.23

NA

NA

0.10

0.44

1.33

NA

NA

XXX amniocentesis. 76948......... ........ A

Echo guide, ova 0.38

0.45

1.35

NA

NA

0.12

0.95

1.85

NA

NA

XXX aspiration. 76948......... 26...... A

Echo guide, ova 0.38

0.11

0.13

0.11

0.13

0.02

0.51

0.53

0.51

0.53

XXX aspiration. 76948......... TC...... A

Echo guide, ova 0.00

0.34

1.23

NA

NA

0.10

0.44

1.33

NA

NA

XXX aspiration. 76950......... ........ A

Echo guidance

0.58

1.16

1.42

NA

NA

0.10

1.84

2.10

NA

NA

XXX radiotherapy. 76950......... 26...... A

Echo guidance

0.58

0.16

0.18

0.16

0.18

0.03

0.77

0.79

0.77

0.79

XXX radiotherapy. 76950......... TC...... A

Echo guidance

0.00

1.00

1.23

NA

NA

0.07

1.07

1.30

NA

NA

XXX radiotherapy. 76965......... ........ A

Echo guidance

1.34

1.18

4.80

NA

NA

0.37

2.89

6.51

NA

NA

XXX radiotherapy. 76965......... 26...... A

Echo guidance

1.34

0.48

0.44

0.48

0.44

0.08

1.90

1.86

1.90

1.86

XXX radiotherapy. 76965......... TC...... A

Echo guidance

0.00

0.70

4.35

NA

NA

0.29

0.99

4.64

NA

NA

XXX radiotherapy. 76970......... ........ A

Ultrasound exam 0.40

2.14

1.42

NA

NA

0.08

2.62

1.90

NA

NA

XXX follow-up. 76970......... 26...... A

Ultrasound exam 0.40

0.11

0.13

0.11

0.13

0.02

0.53

0.55

0.53

0.55

XXX follow-up. 76970......... TC...... A

Ultrasound exam 0.00

2.03

1.30

NA

NA

0.06

2.09

1.36

NA

NA

XXX follow-up. 76975......... ........ A

GI endoscopic

0.81

NA

NA

NA

NA

0.14

NA

NA

NA

NA

XXX ultrasound. 76975......... 26...... A

GI endoscopic

0.81

0.29

0.28

0.29

0.28

0.04

1.14

1.13

1.14

1.13

XXX ultrasound. 76975......... TC...... A

GI endoscopic

0.00

NA

NA

NA

NA

0.10

NA

NA

NA

NA

XXX ultrasound. 76977......... ........ A

Us bone density 0.05

0.11

0.66

NA

NA

0.06

0.22

0.77

NA

NA

XXX measure. 76977......... 26...... A

Us bone density 0.05

0.01

0.02

0.01

0.02

0.01

0.07

0.08

0.07

0.08

XXX measure.

[[Page 49200]]

76977......... TC...... A

Us bone density 0.00

0.09

0.64

NA

NA

0.05

0.14

0.69

NA

NA

XXX measure. 76986......... ........ A

Ultrasound

1.20

NA

NA

NA

NA

0.27

NA

NA

NA

NA

XXX guide intraoper. 76986......... 26...... A

Ultrasound

1.20

0.35

0.39

0.35

0.39

0.13

1.68

1.72

1.68

1.72

XXX guide intraoper. 76986......... TC...... A

Ultrasound

0.00

NA

NA

NA

NA

0.14

NA

NA

NA

NA

XXX guide intraoper. 76999......... ........ C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX examination procedure. 76999......... 26...... C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX examination procedure. 76999......... TC...... C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX examination procedure. 77261......... ........ A

Radiation

1.39

0.41

0.49

0.41

0.49

0.07

1.87

1.95

1.87

1.95

XXX therapy planning. 77262......... ........ A

Radiation

2.11

0.58

0.71

0.58

0.71

0.11

2.80

2.93

2.80

2.93

XXX therapy planning. 77263......... ........ A

Radiation

3.14

0.86

1.05

0.86

1.05

0.16

4.16

4.35

4.16

4.35

XXX therapy planning. 77280......... ........ A

Set radiation

0.70

4.35

3.86

NA

NA

0.22

5.27

4.78

NA

NA

XXX therapy field. 77280......... 26...... A

Set radiation

0.70

0.19

0.21

0.19

0.21

0.04

0.93

0.95

0.93

0.95

XXX therapy field. 77280......... TC...... A

Set radiation

0.00

4.16

3.64

NA

NA

0.18

4.34

3.82

NA

NA

XXX therapy field. 77285......... ........ A

Set radiation

1.05

7.91

6.41

NA

NA

0.35

9.31

7.81

NA

NA

XXX therapy field. 77285......... 26...... A

Set radiation

1.05

0.29

0.33

0.29

0.33

0.05

1.39

1.43

1.39

1.43

XXX therapy field. 77285......... TC...... A

Set radiation

0.00

7.62

6.08

NA

NA

0.30

7.92

6.38

NA

NA

XXX therapy field. 77290......... ........ A

Set radiation

1.56 13.23

8.57

NA

NA

0.43 15.22

10.56

NA

NA

XXX therapy field. 77290......... 26...... A

Set radiation

1.56

0.43

0.48

0.43

0.48

0.08

2.07

2.12

2.07

2.12

XXX therapy field. 77290......... TC...... A

Set radiation

0.00 12.81

8.09

NA

NA

0.35 13.16

8.44

NA

NA

XXX therapy field. 77295......... ........ A

Set radiation

4.56

6.90

23.76

NA

NA

1.71 13.17

30.03

NA

NA

XXX therapy field. 77295......... 26...... A

Set radiation

4.56

1.25

1.41

1.25

1.41

0.23

6.04

6.20

6.04

6.20

XXX therapy field. 77295......... TC...... A

Set radiation

0.00

5.65

22.36

NA

NA

1.48

7.13

23.84

NA

NA

XXX therapy field. 77299......... ........ C

Radiation

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX therapy planning. 77299......... 26...... C

Radiation

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX therapy planning. 77299......... TC...... C

Radiation

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX therapy planning. 77300......... ........ A

Radiation

0.62

1.08

1.43

NA

NA

0.10

1.80

2.15

NA

NA

XXX therapy dose plan. 77300......... 26...... A

Radiation

0.62

0.17

0.19

0.17

0.19

0.03

0.82

0.84

0.82

0.84

XXX therapy dose plan. 77300......... TC...... A

Radiation

0.00

0.91

1.23

NA

NA

0.07

0.98

1.30

NA

NA

XXX therapy dose plan. 77301......... ........ A

Radiotherapy

7.99 53.43

36.23

NA

NA

1.88 63.30

46.10

NA

NA

XXX dose plan, imrt. 77301......... 26...... A

Radiotherapy

7.99

2.19

2.47

2.19

2.47

0.40 10.58

10.86

10.58

10.86

XXX dose plan, imrt. 77301......... TC...... A

Radiotherapy

0.00 51.24

33.76

NA

NA

1.48 52.72

35.24

NA

NA

XXX dose plan, imrt. 77305......... ........ A

Teletx isodose

0.70

0.85

1.78

NA

NA

0.15

1.70

2.63

NA

NA

XXX plan simple. 77305......... 26...... A

Teletx isodose

0.70

0.19

0.22

0.19

0.22

0.04

0.93

0.96

0.93

0.96

XXX plan simple. 77305......... TC...... A

Teletx isodose

0.00

0.65

1.56

NA

NA

0.11

0.76

1.67

NA

NA

XXX plan simple. 77310......... ........ A

Teletx isodose

1.05

1.17

2.30

NA

NA

0.18

2.40

3.53

NA

NA

XXX plan intermed. 77310......... 26...... A

Teletx isodose

1.05

0.28

0.33

0.28

0.33

0.05

1.38

1.43

1.38

1.43

XXX plan intermed. 77310......... TC...... A

Teletx isodose

0.00

0.89

1.97

NA

NA

0.13

1.02

2.10

NA

NA

XXX plan intermed. 77315......... ........ A

Teletx isodose

1.56

1.97

2.86

NA

NA

0.22

3.75

4.64

NA

NA

XXX plan complex. 77315......... 26...... A

Teletx isodose

1.56

0.43

0.48

0.43

0.48

0.08

2.07

2.12

2.07

2.12

XXX plan complex. 77315......... TC...... A

Teletx isodose

0.00

1.54

2.38

NA

NA

0.14

1.68

2.52

NA

NA

XXX plan complex. 77321......... ........ A

Special teletx

0.95

1.38

3.60

NA

NA

0.26

2.59

4.81

NA

NA

XXX port plan. 77321......... 26...... A

Special teletx

0.95

0.26

0.29

0.26

0.29

0.05

1.26

1.29

1.26

1.29

XXX port plan. 77321......... TC...... A

Special teletx

0.00

1.12

3.31

NA

NA

0.21

1.33

3.52

NA

NA

XXX port plan. 77326......... ........ A

Brachytx

0.93

2.78

2.69

NA

NA

0.18

3.89

3.80

NA

NA

XXX isodose calc simp. 77326......... 26...... A

Brachytx

0.93

0.25

0.29

0.25

0.29

0.05

1.23

1.27

1.23

1.27

XXX isodose calc simp. 77326......... TC...... A

Brachytx

0.00

2.53

2.40

NA

NA

0.13

2.66

2.53

NA

NA

XXX isodose calc simp. 77327......... ........ A

Brachytx

1.39

3.84

3.89

NA

NA

0.25

5.48

5.53

NA

NA

XXX isodose calc interm. 77327......... 26...... A

Brachytx

1.39

0.38

0.43

0.38

0.43

0.07

1.84

1.89

1.84

1.89

XXX isodose calc interm. 77327......... TC...... A

Brachytx

0.00

3.46

3.47

NA

NA

0.18

3.64

3.65

NA

NA

XXX isodose calc interm. 77328......... ........ A

Brachytx

2.09

4.93

5.45

NA

NA

0.36

7.38

7.90

NA

NA

XXX isodose plan compl. 77328......... 26...... A

Brachytx

2.09

0.57

0.65

0.57

0.65

0.11

2.77

2.85

2.77

2.85

XXX isodose plan compl. 77328......... TC...... A

Brachytx

0.00

4.36

4.81

NA

NA

0.25

4.61

5.06

NA

NA

XXX isodose plan compl. 77331......... ........ A

Special

0.87

0.72

0.77

NA

NA

0.06

1.65

1.70

NA

NA

XXX radiation dosimetry. 77331......... 26...... A

Special

0.87

0.24

0.27

0.24

0.27

0.04

1.15

1.18

1.15

1.18

XXX radiation dosimetry. 77331......... TC...... A

Special

0.00

0.49

0.50

NA

NA

0.02

0.51

0.52

NA

NA

XXX radiation dosimetry. 77332......... ........ A

Radiation

0.54

1.52

1.51

NA

NA

0.10

2.16

2.15

NA

NA

XXX treatment aid(s).

[[Page 49201]]

77332......... 26...... A

Radiation

0.54

0.15

0.17

0.15

0.17

0.03

0.72

0.74

0.72

0.74

XXX treatment aid(s). 77332......... TC...... A

Radiation

0.00

1.37

1.35

NA

NA

0.07

1.44

1.42

NA

NA

XXX treatment aid(s). 77333......... ........ A

Radiation

0.84

0.46

1.74

NA

NA

0.15

1.45

2.73

NA

NA

XXX treatment aid(s). 77333......... 26...... A

Radiation

0.84

0.23

0.26

0.23

0.26

0.04

1.11

1.14

1.11

1.14

XXX treatment aid(s). 77333......... TC...... A

Radiation

0.00

0.23

1.48

NA

NA

0.11

0.34

1.59

NA

NA

XXX treatment aid(s). 77334......... ........ A

Radiation

1.24

2.61

3.39

NA

NA

0.23

4.08

4.86

NA

NA

XXX treatment aid(s). 77334......... 26...... A

Radiation

1.24

0.34

0.39

0.34

0.39

0.06

1.64

1.69

1.64

1.69

XXX treatment aid(s). 77334......... TC...... A

Radiation

0.00

2.27

3.01

NA

NA

0.17

2.44

3.18

NA

NA

XXX treatment aid(s). 77336......... ........ A

Radiation

0.00

0.92

2.47

NA

NA

0.16

1.08

2.63

NA

NA

XXX physics consult. 77370......... ........ A

Radiation

0.00

2.33

3.20

NA

NA

0.18

2.51

3.38

NA

NA

XXX physics consult. 77399......... ........ C

External

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX radiation dosimetry. 77399......... 26...... C

External

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX radiation dosimetry. 77399......... TC...... C

External

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX radiation dosimetry. 77401......... ........ A

Radiation

0.00

0.49

1.45

NA

NA

0.11

0.60

1.56

NA

NA

XXX treatment delivery. 77402......... ........ A

Radiation

0.00

4.15

2.37

NA

NA

0.11

4.26

2.48

NA

NA

XXX treatment delivery. 77403......... ........ A

Radiation

0.00

3.73

2.26

NA

NA

0.11

3.84

2.37

NA

NA

XXX treatment delivery. 77404......... ........ A

Radiation

0.00

4.19

2.38

NA

NA

0.11

4.30

2.49

NA

NA

XXX treatment delivery. 77406......... ........ A

Radiation

0.00

4.18

2.37

NA

NA

0.11

4.29

2.48

NA

NA

XXX treatment delivery. 77407......... ........ A

Radiation

0.00

5.39

2.92

NA

NA

0.12

5.51

3.04

NA

NA

XXX treatment delivery. 77408......... ........ A

Radiation

0.00

5.18

2.86

NA

NA

0.12

5.30

2.98

NA

NA

XXX treatment delivery. 77409......... ........ A

Radiation

0.00

5.78

3.01

NA

NA

0.12

5.90

3.13

NA

NA

XXX treatment delivery. 77411......... ........ A

Radiation

0.00

5.68

2.99

NA

NA

0.12

5.80

3.11

NA

NA

XXX treatment delivery. 77412......... ........ A

Radiation

0.00

6.78

3.44

NA

NA

0.13

6.91

3.57

NA

NA

XXX treatment delivery. 77413......... ........ A

Radiation

0.00

6.80

3.45

NA

NA

0.13

6.93

3.58

NA

NA

XXX treatment delivery. 77414......... ........ A

Radiation

0.00

7.66

3.66

NA

NA

0.13

7.79

3.79

NA

NA

XXX treatment delivery. 77416......... ........ A

Radiation

0.00

7.65

3.66

NA

NA

0.13

7.78

3.79

NA

NA

XXX treatment delivery. 77417......... ........ A

Radiology port

0.00

0.35

0.53

NA

NA

0.04

0.39

0.57

NA

NA

XXX film(s). 77418......... ........ A

Radiation tx

0.00 13.02

16.77

NA

NA

0.13 13.15

16.90

NA

NA

XXX delivery, imrt. 77421......... ........ A

Stereoscopic x- 0.39

1.95

3.10

NA

NA

0.12

2.46

3.61

NA

NA

XXX ray guidance. 77421......... 26...... A

Stereoscopic x- 0.39

0.11

0.13

0.11

0.13

0.02

0.52

0.54

0.52

0.54

XXX ray guidance. 77421......... TC...... A

Stereoscopic x- 0.00

1.84

2.97

NA

NA

0.10

1.94

3.07

NA

NA

XXX ray guidance. 77422......... ........ A

Neutron beam

0.00 11.79

4.23

NA

NA

0.13 11.92

4.36

NA

NA

XXX tx, simple. 77423......... ........ A

Neutron beam

0.00

7.83

3.65

NA

NA

0.13

7.96

3.78

NA

NA

XXX tx, complex. 77427......... ........ A

Radiation tx

3.31

1.08

1.07

1.08

1.07

0.17

4.56

4.55

4.56

4.55

XXX management, x5. 77431......... ........ A

Radiation

1.81

0.68

0.68

0.68

0.68

0.09

2.58

2.58

2.58

2.58

XXX therapy management. 77432......... ........ A

Stereotactic

7.92

2.17

2.72

2.17

2.72

0.41 10.50

11.05

10.50

11.05

XXX radiation trmt. 77470......... ........ A

Special

2.09

1.76

9.31

NA

NA

0.70

4.55

12.10

NA

NA

XXX radiation treatment. 77470......... 26...... A

Special

2.09

0.57

0.65

0.57

0.65

0.11

2.77

2.85

2.77

2.85

XXX radiation treatment. 77470......... TC...... A

Special

0.00

1.19

8.66

NA

NA

0.59

1.78

9.25

NA

NA

XXX radiation treatment. 77499......... ........ C

Radiation

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX therapy management. 77499......... 26...... C

Radiation

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX therapy management. 77499......... TC...... C

Radiation

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX therapy management. 77520......... ........ C

Proton trmt,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX simple w/o comp. 77522......... ........ C

Proton trmt,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX simple w/comp. 77523......... ........ C

Proton trmt,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX intermediate. 77525......... ........ C

Proton

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX treatment, complex. 77600......... ........ R

Hyperthermia

1.56

9.32

4.99

NA

NA

0.24 11.12

6.79

NA

NA

XXX treatment. 77600......... 26...... R

Hyperthermia

1.56

0.35

0.46

0.35

0.46

0.08

1.99

2.10

1.99

2.10

XXX treatment. 77600......... TC...... R

Hyperthermia

0.00

8.97

4.53

NA

NA

0.16

9.13

4.69

NA

NA

XXX treatment. 77605......... ........ R

Hyperthermia

2.09 16.90

7.77

NA

NA

0.38 19.37

10.24

NA

NA

XXX treatment. 77605......... 26...... R

Hyperthermia

2.09

0.53

0.63

0.53

0.63

0.16

2.78

2.88

2.78

2.88

XXX treatment. 77605......... TC...... R

Hyperthermia

0.00 16.36

7.14

NA

NA

0.22 16.58

7.36

NA

NA

XXX treatment. 77610......... ........ R

Hyperthermia

1.56 16.54

6.81

NA

NA

0.24 18.34

8.61

NA

NA

XXX treatment. 77610......... 26...... R

Hyperthermia

1.56

0.43

0.49

0.43

0.49

0.08

2.07

2.13

2.07

2.13

XXX treatment. 77610......... TC...... R

Hyperthermia

0.00 16.12

6.32

NA

NA

0.16 16.28

6.48

NA

NA

XXX treatment. 77615......... ........ R

Hyperthermia

2.09 24.51

9.67

NA

NA

0.33 26.93

12.09

NA

NA

XXX treatment. 77615......... 26...... R

Hyperthermia

2.09

0.55

0.63

0.55

0.63

0.11

2.75

2.83

2.75

2.83

XXX treatment. 77615......... TC...... R

Hyperthermia

0.00 23.95

9.03

NA

NA

0.22 24.17

9.25

NA

NA

XXX treatment. 77620......... ........ R

Hyperthermia

1.56

9.58

5.07

NA

NA

0.36 11.50

6.99

NA

NA

XXX treatment. 77620......... 26...... R

Hyperthermia

1.56

0.41

0.49

0.41

0.49

0.20

2.17

2.25

2.17

2.25

XXX treatment. 77620......... TC...... R

Hyperthermia

0.00

9.18

4.58

NA

NA

0.16

9.34

4.74

NA

NA

XXX treatment. 77750......... ........ A

Infuse

4.90

4.19

3.22

4.19

3.22

0.32

9.41

8.44

9.41

8.44

090 radioactive materials. 77750......... 26...... A

Infuse

4.90

1.35

1.52

1.35

1.52

0.25

6.50

6.67

6.50

6.67

090 radioactive materials. 77750......... TC...... A

Infuse

0.00

2.84

1.71

2.84

1.71

0.07

2.91

1.78

2.91

1.78

090 radioactive materials. 77761......... ........ A

Apply intrcav

3.80

5.59

4.09

5.59

4.09

0.33

9.72

8.22

9.72

8.22

090 radiat simple. 77761......... 26...... A

Apply intrcav

3.80

1.05

1.08

1.05

1.08

0.19

5.04

5.07

5.04

5.07

090 radiat simple.

[[Page 49202]]

77761......... TC...... A

Apply intrcav

0.00

4.54

3.01

4.54

3.01

0.14

4.68

3.15

4.68

3.15

090 radiat simple. 77762......... ........ A

Apply intrcav

5.71

6.58

5.73

6.58

5.73

0.48 12.77

11.92

12.77

11.92

090 radiat interm. 77762......... 26...... A

Apply intrcav

5.71

1.56

1.76

1.56

1.76

0.29

7.56

7.76

7.56

7.76

090 radiat interm. 77762......... TC...... A

Apply intrcav

0.00

5.03

3.97

5.03

3.97

0.19

5.22

4.16

5.22

4.16

090 radiat interm. 77763......... ........ A

Apply intrcav

8.56

8.87

7.64

8.87

7.64

0.66 18.09

16.86

18.09

16.86

090 radiat compl. 77763......... 26...... A

Apply intrcav

8.56

2.33

2.64

2.33

2.64

0.43 11.32

11.63

11.32

11.63

090 radiat compl. 77763......... TC...... A

Apply intrcav

0.00

6.54

5.00

6.54

5.00

0.23

6.77

5.23

6.77

5.23

090 radiat compl. 77776......... ........ A

Apply interstit 4.65

6.66

4.01

6.66

4.01

0.57 11.88

9.23

11.88

9.23

090 radiat simpl. 77776......... 26...... A

Apply interstit 4.65

1.54

1.10

1.54

1.10

0.44

6.63

6.19

6.63

6.19

090 radiat simpl. 77776......... TC...... A

Apply interstit 0.00

5.12

2.92

5.12

2.92

0.13

5.25

3.05

5.25

3.05

090 radiat simpl. 77777......... ........ A

Apply interstit 7.47

6.93

6.68

6.93

6.68

0.61 15.01

14.76

15.01

14.76

090 radiat inter. 77777......... 26...... A

Apply interstit 7.47

2.18

2.32

2.18

2.32

0.39 10.04

10.18

10.04

10.18

090 radiat inter. 77778......... ........ A

Apply interstit 11.17

9.61

8.92

9.61

8.92

0.84 21.62

20.93

21.62

20.93

090 radiat compl. 77778......... 26...... A

Apply interstit 11.17

3.08

3.45

3.08

3.45

0.57 14.82

15.19

14.82

15.19

090 radiat compl. 77778......... TC...... A

Apply interstit 0.00

6.54

5.48

6.54

5.48

0.27

6.81

5.75

6.81

5.75

090 radiat compl. 77781......... ........ A

High intensity

1.21

4.23

16.68

NA

NA

1.14

6.58

19.03

NA

NA

XXX brachytherapy. 77781......... 26...... A

High intensity

1.21

0.33

0.48

0.33

0.48

0.08

1.62

1.77

1.62

1.77

XXX brachytherapy. 77781......... TC...... A

High intensity

0.00

3.90

16.20

NA

NA

1.06

4.96

17.26

NA

NA

XXX brachytherapy. 77782......... ........ A

High intensity

2.04 12.03

18.83

NA

NA

1.19 15.26

22.06

NA

NA

XXX brachytherapy. 77782......... 26...... A

High intensity

2.04

0.55

0.74

0.55

0.74

0.13

2.72

2.91

2.72

2.91

XXX brachytherapy. 77782......... TC...... A

High intensity

0.00 11.48

18.10

NA

NA

1.06 12.54

19.16

NA

NA

XXX brachytherapy. 77783......... ........ A

High intensity

3.27 23.55

22.01

NA

NA

1.25 28.07

26.53

NA

NA

XXX brachytherapy. 77783......... 26...... A

High intensity

3.27

0.89

1.12

0.89

1.12

0.19

4.35

4.58

4.35

4.58

XXX brachytherapy. 77783......... TC...... A

High intensity

0.00 22.67

20.89

NA

NA

1.06 23.73

21.95

NA

NA

XXX brachytherapy. 77784......... ........ A

High intensity

5.15 44.52

27.71

NA

NA

1.35 51.02

34.21

NA

NA

XXX brachytherapy. 77784......... 26...... A

High intensity

5.15

1.40

1.69

1.40

1.69

0.29

6.84

7.13

6.84

7.13

XXX brachytherapy. 77784......... TC...... A

High intensity

0.00 43.12

26.01

NA

NA

1.06 44.18

27.07

NA

NA

XXX brachytherapy. 77789......... ........ A

Apply surface

1.12

1.95

1.10

1.95

1.10

0.08

3.15

2.30

3.15

2.30

000 radiation. 77789......... 26...... A

Apply surface

1.12

0.35

0.37

0.35

0.37

0.06

1.53

1.55

1.53

1.55

000 radiation. 77789......... TC...... A

Apply surface

0.00

1.60

0.74

1.60

0.74

0.02

1.62

0.76

1.62

0.76

000 radiation. 77790......... ........ A

Radiation

1.05

1.16

0.92

NA

NA

0.07

2.28

2.04

NA

NA

XXX handling. 77790......... 26...... A

Radiation

1.05

0.29

0.33

0.29

0.33

0.05

1.39

1.43

1.39

1.43

XXX handling. 77790......... TC...... A

Radiation

0.00

0.87

0.59

NA

NA

0.02

0.89

0.61

NA

NA

XXX handling. 77799......... ........ C

Radium/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX radioisotope therapy. 77799......... 26...... C

Radium/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX radioisotope therapy. 77799......... TC...... C

Radium/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX radioisotope therapy. 78000......... ........ A

Thyroid, single 0.19

1.85

1.24

NA

NA

0.07

2.11

1.50

NA

NA

XXX uptake. 78000......... 26...... A

Thyroid, single 0.19

0.06

0.06

0.06

0.06

0.01

0.26

0.26

0.26

0.26

XXX uptake. 78000......... TC...... A

Thyroid, single 0.00

1.79

1.18

NA

NA

0.06

1.85

1.24

NA

NA

XXX uptake. 78001......... ........ A

Thyroid,

0.26

2.27

1.62

NA

NA

0.08

2.61

1.96

NA

NA

XXX multiple uptakes. 78001......... 26...... A

Thyroid,

0.26

0.08

0.09

0.08

0.09

0.01

0.35

0.36

0.35

0.36

XXX multiple uptakes. 78001......... TC...... A

Thyroid,

0.00

2.19

1.53

NA

NA

0.07

2.26

1.60

NA

NA

XXX multiple uptakes. 78003......... ........ A

Thyroid

0.33

1.89

1.28

NA

NA

0.07

2.29

1.68

NA

NA

XXX suppress/ stimul. 78003......... 26...... A

Thyroid

0.33

0.10

0.11

0.10

0.11

0.01

0.44

0.45

0.44

0.45

XXX suppress/ stimul. 78003......... TC...... A

Thyroid

0.00

1.78

1.17

NA

NA

0.06

1.84

1.23

NA

NA

XXX suppress/ stimul. 78006......... ........ A

Thyroid imaging 0.49

6.24

3.47

NA

NA

0.15

6.88

4.11

NA

NA

XXX with uptake. 78006......... 26...... A

Thyroid imaging 0.49

0.15

0.16

0.15

0.16

0.02

0.66

0.67

0.66

0.67

XXX with uptake. 78006......... TC...... A

Thyroid imaging 0.00

6.08

3.31

NA

NA

0.13

6.21

3.44

NA

NA

XXX with uptake. 78007......... ........ A

Thyroid image,

0.50

3.02

2.81

NA

NA

0.16

3.68

3.47

NA

NA

XXX mult uptakes. 78007......... 26...... A

Thyroid image,

0.50

0.16

0.17

0.16

0.17

0.02

0.68

0.69

0.68

0.69

XXX mult uptakes. 78007......... TC...... A

Thyroid image,

0.00

2.86

2.64

NA

NA

0.14

3.00

2.78

NA

NA

XXX mult uptakes. 78010......... ........ A

Thyroid imaging 0.39

4.20

2.51

NA

NA

0.13

4.72

3.03

NA

NA

XXX 78010......... 26...... A

Thyroid imaging 0.39

0.12

0.13

0.12

0.13

0.02

0.53

0.54

0.53

0.54

XXX 78010......... TC...... A

Thyroid imaging 0.00

4.08

2.39

NA

NA

0.11

4.19

2.50

NA

NA

XXX 78011......... ........ A

Thyroid imaging 0.45

4.55

3.06

NA

NA

0.15

5.15

3.66

NA

NA

XXX with flow. 78011......... 26...... A

Thyroid imaging 0.45

0.14

0.15

0.14

0.15

0.02

0.61

0.62

0.61

0.62

XXX with flow.

[[Page 49203]]

78011......... TC...... A

Thyroid imaging 0.00

4.41

2.91

NA

NA

0.13

4.54

3.04

NA

NA

XXX with flow. 78015......... ........ A

Thyroid met

0.67

5.43

3.46

NA

NA

0.17

6.27

4.30

NA

NA

XXX imaging. 78015......... 26...... A

Thyroid met

0.67

0.21

0.23

0.21

0.23

0.03

0.91

0.93

0.91

0.93

XXX imaging. 78015......... TC...... A

Thyroid met

0.00

5.22

3.23

NA

NA

0.14

5.36

3.37

NA

NA

XXX imaging. 78016......... ........ A

Thyroid met

0.82

8.63

4.98

NA

NA

0.21

9.66

6.01

NA

NA

XXX imaging/ studies. 78016......... 26...... A

Thyroid met

0.82

0.26

0.28

0.26

0.28

0.03

1.11

1.13

1.11

1.13

XXX imaging/ studies. 78016......... TC...... A

Thyroid met

0.00

8.37

4.70

NA

NA

0.18

8.55

4.88

NA

NA

XXX imaging/ studies. 78018......... ........ A

Thyroid met

0.86

7.96

6.28

NA

NA

0.33

9.15

7.47

NA

NA

XXX imaging, body. 78018......... 26...... A

Thyroid met

0.86

0.27

0.29

0.27

0.29

0.04

1.17

1.19

1.17

1.19

XXX imaging, body. 78018......... TC...... A

Thyroid met

0.00

7.69

5.99

NA

NA

0.29

7.98

6.28

NA

NA

XXX imaging, body. 78020......... ........ A

Thyroid met

0.60

1.79

1.59

1.79

1.59

0.16

2.55

2.35

2.55

2.35

ZZZ uptake. 78020......... 26...... A

Thyroid met

0.60

0.18

0.20

0.18

0.20

0.02

0.80

0.82

0.80

0.82

ZZZ uptake. 78020......... TC...... A

Thyroid met

0.00

1.60

1.38

1.60

1.38

0.14

1.74

1.52

1.74

1.52

ZZZ uptake. 78070......... ........ A

Parathyroid

0.82

3.43

4.27

NA

NA

0.15

4.40

5.24

NA

NA

XXX nuclear imaging. 78070......... 26...... A

Parathyroid

0.82

0.26

0.28

0.26

0.28

0.04

1.12

1.14

1.12

1.14

XXX nuclear imaging. 78070......... TC...... A

Parathyroid

0.00

3.17

4.00

NA

NA

0.11

3.28

4.11

NA

NA

XXX nuclear imaging. 78075......... ........ A

Adrenal nuclear 0.74 11.67

7.18

NA

NA

0.32 12.73

8.24

NA

NA

XXX imaging. 78075......... 26...... A

Adrenal nuclear 0.74

0.23

0.25

0.23

0.25

0.03

1.00

1.02

1.00

1.02

XXX imaging. 78075......... TC...... A

Adrenal nuclear 0.00 11.44

6.93

NA

NA

0.29 11.73

7.22

NA

NA

XXX imaging. 78099......... ........ C

Endocrine

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear procedure. 78099......... 26...... C

Endocrine

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear procedure. 78099......... TC...... C

Endocrine

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear procedure. 78102......... ........ A

Bone marrow

0.55

4.17

2.72

NA

NA

0.14

4.86

3.41

NA

NA

XXX imaging, ltd. 78102......... 26...... A

Bone marrow

0.55

0.17

0.19

0.17

0.19

0.02

0.74

0.76

0.74

0.76

XXX imaging, ltd. 78102......... TC...... A

Bone marrow

0.00

4.00

2.53

NA

NA

0.12

4.12

2.65

NA

NA

XXX imaging, ltd. 78103......... ........ A

Bone marrow

0.75

5.43

3.93

NA

NA

0.20

6.38

4.88

NA

NA

XXX imaging, mult. 78103......... 26...... A

Bone marrow

0.75

0.23

0.25

0.23

0.25

0.03

1.01

1.03

1.01

1.03

XXX imaging, mult. 78103......... TC...... A

Bone marrow

0.00

5.20

3.68

NA

NA

0.17

5.37

3.85

NA

NA

XXX imaging, mult. 78104......... ........ A

Bone marrow

0.80

6.30

4.83

NA

NA

0.25

7.35

5.88

NA

NA

XXX imaging, body. 78104......... 26...... A

Bone marrow

0.80

0.27

0.27

0.27

0.27

0.03

1.10

1.10

1.10

1.10

XXX imaging, body. 78104......... TC...... A

Bone marrow

0.00

6.02

4.56

NA

NA

0.22

6.24

4.78

NA

NA

XXX imaging, body. 78110......... ........ A

Plasma volume,

0.19

2.16

1.31

NA

NA

0.07

2.42

1.57

NA

NA

XXX single. 78110......... 26...... A

Plasma volume,

0.19

0.06

0.07

0.06

0.07

0.01

0.26

0.27

0.26

0.27

XXX single. 78110......... TC...... A

Plasma volume,

0.00

2.10

1.24

NA

NA

0.06

2.16

1.30

NA

NA

XXX single. 78111......... ........ A

Plasma volume,

0.22

2.16

2.53

NA

NA

0.15

2.53

2.90

NA

NA

XXX multiple. 78111......... 26...... A

Plasma volume,

0.22

0.07

0.08

0.07

0.08

0.01

0.30

0.31

0.30

0.31

XXX multiple. 78111......... TC...... A

Plasma volume,

0.00

2.09

2.45

NA

NA

0.14

2.23

2.59

NA

NA

XXX multiple. 78120......... ........ A

Red cell mass,

0.23

2.09

1.88

NA

NA

0.12

2.44

2.23

NA

NA

XXX single. 78120......... 26...... A

Red cell mass,

0.23

0.07

0.08

0.07

0.08

0.01

0.31

0.32

0.31

0.32

XXX single. 78120......... TC...... A

Red cell mass,

0.00

2.02

1.80

NA

NA

0.11

2.13

1.91

NA

NA

XXX single. 78121......... ........ A

Red cell mass,

0.32

2.19

2.81

NA

NA

0.15

2.66

3.28

NA

NA

XXX multiple. 78121......... 26...... A

Red cell mass,

0.32

0.10

0.11

0.10

0.11

0.01

0.43

0.44

0.43

0.44

XXX multiple. 78121......... TC...... A

Red cell mass,

0.00

2.10

2.71

NA

NA

0.14

2.24

2.85

NA

NA

XXX multiple. 78122......... ........ A

Blood volume... 0.45

2.25

4.13

NA

NA

0.26

2.96

4.84

NA

NA

XXX 78122......... 26...... A

Blood volume... 0.45

0.14

0.16

0.14

0.16

0.02

0.61

0.63

0.61

0.63

XXX 78122......... TC...... A

Blood volume... 0.00

2.11

3.98

NA

NA

0.24

2.35

4.22

NA

NA

XXX 78130......... ........ A

Red cell

0.61

3.55

3.18

NA

NA

0.17

4.33

3.96

NA

NA

XXX survival study. 78130......... 26...... A

Red cell

0.61

0.20

0.21

0.20

0.21

0.03

0.84

0.85

0.84

0.85

XXX survival study. 78130......... TC...... A

Red cell

0.00

3.35

2.98

NA

NA

0.14

3.49

3.12

NA

NA

XXX survival study. 78135......... ........ A

Red cell

0.64

8.59

5.97

NA

NA

0.28

9.51

6.89

NA

NA

XXX survival kinetics. 78135......... 26...... A

Red cell

0.64

0.20

0.22

0.20

0.22

0.03

0.87

0.89

0.87

0.89

XXX survival kinetics. 78135......... TC...... A

Red cell

0.00

8.39

5.75

NA

NA

0.25

8.64

6.00

NA

NA

XXX survival kinetics. 78140......... ........ A

Red cell

0.61

2.87

3.82

NA

NA

0.24

3.72

4.67

NA

NA

XXX sequestration. 78140......... 26...... A

Red cell

0.61

0.19

0.20

0.19

0.20

0.03

0.83

0.84

0.83

0.84

XXX sequestration. 78140......... TC...... A

Red cell

0.00

2.68

3.62

NA

NA

0.21

2.89

3.83

NA

NA

XXX sequestration. 78185......... ........ A

Spleen imaging. 0.40

5.22

3.18

NA

NA

0.15

5.77

3.73

NA

NA

XXX 78185......... 26...... A

Spleen imaging. 0.40

0.12

0.14

0.12

0.14

0.02

0.54

0.56

0.54

0.56

XXX 78185......... TC...... A

Spleen imaging. 0.00

5.10

3.05

NA

NA

0.13

5.23

3.18

NA

NA

XXX 78190......... ........ A

Platelet

1.09

9.05

6.84

NA

NA

0.38 10.52

8.31

NA

NA

XXX survival, kinetics. 78190......... 26...... A

Platelet

1.09

0.34

0.38

0.34

0.38

0.08

1.51

1.55

1.51

1.55

XXX survival, kinetics. 78190......... TC...... A

Platelet

0.00

8.71

6.46

NA

NA

0.30

9.01

6.76

NA

NA

XXX survival, kinetics. 78191......... ........ A

Platelet

0.61

3.43

6.51

NA

NA

0.40

4.44

7.52

NA

NA

XXX survival. 78191......... 26...... A

Platelet

0.61

0.19

0.20

0.19

0.20

0.03

0.83

0.84

0.83

0.84

XXX survival. 78191......... TC...... A

Platelet

0.00

3.24

6.32

NA

NA

0.37

3.61

6.69

NA

NA

XXX survival. 78195......... ........ A

Lymph system

1.20

8.66

5.53

NA

NA

0.28 10.14

7.01

NA

NA

XXX imaging. 78195......... 26...... A

Lymph system

1.20

0.37

0.40

0.37

0.40

0.06

1.63

1.66

1.63

1.66

XXX imaging.

[[Page 49204]]

78195......... TC...... A

Lymph system

0.00

8.29

5.13

NA

NA

0.22

8.51

5.35

NA

NA

XXX imaging. 78199......... ........ C

Blood/lymph

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78199......... 26...... C

Blood/lymph

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78199......... TC...... C

Blood/lymph

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78201......... ........ A

Liver imaging.. 0.44

4.75

3.07

NA

NA

0.15

5.34

3.66

NA

NA

XXX 78201......... 26...... A

Liver imaging.. 0.44

0.13

0.15

0.13

0.15

0.02

0.59

0.61

0.59

0.61

XXX 78201......... TC...... A

Liver imaging.. 0.00

4.61

2.92

NA

NA

0.13

4.74

3.05

NA

NA

XXX 78202......... ........ A

Liver imaging

0.51

5.34

3.62

NA

NA

0.16

6.01

4.29

NA

NA

XXX with flow. 78202......... 26...... A

Liver imaging

0.51

0.16

0.17

0.16

0.17

0.02

0.69

0.70

0.69

0.70

XXX with flow. 78202......... TC...... A

Liver imaging

0.00

5.19

3.46

NA

NA

0.14

5.33

3.60

NA

NA

XXX with flow. 78205......... ........ A

Liver imaging

0.71

5.26

5.93

NA

NA

0.34

6.31

6.98

NA

NA

XXX (3D). 78205......... 26...... A

Liver imaging

0.71

0.22

0.24

0.22

0.24

0.03

0.96

0.98

0.96

0.98

XXX (3D). 78205......... TC...... A

Liver imaging

0.00

5.04

5.69

NA

NA

0.31

5.35

6.00

NA

NA

XXX (3D). 78206......... ........ A

Liver image

0.96 14.57

8.32

NA

NA

0.15 15.68

9.43

NA

NA

XXX (3d) with flow. 78206......... 26...... A

Liver image

0.96

0.30

0.32

0.30

0.32

0.04

1.30

1.32

1.30

1.32

XXX (3d) with flow. 78206......... TC...... A

Liver image

0.00 14.26

8.00

NA

NA

0.11 14.37

8.11

NA

NA

XXX (3d) with flow. 78215......... ........ A

Liver and

0.49

4.81

3.53

NA

NA

0.16

5.46

4.18

NA

NA

XXX spleen imaging. 78215......... 26...... A

Liver and

0.49

0.15

0.16

0.15

0.16

0.02

0.66

0.67

0.66

0.67

XXX spleen imaging. 78215......... TC...... A

Liver and

0.00

4.66

3.37

NA

NA

0.14

4.80

3.51

NA

NA

XXX spleen imaging. 78216......... ........ A

Liver & spleen

0.57

2.82

3.46

NA

NA

0.20

3.59

4.23

NA

NA

XXX image/flow. 78216......... 26...... A

Liver & spleen

0.57

0.18

0.19

0.18

0.19

0.02

0.77

0.78

0.77

0.78

XXX image/flow. 78216......... TC...... A

Liver & spleen

0.00

2.64

3.27

NA

NA

0.18

2.82

3.45

NA

NA

XXX image/flow. 78220......... ........ A

Liver function

0.49

3.04

3.67

NA

NA

0.21

3.74

4.37

NA

NA

XXX study. 78220......... 26...... A

Liver function

0.49

0.15

0.16

0.15

0.16

0.02

0.66

0.67

0.66

0.67

XXX study. 78220......... TC...... A

Liver function

0.00

2.89

3.51

NA

NA

0.19

3.08

3.70

NA

NA

XXX study. 78223......... ........ A

Hepatobiliary

0.84

8.49

5.08

NA

NA

0.23

9.56

6.15

NA

NA

XXX imaging. 78223......... 26...... A

Hepatobiliary

0.84

0.26

0.28

0.26

0.28

0.04

1.14

1.16

1.14

1.16

XXX imaging. 78223......... TC...... A

Hepatobiliary

0.00

8.23

4.80

NA

NA

0.19

8.42

4.99

NA

NA

XXX imaging. 78230......... ........ A

Salivary gland

0.45

4.16

2.79

NA

NA

0.15

4.76

3.39

NA

NA

XXX imaging. 78230......... 26...... A

Salivary gland

0.45

0.14

0.15

0.14

0.15

0.02

0.61

0.62

0.61

0.62

XXX imaging. 78230......... TC...... A

Salivary gland

0.00

4.02

2.64

NA

NA

0.13

4.15

2.77

NA

NA

XXX imaging. 78231......... ........ A

Serial salivary 0.52

2.81

3.22

NA

NA

0.19

3.52

3.93

NA

NA

XXX imaging. 78231......... 26...... A

Serial salivary 0.52

0.16

0.18

0.16

0.18

0.02

0.70

0.72

0.70

0.72

XXX imaging. 78231......... TC...... A

Serial salivary 0.00

2.64

3.04

NA

NA

0.17

2.81

3.21

NA

NA

XXX imaging. 78232......... ........ A

Salivary gland

0.47

2.78

3.47

NA

NA

0.20

3.45

4.14

NA

NA

XXX function exam. 78232......... 26...... A

Salivary gland

0.47

0.15

0.16

0.15

0.16

0.02

0.64

0.65

0.64

0.65

XXX function exam. 78232......... TC...... A

Salivary gland

0.00

2.64

3.32

NA

NA

0.18

2.82

3.50

NA

NA

XXX function exam. 78258......... ........ A

Esophageal

0.74

5.83

3.81

NA

NA

0.17

6.74

4.72

NA

NA

XXX motility study. 78258......... 26...... A

Esophageal

0.74

0.27

0.26

0.27

0.26

0.03

1.04

1.03

1.04

1.03

XXX motility study. 78258......... TC...... A

Esophageal

0.00

5.56

3.55

NA

NA

0.14

5.70

3.69

NA

NA

XXX motility study. 78261......... ........ A

Gastric mucosa

0.69

6.07

4.77

NA

NA

0.25

7.01

5.71

NA

NA

XXX imaging. 78261......... 26...... A

Gastric mucosa

0.69

0.22

0.24

0.22

0.24

0.03

0.94

0.96

0.94

0.96

XXX imaging. 78261......... TC...... A

Gastric mucosa

0.00

5.85

4.54

NA

NA

0.22

6.07

4.76

NA

NA

XXX imaging. 78262......... ........ A

Gastroesophagea 0.68

5.94

4.85

NA

NA

0.25

6.87

5.78

NA

NA

XXX l reflux exam. 78262......... 26...... A

Gastroesophagea 0.68

0.20

0.22

0.20

0.22

0.03

0.91

0.93

0.91

0.93

XXX l reflux exam. 78262......... TC...... A

Gastroesophagea 0.00

5.74

4.62

NA

NA

0.22

5.96

4.84

NA

NA

XXX l reflux exam. 78264......... ........ A

Gastric

0.78

7.16

5.08

NA

NA

0.25

8.19

6.11

NA

NA

XXX emptying study. 78264......... 26...... A

Gastric

0.78

0.25

0.26

0.25

0.26

0.03

1.06

1.07

1.06

1.07

XXX emptying study. 78264......... TC...... A

Gastric

0.00

6.91

4.83

NA

NA

0.22

7.13

5.05

NA

NA

XXX emptying study. 78270......... ........ A

Vit B-12

0.20

1.94

1.70

NA

NA

0.11

2.25

2.01

NA

NA

XXX absorption exam. 78270......... 26...... A

Vit B-12

0.20

0.06

0.07

0.06

0.07

0.01

0.27

0.28

0.27

0.28

XXX absorption exam. 78270......... TC...... A

Vit B-12

0.00

1.88

1.63

NA

NA

0.10

1.98

1.73

NA

NA

XXX absorption exam. 78271......... ........ A

Vit b-12 absrp

0.20

1.90

1.76

NA

NA

0.11

2.21

2.07

NA

NA

XXX exam, int fac. 78271......... 26...... A

Vit b-12 absrp

0.20

0.05

0.07

0.05

0.07

0.01

0.26

0.28

0.26

0.28

XXX exam, int fac. 78271......... TC...... A

Vit b-12 absrp

0.00

1.85

1.69

NA

NA

0.10

1.95

1.79

NA

NA

XXX exam, int fac. 78272......... ........ A

Vit B-12

0.27

2.02

2.31

NA

NA

0.14

2.43

2.72

NA

NA

XXX absorp, combined.

[[Page 49205]]

78272......... 26...... A

Vit B-12

0.27

0.07

0.09

0.07

0.09

0.01

0.35

0.37

0.35

0.37

XXX absorp, combined. 78272......... TC...... A

Vit B-12

0.00

1.95

2.23

NA

NA

0.13

2.08

2.36

NA

NA

XXX absorp, combined. 78278......... ........ A

Acute GI blood

0.99

8.57

6.04

NA

NA

0.29

9.85

7.32

NA

NA

XXX loss imaging. 78278......... 26...... A

Acute GI blood

0.99

0.31

0.33

0.31

0.33

0.04

1.34

1.36

1.34

1.36

XXX loss imaging. 78278......... TC...... A

Acute GI blood

0.00

8.26

5.72

NA

NA

0.25

8.51

5.97

NA

NA

XXX loss imaging. 78282......... ........ C

GI protein loss 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX exam. 78282......... 26...... A

GI protein loss 0.38

0.12

0.13

0.12

0.13

0.02

0.52

0.53

0.52

0.53

XXX exam. 78282......... TC...... C

GI protein loss 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX exam. 78290......... ........ A

MeckelIs divert 0.68

8.46

4.58

NA

NA

0.19

9.33

5.45

NA

NA

XXX exam. 78290......... 26...... A

MeckelIs divert 0.68

0.21

0.23

0.21

0.23

0.03

0.92

0.94

0.92

0.94

XXX exam. 78290......... TC...... A

MeckelIs divert 0.00

8.25

4.35

NA

NA

0.16

8.41

4.51

NA

NA

XXX exam. 78291......... ........ A

Leveen/shunt

0.88

6.17

4.06

NA

NA

0.20

7.25

5.14

NA

NA

XXX patency exam. 78291......... 26...... A

Leveen/shunt

0.88

0.27

0.29

0.27

0.29

0.04

1.19

1.21

1.19

1.21

XXX patency exam. 78291......... TC...... A

Leveen/shunt

0.00

5.90

3.77

NA

NA

0.16

6.06

3.93

NA

NA

XXX patency exam. 78299......... ........ C

GI nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 78299......... 26...... C

GI nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 78299......... TC...... C

GI nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 78300......... ........ A

Bone imaging,

0.62

4.20

3.07

NA

NA

0.17

4.99

3.86

NA

NA

XXX limited area. 78300......... 26...... A

Bone imaging,

0.62

0.19

0.21

0.19

0.21

0.03

0.84

0.86

0.84

0.86

XXX limited area. 78300......... TC...... A

Bone imaging,

0.00

4.01

2.86

NA

NA

0.14

4.15

3.00

NA

NA

XXX limited area. 78305......... ........ A

Bone imaging,

0.83

5.46

4.32

NA

NA

0.23

6.52

5.38

NA

NA

XXX multiple areas. 78305......... 26...... A

Bone imaging,

0.83

0.26

0.28

0.26

0.28

0.04

1.13

1.15

1.13

1.15

XXX multiple areas. 78305......... TC...... A

Bone imaging,

0.00

5.20

4.05

NA

NA

0.19

5.39

4.24

NA

NA

XXX multiple areas. 78306......... ........ A

Bone imaging,

0.86

6.05

4.93

NA

NA

0.26

7.17

6.05

NA

NA

XXX whole body. 78306......... 26...... A

Bone imaging,

0.86

0.27

0.29

0.27

0.29

0.04

1.17

1.19

1.17

1.19

XXX whole body. 78306......... TC...... A

Bone imaging,

0.00

5.78

4.65

NA

NA

0.22

6.00

4.87

NA

NA

XXX whole body. 78315......... ........ A

Bone imaging, 3 1.02

8.59

5.99

NA

NA

0.29

9.90

7.30

NA

NA

XXX phase. 78315......... 26...... A

Bone imaging, 3 1.02

0.32

0.34

0.32

0.34

0.04

1.38

1.40

1.38

1.40

XXX phase. 78315......... TC...... A

Bone imaging, 3 0.00

8.27

5.65

NA

NA

0.25

8.52

5.90

NA

NA

XXX phase. 78320......... ........ A

Bone imaging

1.04

5.36

6.04

NA

NA

0.35

6.75

7.43

NA

NA

XXX (3D). 78320......... 26...... A

Bone imaging

1.04

0.33

0.35

0.33

0.35

0.04

1.41

1.43

1.41

1.43

XXX (3D). 78320......... TC...... A

Bone imaging

0.00

5.03

5.69

NA

NA

0.31

5.34

6.00

NA

NA

XXX (3D). 78350......... ........ A

Bone mineral,

0.22

0.56

0.76

NA

NA

0.06

0.84

1.04

NA

NA

XXX single photon. 78350......... 26...... A

Bone mineral,

0.22

0.06

0.07

0.06

0.07

0.01

0.29

0.30

0.29

0.30

XXX single photon. 78350......... TC...... A

Bone mineral,

0.00

0.49

0.69

NA

NA

0.05

0.54

0.74

NA

NA

XXX single photon. 78351......... ........ N

Bone mineral,

0.30

2.80

1.99

0.07

0.11

0.01

3.11

2.30

0.38

0.42

XXX dual photon. 78399......... ........ C

Musculoskeletal 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78399......... 26...... C

Musculoskeletal 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78399......... TC...... C

Musculoskeletal 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78414......... ........ C

Non-imaging

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart function. 78414......... 26...... A

Non-imaging

0.45

0.14

0.16

0.14

0.16

0.02

0.61

0.63

0.61

0.63

XXX heart function. 78414......... TC...... C

Non-imaging

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX heart function. 78428......... ........ A

Cardiac shunt

0.78

5.36

3.25

NA

NA

0.16

6.30

4.19

NA

NA

XXX imaging. 78428......... 26...... A

Cardiac shunt

0.78

0.38

0.31

0.38

0.31

0.03

1.19

1.12

1.19

1.12

XXX imaging. 78428......... TC...... A

Cardiac shunt

0.00

4.98

2.93

NA

NA

0.13

5.11

3.06

NA

NA

XXX imaging. 78445......... ........ A

Vascular flow

0.49

4.63

2.68

NA

NA

0.13

5.25

3.30

NA

NA

XXX imaging. 78445......... 26...... A

Vascular flow

0.49

0.18

0.17

0.18

0.17

0.02

0.69

0.68

0.69

0.68

XXX imaging. 78445......... TC...... A

Vascular flow

0.00

4.45

2.51

NA

NA

0.11

4.56

2.62

NA

NA

XXX imaging. 78456......... ........ A

Acute venous

1.00 10.04

5.75

NA

NA

0.33 11.37

7.08

NA

NA

XXX thrombus image. 78456......... 26...... A

Acute venous

1.00

0.50

0.38

0.50

0.38

0.04

1.54

1.42

1.54

1.42

XXX thrombus image. 78456......... TC...... A

Acute venous

0.00

9.54

5.37

NA

NA

0.29

9.83

5.66

NA

NA

XXX thrombus image. 78457......... ........ A

Venous

0.77

4.73

3.38

NA

NA

0.17

5.67

4.32

NA

NA

XXX thrombosis imaging. 78457......... 26...... A

Venous

0.77

0.24

0.26

0.24

0.26

0.03

1.04

1.06

1.04

1.06

XXX thrombosis imaging. 78457......... TC...... A

Venous

0.00

4.49

3.12

NA

NA

0.14

4.63

3.26

NA

NA

XXX thrombosis imaging. 78458......... ........ A

Ven thrombosis

0.90

4.59

4.40

NA

NA

0.25

5.74

5.55

NA

NA

XXX images, bilat. 78458......... 26...... A

Ven thrombosis

0.90

0.28

0.31

0.28

0.31

0.04

1.22

1.25

1.22

1.25

XXX images, bilat. 78458......... TC...... A

Ven thrombosis

0.00

4.31

4.09

NA

NA

0.21

4.52

4.30

NA

NA

XXX images, bilat. 78459......... ........ C

Heart muscle

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX imaging (PET). 78459......... 26...... A

Heart muscle

1.50

0.55

0.57

0.55

0.57

0.05

2.10

2.12

2.10

2.12

XXX imaging (PET). 78459......... TC...... C

Heart muscle

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX imaging (PET). 78460......... ........ A

Heart muscle

0.86

4.68

3.16

NA

NA

0.17

5.71

4.19

NA

NA

XXX blood, single. 78460......... 26...... A

Heart muscle

0.86

0.29

0.29

0.29

0.29

0.04

1.19

1.19

1.19

1.19

XXX blood, single. 78460......... TC...... A

Heart muscle

0.00

4.39

2.87

NA

NA

0.13

4.52

3.00

NA

NA

XXX blood, single. 78461......... ........ A

Heart muscle

1.23

4.01

4.87

NA

NA

0.30

5.54

6.40

NA

NA

XXX blood, multiple. 78461......... 26...... A

Heart muscle

1.23

0.42

0.43

0.42

0.43

0.05

1.70

1.71

1.70

1.71

XXX blood, multiple. 78461......... TC...... A

Heart muscle

0.00

3.59

4.44

NA

NA

0.25

3.84

4.69

NA

NA

XXX blood, multiple.

[[Page 49206]]

78464......... ........ A

Heart image

1.09

5.91

7.07

NA

NA

0.41

7.41

8.57

NA

NA

XXX (3d), single. 78464......... 26...... A

Heart image

1.09

0.49

0.41

0.49

0.41

0.04

1.62

1.54

1.62

1.54

XXX (3d), single. 78464......... TC...... A

Heart image

0.00

5.42

6.66

NA

NA

0.37

5.79

7.03

NA

NA

XXX (3d), single. 78465......... ........ A

Heart image

1.46 11.58

12.12

NA

NA

0.67 13.71

14.25

NA

NA

XXX (3d), multiple. 78465......... 26...... A

Heart image

1.46

0.71

0.57

0.71

0.57

0.05

2.22

2.08

2.22

2.08

XXX (3d), multiple. 78465......... TC...... A

Heart image

0.00 10.87

11.56

NA

NA

0.62 11.49

12.18

NA

NA

XXX (3d), multiple. 78466......... ........ A

Heart infarct

0.69

4.52

3.28

NA

NA

0.17

5.38

4.14

NA

NA

XXX image. 78466......... 26...... A

Heart infarct

0.69

0.25

0.24

0.25

0.24

0.03

0.97

0.96

0.97

0.96

XXX image. 78466......... TC...... A

Heart infarct

0.00

4.27

3.03

NA

NA

0.14

4.41

3.17

NA

NA

XXX image. 78468......... ........ A

Heart infarct

0.80

6.06

4.46

NA

NA

0.22

7.08

5.48

NA

NA

XXX image (ef). 78468......... 26...... A

Heart infarct

0.80

0.42

0.31

0.42

0.31

0.03

1.25

1.14

1.25

1.14

XXX image (ef). 78468......... TC...... A

Heart infarct

0.00

5.64

4.16

NA

NA

0.19

5.83

4.35

NA

NA

XXX image (ef). 78469......... ........ A

Heart infarct

0.92

6.29

5.72

NA

NA

0.31

7.52

6.95

NA

NA

XXX image (3D). 78469......... 26...... A

Heart infarct

0.92

0.43

0.34

0.43

0.34

0.03

1.38

1.29

1.38

1.29

XXX image (3D). 78469......... TC...... A

Heart infarct

0.00

5.85

5.38

NA

NA

0.28

6.13

5.66

NA

NA

XXX image (3D). 78472......... ........ A

Gated heart,

0.98

6.15

5.93

NA

NA

0.34

7.47

7.25

NA

NA

XXX planar, single. 78472......... 26...... A

Gated heart,

0.98

0.40

0.36

0.40

0.36

0.04

1.42

1.38

1.42

1.38

XXX planar, single. 78472......... TC...... A

Gated heart,

0.00

5.75

5.57

NA

NA

0.30

6.05

5.87

NA

NA

XXX planar, single. 78473......... ........ A

Gated heart,

1.47

7.79

8.52

NA

NA

0.48

9.74

10.47

NA

NA

XXX multiple. 78473......... 26...... A

Gated heart,

1.47

0.62

0.54

0.62

0.54

0.06

2.15

2.07

2.15

2.07

XXX multiple. 78473......... TC...... A

Gated heart,

0.00

7.17

7.99

NA

NA

0.42

7.59

8.41

NA

NA

XXX multiple. 78478......... ........ A

Heart wall

0.50

0.81

1.54

NA

NA

0.12

1.43

2.16

NA

NA

XXX motion add-on. 78478......... 26...... A

Heart wall

0.50

0.24

0.23

0.24

0.23

0.02

0.76

0.75

0.76

0.75

XXX motion add-on. 78478......... TC...... A

Heart wall

0.00

0.57

1.31

NA

NA

0.10

0.67

1.41

NA

NA

XXX motion add-on. 78480......... ........ A

Heart function

0.30

0.71

1.51

NA

NA

0.12

1.13

1.93

NA

NA

XXX add-on. 78480......... 26...... A

Heart function

0.30

0.15

0.20

0.15

0.20

0.02

0.47

0.52

0.47

0.52

XXX add-on. 78480......... TC...... A

Heart function

0.00

0.57

1.31

NA

NA

0.10

0.67

1.41

NA

NA

XXX add-on. 78481......... ........ A

Heart first

0.98

5.12

5.47

NA

NA

0.31

6.41

6.76

NA

NA

XXX pass, single. 78481......... 26...... A

Heart first

0.98

0.49

0.39

0.49

0.39

0.03

1.50

1.40

1.50

1.40

XXX pass, single. 78481......... TC...... A

Heart first

0.00

4.62

5.07

NA

NA

0.28

4.90

5.35

NA

NA

XXX pass, single. 78483......... ........ A

Heart first

1.47

6.93

8.04

NA

NA

0.46

8.86

9.97

NA

NA

XXX pass, multiple. 78483......... 26...... A

Heart first

1.47

0.79

0.60

0.79

0.60

0.05

2.31

2.12

2.31

2.12

XXX pass, multiple. 78483......... TC...... A

Heart first

0.00

6.14

7.44

NA

NA

0.41

6.55

7.85

NA

NA

XXX pass, multiple. 78491......... ........ C

Heart image

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet), single. 78491......... 26...... A

Heart image

1.50

0.62

0.60

0.62

0.60

0.06

2.18

2.16

2.18

2.16

XXX (pet), single. 78491......... TC...... C

Heart image

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet), single. 78492......... ........ C

Heart image

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet), multiple. 78492......... 26...... A

Heart image

1.87

0.91

0.78

0.91

0.78

0.07

2.85

2.72

2.85

2.72

XXX (pet), multiple. 78492......... TC...... C

Heart image

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet), multiple. 78494......... ........ A

Heart image,

1.19

6.30

7.19

NA

NA

0.35

7.84

8.73

NA

NA

XXX spect. 78494......... 26...... A

Heart image,

1.19

0.54

0.45

0.54

0.45

0.05

1.78

1.69

1.78

1.69

XXX spect. 78494......... TC...... A

Heart image,

0.00

5.75

6.74

NA

NA

0.30

6.05

7.04

NA

NA

XXX spect. 78496......... ........ A

Heart first

0.50

0.93

5.67

0.93

5.67

0.32

1.75

6.49

1.75

6.49

ZZZ pass add-on. 78496......... 26...... A

Heart first

0.50

0.25

0.20

0.25

0.20

0.02

0.77

0.72

0.77

0.72

ZZZ pass add-on. 78496......... TC...... A

Heart first

0.00

0.68

5.47

0.68

5.47

0.30

0.98

5.77

0.98

5.77

ZZZ pass add-on. 78499......... ........ C

Cardiovascular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78499......... 26...... C

Cardiovascular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78499......... TC...... C

Cardiovascular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78580......... ........ A

Lung perfusion

0.74

5.12

4.04

NA

NA

0.21

6.07

4.99

NA

NA

XXX imaging. 78580......... 26...... A

Lung perfusion

0.74

0.24

0.25

0.24

0.25

0.03

1.01

1.02

1.01

1.02

XXX imaging. 78580......... TC...... A

Lung perfusion

0.00

4.88

3.79

NA

NA

0.18

5.06

3.97

NA

NA

XXX imaging. 78584......... ........ A

Lung V/Q image

0.99

2.93

3.38

NA

NA

0.21

4.13

4.58

NA

NA

XXX single breath. 78584......... 26...... A

Lung V/Q image

0.99

0.31

0.33

0.31

0.33

0.04

1.34

1.36

1.34

1.36

XXX single breath. 78584......... TC...... A

Lung V/Q image

0.00

2.62

3.06

NA

NA

0.17

2.79

3.23

NA

NA

XXX single breath. 78585......... ........ A

Lung V/Q

1.09

8.60

6.65

NA

NA

0.35 10.04

8.09

NA

NA

XXX imaging. 78585......... 26...... A

Lung V/Q

1.09

0.34

0.36

0.34

0.36

0.05

1.48

1.50

1.48

1.50

XXX imaging.

[[Page 49207]]

78585......... TC...... A

Lung V/Q

0.00

8.26

6.30

NA

NA

0.30

8.56

6.60

NA

NA

XXX imaging. 78586......... ........ A

Aerosol lung

0.40

4.13

3.07

NA

NA

0.16

4.69

3.63

NA

NA

XXX image, single. 78586......... 26...... A

Aerosol lung

0.40

0.12

0.13

0.12

0.13

0.02

0.54

0.55

0.54

0.55

XXX image, single. 78586......... TC...... A

Aerosol lung

0.00

4.01

2.95

NA

NA

0.14

4.15

3.09

NA

NA

XXX image, single. 78587......... ........ A

Aerosol lung

0.49

5.43

3.59

NA

NA

0.16

6.08

4.24

NA

NA

XXX image, multiple. 78587......... 26...... A

Aerosol lung

0.49

0.15

0.17

0.15

0.17

0.02

0.66

0.68

0.66

0.68

XXX image, multiple. 78587......... TC...... A

Aerosol lung

0.00

5.27

3.42

NA

NA

0.14

5.41

3.56

NA

NA

XXX image, multiple. 78588......... ........ A

Perfusion lung

1.09

8.63

4.83

NA

NA

0.23

9.95

6.15

NA

NA

XXX image. 78588......... 26...... A

Perfusion lung

1.09

0.34

0.36

0.34

0.36

0.05

1.48

1.50

1.48

1.50

XXX image. 78588......... TC...... A

Perfusion lung

0.00

8.29

4.47

NA

NA

0.18

8.47

4.65

NA

NA

XXX image. 78591......... ........ A

Vent image, 1

0.40

4.12

3.27

NA

NA

0.16

4.68

3.83

NA

NA

XXX breath, 1 proj. 78591......... 26...... A

Vent image, 1

0.40

0.12

0.13

0.12

0.13

0.02

0.54

0.55

0.54

0.55

XXX breath, 1 proj. 78591......... TC...... A

Vent image, 1

0.00

4.00

3.14

NA

NA

0.14

4.14

3.28

NA

NA

XXX breath, 1 proj. 78593......... ........ A

Vent image, 1

0.49

4.79

3.91

NA

NA

0.20

5.48

4.60

NA

NA

XXX proj, gas. 78593......... 26...... A

Vent image, 1

0.49

0.15

0.16

0.15

0.16

0.02

0.66

0.67

0.66

0.67

XXX proj, gas. 78593......... TC...... A

Vent image, 1

0.00

4.64

3.75

NA

NA

0.18

4.82

3.93

NA

NA

XXX proj, gas. 78594......... ........ A

Vent image,

0.53

5.29

5.19

NA

NA

0.27

6.09

5.99

NA

NA

XXX mult proj, gas. 78594......... 26...... A

Vent image,

0.53

0.16

0.18

0.16

0.18

0.02

0.71

0.73

0.71

0.73

XXX mult proj, gas. 78594......... TC...... A

Vent image,

0.00

5.13

5.02

NA

NA

0.25

5.38

5.27

NA

NA

XXX mult proj, gas. 78596......... ........ A

Lung

1.27

8.73

7.80

NA

NA

0.42 10.42

9.49

NA

NA

XXX differential function. 78596......... 26...... A

Lung

1.27

0.37

0.41

0.37

0.41

0.05

1.69

1.73

1.69

1.73

XXX differential function. 78596......... TC...... A

Lung

0.00

8.36

7.39

NA

NA

0.37

8.73

7.76

NA

NA

XXX differential function. 78599......... ........ C

Respiratory

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78599......... 26...... C

Respiratory

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78599......... TC...... C

Respiratory

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78600......... ........ A

Brain imaging,

0.44

7.30

4.10

NA

NA

0.16

7.90

4.70

NA

NA

XXX ltd static. 78600......... 26...... A

Brain imaging,

0.44

0.14

0.15

0.14

0.15

0.02

0.60

0.61

0.60

0.61

XXX ltd static. 78600......... TC...... A

Brain imaging,

0.00

7.16

3.95

NA

NA

0.14

7.30

4.09

NA

NA

XXX ltd static. 78601......... ........ A

Brain imaging,

0.51

5.35

4.02

NA

NA

0.20

6.06

4.73

NA

NA

XXX ltd w/flow. 78601......... 26...... A

Brain imaging,

0.51

0.16

0.17

0.16

0.17

0.02

0.69

0.70

0.69

0.70

XXX ltd w/flow. 78601......... TC...... A

Brain imaging,

0.00

5.19

3.85

NA

NA

0.18

5.37

4.03

NA

NA

XXX ltd w/flow. 78605......... ........ A

Brain imaging,

0.53

4.75

3.87

NA

NA

0.20

5.48

4.60

NA

NA

XXX complete. 78605......... 26...... A

Brain imaging,

0.53

0.17

0.18

0.17

0.18

0.02

0.72

0.73

0.72

0.73

XXX complete. 78605......... TC...... A

Brain imaging,

0.00

4.59

3.70

NA

NA

0.18

4.77

3.88

NA

NA

XXX complete. 78606......... ........ A

Brain imaging,

0.64

8.54

5.20

NA

NA

0.24

9.42

6.08

NA

NA

XXX compl w/flow. 78606......... 26...... A

Brain imaging,

0.64

0.20

0.21

0.20

0.21

0.03

0.87

0.88

0.87

0.88

XXX compl w/flow. 78606......... TC...... A

Brain imaging,

0.00

8.34

4.99

NA

NA

0.21

8.55

5.20

NA

NA

XXX compl w/flow. 78607......... ........ A

Brain imaging

1.23 15.23

9.04

NA

NA

0.40 16.86

10.67

NA

NA

XXX (3D). 78607......... 26...... A

Brain imaging

1.23

0.38

0.42

0.38

0.42

0.05

1.66

1.70

1.66

1.70

XXX (3D). 78607......... TC...... A

Brain imaging

0.00 14.85

8.63

NA

NA

0.35 15.20

8.98

NA

NA

XXX (3D). 78608......... ........ C

Brain imaging

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (PET). 78608......... 26...... A

Brain imaging

1.50

0.47

0.50

0.47

0.50

0.06

2.03

2.06

2.03

2.06

XXX (PET). 78608......... TC...... C

Brain imaging

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (PET). 78609......... ........ C

Brain imaging

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (PET). 78609......... 26...... A

Brain imaging

1.50

0.47

0.50

0.47

0.50

0.06

2.03

2.06

2.03

2.06

XXX (PET). 78609......... TC...... C

Brain imaging

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (PET). 78610......... ........ A

Brain flow

0.30

4.44

2.38

NA

NA

0.11

4.85

2.79

NA

NA

XXX imaging only. 78610......... 26...... A

Brain flow

0.30

0.09

0.11

0.09

0.11

0.01

0.40

0.42

0.40

0.42

XXX imaging only. 78610......... TC...... A

Brain flow

0.00

4.35

2.27

NA

NA

0.10

4.45

2.37

NA

NA

XXX imaging only. 78615......... ........ A

Cerebral

0.42

5.34

4.34

NA

NA

0.23

5.99

4.99

NA

NA

XXX vascular flow image. 78615......... 26...... A

Cerebral

0.42

0.13

0.15

0.13

0.15

0.02

0.57

0.59

0.57

0.59

XXX vascular flow image. 78615......... TC...... A

Cerebral

0.00

5.21

4.19

NA

NA

0.21

5.42

4.40

NA

NA

XXX vascular flow image. 78630......... ........ A

Cerebrospinal

0.68

8.61

6.10

NA

NA

0.30

9.59

7.08

NA

NA

XXX fluid scan. 78630......... 26...... A

Cerebrospinal

0.68

0.21

0.23

0.21

0.23

0.03

0.92

0.94

0.92

0.94

XXX fluid scan. 78630......... TC...... A

Cerebrospinal

0.00

8.40

5.88

NA

NA

0.27

8.67

6.15

NA

NA

XXX fluid scan. 78635......... ........ A

CSF

0.61

8.54

4.21

NA

NA

0.16

9.31

4.98

NA

NA

XXX ventriculograp hy. 78635......... 26...... A

CSF

0.61

0.19

0.22

0.19

0.22

0.02

0.82

0.85

0.82

0.85

XXX ventriculograp hy. 78635......... TC...... A

CSF

0.00

8.35

3.99

NA

NA

0.14

8.49

4.13

NA

NA

XXX ventriculograp hy. 78645......... ........ A

CSF shunt

0.57

8.43

4.82

NA

NA

0.20

9.20

5.59

NA

NA

XXX evaluation. 78645......... 26...... A

CSF shunt

0.57

0.18

0.19

0.18

0.19

0.02

0.77

0.78

0.77

0.78

XXX evaluation. 78645......... TC...... A

CSF shunt

0.00

8.25

4.64

NA

NA

0.18

8.43

4.82

NA

NA

XXX evaluation. 78647......... ........ A

Cerebrospinal

0.90 14.31

8.24

NA

NA

0.35 15.56

9.49

NA

NA

XXX fluid scan. 78647......... 26...... A

Cerebrospinal

0.90

0.27

0.30

0.27

0.30

0.04

1.21

1.24

1.21

1.24

XXX fluid scan. 78647......... TC...... A

Cerebrospinal

0.00 14.05

7.95

NA

NA

0.31 14.36

8.26

NA

NA

XXX fluid scan. 78650......... ........ A

CSF leakage

0.61

8.62

5.79

NA

NA

0.27

9.50

6.67

NA

NA

XXX imaging. 78650......... 26...... A

CSF leakage

0.61

0.19

0.21

0.19

0.21

0.03

0.83

0.85

0.83

0.85

XXX imaging.

[[Page 49208]]

78650......... TC...... A

CSF leakage

0.00

8.43

5.59

NA

NA

0.24

8.67

5.83

NA

NA

XXX imaging. 78660......... ........ A

Nuclear exam of 0.53

4.24

2.79

NA

NA

0.14

4.91

3.46

NA

NA

XXX tear flow. 78660......... 26...... A

Nuclear exam of 0.53

0.17

0.18

0.17

0.18

0.02

0.72

0.73

0.72

0.73

XXX tear flow. 78660......... TC...... A

Nuclear exam of 0.00

4.07

2.61

NA

NA

0.12

4.19

2.73

NA

NA

XXX tear flow. 78699......... ........ C

Nervous system

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78699......... 26...... C

Nervous system

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78699......... TC...... C

Nervous system

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78700......... ........ A

Kidney imaging, 0.45

4.47

3.52

NA

NA

0.18

5.10

4.15

NA

NA

XXX static. 78700......... 26...... A

Kidney imaging, 0.45

0.15

0.15

0.15

0.15

0.02

0.62

0.62

0.62

0.62

XXX static. 78700......... TC...... A

Kidney imaging, 0.00

4.32

3.37

NA

NA

0.16

4.48

3.53

NA

NA

XXX static. 78701......... ........ A

Kidney imaging

0.49

5.36

4.13

NA

NA

0.20

6.05

4.82

NA

NA

XXX with flow. 78701......... 26...... A

Kidney imaging

0.49

0.15

0.16

0.15

0.16

0.02

0.66

0.67

0.66

0.67

XXX with flow. 78701......... TC...... A

Kidney imaging

0.00

5.21

3.97

NA

NA

0.18

5.39

4.15

NA

NA

XXX with flow. 78704......... ........ A

Imaging

0.74

5.42

4.51

NA

NA

0.24

6.40

5.49

NA

NA

XXX renogram. 78704......... 26...... A

Imaging

0.74

0.23

0.25

0.23

0.25

0.03

1.00

1.02

1.00

1.02

XXX renogram. 78704......... TC...... A

Imaging

0.00

5.19

4.26

NA

NA

0.21

5.40

4.47

NA

NA

XXX renogram. 78707......... ........ A

Kidney flow/

0.96

5.48

4.96

NA

NA

0.27

6.71

6.19

NA

NA

XXX function image. 78707......... 26...... A

Kidney flow/

0.96

0.30

0.32

0.30

0.32

0.04

1.30

1.32

1.30

1.32

XXX function image. 78707......... TC...... A

Kidney flow/

0.00

5.18

4.65

NA

NA

0.23

5.41

4.88

NA

NA

XXX function image. 78708......... ........ A

Kidney flow/

1.21

3.41

4.51

NA

NA

0.28

4.90

6.00

NA

NA

XXX function image. 78708......... 26...... A

Kidney flow/

1.21

0.38

0.40

0.38

0.40

0.05

1.64

1.66

1.64

1.66

XXX function image. 78708......... TC...... A

Kidney flow/

0.00

3.03

4.11

NA

NA

0.23

3.26

4.34

NA

NA

XXX function image. 78709......... ........ A

Kidney flow/

1.41

8.88

5.93

NA

NA

0.29 10.58

7.63

NA

NA

XXX function image. 78709......... 26...... A

Kidney flow/

1.41

0.45

0.47

0.45

0.47

0.06

1.92

1.94

1.92

1.94

XXX function image. 78709......... TC...... A

Kidney flow/

0.00

8.43

5.46

NA

NA

0.23

8.66

5.69

NA

NA

XXX function image. 78710......... ........ A

Kidney imaging

0.66

5.29

5.92

NA

NA

0.34

6.29

6.92

NA

NA

XXX (3D). 78710......... 26...... A

Kidney imaging

0.66

0.21

0.22

0.21

0.22

0.03

0.90

0.91

0.90

0.91

XXX (3D). 78710......... TC...... A

Kidney imaging

0.00

5.08

5.70

NA

NA

0.31

5.39

6.01

NA

NA

XXX (3D). 78715......... ........ A

Renal vascular

0.30

4.82

2.47

NA

NA

0.11

5.23

2.88

NA

NA

XXX flow exam. 78715......... 26...... A

Renal vascular

0.30

0.13

0.12

0.13

0.12

0.01

0.44

0.43

0.44

0.43

XXX flow exam. 78715......... TC...... A

Renal vascular

0.00

4.69

2.36

NA

NA

0.10

4.79

2.46

NA

NA

XXX flow exam. 78725......... ........ A

Kidney function 0.38

2.35

2.02

NA

NA

0.13

2.86

2.53

NA

NA

XXX study. 78725......... 26...... A

Kidney function 0.38

0.12

0.13

0.12

0.13

0.02

0.52

0.53

0.52

0.53

XXX study. 78725......... TC...... A

Kidney function 0.00

2.23

1.89

NA

NA

0.11

2.34

2.00

NA

NA

XXX study. 78730......... ........ A

Urinary bladder 0.36

1.85

1.65

1.85

1.65

0.10

2.31

2.11

2.31

2.11

XXX retention. 78730......... 26...... A

Urinary bladder 0.36

0.14

0.13

0.14

0.13

0.02

0.52

0.51

0.52

0.51

XXX retention. 78730......... TC...... A

Urinary bladder 0.00

1.71

1.52

1.71

1.52

0.08

1.79

1.60

1.79

1.60

XXX retention. 78740......... ........ A

Ureteral reflux 0.57

5.48

3.10

NA

NA

0.15

6.20

3.82

NA

NA

XXX study. 78740......... 26...... A

Ureteral reflux 0.57

0.18

0.19

0.18

0.19

0.03

0.78

0.79

0.78

0.79

XXX study. 78740......... TC...... A

Ureteral reflux 0.00

5.30

2.92

NA

NA

0.12

5.42

3.04

NA

NA

XXX study. 78760......... ........ A

Testicular

0.66

4.52

3.31

NA

NA

0.17

5.35

4.14

NA

NA

XXX imaging. 78760......... 26...... A

Testicular

0.66

0.22

0.22

0.22

0.22

0.03

0.91

0.91

0.91

0.91

XXX imaging. 78760......... TC...... A

Testicular

0.00

4.30

3.09

NA

NA

0.14

4.44

3.23

NA

NA

XXX imaging. 78761......... ........ A

Testicular

0.71

4.96

3.82

NA

NA

0.20

5.87

4.73

NA

NA

XXX imaging/flow. 78761......... 26...... A

Testicular

0.71

0.23

0.24

0.23

0.24

0.03

0.97

0.98

0.97

0.98

XXX imaging/flow. 78761......... TC...... A

Testicular

0.00

4.72

3.58

NA

NA

0.17

4.89

3.75

NA

NA

XXX imaging/flow. 78799......... ........ C

Genitourinary

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78799......... 26...... C

Genitourinary

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78799......... TC...... C

Genitourinary

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX nuclear exam. 78800......... ........ A

Tumor imaging,

0.66

4.29

3.79

NA

NA

0.22

5.17

4.67

NA

NA

XXX limited area. 78800......... 26...... A

Tumor imaging,

0.66

0.20

0.22

0.20

0.22

0.04

0.90

0.92

0.90

0.92

XXX limited area. 78800......... TC...... A

Tumor imaging,

0.00

4.09

3.57

NA

NA

0.18

4.27

3.75

NA

NA

XXX limited area. 78801......... ........ A

Tumor imaging,

0.79

6.10

4.89

NA

NA

0.27

7.16

5.95

NA

NA

XXX mult areas. 78801......... 26...... A

Tumor imaging,

0.79

0.24

0.26

0.24

0.26

0.05

1.08

1.10

1.08

1.10

XXX mult areas. 78801......... TC...... A

Tumor imaging,

0.00

5.86

4.63

NA

NA

0.22

6.08

4.85

NA

NA

XXX mult areas. 78802......... ........ A

Tumor imaging,

0.86

8.17

6.41

NA

NA

0.34

9.37

7.61

NA

NA

XXX whole body.

[[Page 49209]]

78802......... 26...... A

Tumor imaging,

0.86

0.27

0.29

0.27

0.29

0.04

1.17

1.19

1.17

1.19

XXX whole body. 78802......... TC...... A

Tumor imaging,

0.00

7.90

6.12

NA

NA

0.30

8.20

6.42

NA

NA

XXX whole body. 78803......... ........ A

Tumor imaging

1.09 15.02

8.95

NA

NA

0.40 16.51

10.44

NA

NA

XXX (3D). 78803......... 26...... A

Tumor imaging

1.09

0.34

0.37

0.34

0.37

0.05

1.48

1.51

1.48

1.51

XXX (3D). 78803......... TC...... A

Tumor imaging

0.00 14.67

8.58

NA

NA

0.35 15.02

8.93

NA

NA

XXX (3D). 78804......... ........ A

Tumor imaging,

1.07 14.91

12.30

NA

NA

0.34 16.32

13.71

NA

NA

XXX whole body. 78804......... 26...... A

Tumor imaging,

1.07

0.34

0.36

0.34

0.36

0.04

1.45

1.47

1.45

1.47

XXX whole body. 78804......... TC...... A

Tumor imaging,

0.00 14.58

11.94

NA

NA

0.30 14.88

12.24

NA

NA

XXX whole body. 78805......... ........ A

Abscess

0.73

4.20

3.79

NA

NA

0.21

5.14

4.73

NA

NA

XXX imaging, ltd area. 78805......... 26...... A

Abscess

0.73

0.23

0.25

0.23

0.25

0.03

0.99

1.01

0.99

1.01

XXX imaging, ltd area. 78805......... TC...... A

Abscess

0.00

3.97

3.54

NA

NA

0.18

4.15

3.72

NA

NA

XXX imaging, ltd area. 78806......... ........ A

Abscess

0.86

8.35

7.13

NA

NA

0.39

9.60

8.38

NA

NA

XXX imaging, whole body. 78806......... 26...... A

Abscess

0.86

0.27

0.29

0.27

0.29

0.04

1.17

1.19

1.17

1.19

XXX imaging, whole body. 78806......... TC...... A

Abscess

0.00

8.08

6.84

NA

NA

0.35

8.43

7.19

NA

NA

XXX imaging, whole body. 78807......... ........ A

Nuclear

1.09 14.28

8.78

NA

NA

0.39 15.76

10.26

NA

NA

XXX localization/ abscess. 78807......... 26...... A

Nuclear

1.09

0.34

0.38

0.34

0.38

0.04

1.47

1.51

1.47

1.51

XXX localization/ abscess. 78807......... TC...... A

Nuclear

0.00 13.94

8.40

NA

NA

0.35 14.29

8.75

NA

NA

XXX localization/ abscess. 78811......... ........ C

Tumor imaging

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet), limited. 78811......... 26...... A

Tumor imaging

1.54

0.48

0.52

0.48

0.52

0.11

2.13

2.17

2.13

2.17

XXX (pet), limited. 78811......... TC...... C

Tumor imaging

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet), limited. 78812......... ........ C

Tumor image

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet)/skul- thigh. 78812......... 26...... A

Tumor image

1.93

0.61

0.65

0.61

0.65

0.11

2.65

2.69

2.65

2.69

XXX (pet)/skul- thigh. 78812......... TC...... C

Tumor image

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet)/skul- thigh. 78813......... ........ C

Tumor image

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet) full body. 78813......... 26...... A

Tumor image

2.00

0.62

0.67

0.62

0.67

0.11

2.73

2.78

2.73

2.78

XXX (pet) full body. 78813......... TC...... C

Tumor image

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX (pet) full body. 78814......... ........ C

Tumor image pet/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ct, limited. 78814......... 26...... A

Tumor image pet/ 2.20

0.68

0.74

0.68

0.74

0.11

2.99

3.05

2.99

3.05

XXX ct, limited. 78814......... TC...... C

Tumor image pet/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ct, limited. 78815......... ........ C

Tumorimage pet/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ct skul-thigh. 78815......... 26...... A

Tumorimage pet/ 2.44

0.77

0.82

0.77

0.82

0.11

3.32

3.37

3.32

3.37

XXX ct skul-thigh. 78815......... TC...... C

Tumorimage pet/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ct skul-thigh. 78816......... ........ C

Tumor image pet/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ct full body. 78816......... 26...... A

Tumor image pet/ 2.50

0.78

0.84

0.78

0.84

0.11

3.39

3.45

3.39

3.45

XXX ct full body. 78816......... TC...... C

Tumor image pet/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX ct full body. 78890......... ........ B

Nuclear

0.05

0.39

1.10

NA

NA

0.07

0.51

1.22

NA

NA

XXX medicine data proc. 78890......... 26...... B

Nuclear

0.05

0.01

0.02

0.01

0.02

0.01

0.07

0.08

0.07

0.08

XXX medicine data proc. 78890......... TC...... B

Nuclear

0.00

0.38

1.08

NA

NA

0.06

0.44

1.14

NA

NA

XXX medicine data proc. 78891......... ........ B

Nuclear med

0.10

0.89

2.22

NA

NA

0.14

1.13

2.46

NA

NA

XXX data proc. 78891......... 26...... B

Nuclear med

0.10

0.02

0.04

0.02

0.04

0.01

0.13

0.15

0.13

0.15

XXX data proc. 78891......... TC...... B

Nuclear med

0.00

0.86

2.18

NA

NA

0.13

0.99

2.31

NA

NA

XXX data proc. 78999......... ........ C

Nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX diagnostic exam. 78999......... 26...... C

Nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX diagnostic exam. 78999......... TC...... C

Nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX diagnostic exam. 79005......... ........ A

Nuclear rx,

1.80

1.78

2.86

NA

NA

0.22

3.80

4.88

NA

NA

XXX oral admin. 79005......... 26...... A

Nuclear rx,

1.80

0.53

0.58

0.53

0.58

0.08

2.41

2.46

2.41

2.46

XXX oral admin. 79005......... TC...... A

Nuclear rx,

0.00

1.25

2.28

NA

NA

0.14

1.39

2.42

NA

NA

XXX oral admin. 79101......... ........ A

Nuclear rx, iv

1.96

2.10

2.99

NA

NA

0.22

4.28

5.17

NA

NA

XXX admin. 79101......... 26...... A

Nuclear rx, iv

1.96

0.68

0.67

0.68

0.67

0.08

2.72

2.71

2.72

2.71

XXX admin. 79101......... TC...... A

Nuclear rx, iv

0.00

1.41

2.32

NA

NA

0.14

1.55

2.46

NA

NA

XXX admin. 79200......... ........ A

Nuclear rx,

1.99

2.18

3.03

NA

NA

0.23

4.40

5.25

NA

NA

XXX intracav admin. 79200......... 26...... A

Nuclear rx,

1.99

0.59

0.67

0.59

0.67

0.09

2.67

2.75

2.67

2.75

XXX intracav admin. 79200......... TC...... A

Nuclear rx,

0.00

1.60

2.37

NA

NA

0.14

1.74

2.51

NA

NA

XXX intracav admin. 79300......... ........ C

Nuclr rx,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX interstit colloid. 79300......... 26...... A

Nuclr rx,

1.60

0.46

0.54

0.46

0.54

0.13

2.19

2.27

2.19

2.27

XXX interstit colloid. 79300......... TC...... C

Nuclr rx,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX interstit colloid. 79403......... ........ A

Hematopoietic

2.25

2.83

4.58

NA

NA

0.24

5.32

7.07

NA

NA

XXX nuclear tx. 79403......... 26...... A

Hematopoietic

2.25

0.68

0.84

0.68

0.84

0.10

3.03

3.19

3.03

3.19

XXX nuclear tx. 79403......... TC...... A

Hematopoietic

0.00

2.15

3.74

NA

NA

0.14

2.29

3.88

NA

NA

XXX nuclear tx. 79440......... ........ A

Nuclear rx,

1.99

1.77

2.95

NA

NA

0.22

3.98

5.16

NA

NA

XXX intra- articular. 79440......... 26...... A

Nuclear rx,

1.99

0.61

0.69

0.61

0.69

0.08

2.68

2.76

2.68

2.76

XXX intra- articular. 79440......... TC...... A

Nuclear rx,

0.00

1.16

2.26

NA

NA

0.14

1.30

2.40

NA

NA

XXX intra- articular. 79445......... ........ C

Nuclear rx,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX intra-arterial. 79445......... 26...... A

Nuclear rx,

2.40

0.77

0.81

0.77

0.81

0.12

3.29

3.33

3.29

3.33

XXX intra-arterial. 79445......... TC...... C

Nuclear rx,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX intra-arterial. 79999......... ........ C

Nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX medicine therapy.

[[Page 49210]]

79999......... 26...... C

Nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX medicine therapy. 79999......... TC...... C

Nuclear

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX medicine therapy. 80500......... ........ A

Lab pathology

0.37

0.20

0.21

0.11

0.15

0.01

0.58

0.59

0.49

0.53

XXX consultation. 80502......... ........ A

Lab pathology

1.33

0.31

0.48

0.25

0.47

0.04

1.68

1.85

1.62

1.84

XXX consultation. 83020......... 26...... A

Hemoglobin

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX electrophoresi s. 83912......... 26...... A

Genetic

0.37

0.11

0.12

0.11

0.12

0.01

0.49

0.50

0.49

0.50

XXX examination. 84165......... 26...... A

Protein e-

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX phoresis, serum. 84166......... 26...... A

Protein e-

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX phoresis/urine/ csf. 84181......... 26...... A

Western blot

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX test. 84182......... 26...... A

Protein,

0.37

0.12

0.15

0.12

0.15

0.02

0.51

0.54

0.51

0.54

XXX western blot test. 85060......... ........ A

Blood smear

0.45

0.14

0.17

0.14

0.17

0.02

0.61

0.64

0.61

0.64

XXX interpretation. 85097......... ........ A

Bone marrow

0.94

1.30

1.76

0.28

0.38

0.04

2.28

2.74

1.26

1.36

XXX interpretation. 85390......... 26...... A

Fibrinolysins

0.37

0.12

0.13

0.12

0.13

0.01

0.50

0.51

0.50

0.51

XXX screen. 85396......... ........ A

Clotting assay, 0.37

NA

NA

0.05

0.13

0.04

NA

NA

0.46

0.54

XXX whole blood. 85576......... 26...... A

Blood platelet

0.37

0.12

0.15

0.12

0.15

0.01

0.50

0.53

0.50

0.53

XXX aggregation. 86077......... ........ A

Physician blood 0.94

0.38

0.39

0.29

0.37

0.03

1.35

1.36

1.26

1.34

XXX bank service. 86078......... ........ A

Physician blood 0.94

0.38

0.44

0.29

0.37

0.03

1.35

1.41

1.26

1.34

XXX bank service. 86079......... ........ A

Physician blood 0.94

0.38

0.43

0.30

0.38

0.03

1.35

1.40

1.27

1.35

XXX bank service. 86255......... 26...... A

Fluorescent

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX antibody, screen. 86256......... 26...... A

Fluorescent

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX antibody, titer. 86320......... 26...... A

Serum

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX immunoelectrop horesis. 86325......... 26...... A

Other

0.37

0.11

0.13

0.11

0.13

0.01

0.49

0.51

0.49

0.51

XXX immunoelectrop horesis. 86327......... 26...... A

Immunoelectroph 0.42

0.13

0.17

0.13

0.17

0.02

0.57

0.61

0.57

0.61

XXX oresis assay. 86334......... 26...... A

Immunofix e-

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX phoresis, serum. 86335......... 26...... A

Immunfix e-

0.37

0.12

0.14

0.12

0.14

0.01

0.50

0.52

0.50

0.52

XXX phorsis/urine/ csf. 86485......... ........ C

Skin test,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX candida. 86490......... ........ A

Coccidioidomyco 0.00

0.12

0.25

NA

NA

0.02

0.14

0.27

NA

NA

XXX sis skin test. 86510......... ........ A

Histoplasmosis

0.00

0.14

0.28

NA

NA

0.02

0.16

0.30

NA

NA

XXX skin test. 86580......... ........ A

TB intradermal

0.00

0.16

0.23

NA

NA

0.02

0.18

0.25

NA

NA

XXX test. 87164......... 26...... A

Dark field

0.37

0.12

0.12

0.12

0.12

0.01

0.50

0.50

0.50

0.50

XXX examination. 87207......... 26...... A

Smear, special

0.37

0.11

0.15

0.11

0.15

0.01

0.49

0.53

0.49

0.53

XXX stain. 88104......... ........ A

Cytopathology,

0.56

1.16

0.93

NA

NA

0.04

1.76

1.53

NA

NA

XXX fluids. 88104......... 26...... A

Cytopathology,

0.56

0.16

0.22

0.16

0.22

0.02

0.74

0.80

0.74

0.80

XXX fluids. 88104......... TC...... A

Cytopathology,

0.00

1.01

0.71

NA

NA

0.02

1.03

0.73

NA

NA

XXX fluids. 88106......... ........ A

Cytopathology,

0.56

1.52

1.39

NA

NA

0.04

2.12

1.99

NA

NA

XXX fluids. 88106......... 26...... A

Cytopathology,

0.56

0.15

0.22

0.15

0.22

0.02

0.73

0.80

0.73

0.80

XXX fluids. 88106......... TC...... A

Cytopathology,

0.00

1.36

1.17

NA

NA

0.02

1.38

1.19

NA

NA

XXX fluids. 88107......... ........ A

Cytopathology,

0.76

2.02

1.66

NA

NA

0.05

2.83

2.47

NA

NA

XXX fluids. 88107......... 26...... A

Cytopathology,

0.76

0.23

0.31

0.23

0.31

0.03

1.02

1.10

1.02

1.10

XXX fluids. 88107......... TC...... A

Cytopathology,

0.00

1.79

1.36

NA

NA

0.02

1.81

1.38

NA

NA

XXX fluids. 88108......... ........ A

Cytopath,

0.56

1.49

1.28

NA

NA

0.04

2.09

1.88

NA

NA

XXX concentrate tech. 88108......... 26...... A

Cytopath,

0.56

0.16

0.22

0.16

0.22

0.02

0.74

0.80

0.74

0.80

XXX concentrate tech. 88108......... TC...... A

Cytopath,

0.00

1.33

1.06

NA

NA

0.02

1.35

1.08

NA

NA

XXX concentrate tech. 88112......... ........ A

Cytopath, cell

1.18

1.53

1.85

NA

NA

0.04

2.75

3.07

NA

NA

XXX enhance tech. 88112......... 26...... A

Cytopath, cell

1.18

0.31

0.46

0.31

0.46

0.02

1.51

1.66

1.51

1.66

XXX enhance tech. 88112......... TC...... A

Cytopath, cell

0.00

1.22

1.40

NA

NA

0.02

1.24

1.42

NA

NA

XXX enhance tech. 88125......... ........ A

Forensic

0.26

0.25

0.27

NA

NA

0.02

0.53

0.55

NA

NA

XXX cytopathology. 88125......... 26...... A

Forensic

0.26

0.06

0.10

0.06

0.10

0.01

0.33

0.37

0.33

0.37

XXX cytopathology. 88125......... TC...... A

Forensic

0.00

0.20

0.17

NA

NA

0.01

0.21

0.18

NA

NA

XXX cytopathology. 88141......... ........ A

Cytopath, c/v,

0.42

0.38

0.21

0.38

0.21

0.02

0.82

0.65

0.82

0.65

XXX interpret. 88160......... ........ A

Cytopath smear, 0.50

0.91

0.85

NA

NA

0.04

1.45

1.39

NA

NA

XXX other source. 88160......... 26...... A

Cytopath smear, 0.50

0.13

0.19

0.13

0.19

0.02

0.65

0.71

0.65

0.71

XXX other source. 88160......... TC...... A

Cytopath smear, 0.00

0.78

0.66

NA

NA

0.02

0.80

0.68

NA

NA

XXX other source. 88161......... ........ A

Cytopath smear, 0.50

1.13

0.99

NA

NA

0.04

1.67

1.53

NA

NA

XXX other source. 88161......... 26...... A

Cytopath smear, 0.50

0.15

0.20

0.15

0.20

0.02

0.67

0.72

0.67

0.72

XXX other source. 88161......... TC...... A

Cytopath smear, 0.00

0.98

0.79

NA

NA

0.02

1.00

0.81

NA

NA

XXX other source.

[[Page 49211]]

88162......... ........ A

Cytopath smear, 0.76

1.18

1.06

NA

NA

0.05

1.99

1.87

NA

NA

XXX other source. 88162......... 26...... A

Cytopath smear, 0.76

0.17

0.29

0.17

0.29

0.03

0.96

1.08

0.96

1.08

XXX other source. 88162......... TC...... A

Cytopath smear, 0.00

1.01

0.77

NA

NA

0.02

1.03

0.79

NA

NA

XXX other source. 88172......... ........ A

Cytopathology

0.60

0.86

0.76

NA

NA

0.04

1.50

1.40

NA

NA

XXX eval of fna. 88172......... 26...... A

Cytopathology

0.60

0.18

0.24

0.18

0.24

0.02

0.80

0.86

0.80

0.86

XXX eval of fna. 88172......... TC...... A

Cytopathology

0.00

0.68

0.52

NA

NA

0.02

0.70

0.54

NA

NA

XXX eval of fna. 88173......... ........ A

Cytopath eval,

1.39

2.33

2.18

NA

NA

0.07

3.79

3.64

NA

NA

XXX fna, report. 88173......... 26...... A

Cytopath eval,

1.39

0.40

0.54

0.40

0.54

0.05

1.84

1.98

1.84

1.98

XXX fna, report. 88173......... TC...... A

Cytopath eval,

0.00

1.93

1.65

NA

NA

0.02

1.95

1.67

NA

NA

XXX fna, report. 88182......... ........ A

Cell marker

0.77

1.97

1.97

NA

NA

0.07

2.81

2.81

NA

NA

XXX study. 88182......... 26...... A

Cell marker

0.77

0.13

0.28

0.13

0.28

0.03

0.93

1.08

0.93

1.08

XXX study. 88182......... TC...... A

Cell marker

0.00

1.85

1.70

NA

NA

0.04

1.89

1.74

NA

NA

XXX study. 88184......... ........ A

Flowcytometry/

0.00

2.51

1.62

NA

NA

0.02

2.53

1.64

NA

NA

XXX tc, 1 marker. 88185......... ........ A

Flowcytometry/

0.00

1.52

0.86

NA

NA

0.02

1.54

0.88

NA

NA

ZZZ tc, add-on. 88187......... ........ A

Flowcytometry/

1.36

0.39

0.44

0.39

0.44

0.01

1.76

1.81

1.76

1.81

XXX read, 2-8. 88188......... ........ A

Flowcytometry/

1.69

0.44

0.54

0.44

0.54

0.01

2.14

2.24

2.14

2.24

XXX read, 9-15. 88189......... ........ A

Flowcytometry/

2.23

0.49

0.69

0.49

0.69

0.01

2.73

2.93

2.73

2.93

XXX read, 16 & >. 88199......... ........ C

Cytopathology

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 88199......... 26...... C

Cytopathology

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 88199......... TC...... C

Cytopathology

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 88291......... ........ A

Cyto/molecular

0.52

0.28

0.20

0.28

0.20

0.02

0.82

0.74

0.82

0.74

XXX report. 88299......... ........ C

Cytogenetic

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX study. 88300......... ........ A

Surgical path,

0.08

0.60

0.49

NA

NA

0.02

0.70

0.59

NA

NA

XXX gross. 88300......... 26...... A

Surgical path,

0.08

0.02

0.03

0.02

0.03

0.01

0.11

0.12

0.11

0.12

XXX gross. 88300......... TC...... A

Surgical path,

0.00

0.57

0.46

NA

NA

0.01

0.58

0.47

NA

NA

XXX gross. 88302......... ........ A

Tissue exam by

0.13

1.30

1.10

NA

NA

0.03

1.46

1.26

NA

NA

XXX pathologist. 88302......... 26...... A

Tissue exam by

0.13

0.04

0.06

0.04

0.06

0.01

0.18

0.20

0.18

0.20

XXX pathologist. 88302......... TC...... A

Tissue exam by

0.00

1.27

1.05

NA

NA

0.02

1.29

1.07

NA

NA

XXX pathologist. 88304......... ........ A

Tissue exam by

0.22

1.57

1.38

NA

NA

0.03

1.82

1.63

NA

NA

XXX pathologist. 88304......... 26...... A

Tissue exam by

0.22

0.06

0.08

0.06

0.08

0.01

0.29

0.31

0.29

0.31

XXX pathologist. 88304......... TC...... A

Tissue exam by

0.00

1.50

1.30

NA

NA

0.02

1.52

1.32

NA

NA

XXX pathologist. 88305......... ........ A

Tissue exam by

0.75

2.20

1.98

NA

NA

0.07

3.02

2.80

NA

NA

XXX pathologist. 88305......... 26...... A

Tissue exam by

0.75

0.21

0.30

0.21

0.30

0.03

0.99

1.08

0.99

1.08

XXX pathologist. 88305......... TC...... A

Tissue exam by

0.00

1.99

1.68

NA

NA

0.04

2.03

1.72

NA

NA

XXX pathologist. 88307......... ........ A

Tissue exam by

1.59

4.54

3.50

NA

NA

0.12

6.25

5.21

NA

NA

XXX pathologist. 88307......... 26...... A

Tissue exam by

1.59

0.48

0.63

0.48

0.63

0.06

2.13

2.28

2.13

2.28

XXX pathologist. 88307......... TC...... A

Tissue exam by

0.00

4.06

2.87

NA

NA

0.06

4.12

2.93

NA

NA

XXX pathologist. 88309......... ........ A

Tissue exam by

2.80

6.37

4.89

NA

NA

0.14

9.31

7.83

NA

NA

XXX pathologist. 88309......... 26...... A

Tissue exam by

2.80

0.84

0.94

0.84

0.94

0.08

3.72

3.82

3.72

3.82

XXX pathologist. 88309......... TC...... A

Tissue exam by

0.00

5.52

3.95

NA

NA

0.06

5.58

4.01

NA

NA

XXX pathologist. 88311......... ........ A

Decalcify

0.24

0.26

0.24

NA

NA

0.02

0.52

0.50

NA

NA

XXX tissue. 88311......... 26...... A

Decalcify

0.24

0.07

0.09

0.07

0.09

0.01

0.32

0.34

0.32

0.34

XXX tissue. 88311......... TC...... A

Decalcify

0.00

0.18

0.14

NA

NA

0.01

0.19

0.15

NA

NA

XXX tissue. 88312......... ........ A

Special stains. 0.54

2.51

1.77

NA

NA

0.03

3.08

2.34

NA

NA

XXX 88312......... 26...... A

Special stains. 0.54

0.15

0.21

0.15

0.21

0.02

0.71

0.77

0.71

0.77

XXX 88312......... TC...... A

Special stains. 0.00

2.36

1.56

NA

NA

0.01

2.37

1.57

NA

NA

XXX 88313......... ........ A

Special stains. 0.24

1.96

1.43

NA

NA

0.02

2.22

1.69

NA

NA

XXX 88313......... 26...... A

Special stains. 0.24

0.06

0.09

0.06

0.09

0.01

0.31

0.34

0.31

0.34

XXX 88313......... TC...... A

Special stains. 0.00

1.90

1.34

NA

NA

0.01

1.91

1.35

NA

NA

XXX 88314......... ........ A

Histochemical

0.45

1.96

2.04

NA

NA

0.04

2.45

2.53

NA

NA

XXX stain. 88314......... 26...... A

Histochemical

0.45

0.14

0.18

0.14

0.18

0.02

0.61

0.65

0.61

0.65

XXX stain. 88314......... TC...... A

Histochemical

0.00

1.83

1.86

NA

NA

0.02

1.85

1.88

NA

NA

XXX stain. 88318......... ........ A

Chemical

0.42

3.01

1.99

NA

NA

0.03

3.46

2.44

NA

NA

XXX histochemistry. 88318......... 26...... A

Chemical

0.42

0.13

0.17

0.13

0.17

0.02

0.57

0.61

0.57

0.61

XXX histochemistry. 88318......... TC...... A

Chemical

0.00

2.89

1.83

NA

NA

0.01

2.90

1.84

NA

NA

XXX histochemistry. 88319......... ........ A

Enzyme

0.53

3.29

3.38

NA

NA

0.04

3.86

3.95

NA

NA

XXX histochemistry. 88319......... 26...... A

Enzyme

0.53

0.15

0.20

0.15

0.20

0.02

0.70

0.75

0.70

0.75

XXX histochemistry. 88319......... TC...... A

Enzyme

0.00

3.14

3.18

NA

NA

0.02

3.16

3.20

NA

NA

XXX histochemistry. 88321......... ........ A

Microslide

1.63

0.74

0.78

0.48

0.54

0.05

2.42

2.46

2.16

2.22

XXX consultation. 88323......... ........ A

Microslide

1.83

2.23

1.89

NA

NA

0.07

4.13

3.79

NA

NA

XXX consultation. 88323......... 26...... A

Microslide

1.83

0.47

0.55

0.47

0.55

0.05

2.35

2.43

2.35

2.43

XXX consultation. 88323......... TC...... A

Microslide

0.00

1.77

1.35

NA

NA

0.02

1.79

1.37

NA

NA

XXX consultation. 88325......... ........ A

Comprehensive

2.50

2.27

2.77

0.63

0.87

0.07

4.84

5.34

3.20

3.44

XXX review of data. 88329......... ........ A

Path consult

0.67

0.69

0.66

0.21

0.27

0.02

1.38

1.35

0.90

0.96

XXX introp. 88331......... ........ A

Path consult

1.19

1.25

1.14

NA

NA

0.08

2.52

2.41

NA

NA

XXX intraop, 1 bloc. 88331......... 26...... A

Path consult

1.19

0.37

0.48

0.37

0.48

0.04

1.60

1.71

1.60

1.71

XXX intraop, 1 bloc.

[[Page 49212]]

88331......... TC...... A

Path consult

0.00

0.88

0.66

NA

NA

0.04

0.92

0.70

NA

NA

XXX intraop, 1 bloc. 88332......... ........ A

Path consult

0.59

0.48

0.47

NA

NA

0.04

1.11

1.10

NA

NA

XXX intraop, addIl. 88332......... 26...... A

Path consult

0.59

0.18

0.23

0.18

0.23

0.02

0.79

0.84

0.79

0.84

XXX intraop, addIl. 88332......... TC...... A

Path consult

0.00

0.30

0.23

NA

NA

0.02

0.32

0.25

NA

NA

XXX intraop, addIl. 88333......... ........ A

Intraop cyto

1.20

1.36

1.15

NA

NA

0.08

2.64

2.43

NA

NA

XXX path consult, 1. 88333......... 26...... A

Intraop cyto

1.20

0.38

0.49

0.38

0.49

0.04

1.62

1.73

1.62

1.73

XXX path consult, 1. 88333......... TC...... A

Intraop cyto

0.00

0.98

0.66

NA

NA

0.04

1.02

0.70

NA

NA

XXX path consult, 1. 88334......... ........ A

Intraop cyto

0.59

0.75

0.64

NA

NA

0.04

1.38

1.27

NA

NA

XXX path consult, 2. 88334......... 26...... A

Intraop cyto

0.59

0.18

0.24

0.18

0.24

0.02

0.79

0.85

0.79

0.85

XXX path consult, 2. 88334......... TC...... A

Intraop cyto

0.00

0.57

0.40

NA

NA

0.02

0.59

0.42

NA

NA

XXX path consult, 2. 88342......... ........ A

Immunohistochem 0.85

2.05

1.61

NA

NA

0.05

2.95

2.51

NA

NA

XXX istry. 88342......... 26...... A

Immunohistochem 0.85

0.23

0.33

0.23

0.33

0.03

1.11

1.21

1.11

1.21

XXX istry. 88342......... TC...... A

Immunohistochem 0.00

1.82

1.28

NA

NA

0.02

1.84

1.30

NA

NA

XXX istry. 88346......... ........ A

Immunofluoresce 0.86

1.97

1.67

NA

NA

0.05

2.88

2.58

NA

NA

XXX nt study. 88346......... 26...... A

Immunofluoresce 0.86

0.23

0.33

0.23

0.33

0.03

1.12

1.22

1.12

1.22

XXX nt study. 88346......... TC...... A

Immunofluoresce 0.00

1.74

1.34

NA

NA

0.02

1.76

1.36

NA

NA

XXX nt study. 88347......... ........ A

Immunofluoresce 0.86

1.30

1.27

NA

NA

0.05

2.21

2.18

NA

NA

XXX nt study. 88347......... 26...... A

Immunofluoresce 0.86

0.18

0.31

0.18

0.31

0.03

1.07

1.20

1.07

1.20

XXX nt study. 88347......... TC...... A

Immunofluoresce 0.00

1.12

0.96

NA

NA

0.02

1.14

0.98

NA

NA

XXX nt study. 88348......... ........ A

Electron

1.51 18.27

11.58

NA

NA

0.13 19.91

13.22

NA

NA

XXX microscopy. 88348......... 26...... A

Electron

1.51

0.42

0.59

0.42

0.59

0.06

1.99

2.16

1.99

2.16

XXX microscopy. 88348......... TC...... A

Electron

0.00 17.85

11.00

NA

NA

0.07 17.92

11.07

NA

NA

XXX microscopy. 88349......... ........ A

Scanning

0.76

8.97

4.91

NA

NA

0.09

9.82

5.76

NA

NA

XXX electron microscopy. 88349......... 26...... A

Scanning

0.76

0.22

0.30

0.22

0.30

0.03

1.01

1.09

1.01

1.09

XXX electron microscopy. 88349......... TC...... A

Scanning

0.00

8.75

4.61

NA

NA

0.06

8.81

4.67

NA

NA

XXX electron microscopy. 88355......... ........ A

Analysis,

1.85

3.40

7.42

NA

NA

0.13

5.38

9.40

NA

NA

XXX skeletal muscle. 88355......... 26...... A

Analysis,

1.85

0.40

0.69

0.40

0.69

0.07

2.32

2.61

2.32

2.61

XXX skeletal muscle. 88355......... TC...... A

Analysis,

0.00

2.99

6.73

NA

NA

0.06

3.05

6.79

NA

NA

XXX skeletal muscle. 88356......... ........ A

Analysis, nerve 3.02

6.75

4.82

NA

NA

0.19

9.96

8.03

NA

NA

XXX 88356......... 26...... A

Analysis, nerve 3.02

0.79

1.14

0.79

1.14

0.12

3.93

4.28

3.93

4.28

XXX 88356......... TC...... A

Analysis, nerve 0.00

5.96

3.68

NA

NA

0.07

6.03

3.75

NA

NA

XXX 88358......... ........ A

Analysis, tumor 0.95

1.14

0.92

NA

NA

0.17

2.26

2.04

NA

NA

XXX 88358......... 26...... A

Analysis, tumor 0.95

0.17

0.34

0.17

0.34

0.10

1.22

1.39

1.22

1.39

XXX 88358......... TC...... A

Analysis, tumor 0.00

0.97

0.57

NA

NA

0.07

1.04

0.64

NA

NA

XXX 88360......... ........ A

Tumor

1.10

2.33

1.87

NA

NA

0.08

3.51

3.05

NA

NA

XXX immunohistoche m/manual. 88360......... 26...... A

Tumor

1.10

0.28

0.42

0.28

0.42

0.06

1.44

1.58

1.44

1.58

XXX immunohistoche m/manual. 88360......... TC...... A

Tumor

0.00

2.04

1.46

NA

NA

0.02

2.06

1.48

NA

NA

XXX immunohistoche m/manual. 88361......... ........ A

Tumor

1.18

2.79

2.96

NA

NA

0.17

4.14

4.31

NA

NA

XXX immunohistoche m/comput. 88361......... 26...... A

Tumor

1.18

0.26

0.43

0.26

0.43

0.10

1.54

1.71

1.54

1.71

XXX immunohistoche m/comput. 88361......... TC...... A

Tumor

0.00

2.53

2.53

NA

NA

0.07

2.60

2.60

NA

NA

XXX immunohistoche m/comput. 88362......... ........ A

Nerve teasing

2.17

5.31

4.85

NA

NA

0.15

7.63

7.17

NA

NA

XXX preparations. 88362......... 26...... A

Nerve teasing

2.17

0.61

0.84

0.61

0.84

0.09

2.87

3.10

2.87

3.10

XXX preparations. 88362......... TC...... A

Nerve teasing

0.00

4.71

4.01

NA

NA

0.06

4.77

4.07

NA

NA

XXX preparations. 88365......... ........ A

Insitu

1.20

2.99

2.34

NA

NA

0.05

4.24

3.59

NA

NA

XXX hybridization (fish). 88365......... 26...... A

Insitu

1.20

0.25

0.45

0.25

0.45

0.03

1.48

1.68

1.48

1.68

XXX hybridization (fish). 88365......... TC...... A

Insitu

0.00

2.74

1.90

NA

NA

0.02

2.76

1.92

NA

NA

XXX hybridization (fish). 88367......... ........ A

Insitu

1.30

5.30

4.35

NA

NA

0.12

6.72

5.77

NA

NA

XXX hybridization, auto. 88367......... 26...... A

Insitu

1.30

0.23

0.46

0.23

0.46

0.06

1.59

1.82

1.59

1.82

XXX hybridization, auto. 88367......... TC...... A

Insitu

0.00

5.06

3.88

NA

NA

0.06

5.12

3.94

NA

NA

XXX hybridization, auto. 88368......... ........ A

Insitu

1.40

4.83

3.00

NA

NA

0.12

6.35

4.52

NA

NA

XXX hybridization, manual. 88368......... 26...... A

Insitu

1.40

0.22

0.51

0.22

0.51

0.06

1.68

1.97

1.68

1.97

XXX hybridization, manual. 88368......... TC...... A

Insitu

0.00

4.60

2.49

NA

NA

0.06

4.66

2.55

NA

NA

XXX hybridization, manual. 88371......... 26...... A

Protein,

0.37

0.10

0.12

0.10

0.12

0.01

0.48

0.50

0.48

0.50

XXX western blot tissue. 88372......... 26...... A

Protein

0.37

0.11

0.15

0.11

0.15

0.01

0.49

0.53

0.49

0.53

XXX analysis w/ probe. 88380......... ........ C

Microdissection 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 88380......... 26...... C

Microdissection 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX

[[Page 49213]]

88380......... TC...... C

Microdissection 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX 88384......... ........ C

Eval molecular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX probes, 11-50. 88384......... 26...... C

Eval molecular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX probes, 11-50. 88384......... TC...... C

Eval molecular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX probes, 11-50. 88385......... ........ A

Eval molecul

1.50 14.75

9.00

NA

NA

0.12 16.37

10.62

NA

NA

XXX probes, 51-250. 88385......... 26...... A

Eval molecul

1.50

0.24

0.55

0.24

0.55

0.06

1.80

2.11

1.80

2.11

XXX probes, 51-250. 88385......... TC...... A

Eval molecul

0.00 14.51

8.45

NA

NA

0.06 14.57

8.51

NA

NA

XXX probes, 51-250. 88386......... ........ A

Eval molecul

1.88 14.65

8.94

NA

NA

0.16 16.69

10.98

NA

NA

XXX probes, 251- 500. 88386......... 26...... A

Eval molecul

1.88

0.30

0.69

0.30

0.69

0.08

2.26

2.65

2.26

2.65

XXX probes, 251- 500. 88386......... TC...... A

Eval molecul

0.00 14.35

8.25

NA

NA

0.08 14.43

8.33

NA

NA

XXX probes, 251- 500. 88399......... ........ C

Surgical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX pathology procedure. 88399......... 26...... C

Surgical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX pathology procedure. 88399......... TC...... C

Surgical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX pathology procedure. 89049......... ........ A

Chct for mal

1.40

3.62

3.57

0.20

0.25

0.06

5.08

5.03

1.66

1.71

XXX hyperthermia. 89060......... 26...... A

Exam,synovial

0.37

0.12

0.15

0.12

0.15

0.01

0.50

0.53

0.50

0.53

XXX fluid crystals. 89100......... ........ A

Sample

0.60

8.87

3.59

0.59

0.31

0.03

9.50

4.22

1.22

0.94

XXX intestinal contents. 89105......... ........ A

Sample

0.50

7.68

3.59

0.45

0.24

0.02

8.20

4.11

0.97

0.76

XXX intestinal contents. 89130......... ........ A

Sample stomach

0.45

6.95

3.04

0.39

0.20

0.02

7.42

3.51

0.86

0.67

XXX contents. 89132......... ........ A

Sample stomach

0.19

6.51

2.79

0.29

0.12

0.01

6.71

2.99

0.49

0.32

XXX contents. 89135......... ........ A

Sample stomach

0.79

8.87

3.64

0.67

0.36

0.04

9.70

4.47

1.50

1.19

XXX contents. 89136......... ........ A

Sample stomach

0.21

7.13

3.08

0.32

0.15

0.01

7.35

3.30

0.54

0.37

XXX contents. 89140......... ........ A

Sample stomach

0.94

6.89

3.28

0.50

0.33

0.04

7.87

4.26

1.48

1.31

XXX contents. 89141......... ........ A

Sample stomach

0.85

5.54

3.48

0.40

0.35

0.03

6.42

4.36

1.28

1.23

XXX contents. 89220......... ........ A

Sputum specimen 0.00

0.36

0.41

NA

NA

0.02

0.38

0.43

NA

NA

XXX collection. 89230......... ........ A

Collect sweat

0.00

0.08

0.10

NA

NA

0.02

0.10

0.12

NA

NA

XXX for test. 89240......... ........ C

Pathology lab

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 90465......... ........ A

Immune admin 1

0.17

0.45

0.35

NA

NA

0.01

0.63

0.53

NA

NA

XXX inj, 1h. 91038......... 26...... A

Esoph imped

1.10

0.50

0.42

0.50

0.42

0.06

1.66

1.58

1.66

1.58

000 funct test > 1h. 91038......... TC...... A

Esoph imped

0.00

2.28

1.94

2.28

1.94

0.06

2.34

2.00

2.34

2.00

000 funct test > 1h. 91040......... ........ A

Esoph balloon

0.97

9.35

10.69

9.35

10.69

0.12 10.44

11.78

10.44

11.78

000 distension tst. 91040......... 26...... A

Esoph balloon

0.97

0.37

0.35

0.37

0.35

0.06

1.40

1.38

1.40

1.38

000 distension tst. 91040......... TC...... A

Esoph balloon

0.00

8.97

10.34

8.97

10.34

0.06

9.03

10.40

9.03

10.40

000 distension tst. 91052......... ........ A

Gastric

0.79

2.99

2.59

2.99

2.59

0.05

3.83

3.43

3.83

3.43

000 analysis test. 91052......... 26...... A

Gastric

0.79

0.37

0.30

0.37

0.30

0.03

1.19

1.12

1.19

1.12

000 analysis test. 91052......... TC...... A

Gastric

0.00

2.62

2.28

2.62

2.28

0.02

2.64

2.30

2.64

2.30

000 analysis test. 91055......... ........ A

Gastric

0.94

2.44

2.82

2.44

2.82

0.07

3.45

3.83

3.45

3.83

000 intubation for smear. 91055......... 26...... A

Gastric

0.94

0.27

0.27

0.27

0.27

0.05

1.26

1.26

1.26

1.26

000 intubation for smear. 91055......... TC...... A

Gastric

0.00

2.17

2.55

2.17

2.55

0.02

2.19

2.57

2.19

2.57

000 intubation for smear. 91060......... ........ A

Gastric saline

0.45

1.65

1.88

1.65

1.88

0.05

2.15

2.38

2.15

2.38

000 load test. 91060......... 26...... A

Gastric saline

0.45

0.11

0.13

0.11

0.13

0.03

0.59

0.61

0.59

0.61

000 load test. 91060......... TC...... A

Gastric saline

0.00

1.54

1.75

1.54

1.75

0.02

1.56

1.77

1.56

1.77

000 load test. 91065......... ........ A

Breath hydrogen 0.20

1.41

1.45

1.41

1.45

0.03

1.64

1.68

1.64

1.68

000 test. 91065......... 26...... A

Breath hydrogen 0.20

0.07

0.07

0.07

0.07

0.01

0.28

0.28

0.28

0.28

000 test. 91065......... TC...... A

Breath hydrogen 0.00

1.34

1.38

1.34

1.38

0.02

1.36

1.40

1.36

1.40

000 test. 91100......... ........ A

Pass intestine

1.08

2.15

2.63

0.37

0.30

0.07

3.30

3.78

1.52

1.45

000 bleeding tube. 91105......... ........ A

Gastric

0.37

1.76

2.02

0.07

0.09

0.03

2.16

2.42

0.47

0.49

000 intubation treatment. 91110......... ........ A

Gi tract

3.64 20.55

21.77

NA

NA

0.16 24.35

25.57

NA

NA

XXX capsule endoscopy. 91110......... 26...... A

Gi tract

3.64

1.66

1.38

1.66

1.38

0.09

5.39

5.11

5.39

5.11

XXX capsule endoscopy. 91110......... TC...... A

Gi tract

0.00 18.90

20.40

NA

NA

0.07 18.97

20.47

NA

NA

XXX capsule endoscopy. 91120......... ........ A

Rectal

0.97

9.12

10.52

9.12

10.52

0.11 10.20

11.60

10.20

11.60

XXX sensation test. 91120......... 26...... A

Rectal

0.97

0.30

0.33

0.30

0.33

0.07

1.34

1.37

1.34

1.37

XXX sensation test. 91120......... TC...... A

Rectal

0.00

8.82

10.19

8.82

10.19

0.04

8.86

10.23

8.86

10.23

XXX sensation test. 91122......... ........ A

Anal pressure

1.77

3.76

4.77

3.76

4.77

0.21

5.74

6.75

5.74

6.75

000 record. 91122......... 26...... A

Anal pressure

1.77

0.52

0.58

0.52

0.58

0.13

2.42

2.48

2.42

2.48

000 record. 91122......... TC...... A

Anal pressure

0.00

3.24

4.19

3.24

4.19

0.08

3.32

4.27

3.32

4.27

000 record. 91132......... ........ C

Electrogastrogr 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX aphy. 91132......... 26...... A

Electrogastrogr 0.52

0.25

0.20

0.25

0.20

0.02

0.79

0.74

0.79

0.74

XXX aphy. 91132......... TC...... C

Electrogastrogr 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX aphy. 91133......... ........ C

Electrogastrogr 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX aphy w/test. 91133......... 26...... A

Electrogastrogr 0.66

0.30

0.25

0.30

0.25

0.03

0.99

0.94

0.99

0.94

XXX aphy w/test. 91133......... TC...... C

Electrogastrogr 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX aphy w/test. 91299......... ........ C

Gastroenterolog 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX y procedure. 91299......... 26...... C

Gastroenterolog 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX y procedure. 91299......... TC...... C

Gastroenterolog 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX y procedure. 92002......... ........ A

Eye exam, new

0.88

0.97

0.97

0.27

0.32

0.02

1.87

1.87

1.17

1.22

XXX patient. 92004......... ........ A

Eye exam, new

1.67

1.59

1.67

0.54

0.65

0.04

3.30

3.38

2.25

2.36

XXX patient. 92012......... ........ A

Eye exam

0.67

0.94

1.01

0.24

0.28

0.02

1.63

1.70

0.93

0.97

XXX established pat. 92014......... ........ A

Eye exam &

1.10

1.32

1.39

0.38

0.45

0.03

2.45

2.52

1.51

1.58

XXX treatment. 92015......... ........ N

Refraction..... 0.38

0.10

1.14

0.09

0.14

0.01

0.49

1.53

0.48

0.53

XXX 92018......... ........ A

New eye exam &

2.50

NA

NA

0.91

1.03

0.07

NA

NA

3.48

3.60

XXX treatment. 92019......... ........ A

Eye exam &

1.31

NA

NA

0.44

0.53

0.03

NA

NA

1.78

1.87

XXX treatment. 92020......... ........ A

Special eye

0.37

0.26

0.32

0.13

0.15

0.01

0.64

0.70

0.51

0.53

XXX evaluation. 92060......... ........ A

Special eye

0.69

0.79

0.75

NA

NA

0.03

1.51

1.47

NA

NA

XXX evaluation. 92060......... 26...... A

Special eye

0.69

0.23

0.28

0.23

0.28

0.02

0.94

0.99

0.94

0.99

XXX evaluation. 92060......... TC...... A

Special eye

0.00

0.56

0.47

NA

NA

0.01

0.57

0.48

NA

NA

XXX evaluation. 92065......... ........ A

Orthoptic/

0.37

0.89

0.62

NA

NA

0.02

1.28

1.01

NA

NA

XXX pleoptic training. 92065......... 26...... A

Orthoptic/

0.37

0.09

0.14

0.09

0.14

0.01

0.47

0.52

0.47

0.52

XXX pleoptic training. 92065......... TC...... A

Orthoptic/

0.00

0.79

0.48

NA

NA

0.01

0.80

0.49

NA

NA

XXX pleoptic training. 92070......... ........ A

Fitting of

0.70

0.94

1.04

0.24

0.30

0.02

1.66

1.76

0.96

1.02

XXX contact lens. 92081......... ........ A

Visual field

0.36

0.97

0.95

NA

NA

0.02

1.35

1.33

NA

NA

XXX examination(s). 92081......... 26...... A

Visual field

0.36

0.11

0.14

0.11

0.14

0.01

0.48

0.51

0.48

0.51

XXX examination(s). 92081......... TC...... A

Visual field

0.00

0.86

0.81

NA

NA

0.01

0.87

0.82

NA

NA

XXX examination(s).

[[Page 49216]]

92082......... ........ A

Visual field

0.44

1.36

1.26

NA

NA

0.02

1.82

1.72

NA

NA

XXX examination(s). 92082......... 26...... A

Visual field

0.44

0.14

0.18

0.14

0.18

0.01

0.59

0.63

0.59

0.63

XXX examination(s). 92082......... TC...... A

Visual field

0.00

1.22

1.09

NA

NA

0.01

1.23

1.10

NA

NA

XXX examination(s). 92083......... ........ A

Visual field

0.50

1.56

1.46

NA

NA

0.02

2.08

1.98

NA

NA

XXX examination(s). 92083......... 26...... A

Visual field

0.50

0.17

0.21

0.17

0.21

0.01

0.68

0.72

0.68

0.72

XXX examination(s). 92083......... TC...... A

Visual field

0.00

1.39

1.26

NA

NA

0.01

1.40

1.27

NA

NA

XXX examination(s). 92100......... ........ A

Serial

0.92

1.28

1.33

0.29

0.34

0.02

2.22

2.27

1.23

1.28

XXX tonometry exam(s). 92120......... ........ A

Tonography &

0.81

1.00

1.05

0.26

0.31

0.02

1.83

1.88

1.09

1.14

XXX eye evaluation. 92130......... ........ A

Water

0.81

1.21

1.26

0.28

0.35

0.02

2.04

2.09

1.11

1.18

XXX provocation tonography. 92135......... ........ A

Opthalmic dx

0.35

0.81

0.80

NA

NA

0.02

1.18

1.17

NA

NA

XXX imaging. 92135......... 26...... A

Opthalmic dx

0.35

0.12

0.14

0.12

0.14

0.01

0.48

0.50

0.48

0.50

XXX imaging. 92135......... TC...... A

Opthalmic dx

0.00

0.69

0.65

NA

NA

0.01

0.70

0.66

NA

NA

XXX imaging. 92136......... ........ A

Ophthalmic

0.54

1.46

1.60

NA

NA

0.08

2.08

2.22

NA

NA

XXX biometry. 92136......... 26...... A

Ophthalmic

0.54

0.20

0.23

0.20

0.23

0.01

0.75

0.78

0.75

0.78

XXX biometry. 92136......... TC...... A

Ophthalmic

0.00

1.26

1.37

NA

NA

0.07

1.33

1.44

NA

NA

XXX biometry. 92140......... ........ A

Glaucoma

0.50

0.92

0.97

0.15

0.20

0.01

1.43

1.48

0.66

0.71

XXX provocative tests. 92225......... ........ A

Special eye

0.38

0.25

0.23

0.13

0.15

0.01

0.64

0.62

0.52

0.54

XXX exam, initial. 92226......... ........ A

Special eye

0.33

0.24

0.22

0.12

0.14

0.01

0.58

0.56

0.46

0.48

XXX exam, subsequent. 92230......... ........ A

Eye exam with

0.60

0.73

1.33

0.21

0.20

0.02

1.35

1.95

0.83

0.82

XXX photos. 92235......... ........ A

Eye exam with

0.81

2.33

2.54

NA

NA

0.08

3.22

3.43

NA

NA

XXX photos. 92235......... 26...... A

Eye exam with

0.81

0.30

0.35

0.30

0.35

0.02

1.13

1.18

1.13

1.18

XXX photos. 92235......... TC...... A

Eye exam with

0.00

2.02

2.19

NA

NA

0.06

2.08

2.25

NA

NA

XXX photos. 92240......... ........ A

Icg angiography 1.10

4.51

5.70

NA

NA

0.09

5.70

6.89

NA

NA

XXX 92240......... 26...... A

Icg angiography 1.10

0.41

0.48

0.41

0.48

0.03

1.54

1.61

1.54

1.61

XXX 92240......... TC...... A

Icg angiography 0.00

4.09

5.22

NA

NA

0.06

4.15

5.28

NA

NA

XXX 92250......... ........ A

Eye exam with

0.44

1.34

1.48

NA

NA

0.02

1.80

1.94

NA

NA

XXX photos. 92250......... 26...... A

Eye exam with

0.44

0.15

0.18

0.15

0.18

0.01

0.60

0.63

0.60

0.63

XXX photos. 92250......... TC...... A

Eye exam with

0.00

1.19

1.30

NA

NA

0.01

1.20

1.31

NA

NA

XXX photos. 92260......... ........ A

Ophthalmoscopy/ 0.20

0.23

0.25

0.07

0.09

0.01

0.44

0.46

0.28

0.30

XXX dynamometry. 92265......... ........ A

Eye muscle

0.81

1.01

1.37

NA

NA

0.06

1.88

2.24

NA

NA

XXX evaluation. 92265......... 26...... A

Eye muscle

0.81

0.24

0.27

0.24

0.27

0.04

1.09

1.12

1.09

1.12

XXX evaluation. 92265......... TC...... A

Eye muscle

0.00

0.76

1.10

NA

NA

0.02

0.78

1.12

NA

NA

XXX evaluation. 92270......... ........ A

Electro-

0.81

1.42

1.50

NA

NA

0.05

2.28

2.36

NA

NA

XXX oculography. 92270......... 26...... A

Electro-

0.81

0.24

0.31

0.24

0.31

0.03

1.08

1.15

1.08

1.15

XXX oculography. 92270......... TC...... A

Electro-

0.00

1.17

1.19

NA

NA

0.02

1.19

1.21

NA

NA

XXX oculography. 92275......... ........ A

Electroretinogr 1.01

2.48

2.07

NA

NA

0.05

3.54

3.13

NA

NA

XXX aphy. 92275......... 26...... A

Electroretinogr 1.01

0.36

0.41

0.36

0.41

0.03

1.40

1.45

1.40

1.45

XXX aphy. 92275......... TC...... A

Electroretinogr 0.00

2.12

1.66

NA

NA

0.02

2.14

1.68

NA

NA

XXX aphy. 92283......... ........ A

Color vision

0.17

1.02

0.89

NA

NA

0.02

1.21

1.08

NA

NA

XXX examination. 92283......... 26...... A

Color vision

0.17

0.05

0.07

0.05

0.07

0.01

0.23

0.25

0.23

0.25

XXX examination. 92283......... TC...... A

Color vision

0.00

0.96

0.82

NA

NA

0.01

0.97

0.83

NA

NA

XXX examination. 92284......... ........ A

Dark adaptation 0.24

1.25

1.72

NA

NA

0.02

1.51

1.98

NA

NA

XXX eye exam. 92284......... 26...... A

Dark adaptation 0.24

0.09

0.08

0.09

0.08

0.01

0.34

0.33

0.34

0.33

XXX eye exam. 92284......... TC...... A

Dark adaptation 0.00

1.16

1.64

NA

NA

0.01

1.17

1.65

NA

NA

XXX eye exam. 92285......... ........ A

Eye photography 0.20

0.82

0.95

NA

NA

0.02

1.04

1.17

NA

NA

XXX 92285......... 26...... A

Eye photography 0.20

0.07

0.09

0.07

0.09

0.01

0.28

0.30

0.28

0.30

XXX 92285......... TC...... A

Eye photography 0.00

0.75

0.86

NA

NA

0.01

0.76

0.87

NA

NA

XXX 92286......... ........ A

Internal eye

0.66

2.16

2.83

NA

NA

0.04

2.86

3.53

NA

NA

XXX photography. 92286......... 26...... A

Internal eye

0.66

0.24

0.28

0.24

0.28

0.02

0.92

0.96

0.92

0.96

XXX photography. 92286......... TC...... A

Internal eye

0.00

1.92

2.55

NA

NA

0.02

1.94

2.57

NA

NA

XXX photography. 92287......... ........ A

Internal eye

0.81

1.98

2.28

0.30

0.31

0.02

2.81

3.11

1.13

1.14

XXX photography. 92310......... ........ N

Contact lens

1.17

1.07

1.11

0.27

0.41

0.04

2.28

2.32

1.48

1.62

XXX fitting. 92311......... ........ A

Contact lens

1.08

1.31

1.15

0.32

0.34

0.03

2.42

2.26

1.43

1.45

XXX fitting. 92312......... ........ A

Contact lens

1.26

1.51

1.19

0.36

0.47

0.03

2.80

2.48

1.65

1.76

XXX fitting. 92313......... ........ A

Contact lens

0.92

1.49

1.17

0.33

0.30

0.02

2.43

2.11

1.27

1.24

XXX fitting. 92314......... ........ N

Prescription of 0.69

1.15

0.99

0.16

0.24

0.01

1.85

1.69

0.86

0.94

XXX contact lens.

[[Page 49217]]

92315......... ........ A

Prescription of 0.45

1.35

0.98

0.13

0.15

0.01

1.81

1.44

0.59

0.61

XXX contact lens. 92316......... ........ A

Prescription of 0.68

1.69

1.11

0.24

0.28

0.02

2.39

1.81

0.94

0.98

XXX contact lens. 92317......... ........ A

Prescription of 0.45

1.46

1.07

0.14

0.15

0.01

1.92

1.53

0.60

0.61

XXX contact lens. 92325......... ........ A

Modification of 0.00

0.85

0.51

NA

NA

0.01

0.86

0.52

NA

NA

XXX contact lens. 92326......... ........ A

Replacement of

0.00

0.76

1.41

NA

NA

0.06

0.82

1.47

NA

NA

XXX contact lens. 92340......... ........ N

Fitting of

0.37

0.45

0.64

0.09

0.13

0.01

0.83

1.02

0.47

0.51

XXX spectacles. 92341......... ........ N

Fitting of

0.47

0.47

0.67

0.11

0.16

0.01

0.95

1.15

0.59

0.64

XXX spectacles. 92342......... ........ N

Fitting of

0.53

0.48

0.69

0.12

0.19

0.01

1.02

1.23

0.66

0.73

XXX spectacles. 92352......... ........ B

Special

0.37

0.57

0.65

0.09

0.13

0.01

0.95

1.03

0.47

0.51

XXX spectacles fitting. 92353......... ........ B

Special

0.50

0.60

0.70

0.12

0.17

0.02

1.12

1.22

0.64

0.69

XXX spectacles fitting. 92354......... ........ B

Special

0.00

0.29

6.72

NA

NA

0.10

0.39

6.82

NA

NA

XXX spectacles fitting. 92355......... ........ B

Special

0.00

0.45

3.36

NA

NA

0.01

0.46

3.37

NA

NA

XXX spectacles fitting. 92358......... ........ B

Eye prosthesis

0.00

0.24

0.79

NA

NA

0.05

0.29

0.84

NA

NA

XXX service. 92370......... ........ N

Repair & adjust 0.32

0.39

0.51

0.07

0.12

0.02

0.73

0.85

0.41

0.46

XXX spectacles. 92371......... ........ B

Repair & adjust 0.00

0.24

0.53

NA

NA

0.02

0.26

0.55

NA

NA

XXX spectacles. 92499......... ........ C

Eye service or

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 92499......... 26...... C

Eye service or

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 92499......... TC...... C

Eye service or

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 92502......... ........ A

Ear and throat

1.51

NA

NA

0.77

1.03

0.05

NA

NA

2.33

2.59

000 examination. 92504......... ........ A

Ear microscopy

0.18

0.55

0.51

0.05

0.08

0.01

0.74

0.70

0.24

0.27

XXX examination. 92506......... ........ A

Speech/hearing

0.86

3.28

2.76

0.24

0.36

0.03

4.17

3.65

1.13

1.25

XXX evaluation. 92507......... ........ A

Speech/hearing

0.52

1.19

1.13

0.14

0.21

0.02

1.73

1.67

0.68

0.75

XXX therapy. 92508......... ........ A

Speech/hearing

0.26

0.52

0.51

0.08

0.11

0.01

0.79

0.78

0.35

0.38

XXX therapy. 92511......... ........ A

Nasopharyngosco 0.84

2.92

3.21

0.61

0.74

0.03

3.79

4.08

1.48

1.61

000 py. 92512......... ........ A

Nasal function

0.55

0.93

1.09

0.15

0.17

0.02

1.50

1.66

0.72

0.74

XXX studies. 92516......... ........ A

Facial nerve

0.43

1.15

1.19

0.12

0.20

0.01

1.59

1.63

0.56

0.64

XXX function test. 92520......... ........ A

Laryngeal

0.75

0.91

0.61

0.23

0.35

0.03

1.69

1.39

1.01

1.13

XXX function studies. 92526......... ........ A

Oral function

0.55

1.68

1.65

0.16

0.19

0.02

2.25

2.22

0.73

0.76

XXX therapy. 92541......... ........ A

Spontaneous

0.40

1.16

1.06

NA

NA

0.04

1.60

1.50

NA

NA

XXX nystagmus test. 92541......... 26...... A

Spontaneous

0.40

0.12

0.17

0.12

0.17

0.02

0.54

0.59

0.54

0.59

XXX nystagmus test. 92541......... TC...... A

Spontaneous

0.00

1.04

0.89

NA

NA

0.02

1.06

0.91

NA

NA

XXX nystagmus test. 92542......... ........ A

Positional

0.33

1.30

1.18

NA

NA

0.03

1.66

1.54

NA

NA

XXX nystagmus test. 92542......... 26...... A

Positional

0.33

0.10

0.15

0.10

0.15

0.01

0.44

0.49

0.44

0.49

XXX nystagmus test. 92542......... TC...... A

Positional

0.00

1.20

1.04

NA

NA

0.02

1.22

1.06

NA

NA

XXX nystagmus test. 92543......... ........ A

Caloric

0.10

0.66

0.59

NA

NA

0.02

0.78

0.71

NA

NA

XXX vestibular test. 92543......... 26...... A

Caloric

0.10

0.03

0.05

0.03

0.05

0.01

0.14

0.16

0.14

0.16

XXX vestibular test. 92543......... TC...... A

Caloric

0.00

0.63

0.55

NA

NA

0.01

0.64

0.56

NA

NA

XXX vestibular test. 92544......... ........ A

Optokinetic

0.26

1.06

0.94

NA

NA

0.03

1.35

1.23

NA

NA

XXX nystagmus test. 92544......... 26...... A

Optokinetic

0.26

0.08

0.11

0.08

0.11

0.01

0.35

0.38

0.35

0.38

XXX nystagmus test. 92544......... TC...... A

Optokinetic

0.00

0.98

0.83

NA

NA

0.02

1.00

0.85

NA

NA

XXX nystagmus test. 92545......... ........ A

Oscillating

0.23

1.03

0.86

NA

NA

0.03

1.29

1.12

NA

NA

XXX tracking test. 92545......... 26...... A

Oscillating

0.23

0.07

0.10

0.07

0.10

0.01

0.31

0.34

0.31

0.34

XXX tracking test. 92545......... TC...... A

Oscillating

0.00

0.96

0.76

NA

NA

0.02

0.98

0.78

NA

NA

XXX tracking test. 92546......... ........ A

Sinusoidal

0.29

1.90

1.96

NA

NA

0.03

2.22

2.28

NA

NA

XXX rotational test. 92546......... 26...... A

Sinusoidal

0.29

0.09

0.12

0.09

0.12

0.01

0.39

0.42

0.39

0.42

XXX rotational test. 92546......... TC...... A

Sinusoidal

0.00

1.81

1.84

NA

NA

0.02

1.83

1.86

NA

NA

XXX rotational test. 92547......... ........ A

Supplemental

0.00

0.11

0.09

0.11

0.09

0.06

0.17

0.15

0.17

0.15

ZZZ electrical test. 92548......... ........ A

Posturography.. 0.50

1.72

2.12

NA

NA

0.15

2.37

2.77

NA

NA

XXX 92548......... 26...... A

Posturography.. 0.50

0.15

0.23

0.15

0.23

0.02

0.67

0.75

0.67

0.75

XXX 92548......... TC...... A

Posturography.. 0.00

1.57

1.89

NA

NA

0.13

1.70

2.02

NA

NA

XXX 92552......... ........ A

Pure tone

0.00

0.56

0.47

NA

NA

0.04

0.60

0.51

NA

NA

XXX audiometry, air. 92553......... ........ A

Audiometry, air 0.00

0.71

0.67

NA

NA

0.06

0.77

0.73

NA

NA

XXX & bone. 92555......... ........ A

Speech

0.00

0.38

0.38

NA

NA

0.04

0.42

0.42

NA

NA

XXX threshold audiometry. 92556......... ........ A

Speech

0.00

0.52

0.56

NA

NA

0.06

0.58

0.62

NA

NA

XXX audiometry, complete. 92557......... ........ A

Comprehensive

0.00

1.27

1.21

NA

NA

0.12

1.39

1.33

NA

NA

XXX hearing test. 92561......... ........ A

Bekesy

0.00

0.79

0.74

NA

NA

0.06

0.85

0.80

NA

NA

XXX audiometry, diagnosis. 92562......... ........ A

Loudness

0.00

0.67

0.48

NA

NA

0.04

0.71

0.52

NA

NA

XXX balance test. 92563......... ........ A

Tone decay

0.00

0.53

0.42

NA

NA

0.04

0.57

0.46

NA

NA

XXX hearing test. 92564......... ........ A

Sisi hearing

0.00

0.51

0.48

NA

NA

0.05

0.56

0.53

NA

NA

XXX test. 92565......... ........ A

Stenger test,

0.00

0.27

0.37

NA

NA

0.04

0.31

0.41

NA

NA

XXX pure tone. 92567......... ........ A

Tympanometry... 0.00

0.50

0.52

NA

NA

0.06

0.56

0.58

NA

NA

XXX 92568......... ........ A

Acoustic refl

0.00

0.15

0.32

NA

NA

0.04

0.19

0.36

NA

NA

XXX threshold tst. 92569......... ........ A

Acoustic reflex 0.00

0.16

0.35

NA

NA

0.04

0.20

0.39

NA

NA

XXX decay test. 92571......... ........ A

Filtered speech 0.00

0.40

0.39

NA

NA

0.04

0.44

0.43

NA

NA

XXX hearing test. 92572......... ........ A

Staggered

0.00

0.61

0.22

NA

NA

0.01

0.62

0.23

NA

NA

XXX spondaic word test. 92573......... ........ A

Lombard test... 0.00

0.49

0.39

NA

NA

0.04

0.53

0.43

NA

NA

XXX

[[Page 49218]]

92575......... ........ A

Sensorineural

0.00

1.10

0.50

NA

NA

0.02

1.12

0.52

NA

NA

XXX acuity test. 92576......... ........ A

Synthetic

0.00

0.54

0.47

NA

NA

0.05

0.59

0.52

NA

NA

XXX sentence test. 92577......... ........ A

Stenger test,

0.00

0.28

0.61

NA

NA

0.07

0.35

0.68

NA

NA

XXX speech. 92579......... ........ A

Visual

0.00

0.84

0.76

NA

NA

0.06

0.90

0.82

NA

NA

XXX audiometry (vra). 92582......... ........ A

Conditioning

0.00

1.08

0.82

NA

NA

0.06

1.14

0.88

NA

NA

XXX play audiometry. 92583......... ........ A

Select picture

0.00

0.70

0.84

NA

NA

0.08

0.78

0.92

NA

NA

XXX audiometry. 92584......... ........ A

Electrocochleog 0.00

1.28

2.17

NA

NA

0.21

1.49

2.38

NA

NA

XXX raphy. 92585......... ........ A

Auditor evoke

0.50

2.01

2.05

NA

NA

0.17

2.68

2.72

NA

NA

XXX potent, compre. 92585......... 26...... A

Auditor evoke

0.50

0.15

0.20

0.15

0.20

0.03

0.68

0.73

0.68

0.73

XXX potent, compre. 92585......... TC...... A

Auditor evoke

0.00

1.86

1.85

NA

NA

0.14

2.00

1.99

NA

NA

XXX potent, compre. 92586......... ........ A

Auditor evoke

0.00

1.41

1.74

NA

NA

0.14

1.55

1.88

NA

NA

XXX potent, limit. 92587......... ........ A

Evoked auditory 0.13

0.61

1.18

NA

NA

0.12

0.86

1.43

NA

NA

XXX test. 92587......... 26...... A

Evoked auditory 0.13

0.04

0.06

0.04

0.06

0.01

0.18

0.20

0.18

0.20

XXX test. 92587......... TC...... A

Evoked auditory 0.00

0.58

1.13

NA

NA

0.11

0.69

1.24

NA

NA

XXX test. 92588......... ........ A

Evoked auditory 0.36

1.05

1.49

NA

NA

0.14

1.55

1.99

NA

NA

XXX test. 92588......... 26...... A

Evoked auditory 0.36

0.11

0.15

0.11

0.15

0.01

0.48

0.52

0.48

0.52

XXX test. 92588......... TC...... A

Evoked auditory 0.00

0.95

1.34

NA

NA

0.13

1.08

1.47

NA

NA

XXX test. 92596......... ........ A

Ear protector

0.00

0.93

0.68

NA

NA

0.06

0.99

0.74

NA

NA

XXX evaluation. 92597......... ........ A

Oral speech

0.86

1.69

1.69

0.24

0.40

0.03

2.58

2.58

1.13

1.29

XXX device eval. 92601......... ........ A

Cochlear implt

0.00

4.87

3.84

NA

NA

0.07

4.94

3.91

NA

NA

XXX f/up exam . 92604......... ........ A

Reprogram

0.00

2.09

1.54

NA

NA

0.07

2.16

1.61

NA

NA

XXX cochlear implt 7 >. 92607......... ........ A

Ex for speech

0.00

4.28

3.38

NA

NA

0.05

4.33

3.43

NA

NA

XXX device rx, 1hr. 92608......... ........ A

Ex for speech

0.00

0.87

0.63

NA

NA

0.05

0.92

0.68

NA

NA

XXX device rx addl. 92609......... ........ A

Use of speech

0.00

2.30

1.77

NA

NA

0.04

2.34

1.81

NA

NA

XXX device service. 92610......... ........ A

Evaluate

0.00

1.62

2.98

NA

NA

0.08

1.70

3.06

NA

NA

XXX swallowing function. 92611......... ........ A

Motion

0.00

1.90

3.05

NA

NA

0.08

1.98

3.13

NA

NA

XXX fluoroscopy/ swallow. 92612......... ........ A

Endoscopy

1.27

2.74

2.74

0.36

0.59

0.04

4.05

4.05

1.67

1.90

XXX swallow tst (fees). 92613......... ........ A

Endoscopy

0.71

0.22

0.36

0.22

0.35

0.05

0.98

1.12

0.98

1.11

XXX swallow tst (fees). 92614......... ........ A

Laryngoscopic

1.27

2.23

2.43

0.36

0.59

0.04

3.54

3.74

1.67

1.90

XXX sensory test. 92615......... ........ A

Eval

0.63

0.18

0.31

0.18

0.31

0.05

0.86

0.99

0.86

0.99

XXX laryngoscopy sense tst. 92616......... ........ A

Fees w/

1.88

2.91

3.27

0.53

0.88

0.06

4.85

5.21

2.47

2.82

XXX laryngeal sense test. 92617......... ........ A

Interprt fees/

0.79

0.22

0.39

0.22

0.39

0.05

1.06

1.23

1.06

1.23

XXX laryngeal test. 92620......... ........ A

Auditory

0.00

1.87

1.32

NA

NA

0.06

1.93

1.38

NA

NA

XXX function, 60 min. 92621......... ........ A

Auditory

0.00

0.40

0.29

NA

NA

0.06

0.46

0.35

NA

NA

ZZZ function, + 15 min. 92625......... ........ A

Tinnitus

0.00

1.82

1.30

1.82

1.30

0.06

1.88

1.36

1.88

1.36

XXX assessment. 92626......... ........ A

Eval aud rehab

0.00

1.85

2.11

NA

NA

0.06

1.91

2.17

NA

NA

XXX status. 92627......... ........ A

Eval aud status 0.00

0.42

0.52

0.42

0.52

0.02

0.44

0.54

0.44

0.54

ZZZ rehab add-on. 92700......... ........ C

Ent procedure/

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX service. 92950......... ........ A

Heart/lung

3.79

3.24

3.96

0.77

0.92

0.28

7.31

8.03

4.84

4.99

000 resuscitation cpr. 92953......... ........ A

Temporary

0.23

NA

NA

0.07

0.07

0.02

NA

NA

0.32

0.32

000 external pacing. 92960......... ........ A

Cardioversion

2.25

4.42

5.84

1.47

1.25

0.07

6.74

8.16

3.79

3.57

000 electric, ext. 92961......... ........ A

Cardioversion,

4.59

NA

NA

2.49

2.18

0.29

NA

NA

7.37

7.06

000 electric, int. 92970......... ........ A

Cardioassist,

3.51

NA

NA

1.61

1.20

0.16

NA

NA

5.28

4.87

000 internal. 92971......... ........ A

Cardioassist,

1.77

NA

NA

1.08

0.91

0.06

NA

NA

2.91

2.74

000 external. 92973......... ........ A

Percut coronary 3.28

NA

NA

1.79

1.42

0.23

NA

NA

5.30

4.93

ZZZ thrombectomy. 92974......... ........ A

Cath place,

3.00

NA

NA

1.67

1.30

0.21

NA

NA

4.88

4.51

ZZZ cardio brachytx. 92975......... ........ A

Dissolve clot,

7.24

NA

NA

3.88

3.08

0.50

NA

NA

11.62

10.82

000 heart vessel. 92977......... ........ A

Dissolve clot,

0.00

1.73

6.47

NA

NA

0.46

2.19

6.93

NA

NA

XXX heart vessel. 92978......... ........ A

Intravasc us,

1.80

NA

NA

NA

NA

0.30

NA

NA

NA

NA

ZZZ heart add-on. 92978......... 26...... A

Intravasc us,

1.80

0.98

0.78

0.98

0.78

0.06

2.84

2.64

2.84

2.64

ZZZ heart add-on. 92978......... TC...... A

Intravasc us,

0.00

NA

NA

NA

NA

0.24

NA

NA

NA

NA

ZZZ heart add-on. 92979......... ........ A

Intravasc us,

1.44

NA

NA

NA

NA

0.19

NA

NA

NA

NA

ZZZ heart add-on. 92979......... 26...... A

Intravasc us,

1.44

0.78

0.62

0.78

0.62

0.06

2.28

2.12

2.28

2.12

ZZZ heart add-on. 92979......... TC...... A

Intravasc us,

0.00

NA

NA

NA

NA

0.13

NA

NA

NA

NA

ZZZ heart add-on.

[[Page 49219]]

92980......... ........ A

Insert

14.82

NA

NA

8.29

6.61

1.03

NA

NA

24.14

22.46

000 intracoronary stent. 92981......... ........ A

Insert

4.16

NA

NA

2.27

1.79

0.29

NA

NA

6.72

6.24

ZZZ intracoronary stent. 92982......... ........ A

Coronary artery 10.96

NA

NA

6.20

4.95

0.76

NA

NA

17.92

16.67

000 dilation. 92984......... ........ A

Coronary artery 2.97

NA

NA

1.61

1.27

0.21

NA

NA

4.79

4.45

ZZZ dilation. 92986......... ........ A

Revision of

22.64

NA

NA

15.66

12.79

1.51

NA

NA

39.81

36.94

090 aortic valve. 92987......... ........ A

Revision of

23.42

NA

NA

16.09

13.18

1.59

NA

NA

41.10

38.19

090 mitral valve. 92990......... ........ A

Revision of

18.06

NA

NA

11.18

10.14

1.20

NA

NA

30.44

29.40

090 pulmonary valve. 92992......... ........ C

Revision of

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 heart chamber. 92993......... ........ C

Revision of

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

090 heart chamber. 92995......... ........ A

Coronary

12.07

NA

NA

6.81

5.42

0.84

NA

NA

19.72

18.33

000 atherectomy. 92996......... ........ A

Coronary

3.26

NA

NA

1.78

1.40

0.10

NA

NA

5.14

4.76

ZZZ atherectomy add-on. 92997......... ........ A

Pul art balloon 11.98

NA

NA

5.18

4.91

0.40

NA

NA

17.56

17.29

000 repr, percut. 92998......... ........ A

Pul art balloon 5.99

NA

NA

2.74

2.34

0.28

NA

NA

9.01

8.61

ZZZ repr, percut. 93000......... ........ A

Electrocardiogr 0.17

0.35

0.47

0.35

0.47

0.03

0.55

0.67

0.55

0.67

XXX am, complete. 93005......... ........ A

Electrocardiogr 0.00

0.28

0.41

NA

NA

0.02

0.30

0.43

NA

NA

XXX am, tracing. 93010......... ........ A

Electrocardiogr 0.17

0.07

0.06

0.07

0.06

0.01

0.25

0.24

0.25

0.24

XXX am report. 93012......... ........ A

Transmission of 0.00

1.65

4.92

NA

NA

0.18

1.83

5.10

NA

NA

XXX ecg. 93014......... ........ A

Report on

0.52

0.21

0.20

0.21

0.20

0.02

0.75

0.74

0.75

0.74

XXX transmitted ecg. 93015......... ........ A

Cardiovascular

0.75

1.93

1.95

1.93

1.95

0.14

2.82

2.84

2.82

2.84

XXX stress test. 93016......... ........ A

Cardiovascular

0.45

0.23

0.19

0.23

0.19

0.02

0.70

0.66

0.70

0.66

XXX stress test. 93017......... ........ A

Cardiovascular

0.00

1.55

1.65

NA

NA

0.11

1.66

1.76

NA

NA

XXX stress test. 93018......... ........ A

Cardiovascular

0.30

0.15

0.12

0.15

0.12

0.01

0.46

0.43

0.46

0.43

XXX stress test. 93024......... ........ A

Cardiac drug

1.17

2.42

1.78

NA

NA

0.12

3.71

3.07

NA

NA

XXX stress test. 93024......... 26...... A

Cardiac drug

1.17

0.59

0.49

0.59

0.49

0.04

1.80

1.70

1.80

1.70

XXX stress test. 93024......... TC...... A

Cardiac drug

0.00

1.84

1.30

NA

NA

0.08

1.92

1.38

NA

NA

XXX stress test. 93025......... ........ A

Microvolt t-

0.75

3.94

6.68

NA

NA

0.14

4.83

7.57

NA

NA

XXX wave assess. 93025......... 26...... A

Microvolt t-

0.75

0.38

0.31

0.38

0.31

0.03

1.16

1.09

1.16

1.09

XXX wave assess. 93025......... TC...... A

Microvolt t-

0.00

3.56

6.37

NA

NA

0.11

3.67

6.48

NA

NA

XXX wave assess. 93040......... ........ A

Rhythm ECG with 0.16

0.19

0.20

0.19

0.20

0.02

0.37

0.38

0.37

0.38

XXX report. 93041......... ........ A

Rhythm ECG,

0.00

0.14

0.15

NA

NA

0.01

0.15

0.16

NA

NA

XXX tracing. 93042......... ........ A

Rhythm ECG,

0.16

0.05

0.05

0.05

0.05

0.01

0.22

0.22

0.22

0.22

XXX report. 93224......... ........ A

ECG monitor/

0.52

1.99

3.21

1.99

3.21

0.24

2.75

3.97

2.75

3.97

XXX report, 24 hrs. 93225......... ........ A

ECG monitor/

0.00

1.08

1.20

NA

NA

0.08

1.16

1.28

NA

NA

XXX record, 24 hrs. 93226......... ........ A

ECG monitor/

0.00

0.62

1.79

NA

NA

0.14

0.76

1.93

NA

NA

XXX report, 24 hrs. 93227......... ........ A

ECG monitor/

0.52

0.28

0.21

0.28

0.21

0.02

0.82

0.75

0.82

0.75

XXX review, 24 hrs. 93230......... ........ A

ECG monitor/

0.52

1.79

3.37

1.79

3.37

0.26

2.57

4.15

2.57

4.15

XXX report, 24 hrs. 93231......... ........ A

Ecg monitor/

0.00

0.94

1.38

NA

NA

0.11

1.05

1.49

NA

NA

XXX record, 24 hrs. 93232......... ........ A

ECG monitor/

0.00

0.62

1.79

NA

NA

0.13

0.75

1.92

NA

NA

XXX report, 24 hrs. 93233......... ........ A

ECG monitor/

0.52

0.23

0.20

0.23

0.20

0.02

0.77

0.74

0.77

0.74

XXX review, 24 hrs. 93235......... ........ A

ECG monitor/

0.45

0.21

2.14

0.21

2.14

0.16

0.82

2.75

0.82

2.75

XXX report, 24 hrs. 93236......... ........ C

ECG monitor/

0.00

0.00

0.00

NA

NA

0.00

0.00

0.00

NA

NA

XXX report, 24 hrs. 93237......... ........ A

ECG monitor/

0.45

0.21

0.17

0.21

0.17

0.02

0.68

0.64

0.68

0.64

XXX review, 24 hrs. 93268......... ........ A

ECG record/

0.52

0.83

5.79

0.83

5.79

0.28

1.63

6.59

1.63

6.59

XXX review. 93270......... ........ A

ECG recording.. 0.00

0.31

1.01

NA

NA

0.08

0.39

1.09

NA

NA

XXX 93271......... ........ A

Ecg/monitoring

0.00

1.99

5.01

NA

NA

0.18

2.17

5.19

NA

NA

XXX and analysis. 93272......... ........ A

Ecg/review,

0.52

0.24

0.20

0.24

0.20

0.02

0.78

0.74

0.78

0.74

XXX interpret only. 93278......... ........ A

ECG/signal-

0.25

0.59

1.09

NA

NA

0.12

0.96

1.46

NA

NA

XXX averaged. 93278......... 26...... A

ECG/signal-

0.25

0.10

0.10

0.10

0.10

0.01

0.36

0.36

0.36

0.36

XXX averaged. 93278......... TC...... A

ECG/signal-

0.00

0.49

0.99

NA

NA

0.11

0.60

1.10

NA

NA

XXX averaged. 93303......... ........ A

Echo

1.30

4.65

4.42

NA

NA

0.27

6.22

5.99

NA

NA

XXX transthoracic. 93303......... 26...... A

Echo

1.30

0.57

0.50

0.57

0.50

0.04

1.91

1.84

1.91

1.84

XXX transthoracic. 93303......... TC...... A

Echo

0.00

4.07

3.91

NA

NA

0.23

4.30

4.14

NA

NA

XXX transthoracic. 93304......... ........ A

Echo

0.75

3.18

2.46

NA

NA

0.15

4.08

3.36

NA

NA

XXX transthoracic. 93304......... 26...... A

Echo

0.75

0.31

0.29

0.31

0.29

0.02

1.08

1.06

1.08

1.06

XXX transthoracic. 93304......... TC...... A

Echo

0.00

2.87

2.17

NA

NA

0.13

3.00

2.30

NA

NA

XXX transthoracic. 93307......... ........ A

Echo exam of

0.92

3.78

4.10

NA

NA

0.26

4.96

5.28

NA

NA

XXX heart. 93307......... 26...... A

Echo exam of

0.92

0.46

0.38

0.46

0.38

0.03

1.41

1.33

1.41

1.33

XXX heart. 93307......... TC...... A

Echo exam of

0.00

3.32

3.73

NA

NA

0.23

3.55

3.96

NA

NA

XXX heart. 93308......... ........ A

Echo exam of

0.53

2.65

2.27

NA

NA

0.15

3.33

2.95

NA

NA

XXX heart. 93308......... 26...... A

Echo exam of

0.53

0.27

0.22

0.27

0.22

0.02

0.82

0.77

0.82

0.77

XXX heart. 93308......... TC...... A

Echo exam of

0.00

2.38

2.05

NA

NA

0.13

2.51

2.18

NA

NA

XXX heart. 93312......... ........ A

Echo

2.20

7.55

5.32

NA

NA

0.37 10.12

7.89

NA

NA

XXX transesophagea l. 93312......... 26...... A

Echo

2.20

1.01

0.85

1.01

0.85

0.08

3.29

3.13

3.29

3.13

XXX transesophagea l. 93312......... TC...... A

Echo

0.00

6.54

4.47

NA

NA

0.29

6.83

4.76

NA

NA

XXX transesophagea l. 93313......... ........ A

Echo

0.95

NA

NA

0.14

0.19

0.06

NA

NA

1.15

1.20

XXX transesophagea l. 93314......... ........ A

Echo

1.25

7.28

5.01

NA

NA

0.33

8.86

6.59

NA

NA

XXX transesophagea l.

[[Page 49220]]

93314......... 26...... A

Echo

1.25

0.57

0.50

0.57

0.50

0.04

1.86

1.79

1.86

1.79

XXX transesophagea l. 93314......... TC...... A

Echo

0.00

6.71

4.51

NA

NA

0.29

7.00

4.80

NA

NA

XXX transesophagea l. 93315......... ........ C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX transesophagea l. 93315......... 26...... A

Echo

2.78

1.32

1.09

1.32

1.09

0.09

4.19

3.96

4.19

3.96

XXX transesophagea l. 93315......... TC...... C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX transesophagea l. 93316......... ........ A

Echo

0.95

NA

NA

0.26

0.25

0.05

NA

NA

1.26

1.25

XXX transesophagea l. 93317......... ........ C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX transesophagea l. 93317......... 26...... A

Echo

1.83

0.74

0.69

0.74

0.69

0.08

2.65

2.60

2.65

2.60

XXX transesophagea l. 93317......... TC...... C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX transesophagea l. 93318......... ........ C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX transesophagea l intraop. 93318......... 26...... A

Echo

2.20

0.89

0.58

0.89

0.58

0.14

3.23

2.92

3.23

2.92

XXX transesophagea l intraop. 93318......... TC...... C

Echo

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX transesophagea l intraop. 93320......... ........ A

Doppler echo

0.38

1.70

1.81

1.70

1.81

0.13

2.21

2.32

2.21

2.32

ZZZ exam, heart. 93320......... 26...... A

Doppler echo

0.38

0.19

0.16

0.19

0.16

0.01

0.58

0.55

0.58

0.55

ZZZ exam, heart. 93320......... TC...... A

Doppler echo

0.00

1.51

1.66

1.51

1.66

0.12

1.63

1.78

1.63

1.78

ZZZ exam, heart. 93321......... ........ A

Doppler echo

0.15

0.62

1.03

0.62

1.03

0.09

0.86

1.27

0.86

1.27

ZZZ exam, heart. 93321......... 26...... A

Doppler echo

0.15

0.08

0.07

0.08

0.07

0.01

0.24

0.23

0.24

0.23

ZZZ exam, heart. 93321......... TC...... A

Doppler echo

0.00

0.55

0.97

0.55

0.97

0.08

0.63

1.05

0.63

1.05

ZZZ exam, heart. 93325......... ........ A

Doppler color

0.07

0.67

2.37

0.67

2.37

0.22

0.96

2.66

0.96

2.66

ZZZ flow add-on. 93325......... 26...... A

Doppler color

0.07

0.04

0.03

0.04

0.03

0.01

0.12

0.11

0.12

0.11

ZZZ flow add-on. 93325......... TC...... A

Doppler color

0.00

0.64

2.34

0.64

2.34

0.21

0.85

2.55

0.85

2.55

ZZZ flow add-on. 93350......... ........ A

Echo

1.48

5.16

3.04

NA

NA

0.18

6.82

4.70

NA

NA

XXX transthoracic. 93350......... 26...... A

Echo

1.48

0.78

0.62

0.78

0.62

0.05

2.31

2.15

2.31

2.15

XXX transthoracic. 93350......... TC...... A

Echo

0.00

4.38

2.42

NA

NA

0.13

4.51

2.55

NA

NA

XXX transthoracic. 93501......... ........ A

Right heart

3.02 23.11

19.32

23.11

19.32

1.26 27.39

23.60

27.39

23.60

000 catheterizatio n. 93501......... 26...... A

Right heart

3.02

1.61

1.27

1.61

1.27

0.21

4.84

4.50

4.84

4.50

000 catheterizatio n. 93501......... TC...... A

Right heart

0.00 21.49

18.05

21.49

18.05

1.05 22.54

19.10

22.54

19.10

000 catheterizatio n. 93503......... ........ A

Insert/place

2.91

NA

NA

0.49

0.63

0.20

NA

NA

3.60

3.74

000 heart catheter. 93505......... ........ A

Biopsy of heart 4.37 25.12

9.03

25.12

9.03

0.46 29.95

13.86

29.95

13.86

000 lining. 93505......... 26...... A

Biopsy of heart 4.37

2.33

1.84

2.33

1.84

0.30

7.00

6.51

7.00

6.51

000 lining. 93505......... TC...... A

Biopsy of heart 0.00 22.78

7.18

22.78

7.18

0.16 22.94

7.34

22.94

7.34

000 lining. 93508......... ........ A

Cath placement, 4.09 18.46

15.63

18.46

15.63

0.93 23.48

20.65

23.48

20.65

000 angiography. 93508......... 26...... A

Cath placement, 4.09

2.23

2.12

2.23

2.12

0.28

6.60

6.49

6.60

6.49

000 angiography. 93508......... TC...... A

Cath placement, 0.00 16.23

13.51

16.23

13.51

0.65 16.88

14.16

16.88

14.16

000 angiography. 93510......... ........ C

Left heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 catheterizatio n. 93510......... 26...... A

Left heart

4.32

2.35

2.22

2.35

2.22

0.30

6.97

6.84

6.97

6.84

000 catheterizatio n. 93510......... TC...... C

Left heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 catheterizatio n. 93511......... ........ C

Left heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheterizatio n. 93511......... 26...... A

Left heart

5.02

2.66

2.50

2.66

2.50

0.35

8.03

7.87

8.03

7.87

000 catheterizatio n. 93511......... TC...... C

Left heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheterizatio n. 93514......... ........ C

Left heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 catheterizatio n. 93514......... 26...... A

Left heart

7.04

3.22

3.15

3.22

3.15

0.49 10.75

10.68

10.75

10.68

000 catheterizatio n. 93514......... TC...... C

Left heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 catheterizatio n. 93524......... ........ C

Left heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheterizatio n. 93524......... 26...... A

Left heart

6.94

3.72

3.31

3.72

3.31

0.48 11.14

10.73

11.14

10.73

000 catheterizatio n. 93524......... TC...... C

Left heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheterizatio n. 93526......... ........ C

Rt & Lt heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 catheters. 93526......... 26...... A

Rt & Lt heart

5.98

3.25

2.92

3.25

2.92

0.42

9.65

9.32

9.65

9.32

000 catheters. 93526......... TC...... C

Rt & Lt heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 catheters. 93527......... ........ C

Rt & Lt heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheters. 93527......... 26...... A

Rt & Lt heart

7.27

3.99

3.48

3.99

3.48

0.51 11.77

11.26

11.77

11.26

000 catheters. 93527......... TC...... C

Rt & Lt heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheters. 93528......... ........ C

Rt & Lt heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheters. 93528......... 26...... A

Rt & Lt heart

8.99

4.69

4.20

4.69

4.20

0.62 14.30

13.81

14.30

13.81

000 catheters. 93528......... TC...... C

Rt & Lt heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheters. 93529......... ........ C

Rt, lt heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheterizatio n.

[[Page 49221]]

93529......... 26...... A

Rt, lt heart

4.79

2.62

2.36

2.62

2.36

0.33

7.74

7.48

7.74

7.48

000 catheterizatio n. 93529......... TC...... C

Rt, lt heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 catheterizatio n. 93530......... ........ C

Rt heart cath,

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 congenital. 93530......... 26...... A

Rt heart cath,

4.22

1.84

1.91

1.84

1.91

0.29

6.35

6.42

6.35

6.42

000 congenital. 93530......... TC...... C

Rt heart cath,

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 congenital. 93531......... ........ C

R & l heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 cath, congenital. 93531......... 26...... A

R & l heart

8.34

3.72

3.62

3.72

3.62

0.58 12.64

12.54

12.64

12.54

000 cath, congenital. 93531......... TC...... C

R & l heart

0.00

NA

NA

0.00

0.00

0.00

NA

NA

0.00

0.00

000 cath, congenital. 93532......... ........ C

R & l heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 cath, congenital. 93532......... 26...... A

R & l heart

9.99

4.60

4.34

4.60

4.34

0.69 15.28

15.02

15.28

15.02

000 cath, congenital. 93532......... TC...... C

R & l heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 cath, congenital. 93533......... ........ C

R & l heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 cath, congenital. 93533......... 26...... A

R & l heart

6.69

3.03

2.85

3.03

2.85

0.47 10.19

10.01

10.19

10.01

000 cath, congenital. 93533......... TC...... C

R & l heart

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 cath, congenital. 93539......... ........ A

Injection,

0.40

NA

NA

0.22

0.18

0.01

NA

NA

0.63

0.59

000 cardiac cath. 93540......... ........ A

Injection,

0.43

NA

NA

0.24

0.19

0.01

NA

NA

0.68

0.63

000 cardiac cath. 93541......... ........ A

Injection for

0.29

NA

NA

0.15

0.12

0.01

NA

NA

0.45

0.42

000 lung angiogram. 93542......... ........ A

Injection for

0.29

NA

NA

0.15

0.12

0.01

NA

NA

0.45

0.42

000 heart x-rays. 93543......... ........ A

Injection for

0.29

NA

NA

0.16

0.12

0.01

NA

NA

0.46

0.42

000 heart x-rays. 93544......... ........ A

Injection for

0.25

NA

NA

0.14

0.11

0.01

NA

NA

0.40

0.37

000 aortography. 93545......... ........ A

Inject for

0.40

NA

NA

0.22

0.18

0.01

NA

NA

0.63

0.59

000 coronary x- rays. 93555......... ........ A

Imaging,

0.81

0.65

5.11

NA

NA

0.37

1.83

6.29

NA

NA

XXX cardiac cath. 93555......... 26...... A

Imaging,

0.81

0.44

0.35

0.44

0.35

0.03

1.28

1.19

1.28

1.19

XXX cardiac cath. 93555......... TC...... A

Imaging,

0.00

0.21

4.76

NA

NA

0.34

0.55

5.10

NA

NA

XXX cardiac cath. 93556......... ........ A

Imaging,

0.83

0.93

7.89

NA

NA

0.54

2.30

9.26

NA

NA

XXX cardiac cath. 93556......... 26...... A

Imaging,

0.83

0.45

0.35

0.45

0.35

0.03

1.31

1.21

1.31

1.21

XXX cardiac cath. 93556......... TC...... A

Imaging,

0.00

0.48

7.54

NA

NA

0.51

0.99

8.05

NA

NA

XXX cardiac cath. 93561......... ........ A

Cardiac output

0.50

NA

NA

NA

NA

0.08

NA

NA

NA

NA

000 measurement. 93561......... 26...... A

Cardiac output

0.50

0.14

0.16

0.14

0.16

0.02

0.66

0.68

0.66

0.68

000 measurement. 93561......... TC...... A

Cardiac output

0.00

NA

NA

NA

NA

0.06

NA

NA

NA

NA

000 measurement. 93562......... ........ A

Cardiac output

0.16

NA

NA

NA

NA

0.05

NA

NA

NA

NA

000 measurement. 93562......... 26...... A

Cardiac output

0.16

0.03

0.05

0.03

0.05

0.01

0.20

0.22

0.20

0.22

000 measurement. 93562......... TC...... A

Cardiac output

0.00

NA

NA

NA

NA

0.04

NA

NA

NA

NA

000 measurement. 93571......... ........ A

Heart flow

1.80

NA

NA

NA

NA

0.30

NA

NA

NA

NA

ZZZ reserve measure. 93571......... 26...... A

Heart flow

1.80

0.98

0.76

0.98

0.76

0.06

2.84

2.62

2.84

2.62

ZZZ reserve measure. 93571......... TC...... A

Heart flow

0.00

NA

NA

NA

NA

0.24

NA

NA

NA

NA

ZZZ reserve measure. 93572......... ........ C

Heart flow

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ reserve measure. 93572......... 26...... A

Heart flow

1.44

0.74

0.56

0.74

0.56

0.04

2.22

2.04

2.22

2.04

ZZZ reserve measure. 93572......... TC...... C

Heart flow

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ reserve measure. 93580......... ........ A

Transcath

17.97

NA

NA

9.50

7.91

1.25

NA

NA

28.72

27.13

000 closure of asd. 93581......... ........ A

Transcath

24.39

NA

NA

13.17

10.34

1.71

NA

NA

39.27

36.44

000 closure of vsd. 93600......... ........ A

Bundle of His

2.12

NA

NA

NA

NA

0.29

NA

NA

NA

NA

000 recording. 93600......... 26...... A

Bundle of His

2.12

1.09

0.90

1.09

0.90

0.16

3.37

3.18

3.37

3.18

000 recording. 93600......... TC...... A

Bundle of His

0.00

NA

NA

NA

NA

0.13

NA

NA

NA

NA

000 recording. 93602......... ........ A

Intra-atrial

2.12

NA

NA

NA

NA

0.24

NA

NA

NA

NA

000 recording. 93602......... 26...... A

Intra-atrial

2.12

1.07

0.88

1.07

0.88

0.17

3.36

3.17

3.36

3.17

000 recording. 93602......... TC...... A

Intra-atrial

0.00

NA

NA

NA

NA

0.07

NA

NA

NA

NA

000 recording. 93603......... ........ A

Right

2.12

NA

NA

NA

NA

0.29

NA

NA

NA

NA

000 ventricular recording. 93603......... 26...... A

Right

2.12

1.06

0.87

1.06

0.87

0.18

3.36

3.17

3.36

3.17

000 ventricular recording. 93603......... TC...... A

Right

0.00

NA

NA

NA

NA

0.11

NA

NA

NA

NA

000 ventricular recording. 93609......... ........ A

Map

4.99

NA

NA

NA

NA

0.52

NA

NA

NA

NA

ZZZ tachycardia, add-on. 93609......... 26...... A

Map

4.99

2.68

2.13

2.68

2.13

0.35

8.02

7.47

8.02

7.47

ZZZ tachycardia, add-on. 93609......... TC...... A

Map

0.00

NA

NA

NA

NA

0.17

NA

NA

NA

NA

ZZZ tachycardia, add-on. 93610......... ........ A

Intra-atrial

3.02

NA

NA

NA

NA

0.34

NA

NA

NA

NA

000 pacing. 93610......... 26...... A

Intra-atrial

3.02

1.50

1.25

1.50

1.25

0.24

4.76

4.51

4.76

4.51

000 pacing. 93610......... TC...... A

Intra-atrial

0.00

NA

NA

NA

NA

0.10

NA

NA

NA

NA

000 pacing. 93612......... ........ A

Intraventricula 3.02

NA

NA

NA

NA

0.36

NA

NA

NA

NA

000 r pacing. 93612......... 26...... A

Intraventricula 3.02

1.45

1.23

1.45

1.23

0.25

4.72

4.50

4.72

4.50

000 r pacing. 93612......... TC...... A

Intraventricula 0.00

NA

NA

NA

NA

0.11

NA

NA

NA

NA

000 r pacing. 93613......... ........ A

Electrophys map 6.99

NA

NA

3.78

3.02

0.49

NA

NA

11.26

10.50

ZZZ 3d, add-on. 93615......... ........ A

Esophageal

0.99

NA

NA

NA

NA

0.05

NA

NA

NA

NA

000 recording. 93615......... 26...... A

Esophageal

0.99

0.49

0.33

0.49

0.33

0.03

1.51

1.35

1.51

1.35

000 recording. 93615......... TC...... A

Esophageal

0.00

NA

NA

NA

NA

0.02

NA

NA

NA

NA

000 recording. 93616......... ........ C

Esophageal

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 recording. 93616......... 26...... A

Esophageal

1.49

0.37

0.42

0.37

0.42

0.09

1.95

2.00

1.95

2.00

000 recording. 93616......... TC...... C

Esophageal

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 recording.

[[Page 49222]]

93618......... ........ A

Heart rhythm

4.25

NA

NA

NA

NA

0.54

NA

NA

NA

NA

000 pacing. 93618......... 26...... A

Heart rhythm

4.25

2.32

1.83

2.32

1.83

0.30

6.87

6.38

6.87

6.38

000 pacing. 93618......... TC...... A

Heart rhythm

0.00

NA

NA

NA

NA

0.24

NA

NA

NA

NA

000 pacing. 93619......... ........ A

Electrophysiolo 7.31

NA

NA

NA

NA

0.98

NA

NA

NA

NA

000 gy evaluation. 93619......... 26...... A

Electrophysiolo 7.31

3.87

3.35

3.87

3.35

0.51 11.69

11.17

11.69

11.17

000 gy evaluation. 93619......... TC...... A

Electrophysiolo 0.00

NA

NA

NA

NA

0.47

NA

NA

NA

NA

000 gy evaluation. 93620......... ........ C

Electrophysiolo 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 gy evaluation. 93620......... 26...... A

Electrophysiolo 11.57

6.24

5.19

6.24

5.19

0.80 18.61

17.56

18.61

17.56

000 gy evaluation. 93620......... TC...... C

Electrophysiolo 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 gy evaluation. 93621......... ........ C

Electrophysiolo 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ gy evaluation. 93621......... 26...... A

Electrophysiolo 2.10

1.13

0.90

1.13

0.90

0.15

3.38

3.15

3.38

3.15

ZZZ gy evaluation. 93621......... TC...... C

Electrophysiolo 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ gy evaluation. 93622......... ........ C

Electrophysiolo 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ gy evaluation. 93622......... 26...... A

Electrophysiolo 3.10

1.68

1.33

1.68

1.33

0.22

5.00

4.65

5.00

4.65

ZZZ gy evaluation. 93622......... TC...... C

Electrophysiolo 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ gy evaluation. 93623......... ........ C

Stimulation,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ pacing heart. 93623......... 26...... A

Stimulation,

2.85

1.54

1.22

1.54

1.22

0.20

4.59

4.27

4.59

4.27

ZZZ pacing heart. 93623......... TC...... C

Stimulation,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ pacing heart. 93624......... ........ A

Electrophysiolo 4.80

NA

NA

.

4.18

0.46

NA

NA

5.26

9.44

000 gic study. 93624......... 26...... A

Electrophysiolo 4.80

2.63

2.30

2.63

2.30

0.33

7.76

7.43

7.76

7.43

000 gic study. 93624......... TC...... A

Electrophysiolo 0.00

NA

NA

.

1.98

0.13

NA

NA

0.13

2.11

000 gic study. 93631......... ........ C

Heart pacing,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 mapping. 93631......... 26...... A

Heart pacing,

7.59

2.74

2.76

2.74

2.76

0.97 11.30

11.32

11.30

11.32

000 mapping. 93631......... TC...... C

Heart pacing,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000 mapping. 93640......... ........ A

Evaluation

3.51

NA

NA

NA

NA

0.66

NA

NA

NA

NA

000 heart device. 93640......... 26...... A

Evaluation

3.51

1.89

1.49

1.89

1.49

0.24

5.64

5.24

5.64

5.24

000 heart device. 93640......... TC...... A

Evaluation

0.00

NA

NA

NA

NA

0.42

NA

NA

NA

NA

000 heart device. 93641......... ........ A

Electrophysiolo 5.92

NA

NA

NA

NA

0.83

NA

NA

NA

NA

000 gy evaluation. 93641......... 26...... A

Electrophysiolo 5.92

3.18

2.53

3.18

2.53

0.41

9.51

8.86

9.51

8.86

000 gy evaluation. 93641......... TC...... A

Electrophysiolo 0.00

NA

NA

NA

NA

0.42

NA

NA

NA

NA

000 gy evaluation. 93642......... ........ A

Electrophysiolo 4.88

7.45

8.90

7.45

8.90

0.57 12.90

14.35

12.90

14.35

000 gy evaluation. 93642......... 26...... A

Electrophysiolo 4.88

2.63

2.32

2.63

2.32

0.15

7.66

7.35

7.66

7.35

000 gy evaluation. 93642......... TC...... A

Electrophysiolo 0.00

4.81

6.58

4.81

6.58

0.42

5.23

7.00

5.23

7.00

000 gy evaluation. 93650......... ........ A

Ablate heart

10.49

NA

NA

5.97

4.82

0.73

NA

NA

17.19

16.04

000 dysrhythm focus. 93651......... ........ A

Ablate heart

16.23

NA

NA

8.75

6.93

1.13

NA

NA

26.11

24.29

000 dysrhythm focus. 93652......... ........ A

Ablate heart

17.65

NA

NA

9.52

7.54

1.23

NA

NA

28.40

26.42

000 dysrhythm focus. 93660......... ........ A

Tilt table

1.89

3.05

2.57

3.05

2.57

0.08

5.02

4.54

5.02

4.54

000 evaluation. 93660......... 26...... A

Tilt table

1.89

0.99

0.80

0.99

0.80

0.06

2.94

2.75

2.94

2.75

000 evaluation. 93660......... TC...... A

Tilt table

0.00

2.06

1.78

2.06

1.78

0.02

2.08

1.80

2.08

1.80

000 evaluation. 93662......... ........ C

Intracardiac

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ ecg (ice). 93662......... 26...... A

Intracardiac

2.80

1.51

1.21

1.51

1.21

0.09

4.40

4.10

4.40

4.10

ZZZ ecg (ice). 93662......... TC...... C

Intracardiac

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ ecg (ice). 93701......... ........ A

Bioimpedance,

0.17

0.70

0.91

NA

NA

0.02

0.89

1.10

NA

NA

XXX thoracic. 93701......... 26...... A

Bioimpedance,

0.17

0.06

0.07

0.06

0.07

0.01

0.24

0.25

0.24

0.25

XXX thoracic. 93701......... TC...... A

Bioimpedance,

0.00

0.64

0.84

NA

NA

0.01

0.65

0.85

NA

NA

XXX thoracic. 93720......... ........ A

Total body

0.17

1.30

0.90

1.30

0.90

0.07

1.54

1.14

1.54

1.14

XXX plethysmograph y. 93721......... ........ A

Plethysmography 0.00

1.15

0.82

NA

NA

0.06

1.21

0.88

NA

NA

XXX tracing. 93722......... ........ A

Plethysmography 0.17

0.04

0.05

0.04

0.05

0.01

0.22

0.23

0.22

0.23

XXX report. 93724......... ........ A

Analyze

4.88

3.49

5.28

3.49

5.28

0.39

8.76

10.55

8.76

10.55

000 pacemaker system. 93724......... 26...... A

Analyze

4.88

2.58

2.08

2.58

2.08

0.15

7.61

7.11

7.61

7.11

000 pacemaker system. 93724......... TC...... A

Analyze

0.00

0.92

3.20

0.92

3.20

0.24

1.16

3.44

1.16

3.44

000 pacemaker system. 93727......... ........ A

Analyze ilr

0.52

0.65

0.31

0.65

0.31

0.02

1.19

0.85

1.19

0.85

XXX system. 93731......... ........ A

Analyze

0.45

0.80

0.70

NA

NA

0.05

1.30

1.20

NA

NA

XXX pacemaker system. 93731......... 26...... A

Analyze

0.45

0.24

0.19

0.24

0.19

0.01

0.70

0.65

0.70

0.65

XXX pacemaker system. 93731......... TC...... A

Analyze

0.00

0.56

0.51

NA

NA

0.04

0.60

0.55

NA

NA

XXX pacemaker system. 93732......... ........ A

Analyze

0.92

1.17

0.94

NA

NA

0.07

2.16

1.93

NA

NA

XXX pacemaker system.

[[Page 49223]]

93732......... 26...... A

Analyze

0.92

0.49

0.39

0.49

0.39

0.03

1.44

1.34

1.44

1.34

XXX pacemaker system. 93732......... TC...... A

Analyze

0.00

0.68

0.55

NA

NA

0.04

0.72

0.59

NA

NA

XXX pacemaker system. 93733......... ........ A

Telephone

0.17

0.32

0.68

NA

NA

0.07

0.56

0.92

NA

NA

XXX analy, pacemaker. 93733......... 26...... A

Telephone

0.17

0.09

0.08

0.09

0.08

0.01

0.27

0.26

0.27

0.26

XXX analy, pacemaker. 93733......... TC...... A

Telephone

0.00

0.23

0.61

NA

NA

0.06

0.29

0.67

NA

NA

XXX analy, pacemaker. 93734......... ........ A

Analyze

0.38

0.71

0.55

NA

NA

0.03

1.12

0.96

NA

NA

XXX pacemaker system. 93734......... 26...... A

Analyze

0.38

0.20

0.16

0.20

0.16

0.01

0.59

0.55

0.59

0.55

XXX pacemaker system. 93734......... TC...... A

Analyze

0.00

0.51

0.39

NA

NA

0.02

0.53

0.41

NA

NA

XXX pacemaker system. 93735......... ........ A

Analyze

0.74

0.97

0.78

NA

NA

0.06

1.77

1.58

NA

NA

XXX pacemaker system. 93735......... 26...... A

Analyze

0.74

0.39

0.31

0.39

0.31

0.02

1.15

1.07

1.15

1.07

XXX pacemaker system. 93735......... TC...... A

Analyze

0.00

0.58

0.48

NA

NA

0.04

0.62

0.52

NA

NA

XXX pacemaker system. 93736......... ........ A

Telephonic

0.15

0.28

0.59

NA

NA

0.07

0.50

0.81

NA

NA

XXX analy, pacemaker. 93736......... 26...... A

Telephonic

0.15

0.08

0.07

0.08

0.07

0.01

0.24

0.23

0.24

0.23

XXX analy, pacemaker. 93736......... TC...... A

Telephonic

0.00

0.21

0.53

NA

NA

0.06

0.27

0.59

NA

NA

XXX analy, pacemaker. 93740......... ........ B

Temperature

0.16

0.04

0.15

NA

NA

0.02

0.22

0.33

NA

NA

XXX gradient studies. 93740......... 26...... B

Temperature

0.16

0.04

0.04

0.04

0.04

0.01

0.21

0.21

0.21

0.21

XXX gradient studies. 93740......... TC...... B

Temperature

0.00

0.00

0.11

NA

NA

0.01

0.01

0.12

NA

NA

XXX gradient studies. 93741......... ........ A

Analyze ht pace 0.80

1.04

1.00

NA

NA

0.07

1.91

1.87

NA

NA

XXX device sngl. 93741......... 26...... A

Analyze ht pace 0.80

0.43

0.34

0.43

0.34

0.03

1.26

1.17

1.26

1.17

XXX device sngl. 93741......... TC...... A

Analyze ht pace 0.00

0.60

0.65

NA

NA

0.04

0.64

0.69

NA

NA

XXX device sngl. 93742......... ........ A

Analyze ht pace 0.91

1.17

1.07

NA

NA

0.07

2.15

2.05

NA

NA

XXX device sngl. 93742......... 26...... A

Analyze ht pace 0.91

0.50

0.40

0.50

0.40

0.03

1.44

1.34

1.44

1.34

XXX device sngl. 93742......... TC...... A

Analyze ht pace 0.00

0.68

0.67

NA

NA

0.04

0.72

0.71

NA

NA

XXX device sngl. 93743......... ........ A

Analyze ht pace 1.03

1.21

1.15

NA

NA

0.07

2.31

2.25

NA

NA

XXX device dual. 93743......... 26...... A

Analyze ht pace 1.03

0.56

0.44

0.56

0.44

0.03

1.62

1.50

1.62

1.50

XXX device dual. 93743......... TC...... A

Analyze ht pace 0.00

0.65

0.71

NA

NA

0.04

0.69

0.75

NA

NA

XXX device dual. 93744......... ........ A

Analyze ht pace 1.18

1.36

1.19

NA

NA

0.08

2.62

2.45

NA

NA

XXX device dual. 93744......... 26...... A

Analyze ht pace 1.18

0.64

0.51

0.64

0.51

0.04

1.86

1.73

1.86

1.73

XXX device dual. 93744......... TC...... A

Analyze ht pace 0.00

0.73

0.69

NA

NA

0.04

0.77

0.73

NA

NA

XXX device dual. 93745......... ........ C

Set-up

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX cardiovert- defibrill. 93745......... 26...... C

Set-up

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX cardiovert- defibrill. 93745......... TC...... C

Set-up

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX cardiovert- defibrill. 93770......... ........ B

Measure venous

0.16

0.04

0.07

NA

NA

0.02

0.22

0.25

NA

NA

XXX pressure. 93770......... 26...... B

Measure venous

0.16

0.04

0.05

0.04

0.05

0.01

0.21

0.22

0.21

0.22

XXX pressure. 93770......... TC...... B

Measure venous

0.00

0.00

0.02

NA

NA

0.01

0.01

0.03

NA

NA

XXX pressure. 93784......... ........ A

Ambulatory BP

0.38

1.36

1.50

1.36

1.50

0.03

1.77

1.91

1.77

1.91

XXX monitoring. 93786......... ........ A

Ambulatory BP

0.00

1.09

0.96

NA

NA

0.01

1.10

0.97

NA

NA

XXX recording. 93788......... ........ A

Ambulatory BP

0.00

0.73

0.57

NA

NA

0.01

0.74

0.58

NA

NA

XXX analysis. 93790......... ........ A

Review/report

0.38

0.14

0.13

0.14

0.13

0.01

0.53

0.52

0.53

0.52

XXX BP recording. 93797......... ........ A

Cardiac rehab.. 0.18

0.32

0.31

0.09

0.08

0.01

0.51

0.50

0.28

0.27

000 93798......... ........ A

Cardiac rehab/

0.28

0.44

0.46

0.13

0.12

0.01

0.73

0.75

0.42

0.41

000 monitor. 93799......... ........ C

Cardiovascular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 93799......... 26...... C

Cardiovascular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 93799......... TC...... C

Cardiovascular

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 93875......... ........ A

Extracranial

0.22

2.65

2.41

NA

NA

0.12

2.99

2.75

NA

NA

XXX study. 93875......... 26...... A

Extracranial

0.22

0.08

0.08

0.08

0.08

0.01

0.31

0.31

0.31

0.31

XXX study. 93875......... TC...... A

Extracranial

0.00

2.57

2.33

NA

NA

0.11

2.68

2.44

NA

NA

XXX study. 93880......... ........ A

Extracranial

0.60

6.23

5.72

NA

NA

0.39

7.22

6.71

NA

NA

XXX study. 93880......... 26...... A

Extracranial

0.60

0.21

0.20

0.21

0.20

0.04

0.85

0.84

0.85

0.84

XXX study. 93880......... TC...... A

Extracranial

0.00

6.03

5.52

NA

NA

0.35

6.38

5.87

NA

NA

XXX study. 93882......... ........ A

Extracranial

0.40

4.17

3.67

NA

NA

0.26

4.83

4.33

NA

NA

XXX study. 93882......... 26...... A

Extracranial

0.40

0.12

0.14

0.12

0.14

0.04

0.56

0.58

0.56

0.58

XXX study. 93882......... TC...... A

Extracranial

0.00

4.05

3.53

NA

NA

0.22

4.27

3.75

NA

NA

XXX study. 93886......... ........ A

Intracranial

0.94

7.31

6.88

NA

NA

0.45

8.70

8.27

NA

NA

XXX study. 93886......... 26...... A

Intracranial

0.94

0.31

0.36

0.31

0.36

0.06

1.31

1.36

1.31

1.36

XXX study. 93886......... TC...... A

Intracranial

0.00

7.00

6.53

NA

NA

0.39

7.39

6.92

NA

NA

XXX study. 93888......... ........ A

Intracranial

0.62

4.91

4.41

NA

NA

0.32

5.85

5.35

NA

NA

XXX study. 93888......... 26...... A

Intracranial

0.62

0.20

0.22

0.20

0.22

0.05

0.87

0.89

0.87

0.89

XXX study. 93888......... TC...... A

Intracranial

0.00

4.71

4.19

NA

NA

0.27

4.98

4.46

NA

NA

XXX study. 93890......... ........ A

Tcd,

1.00

6.47

5.29

NA

NA

0.45

7.92

6.74

NA

NA

XXX vasoreactivity study. 93890......... 26...... A

Tcd,

1.00

0.33

0.38

0.33

0.38

0.06

1.39

1.44

1.39

1.44

XXX vasoreactivity study. 93890......... TC...... A

Tcd,

0.00

6.13

4.91

NA

NA

0.39

6.52

5.30

NA

NA

XXX vasoreactivity study. 93892......... ........ A

Tcd, emboli

1.15

7.00

5.62

NA

NA

0.45

8.60

7.22

NA

NA

XXX detect w/o inj. 93892......... 26...... A

Tcd, emboli

1.15

0.38

0.44

0.38

0.44

0.06

1.59

1.65

1.59

1.65

XXX detect w/o inj. 93892......... TC...... A

Tcd, emboli

0.00

6.62

5.18

NA

NA

0.39

7.01

5.57

NA

NA

XXX detect w/o inj. 93893......... ........ A

Tcd, emboli

1.15

6.67

5.44

NA

NA

0.45

8.27

7.04

NA

NA

XXX detect w/inj.

[[Page 49224]]

93893......... 26...... A

Tcd, emboli

1.15

0.38

0.44

0.38

0.44

0.06

1.59

1.65

1.59

1.65

XXX detect w/inj. 93893......... TC...... A

Tcd, emboli

0.00

6.29

5.00

NA

NA

0.39

6.68

5.39

NA

NA

XXX detect w/inj. 93922......... ........ A

Extremity study 0.25

3.16

2.80

NA

NA

0.15

3.56

3.20

NA

NA

XXX 93922......... 26...... A

Extremity study 0.25

0.08

0.08

0.08

0.08

0.02

0.35

0.35

0.35

0.35

XXX 93922......... TC...... A

Extremity study 0.00

3.08

2.72

NA

NA

0.13

3.21

2.85

NA

NA

XXX 93923......... ........ A

Extremity study 0.45

4.80

4.22

NA

NA

0.26

5.51

4.93

NA

NA

XXX 93923......... 26...... A

Extremity study 0.45

0.14

0.15

0.14

0.15

0.04

0.63

0.64

0.63

0.64

XXX 93923......... TC...... A

Extremity study 0.00

4.66

4.08

NA

NA

0.22

4.88

4.30

NA

NA

XXX 93924......... ........ A

Extremity study 0.50

6.06

5.11

NA

NA

0.30

6.86

5.91

NA

NA

XXX 93924......... 26...... A

Extremity study 0.50

0.17

0.17

0.17

0.17

0.05

0.72

0.72

0.72

0.72

XXX 93924......... TC...... A

Extremity study 0.00

5.89

4.94

NA

NA

0.25

6.14

5.19

NA

NA

XXX 93925......... ........ A

Lower extremity 0.58

8.24

7.15

NA

NA

0.39

9.21

8.12

NA

NA

XXX study. 93925......... 26...... A

Lower extremity 0.58

0.20

0.20

0.20

0.20

0.04

0.82

0.82

0.82

0.82

XXX study. 93925......... TC...... A

Lower extremity 0.00

8.04

6.95

NA

NA

0.35

8.39

7.30

NA

NA

XXX study. 93926......... ........ A

Lower extremity 0.39

5.25

4.35

NA

NA

0.27

5.91

5.01

NA

NA

XXX study. 93926......... 26...... A

Lower extremity 0.39

0.12

0.13

0.12

0.13

0.04

0.55

0.56

0.55

0.56

XXX study. 93926......... TC...... A

Lower extremity 0.00

5.13

4.22

NA

NA

0.23

5.36

4.45

NA

NA

XXX study. 93930......... ........ A

Upper extremity 0.46

6.35

5.60

NA

NA

0.41

7.22

6.47

NA

NA

XXX study. 93930......... 26...... A

Upper extremity 0.46

0.15

0.16

0.15

0.16

0.04

0.65

0.66

0.65

0.66

XXX study. 93930......... TC...... A

Upper extremity 0.00

6.20

5.44

NA

NA

0.37

6.57

5.81

NA

NA

XXX study. 93931......... ........ A

Upper extremity 0.31

4.32

3.69

NA

NA

0.27

4.90

4.27

NA

NA

XXX study. 93931......... 26...... A

Upper extremity 0.31

0.10

0.10

0.10

0.10

0.03

0.44

0.44

0.44

0.44

XXX study. 93931......... TC...... A

Upper extremity 0.00

4.22

3.59

NA

NA

0.24

4.46

3.83

NA

NA

XXX study. 93965......... ........ A

Extremity study 0.35

3.13

2.88

NA

NA

0.14

3.62

3.37

NA

NA

XXX 93965......... 26...... A

Extremity study 0.35

0.12

0.12

0.12

0.12

0.02

0.49

0.49

0.49

0.49

XXX 93965......... TC...... A

Extremity study 0.00

3.02

2.76

NA

NA

0.12

3.14

2.88

NA

NA

XXX 93970......... ........ A

Extremity study 0.68

6.32

5.51

NA

NA

0.46

7.46

6.65

NA

NA

XXX 93970......... 26...... A

Extremity study 0.68

0.21

0.23

0.21

0.23

0.06

0.95

0.97

0.95

0.97

XXX 93970......... TC...... A

Extremity study 0.00

6.11

5.29

NA

NA

0.40

6.51

5.69

NA

NA

XXX 93971......... ........ A

Extremity study 0.45

4.12

3.72

NA

NA

0.30

4.87

4.47

NA

NA

XXX 93971......... 26...... A

Extremity study 0.45

0.14

0.15

0.14

0.15

0.03

0.62

0.63

0.62

0.63

XXX 93971......... TC...... A

Extremity study 0.00

3.98

3.58

NA

NA

0.27

4.25

3.85

NA

NA

XXX 93975......... ........ A

Vascular study. 1.80

8.56

7.86

NA

NA

0.56 10.92

10.22

NA

NA

XXX 93975......... 26...... A

Vascular study. 1.80

0.62

0.61

0.62

0.61

0.13

2.55

2.54

2.55

2.54

XXX 93975......... TC...... A

Vascular study. 0.00

7.95

7.26

NA

NA

0.43

8.38

7.69

NA

NA

XXX 93976......... ........ A

Vascular study. 1.21

4.57

4.39

NA

NA

0.35

6.13

5.95

NA

NA

XXX 93976......... 26...... A

Vascular study. 1.21

0.39

0.40

0.39

0.40

0.05

1.65

1.66

1.65

1.66

XXX 93976......... TC...... A

Vascular study. 0.00

4.18

3.99

NA

NA

0.30

4.48

4.29

NA

NA

XXX 93978......... ........ A

Vascular study. 0.65

6.15

4.92

NA

NA

0.43

7.23

6.00

NA

NA

XXX 93978......... 26...... A

Vascular study. 0.65

0.23

0.22

0.23

0.22

0.06

0.94

0.93

0.94

0.93

XXX 93978......... TC...... A

Vascular study. 0.00

5.93

4.70

NA

NA

0.37

6.30

5.07

NA

NA

XXX 93979......... ........ A

Vascular study. 0.44

4.40

3.51

NA

NA

0.27

5.11

4.22

NA

NA

XXX 93979......... 26...... A

Vascular study. 0.44

0.16

0.15

0.16

0.15

0.03

0.63

0.62

0.63

0.62

XXX 93979......... TC...... A

Vascular study. 0.00

4.23

3.35

NA

NA

0.24

4.47

3.59

NA

NA

XXX 93980......... ........ A

Penile vascular 1.25

3.49

3.01

NA

NA

0.42

5.16

4.68

NA

NA

XXX study. 93980......... 26...... A

Penile vascular 1.25

0.44

0.42

0.44

0.42

0.08

1.77

1.75

1.77

1.75

XXX study. 93980......... TC...... A

Penile vascular 0.00

3.05

2.59

NA

NA

0.34

3.39

2.93

NA

NA

XXX study. 93981......... ........ A

Penile vascular 0.44

2.88

2.87

NA

NA

0.33

3.65

3.64

NA

NA

XXX study. 93981......... 26...... A

Penile vascular 0.44

0.16

0.15

0.16

0.15

0.02

0.62

0.61

0.62

0.61

XXX study. 93981......... TC...... A

Penile vascular 0.00

2.71

2.73

NA

NA

0.31

3.02

3.04

NA

NA

XXX study. 93990......... ........ A

Doppler flow

0.25

5.34

4.33

NA

NA

0.26

5.85

4.84

NA

NA

XXX testing. 93990......... 26...... A

Doppler flow

0.25

0.07

0.09

0.07

0.09

0.03

0.35

0.37

0.35

0.37

XXX testing. 93990......... TC...... A

Doppler flow

0.00

5.27

4.24

NA

NA

0.23

5.50

4.47

NA

NA

XXX testing. 94010......... ........ A

Breathing

0.17

0.74

0.69

NA

NA

0.03

0.94

0.89

NA

NA

XXX capacity test. 94010......... 26...... A

Breathing

0.17

0.04

0.05

0.04

0.05

0.01

0.22

0.23

0.22

0.23

XXX capacity test. 94010......... TC...... A

Breathing

0.00

0.70

0.64

NA

NA

0.02

0.72

0.66

NA

NA

XXX capacity test.

[[Page 49225]]

94014......... ........ A

Patient

0.52

0.93

0.80

0.93

0.80

0.03

1.48

1.35

1.48

1.35

XXX recorded spirometry. 94015......... ........ A

Patient

0.00

0.76

0.63

NA

NA

0.01

0.77

0.64

NA

NA

XXX recorded spirometry. 94016......... ........ A

Review patient

0.52

0.17

0.17

0.17

0.17

0.02

0.71

0.71

0.71

0.71

XXX spirometry. 94060......... ........ A

Evaluation of

0.31

1.32

1.13

1.32

1.13

0.07

1.70

1.51

1.70

1.51

XXX wheezing. 94060......... 26...... A

Evaluation of

0.31

0.08

0.09

0.08

0.09

0.01

0.40

0.41

0.40

0.41

XXX wheezing. 94060......... TC...... A

Evaluation of

0.00

1.24

1.05

1.24

1.05

0.06

1.30

1.11

1.30

1.11

XXX wheezing. 94070......... ........ A

Evaluation of

0.60

1.01

0.87

NA

NA

0.13

1.74

1.60

NA

NA

XXX wheezing. 94070......... 26...... A

Evaluation of

0.60

0.15

0.17

0.15

0.17

0.03

0.78

0.80

0.78

0.80

XXX wheezing. 94070......... TC...... A

Evaluation of

0.00

0.85

0.69

NA

NA

0.10

0.95

0.79

NA

NA

XXX wheezing. 94150......... ........ B

Vital capacity

0.07

0.48

0.47

NA

NA

0.02

0.57

0.56

NA

NA

XXX test. 94150......... 26...... B

Vital capacity

0.07

0.02

0.03

0.02

0.03

0.01

0.10

0.11

0.10

0.11

XXX test. 94150......... TC...... B

Vital capacity

0.00

0.47

0.45

NA

NA

0.01

0.48

0.46

NA

NA

XXX test. 94200......... ........ A

Lung function

0.11

0.51

0.46

NA

NA

0.03

0.65

0.60

NA

NA

XXX test (MBC/MVV). 94200......... 26...... A

Lung function

0.11

0.03

0.03

0.03

0.03

0.01

0.15

0.15

0.15

0.15

XXX test (MBC/MVV). 94200......... TC...... A

Lung function

0.00

0.48

0.43

NA

NA

0.02

0.50

0.45

NA

NA

XXX test (MBC/MVV). 94240......... ........ A

Residual lung

0.26

0.84

0.71

NA

NA

0.06

1.16

1.03

NA

NA

XXX capacity. 94240......... 26...... A

Residual lung

0.26

0.07

0.08

0.07

0.08

0.01

0.34

0.35

0.34

0.35

XXX capacity. 94240......... TC...... A

Residual lung

0.00

0.77

0.63

NA

NA

0.05

0.82

0.68

NA

NA

XXX capacity. 94250......... ........ A

Expired gas

0.11

0.57

0.62

NA

NA

0.02

0.70

0.75

NA

NA

XXX collection. 94250......... 26...... A

Expired gas

0.11

0.04

0.03

0.04

0.03

0.01

0.16

0.15

0.16

0.15

XXX collection. 94250......... TC...... A

Expired gas

0.00

0.53

0.59

NA

NA

0.01

0.54

0.60

NA

NA

XXX collection. 94260......... ........ A

Thoracic gas

0.13

0.77

0.63

NA

NA

0.05

0.95

0.81

NA

NA

XXX volume. 94260......... 26...... A

Thoracic gas

0.13

0.03

0.04

0.03

0.04

0.01

0.17

0.18

0.17

0.18

XXX volume. 94260......... TC...... A

Thoracic gas

0.00

0.74

0.59

NA

NA

0.04

0.78

0.63

NA

NA

XXX volume. 94350......... ........ A

Lung nitrogen

0.26

0.67

0.74

NA

NA

0.05

0.98

1.05

NA

NA

XXX washout curve. 94350......... 26...... A

Lung nitrogen

0.26

0.08

0.08

0.08

0.08

0.01

0.35

0.35

0.35

0.35

XXX washout curve. 94350......... TC...... A

Lung nitrogen

0.00

0.59

0.66

NA

NA

0.04

0.63

0.70

NA

NA

XXX washout curve. 94360......... ........ A

Measure airflow 0.26

0.99

0.77

NA

NA

0.07

1.32

1.10

NA

NA

XXX resistance. 94360......... 26...... A

Measure airflow 0.26

0.07

0.08

0.07

0.08

0.01

0.34

0.35

0.34

0.35

XXX resistance. 94360......... TC...... A

Measure airflow 0.00

0.92

0.70

NA

NA

0.06

0.98

0.76

NA

NA

XXX resistance. 94370......... ........ A

Breath airway

0.26

0.67

0.71

NA

NA

0.03

0.96

1.00

NA

NA

XXX closing volume. 94370......... 26...... A

Breath airway

0.26

0.09

0.08

0.09

0.08

0.01

0.36

0.35

0.36

0.35

XXX closing volume. 94370......... TC...... A

Breath airway

0.00

0.58

0.63

NA

NA

0.02

0.60

0.65

NA

NA

XXX closing volume. 94375......... ........ A

Respiratory

0.31

0.75

0.64

NA

NA

0.03

1.09

0.98

NA

NA

XXX flow volume loop. 94375......... 26...... A

Respiratory

0.31

0.08

0.09

0.08

0.09

0.01

0.40

0.41

0.40

0.41

XXX flow volume loop. 94375......... TC...... A

Respiratory

0.00

0.66

0.55

NA

NA

0.02

0.68

0.57

NA

NA

XXX flow volume loop. 94400......... ........ A

CO2 breathing

0.40

1.03

0.89

NA

NA

0.09

1.52

1.38

NA

NA

XXX response curve. 94400......... 26...... A

CO2 breathing

0.40

0.10

0.12

0.10

0.12

0.03

0.53

0.55

0.53

0.55

XXX response curve. 94400......... TC...... A

CO2 breathing

0.00

0.93

0.77

NA

NA

0.06

0.99

0.83

NA

NA

XXX response curve. 94450......... ........ A

Hypoxia

0.40

1.03

0.90

NA

NA

0.04

1.47

1.34

NA

NA

XXX response curve. 94450......... 26...... A

Hypoxia

0.40

0.09

0.11

0.09

0.11

0.02

0.51

0.53

0.51

0.53

XXX response curve. 94450......... TC...... A

Hypoxia

0.00

0.95

0.79

NA

NA

0.02

0.97

0.81

NA

NA

XXX response curve. 94452......... ........ A

Hast w/report.. 0.31

1.21

1.07

NA

NA

0.04

1.56

1.42

NA

NA

XXX 94452......... 26...... A

Hast w/report.. 0.31

0.09

0.09

0.09

0.09

0.02

0.42

0.42

0.42

0.42

XXX 94452......... TC...... A

Hast w/report.. 0.00

1.12

0.98

NA

NA

0.02

1.14

1.00

NA

NA

XXX 94453......... ........ A

Hast w/oxygen

0.40

1.69

1.56

NA

NA

0.04

2.13

2.00

NA

NA

XXX titrate. 94453......... 26...... A

Hast w/oxygen

0.40

0.11

0.12

0.11

0.12

0.02

0.53

0.54

0.53

0.54

XXX titrate. 94453......... TC...... A

Hast w/oxygen

0.00

1.58

1.44

NA

NA

0.02

1.60

1.46

NA

NA

XXX titrate. 94620......... ........ A

Pulmonary

0.64

0.88

2.09

NA

NA

0.13

1.65

2.86

NA

NA

XXX stress test/ simple. 94620......... 26...... A

Pulmonary

0.64

0.20

0.20

0.20

0.20

0.03

0.87

0.87

0.87

0.87

XXX stress test/ simple. 94620......... TC...... A

Pulmonary

0.00

0.68

1.89

NA

NA

0.10

0.78

1.99

NA

NA

XXX stress test/ simple. 94621......... ........ A

Pulm stress

1.42

3.18

2.45

NA

NA

0.16

4.76

4.03

NA

NA

XXX test/complex. 94621......... 26...... A

Pulm stress

1.42

0.45

0.44

0.45

0.44

0.06

1.93

1.92

1.93

1.92

XXX test/complex. 94621......... TC...... A

Pulm stress

0.00

2.73

2.00

NA

NA

0.10

2.83

2.10

NA

NA

XXX test/complex. 94640......... ........ A

Airway

0.00

0.37

0.32

NA

NA

0.02

0.39

0.34

NA

NA

XXX inhalation treatment. 94642......... ........ C

Aerosol

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX inhalation treatment. 94656......... ........ A

Initial

1.22

1.12

1.15

0.24

0.30

0.06

2.40

2.43

1.52

1.58

XXX ventilator mgmt. 94657......... ........ A

Continued

0.83

1.15

1.02

0.19

0.24

0.04

2.02

1.89

1.06

1.11

XXX ventilator mgmt. 94660......... ........ A

Pos airway

0.76

0.82

0.69

0.20

0.22

0.04

1.62

1.49

1.00

1.02

XXX pressure, CPAP. 94662......... ........ A

Neg press

0.76

NA

NA

0.18

0.22

0.03

NA

NA

0.97

1.01

XXX ventilation, cnp. 94664......... ........ A

Evaluate pt use 0.00

0.40

0.33

NA

NA

0.04

0.44

0.37

NA

NA

XXX of inhaler. 94667......... ........ A

Chest wall

0.00

0.55

0.53

NA

NA

0.05

0.60

0.58

NA

NA

XXX manipulation. 94668......... ........ A

Chest wall

0.00

0.51

0.47

NA

NA

0.02

0.53

0.49

NA

NA

XXX manipulation. 94680......... ........ A

Exhaled air

0.26

1.11

1.67

1.11

1.67

0.07

1.44

2.00

1.44

2.00

XXX analysis, o2. 94680......... 26...... A

Exhaled air

0.26

0.07

0.08

0.07

0.08

0.01

0.34

0.35

0.34

0.35

XXX analysis, o2. 94680......... TC...... A

Exhaled air

0.00

1.04

1.60

1.04

1.60

0.06

1.10

1.66

1.10

1.66

XXX analysis, o2.

[[Page 49226]]

94681......... ........ A

Exhaled air

0.20

1.10

2.17

NA

NA

0.13

1.43

2.50

NA

NA

XXX analysis, o2/ co2. 94681......... 26...... A

Exhaled air

0.20

0.05

0.06

0.05

0.06

0.01

0.26

0.27

0.26

0.27

XXX analysis, o2/ co2. 94681......... TC...... A

Exhaled air

0.00

1.04

2.11

NA

NA

0.12

1.16

2.23

NA

NA

XXX analysis, o2/ co2. 94690......... ........ A

Exhaled air

0.07

0.89

1.72

NA

NA

0.05

1.01

1.84

NA

NA

XXX analysis. 94690......... 26...... A

Exhaled air

0.07

0.02

0.02

0.02

0.02

0.01

0.10

0.10

0.10

0.10

XXX analysis. 94690......... TC...... A

Exhaled air

0.00

0.87

1.70

NA

NA

0.04

0.91

1.74

NA

NA

XXX analysis. 94720......... ........ A

Monoxide

0.26

1.18

1.05

NA

NA

0.07

1.51

1.38

NA

NA

XXX diffusing capacity. 94720......... 26...... A

Monoxide

0.26

0.06

0.08

0.06

0.08

0.01

0.33

0.35

0.33

0.35

XXX diffusing capacity. 94720......... TC...... A

Monoxide

0.00

1.11

0.97

NA

NA

0.06

1.17

1.03

NA

NA

XXX diffusing capacity. 94725......... ........ A

Membrane

0.26

1.10

2.46

NA

NA

0.13

1.49

2.85

NA

NA

XXX diffusion capacity. 94725......... 26...... A

Membrane

0.26

0.09

0.08

0.09

0.08

0.01

0.36

0.35

0.36

0.35

XXX diffusion capacity. 94725......... TC...... A

Membrane

0.00

1.01

2.38

NA

NA

0.12

1.13

2.50

NA

NA

XXX diffusion capacity. 94750......... ........ A

Pulmonary

0.23

1.90

1.48

NA

NA

0.05

2.18

1.76

NA

NA

XXX compliance study. 94750......... 26...... A

Pulmonary

0.23

0.08

0.07

0.08

0.07

0.01

0.32

0.31

0.32

0.31

XXX compliance study. 94750......... TC...... A

Pulmonary

0.00

1.82

1.41

NA

NA

0.04

1.86

1.45

NA

NA

XXX compliance study. 94760......... ........ T

Measure blood

0.00

0.06

0.05

NA

NA

0.02

0.08

0.07

NA

NA

XXX oxygen level. 94761......... ........ T

Measure blood

0.00

0.12

0.08

NA

NA

0.06

0.18

0.14

NA

NA

XXX oxygen level. 94762......... ........ A

Measure blood

0.00

0.96

0.59

NA

NA

0.10

1.06

0.69

NA

NA

XXX oxygen level. 94770......... ........ A

Exhaled carbon

0.15

0.85

0.78

NA

NA

0.08

1.08

1.01

NA

NA

XXX dioxide test. 94770......... 26...... A

Exhaled carbon

0.15

0.04

0.04

0.04

0.04

0.01

0.20

0.20

0.20

0.20

XXX dioxide test. 94770......... TC...... A

Exhaled carbon

0.00

0.81

0.74

NA

NA

0.07

0.88

0.81

NA

NA

XXX dioxide test. 94772......... ........ C

Breath

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX recording, infant. 94772......... 26...... C

Breath

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX recording, infant. 94772......... TC...... C

Breath

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX recording, infant. 94799......... ........ C

Pulmonary

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX service/ procedure. 94799......... 26...... C

Pulmonary

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX service/ procedure. 94799......... TC...... C

Pulmonary

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX service/ procedure. 95004......... ........ A

Percut allergy

0.00

0.16

0.12

NA

NA

0.01

0.17

0.13

NA

NA

XXX skin tests. 95010......... ........ A

Percut allergy

0.15

0.30

0.32

0.04

0.06

0.01

0.46

0.48

0.20

0.22

XXX titrate test. 95015......... ........ A

Id allergy

0.15

0.20

0.16

0.04

0.06

0.01

0.36

0.32

0.20

0.22

XXX titrate-drug/ bug. 95024......... ........ A

Id allergy

0.00

0.21

0.17

NA

NA

0.01

0.22

0.18

NA

NA

XXX test, drug/bug. 95027......... ........ A

Id allergy

0.00

0.24

0.17

NA

NA

0.01

0.25

0.18

NA

NA

XXX titrate- airborne. 95028......... ........ A

Id allergy test- 0.00

0.29

0.25

NA

NA

0.01

0.30

0.26

NA

NA

XXX delayed type. 95044......... ........ A

Allergy patch

0.00

0.15

0.19

NA

NA

0.01

0.16

0.20

NA

NA

XXX tests. 95052......... ........ A

Photo patch

0.00

0.15

0.23

NA

NA

0.01

0.16

0.24

NA

NA

XXX test. 95056......... ........ A

Photosensitivit 0.00

1.18

0.42

NA

NA

0.01

1.19

0.43

NA

NA

XXX y tests. 95060......... ........ A

Eye allergy

0.00

0.75

0.45

NA

NA

0.02

0.77

0.47

NA

NA

XXX tests. 95065......... ........ A

Nose allergy

0.00

0.67

0.32

NA

NA

0.01

0.68

0.33

NA

NA

XXX test. 95070......... ........ A

Bronchial

0.00

0.80

1.91

NA

NA

0.02

0.82

1.93

NA

NA

XXX allergy tests. 95071......... ........ A

Bronchial

0.00

0.89

2.41

NA

NA

0.02

0.91

2.43

NA

NA

XXX allergy tests. 95075......... ........ A

Ingestion

0.95

0.67

0.78

0.25

0.35

0.03

1.65

1.76

1.23

1.33

XXX challenge test. 95078......... ........ A

Provocative

0.00

0.33

0.27

NA

NA

0.02

0.35

0.29

NA

NA

XXX testing. 95115......... ........ A

Immunotherapy,

0.00

0.22

0.35

0.00

0.29

0.02

0.24

0.37

0.02

0.31

XXX one injection. 95117......... ........ A

Immunotherapy

0.00

0.27

0.44

0.00

0.38

0.02

0.29

0.46

0.02

0.40

XXX injections. 95144......... ........ A

Antigen therapy 0.06

0.26

0.21

0.02

0.02

0.01

0.33

0.28

0.09

0.09

XXX services. 95145......... ........ A

Antigen therapy 0.06

0.35

0.33

0.02

0.02

0.01

0.42

0.40

0.09

0.09

XXX services. 95146......... ........ A

Antigen therapy 0.06

0.66

0.50

0.02

0.03

0.01

0.73

0.57

0.09

0.10

XXX services. 95147......... ........ A

Antigen therapy 0.06

0.64

0.48

0.02

0.02

0.01

0.71

0.55

0.09

0.09

XXX services. 95148......... ........ A

Antigen therapy 0.06

0.94

0.67

0.02

0.03

0.01

1.01

0.74

0.09

0.10

XXX services. 95149......... ........ A

Antigen therapy 0.06

1.25

0.91

0.02

0.03

0.01

1.32

0.98

0.09

0.10

XXX services. 95165......... ........ A

Antigen therapy 0.06

0.25

0.21

0.02

0.02

0.01

0.32

0.28

0.09

0.09

XXX services. 95170......... ........ A

Antigen therapy 0.06

0.20

0.15

0.02

0.03

0.01

0.27

0.22

0.09

0.10

XXX services. 95180......... ........ A

Rapid

2.01

1.57

1.92

0.71

0.88

0.04

3.62

3.97

2.76

2.93

XXX desensitizatio n. 95199......... ........ C

Allergy

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX immunology services. 95250......... ........ A

Glucose

0.00

3.53

3.96

NA

NA

0.01

3.54

3.97

NA

NA

XXX monitoring, cont. 95251......... ........ A

Gluc monitor,

0.52

0.16

0.18

0.16

0.18

0.02

0.70

0.72

0.70

0.72

XXX cont, phys i&r.

[[Page 49227]]

95805......... ........ A

Multiple sleep

1.88

7.27

14.76

NA

NA

0.43

9.58

17.07

NA

NA

XXX latency test. 95805......... 26...... A

Multiple sleep

1.88

0.51

0.62

0.51

0.62

0.09

2.48

2.59

2.48

2.59

XXX latency test. 95805......... TC...... A

Multiple sleep

0.00

6.76

14.14

NA

NA

0.34

7.10

14.48

NA

NA

XXX latency test. 95806......... ........ A

Sleep study,

1.66

4.02

3.50

NA

NA

0.39

6.07

5.55

NA

NA

XXX unattended. 95806......... 26...... A

Sleep study,

1.66

0.50

0.53

0.50

0.53

0.08

2.24

2.27

2.24

2.27

XXX unattended. 95806......... TC...... A

Sleep study,

0.00

3.52

2.97

NA

NA

0.31

3.83

3.28

NA

NA

XXX unattended. 95807......... ........ A

Sleep study,

1.66 12.81

12.09

NA

NA

0.50 14.97

14.25

NA

NA

XXX attended. 95807......... 26...... A

Sleep study,

1.66

0.51

0.53

0.51

0.53

0.08

2.25

2.27

2.25

2.27

XXX attended. 95807......... TC...... A

Sleep study,

0.00 12.30

11.57

NA

NA

0.42 12.72

11.99

NA

NA

XXX attended. 95808......... ........ A

Polysomnography 2.65 15.72

13.82

NA

NA

0.55 18.92

17.02

NA

NA

XXX , 1-3. 95808......... 26...... A

Polysomnography 2.65

0.69

0.86

0.69

0.86

0.13

3.47

3.64

3.47

3.64

XXX , 1-3. 95808......... TC...... A

Polysomnography 0.00 15.03

12.96

NA

NA

0.42 15.45

13.38

NA

NA

XXX , 1-3. 95810......... ........ A

Polysomnography 3.52 18.60

17.77

NA

NA

0.59 22.71

21.88

NA

NA

XXX , 4 or more. 95810......... 26...... A

Polysomnography 3.52

0.98

1.13

0.98

1.13

0.17

4.67

4.82

4.67

4.82

XXX , 4 or more. 95810......... TC...... A

Polysomnography 0.00 17.62

16.64

NA

NA

0.42 18.04

17.06

NA

NA

XXX , 4 or more. 95811......... ........ A

Polysomnography 3.79 20.70

19.56

NA

NA

0.61 25.10

23.96

NA

NA

XXX w/cpap. 95811......... 26...... A

Polysomnography 3.79

1.05

1.22

1.05

1.22

0.18

5.02

5.19

5.02

5.19

XXX w/cpap. 95811......... TC...... A

Polysomnography 0.00 19.66

18.36

NA

NA

0.43 20.09

18.79

NA

NA

XXX w/cpap. 95812......... ........ A

Eeg, 41-60

1.08

5.90

4.50

NA

NA

0.17

7.15

5.75

NA

NA

XXX minutes. 95812......... 26...... A

Eeg, 41-60

1.08

0.31

0.42

0.31

0.42

0.06

1.45

1.56

1.45

1.56

XXX minutes. 95812......... TC...... A

Eeg, 41-60

0.00

5.59

4.08

NA

NA

0.11

5.70

4.19

NA

NA

XXX minutes. 95813......... ........ A

Eeg, over 1

1.73

6.64

5.43

NA

NA

0.20

8.57

7.36

NA

NA

XXX hour. 95813......... 26...... A

Eeg, over 1

1.73

0.50

0.65

0.50

0.65

0.09

2.32

2.47

2.32

2.47

XXX hour. 95813......... TC...... A

Eeg, over 1

0.00

6.14

4.78

NA

NA

0.11

6.25

4.89

NA

NA

XXX hour. 95816......... ........ A

Eeg, awake and

1.08

5.30

4.11

NA

NA

0.16

6.54

5.35

NA

NA

XXX drowsy. 95816......... 26...... A

Eeg, awake and

1.08

0.30

0.42

0.30

0.42

0.06

1.44

1.56

1.44

1.56

XXX drowsy. 95816......... TC...... A

Eeg, awake and

0.00

4.99

3.69

NA

NA

0.10

5.09

3.79

NA

NA

XXX drowsy. 95819......... ........ A

Eeg, awake and

1.08

6.15

3.77

NA

NA

0.16

7.39

5.01

NA

NA

XXX asleep. 95819......... 26...... A

Eeg, awake and

1.08

0.30

0.42

0.30

0.42

0.06

1.44

1.56

1.44

1.56

XXX asleep. 95819......... TC...... A

Eeg, awake and

0.00

5.84

3.35

NA

NA

0.10

5.94

3.45

NA

NA

XXX asleep. 95822......... ........ A

Eeg, coma or

1.08

5.53

4.83

NA

NA

0.19

6.80

6.10

NA

NA

XXX sleep only. 95822......... 26...... A

Eeg, coma or

1.08

0.30

0.42

0.30

0.42

0.06

1.44

1.56

1.44

1.56

XXX sleep only. 95822......... TC...... A

Eeg, coma or

0.00

5.23

4.41

NA

NA

0.13

5.36

4.54

NA

NA

XXX sleep only. 95824......... ........ C

Eeg, cerebral

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX death only. 95824......... 26...... A

Eeg, cerebral

0.74

0.21

0.29

0.21

0.29

0.04

0.99

1.07

0.99

1.07

XXX death only. 95824......... TC...... C

Eeg, cerebral

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX death only. 95827......... ........ A

Eeg, all night

1.08 11.57

4.92

NA

NA

0.19 12.84

6.19

NA

NA

XXX recording. 95827......... 26...... A

Eeg, all night

1.08

0.29

0.38

0.29

0.38

0.05

1.42

1.51

1.42

1.51

XXX recording. 95827......... TC...... A

Eeg, all night

0.00 11.28

4.54

NA

NA

0.14 11.42

4.68

NA

NA

XXX recording. 95829......... ........ A

Surgery

6.20 25.44

29.61

NA

NA

0.50 32.14

36.31

NA

NA

XXX electrocortico gram. 95829......... 26...... A

Surgery

6.20

1.79

2.18

1.79

2.18

0.48

8.47

8.86

8.47

8.86

XXX electrocortico gram. 95829......... TC...... A

Surgery

0.00 23.65

27.43

NA

NA

0.02 23.67

27.45

NA

NA

XXX electrocortico gram. 95830......... ........ A

Insert

1.70

2.99

3.22

0.42

0.65

0.11

4.80

5.03

2.23

2.46

XXX electrodes for EEG. 95831......... ........ A

Limb muscle

0.28

0.39

0.44

0.09

0.12

0.01

0.68

0.73

0.38

0.41

XXX testing, manual. 95832......... ........ A

Hand muscle

0.29

0.37

0.34

0.10

0.12

0.02

0.68

0.65

0.41

0.43

XXX testing, manual. 95833......... ........ A

Body muscle

0.47

0.47

0.55

0.13

0.21

0.02

0.96

1.04

0.62

0.70

XXX testing, manual. 95834......... ........ A

Body muscle

0.60

0.55

0.61

0.18

0.26

0.03

1.18

1.24

0.81

0.89

XXX testing, manual. 95851......... ........ A

Range of motion 0.16

0.26

0.34

0.04

0.07

0.01

0.43

0.51

0.21

0.24

XXX measurements. 95852......... ........ A

Range of motion 0.11

0.21

0.25

0.03

0.05

0.01

0.33

0.37

0.15

0.17

XXX measurements. 95857......... ........ A

Tensilon test.. 0.53

0.59

0.60

0.16

0.21

0.02

1.14

1.15

0.71

0.76

XXX 95860......... ........ A

Muscle test,

0.96

1.16

1.36

NA

NA

0.07

2.19

2.39

NA

NA

XXX one limb. 95860......... 26...... A

Muscle test,

0.96

0.32

0.40

0.32

0.40

0.05

1.33

1.41

1.33

1.41

XXX one limb. 95860......... TC...... A

Muscle test,

0.00

0.84

0.96

NA

NA

0.02

0.86

0.98

NA

NA

XXX one limb. 95861......... ........ A

Muscle test, 2

1.54

1.67

1.48

NA

NA

0.13

3.34

3.15

NA

NA

XXX limbs. 95861......... 26...... A

Muscle test, 2

1.54

0.51

0.64

0.51

0.64

0.07

2.12

2.25

2.12

2.25

XXX limbs. 95861......... TC...... A

Muscle test, 2

0.00

1.16

0.84

NA

NA

0.06

1.22

0.90

NA

NA

XXX limbs. 95863......... ........ A

Muscle test, 3

1.87

1.94

1.78

NA

NA

0.15

3.96

3.80

NA

NA

XXX limbs. 95863......... 26...... A

Muscle test, 3

1.87

0.58

0.75

0.58

0.75

0.09

2.54

2.71

2.54

2.71

XXX limbs. 95863......... TC...... A

Muscle test, 3

0.00

1.36

1.05

NA

NA

0.06

1.42

1.11

NA

NA

XXX limbs. 95864......... ........ A

Muscle test, 4

1.99

2.20

2.54

NA

NA

0.21

4.40

4.74

NA

NA

XXX limbs. 95864......... 26...... A

Muscle test, 4

1.99

0.63

0.81

0.63

0.81

0.09

2.71

2.89

2.71

2.89

XXX limbs. 95864......... TC...... A

Muscle test, 4

0.00

1.57

1.73

NA

NA

0.12

1.69

1.85

NA

NA

XXX limbs. 95865......... ........ A

Muscle test,

1.57

1.34

1.42

NA

NA

0.11

3.02

3.10

NA

NA

XXX larynx. 95865......... 26...... A

Muscle test,

1.57

0.46

0.69

0.46

0.69

0.08

2.11

2.34

2.11

2.34

XXX larynx. 95865......... TC...... A

Muscle test,

0.00

0.88

0.73

NA

NA

0.03

0.91

0.76

NA

NA

XXX larynx. 95866......... ........ A

Muscle test,

1.25

1.34

0.91

NA

NA

0.10

2.69

2.26

NA

NA

XXX hemidiaphragm.

[[Page 49228]]

95866......... 26...... A

Muscle test,

1.25

0.40

0.52

0.40

0.52

0.07

1.72

1.84

1.72

1.84

XXX hemidiaphragm. 95866......... TC...... A

Muscle test,

0.00

0.94

0.39

NA

NA

0.03

0.97

0.42

NA

NA

XXX hemidiaphragm. 95867......... ........ A

Muscle test

0.79

1.12

0.98

NA

NA

0.07

1.98

1.84

NA

NA

XXX cran nerv unilat. 95867......... 26...... A

Muscle test

0.79

0.23

0.32

0.23

0.32

0.03

1.05

1.14

1.05

1.14

XXX cran nerv unilat. 95867......... TC...... A

Muscle test

0.00

0.89

0.66

NA

NA

0.04

0.93

0.70

NA

NA

XXX cran nerv unilat. 95868......... ........ A

Muscle test

1.18

1.43

1.27

NA

NA

0.10

2.71

2.55

NA

NA

XXX cran nerve bilat. 95868......... 26...... A

Muscle test

1.18

0.35

0.47

0.35

0.47

0.05

1.58

1.70

1.58

1.70

XXX cran nerve bilat. 95868......... TC...... A

Muscle test

0.00

1.08

0.80

NA

NA

0.05

1.13

0.85

NA

NA

XXX cran nerve bilat. 95869......... ........ A

Muscle test,

0.37

1.03

0.54

NA

NA

0.04

1.44

0.95

NA

NA

XXX thor paraspinal. 95869......... 26...... A

Muscle test,

0.37

0.12

0.15

0.12

0.15

0.02

0.51

0.54

0.51

0.54

XXX thor paraspinal. 95869......... TC...... A

Muscle test,

0.00

0.91

0.39

NA

NA

0.02

0.93

0.41

NA

NA

XXX thor paraspinal. 95870......... ........ A

Muscle test,

0.37

1.00

0.53

NA

NA

0.04

1.41

0.94

NA

NA

XXX nonparaspinal. 95870......... 26...... A

Muscle test,

0.37

0.12

0.15

0.12

0.15

0.02

0.51

0.54

0.51

0.54

XXX nonparaspinal. 95870......... TC...... A

Muscle test,

0.00

0.88

0.38

NA

NA

0.02

0.90

0.40

NA

NA

XXX nonparaspinal. 95872......... ........ A

Muscle test,

2.00

1.42

1.28

NA

NA

0.13

3.55

3.41

NA

NA

XXX one fiber. 95872......... 26...... A

Muscle test,

2.00

0.65

0.64

0.65

0.64

0.08

2.73

2.72

2.73

2.72

XXX one fiber. 95872......... TC...... A

Muscle test,

0.00

0.78

0.65

NA

NA

0.05

0.83

0.70

NA

NA

XXX one fiber. 95873......... ........ A

Guide nerv

0.37

0.95

0.51

0.95

0.51

0.04

1.36

0.92

1.36

0.92

ZZZ destr, elec stim. 95873......... 26...... A

Guide nerv

0.37

0.12

0.15

0.12

0.15

0.02

0.51

0.54

0.51

0.54

ZZZ destr, elec stim. 95873......... TC...... A

Guide nerv

0.00

0.83

0.36

0.83

0.36

0.02

0.85

0.38

0.85

0.38

ZZZ destr, elec stim. 95874......... ........ A

Guide nerv

0.37

0.96

0.52

0.96

0.52

0.04

1.37

0.93

1.37

0.93

ZZZ destr, needle emg. 95874......... 26...... A

Guide nerv

0.37

0.12

0.16

0.12

0.16

0.02

0.51

0.55

0.51

0.55

ZZZ destr, needle emg. 95874......... TC...... A

Guide nerv

0.00

0.84

0.36

0.84

0.36

0.02

0.86

0.38

0.86

0.38

ZZZ destr, needle emg. 95875......... ........ A

Limb exercise

1.10

1.31

1.42

NA

NA

0.11

2.52

2.63

NA

NA

XXX test. 95875......... 26...... A

Limb exercise

1.10

0.31

0.43

0.31

0.43

0.05

1.46

1.58

1.46

1.58

XXX test. 95875......... TC...... A

Limb exercise

0.00

1.00

0.99

NA

NA

0.06

1.06

1.05

NA

NA

XXX test. 95900......... ........ A

Motor nerve

0.42

0.94

1.18

NA

NA

0.04

1.40

1.64

NA

NA

XXX conduction test. 95900......... 26...... A

Motor nerve

0.42

0.14

0.17

0.14

0.17

0.02

0.58

0.61

0.58

0.61

XXX conduction test. 95900......... TC...... A

Motor nerve

0.00

0.80

1.01

NA

NA

0.02

0.82

1.03

NA

NA

XXX conduction test. 95903......... ........ A

Motor nerve

0.60

1.04

1.15

NA

NA

0.05

1.69

1.80

NA

NA

XXX conduction test. 95903......... 26...... A

Motor nerve

0.60

0.18

0.24

0.18

0.24

0.03

0.81

0.87

0.81

0.87

XXX conduction test. 95903......... TC...... A

Motor nerve

0.00

0.86

0.91

NA

NA

0.02

0.88

0.93

NA

NA

XXX conduction test. 95904......... ........ A

Sense nerve

0.34

0.88

1.04

NA

NA

0.04

1.26

1.42

NA

NA

XXX conduction test. 95904......... 26...... A

Sense nerve

0.34

0.11

0.14

0.11

0.14

0.02

0.47

0.50

0.47

0.50

XXX conduction test. 95904......... TC...... A

Sense nerve

0.00

0.77

0.90

NA

NA

0.02

0.79

0.92

NA

NA

XXX conduction test. 95920......... ........ A

Intraop nerve

2.11

1.80

2.12

1.80

2.12

0.23

4.14

4.46

4.14

4.46

ZZZ test add-on. 95920......... 26...... A

Intraop nerve

2.11

0.66

0.86

0.66

0.86

0.16

2.93

3.13

2.93

3.13

ZZZ test add-on. 95920......... TC...... A

Intraop nerve

0.00

1.14

1.27

1.14

1.27

0.07

1.21

1.34

1.21

1.34

ZZZ test add-on. 95921......... ........ A

Autonomic nerv

0.90

1.14

0.82

NA

NA

0.06

2.10

1.78

NA

NA

XXX function test. 95921......... 26...... A

Autonomic nerv

0.90

0.24

0.31

0.24

0.31

0.04

1.18

1.25

1.18

1.25

XXX function test. 95921......... TC...... A

Autonomic nerv

0.00

0.89

0.51

NA

NA

0.02

0.91

0.53

NA

NA

XXX function test. 95922......... ........ A

Autonomic nerv

0.96

1.65

1.00

NA

NA

0.07

2.68

2.03

NA

NA

XXX function test. 95922......... 26...... A

Autonomic nerv

0.96

0.27

0.37

0.27

0.37

0.05

1.28

1.38

1.28

1.38

XXX function test. 95922......... TC...... A

Autonomic nerv

0.00

1.38

0.63

NA

NA

0.02

1.40

0.65

NA

NA

XXX function test. 95923......... ........ A

Autonomic nerv

0.90

2.12

1.98

NA

NA

0.07

3.09

2.95

NA

NA

XXX function test. 95923......... 26...... A

Autonomic nerv

0.90

0.24

0.35

0.24

0.35

0.05

1.19

1.30

1.19

1.30

XXX function test. 95923......... TC...... A

Autonomic nerv

0.00

1.88

1.64

NA

NA

0.02

1.90

1.66

NA

NA

XXX function test. 95925......... ........ A

Somatosensory

0.54

3.19

1.65

NA

NA

0.10

3.83

2.29

NA

NA

XXX testing. 95925......... 26...... A

Somatosensory

0.54

0.17

0.21

0.17

0.21

0.04

0.75

0.79

0.75

0.79

XXX testing. 95925......... TC...... A

Somatosensory

0.00

3.02

1.44

NA

NA

0.06

3.08

1.50

NA

NA

XXX testing. 95926......... ........ A

Somatosensory

0.54

3.06

1.62

NA

NA

0.09

3.69

2.25

NA

NA

XXX testing. 95926......... 26...... A

Somatosensory

0.54

0.16

0.21

0.16

0.21

0.03

0.73

0.78

0.73

0.78

XXX testing. 95926......... TC...... A

Somatosensory

0.00

2.90

1.41

NA

NA

0.06

2.96

1.47

NA

NA

XXX testing. 95927......... ........ A

Somatosensory

0.54

3.08

1.64

NA

NA

0.10

3.72

2.28

NA

NA

XXX testing. 95927......... 26...... A

Somatosensory

0.54

0.16

0.23

0.16

0.23

0.04

0.74

0.81

0.74

0.81

XXX testing. 95927......... TC...... A

Somatosensory

0.00

2.93

1.42

NA

NA

0.06

2.99

1.48

NA

NA

XXX testing.

[[Page 49229]]

95928......... ........ A

C motor evoked, 1.50

3.98

3.26

NA

NA

0.09

5.57

4.85

NA

NA

XXX uppr limbs. 95928......... 26...... A

C motor evoked, 1.50

0.46

0.60

0.46

0.60

0.06

2.02

2.16

2.02

2.16

XXX uppr limbs. 95928......... TC...... A

C motor evoked, 0.00

3.53

2.66

NA

NA

0.03

3.56

2.69

NA

NA

XXX uppr limbs. 95929......... ........ A

C motor evoked, 1.50

4.30

3.48

NA

NA

0.09

5.89

5.07

NA

NA

XXX lwr limbs. 95929......... 26...... A

C motor evoked, 1.50

0.46

0.60

0.46

0.60

0.06

2.02

2.16

2.02

2.16

XXX lwr limbs. 95930......... ........ A

Visual evoked

0.35

2.64

2.34

NA

NA

0.03

3.02

2.72

NA

NA

XXX potential test. 95930......... 26...... A

Visual evoked

0.35

0.10

0.14

0.10

0.14

0.02

0.47

0.51

0.47

0.51

XXX potential test. 95930......... TC...... A

Visual evoked

0.00

2.54

2.20

NA

NA

0.01

2.55

2.21

NA

NA

XXX potential test. 95933......... ........ A

Blink reflex

0.59

1.10

1.04

NA

NA

0.10

1.79

1.73

NA

NA

XXX test. 95933......... 26...... A

Blink reflex

0.59

0.17

0.22

0.17

0.22

0.04

0.80

0.85

0.80

0.85

XXX test. 95933......... TC...... A

Blink reflex

0.00

0.93

0.82

NA

NA

0.06

0.99

0.88

NA

NA

XXX test. 95934......... ........ A

H-reflex test.. 0.51

0.90

0.55

NA

NA

0.04

1.45

1.10

NA

NA

XXX 95934......... 26...... A

H-reflex test.. 0.51

0.16

0.21

0.16

0.21

0.02

0.69

0.74

0.69

0.74

XXX 95934......... TC...... A

H-reflex test.. 0.00

0.73

0.34

NA

NA

0.02

0.75

0.36

NA

NA

XXX 95936......... ........ A

H-reflex test.. 0.55

0.62

0.49

NA

NA

0.05

1.22

1.09

NA

NA

XXX 95936......... 26...... A

H-reflex test.. 0.55

0.17

0.22

0.17

0.22

0.03

0.75

0.80

0.75

0.80

XXX 95936......... TC...... A

H-reflex test.. 0.00

0.44

0.27

NA

NA

0.02

0.46

0.29

NA

NA

XXX 95937......... ........ A

Neuromuscular

0.65

0.92

0.69

NA

NA

0.10

1.67

1.44

NA

NA

XXX junction test. 95937......... 26...... A

Neuromuscular

0.65

0.20

0.25

0.20

0.25

0.08

0.93

0.98

0.93

0.98

XXX junction test. 95937......... TC...... A

Neuromuscular

0.00

0.72

0.44

NA

NA

0.02

0.74

0.46

NA

NA

XXX junction test. 95950......... ........ A

Ambulatory eeg

1.51

4.93

4.18

NA

NA

0.51

6.95

6.20

NA

NA

XXX monitoring. 95950......... 26...... A

Ambulatory eeg

1.51

0.42

0.59

0.42

0.59

0.08

2.01

2.18

2.01

2.18

XXX monitoring. 95950......... TC...... A

Ambulatory eeg

0.00

4.52

3.60

NA

NA

0.43

4.95

4.03

NA

NA

XXX monitoring. 95951......... ........ C

EEG monitoring/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX videorecord. 95951......... 26...... A

EEG monitoring/ 5.99

1.69

2.34

1.69

2.34

0.32

8.00

8.65

8.00

8.65

XXX videorecord. 95951......... TC...... C

EEG monitoring/ 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX videorecord. 95953......... ........ A

EEG monitoring/ 3.30

7.24

7.53

NA

NA

0.60 11.14

11.43

NA

NA

XXX computer. 95953......... 26...... A

EEG monitoring/ 3.30

0.93

1.20

0.93

1.20

0.17

4.40

4.67

4.40

4.67

XXX computer. 95953......... TC...... A

EEG monitoring/ 0.00

6.31

6.33

NA

NA

0.43

6.74

6.76

NA

NA

XXX computer. 95954......... ........ A

EEG monitoring/ 2.45

4.90

4.39

NA

NA

0.19

7.54

7.03

NA

NA

XXX giving drugs. 95954......... 26...... A

EEG monitoring/ 2.45

0.51

0.91

0.51

0.91

0.13

3.09

3.49

3.09

3.49

XXX giving drugs. 95954......... TC...... A

EEG monitoring/ 0.00

4.39

3.48

NA

NA

0.06

4.45

3.54

NA

NA

XXX giving drugs. 95955......... ........ A

EEG during

1.01

2.83

2.45

2.83

2.45

0.22

4.06

3.68

4.06

3.68

XXX surgery. 95955......... 26...... A

EEG during

1.01

0.29

0.34

0.29

0.34

0.05

1.35

1.40

1.35

1.40

XXX surgery. 95955......... TC...... A

EEG during

0.00

2.54

2.11

2.54

2.11

0.17

2.71

2.28

2.71

2.28

XXX surgery. 95956......... ........ A

Eeg monitoring, 3.08 17.21

15.86

NA

NA

0.59 20.88

19.53

NA

NA

XXX cable/radio. 95956......... 26...... A

Eeg monitoring, 3.08

1.03

1.23

1.03

1.23

0.16

4.27

4.47

4.27

4.47

XXX cable/radio. 95956......... TC...... A

Eeg monitoring, 0.00 16.18

14.63

NA

NA

0.43 16.61

15.06

NA

NA

XXX cable/radio. 95957......... ........ A

EEG digital

1.98

5.88

3.38

NA

NA

0.23

8.09

5.59

NA

NA

XXX analysis. 95957......... 26...... A

EEG digital

1.98

0.55

0.78

0.55

0.78

0.11

2.64

2.87

2.64

2.87

XXX analysis. 95957......... TC...... A

EEG digital

0.00

5.32

2.61

NA

NA

0.12

5.44

2.73

NA

NA

XXX analysis. 95958......... ........ A

EEG monitoring/ 4.24

6.67

4.29

NA

NA

0.34 11.25

8.87

NA

NA

XXX function test. 95958......... 26...... A

EEG monitoring/ 4.24

1.21

1.61

1.21

1.61

0.21

5.66

6.06

5.66

6.06

XXX function test. 95958......... TC...... A

EEG monitoring/ 0.00

5.46

2.67

NA

NA

0.13

5.59

2.80

NA

NA

XXX function test. 95961......... ........ A

Electrode

2.97

3.12

2.75

NA

NA

0.55

6.64

6.27

NA

NA

XXX stimulation, brain. 95961......... 26...... A

Electrode

2.97

0.90

1.22

0.90

1.22

0.48

4.35

4.67

4.35

4.67

XXX stimulation, brain. 95961......... TC...... A

Electrode

0.00

2.22

1.54

NA

NA

0.07

2.29

1.61

NA

NA

XXX stimulation, brain. 95962......... ........ A

Electrode stim, 3.21

2.21

2.57

2.21

2.57

0.39

5.81

6.17

5.81

6.17

ZZZ brain add-on. 95962......... 26...... A

Electrode stim, 3.21

0.91

1.27

0.91

1.27

0.32

4.44

4.80

4.44

4.80

ZZZ brain add-on. 95962......... TC...... A

Electrode stim, 0.00

1.30

1.31

1.30

1.31

0.07

1.37

1.38

1.37

1.38

ZZZ brain add-on. 95965......... ........ C

Meg,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX spontaneous. 95965......... 26...... A

Meg,

7.99

2.29

3.14

2.29

3.14

0.46 10.74

11.59

10.74

11.59

XXX spontaneous. 95965......... TC...... C

Meg,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX spontaneous. 95966......... ........ C

Meg, evoked,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX single. 95966......... 26...... A

Meg, evoked,

3.99

1.22

1.59

1.22

1.59

0.19

5.40

5.77

5.40

5.77

XXX single. 95966......... TC...... C

Meg, evoked,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX single. 95967......... ........ C

Meg, evoked,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ each addIl. 95967......... 26...... A

Meg, evoked,

3.49

1.04

1.15

1.04

1.15

0.16

4.69

4.80

4.69

4.80

ZZZ each addIl. 95967......... TC...... C

Meg, evoked,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

ZZZ each addIl. 95970......... ........ A

Analyze

0.45

0.89

0.86

0.13

0.14

0.03

1.37

1.34

0.61

0.62

XXX neurostim, no prog. 95971......... ........ A

Analyze

0.78

0.62

0.67

0.20

0.22

0.07

1.47

1.52

1.05

1.07

XXX neurostim, simple. 95972......... ........ A

Analyze

1.50

1.20

1.21

0.46

0.48

0.14

2.84

2.85

2.10

2.12

XXX neurostim, complex. 95973......... ........ A

Analyze

0.92

0.56

0.61

0.24

0.32

0.07

1.55

1.60

1.23

1.31

ZZZ neurostim, complex. 95974......... ........ A

Cranial

3.00

1.48

1.65

0.85

1.19

0.16

4.64

4.81

4.01

4.35

XXX neurostim, complex. 95975......... ........ A

Cranial

1.70

0.74

0.85

0.48

0.67

0.12

2.56

2.67

2.30

2.49

ZZZ neurostim, complex. 95978......... ........ A

Analyze

3.50

1.84

1.91

1.04

1.24

0.18

5.52

5.59

4.72

4.92

XXX neurostim brain/1h.

[[Page 49230]]

95979......... ........ A

Analyz

1.64

0.73

0.84

0.47

0.64

0.08

2.45

2.56

2.19

2.36

ZZZ neurostim brain addon. 95990......... ........ A

Spin/brain pump 0.00

1.67

1.54

NA

NA

0.06

1.73

1.60

NA

NA

XXX refil & main. 95991......... ........ A

Spin/brain pump 0.77

1.67

1.54

NA

NA

0.06

2.50

2.37

NA

NA

XXX refil & main. 95999......... ........ C

Neurological

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 96000......... ........ A

Motion

1.80

NA

NA

0.58

0.54

0.11

NA

NA

2.49

2.45

XXX analysis, video/3d. 96001......... ........ A

Motion test w/

2.15

NA

NA

0.53

0.63

0.10

NA

NA

2.78

2.88

XXX ft press meas. 96002......... ........ A

Dynamic surface 0.41

NA

NA

0.11

0.14

0.02

NA

NA

0.54

0.57

XXX emg. 96003......... ........ A

Dynamic fine

0.37

NA

NA

0.14

0.13

0.02

NA

NA

0.53

0.52

XXX wire emg. 96004......... ........ A

Phys review of

2.14

0.54

0.84

0.54

0.84

0.11

2.79

3.09

2.79

3.09

XXX motion tests. 96101......... ........ A

Psycho testing

1.86

0.34

0.57

0.33

0.56

0.05

2.25

2.48

2.24

2.47

XXX by psych/phys. 96102......... ........ A

Psycho testing

0.50

1.20

0.80

0.09

0.15

0.01

1.71

1.31

0.60

0.66

XXX by technician. 96103......... ........ A

Psycho testing

0.51

1.31

0.49

0.09

0.15

0.02

1.84

1.02

0.62

0.68

XXX admin by comp. 96105......... ........ A

Assessment of

0.00

2.06

1.84

NA

NA

0.18

2.24

2.02

NA

NA

XXX aphasia. 96110......... ........ A

Developmental

0.00

0.18

0.18

NA

NA

0.18

0.36

0.36

NA

NA

XXX test, lim. 96111......... ........ A

Developmental

2.60

0.66

0.95

0.53

0.92

0.18

3.44

3.73

3.31

3.70

XXX test, extend. 96116......... ........ A

Neurobehavioral 1.86

0.53

0.76

0.42

0.59

0.18

2.57

2.80

2.46

2.63

XXX status exam. 96118......... ........ A

Neuropsych tst

1.86

0.81

1.25

0.32

0.55

0.18

2.85

3.29

2.36

2.59

XXX by psych/phys. 96119......... ........ A

Neuropsych

0.55

1.53

1.15

0.09

0.17

0.18

2.26

1.88

0.82

0.90

XXX testing by tech. 96120......... ........ A

Neuropsych tst

0.51

1.91

1.03

0.09

0.15

0.02

2.44

1.56

0.62

0.68

XXX admin w/comp. 96150......... ........ A

Assess hlth/

0.50

0.10

0.16

0.09

0.16

0.01

0.61

0.67

0.60

0.67

XXX behave, init. 96151......... ........ A

Assess hlth/

0.48

0.09

0.16

0.09

0.15

0.01

0.58

0.65

0.58

0.64

XXX behave, subseq. 96152......... ........ A

Intervene hlth/ 0.46

0.09

0.15

0.08

0.14

0.01

0.56

0.62

0.55

0.61

XXX behave, indiv. 96153......... ........ A

Intervene hlth/ 0.10

0.02

0.04

0.02

0.03

0.01

0.13

0.15

0.13

0.14

XXX behave, group. 96154......... ........ A

Interv hlth/

0.45

0.09

0.15

0.08

0.14

0.01

0.55

0.61

0.54

0.60

XXX behav, fam w/ pt. 96155......... ........ N

Interv hlth/

0.44

0.10

0.16

0.10

0.15

0.02

0.56

0.62

0.56

0.61

XXX behav fam no pt. 96401......... ........ A

Chemo, anti-

0.21

1.87

1.35

NA

NA

0.01

2.09

1.57

NA

NA

XXX neopl, sq/im. 96402......... ........ A

Chemo hormon

0.19

0.72

0.94

NA

NA

0.01

0.92

1.14

NA

NA

XXX antineopl sq/ im. 96405......... ........ A

Chemo

0.52

3.49

2.70

0.22

0.24

0.03

4.04

3.25

0.77

0.79

000 intralesional, up to 7. 96406......... ........ A

Chemo

0.80

3.26

3.07

0.27

0.29

0.03

4.09

3.90

1.10

1.12

000 intralesional over 7. 96409......... ........ A

Chemo, iv push, 0.24

2.78

2.89

NA

NA

0.06

3.08

3.19

NA

NA

XXX sngl drug. 96411......... ........ A

Chemo, iv push, 0.20

1.50

1.58

NA

NA

0.06

1.76

1.84

NA

NA

ZZZ addl drug. 96413......... ........ A

Chemo, iv

0.28

3.63

4.05

NA

NA

0.08

3.99

4.41

NA

NA

XXX infusion, 1 hr. 96415......... ........ A

Chemo, iv

0.19

0.66

0.74

NA

NA

0.07

0.92

1.00

NA

NA

ZZZ infusion, addl hr. 96416......... ........ A

Chemo prolong

0.21

4.08

4.47

NA

NA

0.08

4.37

4.76

NA

NA

XXX infuse w/pump. 96417......... ........ A

Chemo iv infus

0.21

1.72

1.89

NA

NA

0.07

2.00

2.17

NA

NA

ZZZ each addl seq. 96420......... ........ A

Chemo, ia, push 0.17

2.70

2.67

NA

NA

0.08

2.95

2.92

NA

NA

XXX tecnique. 96422......... ........ A

Chemo ia

0.17

3.70

4.55

NA

NA

0.08

3.95

4.80

NA

NA

XXX infusion up to 1 hr. 96423......... ........ A

Chemo ia infuse 0.17

1.93

1.89

NA

NA

0.02

2.12

2.08

NA

NA

ZZZ each addl hr. 96425......... ........ A

Chemotherapy,in 0.17

4.54

4.49

NA

NA

0.08

4.79

4.74

NA

NA

XXX fusion method. 96440......... ........ A

Chemotherapy,

2.37

5.56

7.49

1.00

1.17

0.17

8.10

10.03

3.54

3.71

000 intracavitary. 96445......... ........ A

Chemotherapy,

2.20

5.45

7.39

0.94

1.12

0.14

7.79

9.73

3.28

3.46

000 intracavitary. 96450......... ........ A

Chemotherapy,

1.53

5.02

6.47

0.83

1.18

0.09

6.64

8.09

2.45

2.80

000 into CNS. 96521......... ........ A

Refill/maint,

0.21

3.14

3.61

NA

NA

0.06

3.41

3.88

NA

NA

XXX portable pump. 96522......... ........ A

Refill/maint

0.21

2.74

2.67

NA

NA

0.06

3.01

2.94

NA

NA

XXX pump/resvr syst. 96523......... ........ T

Irrig drug

0.04

0.64

0.68

NA

NA

0.01

0.69

0.73

NA

NA

XXX delivery device. 96542......... ........ A

Chemotherapy

0.75

3.55

4.08

0.32

0.58

0.07

4.37

4.90

1.14

1.40

XXX injection. 96549......... ........ C

Chemotherapy,

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX unspecified. 96567......... ........ A

Photodynamic

0.00

3.65

2.38

NA

NA

0.04

3.69

2.42

NA

NA

XXX tx, skin. 96570......... ........ A

Photodynamic

1.10

0.41

0.38

0.41

0.38

0.11

1.62

1.59

1.62

1.59

ZZZ tx, 30 min. 96571......... ........ A

Photodynamic

0.55

0.20

0.19

0.20

0.19

0.03

0.78

0.77

0.78

0.77

ZZZ tx, addl 15 min. 96900......... ........ A

Ultraviolet

0.00

0.55

0.47

NA

NA

0.02

0.57

0.49

NA

NA

XXX light therapy. 96902......... ........ B

Trichogram..... 0.41

0.11

0.16

0.10

0.15

0.01

0.53

0.58

0.52

0.57

XXX 96910......... ........ A

Photochemothera 0.00

1.95

1.23

NA

NA

0.04

1.99

1.27

NA

NA

XXX py with UV-B. 96912......... ........ A

Photochemothera 0.00

2.51

1.57

NA

NA

0.05

2.56

1.62

NA

NA

XXX py with UV-A. 96913......... ........ A

Photochemothera 0.00

3.55

2.15

NA

NA

0.10

3.65

2.25

NA

NA

XXX py, UV-A or B. 96920......... ........ A

Laser tx, skin

1.15

3.48

2.77

0.54

0.56

0.02

4.65

3.94

1.71

1.73

000 500 sq cm. 96999......... ........ C

Dermatological

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX procedure. 97001......... ........ A

Pt evaluation.. 1.20

0.68

0.73

NA

NA

0.05

1.93

1.98

NA

NA

XXX 97002......... ........ A

Pt re-

0.60

0.43

0.44

NA

NA

0.02

1.05

1.06

NA

NA

XXX evaluation. 97003......... ........ A

Ot evaluation.. 1.20

0.77

0.85

NA

NA

0.06

2.03

2.11

NA

NA

XXX 97004......... ........ A

Ot re-

0.60

0.54

0.64

NA

NA

0.02

1.16

1.26

NA

NA

XXX evaluation. 97010......... ........ B

Hot or cold

0.06

0.07

0.06

NA

NA

0.01

0.14

0.13

NA

NA

XXX packs therapy. 97012......... ........ A

Mechanical

0.25

0.15

0.14

NA

NA

0.01

0.41

0.40

NA

NA

XXX traction therapy. 97014......... ........ I

Electric

0.18

0.19

0.19

NA

NA

0.01

0.38

0.38

NA

NA

XXX stimulation therapy. 97016......... ........ A

Vasopneumatic

0.18

0.25

0.20

NA

NA

0.01

0.44

0.39

NA

NA

XXX device therapy. 97018......... ........ A

Paraffin bath

0.06

0.17

0.12

NA

NA

0.01

0.24

0.19

NA

NA

XXX therapy. 97022......... ........ A

Whirlpool

0.17

0.34

0.24

NA

NA

0.01

0.52

0.42

NA

NA

XXX therapy. 97024......... ........ A

Diathermy eg,

0.06

0.08

0.07

NA

NA

0.01

0.15

0.14

NA

NA

XXX microwave. 97026......... ........ A

Infrared

0.06

0.07

0.06

NA

NA

0.01

0.14

0.13

NA

NA

XXX therapy. 97028......... ........ A

Ultraviolet

0.08

0.09

0.08

NA

NA

0.01

0.18

0.17

NA

NA

XXX therapy. 97032......... ........ A

Electrical

0.25

0.20

0.17

NA

NA

0.01

0.46

0.43

NA

NA

XXX stimulation. 97033......... ........ A

Electric

0.26

0.46

0.32

NA

NA

0.01

0.73

0.59

NA

NA

XXX current therapy. 97034......... ........ A

Contrast bath

0.21

0.21

0.17

NA

NA

0.01

0.43

0.39

NA

NA

XXX therapy. 97035......... ........ A

Ultrasound

0.21

0.10

0.10

NA

NA

0.01

0.32

0.32

NA

NA

XXX therapy. 97036......... ........ A

Hydrotherapy... 0.28

0.45

0.35

NA

NA

0.01

0.74

0.64

NA

NA

XXX 97039......... ........ C

Physical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX therapy treatment. 97110......... ........ A

Therapeutic

0.45

0.33

0.29

NA

NA

0.02

0.80

0.76

NA

NA

XXX exercises. 97112......... ........ A

Neuromuscular

0.45

0.36

0.32

NA

NA

0.01

0.82

0.78

NA

NA

XXX reeducation. 97113......... ........ A

Aquatic therapy/ 0.44

0.55

0.43

NA

NA

0.01

1.00

0.88

NA

NA

XXX exercises. 97116......... ........ A

Gait training

0.40

0.29

0.25

NA

NA

0.01

0.70

0.66

NA

NA

XXX therapy. 97124......... ........ A

Massage therapy 0.35

0.28

0.24

NA

NA

0.01

0.64

0.60

NA

NA

XXX 97139......... ........ C

Physical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX medicine procedure. 97140......... ........ A

Manual therapy. 0.43

0.30

0.26

NA

NA

0.01

0.74

0.70

NA

NA

XXX 97150......... ........ A

Group

0.27

0.22

0.19

NA

NA

0.01

0.50

0.47

NA

NA

XXX therapeutic procedures. 97530......... ........ A

Therapeutic

0.44

0.39

0.34

NA

NA

0.01

0.84

0.79

NA

NA

XXX activities. 97532......... ........ A

Cognitive

0.44

0.23

0.21

NA

NA

0.01

0.68

0.66

NA

NA

XXX skills development. 97533......... ........ A

Sensory

0.44

0.28

0.25

NA

NA

0.01

0.73

0.70

NA

NA

XXX integration. 97535......... ........ A

Self care

0.45

0.39

0.35

NA

NA

0.01

0.85

0.81

NA

NA

XXX mngment training. 97537......... ........ A

Community/work

0.45

0.29

0.27

NA

NA

0.01

0.75

0.73

NA

NA

XXX reintegration. 97542......... ........ A

Wheelchair

0.45

0.30

0.29

NA

NA

0.01

0.76

0.75

NA

NA

XXX mngment training. 97597......... ........ A

Active wound

0.58

1.13

0.78

0.13

0.53

0.05

1.76

1.41

0.76

1.16

XXX care/20 cm or 20 cm. 97605......... ........ A

Neg press wound 0.55

0.42

0.36

0.12

0.20

0.02

0.99

0.93

0.69

0.77

XXX tx, 50 cm. 97750......... ........ A

Physical

0.45

0.34

0.33

NA

NA

0.02

0.81

0.80

NA

NA

XXX performance test. 97755......... ........ A

Assistive

0.62

0.29

0.28

NA

NA

0.02

0.93

0.92

NA

NA

XXX technology assess. 97760......... ........ A

Orthotic mgmt

0.45

0.44

0.37

NA

NA

0.03

0.92

0.85

NA

NA

XXX and training. 97761......... ........ A

Prosthetic

0.45

0.34

0.30

NA

NA

0.02

0.81

0.77

NA

NA

XXX training. 97762......... ........ A

C/o for

0.25

0.75

0.50

NA

NA

0.02

1.02

0.77

NA

NA

XXX orthotic/ prosth use. 97799......... ........ C

Physical

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX medicine procedure. 97802......... ........ A

Medical

0.45

0.12

0.38

0.11

0.38

0.01

0.58

0.84

0.57

0.84

XXX nutrition, indiv, in. 97803......... ........ A

Med nutrition,

0.37

0.10

0.38

0.09

0.38

0.01

0.48

0.76

0.47

0.76

XXX indiv, subseq. 97804......... ........ A

Medical

0.25

0.06

0.15

0.06

0.15

0.01

0.32

0.41

0.32

0.41

XXX nutrition, group. 97810......... ........ N

Acupunct w/o

0.60

0.26

0.35

0.14

0.21

0.03

0.89

0.98

0.77

0.84

XXX stimul 15 min. 97811......... ........ N

Acupunct w/o

0.50

0.16

0.23

0.12

0.17

0.03

0.69

0.76

0.65

0.70

ZZZ stimul addl 15m. 97813......... ........ N

Acupunct w/

0.65

0.27

0.37

0.15

0.23

0.03

0.95

1.05

0.83

0.91

XXX stimul 15 min. 97814......... ........ N

Acupunct w/

0.55

0.19

0.27

0.13

0.19

0.03

0.77

0.85

0.71

0.77

ZZZ stimul addl 15m. 98925......... ........ A

Osteopathic

0.45

0.28

0.31

0.12

0.14

0.02

0.75

0.78

0.59

0.61

000 manipulation. 98926......... ........ A

Osteopathic

0.65

0.36

0.40

0.16

0.23

0.03

1.04

1.08

0.84

0.91

000 manipulation. 98927......... ........ A

Osteopathic

0.87

0.45

0.49

0.22

0.27

0.03

1.35

1.39

1.12

1.17

000 manipulation. 98928......... ........ A

Osteopathic

1.03

0.50

0.57

0.26

0.32

0.04

1.57

1.64

1.33

1.39

000 manipulation. 98929......... ........ A

Osteopathic

1.19

0.57

0.65

0.29

0.35

0.05

1.81

1.89

1.53

1.59

000 manipulation. 98940......... ........ A

Chiropractic

0.45

0.21

0.23

0.12

0.12

0.01

0.67

0.69

0.58

0.58

000 manipulation. 98941......... ........ A

Chiropractic

0.65

0.27

0.29

0.17

0.17

0.01

0.93

0.95

0.83

0.83

000 manipulation. 98942......... ........ A

Chiropractic

0.87

0.33

0.35

0.23

0.23

0.02

1.22

1.24

1.12

1.12

000 manipulation. 98943......... ........ N

Chiropractic

0.40

0.18

0.23

0.09

0.14

0.01

0.59

0.64

0.50

0.55

XXX manipulation. 99082......... ........ C

Unusual

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX physician travel. 99143......... ........ C

Mod cs by same

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX phys, 10. Gxxx1......... ........ A

Ultrasound exam 0.58

2.42

1.81

NA

NA

0.11

3.11

2.50

NA

NA

XXX AAA screen. Gxxx1......... 26...... A

Ultrasound exam 0.58

0.19

0.19

0.19

0.19

0.03

0.80

0.80

0.80

0.80

XXX AAA screen. Gxxx1......... TC...... A

Ultrasound exam 0.00

2.23

1.62

NA

NA

0.08

2.31

1.70

NA

NA

XXX AAA screen. M0064......... ........ A

Visit for drug

0.37

0.89

0.48

0.06

0.11

0.01

1.27

0.86

0.44

0.49

XXX monitoring. P3001......... ........ A

Screening pap

0.42

0.38

0.21

0.38

0.21

0.02

0.82

0.65

0.82

0.65

XXX smear by phys. Q0035......... ........ A

Cardiokymograph 0.17

0.30

0.41

NA

NA

0.03

0.50

0.61

NA

NA

XXX y. Q0035......... 26...... A

Cardiokymograph 0.17

0.05

0.06

0.05

0.06

0.01

0.23

0.24

0.23

0.24

XXX y. Q0035......... TC...... A

Cardiokymograph 0.00

0.25

0.36

NA

NA

0.02

0.27

0.38

NA

NA

XXX y. Q0091......... ........ A

Obtaining

0.37

0.76

0.69

0.10

0.13

0.02

1.15

1.08

0.49

0.52

XXX screen pap smear. Q0092......... ........ A

Set up port

0.00

0.50

0.37

0.50

0.37

0.01

0.51

0.38

0.51

0.38

XXX xray equipment. Q3001......... ........ C

Brachytherapy

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

XXX Radioelements. R0070......... ........ C

Transport

0.00

0.00

0.00

0.00

0.00

0

0.00

0.00

0.00

0.00

XXX portable x-ray. R0075......... ........ C

Transport port

0.00

0.00

0.00

0.00

0.00

0

0.00

0.00

0.00

0.00

XXX x-ray multipl.

\1\ CPT codes and descriptors only are copyright 2005 American Medical Association. All rights reserved. Applicable FARS/DFARS apply. \2\ Copyright 2005 American Dental Association. All rights reserved.

[[Page 49236]]

Addendum C.--Codes for Which We Received PERC Recommendations on PE Direct Cost Inputs

CPT Codes

Short descriptor

00100............................. Anesth, salivary gland 00102............................. Anesth, repair of cleft lip 00103............................. Anesth, blepharoplasty 00104............................. Anesth, electroshock 00120............................. Anesth, ear surgery 00124............................. Anesth, ear exam 00126............................. Anesth, tympanotomy 00140............................. Anesth, procedures on eye 00142............................. Anesth, lens surgery 00144............................. Anesth, corneal transplant 00145............................. Anesth, vitreoretinal surg 00147............................. Anesth, iridectomy 00148............................. Anesth, eye exam 00160............................. Anesth, nose/sinus surgery 00162............................. Anesth, nose/sinus surgery 00164............................. Anesth, biopsy of nose 00170............................. Anesth, procedure on mouth 00172............................. Anesth, cleft palate repair 00174............................. Anesth, pharyngeal surgery 00176............................. Anesth, pharyngeal surgery 00190............................. Anesth, face/skull bone surg 00192............................. Anesth, facial bone surgery 00210............................. Anesth, open head surgery 00212............................. Anesth, skull drainage 00214............................. Anesth, skull drainage 00215............................. Anesth, skull repair/fract 00216............................. Anesth, head vessel surgery 00218............................. Anesth, special head surgery 00220............................. Anesth, intrcrn nerve 00222............................. Anesth, head nerve surgery 00300............................. Anesth, head/neck/ptrunk 00320............................. Anesth, neck organ, 1 & over 00322............................. Anesth, biopsy of thyroid 00326............................. Anesth, larynx/trach, 1h 92002............................. Eye exam, new patient 92004............................. Eye exam, new patient 92012............................. Eye exam established pat 92014............................. Eye exam & treatment 92015............................. Refraction 92018............................. New eye exam & treatment 92019............................. Eye exam & treatment 92020............................. Special eye evaluation 92060............................. Special eye evaluation 92065............................. Orthoptic/pleoptic training 92070............................. Fitting of contact lens 92081............................. Visual field examination(s) 92082............................. Visual field examination(s) 92083............................. Visual field examination(s) 92100............................. Serial tonometry exam(s) 92120............................. Tonography & eye evaluation 92130............................. Water provocation tonography 92135............................. Opthalmic dx imaging 92136............................. Ophthalmic biometry 92140............................. Glaucoma provocative tests 92225............................. Special eye exam, initial 92226............................. Special eye exam, subsequent 92230............................. Eye exam with photos 92235............................. Eye exam with photos 92240............................. Icg angiography 92250............................. Eye exam with photos 92260............................. Ophthalmoscopy/dynamome try 92265............................. Eye muscle evaluation 92270............................. Electro-oculography 92275............................. Electroretinography 92283............................. Color vision examination 92284............................. Dark adaptation eye exam 92285............................. Eye photography 92286............................. Internal eye photography 92287............................. Internal eye photography 92310............................. Contact lens fitting 92311............................. Contact lens fitting 92312............................. Contact lens fitting 92313............................. Contact lens fitting 92314............................. Prescription of contact lens 92315............................. Prescription of contact lens 92316............................. Prescription of contact lens 92317............................. Prescription of contact lens 92325............................. Modification of contact lens 92326............................. Replacement of contact lens

Addendum D.--Proposed 2007 Geographic Practice Cost Indices by Medicare Carrier and Locality

Carrier

Locality

Locality name

Work GPCI PE GPCI MP GPCI

00510.........................

00 Alabama......................... 0.982 0.847 0.740 00831.........................

01 Alaska.......................... 1.017 1.105 1.013 00832.........................

00 Arizona......................... 0.987 0.994 1.052 00520.........................

13 Arkansas........................ 0.961 0.832 0.431 31140.........................

03 Marin/Napa/Solano, CA........... 1.035 1.342 0.640 31140.........................

05 San Francisco, CA............... 1.060 1.546 0.640 31140.........................

06 San Mateo, CA................... 1.073 1.539 0.629 31140.........................

07 Oakland/Berkley, CA............. 1.054 1.373 0.640 31140.........................

09 Santa Clara, CA................. 1.083 1.543 0.595 31146.........................

17 Ventura, CA..................... 1.028 1.181 0.732 31146.........................

18 Los Angeles, CA................. 1.041 1.158 0.939 31146.........................

26 Anaheim/Santa Ana, CA........... 1.034 1.238 0.939 31140.........................

99 Rest of California*............. 1.007 1.054 0.721 31146.........................

99 Rest of California*............. 1.007 1.054 0.721 00824.........................

01 Colorado........................ 0.986 1.015 0.790 00591.........................

00 Connecticut..................... 1.038 1.172 0.886 00903.........................

01 DC + MD/VA Suburbs.............. 1.048 1.252 0.911 00902.........................

01 Delaware........................ 1.012 1.020 0.877 00590.........................

03 Fort Lauderdale, FL............. 0.988 0.990 1.675 00590.........................

04 Miami, FL....................... 1.000 1.048 2.233 00590.........................

99 Rest of Florida................. 0.973 0.936 1.251 00511.........................

01 Atlanta, GA..................... 1.010 1.091 0.950 00511.........................

99 Rest of Georgia................. 0.979 0.874 0.950 00833.........................

01 Hawaii/Guam..................... 1.005 1.113 0.787 05130.........................

00 Idaho........................... 0.968 0.869 0.452 00952.........................

12 East St. Louis, IL.............. 0.988 0.940 1.722 00952.........................

15 Suburban Chicago, IL............ 1.018 1.117 1.626 00952.........................

16 Chicago, IL..................... 1.025 1.128 1.837 00952.........................

99 Rest of Illinois................ 0.974 0.874 1.174 00630.........................

00 Indiana......................... 0.985 0.908 0.429 00826.........................

00 Iowa............................ 0.967 0.869 0.579 00650.........................

00 Kansas*......................... 0.968 0.880 0.709 00740.........................

04 Kansas*......................... 0.968 0.880 0.709 00660.........................

00 Kentucky........................ 0.970 0.855 0.859 00528.........................

01 New Orleans, LA................. 0.986 0.947 1.178 00528.........................

99 Rest of Louisiana............... 0.970 0.848 1.000 31142.........................

03 Southern Maine.................. 0.980 1.014 0.626 31142.........................

99 Rest of Maine................... 0.962 0.887 0.626 00901.........................

01 Baltimore/Surr. Cntys, MD....... 1.012 1.080 0.932 00901.........................

99 Rest of Maryland................ 0.993 0.981 0.748 31143.........................

01 Metropolitan Boston............. 1.030 1.331 0.810 31143.........................

99 Rest of Massachusetts........... 1.007 1.015 0.810 00953.........................

01 Detroit, MI..................... 1.037 1.056 2.700 00953.........................

99 Rest of Michigan................ 0.997 0.922 1.494 00954.........................

00 Minnesota....................... 0.991 1.006 0.404

[[Page 49247]]

00512.........................

00 Mississippi..................... 0.960 0.841 0.711 00523.........................

01 Metropolitan St. Louis, MO...... 0.992 0.956 0.926 00740.........................

02 Metropolitan Kansas City, MO.... 0.989 0.977 0.931 00523.........................

99 Rest of Missouri*............... 0.950 0.803 0.878 00740.........................

99 Rest of Missouri*............... 0.950 0.803 0.878 00751.........................

01 Montana......................... 0.950 0.845 0.889 00655.........................

00 Nebraska........................ 0.959 0.876 0.447 00834.........................

00 Nevada.......................... 1.003 1.045 1.050 31144.........................

40 New Hampshire................... 0.981 1.029 0.927 00805.........................

01 Northern NJ..................... 1.058 1.222 0.958 00805.........................

99 Rest of New Jersey.............. 1.043 1.121 0.958 00521.........................

05 New Mexico...................... 0.972 0.888 0.880 00801.........................

99 Rest of New York................ 0.997 0.919 0.666 00803.........................

01 Manhattan, NY................... 1.065 1.300 1.000 00803.........................

02 NYC Suburbs/Long I., NY......... 1.052 1.283 1.756 00803.........................

03 Poughkpsie/N NYC Suburbs, NY.... 1.014 1.076 1.148 14330.........................

04 Queens, NY...................... 1.032 1.230 1.682 05535.........................

00 North Carolina.................. 0.971 0.922 0.630 00820.........................

01 North Dakota.................... 0.946 0.861 0.593 00883.........................

00 Ohio............................ 0.992 0.934 0.960 00522.........................

00 Oklahoma........................ 0.964 0.856 0.376 00835.........................

01 Portland, OR.................... 1.002 1.059 0.434 00835.........................

99 Rest of Oregon.................. 0.968 0.927 0.434 00865.........................

01 Metropolitan Philadelphia, PA... 1.016 1.106 1.364 00865.........................

99 Rest of Pennsylvania............ 0.992 0.904 0.793 00973.........................

20 Puerto Rico..................... 0.906 0.699 0.257 00524.........................

01 Rhode Island.................... 1.045 0.991 0.895 00880.........................

01 South Carolina.................. 0.975 0.894 0.388 00820.........................

02 South Dakota.................... 0.943 0.877 0.359 05440.........................

35 Tennessee....................... 0.977 0.881 0.621 00900.........................

09 Brazoria, TX.................... 1.020 0.963 1.277 00900.........................

11 Dallas, TX...................... 1.009 1.064 1.044 00900.........................

15 Galveston, TX................... 0.990 0.954 1.277 00900.........................

18 Houston, TX..................... 1.016 1.016 1.276 00900.........................

20 Beaumont, TX.................... 0.983 0.862 1.277 00900.........................

28 Fort Worth, TX.................. 0.997 0.991 1.044 00900.........................

31 Austin, TX...................... 0.991 1.048 0.970 00900.........................

99 Rest of Texas................... 0.968 0.866 1.120 00910.........................

09 Utah............................ 0.977 0.938 0.651 31145.........................

50 Vermont......................... 0.968 0.970 0.505 00973.........................

50 Virgin Islands.................. 0.967 1.015 0.987 00904.........................

00 Virginia........................ 0.981 0.942 0.569 00836.........................

02 Seattle (King Cnty), WA......... 1.014 1.133 0.805 00836.........................

99 Rest of Washington.............. 0.987 0.980 0.805 00884.........................

16 West Virginia................... 0.973 0.820 1.522 00951.........................

00 Wisconsin....................... 0.987 0.920 0.777 00825.........................

21 Wyoming......................... 0.956 0.855 0.920

Addendum E.--2007 Proposed GAFs

Carrier

Locality

Locality name

GAF

31140..........................................

09 Santa Clara, CA........................ 1.265 31140..........................................

06 San Mateo, CA.......................... 1.259 31140..........................................

05 San Francisco, CA...................... 1.256 00803..........................................

02 NYC Suburbs/Long I., NY................ 1.180 31140..........................................

07 Oakland/Berkley, CA.................... 1.177 00803..........................................

01 Manhattan, NY.......................... 1.165 31140..........................................

03 Marin/Napa/Solano, CA.................. 1.154 31143..........................................

01 Metropolitan Boston.................... 1.153 14330..........................................

04 Queens, NY............................. 1.144 00903..........................................

01 DC + MD/VA Suburbs..................... 1.132 00805..........................................

01 Northern NJ............................ 1.126 31146..........................................

26 Anaheim/Santa Ana, CA.................. 1.120 00953..........................................

01 Detroit, MI............................ 1.110 00952..........................................

16 Chicago, IL............................ 1.102 00591..........................................

00 Connecticut............................ 1.091 31146..........................................

18 Los Angeles, CA........................ 1.088 00952..........................................

15 Suburban Chicago, IL................... 1.085

[[Page 49248]]

31146..........................................

17 Ventura, CA............................ 1.084 00805..........................................

99 Rest of New Jersey..................... 1.074 00865..........................................

01 Metropolitan Philadelphia, PA.......... 1.069 00590..........................................

04 Miami, FL.............................. 1.069 00836..........................................

02 Seattle (King Cnty), WA................ 1.058 00831..........................................

01 Alaska................................. 1.055 00803..........................................

03 Poughkpsie/N NYC Suburbs, NY........... 1.046 00833..........................................

01 Hawaii/Guam............................ 1.044 00511..........................................

01 Atlanta, GA............................ 1.043 00901..........................................

01 Baltimore/Surr. Cntys, MD.............. 1.039 00900..........................................

11 Dallas, TX............................. 1.035 00900..........................................

18 Houston, TX............................ 1.026 00834..........................................

00 Nevada................................. 1.023 31140..........................................

99 Rest of California*.................... 1.017 31146..........................................

99 Rest of California*.................... 1.017 00524..........................................

01 Rhode Island........................... 1.016 00590..........................................

03 Fort Lauderdale, FL.................... 1.015 00900..........................................

31 Austin, TX............................. 1.015 00902..........................................

01 Delaware............................... 1.011 00900..........................................

09 Brazoria, TX........................... 1.005 00835..........................................

01 Portland, OR........................... 1.005 31143..........................................

99 Rest of Massachusetts.................. 1.003 31144..........................................

40 New Hampshire.......................... 1.000 00900..........................................

28 Fort Worth, TX......................... 0.996 00952..........................................

12 East St. Louis, IL..................... 0.995 00832..........................................

00 Arizona................................ 0.993 00824..........................................

01 Colorado............................... 0.991 00973..........................................

50 Virgin Islands......................... 0.989 00900..........................................

15 Galveston, TX.......................... 0.985 00953..........................................

99 Rest of Michigan....................... 0.984 00740..........................................

02 Metropolitan Kansas City, MO........... 0.982 31142..........................................

03 Southern Maine......................... 0.981 00901..........................................

99 Rest of Maryland....................... 0.978 00836..........................................

99 Rest of Washington..................... 0.977 00528..........................................

01 New Orleans, LA........................ 0.976 00954..........................................

00 Minnesota.............................. 0.975 00523..........................................

01 Metropolitan St. Louis, MO............. 0.974 00590..........................................

99 Rest of Florida........................ 0.968 00883..........................................

00 Ohio................................... 0.965 31145..........................................

50 Vermont................................ 0.951 00801..........................................

99 Rest of New York....................... 0.950 00951..........................................

00 Wisconsin.............................. 0.950 00904..........................................

00 Virginia............................... 0.948 00910..........................................

09 Utah................................... 0.947 00865..........................................

99 Rest of Pennsylvania................... 0.946 00900..........................................

20 Beaumont, TX........................... 0.942 00952..........................................

99 Rest of Illinois....................... 0.938 05535..........................................

00 North Carolina......................... 0.936 00511..........................................

99 Rest of Georgia........................ 0.932 00521..........................................

05 New Mexico............................. 0.932 00630..........................................

00 Indiana................................ 0.930 00835..........................................

99 Rest of Oregon......................... 0.929 00900..........................................

99 Rest of Texas.......................... 0.929 00884..........................................

16 West Virginia.......................... 0.927 05440..........................................

35 Tennessee.............................. 0.921 00650..........................................

00 Kansas*................................ 0.919 00740..........................................

04 Kansas*................................ 0.919 00528..........................................

99 Rest of Louisiana...................... 0.918 00880..........................................

01 South Carolina......................... 0.917 31142..........................................

99 Rest of Maine.......................... 0.916 00660..........................................

00 Kentucky............................... 0.915 00510..........................................

00 Alabama................................ 0.914 00825..........................................

21 Wyoming................................ 0.910 00826..........................................

00 Iowa................................... 0.909 05130..........................................

00 Idaho.................................. 0.905 00655..........................................

00 Nebraska............................... 0.903 00751..........................................

01 Montana................................ 0.902 00512..........................................

00 Mississippi............................ 0.898 00820..........................................

01 North Dakota........................... 0.895 00522..........................................

00 Oklahoma............................... 0.894 00820..........................................

02 South Dakota........................... 0.891 00520..........................................

13 Arkansas............................... 0.884

[[Page 49249]]

00523..........................................

99 Rest of Missouri....................... 0.883 00740..........................................

99 Rest of Missouri....................... 0.883 00973..........................................

20 Puerto Rico............................ 0.790

Addendum F.--Proposed CPT/HCPCS Imaging Codes Defined by Section 5102(b) of the DRA

HCPCS/ CPT

Short descriptor

31620............................. Endobronchial us add-on 37250............................. Iv us first vessel add-on 37251............................. Iv us each add vessel add-on 51798............................. Us urine capacity measure 70010............................. Contrast x-ray of brain 70015............................. Contrast x-ray of brain 70030............................. X-ray eye for foreign body 70100............................. X-ray exam of jaw 70110............................. X-ray exam of jaw 70120............................. X-ray exam of mastoids 70130............................. X-ray exam of mastoids 70134............................. X-ray exam of middle ear 70140............................. X-ray exam of facial bones 70150............................. X-ray exam of facial bones 70160............................. X-ray exam of nasal bones 70170............................. X-ray exam of tear duct 70190............................. X-ray exam of eye sockets 70200............................. X-ray exam of eye sockets 70210............................. X-ray exam of sinuses 70220............................. X-ray exam of sinuses 70240............................. X-ray exam, pituitary saddle 70250............................. X-ray exam of skull 70260............................. X-ray exam of skull 70300............................. X-ray exam of teeth 70310............................. X-ray exam of teeth 70320............................. Full mouth x-ray of teeth 70328............................. X-ray exam of jaw joint 70330............................. X-ray exam of jaw joints 70332............................. X-ray exam of jaw joint 70336............................. Magnetic image, jaw joint 70350............................. X-ray head for orthodontia 70355............................. Panoramic x-ray of jaws 70360............................. X-ray exam of neck 70370............................. Throat x-ray & fluoroscopy 70371............................. Speech evaluation, complex 70373............................. Contrast x-ray of larynx 70380............................. X-ray exam of salivary gland 70390............................. X-ray exam of salivary duct 70450............................. Ct head/brain w/o dye 70460............................. Ct head/brain w/dye 70470............................. Ct head/brain w/o & w/dye 70480............................. Ct orbit/ear/fossa w/o dye 70481............................. Ct orbit/ear/fossa w/dye 70482............................. Ct orbit/ear/fossa w/o& w/dye 70486............................. Ct maxillofacial w/o dye 70487............................. Ct maxillofacial w/dye 70488............................. Ct maxillofacial w/o & w/dye 70490............................. Ct soft tissue neck w/o dye 70491............................. Ct soft tissue neck w/dye 70492............................. Ct sft tsue nck w/o & w/dye 70496............................. Ct angiography, head 70498............................. Ct angiography, neck 70540............................. Mri orbit/face/neck w/o dye 70542............................. Mri orbit/face/neck w/dye 70543............................. Mri orbt/fac/nck w/o & w/dye 70544............................. Mr angiography head w/o dye 70545............................. Mr angiography head w/dye 70546............................. Mr angiograph head w/o & w/dye 70547............................. Mr angiography neck w/o dye 70548............................. Mr angiography neck w/dye 70549............................. Mr angiograph neck w/o & w/dye 70551............................. Mri brain w/o dye 70552............................. Mri brain w/dye 70553............................. Mri brain w/o & w/dye 70557............................. Mri brain w/o dye 70558............................. Mri brain w/dye 70559............................. Mri brain w/o & w/dye 71010............................. Chest x-ray 71015............................. Chest x-ray 71020............................. Chest x-ray 71021............................. Chest x-ray 71022............................. Chest x-ray 71023............................. Chest x-ray and fluoroscopy 71030............................. Chest x-ray 71034............................. Chest x-ray and fluoroscopy 71035............................. Chest x-ray 71040............................. Contrast x-ray of bronchi 71060............................. Contrast x-ray of bronchi 71090............................. X-ray & pacemaker insertion 71100............................. X-ray exam of ribs 71101............................. X-ray exam of ribs/chest 71110............................. X-ray exam of ribs 71111............................. X-ray exam of ribs/chest 71120............................. X-ray exam of breastbone 71130............................. X-ray exam of breastbone 71250............................. Ct thorax w/o dye 71260............................. Ct thorax w/dye 71270............................. Ct thorax w/o & w/dye 71275............................. Ct angiography, chest 71550............................. Mri chest w/o dye 71551............................. Mri chest w/dye 71552............................. Mri chest w/o & w/dye 71555............................. Mri angio chest w or w/o dye 72010............................. X-ray exam of spine 72020............................. X-ray exam of spine 72040............................. X-ray exam of neck spine 72050............................. X-ray exam of neck spine 72052............................. X-ray exam of neck spine 72069............................. X-ray exam of trunk spine 72070............................. X-ray exam of thoracic spine 72072............................. X-ray exam of thoracic spine 72074............................. X-ray exam of thoracic spine 72080............................. X-ray exam of trunk spine 72090............................. X-ray exam of trunk spine 72100............................. X-ray exam of lower spine 72110............................. X-ray exam of lower spine 72114............................. X-ray exam of lower spine 72120............................. X-ray exam of lower spine 72125............................. Ct neck spine w/o dye 72126............................. Ct neck spine w/dye 72127............................. Ct neck spine w/o & w/dye 72128............................. Ct chest spine w/o dye 72129............................. Ct chest spine w/dye 72130............................. Ct chest spine w/o & w/dye 72131............................. Ct lumbar spine w/o dye 72132............................. Ct lumbar spine w/dye 72133............................. Ct lumbar spine w/o & w/dye 72141............................. Mri neck spine w/o dye 72142............................. Mri neck spine w/dye 72146............................. Mri chest spine w/o dye 72147............................. Mri chest spine w/dye 72148............................. Mri lumbar spine w/o dye 72149............................. Mri lumbar spine w/dye 72156............................. Mri neck spine w/o & w/dye 72157............................. Mri chest spine w/o & w/dye 72158............................. Mri lumbar spine w/o & w/dye 72159............................. Mr angio spine w/o & w/dye 72170............................. X-ray exam of pelvis 72190............................. X-ray exam of pelvis 72191............................. Ct angiograph pelv w/o & w/dye 72192............................. Ct pelvis w/o dye 72193............................. Ct pelvis w/dye 72194............................. Ct pelvis w/o & w/dye 72195............................. Mri pelvis w/o dye 72196............................. Mri pelvis w/dye 72197............................. Mri pelvis w/o & w/dye 72198............................. Mr angio pelvis w/o & w/dye 72200............................. X-ray exam sacroiliac joints 72202............................. X-ray exam sacroiliac joints 72220............................. X-ray exam of tailbone 72240............................. Contrast x-ray of neck spine 72255............................. Contrast x-ray, thorax spine 72265............................. Contrast x-ray, lower spine 72270............................. Contrast x-ray, spine 72275............................. Epidurography 72285............................. X-ray c/t spine disk 72295............................. X-ray of lower spine disk 73000............................. X-ray exam of collar bone 73010............................. X-ray exam of shoulder blade 73020............................. X-ray exam of shoulder 73030............................. X-ray exam of shoulder 73040............................. Contrast x-ray of shoulder 73050............................. X-ray exam of shoulders 73060............................. X-ray exam of humerus 73070............................. X-ray exam of elbow 73080............................. X-ray exam of elbow 73085............................. Contrast x-ray of elbow 73090............................. X-ray exam of forearm 73092............................. X-ray exam of arm, infant 73100............................. X-ray exam of wrist 73110............................. X-ray exam of wrist 73115............................. Contrast x-ray of wrist 73120............................. X-ray exam of hand 73130............................. X-ray exam of hand 73140............................. X-ray exam of finger(s) 73200............................. Ct upper extremity w/o dye 73201............................. Ct upper extremity w/dye 73202............................. Ct uppr extremity w/o & w/dye 73206............................. Ct angio upr extrm w/o & w/dye 73218............................. Mri upper extremity w/o dye 73219............................. Mri upper extremity w/dye 73220............................. Mri uppr extremity w/o & w/dye 73221............................. Mri joint upr extrem w/o dye 73222............................. Mri joint upr extrem w/dye 73223............................. Mri joint upr extr w/o & w/dye 73225............................. Mr angio upr extr w/o & w/dye 73500............................. X-ray exam of hip

[[Page 49250]]

73510............................. X-ray exam of hip 73520............................. X-ray exam of hips 73525............................. Contrast x-ray of hip 73530............................. X-ray exam of hip 73540............................. X-ray exam of pelvis & hips 73542............................. X-ray exam, sacroiliac joint 73550............................. X-ray exam of thigh 73560............................. X-ray exam of knee, 1 or 2 73562............................. X-ray exam of knee, 3 73564............................. X-ray exam, knee, 4 or more 73565............................. X-ray exam of knees 73580............................. Contrast x-ray of knee joint 73590............................. X-ray exam of lower leg 73592............................. X-ray exam of leg, infant 73600............................. X-ray exam of ankle 73610............................. X-ray exam of ankle 73615............................. Contrast x-ray of ankle 73620............................. X-ray exam of foot 73630............................. X-ray exam of foot 73650............................. X-ray exam of heel 73660............................. X-ray exam of toe(s) 73700............................. Ct lower extremity w/o dye 73701............................. Ct lower extremity w/dye 73702............................. Ct lwr extremity w/o & w/dye 73706............................. Ct angio lwr extr w/o & w/dye 73718............................. Mri lower extremity w/o dye 73719............................. Mri lower extremity w/dye 73720............................. Mri lwr extremity w/o & w/dye 73721............................. Mri jnt of lwr extre w/o dye 73722............................. Mri joint of lwr extr w/dye 73723............................. Mri joint lwr extr w/o & w/dye 73725............................. Mr ang lwr ext w or w/o dye 74000............................. X-ray exam of abdomen 74010............................. X-ray exam of abdomen 74020............................. X-ray exam of abdomen 74022............................. X-ray exam series, abdomen 74150............................. Ct abdomen w/o dye 74160............................. Ct abdomen w/dye 74170............................. Ct abdomen w/o & w/dye 74175............................. Ct angio abdom w/o & w/dye 74181............................. Mri abdomen w/o dye 74182............................. Mri abdomen w/dye 74183............................. Mri abdomen w/o & w/dye 74185............................. Mri angio, abdom w orw/o dye 74190............................. X-ray exam of peritoneum 74210............................. Contrst x-ray exam of throat 74220............................. Contrast x-ray, esophagus 74230............................. Cine/vid x-ray, throat/esoph 74235............................. Remove esophagus obstruction 74240............................. X-ray exam, upper gi tract 74241............................. X-ray exam, upper gi tract 74245............................. X-ray exam, upper gi tract 74246............................. Contrst x-ray uppr gi tract 74247............................. Contrst x-ray uppr gi tract 74249............................. Contrst x-ray uppr gi tract 74250............................. X-ray exam of small bowel 74251............................. X-ray exam of small bowel 74260............................. X-ray exam of small bowel 74270............................. Contrast x-ray exam of colon 74280............................. Contrast x-ray exam of colon 74283............................. Contrast x-ray exam of colon 74290............................. Contrast x-ray, gallbladder 74291............................. Contrast x-rays, gallbladder 74300............................. X-ray bile ducts/pancreas 74301............................. X-rays at surgery add-on 74305............................. X-ray bile ducts/pancreas 74320............................. Contrast x-ray of bile ducts 74327............................. X-ray bile stone removal 74328............................. X-ray bile duct endoscopy 74329............................. X-ray for pancreas endoscopy 74330............................. X-ray bile/panc endoscopy 74340............................. X-ray guide for GI tube 74350............................. X-ray guide, stomach tube 74355............................. X-ray guide, intestinal tube 74360............................. X-ray guide, GI dilation 74363............................. X-ray, bile duct dilation 74400............................. Contrst x-ray, urinary tract 74410............................. Contrst x-ray, urinary tract 74415............................. Contrst x-ray, urinary tract 74420............................. Contrst x-ray, urinary tract 74425............................. Contrst x-ray, urinary tract 74430............................. Contrast x-ray, bladder 74440............................. X-ray, male genital tract 74445............................. X-ray exam of penis 74450............................. X-ray, urethra/bladder 74455............................. X-ray, urethra/bladder 74470............................. X-ray exam of kidney lesion 74475............................. X-ray control, cath insert 74480............................. X-ray control, cath insert 74485............................. X-ray guide, GU dilation 74710............................. X-ray measurement of pelvis 74740............................. X-ray, female genital tract 74742............................. X-ray, fallopian tube 74775............................. X-ray exam of perineum 75552............................. Heart mri for morph w/o dye 75553............................. Heart mri for morph w/dye 75554............................. Cardiac MRI/function 75555............................. Cardiac MRI/limited study 75556............................. Cardiac MRI/flow mapping 75600............................. Contrast x-ray exam of aorta 75605............................. Contrast x-ray exam of aorta 75625............................. Contrast x-ray exam of aorta 75630............................. X-ray aorta, leg arteries 75635............................. Ct angio abdominal arteries 75650............................. Artery x-rays, head & neck 75658............................. Artery x-rays, arm 75660............................. Artery x-rays, head & neck 75662............................. Artery x-rays, head & neck 75665............................. Artery x-rays, head & neck 75671............................. Artery x-rays, head & neck 75676............................. Artery x-rays, neck 75680............................. Artery x-rays, neck 75685............................. Artery x-rays, spine 75705............................. Artery x-rays, spine 75710............................. Artery x-rays, arm/leg 75716............................. Artery x-rays, arms/legs 75722............................. Artery x-rays, kidney 75724............................. Artery x-rays, kidneys 75726............................. Artery x-rays, abdomen 75731............................. Artery x-rays, adrenal gland 75733............................. Artery x-rays, adrenals 75736............................. Artery x-rays, pelvis 75741............................. Artery x-rays, lung 75743............................. Artery x-rays, lungs 75746............................. Artery x-rays, lung 75756............................. Artery x-rays, chest 75774............................. Artery x-ray, each vessel 75790............................. Visualize A-V shunt 75801............................. Lymph vessel x-ray, arm/leg 75803............................. Lymph vessel x-ray,arms/legs 75805............................. Lymph vessel x-ray, trunk 75807............................. Lymph vessel x-ray, trunk 75809............................. Nonvascular shunt, x-ray 75810............................. Vein x-ray, spleen/liver 75820............................. Vein x-ray, arm/leg 75822............................. Vein x-ray, arms/legs 75825............................. Vein x-ray, trunk 75827............................. Vein x-ray, chest 75831............................. Vein x-ray, kidney 75833............................. Vein x-ray, kidneys 75840............................. Vein x-ray, adrenal gland 75842............................. Vein x-ray, adrenal glands 75860............................. Vein x-ray, neck 75870............................. Vein x-ray, skull 75872............................. Vein x-ray, skull 75880............................. Vein x-ray, eye socket 75885............................. Vein x-ray, liver 75887............................. Vein x-ray, liver 75889............................. Vein x-ray, liver 75891............................. Vein x-ray, liver 75893............................. Venous sampling by catheter 75894............................. X-rays, transcath therapy 75896............................. X-rays, transcath therapy 75898............................. Follow-up angiography 75900............................. Intravascular cath exchange 75901............................. Remove cva device obstruct 75902............................. Remove cva lumen obstruct 75940............................. X-ray placement, vein filter 75945............................. Intravascular us 75946............................. Intravascular us add-on 75952............................. Endovasc repair abdom aorta 75953............................. Abdom aneurysm endovas rpr 75954............................. Iliac aneurysm endovas rpr 75956............................. Xray, endovasc thor ao repr 75957............................. Xray, endovasc thor ao repr 75958............................. Xray, place prox ext thor ao 75959............................. Xray, place dist ext thor ao 75960............................. Transcath iv stent rs&i 75961............................. Retrieval, broken catheter 75962............................. Repair arterial blockage 75964............................. Repair artery blockage, each 75966............................. Repair arterial blockage 75968............................. Repair artery blockage, each 75970............................. Vascular biopsy 75978............................. Repair venous blockage 75980............................. Contrast xray exam bile duct 75982............................. Contrast xray exam bile duct 75984............................. Xray control catheter change 75989............................. Abscess drainage under x-ray 75992............................. Atherectomy, x-ray exam 75993............................. Atherectomy, x-ray exam 75994............................. Atherectomy, x-ray exam 75995............................. Atherectomy, x-ray exam 75996............................. Atherectomy, x-ray exam 75998............................. Fluoroguide for vein device 76000............................. Fluoroscope examination 76001............................. Fluoroscope exam, extensive 76003............................. Needle localization by x-ray 76005............................. Fluoroguide for spine inject 76006............................. X-ray stress view 76010............................. X-ray, nose to rectum 76012............................. Percut vertebroplasty fluor 76013............................. Percut vertebroplasty, ct 76020............................. X-rays for bone age 76040............................. X-rays, bone evaluation 76061............................. X-rays, bone survey 76062............................. X-rays, bone survey 76065............................. X-rays, bone evaluation 76066............................. Joint survey, single view 76070............................. Ct bone density, axial 76071............................. Ct bone density, peripheral

[[Page 49251]]

76075............................. Dxa bone density, axial 76076............................. Dxa bone density/peripheral 76077............................. Dxa bone density/v-fracture 76078............................. Radiographic absorptiometry 76080............................. X-ray exam of fistula 76086............................. X-ray of mammary duct 76088............................. X-ray of mammary ducts 76093............................. Magnetic image, breast 76094............................. Magnetic image, both breasts 76095............................. Stereotactic breast biopsy 76096............................. X-ray of needle wire, breast 76098............................. X-ray exam, breast specimen 76100............................. X-ray exam of body section 76101............................. Complex body section x-ray 76102............................. Complex body section x-rays 76120............................. Cine/video x-rays 76125............................. Cine/video x-rays add-on 76140............................. X-ray consultation 76150............................. X-ray exam, dry process 76350............................. Special x-ray contrast study 76355............................. Ct scan for localization 76360............................. Ct scan for needle biopsy 76362............................. Ct guide for tissue ablation 76370............................. Ct scan for therapy guide 76376............................. 3d render w/o postprocess 76377............................. 3d rendering w/postprocess 76380............................. CAT scan follow-up study 76390............................. Mr spectroscopy 76393............................. Mr guidance for needle place 76394............................. Mri for tissue ablation 76400............................. Magnetic image, bone marrow 76496............................. Fluoroscopic procedure 76497............................. Ct procedure 76498............................. Mri procedure 76506............................. Echo exam of head 76510............................. Ophth us, b & quant a 76511............................. Ophth us, quant a only 76512............................. Ophth us, b w/non-quant a 76513............................. Echo exam of eye, water bath 76514............................. Echo exam of eye, thickness 76516............................. Echo exam of eye 76519............................. Echo exam of eye 76529............................. Echo exam of eye 76536............................. Us exam of head and neck 76604............................. Us exam, chest, b-scan 76645............................. Us exam, breast(s) 76700............................. Us exam, abdom, complete 76705............................. Echo exam of abdomen 76770............................. Us exam abdo back wall, comp 76775............................. Us exam abdo back wall, lim 76778............................. Us exam kidney transplant 76800............................. Us exam, spinal canal 76801............................. Ob us /= 14 wks, sngl fetus 76810............................. Ob us >/= 14 wks, addl fetus 76811............................. Ob us, detailed, sngl fetus 76812............................. Ob us, detailed, addl fetus 76815............................. Ob us, limited, fetus(s) 76816............................. Ob us, follow-up, per fetus 76817............................. Transvaginal us, obstetric 76818............................. Fetal biophys profile w/nst 76819............................. Fetal biophys profil w/o nst 76820............................. Umbilical artery echo 76821............................. Middle cerebral artery echo 76825............................. Echo exam of fetal heart 76826............................. Echo exam of fetal heart 76827............................. Echo exam of fetal heart 76828............................. Echo exam of fetal heart 76830............................. Transvaginal us, non-ob 76831............................. Echo exam, uterus 76856............................. Us exam, pelvic, complete 76857............................. Us exam, pelvic, limited 76870............................. Us exam, scrotum 76872............................. Us, transrectal 76873............................. Echograp trans r, pros study 76880............................. Us exam, extremity 76885............................. Us exam infant hips, dynamic 76886............................. Us exam infant hips, static 76930............................. Echo guide, cardiocentesis 76932............................. Echo guide for heart biopsy 76936............................. Echo guide for artery repair 76937............................. Us guide, vascular access 76940............................. Us guide, tissue ablation 76941............................. Echo guide for transfusion 76942............................. Echo guide for biopsy 76945............................. Echo guide, villus sampling 76946............................. Echo guide for amniocentesis 76948............................. Echo guide, ova aspiration 76950............................. Echo guidance radiotherapy 76965............................. Echo guidance radiotherapy 76970............................. Ultrasound exam follow-up 76975............................. GI endoscopic ultrasound 76977............................. Us bone density measure 76986............................. Ultrasound guide intraoper 77417............................. Radiology port film(s) 77421............................. Stereoscopic x-ray guidance 78006............................. Thyroid imaging with uptake 78007............................. Thyroid image, mult uptakes 78010............................. Thyroid imaging 78011............................. Thyroid imaging with flow 78015............................. Thyroid met imaging 78016............................. Thyroid met imaging/studies 78018............................. Thyroid met imaging, body 78020............................. Thyroid met uptake 78070............................. Parathyroid nuclear imaging 78075............................. Adrenal nuclear imaging 78102............................. Bone marrow imaging, ltd 78103............................. Bone marrow imaging, mult 78104............................. Bone marrow imaging, body 78135............................. Red cell survival kinetics 78140............................. Red cell sequestration 78185............................. Spleen imaging 78190............................. Platelet survival, kinetics 78195............................. Lymph system imaging 78201............................. Liver imaging 78202............................. Liver imaging with flow 78205............................. Liver imaging (3D) 78206............................. Liver image (3d) with flow 78215............................. Liver and spleen imaging 78216............................. Liver & spleen image/flow 78220............................. Liver function study 78223............................. Hepatobiliary imaging 78230............................. Salivary gland imaging 78231............................. Serial salivary imaging 78232............................. Salivary gland function exam 78258............................. Esophageal motility study 78261............................. Gastric mucosa imaging 78262............................. Gastroesophageal reflux exam 78264............................. Gastric emptying study 78278............................. Acute GI blood loss imaging 78282............................. GI protein loss exam 78290............................. Meckel's divert exam 78291............................. Leveen/shunt patency exam 78300............................. Bone imaging, limited area 78305............................. Bone imaging, multiple areas 78306............................. Bone imaging, whole body 78315............................. Bone imaging, 3 phase 78320............................. Bone imaging (3D) 78350............................. Bone mineral, single photon 78351............................. Bone mineral, dual photon 78428............................. Cardiac shunt imaging 78445............................. Vascular flow imaging 78456............................. Acute venous thrombus image 78457............................. Venous thrombosis imaging 78458............................. Ven thrombosis images, bilat 78459............................. Heart muscle imaging (PET) 78460............................. Heart muscle blood, single 78461............................. Heart muscle blood, multiple 78464............................. Heart image (3d), single 78465............................. Heart image (3d), multiple 78466............................. Heart infarct image 78468............................. Heart infarct image (ef) 78469............................. Heart infarct image (3D) 78472............................. Gated heart, planar, single 78473............................. Gated heart, multiple 78478............................. Heart wall motion add-on 78480............................. Heart function add-on 78481............................. Heart first pass, single 78483............................. Heart first pass, multiple 78491............................. Heart image (pet), single 78492............................. Heart image (pet), multiple 78494............................. Heart image, spect 78496............................. Heart first pass add-on 78580............................. Lung perfusion imaging 78584............................. Lung V/Q image single breath 78585............................. Lung V/Q imaging 78586............................. Aerosol lung image, single 78587............................. Aerosol lung image, multiple 78588............................. Perfusion lung image 78591............................. Vent image, 1 breath, 1 proj 78593............................. Vent image, 1 proj, gas 78594............................. Vent image, mult proj, gas 78596............................. Lung differential function 78600............................. Brain imaging, ltd static 78601............................. Brain imaging, ltd w/flow 78605............................. Brain imaging, complete 78606............................. Brain imaging, compl w/flow 78607............................. Brain imaging (3D) 78608............................. Brain imaging (PET) 78609............................. Brain imaging (PET) 78610............................. Brain flow imaging only 78615............................. Cerebral vascular flow image 78630............................. Cerebrospinal fluid scan 78635............................. CSF ventriculography 78645............................. CSF shunt evaluation 78647............................. Cerebrospinal fluid scan 78650............................. CSF leakage imaging 78660............................. Nuclear exam of tear flow 78700............................. Kidney imaging, static 78701............................. Kidney imaging with flow 78704............................. Imaging renogram 78707............................. Kidney flow/function image 78708............................. Kidney flow/function image 78709............................. Kidney flow/function image 78710............................. Kidney imaging (3D) 78715............................. Renal vascular flow exam 78730............................. Urinary bladder retention 78740............................. Ureteral reflux study 78760............................. Testicular imaging 78761............................. Testicular imaging/flow

[[Page 49252]]

78800............................. Tumor imaging, limited area 78801............................. Tumor imaging, mult areas 78802............................. Tumor imaging, whole body 78803............................. Tumor imaging (3D) 78804............................. Tumor imaging, whole body 78805............................. Abscess imaging, ltd area 78806............................. Abscess imaging, whole body 78807............................. Nuclear localization/absce ss 78811............................. Tumor imaging (pet), limited 78812............................. Tumor image (pet)/skul-thigh 78813............................. Tumor image (pet) full body 78814............................. Tumor image pet/ct, limited 78815............................. Tumorimage pet/ct skul-thigh 78816............................. Tumor image pet/ct full body 78890............................. Nuclear medicine data proc 78891............................. Nuclear med data proc 93303............................. Echo transthoracic 93304............................. Echo transthoracic 93307............................. Echo exam of heart 93308............................. Echo exam of heart 93312............................. Echo transesophageal 93313............................. Echo transesophageal 93314............................. Echo transesophageal 93315............................. Echo transesophageal 93316............................. Echo transesophageal 93317............................. Echo transesophageal 93318............................. Echo transesophageal intraop 93320............................. Doppler echo exam, heart 93321............................. Doppler echo exam, heart 93325............................. Doppler color flow add-on 93350............................. Echo transthoracic 93555............................. Imaging, cardiac cath 93556............................. Imaging, cardiac cath 93571............................. Heart flow reserve measure 93572............................. Heart flow reserve measure 93875............................. Extracranial study 93880............................. Extracranial study 93882............................. Extracranial study 93886............................. Intracranial study 93888............................. Intracranial study 93890............................. Tcd, vasoreactivity study 93892............................. Tcd, emboli detect w/o inj 93893............................. Tcd, emboli detect w/inj 93922............................. Extremity study 93923............................. Extremity study 93924............................. Extremity study 93925............................. Lower extremity study 93926............................. Lower extremity study 93930............................. Upper extremity study 93931............................. Upper extremity study 93965............................. Extremity study 93970............................. Extremity study 93971............................. Extremity study 93975............................. Vascular study 93976............................. Vascular study 93978............................. Vascular study 93979............................. Vascular study 93980............................. Penile vascular study 93981............................. Penile vascular study 93990............................. Doppler flow testing 0028T............................. Dexa body composition study 0042T............................. Ct perfusion w/contrast, cbf 0066T............................. Ct colonography;scree n 0067T............................. Ct colonography;dx 0080T............................. Endovasc aort repr rad s&i 0081T............................. Endovasc visc extnsn s&i 0144T............................. CT heart wo dye; qual calc 0145T............................. CT heart w/wo dye funct 0146T............................. CCTA w/wo dye 0147T............................. CCTA w/wo, quan calcium 0148T............................. CCTA w/wo, strxr 0149T............................. CCTA w/wo, strxr quan calc 0150T............................. CCTA w/wo, disease strxr 0151T............................. CT heart funct add-on 0152T............................. Computer chest add-on G0120............................. Colon ca scrn; barium enema G0122............................. Colon ca scrn; barium enema G0130............................. Single energy x-ray study G0219............................. PET img wholbod melano nonco G0235............................. PET not otherwise specified G0275............................. Renal angio, cardiac cath G0278............................. Iliac art angio,cardiac cath G0288............................. Recon, CTA for surg plan G0365............................. Vessel mapping hemo access

[FR Doc. 06-6843 Filed 8-8-06; 4:15 pm]

BILLING CODE 4120-03-P